Citrus Sinensis ID: 007668
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 594 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGF4 | 591 | LRR receptor-like serine/ | yes | no | 0.952 | 0.957 | 0.795 | 0.0 | |
| C0LGL9 | 589 | LRR receptor-like serine/ | no | no | 0.989 | 0.998 | 0.774 | 0.0 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.809 | 0.403 | 0.389 | 1e-92 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.920 | 0.889 | 0.350 | 6e-92 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.897 | 0.859 | 0.357 | 3e-89 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.819 | 0.441 | 0.390 | 2e-88 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.811 | 0.493 | 0.355 | 3e-88 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.801 | 0.492 | 0.376 | 9e-88 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.791 | 0.460 | 0.400 | 1e-86 | |
| C0LGT1 | 613 | Probable LRR receptor-lik | no | no | 0.910 | 0.882 | 0.345 | 2e-86 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 938 bits (2425), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/572 (79%), Positives = 509/572 (88%), Gaps = 6/572 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 25 NESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 84
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ D+GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+G+
Sbjct: 85 KIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGD 144
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 145 LPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 204
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK ++V C++DSG ++ SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 205 NLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 259
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 260 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 320 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379
Query: 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442
D+LPGGSLDEALHER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLDG
Sbjct: 380 DYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDG 439
Query: 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL 502
NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL
Sbjct: 440 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL 499
Query: 503 SGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSS 562
SGKRPTDASFIEKGLN+VGWL FLISE R R+I+DPNCEG+Q ESLDALL++ATQCVS S
Sbjct: 500 SGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQCVSPS 559
Query: 563 PDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
P++RPTMHRVVQ+LESEVMTPCPS+FYDS+SD
Sbjct: 560 PEERPTMHRVVQLLESEVMTPCPSEFYDSSSD 591
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGL9|FEI2_ARATH LRR receptor-like serine/threonine-protein kinase FEI 2 OS=Arabidopsis thaliana GN=FEI2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 914 bits (2363), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/595 (77%), Positives = 516/595 (86%), Gaps = 7/595 (1%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ +K W L I L + N++ AI+ DGEALLSFR V++SDG + WRPEDPDP
Sbjct: 1 MGICLMKRCCSWFLLISFLSALTNENEAISPDGEALLSFRNGVLASDGVIGLWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNWKGV CD K KRVI LSLT HKL GP+ +LGKLDQL+ L LH+N Y IP+ LGNC
Sbjct: 61 CNWKGVTCDAKTKRVIALSLTYHKLRGPLPPELGKLDQLRLLMLHNNALYQSIPASLGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
T L+G+ LQ+NY++G+IPSE+GNLS L NLD+S+N+L+ IP SLG+L+RL FNVSNNF
Sbjct: 121 TALEGIYLQNNYITGTIPSEIGNLSGLKNLDLSNNNLNGAIPASLGQLKRLTKFNVSNNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IPSDG+L + S SF GNR LCGKQI++ C NDSG ST S SP QGG N
Sbjct: 181 LVGKIPSDGLLARLSRDSFNGNRNLCGKQIDIVC-NDSGNSTA-SGSPTG---QGGN-NP 234
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
RLLISASATVG LLLVALMCFWGCFLYKKLG+ ESK L DVGGGASIVMFHGDLPY+S
Sbjct: 235 KRLLISASATVGGLLLVALMCFWGCFLYKKLGRVESKSLVIDVGGGASIVMFHGDLPYAS 294
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLE+L+++HIIG GGFGTVYKL+MDDGNVFALKRI KLNEGFDRFFERELEILGS
Sbjct: 295 KDIIKKLESLNEEHIIGCGGFGTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEILGS 354
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
IKHRYLVNLRGYCNSPTSKLL+YD+LPGGSLDEALH+R EQLDWD+R+NII+GAAKGLAY
Sbjct: 355 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRGEQLDWDSRVNIIIGAAKGLAY 414
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY
Sbjct: 415 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 474
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
MQSGRATEKTDVYSFGVLVLEVLSGK PTDASFIEKG NIVGWLNFLISE+R +EI+D +
Sbjct: 475 MQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEKGFNIVGWLNFLISENRAKEIVDLS 534
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
CEGV+ ESLDALL++AT+CVSSSPD+RPTMHRVVQ+LESEVMTPCPSDFYDS+SD
Sbjct: 535 CEGVERESLDALLSIATKCVSSSPDERPTMHRVVQLLESEVMTPCPSDFYDSSSD 589
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (873), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 209/536 (38%), Positives = 296/536 (55%), Gaps = 55/536 (10%)
Query: 74 VITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
++ L+LT +KL GP+ A LG L +L ++L NN GE+ SEL +L GL ++ N +
Sbjct: 678 LVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFT 737
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKF 193
G IPSELGNL+ L LD+S N LS IP + L L N++ N L G +PSDGV
Sbjct: 738 GEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDP 797
Query: 194 SESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGAL 253
S++ GN+ LCG+ + CK + G L SA G +
Sbjct: 798 SKALLSGNKELCGRVVGSDCKIE-----------------------GTKLRSAWGIAGLM 834
Query: 254 LLVALMCFWGCFLYKK---------------LGKNESKGLARD----VGGGAS------- 287
L ++ F F ++ + ++ KG + G S
Sbjct: 835 LGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSIN 894
Query: 288 IVMFHGDL-PYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF 346
I MF L DI++ + +IIG GGFGTVYK + A+K++ +
Sbjct: 895 IAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQG 954
Query: 347 DRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS---EQLDW 403
+R F E+E LG +KH LV+L GYC+ KLL+Y+++ GSLD L ++ E LDW
Sbjct: 955 NREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDW 1014
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
RL I +GAA+GLA+LHH P IIHRDIK+SNILLDG+ E +V+DFGLA+L+ ESH
Sbjct: 1015 SKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESH 1074
Query: 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIE-KGLNIVGW 522
++T++AGTFGY+ PEY QS RAT K DVYSFGV++LE+++GK PT F E +G N+VGW
Sbjct: 1075 VSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGW 1134
Query: 523 LNFLISEDRQREIIDPNCEGVQ-SESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
I++ + ++IDP V S LL +A C++ +P RP M V++ L+
Sbjct: 1135 AIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALK 1190
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 338 bits (867), Expect = 6e-92, Method: Compositional matrix adjust.
Identities = 202/576 (35%), Positives = 321/576 (55%), Gaps = 29/576 (5%)
Query: 12 WLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKN 71
WL+ +L L + ++ N++G+AL + + ++ + L W PC W V C+ +
Sbjct: 12 WLILVLDLVLRVSG----NAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFHVTCNSD 67
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
V + L N LSG + LG+L L++L L+SNN G IP +LGN TEL L L N
Sbjct: 68 NSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSLDLYLNN 127
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
LSG IPS LG L L L +++NSLS IP SL + L ++SNN L G IP +G +
Sbjct: 128 LSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIPVNGSFS 187
Query: 192 KFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVG 251
F+ S F N L + + + + GG LL + A
Sbjct: 188 LFTPIS-FANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAAGAALLFAVPAIA- 245
Query: 252 ALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLD 310
+ +W + + + DV + G L +S +++ +
Sbjct: 246 -------LAWWR--------RKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFS 290
Query: 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+ +I+G GGFG VYK + DG + A+KR+ ++ +G + F+ E+E++ HR L+ LR
Sbjct: 291 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 350
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSP 426
G+C +PT +LL+Y ++ GS+ L ER E LDW R I +G+A+GLAYLH C P
Sbjct: 351 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 410
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRAT 486
+IIHRD+K++NILLD EA V DFGLAKL++ +++H+TT V GT G++APEY+ +G+++
Sbjct: 411 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 470
Query: 487 EKTDVYSFGVLVLEVLSGKRPTDASFI--EKGLNIVGWLNFLISEDRQREIIDPNCEG-V 543
EKTDV+ +GV++LE+++G+R D + + + + ++ W+ L+ E + ++D + +G
Sbjct: 471 EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNY 530
Query: 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579
+ E ++ L+ VA C SSP +RP M VV++LE +
Sbjct: 531 KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 566
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 330 bits (845), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 201/563 (35%), Positives = 317/563 (56%), Gaps = 30/563 (5%)
Query: 28 AINSDGEALLSFRTAVVSSD---GFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKL 84
A N++G+AL + ++ S D L W PC W V C+ +V + L N KL
Sbjct: 28 AGNAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKL 87
Query: 85 SGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS 144
SG + +LG+L L++L L+SNN GEIP ELG+ EL L L +N +SG IPS LG L
Sbjct: 88 SGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLG 147
Query: 145 NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204
L L +++NSLS IP +L +Q L ++SNN L G IP +G + F+ SF N
Sbjct: 148 KLRFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANN--- 203
Query: 205 CGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGC 264
D S SP GG+ + A+ + A+ W
Sbjct: 204 --------SLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGAALLFAVPAIAFAW-- 253
Query: 265 FLYKKLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTV 323
+L +K + DV + G L ++ ++++ + + +++G GGFG V
Sbjct: 254 WLRRK-----PQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKV 308
Query: 324 YKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
YK + DGN+ A+KR+ ++ +G + F+ E+E++ HR L+ LRG+C +PT +LL+Y
Sbjct: 309 YKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 368
Query: 383 DFLPGGSLDEALHERSE---QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439
++ GS+ L ER E LDW R +I +G+A+GLAYLH C +IIHRD+K++NIL
Sbjct: 369 PYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANIL 428
Query: 440 LDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVL 499
LD EA V DFGLAKL+ +SH+TT V GT G++APEY+ +G+++EKTDV+ +GV++L
Sbjct: 429 LDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 488
Query: 500 EVLSGKRPTDASFI--EKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES-LDALLAVAT 556
E+++G++ D + + + + ++ W+ ++ E + ++D EG E+ ++ L+ +A
Sbjct: 489 ELITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMAL 548
Query: 557 QCVSSSPDDRPTMHRVVQILESE 579
C SS +RP M VV++LE +
Sbjct: 549 LCTQSSAMERPKMSEVVRMLEGD 571
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (838), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 202/517 (39%), Positives = 296/517 (57%), Gaps = 30/517 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQ-GLSLQSNYLSGS 135
L L+N+ LSG I LG L +L L + N F G IP ELG+ T LQ L+L N L+G
Sbjct: 582 LKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGE 641
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSE 195
IP EL NL L L +++N+LS IP S L L+ +N S N L G IP +L S
Sbjct: 642 IPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISM 698
Query: 196 SSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVG--AL 253
SSF GN GLCG +N + T +P+ + + G S +++ +A +G +L
Sbjct: 699 SSFIGNEGLCGPPLNQCIQ-------TQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSL 751
Query: 254 LLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDH 313
+L+AL+ + + + + G ++ + + F ++ +D++ + D+
Sbjct: 752 MLIALIVYLMRRPVRTVASSAQDGQPSEM---SLDIYFPPKEGFTFQDLVAATDNFDESF 808
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG-----FDRFFERELEILGSIKHRYLVNL 368
++G G GTVYK + G A+K++ +EG D F E+ LG+I+HR +V L
Sbjct: 809 VVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKL 868
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G+CN S LL+Y+++P GSL E LH+ S LDW R I +GAA+GLAYLHHDC PRI
Sbjct: 869 HGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRI 928
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEK 488
HRDIKS+NILLD EA V DFGLAK+++ S + +AG++GY+APEY + + TEK
Sbjct: 929 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEK 988
Query: 489 TDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE-IIDPNC----EGV 543
+D+YS+GV++LE+L+GK P I++G ++V W+ I D ++D E +
Sbjct: 989 SDIYSYGVVLLELLTGKAPVQP--IDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERI 1046
Query: 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQIL-ESE 579
S L +L +A C S SP RP+M +VV +L ESE
Sbjct: 1047 VSHML-TVLKIALLCTSVSPVARPSMRQVVLMLIESE 1082
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 326 bits (836), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 199/559 (35%), Positives = 307/559 (54%), Gaps = 77/559 (13%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L+L+++ + GPI +L ++ L L+L +N G IPS LG+ L ++L N+++G +
Sbjct: 408 LNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVV 467
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI-----------------------TF 173
P + GNL +++ +D+S+N +S IP L +LQ +I
Sbjct: 468 PGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVL 527
Query: 174 NVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQ 233
NVS+N LVG IP + ++FS SF GN GLCG +N C +
Sbjct: 528 NVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWLNSPCHD------------------ 569
Query: 234 GGKKNSGRLLISASA----TVGALLLVALMCFWGC-------FLYKKLGKNESKGLARDV 282
+ + R+ IS +A +G L+++ ++ C FL L K + +
Sbjct: 570 --SRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHNPPPFLDGSLDKPVTYSTPK-- 625
Query: 283 GGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDK 341
+V+ H ++ + +DI++ E L + +IIG G TVYK + + A+KR+
Sbjct: 626 -----LVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYS 680
Query: 342 LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH--ERSE 399
N + FE ELE+L SIKHR LV+L+ Y S LL YD+L GSL + LH + +
Sbjct: 681 HNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKK 740
Query: 400 QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459
LDWD RL I GAA+GLAYLHHDCSPRIIHRD+KSSNILLD +LEAR++DFG+AK L
Sbjct: 741 TLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCV 800
Query: 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI 519
+SH +T V GT GY+ PEY ++ R TEK+DVYS+G+++LE+L+ ++ D E L+
Sbjct: 801 SKSHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDD---ESNLH- 856
Query: 520 VGWLNFLISEDRQREIIDPNCEGVQSESLD-----ALLAVATQCVSSSPDDRPTMHRVVQ 574
+ ++S+ E+++ + S D + +A C P+DRPTMH+V +
Sbjct: 857 ----HLIMSKTGNNEVMEMADPDITSTCKDLGVVKKVFQLALLCTKRQPNDRPTMHQVTR 912
Query: 575 ILESEVMTPCPSDFYDSNS 593
+L S +++ P D+++
Sbjct: 913 VLGSFMLSEQPPAATDTSA 931
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 9e-88, Method: Compositional matrix adjust.
Identities = 202/537 (37%), Positives = 287/537 (53%), Gaps = 61/537 (11%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L+L+++ G I A+LG + L L+L NNF G IP LG+ L L+L N+L+G++
Sbjct: 413 LNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTL 472
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ------------------------RLIT 172
P+E GNL ++ +D+S N L+ IP LG+LQ L
Sbjct: 473 PAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLAN 532
Query: 173 FNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQN 232
N+S N L G IP T+FS +SFFGN LCG + C G S SQ
Sbjct: 533 LNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSIC----GPSLPKSQ------- 581
Query: 233 QGGKKNSGRLLISASATVGALLLVALMCFWGCFLYK-KLGKNESKGLARDVGGGASIVMF 291
+ + L + L+C +YK K K KG ++ G +V+
Sbjct: 582 ---------VFTRVAVICMVLGFITLICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLVIL 632
Query: 292 HGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFF 350
H D+ ++ DI++ E LD+ +IIG G TVYK A+KRI R F
Sbjct: 633 HMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREF 692
Query: 351 ERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE--RSEQLDWDARLN 408
E ELE +GSI+HR +V+L GY SP LL YD++ GSL + LH + +LDW+ RL
Sbjct: 693 ETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLK 752
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
I +GAA+GLAYLHHDC+PRIIHRDIKSSNILLDGN EAR+SDFG+AK + +++ +T V
Sbjct: 753 IAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYV 812
Query: 469 AGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528
GT GY+ PEY ++ R EK+D+YSFG+++LE+L+GK+ D N ++S
Sbjct: 813 LGTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGKKAVD--------NEANLHQMILS 864
Query: 529 EDRQREIIDPNCEGVQSESLDA-----LLAVATQCVSSSPDDRPTMHRVVQILESEV 580
+ +++ V +D+ +A C +P +RPTM V ++L S V
Sbjct: 865 KADDNTVMEAVDAEVSVTCMDSGHIKKTFQLALLCTKRNPLERPTMQEVSRVLLSLV 921
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (822), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 196/489 (40%), Positives = 281/489 (57%), Gaps = 19/489 (3%)
Query: 100 FLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDY 159
++L N+ G I E G+ +L L+L++N LSG+IP+ L +++L LD+S N+LS
Sbjct: 537 MIDLSYNSLNGSIWPEFGDLRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGN 596
Query: 160 IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGG 219
IPPSL KL L TF+V+ N L G IP+ F SSF GN+GLCG+ S
Sbjct: 597 IPPSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGEHA-------SPC 649
Query: 220 STTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGCFLYKKLGK--NESKG 277
TD QSP+ + + KKN +++ A T + + + G+ E K
Sbjct: 650 HITD-QSPHGSAVKS-KKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTSRGEVDPEKKA 707
Query: 278 LARDVG-GGASIVMFH---GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNV 333
A ++ G S+V+FH + S DI+K + + +IIG GGFG VYK + DG
Sbjct: 708 DADEIELGSRSVVLFHNKDSNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTK 767
Query: 334 FALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEA 393
A+KR+ DR F+ E+E L +H LV+L GYCN KLLIY ++ GSLD
Sbjct: 768 VAIKRLSGDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYW 827
Query: 394 LHERSE---QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450
LHE+ + LDW RL I GAA+GLAYLH C P I+HRDIKSSNILL A ++D
Sbjct: 828 LHEKVDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLAD 887
Query: 451 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA 510
FGLA+L+ ++H+TT + GT GY+ PEY Q+ AT K DVYSFGV++LE+L+G+RP D
Sbjct: 888 FGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPMDV 947
Query: 511 SFIEKGLNIVGWLNFLISEDRQREIIDPNC-EGVQSESLDALLAVATQCVSSSPDDRPTM 569
+++ W+ + +E R+ EI DP + +E + +L +A +C+ +P RPT
Sbjct: 948 CKPRGSRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVLEIACRCLGENPKTRPTT 1007
Query: 570 HRVVQILES 578
++V LE+
Sbjct: 1008 QQLVSWLEN 1016
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT1|Y5129_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g10290 OS=Arabidopsis thaliana GN=At5g10290 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 200/579 (34%), Positives = 315/579 (54%), Gaps = 38/579 (6%)
Query: 13 LLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNK 72
LLF LC ++ ++ G+AL + R ++ + L+ W +PC W V CD
Sbjct: 15 LLFFACLCSFVSP----DAQGDALFALRISLRALPNQLSDWNQNQVNPCTWSQVICDDKN 70
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
V +L+L++ SG +S+ +G L+ LK L L N GEIP + GN T L L L+ N L
Sbjct: 71 FVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGNLTSLTSLDLEDNQL 130
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+G IPS +GNL L L +S N L+ IP SL L L+ + +N L G IP L +
Sbjct: 131 TGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSNSLSGQIPQS--LFE 188
Query: 193 FSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGA 252
+ +F N CG + C + + + DS P + +I+
Sbjct: 189 IPKYNFTSNNLNCGGRQPHPCVS-AVAHSGDSSKPKTG------------IIAGVVAGVT 235
Query: 253 LLLVALMCFWGCFLYKKLGKNESKGLARDV----GGGASIVMFHGDLP-YSSKDIIKKLE 307
++L ++ F C K+ KG RDV G + G L ++ +++ +
Sbjct: 236 VVLFGILLFLFC-------KDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAWRELQLATD 288
Query: 308 TLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLV 366
+ +++G GGFG VYK + D A+KR+ D + G D F+RE+E++ HR L+
Sbjct: 289 NFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMISVAVHRNLL 348
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSE---QLDWDARLNIIMGAAKGLAYLHHD 423
L G+C + T +LL+Y F+ SL L E LDW+ R I +GAA+G YLH
Sbjct: 349 RLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAARGFEYLHEH 408
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
C+P+IIHRD+K++N+LLD + EA V DFGLAKL++ +++TT V GT G++APEY+ +G
Sbjct: 409 CNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPEYLSTG 468
Query: 484 RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI--VGWLNFLISEDRQREIIDPNCE 541
+++E+TDV+ +G+++LE+++G+R D S +E+ ++ + + L E R I+D N +
Sbjct: 469 KSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLGAIVDKNLD 528
Query: 542 GVQ-SESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579
G E ++ ++ VA C SP+DRP M VV++LE E
Sbjct: 529 GEYIKEEVEMMIQVALLCTQGSPEDRPVMSEVVRMLEGE 567
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 594 | ||||||
| 255557731 | 596 | BRASSINOSTEROID INSENSITIVE 1-associated | 1.0 | 0.996 | 0.843 | 0.0 | |
| 359474742 | 596 | PREDICTED: LRR receptor-like serine/thre | 1.0 | 0.996 | 0.827 | 0.0 | |
| 358248000 | 590 | LRR receptor-like serine/threonine-prote | 0.991 | 0.998 | 0.813 | 0.0 | |
| 359474744 | 592 | PREDICTED: LRR receptor-like serine/thre | 0.994 | 0.998 | 0.821 | 0.0 | |
| 449462503 | 595 | PREDICTED: LRR receptor-like serine/thre | 1.0 | 0.998 | 0.791 | 0.0 | |
| 449455673 | 599 | PREDICTED: LRR receptor-like serine/thre | 0.994 | 0.986 | 0.786 | 0.0 | |
| 12322537 | 590 | protein kinase, putative [Arabidopsis th | 0.952 | 0.959 | 0.795 | 0.0 | |
| 334182976 | 591 | leucine-rich repeat protein kinase-like | 0.952 | 0.957 | 0.795 | 0.0 | |
| 297851928 | 592 | hypothetical protein ARALYDRAFT_891122 [ | 0.952 | 0.956 | 0.795 | 0.0 | |
| 42562442 | 592 | leucine-rich repeat protein kinase-like | 0.952 | 0.956 | 0.794 | 0.0 |
| >gi|255557731|ref|XP_002519895.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223540941|gb|EEF42499.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1027 bits (2655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 503/596 (84%), Positives = 543/596 (91%), Gaps = 2/596 (0%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
M +Y +C+G WL +IL+L I + KS AINSDGEALL+F+ A+VSSDG L WRPEDPDP
Sbjct: 1 MAIYLRRCQGTWLFYILVLYIFVQKSGAINSDGEALLNFKNAIVSSDGILPLWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNW+GV CD K KRVI LSL NHKLSG IS D+GKL L+ L L++NNFYG IPSELGNC
Sbjct: 61 CNWRGVTCDQKTKRVIYLSLKNHKLSGSISPDIGKLQHLRILALYNNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
TELQGL LQ NYLSG IPSELG LS L LDISSNSLS IPPSLGKL +LITFNVSNNF
Sbjct: 121 TELQGLYLQGNYLSGLIPSELGKLSELQYLDISSNSLSGSIPPSLGKLNKLITFNVSNNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKN- 238
LVG IPSDGVL FS+SSF GNRGLCG QIN+ CK+++GG +++S SP SAQNQGGKK
Sbjct: 181 LVGPIPSDGVLFNFSQSSFTGNRGLCGNQINMNCKDETGGPSSNSGSPTSAQNQGGKKKY 240
Query: 239 SGRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYS 298
SGRLLISASATVGALLLVALMCFWGCFLYKK GKNES +A DV GGASIVMFHGDLPYS
Sbjct: 241 SGRLLISASATVGALLLVALMCFWGCFLYKKFGKNESNSIAMDVSGGASIVMFHGDLPYS 300
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
SKDIIKKLETL+++HIIG GGFGTVYKLAMDDG+VFALKRI KLNEGFDRFFERELEILG
Sbjct: 301 SKDIIKKLETLNEEHIIGCGGFGTVYKLAMDDGSVFALKRIVKLNEGFDRFFERELEILG 360
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA
Sbjct: 361 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 420
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
YLHHDC+PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE
Sbjct: 421 YLHHDCAPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 480
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538
YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA+FIEKGLNIVGWLNFL++E+R+R+IIDP
Sbjct: 481 YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDAAFIEKGLNIVGWLNFLVTENRRRDIIDP 540
Query: 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
NCEGVQ+ESLDALL+VATQCVSSSP+DRPTMHRVVQ+LESEVMTPCPSDFYDS+SD
Sbjct: 541 NCEGVQTESLDALLSVATQCVSSSPEDRPTMHRVVQLLESEVMTPCPSDFYDSSSD 596
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474742|ref|XP_002266702.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like isoform 1 [Vitis vinifera] gi|296085503|emb|CBI29235.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2524), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/596 (82%), Positives = 534/596 (89%), Gaps = 2/596 (0%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
M + I+C ++LLL I++N+S+A++ DGEALLSFR ++VSSDG L QWRPEDPDP
Sbjct: 1 MSTFLIRCLVPLPFYLLLLYILMNQSKALSPDGEALLSFRNSIVSSDGVLRQWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
C WKGV CD + KRVI L+L +HKLSG IS D+GKL+ LK L L +NNFYG IPSELGNC
Sbjct: 61 CGWKGVTCDLETKRVIYLNLPHHKLSGSISPDIGKLELLKLLALQNNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
TELQ L LQ NYLSG IPSELG+L L +LDISSNSLS YIPPSLGKL +L TFNVS NF
Sbjct: 121 TELQALYLQGNYLSGLIPSELGSLLELKDLDISSNSLSGYIPPSLGKLDKLSTFNVSTNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKN- 238
LVG IPSDGVLT FS +SF GNRGLCGKQIN+TCK+DSGG+ T SQ P QNQ GKK
Sbjct: 181 LVGPIPSDGVLTNFSGNSFVGNRGLCGKQINITCKDDSGGAGTKSQPPILDQNQVGKKKY 240
Query: 239 SGRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYS 298
SGRLLISASATVGALLLVALMCFWGCFLYKK GKN+ + LA DV GGASIVMFHGDLPYS
Sbjct: 241 SGRLLISASATVGALLLVALMCFWGCFLYKKCGKNDGRSLAMDVSGGASIVMFHGDLPYS 300
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
SKDIIKKLETL+++HIIGSGGFGTVYKLAMDDGNVFALKRI K+NE FDRFFERELEILG
Sbjct: 301 SKDIIKKLETLNEEHIIGSGGFGTVYKLAMDDGNVFALKRIVKMNECFDRFFERELEILG 360
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
SIKHRYLVNLRGYCNSPTSKLLIYD+LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA
Sbjct: 361 SIKHRYLVNLRGYCNSPTSKLLIYDYLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 420
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE
Sbjct: 421 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 480
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538
YMQSGRATEKTD+YSFGVL+LEVL+GKRPTDASFIEKGLNIVGWLNFL++E+RQREI+DP
Sbjct: 481 YMQSGRATEKTDIYSFGVLMLEVLAGKRPTDASFIEKGLNIVGWLNFLVTENRQREIVDP 540
Query: 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
CEGVQSESLDALL+VA QCVS P+DRPTMHRVVQILESEVMTPCPSDFYDSNSD
Sbjct: 541 QCEGVQSESLDALLSVAIQCVSPGPEDRPTMHRVVQILESEVMTPCPSDFYDSNSD 596
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248000|ref|NP_001239788.1| LRR receptor-like serine/threonine-protein kinase FEI 1 precursor [Glycine max] gi|223452450|gb|ACM89552.1| leucine-rich repeat transmembrane protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2506), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 484/595 (81%), Positives = 524/595 (88%), Gaps = 6/595 (1%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ K + WLL++LL+ ++I KS AI DGE LLSFRT+VVSSDG L QWRPEDPDP
Sbjct: 1 MGICLWKWQWPWLLYVLLIHVVIYKSGAITPDGEVLLSFRTSVVSSDGILLQWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
C WKGVKCD K KRV LSL++HKLSG IS DLGKL+ L+ L LH+NNFYG IPSELGNC
Sbjct: 61 CKWKGVKCDPKTKRVTHLSLSHHKLSGSISPDLGKLENLRVLALHNNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
TEL+G+ LQ NYLSG IP E+GNLS L NLDISSNSLS IP SLGKL L FNVS NF
Sbjct: 121 TELEGIFLQGNYLSGVIPIEIGNLSQLQNLDISSNSLSGNIPASLGKLYNLKNFNVSTNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IP+DGVL F+ SSF GNRGLCG +IN TC++D G T+ QS +S G KK S
Sbjct: 181 LVGPIPADGVLANFTGSSFVGNRGLCGVKINSTCRDD-GSPDTNGQSTSS----GKKKYS 235
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
GRLLISASATVGALLLVALMCFWGCFLYKK GKN+ LA DVG GASIVMFHGDLPYSS
Sbjct: 236 GRLLISASATVGALLLVALMCFWGCFLYKKFGKNDRISLAMDVGSGASIVMFHGDLPYSS 295
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLETL+++HIIG GGFGTVYKLAMDDGNVFALKRI KLNEGFDRFFERELEILGS
Sbjct: 296 KDIIKKLETLNEEHIIGIGGFGTVYKLAMDDGNVFALKRIVKLNEGFDRFFERELEILGS 355
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
IKHRYLVNLRGYCNSPTSKLLIYD+LPGGSLDEALHER++QLDWD+RLNIIMGAAKGLAY
Sbjct: 356 IKHRYLVNLRGYCNSPTSKLLIYDYLPGGSLDEALHERADQLDWDSRLNIIMGAAKGLAY 415
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY
Sbjct: 416 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 475
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
MQSGRATEK+DVYSFGVL LEVLSGKRPTDA+FIEKGLNIVGWLNFLI+E+R REI+DP
Sbjct: 476 MQSGRATEKSDVYSFGVLTLEVLSGKRPTDAAFIEKGLNIVGWLNFLITENRPREIVDPL 535
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
CEGVQ ESLDALL+VA QCVSSSP+DRPTMHRVVQ+LESEV+TPCPSDFYDSNSD
Sbjct: 536 CEGVQMESLDALLSVAIQCVSSSPEDRPTMHRVVQLLESEVVTPCPSDFYDSNSD 590
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359474744|ref|XP_003631527.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 969 bits (2505), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 489/595 (82%), Positives = 532/595 (89%), Gaps = 4/595 (0%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
M + I+C ++LLL I++N+S+A++ DGEALLSFR ++VSSDG L QWRPEDPDP
Sbjct: 1 MSTFLIRCLVPLPFYLLLLYILMNQSKALSPDGEALLSFRNSIVSSDGVLRQWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
C WKGV CD + KRVI L+L +HKLSG IS D+GKL+ LK L L +NNFYG IPSELGNC
Sbjct: 61 CGWKGVTCDLETKRVIYLNLPHHKLSGSISPDIGKLELLKLLALQNNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
TELQ L LQ NYLSG IPSELG+L L +LDISSNSLS YIPPSLGKL +L TFNVS NF
Sbjct: 121 TELQALYLQGNYLSGLIPSELGSLLELKDLDISSNSLSGYIPPSLGKLDKLSTFNVSTNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IPSDGVLT FS +SF GNRGLCGKQIN+TCK+DSGG+ T SQ P ++ KK S
Sbjct: 181 LVGPIPSDGVLTNFSGNSFVGNRGLCGKQINITCKDDSGGAGTKSQPPILGRS---KKYS 237
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
GRLLISASATVGALLLVALMCFWGCFLYKK GKN+ + LA DV GGASIVMFHGDLPYSS
Sbjct: 238 GRLLISASATVGALLLVALMCFWGCFLYKKCGKNDGRSLAMDVSGGASIVMFHGDLPYSS 297
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLETL+++HIIGSGGFGTVYKLAMDDGNVFALKRI K+NE FDRFFERELEILGS
Sbjct: 298 KDIIKKLETLNEEHIIGSGGFGTVYKLAMDDGNVFALKRIVKMNECFDRFFERELEILGS 357
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
IKHRYLVNLRGYCNSPTSKLLIYD+LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY
Sbjct: 358 IKHRYLVNLRGYCNSPTSKLLIYDYLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 417
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY
Sbjct: 418 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 477
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
MQSGRATEKTD+YSFGVL+LEVL+GKRPTDASFIEKGLNIVGWLNFL++E+RQREI+DP
Sbjct: 478 MQSGRATEKTDIYSFGVLMLEVLAGKRPTDASFIEKGLNIVGWLNFLVTENRQREIVDPQ 537
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
CEGVQSESLDALL+VA QCVS P+DRPTMHRVVQILESEVMTPCPSDFYDSNSD
Sbjct: 538 CEGVQSESLDALLSVAIQCVSPGPEDRPTMHRVVQILESEVMTPCPSDFYDSNSD 592
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462503|ref|XP_004148980.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Cucumis sativus] gi|449515017|ref|XP_004164546.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 959 bits (2479), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/595 (79%), Positives = 525/595 (88%), Gaps = 1/595 (0%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ +KC G +L +LLLC+ +NKS + DG ALLSFR AV SSDG + QWRPEDP+P
Sbjct: 1 MGICLVKCSGLLILHVLLLCMAMNKSTGLTPDGAALLSFRMAVASSDGVIFQWRPEDPNP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNW GV CD K KRVI+L L +HKLSG I+ +LGKLDQLK L L NN YG IPSELGNC
Sbjct: 61 CNWTGVVCDPKTKRVISLKLASHKLSGFIAPELGKLDQLKTLILSDNNLYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
++LQG+ LQ NYLSG IP ELGNL L LD+SSNSLS IP SLG L +L NVS+NF
Sbjct: 121 SQLQGMFLQRNYLSGVIPYELGNLLELEMLDVSSNSLSGNIPTSLGNLDKLAILNVSSNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
L+G +PSDGVL+KFSE+SF GNRGLCGKQ+NV CK+D+ S T+S+S +S QNQ +K S
Sbjct: 181 LIGPVPSDGVLSKFSETSFVGNRGLCGKQVNVVCKDDNNESGTNSESTSSGQNQMRRKYS 240
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
GRLLISASATVGALLLVALMCFWGCFLYK+ GKN+ KGLA+DVGGGAS+VMFHGDLPYSS
Sbjct: 241 GRLLISASATVGALLLVALMCFWGCFLYKRFGKNDKKGLAKDVGGGASVVMFHGDLPYSS 300
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDI+KKLETL+++HIIGSGGFGTVY+LAMDDGNVFALK I K+NEGFD FFERELEILGS
Sbjct: 301 KDIMKKLETLNEEHIIGSGGFGTVYRLAMDDGNVFALKNIVKINEGFDHFFERELEILGS 360
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
+KHRYLVNLRGYCNSPTSKLLIYD+L GGSLDEALHERSEQLDWD RLNII+GAAKGLAY
Sbjct: 361 LKHRYLVNLRGYCNSPTSKLLIYDYLSGGSLDEALHERSEQLDWDTRLNIILGAAKGLAY 420
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
LHHDCSPRIIHRDIKSSNILLDGNL+ARVSDFGLAKLL+D++SHITTIVAGTFGYLAPEY
Sbjct: 421 LHHDCSPRIIHRDIKSSNILLDGNLDARVSDFGLAKLLDDDKSHITTIVAGTFGYLAPEY 480
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL++E+RQREI+DP
Sbjct: 481 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLVTENRQREIVDPQ 540
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
CEGVQSE+LD+LL +A QCVSSSPDDRPTMHRVVQ ESEVMTPCPSDF DSNSD
Sbjct: 541 CEGVQSETLDSLLRLAIQCVSSSPDDRPTMHRVVQFFESEVMTPCPSDFDDSNSD 595
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455673|ref|XP_004145576.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Cucumis sativus] gi|449485054|ref|XP_004157058.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2433), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/600 (78%), Positives = 518/600 (86%), Gaps = 9/600 (1%)
Query: 1 MGMYQIKCRGQWLLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG Y +K + +L I+ LC+I+++S I SDGEALLSFR +++ SDG L QW+PE+P P
Sbjct: 1 MGFYTVKWQWLLILHIVPLCMIMSRSSGITSDGEALLSFRASILDSDGVLLQWKPEEPHP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
C WKG+ CD K KRVI LSL HKLSG +S +LGKLD LK L LH NNFYG IPSELGNC
Sbjct: 61 CKWKGITCDPKTKRVIYLSLPYHKLSGSLSPELGKLDHLKILALHDNNFYGTIPSELGNC 120
Query: 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
++LQG+ LQ NY SGSIP+ELGNL L NLDISSNSL IP SLGKL L++ NVS NF
Sbjct: 121 SQLQGMFLQGNYFSGSIPNELGNLWALKNLDISSNSLGGNIPISLGKLSNLVSLNVSANF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQ-GGKKN 238
LVG IP+ G+L FSESSF GNRGLCGKQINV CK+D T+ +SP S QNQ G KK
Sbjct: 181 LVGTIPNVGMLLNFSESSFLGNRGLCGKQINVMCKDDKKEPETN-ESPFSVQNQIGKKKY 239
Query: 239 SGRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGA--SIVMFHGDLP 296
SGRLLISASATVGALLLVALMCFWGCFLYKK GKN+SKGL + GGA S VMFHGDLP
Sbjct: 240 SGRLLISASATVGALLLVALMCFWGCFLYKKFGKNDSKGLVLNGCGGARASGVMFHGDLP 299
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEI 356
Y SKDIIKK ETL+++HIIG GGFGTVYKLAMDDGNVFALKRI KLNEGFDRFFERELEI
Sbjct: 300 YMSKDIIKKFETLNEEHIIGCGGFGTVYKLAMDDGNVFALKRIIKLNEGFDRFFERELEI 359
Query: 357 LGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH----ERSEQLDWDARLNIIMG 412
LGSIKHR+LVNLRGYCNSPTSKLLIYDFLPGGSLDEALH E SEQLDWDARLNIIMG
Sbjct: 360 LGSIKHRFLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHGLRTEGSEQLDWDARLNIIMG 419
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
AAKGLAYLHHDCSPRIIHRDIKSSNILLD NLEARVSDFGLAKLLEDEESHITTIVAGTF
Sbjct: 420 AAKGLAYLHHDCSPRIIHRDIKSSNILLDANLEARVSDFGLAKLLEDEESHITTIVAGTF 479
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQ 532
GYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL++E+RQ
Sbjct: 480 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLVTENRQ 539
Query: 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSN 592
REI+D CEG+Q+ESLDALL+VA +CVSSSP++RPTMHRVVQILESE+MTPCPSDFYD++
Sbjct: 540 REIVDLQCEGMQAESLDALLSVAIRCVSSSPEERPTMHRVVQILESEIMTPCPSDFYDTD 599
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|12322537|gb|AAG51266.1|AC027135_7 protein kinase, putative [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 939 bits (2426), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/572 (79%), Positives = 509/572 (88%), Gaps = 6/572 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 24 NESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 83
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ D+GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+G+
Sbjct: 84 KIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGD 143
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 144 LPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 203
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK ++V C++DSG ++ SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 204 NLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 258
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 259 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 318
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 319 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 378
Query: 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442
D+LPGGSLDEALHER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLDG
Sbjct: 379 DYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDG 438
Query: 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL 502
NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL
Sbjct: 439 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL 498
Query: 503 SGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSS 562
SGKRPTDASFIEKGLN+VGWL FLISE R R+I+DPNCEG+Q ESLDALL++ATQCVS S
Sbjct: 499 SGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQCVSPS 558
Query: 563 PDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
P++RPTMHRVVQ+LESEVMTPCPS+FYDS+SD
Sbjct: 559 PEERPTMHRVVQLLESEVMTPCPSEFYDSSSD 590
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334182976|ref|NP_001185122.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|263419027|sp|C0LGF4.1|FEI1_ARATH RecName: Full=LRR receptor-like serine/threonine-protein kinase FEI 1; Flags: Precursor gi|224589410|gb|ACN59239.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332193233|gb|AEE31354.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 938 bits (2425), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/572 (79%), Positives = 509/572 (88%), Gaps = 6/572 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 25 NESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 84
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ D+GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+G+
Sbjct: 85 KIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGD 144
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 145 LPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 204
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK ++V C++DSG ++ SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 205 NLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 259
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 260 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 320 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379
Query: 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442
D+LPGGSLDEALHER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLDG
Sbjct: 380 DYLPGGSLDEALHERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDG 439
Query: 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL 502
NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL
Sbjct: 440 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL 499
Query: 503 SGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSS 562
SGKRPTDASFIEKGLN+VGWL FLISE R R+I+DPNCEG+Q ESLDALL++ATQCVS S
Sbjct: 500 SGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQCVSPS 559
Query: 563 PDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
P++RPTMHRVVQ+LESEVMTPCPS+FYDS+SD
Sbjct: 560 PEERPTMHRVVQLLESEVMTPCPSEFYDSSSD 591
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297851928|ref|XP_002893845.1| hypothetical protein ARALYDRAFT_891122 [Arabidopsis lyrata subsp. lyrata] gi|297339687|gb|EFH70104.1| hypothetical protein ARALYDRAFT_891122 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/573 (79%), Positives = 509/573 (88%), Gaps = 7/573 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 25 NESQAISPDGEALLSFRNAVSRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 84
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ ++GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+GN
Sbjct: 85 KIMGPLPPEIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGN 144
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 145 LHGLQKLDMSSNTLSGAIPASLGQLKKLTNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 204
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK I+V C++DSG +++SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 205 NLCGKHIDVVCQDDSGNPSSNSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 259
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 260 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 320 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379
Query: 383 DFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
D+LPGGSLDEALH ER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLD
Sbjct: 380 DYLPGGSLDEALHVERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLD 439
Query: 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV 501
GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV
Sbjct: 440 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV 499
Query: 502 LSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSS 561
LSGKRPTDASFIEKGLN+VGWL LISE R REI+D NCEG+Q ESLDALL++ATQCVSS
Sbjct: 500 LSGKRPTDASFIEKGLNVVGWLKLLISEKRPREIVDRNCEGMQIESLDALLSIATQCVSS 559
Query: 562 SPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
SP++RPTMHRVVQ+LESEVMTPCPS+FYDS+SD
Sbjct: 560 SPEERPTMHRVVQLLESEVMTPCPSEFYDSSSD 592
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42562442|ref|NP_174427.3| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|332193232|gb|AEE31353.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/573 (79%), Positives = 509/573 (88%), Gaps = 7/573 (1%)
Query: 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNH 82
N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDPCNW GV CD K KRVITL+LT H
Sbjct: 25 NESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYH 84
Query: 83 KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
K+ GP+ D+GKLD L+ L LH+N YG IP+ LGNCT L+ + LQSNY +G IP+E+G+
Sbjct: 85 KIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGD 144
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
L L LD+SSN+LS IP SLG+L++L FNVSNNFLVG IPSDGVL+ FS++SF GN
Sbjct: 145 LPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNL 204
Query: 203 GLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFW 262
LCGK ++V C++DSG ++ SQS QNQ KKNSG+LLISASATVGALLLVALMCFW
Sbjct: 205 NLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNSGKLLISASATVGALLLVALMCFW 259
Query: 263 GCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
GCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSSKDIIKKLE L+++HIIG GGFGT
Sbjct: 260 GCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGFGT 319
Query: 323 VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382
VYKLAMDDG VFALKRI KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL+Y
Sbjct: 320 VYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLY 379
Query: 383 DFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
D+LPGGSLDEALH ER EQLDWD+R+NII+GAAKGL+YLHHDCSPRIIHRDIKSSNILLD
Sbjct: 380 DYLPGGSLDEALHVERGEQLDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSNILLD 439
Query: 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV 501
GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV
Sbjct: 440 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV 499
Query: 502 LSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSS 561
LSGKRPTDASFIEKGLN+VGWL FLISE R R+I+DPNCEG+Q ESLDALL++ATQCVS
Sbjct: 500 LSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQCVSP 559
Query: 562 SPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
SP++RPTMHRVVQ+LESEVMTPCPS+FYDS+SD
Sbjct: 560 SPEERPTMHRVVQLLESEVMTPCPSEFYDSSSD 592
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 594 | ||||||
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.991 | 0.994 | 0.751 | 1.7e-240 | |
| TAIR|locus:2058759 | 589 | FEI2 "FEI 2" [Arabidopsis thal | 0.989 | 0.998 | 0.747 | 5.4e-237 | |
| TAIR|locus:2170668 | 604 | AT5G62710 [Arabidopsis thalian | 0.956 | 0.940 | 0.487 | 1.2e-147 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.789 | 0.465 | 0.375 | 1.5e-91 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.813 | 0.414 | 0.378 | 3.2e-91 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.915 | 0.866 | 0.347 | 1.8e-87 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.912 | 0.867 | 0.351 | 2.9e-87 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.791 | 0.403 | 0.371 | 5.9e-84 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.893 | 0.856 | 0.345 | 1.9e-83 | |
| TAIR|locus:2207056 | 1095 | PSY1R "PSY1 receptor" [Arabido | 0.777 | 0.421 | 0.370 | 2.3e-82 |
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2318 (821.0 bits), Expect = 1.7e-240, P = 1.7e-240
Identities = 448/596 (75%), Positives = 500/596 (83%)
Query: 1 MGMYQIKCRGQWXXXXXXXXXXXNKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ ++K W N+S+AI+ DGEALLSFR AV SD F++QWRPEDPDP
Sbjct: 2 MGICEMKSCCSWLLLISLLCSLSNESQAISPDGEALLSFRNAVTRSDSFIHQWRPEDPDP 61
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNW GV CD K KRVITL+LT HK+ GP+ D+GKLD L+ L LH+N YG IP+ LGNC
Sbjct: 62 CNWNGVTCDAKTKRVITLNLTYHKIMGPLPPDIGKLDHLRLLMLHNNALYGAIPTALGNC 121
Query: 120 TELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDYIPPSLGKLQRLITFNVSNNF 179
T L+ + LQSNY +G IP IP SLG+L++L FNVSNNF
Sbjct: 122 TALEEIHLQSNYFTGPIPAEMGDLPGLQKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNF 181
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IPSDGVL+ FS++SF GN LCGK ++V C++DSG ++ SQS QNQ KKNS
Sbjct: 182 LVGQIPSDGVLSGFSKNSFIGNLNLCGKHVDVVCQDDSGNPSSHSQS---GQNQ--KKNS 236
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
G+LLISASATVGALLLVALMCFWGCFLYKKLGK E K LA+DVGGGASIVMFHGDLPYSS
Sbjct: 237 GKLLISASATVGALLLVALMCFWGCFLYKKLGKVEIKSLAKDVGGGASIVMFHGDLPYSS 296
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLE L+++HIIG GGFGTVYKLAMDDG VFALKRI KLNEGFDRFFERELEILGS
Sbjct: 297 KDIIKKLEMLNEEHIIGCGGFGTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGS 356
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLA 418
IKHRYLVNLRGYCNSPTSKLL+YD+LPGGSLDEALH ER EQLDWD+R+NII+GAAKGL+
Sbjct: 357 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHVERGEQLDWDSRVNIIIGAAKGLS 416
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE
Sbjct: 417 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 476
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538
YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN+VGWL FLISE R R+I+DP
Sbjct: 477 YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDP 536
Query: 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
NCEG+Q ESLDALL++ATQCVS SP++RPTMHRVVQ+LESEVMTPCPS+FYDS+SD
Sbjct: 537 NCEGMQMESLDALLSIATQCVSPSPEERPTMHRVVQLLESEVMTPCPSEFYDSSSD 592
|
|
| TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2285 (809.4 bits), Expect = 5.4e-237, P = 5.4e-237
Identities = 445/595 (74%), Positives = 494/595 (83%)
Query: 1 MGMYQIKCRGQWXXXXXXXXXXXNKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDP 60
MG+ +K W N++ AI+ DGEALLSFR V++SDG + WRPEDPDP
Sbjct: 1 MGICLMKRCCSWFLLISFLSALTNENEAISPDGEALLSFRNGVLASDGVIGLWRPEDPDP 60
Query: 61 CNWKGVKCD-KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC 119
CNWKGV CD K KRVI LSLT HKL GP+ +LGKLDQL+ L LH+N Y IP+ LGNC
Sbjct: 61 CNWKGVTCDAKTKRVIALSLTYHKLRGPLPPELGKLDQLRLLMLHNNALYQSIPASLGNC 120
Query: 120 TELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDYIPPSLGKLQRLITFNVSNNF 179
T L+G+ LQ+NY++G+IP IP SLG+L+RL FNVSNNF
Sbjct: 121 TALEGIYLQNNYITGTIPSEIGNLSGLKNLDLSNNNLNGAIPASLGQLKRLTKFNVSNNF 180
Query: 180 LVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNS 239
LVG IPSDG+L + S SF GNR LCGKQI++ C NDSG ST S SP QGG N
Sbjct: 181 LVGKIPSDGLLARLSRDSFNGNRNLCGKQIDIVC-NDSGNSTA-SGSPTG---QGGN-NP 234
Query: 240 GRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYSS 299
RLLISASATVG LLLVALMCFWGCFLYKKLG+ ESK L DVGGGASIVMFHGDLPY+S
Sbjct: 235 KRLLISASATVGGLLLVALMCFWGCFLYKKLGRVESKSLVIDVGGGASIVMFHGDLPYAS 294
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS 359
KDIIKKLE+L+++HIIG GGFGTVYKL+MDDGNVFALKRI KLNEGFDRFFERELEILGS
Sbjct: 295 KDIIKKLESLNEEHIIGCGGFGTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEILGS 354
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
IKHRYLVNLRGYCNSPTSKLL+YD+LPGGSLDEALH+R EQLDWD+R+NII+GAAKGLAY
Sbjct: 355 IKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRGEQLDWDSRVNIIIGAAKGLAY 414
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY
Sbjct: 415 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 474
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
MQSGRATEKTDVYSFGVLVLEVLSGK PTDASFIEKG NIVGWLNFLISE+R +EI+D +
Sbjct: 475 MQSGRATEKTDVYSFGVLVLEVLSGKLPTDASFIEKGFNIVGWLNFLISENRAKEIVDLS 534
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
CEGV+ ESLDALL++AT+CVSSSPD+RPTMHRVVQ+LESEVMTPCPSDFYDS+SD
Sbjct: 535 CEGVERESLDALLSIATKCVSSSPDERPTMHRVVQLLESEVMTPCPSDFYDSSSD 589
|
|
| TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1442 (512.7 bits), Expect = 1.2e-147, P = 1.2e-147
Identities = 284/583 (48%), Positives = 394/583 (67%)
Query: 26 SRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCD-KNKRVITLSLTNHKL 84
S A+ DG ALL ++ + L W+ D PC+W GV C+ +++RV++++L +L
Sbjct: 21 SFALTLDGFALLELKSGFNDTRNSLENWKDSDESPCSWTGVSCNPQDQRVVSINLPYMQL 80
Query: 85 SGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXX 144
G IS +GKL +L+ L LH N+ +G IP+E+ NCTEL+ + L++N+L G IP
Sbjct: 81 GGIISPSIGKLSRLQRLALHQNSLHGNIPNEITNCTELRAMYLRANFLQGGIPPDLGNLT 140
Query: 145 XXXXXXXXXXXXXDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204
IP S+ +L RL + N+S NF G IP GVL++F +F GN L
Sbjct: 141 FLTILDLSSNTLKGAIPSSISRLTRLRSLNLSTNFFSGEIPDIGVLSRFGVETFTGNLDL 200
Query: 205 CGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRL----LISASATVGALLLVALMC 260
CG+QI C++ G + SA K S RL LI A +T+ +V +
Sbjct: 201 CGRQIRKPCRSSMGFPVVLPHA-ESADESDSPKRSSRLIKGILIGAMSTMALAFIVIFVF 259
Query: 261 FWGCFLYKKLGK----NESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIG 316
W L KK K E K ++ FHGDLPYSS ++I+KLE+LD++ I+G
Sbjct: 260 LWIWMLSKKERKVKKYTEVKKQKDPSETSKKLITFHGDLPYSSTELIEKLESLDEEDIVG 319
Query: 317 SGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376
SGGFGTVY++ M+D FA+K+ID+ +G DR FERE+EILGS+KH LVNLRGYC P+
Sbjct: 320 SGGFGTVYRMVMNDLGTFAVKKIDRSRQGSDRVFEREVEILGSVKHINLVNLRGYCRLPS 379
Query: 377 SKLLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
S+LLIYD+L GSLD+ LHER+++ L+W+ARL I +G+A+GLAYLHHDCSP+I+HRDI
Sbjct: 380 SRLLIYDYLTLGSLDDLLHERAQEDGLLNWNARLKIALGSARGLAYLHHDCSPKIVHRDI 439
Query: 434 KSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYS 493
KSSNILL+ LE RVSDFGLAKLL DE++H+TT+VAGTFGYLAPEY+Q+GRATEK+DVYS
Sbjct: 440 KSSNILLNDKLEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYLAPEYLQNGRATEKSDVYS 499
Query: 494 FGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLA 553
FGVL+LE+++GKRPTD F+++GLN+VGW+N ++ E+R ++ID C V ES++ALL
Sbjct: 500 FGVLLLELVTGKRPTDPIFVKRGLNVVGWMNTVLKENRLEDVIDKRCTDVDEESVEALLE 559
Query: 554 VATQCVSSSPDDRPTMHRVVQILESEVMTPCPS-DFYD-SNSD 594
+A +C ++P++RP M++V Q+LE EVM+P D+YD S+SD
Sbjct: 560 IAERCTDANPENRPAMNQVAQLLEQEVMSPSSGIDYYDDSHSD 602
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 1.5e-91, Sum P(2) = 1.5e-91
Identities = 183/487 (37%), Positives = 259/487 (53%)
Query: 101 LNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDYI 160
+ L NN G I E GN +L L+ N LSGSIP I
Sbjct: 528 IELGHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSI 587
Query: 161 PPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGS 220
P SL +L L F+V+ N L G IPS G F SSF N LCG+ C S G
Sbjct: 588 PVSLQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESNH-LCGEH-RFPC---SEG- 641
Query: 221 TTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGCFLYKKLGKN--ESKGL 278
T + S +++GG + G + A +V L L++L+ ++ ES+ +
Sbjct: 642 TESALIKRSRRSRGG--DIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESM 699
Query: 279 AR-DVG--GGASIVMFHG-DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVF 334
R ++G G +V+F D S D++ + D +IIG GGFG VYK + DG
Sbjct: 700 NRKELGEIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKV 759
Query: 335 ALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEAL 394
A+K++ +R FE E+E L +H LV LRG+C +LLIY ++ GSLD L
Sbjct: 760 AIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWL 819
Query: 395 HERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451
HER++ L W RL I GAAKGL YLH C P I+HRDIKSSNILLD N + ++DF
Sbjct: 820 HERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADF 879
Query: 452 GLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDAS 511
GLA+L+ E+H++T + GT GY+ PEY Q+ AT K DVYSFGV++LE+L+ KRP D
Sbjct: 880 GLARLMSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMC 939
Query: 512 FIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES-LDALLAVATQCVSSSPDDRPTMH 570
+ +++ W+ + E R E+ DP +++ + +L +A C+S +P RPT
Sbjct: 940 KPKGCRDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQ 999
Query: 571 RVVQILE 577
++V L+
Sbjct: 1000 QLVSWLD 1006
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 3.2e-91, Sum P(3) = 3.2e-91
Identities = 194/512 (37%), Positives = 276/512 (53%)
Query: 100 FLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDY 159
+L+L N G IP G LQ L+L N L+G+IP +
Sbjct: 643 YLDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGF 702
Query: 160 IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGG 219
+P SLG L L +VSNN L G IP G LT F + + N GLCG + C SG
Sbjct: 703 LPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLP-PCS--SGS 759
Query: 220 STTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGCFLYKKLGKNESKGLA 279
T S + Q+ ++G ++ S V +L++AL + + KK + E +
Sbjct: 760 RPTRSHAHPKKQSIATGMSAG-IVFSFMCIV--MLIMAL--YRARKVQKKEKQREKYIES 814
Query: 280 RDVGGGAS--IVMFHGDLPYSSKDIIKKLETLDDDHI------------IGSGGFGTVYK 325
G +S + H L + K L L H+ IGSGGFG VYK
Sbjct: 815 LPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYK 874
Query: 326 LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385
+ DG+V A+K++ ++ DR F E+E +G IKHR LV L GYC +LL+Y+++
Sbjct: 875 AKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYM 934
Query: 386 PGGSLDEALHERSEQ----LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
GSL+ LHE++++ LDW AR I +GAA+GLA+LHH C P IIHRD+KSSN+LLD
Sbjct: 935 KYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLD 994
Query: 442 GNLEARVSDFGLAKLLEDEESHIT-TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLE 500
+ ARVSDFG+A+L+ ++H++ + +AGT GY+ PEY QS R T K DVYS+GV++LE
Sbjct: 995 QDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLE 1054
Query: 501 VLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDAL--LAVATQC 558
+LSGK+P D + N+VGW L E R EI+DP +S ++ L L +A+QC
Sbjct: 1055 LLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQC 1114
Query: 559 VSSSPDDRPTMHRVVQILESEVMTPCPSDFYD 590
+ P RPTM +V+ + + V +D D
Sbjct: 1115 LDDRPFKRPTMIQVMTMFKELVQVDTENDSLD 1146
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 874 (312.7 bits), Expect = 1.8e-87, P = 1.8e-87
Identities = 194/559 (34%), Positives = 305/559 (54%)
Query: 30 NSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPIS 89
N +G+AL S R +V + L W P +PC W V C+ VI + L N LSG +
Sbjct: 30 NMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNADLSGQLV 89
Query: 90 ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXX 149
LG+L L++L L+SNN G +PS+LGN T L L L N +G IP
Sbjct: 90 PQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVSLDLYLNSFTGPIPDSLGKLFKLRFL 149
Query: 150 XXXXXXXXDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209
IP SL + L ++SNN L G++P +G + F+ SF N LCG
Sbjct: 150 RLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVT 209
Query: 210 NVTCKNDSGGSTTDSQSPNS-AQNQGGKKNSGRLLISASATVGALLLVALMCFWGCFLYK 268
+ C S P GG +G I+ GA LL A F +
Sbjct: 210 SRPCPGSPPFSPPPPFIPPPIVPTPGGYSATGA--IAGGVAAGAALLFAAPAL--AFAWW 265
Query: 269 KLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYKLA 327
+ K + DV + G L +S +++ ++ + +I+G GGFG VYK
Sbjct: 266 RRRKPQE--FFFDVPAEEDPEVHLGQLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGR 323
Query: 328 MDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386
+ DG + A+KR+ ++ G + F+ E+E++ HR L+ LRG+C +PT +LL+Y ++
Sbjct: 324 LADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 383
Query: 387 GGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN 443
GS+ L ER L W R I +G+A+GL+YLH C P+IIHRD+K++NILLD
Sbjct: 384 NGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEE 443
Query: 444 LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
EA V DFGLA+L++ +++H+TT V GT G++APEY+ +G+++EKTDV+ +G+++LE+++
Sbjct: 444 FEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELIT 503
Query: 504 GKRPTDASFI--EKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES-LDALLAVATQCVS 560
G+R D + + + + ++ W+ L+ E + ++DP+ + +E+ ++ L+ VA C
Sbjct: 504 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQ 563
Query: 561 SSPDDRPTMHRVVQILESE 579
SSP +RP M VV++LE +
Sbjct: 564 SSPMERPKMSEVVRMLEGD 582
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 2.9e-87, P = 2.9e-87
Identities = 197/561 (35%), Positives = 305/561 (54%)
Query: 30 NSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPIS 89
N +G+AL + R +V + L W P +PC W V C+ VI + L N +LSG +
Sbjct: 27 NLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIRVDLGNAELSGHLV 86
Query: 90 ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXX 149
+LG L L++L L+SNN G IPS LGN T L L L N SG IP
Sbjct: 87 PELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRFL 146
Query: 150 XXXXXXXXDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209
IP SL + L ++SNN L G++P +G + F+ SF N LCG
Sbjct: 147 RLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVT 206
Query: 210 NVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASA---TVGALLLVALMCFWGCFL 266
+ C GS S P Q SG + A A GA LL A F
Sbjct: 207 SHPCP----GSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAI--AFA 260
Query: 267 YKKLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYK 325
+ + + + + DV + G L +S +++ + + +I+G GGFG VYK
Sbjct: 261 WWR--RRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNKNILGRGGFGKVYK 318
Query: 326 LAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384
+ DG + A+KR+ ++ G + F+ E+E++ HR L+ LRG+C +PT +LL+Y +
Sbjct: 319 GRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 378
Query: 385 LPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
+ GS+ L ER LDW R I +G+A+GL+YLH C P+IIHRD+K++NILLD
Sbjct: 379 MANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILLD 438
Query: 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV 501
EA V DFGLAKL++ +++H+TT V GT G++APEY+ +G+++EKTDV+ +G+++LE+
Sbjct: 439 EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLEL 498
Query: 502 LSGKRPTDASFI--EKGLNIVGWLNFLISEDRQREIIDPNCE-GVQSESLDALLAVATQC 558
++G+R D + + + + ++ W+ L+ E + ++DP+ + + L+ ++ VA C
Sbjct: 499 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLC 558
Query: 559 VSSSPDDRPTMHRVVQILESE 579
SP +RP M VV++LE +
Sbjct: 559 TQGSPMERPKMSEVVRMLEGD 579
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 738 (264.8 bits), Expect = 5.9e-84, Sum P(2) = 5.9e-84
Identities = 186/501 (37%), Positives = 266/501 (53%)
Query: 100 FLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDY 159
+ ++ N G IP GN LQ L+L N ++G+IP Y
Sbjct: 643 YFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGY 702
Query: 160 IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGG 219
+P SLG L L +VSNN L G IP G LT F S + N GLCG + C G
Sbjct: 703 LPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLR-PC-----G 756
Query: 220 STTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGCF-LYKKLGKNESKGL 278
S + P +++ K+ +I+ A ++ +M + + KK K E
Sbjct: 757 SAP--RRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIE 814
Query: 279 ARDVGGGASIVMFHGDLPYSSK--DIIKKLETLDDDHI------------IGSGGFGTVY 324
+ G S + P S K L L H+ +GSGGFG VY
Sbjct: 815 SLPTSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVY 874
Query: 325 KLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384
K + DG+V A+K++ ++ DR F E+E +G IKHR LV L GYC +LL+Y++
Sbjct: 875 KAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEY 934
Query: 385 LPGGSLDEALHERSEQ-----LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439
+ GSL+ LHE+S + L+W AR I +GAA+GLA+LHH C P IIHRD+KSSN+L
Sbjct: 935 MKWGSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVL 994
Query: 440 LDGNLEARVSDFGLAKLLEDEESHIT-TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLV 498
LD + EARVSDFG+A+L+ ++H++ + +AGT GY+ PEY QS R T K DVYS+GV++
Sbjct: 995 LDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVIL 1054
Query: 499 LEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDAL--LAVAT 556
LE+LSGK+P D + N+VGW L E R EI+DP +S ++ L +A+
Sbjct: 1055 LELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIAS 1114
Query: 557 QCVSSSPDDRPTMHRVVQILE 577
QC+ P RPTM +++ + +
Sbjct: 1115 QCLDDRPFKRPTMIQLMAMFK 1135
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 836 (299.3 bits), Expect = 1.9e-83, P = 1.9e-83
Identities = 194/561 (34%), Positives = 307/561 (54%)
Query: 30 NSDGEALLSFRTAVVSSD---GFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSG 86
N++G+AL + ++ S D L W PC W V C+ +V + L N KLSG
Sbjct: 30 NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSG 89
Query: 87 PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXX 146
+ +LG+L L++L L+SNN GEIP ELG+ EL L L +N +SG IP
Sbjct: 90 KLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKL 149
Query: 147 XXXXXXXXXXXDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCG 206
IP +L +Q L ++SNN L G IP +G + F+ SF N
Sbjct: 150 RFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIPVNGSFSLFTPISFANN----- 203
Query: 207 KQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVGALLLVALMCFWGCFL 266
++T D S SP GG+ + I+ GA LL A+ F
Sbjct: 204 ---SLT---DLPEPPPTSTSPTPPPPSGGQMTAA---IAGGVAAGAALLFAVPAI--AFA 252
Query: 267 YKKLGKNESKGLARDVGGGASIVMFHGDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYK 325
+ K + DV + G L ++ ++++ + + +++G GGFG VYK
Sbjct: 253 WWLRRKPQDHFF--DVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYK 310
Query: 326 LAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384
+ DGN+ A+KR+ ++ +G + F+ E+E++ HR L+ LRG+C +PT +LL+Y +
Sbjct: 311 GRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 370
Query: 385 LPGGSLDEALHERSE---QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441
+ GS+ L ER E LDW R +I +G+A+GLAYLH C +IIHRD+K++NILLD
Sbjct: 371 MANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLD 430
Query: 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV 501
EA V DFGLAKL+ +SH+TT V GT G++APEY+ +G+++EKTDV+ +GV++LE+
Sbjct: 431 EEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 490
Query: 502 LSGKRPTDASFI--EKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES-LDALLAVATQC 558
++G++ D + + + + ++ W+ ++ E + ++D EG E+ ++ L+ +A C
Sbjct: 491 ITGQKAFDLARLANDDDIMLLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLC 550
Query: 559 VSSSPDDRPTMHRVVQILESE 579
SS +RP M VV++LE +
Sbjct: 551 TQSSAMERPKMSEVVRMLEGD 571
|
|
| TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 721 (258.9 bits), Expect = 2.3e-82, Sum P(2) = 2.3e-82
Identities = 184/497 (37%), Positives = 264/497 (53%)
Query: 106 NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPXXXXXXXXXXXXXXXXXXXXDYIPPSLG 165
NN G IP E+G L L L N SGSIP IP SL
Sbjct: 591 NNLTGTIPVEVGQLKVLHILELLGNNFSGSIPDELSNLTNLERLDLSNNNLSGRIPWSLT 650
Query: 166 KLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQ 225
L L FNV+NN L G IP+ F +++F GN LCG + +C + + STT
Sbjct: 651 GLHFLSYFNVANNTLSGPIPTGTQFDTFPKANFEGNPLLCGGVLLTSC-DPTQHSTTKMG 709
Query: 226 SPNSAQNQGGKKNSGRLL-ISASATVGALLLVALMCFWGCFLYKKL---GKNE------- 274
GK N +L + G L++ L+ L K+ G +E
Sbjct: 710 K--------GKVNRTLVLGLVLGLFFGVSLILVLLAL--LVLSKRRVNPGDSENAELEIN 759
Query: 275 SKGLARDVGGGA----SIVMFHGDLPYSSKDI-----IKKLETLDDDHIIGSGGFGTVYK 325
S G +V G+ S+V+ G+ Y KD+ +K + +IIG GGFG VYK
Sbjct: 760 SNGSYSEVPPGSDKDISLVLLFGNSRYEVKDLTIFELLKATDNFSQANIIGCGGFGLVYK 819
Query: 326 LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385
+D+G A+K++ ++ F+ E+E+L KH LV L+GYC ++++LIY F+
Sbjct: 820 ATLDNGTKLAVKKLTGDYGMMEKEFKAEVEVLSRAKHENLVALQGYCVHDSARILIYSFM 879
Query: 386 PGGSLDEALHERSE---QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442
GSLD LHE E QLDW RLNI+ GA+ GLAY+H C P I+HRDIKSSNILLDG
Sbjct: 880 ENGSLDYWLHENPEGPAQLDWPKRLNIMRGASSGLAYMHQICEPHIVHRDIKSSNILLDG 939
Query: 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL 502
N +A V+DFGL++L+ +H+TT + GT GY+ PEY Q+ AT + DVYSFGV++LE+L
Sbjct: 940 NFKAYVADFGLSRLILPYRTHVTTELVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELL 999
Query: 503 SGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC-EGVQSESLDALLAVATQCVSS 561
+GKRP + + +V W++ + + + E+ D E E++ +L +A CV+
Sbjct: 1000 TGKRPMEVFRPKMSRELVAWVHTMKRDGKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQ 1059
Query: 562 SPDDRPTMHRVVQILES 578
+P RP + +VV L++
Sbjct: 1060 NPMKRPNIQQVVDWLKN 1076
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGF4 | FEI1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7954 | 0.9528 | 0.9576 | yes | no |
| C0LGL9 | FEI2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7747 | 0.9898 | 0.9983 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00007621001 | SubName- Full=Chromosome chr2 scaffold_196, whole genome shotgun sequence; (598 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 594 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-48 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-19 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-16 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-14 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-10 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 9e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 1e-57
Identities = 159/514 (30%), Positives = 247/514 (48%), Gaps = 45/514 (8%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
KR+ L L+ ++ SG + LG L +L L L N GEIP EL +C +L L L N
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
LSG IP+ + L LD+S N LS IP +LG ++ L+ N+S+N L G++PS G
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL 594
Query: 192 KFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASATVG 251
+ S+ GN LC GG TT P +K T+G
Sbjct: 595 AINASAVAGNIDLC------------GGDTTSGLPPCKRV----RKTPSWWFYITC-TLG 637
Query: 252 ALLLVALMCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGDLPYS--SKDIIKKLETL 309
A L++AL+ F F++ + N + G + F + S DI L +L
Sbjct: 638 AFLVLALVAF--GFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSL 692
Query: 310 DDDHIIGSGGFGTVYKLAMDDGNV-FALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
++++I G G YK + F +K I+ +N E+ +G ++H +V L
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKL 748
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G C S LI++++ G +L E L L W+ R I +G AK L +LH CSP +
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAPEYMQSGRATE 487
+ ++ I++DG E + L LL D + I++ Y+APE ++ TE
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITE 857
Query: 488 KTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG---VQ 544
K+D+Y FG++++E+L+GK P DA F G +IV W + S+ IDP+ G V
Sbjct: 858 KSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ ++ +A C ++ P RP + V++ LES
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-49
Identities = 76/190 (40%), Positives = 107/190 (56%), Gaps = 8/190 (4%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDR-FFERELEILGSIKHRYLVNLRGYC 372
+G GGFGTVY G A+K I K + RE+EIL + H +V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
L+ ++ GGSL + L E +L D L I++ +GL YLH S IIHRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 433 IKSSNILLD-GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE-YMQSGRATEKTD 490
+K NILLD N + +++DFGL+KLL ++S + TIV GT Y+APE + G +EK+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSD 176
Query: 491 VYSFGVLVLE 500
++S GV++ E
Sbjct: 177 IWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 37/278 (13%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGN------VFALKRIDKLNEGFDRFFERELEILGSIKHR 363
+G G FG VYK L G V LK + + F RE I+ + H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE--FLREARIMRKLDHP 61
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+V L G C ++ +++ GG L L + +L L+ + A+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
S IHRD+ + N L+ NL ++SDFGL++ L D++ + ++APE ++ G
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 484 RATEKTDVYSFGVLVLEVLS-GKRP----TDASFIEKGLNIVGWLNFLISEDRQREIIDP 538
+ T K+DV+SFGVL+ E+ + G++P ++ +E + + P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEY-----------LKNGYRLPQP-P 226
Query: 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
NC L + QC + P+DRPT +V+IL
Sbjct: 227 NCP-------PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 34/277 (12%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFDRF----FERELEILGSIKHRYL 365
+G G FG VYK L + L E F RE I+ + H +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDC 424
V L G C +++ +++PGG L + L + + L L+ + A+G+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
S IHRD+ + N L+ NL ++SDFGL++ L D++ + ++APE ++ G+
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 485 ATEKTDVYSFGVLVLEVLS-GKRP----TDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
T K+DV+SFGVL+ E+ + G+ P ++A +E + R PN
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY------------LKKGYRLPKPPN 228
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
C L + QC + P+DRPT +V+IL
Sbjct: 229 CP-------PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-46
Identities = 88/273 (32%), Positives = 126/273 (46%), Gaps = 23/273 (8%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLR 369
+GSG FGTVYK A G + A+K + K D+ RE+ IL + H +V L
Sbjct: 6 KLGSGSFGTVYK-AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
L+ ++ GG L + L R L D I + +GL YLH S II
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLH---SNGII 120
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR-ATEK 488
HRD+K NILLD N +++DFGLAK L + S T GT Y+APE + G K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179
Query: 489 TDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESL 548
DV+S GV++ E+L+GK P F + + L I ++ + S S
Sbjct: 180 VDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRI----LGPPLEFDEPKWSSGS- 230
Query: 549 DALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581
+ + +C++ P RPT +IL+
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAE---EILQHPWF 260
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 9e-45
Identities = 69/197 (35%), Positives = 103/197 (52%), Gaps = 10/197 (5%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G FG VY A D G + A+K I K + RE++IL +KH +V L
Sbjct: 6 KLGEGSFGKVYL-ARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
L+ ++ GG L + L +R + +AR + L YLH S I+H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-FYLRQILSALEYLH---SKGIVH 120
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RD+K NILLD + +++DFGLA+ L+ E +TT V GT Y+APE + + D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTFV-GTPEYMAPEVLLGKGYGKAVD 178
Query: 491 VYSFGVLVLEVLSGKRP 507
++S GV++ E+L+GK P
Sbjct: 179 IWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 4e-42
Identities = 84/284 (29%), Positives = 132/284 (46%), Gaps = 48/284 (16%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF---ALKRIDKLNEGFD----RFFERELEILGSIKH 362
+G G FG VYK L D A+K L EG F E I+ + H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREEFLEEASIMKKLSH 60
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L G C ++ +++PGG L + L + E+L L + + AKG+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL-----AP 477
S +HRD+ + N L+ NL ++SDFGL++ + +++ + G L AP
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGGKLPIKWMAP 173
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLS-GKRP----TDASFIEKGLNIVGWLNFLISEDRQ 532
E ++ G+ T K+DV+SFGVL+ E+ + G++P ++ +E L ED
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE----------LL--EDGY 221
Query: 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
R NC + L L+ QC + P+DRPT +V+ L
Sbjct: 222 RLPRPENC----PDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 78/284 (27%), Positives = 127/284 (44%), Gaps = 43/284 (15%)
Query: 314 IIGSGGFGTVYK--LAMDDGNVF--ALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG VYK L DG A+K + + +E + F +E ++ + H +V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ--------LDWDARLNIIMGAAKGLAYL 420
G C L+ +++ GG L + L + L L+ + AKG+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT-----IVAGTFGYL 475
S + +HRD+ + N L+ +L ++SDFGL++ + D++ + + ++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WM 174
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP-TDASFIEKGLNIVGWLNFLISEDRQR 533
APE ++ G T K+DV+SFGVL+ E+ + G P S E L +L R
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYL--RKGYR 225
Query: 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
C D L + C P+DRPT +V+ LE
Sbjct: 226 LPKPEYC-------PDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 32/212 (15%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNL 368
++G G FG+VY LA+D G + A+K ++ +E ERE+ IL S++H +V
Sbjct: 6 ELLGRGSFGSVY-LALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 369 RGYCNSPTSK-LLIY-DFLPGGSLDEALHERSEQLDWDARLN----------IIMGAAKG 416
G L I+ +++ GGSL L + +L I+ +G
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-------KLPEPVIRKYTRQIL----EG 113
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-SHITTIVAGTFGYL 475
LAYLH S I+HRDIK +NIL+D + +++DFG AK L D E T V GT ++
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
APE ++ D++S G V+E+ +GK P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 67/197 (34%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG-- 370
IG GGFG VYK A G A+K I ++ E++IL KH +V G
Sbjct: 8 IGKGGFGEVYK-ARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ +F GGSL + L ++ L + KGL YLH S IIH
Sbjct: 67 LKKDELW--IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIH 121
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RDIK++NILL + E ++ DFGL+ L D ++ T + GT ++APE + K D
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYKAD 179
Query: 491 VYSFGVLVLEVLSGKRP 507
++S G+ +E+ GK P
Sbjct: 180 IWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 75/277 (27%), Positives = 126/277 (45%), Gaps = 42/277 (15%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G FG VY + DG ++ LK ID ++E E++IL + H ++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQ---------LDWDARLNIIMGAAKGLAYLHH 422
++ ++ GG L + + ++ ++ LDW +L L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYLH- 120
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
S +I+HRDIK NI L N ++ DFG++K+L T+V GT YL+PE Q+
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQN 177
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRPTDA-SFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541
K+D++S G ++ E+ + K P + + +E L I+ + P
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL------------KGQYPP-IP 224
Query: 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
S L L+ + + P++RP+ + QIL+S
Sbjct: 225 SQYSSELRNLV---SSLLQKDPEERPS---IAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 88/292 (30%), Positives = 135/292 (46%), Gaps = 45/292 (15%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLN----EGFDRFFERELEILGSIKHRYLVNL 368
+G G FG V D N + LN E FERE+EIL ++ H +V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 369 RGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+G C P + LI ++LP GSL + L +Q++ L KG+ YL S
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQ 128
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLL----------EDEESHITTIVAGTFGYLA 476
R IHRD+ + NIL++ ++SDFGLAK+L E ES I F Y A
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI-------FWY-A 180
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTD---ASF-----IEKGLNIVGWLNFLIS 528
PE +++ + + +DV+SFGV + E+ + P+ A F I +G IV L L+
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL- 239
Query: 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580
++ +R P+C D + + C + P DRP+ ++ I++
Sbjct: 240 KEGERLPRPPSCP-------DEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 72/203 (35%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDK----LNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG V L D G ++A+K + K + + E IL I H ++V L
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKL 58
Query: 369 RGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDC 424
Y KL L+ ++ PGG L L + + AR I++ L YLH
Sbjct: 59 H-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYLH--- 110
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
S II+RD+K NILLD + +++DFGLAK L E S T GT YLAPE +
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 485 ATEKTDVYSFGVLVLEVLSGKRP 507
+ D +S GVL+ E+L+GK P
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 3e-31
Identities = 83/275 (30%), Positives = 125/275 (45%), Gaps = 23/275 (8%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKH-RYLVNLRG 370
+G G FG VY LA D V ALK + K F RE++IL S+ H +V L
Sbjct: 8 LGEGSFGEVY-LARDRKLV-ALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ S L+ +++ GGSL++ L + + L L I+ L YLH S I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122
Query: 429 IHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEESH-----ITTIVAGTFGYLAPEYMQS 482
IHRDIK NILLD + ++ DFGLAKLL D S + + GT GY+APE +
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 483 ---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
A+ +D++S G+ + E+L+G P + EK + +I E + P
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEG---EKNSSATSQTLKIILELPTPSLASPL 239
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
A + + ++ P +R + +
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 68/198 (34%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + D +FA+K ++K + +G R E IL + H +LVNL
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ L+ D L GG L L ++ + + + I L YLH S II
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEIVLALEYLH---SKGII 122
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKT 489
HRDIK NILLD ++DF +A + + +TT +GT GY+APE + +
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAV 180
Query: 490 DVYSFGVLVLEVLSGKRP 507
D +S GV E L GKRP
Sbjct: 181 DWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 9e-30
Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 34/276 (12%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKHRYLVNLRG 370
++G G G VYK G ++ALK+I +E F + REL+ L S + Y+V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAA----KGLAYLHHD 423
++ +++ GGSL + L + E ++ A KGL YLH
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEP--------VLAYIARQILKGLDYLHTK 118
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
IIHRDIK SN+L++ E +++DFG++K+LE+ T V GT Y++PE +Q
Sbjct: 119 --RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGE 175
Query: 484 RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543
+ D++S G+ +LE GK P + L+
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLP------PGQPSFFE-LMQAICDGPPPSLP-AEE 227
Query: 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579
S ++ C+ P RP+ ++L+
Sbjct: 228 FSPEFRDFIS---ACLQKDPKKRPS---AAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 71/203 (34%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G FG V+K+ D V+A+K+ID K+N E +L + Y++ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR---Y 64
Query: 372 CNSPTSKLLIY---DFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
S K + ++ G L + L +R L D + GLA+LH S +
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKK 121
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE 487
I+HRDIKS N+ LD ++ D G+AKLL D + TIV GT YL+PE + E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKPYNE 180
Query: 488 KTDVYSFGVLVLEVLSGKRPTDA 510
K+DV++ GV++ E +GK P DA
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 23/232 (9%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK-LAMDDG-NVFALKRIDKLNEGFDRF----FERELE 355
I K L+ ++GSG FGTVYK + + +G V I L E E
Sbjct: 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
++ S+ H ++V L G C S LI +P G L + + + + LN + AK
Sbjct: 62 VMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG---TF 472
G++YL R++HRD+ + N+L+ +++DFGLAKLL+ +E G
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPI 175
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDA-------SFIEKG 516
++A E + T K+DV+S+GV V E+++ G +P + +EKG
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 34/211 (16%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNL 368
IG G +G VYK A + G + ALK+I NE GF RE+++L ++H +V L
Sbjct: 5 AQIGEGTYGQVYK-ARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 369 RGYCNSPTSK--LLIYDFLP---GGSLDEALHERSE--------QLDWDARLNIIMGAAK 415
+ S ++++++ G LD + +E QL +
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------------LE 111
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
GL YLH + I+HRDIK SNIL++ + +++DFGLA+ S T T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168
Query: 476 APE-YMQSGRATEKTDVYSFGVLVLEVLSGK 505
PE + + R + D++S G ++ E+ GK
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 62/197 (31%), Positives = 107/197 (54%), Gaps = 8/197 (4%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+IG G FG VYK L ++ G+ A+K+I K+ E + +E+++L ++KH +V G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ S +I ++ GSL + + + + +GLAYLH +IH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLVAVYVYQVLQGLAYLH---EQGVIH 122
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RDIK++NIL + +++DFG+A L D ++V GT ++APE ++ A+ +D
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGASTASD 181
Query: 491 VYSFGVLVLEVLSGKRP 507
++S G V+E+L+G P
Sbjct: 182 IWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-----RFFERELEILGSIKHRYLVNL 368
+GSG FG+VY+ L +DDG+ FA+K + ++G + E+E+ +L ++H +V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 369 RGYCNSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
G L I+ + +PGGSL L ++ GL YLH
Sbjct: 68 LGTERE-EDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY-MQSGRAT 486
+HRDIK +NIL+D N +++DFG+AK + E G+ ++APE Q G
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 487 EKTDVYSFGVLVLEVLSGKRP 507
D++S G VLE+ +GK P
Sbjct: 181 LAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 82/274 (29%), Positives = 131/274 (47%), Gaps = 33/274 (12%)
Query: 315 IGSGGFGTVYKLAMD-----DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG+V D G V A+K++ R FERE+EIL S++H +V +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 370 GYCNSP--TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
G C S + L+ ++LP GSL + L + E+LD L KG+ YL S R
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKR 128
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG---TFGYLAPEYMQSGR 484
+HRD+ + NIL++ ++ DFGL K+L ++ + G F Y APE + +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESK 187
Query: 485 ATEKTDVYSFGVLVLEVLS----GKRPTDASFIE------KGLNIVGWLNFLISEDRQRE 534
+ +DV+SFGV++ E+ + P A F+ +G IV L L+ ++ R
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPP-AEFMRMMGNDKQGQMIVYHLIELL-KNNGRL 245
Query: 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT 568
P C + A+ +C ++ P RP+
Sbjct: 246 PAPPGCP-------AEIYAIMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 7/202 (3%)
Query: 307 ETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL 365
E D +G G +G+VYK + + G V A+K + + E +E+ IL Y+
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEI-IKEISILKQCDSPYI 60
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
V G T ++ ++ GS+ + + ++ L + I+ KGL YLH S
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---S 117
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
+ IHRDIK+ NILL+ +A+++DFG++ L D + T V GT ++APE +Q
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGY 176
Query: 486 TEKTDVYSFGVLVLEVLSGKRP 507
K D++S G+ +E+ GK P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 82/271 (30%), Positives = 126/271 (46%), Gaps = 37/271 (13%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+ IG G FG VY + +D G + A+K RI + + E+++L +KH LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 370 GYCNSPTSKLLIY-DFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAK----GLAYLHHD 423
G K+ I+ ++ GG+L+E L R ++I GLAYLH
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHGRILDE------HVIRVYTLQLLEGLAYLH-- 116
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG---YLAPEYM 480
S I+HRDIK +NI LD N ++ DFG A L++ + + V G Y+APE +
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 481 QSGRATEK---TDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537
G+ D++S G +VLE+ +GKRP S ++ I+ + + I
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHVGA-----GHKPPI- 227
Query: 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPT 568
P+ + E D L +C+ S P RPT
Sbjct: 228 PDSLQLSPEGKDFL----DRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 306 LETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKHR 363
LE L + +G+G G V K L G + A+K I ++NE + REL+IL
Sbjct: 3 LEYLGE---LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
Y+V G + + +++ GGSLD+ L E ++ I + KGL YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
IIHRD+K SNIL++ + ++ DFG++ L + + GT Y+APE +Q
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAPERIQGN 174
Query: 484 RATEKTDVYSFGVLVLEVLSGKRP 507
+ K+D++S G+ ++E+ +G+ P
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 84/278 (30%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G G+V K + + G +FALK I N + RELEI S K Y+V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 372 C--NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN------IIMGAAKGLAYLHHD 423
S +S + ++ GGSLD + ++ R+ I KGL+YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKR---GGRIGEKVLGKIAESVLKGLSYLH-- 122
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG----YLAPEY 479
S +IIHRDIK SNILL + ++ DFG++ L +AGTF Y+APE
Sbjct: 123 -SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-------VNSLAGTFTGTSFYMAPER 174
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVG---WLNFLISEDRQREII 536
+Q + +DV+S G+ +LEV + P F +G +G L+++++
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNRFP----FPPEGEPPLGPIELLSYIVNMPNPELKD 230
Query: 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+P SE + QC+ P RPT +++
Sbjct: 231 EPGNGIKWSEEFKDFIK---QCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF--DRFFERELEILGSIKHRYLVNLRGYC 372
IGSG FG V+ + A+K I EG + F E +++ + H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+ L+++F+ G L + L + + + L + + +G+AYL +IHRD
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVY 492
+ + N L+ N +VSDFG+ + + D++ +T + +PE + + K+DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 493 SFGVLVLEVLS-GKRPTD 509
SFGVL+ EV S GK P +
Sbjct: 186 SFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 50/286 (17%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER----------ELEILGSIK 361
+IG G +G VY LA+ G + A+K+++ R R E+E L +
Sbjct: 8 LIGKGTYGRVY-LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEAL--HERSEQLDWDARLNIIMGAAKGLAY 419
H +V G+ + + +++PGGS+ L + R E+ ++ +GLAY
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL---EGLAY 123
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAPE 478
LH S I+HRD+K+ N+L+D + ++SDFG++K +D ++ + G+ ++APE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 479 YMQSGRA--TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLN-------FLISE 529
+ S + K D++S G +VLE+ +G+RP W + F +
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------------WSDEEAIAAMFKLGN 226
Query: 530 DRQREIIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
R I P+ + +LD L A C + +PD+RPT ++Q
Sbjct: 227 KRSAPPIPPDVSMNLSPVALDFLNA----CFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 312 DHIIGSGGFGTVY----KLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLV 366
+ +IG G FG V KL A+K + ++ F E I+G H ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
L G ++I +++ GSLD+ L E + + ++ G A G+ YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG---TFGYLAPEYMQSG 483
+HRD+ + NIL++ NL +VSDFGL++ LED E+ TT G + APE +
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT--KGGKIPIRWTAPEAIAYR 183
Query: 484 RATEKTDVYSFGVLVLEVLS-GKRP 507
+ T +DV+SFG+++ EV+S G+RP
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 70/211 (33%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRI---------DKLNEGFDRFFERELEILGSIKH 362
+IGSG FG+VY L M+ G + A+K++ RE+ +L ++H
Sbjct: 7 LIGSGSFGSVY-LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 363 RYLVNLRGYCNSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
+V G + L I+ +++PGGS+ AL + N + KGL YLH
Sbjct: 66 ENIVQYLG-SSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA-----GTFGYLA 476
+ IIHRDIK +NIL+D ++SDFG++K LE T A G+ ++A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
PE ++ T K D++S G LV+E+L+GK P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 68/264 (25%), Positives = 128/264 (48%), Gaps = 33/264 (12%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
+GSG FG V++ + A+K + + + F++E++ L ++H++L++L C+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 375 PTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
+I + + GSL L Q L + +++ A+G+AYL IHRD+
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130
Query: 434 KSSNILLDGNLEARVSDFGLAKLLEDE--ESHITTIVAGTFGYLAPEYMQSGRATEKTDV 491
+ NIL+ +L +V+DFGLA+L++++ S I + + APE G + K+DV
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI---PYKWTAPEAASHGTFSTKSDV 187
Query: 492 YSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ----SE 546
+SFG+L+ E+ + G+ P G N E+ D G + ++
Sbjct: 188 WSFGILLYEMFTYGQVPYP-----------GMNN--------HEVYDQITAGYRMPCPAK 228
Query: 547 SLDALLAVATQCVSSSPDDRPTMH 570
+ + +C ++ P+DRP+
Sbjct: 229 CPQEIYKIMLECWAAEPEDRPSFK 252
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 47/287 (16%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRID--KLNEGFDRFFER-----ELEILGSIKHRYL 365
IG G FGTV K+ DG + K ID + E E+ E+ IL +KH +
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-----EKQQLVSEVNILRELKHPNI 61
Query: 366 VNLRGYC----NSPTSKLLIY-DFLPGGSLDEAL---HERSEQLDWDARLNIIMGAAKGL 417
V Y + L I ++ GG L + + + + ++ + I+ L
Sbjct: 62 V---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 418 AYLHH--DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
H+ D ++HRD+K +NI LD N ++ DFGLAK+L + S T V GT Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYM 177
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRP-TDASFIEKGLNIVGWLNFLISEDRQRE 534
+PE + EK+D++S G L+ E+ + P T + ++ L I E + R
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--------LASKIKEGKFRR 229
Query: 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581
I L V ++ PD RP+ ++L+ ++
Sbjct: 230 I--------PYRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 75/230 (32%), Positives = 122/230 (53%), Gaps = 20/230 (8%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALK-RIDKLNEGF----DRFFERELE 355
I+K+ E L ++GSG FGTVYK + + +G + I LNE + F E
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
I+ S+ H +LV L G C SPT +L + +P G L + +HE + + LN + AK
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE-DEESHITTIVAGTFGY 474
G+ YL R++HRD+ + N+L+ +++DFGLA+LLE DE+ + +
Sbjct: 121 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 475 LAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDA-------SFIEKG 516
+A E + + T ++DV+S+GV + E+++ G +P D +EKG
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSIK-HRYLVNL 368
IIG G F TV + +A+K +DK + E ++ + E E+L + H ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ + ++ P G L + + + LD L YLH S I
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGI 123
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA------------------- 469
IHRD+K NILLD ++ +++DFG AK+L+ S +
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDAS 511
GT Y++PE + A + +D+++ G ++ ++L+GK P S
Sbjct: 184 GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-23
Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 31/272 (11%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG VYK + A+K R L R F +E EIL H +V L G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ + +PGGSL L ++ +L L + + AA G+ YL IHRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---IHRD 118
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT----FGYLAPEYMQSGRATEK 488
+ + N L+ N ++SDFG+++ +EE I T+ G + APE + GR T +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175
Query: 489 TDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547
+DV+S+G+L+ E S G P G N + RE I+ +
Sbjct: 176 SDVWSYGILLWETFSLGDTPYP-----------GMSN-----QQTRERIESGYRMPAPQL 219
Query: 548 L-DALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ + + QC + P++RP+ + L+
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 60/188 (31%), Positives = 101/188 (53%), Gaps = 6/188 (3%)
Query: 13 LLFILLLCIIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNK 72
L +L + +N S + E LLSF++++ +L+ W D C W+G+ C+ +
Sbjct: 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSA-DVCLWQGITCNNSS 69
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNY 131
RV+++ L+ +SG IS+ + +L ++ +NL +N G IP ++ + L+ L+L +N
Sbjct: 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
+GSIP G++ NL LD+S+N LS IP +G L ++ N LVG IP LT
Sbjct: 130 FTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP--NSLT 185
Query: 192 KFSESSFF 199
+ F
Sbjct: 186 NLTSLEFL 193
|
Length = 968 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 73/231 (31%), Positives = 120/231 (51%), Gaps = 23/231 (9%)
Query: 303 IKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVF----ALKRIDKLN--EGFDRFFERELE 355
I K L ++GSG FGTV+K + + +G+ A+K I + + F + L
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA 414
+ GS+ H Y+V L G C P + L L+ P GSL + + + + LD LN + A
Sbjct: 63 M-GSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFG 473
KG+ YL ++HR++ + NILL + +++DFG+A LL D++ + +
Sbjct: 120 KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 474 YLAPEYMQSGRATEKTDVYSFGVLVLEVLS-------GKRPTDA-SFIEKG 516
++A E + GR T ++DV+S+GV V E++S G RP + +EKG
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 22/210 (10%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
E + IG G G VYK A D G A+K++ + + E+ I+ KH
Sbjct: 19 ELYKNLEKIGEGASGEVYK-ATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPN 76
Query: 365 LVNLRGYCNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA-KGL 417
+V+ S L ++ +++ GGSL + + + +++ + ++ + +GL
Sbjct: 77 IVDYYD------SYLVGDELWVVMEYMDGGSLTDIITQNFVRMN-EPQIAYVCREVLQGL 129
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YLH S +IHRDIKS NILL + +++DFG A L E+S ++V GT ++AP
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAP 185
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
E ++ K D++S G++ +E+ G+ P
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRF----FERELEILGSIKHRYLVNL 368
+IG+G FG V++ + G I L G+ F E I+G H ++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G ++I +++ G+LD+ L + + + ++ G A G+ YL
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNY 128
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG--YLAPEYMQSGRAT 486
+HRD+ + NIL++ NLE +VSDFGL+++LED+ T G + APE + + T
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 487 EKTDVYSFGVLVLEVLS-GKRP 507
+DV+SFG+++ EV+S G+RP
Sbjct: 189 SASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 22/273 (8%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
E+L D +G G FG V+ + A+K + + F + E +I+ ++H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ-EAQIMKKLRHDKLV 64
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
L S ++ +F+ GSL + L E + L +++ A G+AY+
Sbjct: 65 PLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER--- 120
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
IHRD++++NIL+ NL +++DFGLA+L+ED E + APE GR
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 486 TEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544
T K+DV+SFG+L+ E+++ G+ P G +N + E +R P +G
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYP-----------GMVNREVLEQVERGYRMPCPQGC- 228
Query: 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
ESL L+ C PD+RPT + LE
Sbjct: 229 PESLHELM---KLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G +G VYK A D G + ALK R+D EG RE+ +L +KH +V L
Sbjct: 6 KLGEGTYGVVYK-ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA----KGLAYLHHDCS 425
++ L++++ L + L +R L N+I +GLAY H S
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----PNLIKSIMYQLLRGLAYCH---S 116
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
RI+HRD+K NIL++ + +++DFGLA+ T V T Y APE + +
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKH 175
Query: 486 -TEKTDVYSFGVLVLEVLSGK 505
+ D++S G + E+++GK
Sbjct: 176 YSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 52/109 (47%), Positives = 70/109 (64%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L+L +++L G I +LG++ LK++ L NN GEIP E+G T L L L N L+G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
PS LGNL NL L + N LS IPPS+ LQ+LI+ ++S+N L G IP
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 315 IGSGGFGTVYKL-AMDDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRG 370
+G GGFG V + FALK + K + G E EIL H ++V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ ++ GG L L +R ++ AR I YLH+ II+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLAFEYLHNR---GIIY 116
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RD+K N+LLD N ++ DFG AK L+ + T GT Y+APE + + D
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEIILNKGYDFSVD 174
Query: 491 VYSFGVLVLEVLSGKRP 507
+S G+L+ E+L+G+ P
Sbjct: 175 YWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 3e-22
Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 312 DHIIGSGGFGTVY----KLAMDDGNVFALKRIDKLNEGFD----RFFERELEILGSIKHR 363
+ +IG+G FG V KL A+K L G+ R F E I+G H
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIK---TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+++L G ++I +F+ G+LD L + Q + ++ G A G+ YL
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG------YLAP 477
+HRD+ + NIL++ NL +VSDFGL++ LED+ S T + G + AP
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAP 180
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLS-GKRP 507
E + + T +DV+S+G+++ EV+S G+RP
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 72/284 (25%), Positives = 139/284 (48%), Gaps = 44/284 (15%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
E+L + +G+G FG V+ + A+K + + + F E ++ +++H LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKLV 64
Query: 367 NLRGYCNSPTSKLLIY---DFLPGGSLDEALHERSEQ---------LDWDARLNIIMGAA 414
L ++ +K IY +F+ GSL + L +S++ +D+ A++ A
Sbjct: 65 KL----HAVVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQI------A 112
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
+G+A++ IHRD++++NIL+ +L +++DFGLA+++ED E +
Sbjct: 113 EGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169
Query: 475 LAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQR 533
APE + G T K+DV+SFG+L++E+++ G+ P G N + +R
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP-----------GMSNPEVIRALER 218
Query: 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
P E E + ++ +C + P++RPT + +L+
Sbjct: 219 GYRMPRPENCPEELYNIMM----RCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 312 DHIIGSGGFGTVY--KLAMDDGNVFALKRIDKLNEGFD----RFFERELEILGSIKHRYL 365
+ +IG+G FG V +L + + I L G+ R F E I+G H +
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVA-IKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
++L G +++ +++ GSLD L + Q + ++ G A G+ YL D
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS-DMG 126
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG--YLAPEYMQSG 483
+HRD+ + NIL++ NL +VSDFGL+++LED+ T G + APE +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 484 RATEKTDVYSFGVLVLEVLS-GKRP 507
+ T +DV+S+G+++ EV+S G+RP
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 22/214 (10%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEIL 357
+SK++ IG G FG V L G A+K + K + + F E ++
Sbjct: 4 NSKELKLG-------ATIGKGEFGDVM-LGDYRGQKVAVKCL-KDDSTAAQAFLAEASVM 54
Query: 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKG 416
+++H LV L G ++ +++ GSL + L R + +L + +G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GY 474
+ YL +HRD+ + N+L+ +L A+VSDFGLAK + + G +
Sbjct: 115 MEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKW 165
Query: 475 LAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP 507
APE ++ + + K+DV+SFG+L+ E+ S G+ P
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-----RFFERELEILGSIKHRYLVN 367
++G G FG VY +D G A+K++ + + E E+++L +++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDC 424
G + + +++PGGS+ + L +E + I+ +G+ YLH
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGVEYLH--- 121
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI--VAGTFGYLAPEYMQS 482
S I+HRDIK +NIL D ++ DFG +K L+ S T + V GT +++PE +
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP 507
K DV+S G V+E+L+ K P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 315 IGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRYL 365
+G GGFG V + G ++A K++DK R +R E +IL + R++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK-----KRLKKRKGEQMALNEKKILEKVSSRFI 55
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLHH 422
V+L + L+ + GG L ++ E +AR I AA+ GL +LH
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR--AIFYAAQIICGLEHLHQ 113
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
RI++RD+K N+LLD + R+SD GLA L+ + AGT GY+APE +Q
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQG 168
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP 507
D ++ G + E+++G+ P
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 85/304 (27%), Positives = 138/304 (45%), Gaps = 64/304 (21%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNV-FALKRIDKLNEGFDRFFER 352
++P S + +KL G+G FG V+ +G A+K + + F +
Sbjct: 2 EIPRESLKLERKL---------GAGQFGEVWM-GTWNGTTKVAVKTLKPGTMSPEAFLQ- 50
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN--II 410
E +I+ ++H LV L C+ ++ +++ GSL + L + RL +
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK---KLRLPQLVD 107
Query: 411 MGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
M A A+G+AYL S IHRD+ + NIL+ NL +++DFGLA+L+ED+E T
Sbjct: 108 MAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE--YTARE 162
Query: 469 AGTF--GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNF 525
F + APE GR T K+DV+SFG+L+ E+++ G+ P G+
Sbjct: 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY------PGMT------- 209
Query: 526 LISEDRQREIID-----------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
RE+++ PNC + L + QC P++RPT +
Sbjct: 210 ------NREVLEQVERGYRMPRPPNCP-------EELYDLMLQCWDKDPEERPTFEYLQS 256
Query: 575 ILES 578
LE
Sbjct: 257 FLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G VY + + + A+KRID K D +E++ + H +V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTS 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYLHHDCSPRII 429
L+ +L GGSL + + + LD ++ KGL YLH S I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLE---DEESHITTIVAGTFGYLAPEYMQSGRA- 485
HRDIK+ NILL + +++DFG++ L D + GT ++APE M+
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 486 TEKTDVYSFGVLVLEVLSGKRP 507
K D++SFG+ +E+ +G P
Sbjct: 185 DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 73/271 (26%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 315 IGSGGFGTVYK--LAMDDGNVF--ALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG+V K M G A+K + + + G F RE ++ + H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-REASVMAQLDHPCIVRL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G C +L+ + P G L + L +R E D + A G+AYL S
Sbjct: 62 IGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-KELAHQVAMGMAYLE---SKHF 116
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYMQSGRAT 486
+HRD+ + N+LL +A++SDFG+++ L + AG + + APE + G+ +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 487 EKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545
K+DV+S+GV + E S G +P KG ++ L E +R C
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEM---KGAEVIAML-----ESGERLPRPEECP---- 224
Query: 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
+ ++ C P+DRPT +
Sbjct: 225 ---QEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 315 IGSGGFGTVYKL-AMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +G VYK G + A+K+I +EG + RE+++L + H ++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
L+++F+ L + + +R L + + +GLA+ H S I+HR
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM-QSGRATEKTD 490
D+K N+L++ +++DFGLA+ T V T Y APE + + D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTPVD 181
Query: 491 VYSFGVLVLEVLSGK 505
++S G + E+LS +
Sbjct: 182 IWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 41/270 (15%)
Query: 315 IGSGGFGTVYKLAMDD--GNVF--ALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG V + G V A+K + DKL++ D F +E I+ S+ H L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLIRL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD-------WDARLNIIMGAAKGLAYLH 421
G + + + + P GSL + L R + L D + I A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLDRL--RKDALGHFLISTLCDYAVQI----ANGMRYLE 114
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT--FGYLAPEY 479
S R IHRD+ + NILL + + ++ DFGL + L E H F + APE
Sbjct: 115 ---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 480 MQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538
+++ + +DV+ FGV + E+ + G+ P GL+ L I ++ +R
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPW------AGLSGSQILK-KIDKEGERLERPE 224
Query: 539 NCEGVQSESLDALLAVATQCVSSSPDDRPT 568
C D + V QC + +P DRPT
Sbjct: 225 AC------PQD-IYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-21
Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 30/277 (10%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
E+L + +G G FG V+ + A+K + + F + E +++ ++H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLV 64
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
L S ++ +++ GSL + L E + L +++ A G+AY+
Sbjct: 65 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER--- 120
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
+HRD++++NIL+ NL +V+DFGLA+L+ED E + APE GR
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 486 TEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544
T K+DV+SFG+L+ E+ + G+ P G +N RE++D G +
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYP-----------GMVN--------REVLDQVERGYR 221
Query: 545 ----SESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
E ++L + QC P++RPT + LE
Sbjct: 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-21
Identities = 83/286 (29%), Positives = 133/286 (46%), Gaps = 31/286 (10%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
++P S +IKKL G+G FG V+ + A+K + + F E E
Sbjct: 2 EIPRESLQLIKKL---------GNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE-E 51
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMG 412
+I+ ++H LV L S ++ +++ GSL + L + L +++
Sbjct: 52 AQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
A G+AY+ IHRD++S+NIL+ L +++DFGLA+L+ED E
Sbjct: 111 VAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531
+ APE GR T K+DV+SFG+L+ E+++ G+ P G+N N + E
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY------PGMN-----NREVLEQV 216
Query: 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+R P C SL L+ QC P++RPT + LE
Sbjct: 217 ERGYRMP-CPQDCPISLHELM---LQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 46/214 (21%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK------------LNEGFDRFFERELEILGSI 360
+G+G FG V L G +ALK + K LNE IL SI
Sbjct: 9 LGTGSFGRV-MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNE---------KRILQSI 58
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARL---NIIMGAAKG 416
+H +LVNL G ++ L+ +++PGG L + +S + AR +++
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEPVARFYAAQVVLA---- 113
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L YLH I++RD+K N+LLD + +++DFG AK ++ T+ GT YLA
Sbjct: 114 LEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLC-GTPEYLA 166
Query: 477 PEYMQS---GRATEKTDVYSFGVLVLEVLSGKRP 507
PE + S G+A D ++ G+L+ E+L+G P
Sbjct: 167 PEIILSKGYGKA---VDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 70/230 (30%), Positives = 118/230 (51%), Gaps = 20/230 (8%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK-LAMDDG-NVFALKRIDKLNEGFDRFFEREL----E 355
I+K+ E ++GSG FGTVYK L + +G V I +L E +E+
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
++ S+ + ++ L G C + T +L I +P G L + + E + + LN + AK
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGY 474
G+ YL R++HRD+ + N+L+ +++DFGLAKLL DE+ + +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 475 LAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTD-------ASFIEKG 516
+A E + T ++DV+S+GV V E+++ G +P D +S +EKG
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G G V+K A D G ALK++ +L G RE++ L + +H Y+V L
Sbjct: 8 IGEGAHGIVFK-AKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQL-DWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ +L+ +++P L E L + L + + + M KG+AY+H + I+
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM-LLKGVAYMH---ANGIM 121
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-TEK 488
HRD+K +N+L+ + +++DFGLA+L +EE + + T Y APE + R
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 489 TDVYSFGVLVLEVLSG 504
D+++ G + E+L+G
Sbjct: 182 VDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 315 IGSGGFGTVYKLAMDDGNVF-ALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL-RGYC 372
+G G FG VYK + +F A K I +E F E++IL KH +V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 373 NSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
KL I +F GG+LD + E L + + L +LH S ++IHR
Sbjct: 73 YEN--KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHR 127
Query: 432 DIKSSNILLDGNLEARVSDFGL-AKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE--- 487
D+K+ NILL + + +++DFG+ AK + T I GT ++APE + A E
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVV----ACETFK 181
Query: 488 ------KTDVYSFGVLVLEVLSGKRP 507
K D++S G+ ++E L+ P
Sbjct: 182 DNPYDYKADIWSLGITLIE-LAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 9e-21
Identities = 74/292 (25%), Positives = 131/292 (44%), Gaps = 42/292 (14%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
++P S ++KKL G+G FG V+ ++ A+K + F E E
Sbjct: 2 EIPRESIKLVKKL---------GAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE-E 51
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS-------EQLDWDAR 406
++ +++H LV L +I +++ GSL + L + +D+ A+
Sbjct: 52 ANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 111
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
+ A+G+AY+ IHRD++++N+L+ +L +++DFGLA+++ED E
Sbjct: 112 I------AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162
Query: 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNF 525
+ APE + G T K+DV+SFG+L+ E+++ GK P G N
Sbjct: 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP-----------GMSNS 211
Query: 526 LISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ QR P E E D + C ++RPT + +L+
Sbjct: 212 DVMSALQRGYRMPRMENCPDELYD----IMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 9e-21
Identities = 74/269 (27%), Positives = 119/269 (44%), Gaps = 32/269 (11%)
Query: 315 IGSGGFGTVYKLAMDDGNV-FALKRIDKLNEGF---DRFFERELEILGSIKHRYLVNLRG 370
+GSG FG V L G + A+K I EG D F E E +++ + H LV L G
Sbjct: 12 LGSGQFGVV-HLGKWRGKIDVAIKMI---REGAMSEDDFIE-EAKVMMKLSHPNLVQLYG 66
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
C ++ +++ G L L ER +L + L++ + + YL + IH
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYMQSGRATEK 488
RD+ + N L+ + +VSDFGLA+ + D++ T+ F + PE R + K
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--YTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 489 TDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547
+DV+SFGVL+ EV S GK P + + N + E + +E
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYE-----------RFSNSEVVESVSAGYRLYRPKLAPTE- 229
Query: 548 LDALLAVATQCVSSSPDDRPTMHRVVQIL 576
+ + C P+DRP +++ L
Sbjct: 230 ---VYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 41/266 (15%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
+G+G FG V++ ++ A+K + K + F E +I+ ++H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 375 PTSKLLIYDFLPGGSLDEALHER-------SEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
++ + + GSL E L + +D A++ A G+AYL +
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV------ASGMAYLE---AQN 123
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE 487
IHRD+ + N+L+ N +V+DFGLA++++++ + APE R +
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 488 KTDVYSFGVLVLEVLS-GKRP----TDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
K+DV+SFG+L+ E+++ G+ P T+A +++ + R P C
Sbjct: 184 KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ------------VDQGYRMPCPPGCP- 230
Query: 543 VQSESLDALLAVATQCVSSSPDDRPT 568
L + C PDDRPT
Sbjct: 231 ------KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 73/289 (25%), Positives = 121/289 (41%), Gaps = 41/289 (14%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN------------EGFDRF 349
I ++ TL IG G FG VY+ V+ +K+ ++F
Sbjct: 3 IQREDITLGR--CIGEGQFGDVYQ------GVYMSPENEKIAVAVKTCKNCTSPSVREKF 54
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNI 409
+ E I+ H ++V L G ++ + P G L L LD + +
Sbjct: 55 LQ-EAYIMRQFDHPHIVKLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILY 112
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+ LAYL S R +HRDI + N+L+ ++ DFGL++ LEDE + +
Sbjct: 113 SYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK 169
Query: 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLIS 528
++APE + R T +DV+ FGV + E+L G +P K +++G +
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF---QGVKNNDVIGRI----- 221
Query: 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
E+ +R + PNC L ++ T+C + P RP + L
Sbjct: 222 ENGERLPMPPNCP-------PTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-20
Identities = 81/264 (30%), Positives = 124/264 (46%), Gaps = 27/264 (10%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRF--FERELEILGSIKHRYLVNLRG 370
IG G FG V+K +D+ V A+K ID L E D ++E+ +L Y+ G
Sbjct: 12 IGKGSFGEVFK-GIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
T +I ++L GGS + L LD I+ KGL YLH S + IH
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH---SEKKIH 124
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RDIK++N+LL + E +++DFG+A L D + T V F ++APE ++ K D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKAD 183
Query: 491 VYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDA 550
++S G+ +E+ G+ P K L FLI ++ P EG S+ L
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVL-------FLIPKNNP-----PTLEGNYSKPLKE 231
Query: 551 LLAVATQCVSSSPDDRPTMHRVVQ 574
+ C++ P RPT +++
Sbjct: 232 FVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 68/198 (34%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRFFE--RELEILGSIKHRYLVNLRG 370
IG G FG VYK A+D V A+K ID L E D + +E++ L + Y+ G
Sbjct: 9 IGKGSFGEVYK-AIDKRTNQVVAIKVID-LEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 371 YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
SKL +I ++ GGS + L + +LD I+ GL YLH + I
Sbjct: 67 -SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE---GKI 120
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKT 489
HRDIK++NILL + +++DFG++ L S T V GT ++APE ++ EK
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKA 179
Query: 490 DVYSFGVLVLEVLSGKRP 507
D++S G+ +E+ G+ P
Sbjct: 180 DIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRI-----DKLN-EGFDRFFERELEILGSIKHRYLVN 367
++G G +GTVY + G + A+K++ + L E + E+++L S+KH +V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
G C + + +F+PGGS+ L R L G+AYLH++C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNC--- 122
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLL-----EDEESHITTIVAGTFGYLAPEYMQS 482
++HRDIK +N++L N ++ DFG A+ L S++ + GT ++APE +
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP 507
K+D++S G V E+ +GK P
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-20
Identities = 53/138 (38%), Positives = 73/138 (52%), Gaps = 11/138 (7%)
Query: 59 DPC-----NWKGVKC--DKNKR---VITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF 108
DPC W G C D K + L L N L G I D+ KL L+ +NL N+
Sbjct: 395 DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSI 454
Query: 109 YGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLG-KL 167
G IP LG+ T L+ L L N +GSIP LG L++L L+++ NSLS +P +LG +L
Sbjct: 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
Query: 168 QRLITFNVSNNFLVGAIP 185
+FN ++N + IP
Sbjct: 515 LHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 54/288 (18%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRID--KLNEGFDRFFER-----E 353
++KKL G G +G+VYK+ + D +ALK +D +++ ER E
Sbjct: 4 VLKKL---------GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-----EREDAVNE 49
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS-------EQLDWDAR 406
+ IL S+ H +++ + ++ ++ P G L +A+ +R EQ W
Sbjct: 50 IRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--- 106
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
I + +GL LH +I+HRD+KS+NILL N ++ D G++K+L + ++
Sbjct: 107 -RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAK 159
Query: 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL 526
GT Y+APE + + K+D++S G L+ E+ + P +A ++ L +
Sbjct: 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYK 212
Query: 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ QR P + L + P RP +++
Sbjct: 213 V----QRGKYPP----IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 37/278 (13%)
Query: 312 DHIIGSGGFGTVYKLAMDDG--NVFALKRIDKLNEGFDRFFERELEILGSI--------- 360
+H+ GSG FG VYK+ + N+ ALK I+ N F + + +G I
Sbjct: 6 EHL-GSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 361 --KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDE---ALHERSEQLDWDARLNIIMGAAK 415
+H +V ++ D + G L E +L E+ ++ + NI +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
L YLH + RI+HRD+ +NI+L + + ++DFGLAK + ES +T+ V GT Y
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTS-VVGTILYS 180
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRP-TDASFIEKGLNIVGWLNFLISEDRQRE 534
PE +++ EK DV++FG ++ ++ + + P + + IV
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV------------EA 228
Query: 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRV 572
+ +P EG+ SE + ++ T C++ + RP + +V
Sbjct: 229 VYEPLPEGMYSEDVTDVI---TSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-RFFERELEILGSIK 361
++LE +IG G +G VY+ + G V ALK I+ D +RE+ +L ++
Sbjct: 4 QRLE------LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLR 57
Query: 362 HRYLVNLRGYCNS---PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
N+ Y S +I ++ GGS+ + ++ + II L
Sbjct: 58 QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALK 115
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
Y+H +IHRDIK++NIL+ ++ DFG+A LL S +T V GT ++APE
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPE 171
Query: 479 YMQSGRATE-KTDVYSFGVLVLEVLSGKRP 507
+ G+ + K D++S G+ + E+ +G P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-20
Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 4/191 (2%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G G FG V+K + D A+K + L + F E IL H +V L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ + +PGG L ++ ++L + + AA G+AYL S IHRD
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVY 492
+ + N L+ N ++SDFG+++ +D + + + APE + GR + ++DV+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 493 SFGVLVLEVLS 503
S+G+L+ E S
Sbjct: 179 SYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 74/283 (26%), Positives = 133/283 (46%), Gaps = 31/283 (10%)
Query: 315 IGSGGFGTVYKLAMD-----DGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNL 368
+G G FG V D G A+K + + G ++E+EIL ++ H +V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 369 RGYCNSP--TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+G C LI +FLP GSL E L +++ +L + KG+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT---IVAGTFGYLAPEYMQSG 483
+ +HRD+ + N+L++ + ++ DFGL K +E ++ + T + + F Y APE +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQS 187
Query: 484 RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS--------EDRQREI 535
+ +DV+SFGV + E+L+ +++S + L ++G + ++ E+ +R
Sbjct: 188 KFYIASDVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP 246
Query: 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
PNC E + L+ +C P R T +++ E+
Sbjct: 247 RPPNC----PEEVYQLM---RKCWEFQPSKRTTFQNLIEGFEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 6e-20
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 315 IGSGGFGTVYKLAMDDGNV-FALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G+G FG V K G A+K I + + D F E E +++ + H LV L G C
Sbjct: 12 LGTGQFGVV-KYGKWRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMKLSHEKLVQLYGVCT 69
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
++ +++ G L L E ++ L + +G+AYL S + IHRD+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDL 126
Query: 434 KSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYMQSGRATEKTDV 491
+ N L+D +VSDFGL++ + D+E T+ V F + PE + + + K+DV
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 492 YSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ----SE 546
++FGVL+ EV S GK P + N E ++ +G++
Sbjct: 185 WAFGVLMWEVYSLGKMPYER------FN-------------NSETVEKVSQGLRLYRPHL 225
Query: 547 SLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ + + A+ C ++RPT +++ +E
Sbjct: 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 64/201 (31%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD-RFFERELEILGSIKHRYLVNLRG- 370
IGSG +G VYK A D G + A+K I KL G D ++E+ +L +H +V G
Sbjct: 11 IGSGTYGDVYK-ARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 371 YCNSPTSKLLI-YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
Y KL I ++ GGSL + L + KGLAYLH I
Sbjct: 69 YLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKI 123
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ---SGRAT 486
HRDIK +NILL + + +++DFG++ L + + + GT ++APE G
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYD 182
Query: 487 EKTDVYSFGVLVLEVLSGKRP 507
K D+++ G+ +E+ + P
Sbjct: 183 GKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 78/263 (29%), Positives = 121/263 (46%), Gaps = 25/263 (9%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRF--FERELEILGSIKHRYLVNLRGY 371
IG G FG VYK + V A+K ID L E D ++E+ +L Y+ G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
T +I ++L GGS + L + L+ I+ KGL YLH S R IHR
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLH---SERKIHR 125
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDV 491
DIK++N+LL + +++DFG+A L D + T V F ++APE ++ K D+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDFKADI 184
Query: 492 YSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDAL 551
+S G+ +E+ G+ P + L FLI ++ P EG S+
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKNSP-----PTLEGQYSKPFKEF 232
Query: 552 LAVATQCVSSSPDDRPTMHRVVQ 574
+ C++ P RPT +++
Sbjct: 233 VEA---CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 9e-20
Identities = 74/263 (28%), Positives = 128/263 (48%), Gaps = 31/263 (11%)
Query: 314 IIGSGGFG--TVYKLAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLR 369
++G G FG T+Y+ DD V K ++ +L+E R E+ IL ++H N+
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLV-VWKEVNLTRLSEKERRDALNEIVILSLLQHP---NII 62
Query: 370 GYCNS---PTSKLLIYDFLPGGSLDEALHERSEQL-DWDARLNIIMGAAKGLAYLHHDCS 425
Y N + L+ ++ GG+L + + + QL + + L + ++Y+H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---K 119
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
I+HRDIK+ NI L ++ DFG++K+L E S T+V GT Y++PE Q +
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 486 TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545
K+D+++ G ++ E+L+ KR DA+ LN+V +I+ N V S
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDAT---NPLNLV------------VKIVQGNYTPVVS 223
Query: 546 ESLDALLAVATQCVSSSPDDRPT 568
L+++ + P+ RPT
Sbjct: 224 VYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 67/200 (33%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 314 IIGSGGFGTVY----KLAMDDGNVFALKRIDKLN-EGFDRFFER-ELEILGSIKHRYLVN 367
++G G FG V+ D G ++A+K + K + DR + E +IL + H ++V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
L + LI DFL GG L L + + D + + A L +LH S
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH---SLG 118
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE 487
II+RD+K NILLD +++DFGL+K D E GT Y+APE + T+
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVNRRGHTQ 177
Query: 488 KTDVYSFGVLVLEVLSGKRP 507
D +SFGVL+ E+L+G P
Sbjct: 178 SADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 63/217 (29%), Positives = 113/217 (52%), Gaps = 20/217 (9%)
Query: 315 IGSGGFGTV----YKLAMDDGNVFALKRIDKLNEGFDR-FFERELEILGSIKHRYLVNLR 369
+GSG FG V YK+ +V A+K + NE R RE EI+ + + Y+V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
G C + + +L+ + GG L++ L + +++ + ++ + G+ YL +
Sbjct: 62 GVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYMQSGRATE 487
HRD+ + N+LL A++SDFGL+K L ++S+ AG + + APE + + +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 488 KTDVYSFGVLVLEVLS-GKRPTDA-------SFIEKG 516
++DV+S+G+ + E S G++P SFIE+G
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 62/209 (29%), Positives = 110/209 (52%), Gaps = 13/209 (6%)
Query: 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHR 363
LET+ D +G+G G+V K+ K++ + + REL+I+ +
Sbjct: 7 LETISD---LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSP 63
Query: 364 YLVNLRG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
Y+V+ G + N + + +F+ GSLD ++++ + + I + +GL YL++
Sbjct: 64 YIVSFYGAFLNENNICMCM-EFMDCGSLD-RIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
RI+HRDIK SNIL++ + ++ DFG++ L + I GT Y++PE +Q
Sbjct: 122 --VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQG 176
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRPTDAS 511
G+ T K+DV+S G+ ++E+ GK P S
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFAFS 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRF--FERELEILGSIKHRYLVNLRG 370
IG G FG V+K +D+ V A+K ID L E D ++E+ +L Y+ G
Sbjct: 12 IGKGSFGEVFK-GIDNRTQQVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
T +I ++L GGS + L R+ D ++ KGL YLH S + IH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEILKGLDYLH---SEKKIH 124
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RDIK++N+LL + +++DFG+A L D + T V F ++APE +Q K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSAYDSKAD 183
Query: 491 VYSFGVLVLEVLSGKRP 507
++S G+ +E+ G+ P
Sbjct: 184 IWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALK-----RIDKLNEGFDRFFERELEILGSIKHRYLVN 367
+G+G FG V+ L D + +ALK + +L + ++ E +L + H +++
Sbjct: 9 VGTGTFGRVH-LVRDRISEHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSHPFIIR 65
Query: 368 LRGYCNSPTSKLL--IYDFLPGGSLDEALHERSEQLDWDARLNIIMG---AAK---GLAY 419
L + + L + +++PGG L L R + G A++ L Y
Sbjct: 66 L--FWTEHDQRFLYMLMEYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEY 116
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
LH S I++RD+K NILLD +++DFG AK L D T + GT YLAPE
Sbjct: 117 LH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEV 169
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+QS + D ++ G+L+ E+L G P
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 43/300 (14%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTV----YKLAMDD-GNVFALKRIDKLNEGFDRF-FERE 353
K +KK+ L G G FG V Y A D G + A+K + + + +++E
Sbjct: 3 KRYLKKIRVL------GEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKE 56
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIM 411
+ IL ++ H +V +G C+ K LI +++P GSL + L + L A+L +
Sbjct: 57 INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL---AQLLLFA 113
Query: 412 GA-AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
+G+AYLH S IHRD+ + N+LLD + ++ DFGLAK + + + G
Sbjct: 114 QQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 471 ---TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS---GKRPTDASFIE------KGLN 518
F Y A E ++ + + +DV+SFGV + E+L+ K+ F E +
Sbjct: 171 DSPVFWY-AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
Query: 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+V + L E R NC + + C + RPT ++ IL+
Sbjct: 230 VVRLIELL--ERGMRLPCPKNCP-------QEVYILMKNCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 82/302 (27%), Positives = 136/302 (45%), Gaps = 44/302 (14%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFDRFFEREL----E 355
I+K+ E L ++GSG FGTVYK D NV I L E +E+
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
++ + Y+ L G C + T +L + +P G L + + E +++ LN + AK
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE-DEESHITTIVAGTFGY 474
G++YL R++HRD+ + N+L+ +++DFGLA+LL+ DE + +
Sbjct: 121 GMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177
Query: 475 LAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDA-------SFIEKGLNIVGWLNFL 526
+A E + R T ++DV+S+GV V E+++ G +P D +EKG
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG---------- 227
Query: 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPS 586
+R P C ++D + + +C + RP +V E M PS
Sbjct: 228 -----ERLPQPPIC------TIDVYM-IMVKCWMIDSECRPRFRELVD--EFSRMARDPS 273
Query: 587 DF 588
F
Sbjct: 274 RF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 70/214 (32%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIK 361
K L L+ + IGSG GTVYK + G ++ALK I + R RE+EIL +
Sbjct: 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN 130
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
H +V + ++ +F+ GGSL E H EQ D I+ G+AYLH
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQFLADVARQIL----SGIAYLH 185
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
I+HRDIK SN+L++ +++DFG++++L + V GT Y++PE +
Sbjct: 186 ---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERIN 241
Query: 482 S--------GRATEKTDVYSFGVLVLEVLSGKRP 507
+ G A D++S GV +LE G+ P
Sbjct: 242 TDLNHGAYDGYA---GDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 69/207 (33%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRFFER---ELEILGSIKHRYLVNLR 369
I G +G V+ LA G+++A+K I K + ++ E +IL + Y+V L
Sbjct: 1 ISKGAYGRVF-LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 370 GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y L L+ ++LPGG L L LD D I L YLH S I
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVARIYIAEIVLALEYLH---SNGI 114
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKL--------LEDEESHITTIVAGTFGYLAPEYM 480
IHRD+K NIL+D N +++DFGL+K+ L D+E IV GT Y+APE +
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVI 173
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRP 507
++ D +S G ++ E L G P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 74/294 (25%), Positives = 137/294 (46%), Gaps = 47/294 (15%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
++P + ++KKL G+G FG V+ + A+K + + + + F E
Sbjct: 2 EVPRETLKLVKKL---------GAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA-E 51
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIY---DFLPGGSLDEALH-ERSEQLDWDARLNI 409
++ ++H LV L + ++ IY +++ GSL + L +L + +++
Sbjct: 52 ANLMKQLQHPRLVRL----YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
A+G+A++ IHRD++++NIL+ L +++DFGLA+L+ED E
Sbjct: 108 AAQIAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAK 164
Query: 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP----TDASFIEKGLNIVGWLN 524
+ APE + G T K+DV+SFG+L+ E+++ G+ P T+ I+ N+
Sbjct: 165 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ---NL----- 216
Query: 525 FLISEDRQREIIDP-NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+R + P NC L + C P++RPT + +LE
Sbjct: 217 -----ERGYRMPRPDNCPE-------ELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 70/280 (25%), Positives = 120/280 (42%), Gaps = 33/280 (11%)
Query: 314 IIGSGGFGTVYKLAM---DDGNVFALKRIDKLNEGFDRF----FERELEILGSIKHRYLV 366
+G G FG V+ ++ L + L + D F REL++ + H+ +V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEAL--------HERSEQLDWDARLNIIMGAAKGLA 418
L G C +I ++ G L + L + L ++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
+L + R +HRD+ + N L+ E +VS L+K + + E + +LAPE
Sbjct: 132 HLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537
+Q + K+DV+SFGVL+ EV + G+ P GL+ LN L + + + +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELP------FYGLSDEEVLNRLQAGKLELPVPE 242
Query: 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
C L L+ T+C + +P DRP+ +V L
Sbjct: 243 -GC----PSRLYKLM---TRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 315 IGSGGFGTV--------YKLAMDDGNVFALKRIDKLNEGF---DRFFERELEILGSIKHR 363
+GSG FG V K+A I +NEG + F E E +++ + H
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVA-----------IKAINEGAMSEEDFIE-EAKVMMKLSHP 59
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
LV L G C ++ +F+ G L L +R +L D L++ +G+ YL +
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
IHRD+ + N L+ +VSDFG+ + + D+E ++ + PE
Sbjct: 120 ---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176
Query: 484 RATEKTDVYSFGVLVLEVLS-GKRP 507
+ + K+DV+SFGVL+ EV + GK P
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKLNEGFDRF----FERELEILGSIKHRYLVN 367
+G G FG V+ ++ N L + L E FERE E+L + +H +V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEAL-----------HERSE--QLDWDARLNIIMGAA 414
G C +++++++ G L++ L S +L L I + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT--- 471
G+ YL S +HRD+ + N L+ +L ++ DFG+++ D + V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTML 186
Query: 472 -FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP 507
++ PE + + T ++DV+SFGV++ E+ + GK+P
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
++ L IG G FG V L GN A+K I N+ + F E ++ ++H
Sbjct: 4 NMKELKLLQTIGKGEFGDVM-LGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSN 60
Query: 365 LVNLRGYCNSPTSKLLIY-DFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHH 422
LV L G L I +++ GSL + L R L D L + + + YL
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 119
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
+ +HRD+ + N+L+ + A+VSDFGL K E S + APE ++
Sbjct: 120 --ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALRE 173
Query: 483 GRATEKTDVYSFGVLVLEVLS-GKRP 507
+ + K+DV+SFG+L+ E+ S G+ P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 18/197 (9%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G G FG VYK + G + A K I+ +E + E+EIL + H Y+V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
++ +F PGG++D + E L I + L YLH S +IIHRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDL 136
Query: 434 KSSNILLDGNLEARVSDFGLA----KLLEDEESHITTIVAGTFGYLAPEY-----MQSGR 484
K+ N+LL + + +++DFG++ K L+ +S I GT ++APE M+
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMKDTP 191
Query: 485 ATEKTDVYSFGVLVLEV 501
K D++S G+ ++E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 33/211 (15%)
Query: 314 IIGSGGFGTVYKL-AMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL--RG 370
IIG GGFG VY D G ++A+K +DK R ++ E L ++ R +++L G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETL-ALNERIMLSLVSTG 54
Query: 371 YC----------NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGL 417
C ++P I D + GG L L + + + R II+G
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG----- 109
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
L H + +++RD+K +NILLD + R+SD GLA ++ H + GT GY+AP
Sbjct: 110 --LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 478 EYMQSGRATEKT-DVYSFGVLVLEVLSGKRP 507
E +Q G A + + D +S G ++ ++L G P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 12/194 (6%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
H +G G +G VY+ + A+K + + + F +E ++ IKH LV L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL-KEAAVMKEIKHPNLVQLLGV 70
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
C +I +F+ G+L + L E + Q ++ L + + + YL IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT---FGYLAPEYMQSGRATE 487
RD+ + N L+ N +V+DFGL++L+ + T AG + APE + + +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 488 KTDVYSFGVLVLEV 501
K+DV++FGVL+ E+
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 33/211 (15%)
Query: 314 IIGSGGFGTVYKL-AMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL--RG 370
IIG GGFG VY D G ++A+K +DK R ++ E L ++ R +++L G
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDK-----KRIKMKQGETL-ALNERIMLSLVSTG 54
Query: 371 YC----------NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGL 417
C ++P I D + GG L L + + + R II+G
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG----- 109
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
L H + +++RD+K +NILLD + R+SD GLA ++ H + GT GY+AP
Sbjct: 110 --LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 478 EYMQSGRATEKT-DVYSFGVLVLEVLSGKRP 507
E +Q G A + + D +S G ++ ++L G P
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-18
Identities = 50/116 (43%), Positives = 65/116 (56%), Gaps = 2/116 (1%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
K+ + I L N LSG I ++G L L L+L NN G IPS LGN LQ L L
Sbjct: 212 KSLKWIYLGYNN--LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
N LSG IP + +L L++LD+S NSLS IP + +LQ L ++ +N G IP
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 60/198 (30%), Positives = 104/198 (52%), Gaps = 10/198 (5%)
Query: 315 IGSGGFGTVYKLAMDD-GNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRG 370
+G GGFG V + + + G ++A K++DK + ++ E EIL + ++VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRII 429
S T L+ + GG L ++ E+ L+ + ++ G+ +LH S I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKT 489
+RD+K N+LLD R+SD GLA L+D ++ T AGT GY+APE ++ +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 490 DVYSFGVLVLEVLSGKRP 507
D ++ G + E+++G+ P
Sbjct: 176 DWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 75/277 (27%), Positives = 118/277 (42%), Gaps = 40/277 (14%)
Query: 315 IGSGGFGTVY--KLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG V+ +L D+ V + L F +E IL H +V L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ + + GG L +L + ++ AA G+ YL IHRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHRD 119
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG-------YLAPEYMQSGRA 485
+ + N L+ ++SDFG+++ ED + A T G + APE + GR
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEED------GVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 486 TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545
+ ++DV+SFG+L+ E S L V + N +S + RE I+ +GV+
Sbjct: 174 SSESDVWSFGILLWEAFS-------------LGAVPYAN--LSNQQTREAIE---QGVRL 215
Query: 546 E----SLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
DA+ + +C P RP+ V Q L+S
Sbjct: 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 9e-18
Identities = 48/111 (43%), Positives = 64/111 (57%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL L+N+ LSG I D+G LK L+L N G+IP+ L N T L+ L+L SN L G
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQ 203
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
IP ELG + +L + + N+LS IP +G L L ++ N L G IPS
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-18
Identities = 84/280 (30%), Positives = 133/280 (47%), Gaps = 38/280 (13%)
Query: 314 IIGSGGFGTVY--KLAMDDGN-----VFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
+IG G FG VY L DG V +L RI L E ++F +E I+ H ++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFL-KEGIIMKDFSHPNVL 59
Query: 367 NLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG--AAKGLAYLHHD 423
+L G C S S L++ ++ G L + RSE + + I G AKG+ YL
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL--- 114
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE---SHITTIVAGTFGYLAPEYM 480
S + +HRD+ + N +LD + +V+DFGLA+ + D+E H T ++A E +
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 481 QSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
Q+ + T K+DV+SFGVL+ E+++ G P ++ +L+ + R ++ P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVDSFDITVYLL---QGRRLLQPE 225
Query: 540 -CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
C D L V C P+ RPT +V +E
Sbjct: 226 YCP-------DPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 51/119 (42%), Positives = 71/119 (59%), Gaps = 6/119 (5%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+++I+L L+++ LSG I + +L L+ L+L SNNF G+IP L + LQ L L SN
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSL---GKLQRLITFNVSNNFLVGAIPSD 187
SG IP LG +NL LD+S+N+L+ IP L G L +LI F +N L G IP
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF---SNSLEGEIPKS 399
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 37/222 (16%)
Query: 315 IGSGGFGTVYK------LAMDDGNVFALKRIDKLNEGFDRF-FERELEILGSIKHRYLVN 367
+G G FG VYK A+K + + E + F +E E++ ++H +V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMG 412
L G C +++++L G L E L S LD L+I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 413 AAKGLAYL--HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
A G+ YL HH +HRD+ + N L+ L ++SDFGL++ D S V
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQS 184
Query: 471 T----FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP 507
++ PE + G+ T ++D++SFGV++ E+ S G +P
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALK--RIDKLNEGFDRFFERELEILGSIK 361
K E L ++G G +G V K G + A+K + + +E + RE+++L ++
Sbjct: 2 KYEVL---GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR 58
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
H +VNL+ L+++++ L+ L L DA + I + +AY H
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAPE-- 478
S IIHRDIK NIL+ + ++ DFG A+ L S +T VA T Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELL 173
Query: 479 --YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
G+ DV++ G ++ E+L G P
Sbjct: 174 VGDTNYGKP---VDVWAIGCIMAELLDG-EP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 56/224 (25%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE---------RELEILGSIK 361
IGSG +G V A+D G A+K+I F+ RE+++L ++
Sbjct: 6 KPIGSGAYGVVC-SAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLR 57
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDE-------------ALHE--RSEQLDWDAR 406
H ++ L D L S ++ LH+ +S Q D
Sbjct: 58 HENIIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDH 104
Query: 407 LNIIM-GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI- 464
+ + +GL YLH S +IHRD+K SNIL++ N + ++ DFGLA+ ++ +E
Sbjct: 105 IQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161
Query: 465 --TTIVAGTFGYLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
T V T Y APE + S R T+ D++S G + E+L+ K
Sbjct: 162 FLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 78/289 (26%), Positives = 131/289 (45%), Gaps = 47/289 (16%)
Query: 314 IIGSGGFGTVYK------LAMDDGNV-FALKRIDK--LNEGFDRFFERELEILGSIKHRY 364
+GSG FG VY+ L G + A+K + K ++ F +E ++ + H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFL-KEAHLMSNFNHPN 60
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ------LDWDARLNIIMGAAKGLA 418
+V L G C + +I + + GG L L + + L L+I + AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 419 YLHHDCSPRIIHRDIKSSNILL-----DGNLEARVSDFGLAKLLEDEESHITTIVAGT-- 471
YL IHRD+ + N L+ D + ++ DFGLA+ + + + G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR---KEGEGL 174
Query: 472 --FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLIS 528
++APE + G+ T ++DV+SFGVL+ E+L+ G++P A LN L + +
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA------LNNQEVLQHVTA 228
Query: 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
R ++ NC D + + T C + P +RPT R+ +IL+
Sbjct: 229 GGRLQK--PENCP-------DKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 72/233 (30%), Positives = 111/233 (47%), Gaps = 36/233 (15%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYL 365
IGSG +G V A+D G A+K+I FD R REL+IL KH +
Sbjct: 12 NIGSGAYGVVCS-AIDTRSGKKVAIKKIPH---AFDVPTLAKRTL-RELKILRHFKHDNI 66
Query: 366 VNLRGYCNSPTSKL----LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA-KGLAYL 420
+ +R P + ++ D L L +H S+Q + + + +GL Y+
Sbjct: 67 IAIRDILRPPGADFKDVYVVMD-LMESDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL----EDEESHITTIVAGTFGYLA 476
H S +IHRD+K SN+L++ + E R+ DFG+A+ L + + +T VA T Y A
Sbjct: 124 H---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRWYRA 179
Query: 477 PEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528
PE + S T D++S G + E+L G+R + G N V L ++S
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ-----LFPGKNYVHQLKLILS 226
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 60/196 (30%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVN-LRGY 371
IG G GTVY A+D G A+K+++ + E+ ++ KH +VN L Y
Sbjct: 27 IGQGASGTVY-TAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
++ ++L GGSL + + E +D + + L +LH S ++IHR
Sbjct: 86 LVG-DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDV 491
DIKS NILL + +++DFG + E+S +T+V GT ++APE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 492 YSFGVLVLEVLSGKRP 507
+S G++ +E++ G+ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 28/205 (13%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYLV 366
+GSG +G V A D G A+K KL+ F R + REL +L + H ++
Sbjct: 23 VGSGAYGQVCS-AFDTKTGRKVAIK---KLSRPFQSAIHAKRTY-RELRLLKHMDHENVI 77
Query: 367 NLRGYCNSPTSKLLIYDF-----LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
L +S D L G L+ + + ++L D ++ +GL Y+H
Sbjct: 78 GLLDVFTPASSLEDFQDVYLVTHLMGADLNNIV--KCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
S IIHRD+K SNI ++ + E ++ DFGLA+ +DE +T VA T Y APE M
Sbjct: 136 ---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVA-TRWYRAPEIML 188
Query: 482 S-GRATEKTDVYSFGVLVLEVLSGK 505
+ + D++S G ++ E+L+GK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 303 IKKLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALK--RIDKLNEGFDRFFERELEILGS 359
+ + E L + IG G +G VY+ G + ALK R+D +G RE+ +L +
Sbjct: 6 VTEFEKL---NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62
Query: 360 IKHRYLVNLR---------------GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD 404
++H +V L+ YC + LL D +P + + QL
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQVKCLMLQL--- 117
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464
+GL YLH + IIHRD+K SN+LL +++DFGLA+ +
Sbjct: 118 ---------LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 465 TTIVAGTFGYLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
T V T Y APE + T D+++ G ++ E+L+ K
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 5/197 (2%)
Query: 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER---ELEILGSIKHRYLVNLRG 370
+G GGFG V M G ++A K+++K + +E E IL + R++V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ T L+ + GG L ++ E+ A+ ++ L H RII+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RD+K N+LLD + R+SD GLA L+D +S T AGT G++APE +Q D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDFSVD 179
Query: 491 VYSFGVLVLEVLSGKRP 507
++ GV + E+++ + P
Sbjct: 180 YFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 68/258 (26%), Positives = 112/258 (43%), Gaps = 22/258 (8%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
I+G G GTVYK + + A+K I + + ELEIL Y++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
+ +F+ GGSLD L I + KGL YL S +I+HR
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHR 119
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDV 491
D+K SN+L++ + ++ DFG++ L + I GT Y+APE + + +DV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 492 YSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ-SESLDA 550
+S G+ +E+ G+ P +G L+ + I+D + + + +
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQG--------SLMPLQLLQCIVDEDPPVLPVGQFSEK 228
Query: 551 LLAVATQCVSSSPDDRPT 568
+ TQC+ P +RP
Sbjct: 229 FVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 88/292 (30%), Positives = 133/292 (45%), Gaps = 45/292 (15%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFD-----RFFERELEILG 358
K E L ++G G +G V K + G + A+K K E D + RE+ +L
Sbjct: 2 KYENLG---LVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLK 55
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
++H LVNL L+++F+ LD+ L + LD + +G+
Sbjct: 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIE 114
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
+ H S IIHRDIK NIL+ + ++ DFG A+ L T VA T Y APE
Sbjct: 115 FCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPE 170
Query: 479 YM----QSGRATEKTDVYSFGVLVLEVLSGKR--PTDASFIEKGLNIVGWLNFLISEDRQ 532
+ + GRA D+++ G LV E+L+G+ P D S I++ +I+ L LI R
Sbjct: 171 LLVGDTKYGRA---VDIWAVGCLVTEMLTGEPLFPGD-SDIDQLYHIIKCLGNLIP--RH 224
Query: 533 REIIDPNCEGV--------QSESLD--------ALLAVATQCVSSSPDDRPT 568
+EI N + E L+ +L +A QC+ PDDRP+
Sbjct: 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 77/276 (27%), Positives = 129/276 (46%), Gaps = 30/276 (10%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKH 362
++E LD+ +G G +G+VYK L G A+K I +L+E EL+IL
Sbjct: 2 EIEVLDE---LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS 58
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYL 420
Y+V+ G + + +++ GSLD+ + D I KGL +L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM 480
+ + IIHRD+K +N+L++GN + ++ DFG++ L + T I G Y+APE +
Sbjct: 119 KEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK-TNI--GCQSYMAPERI 173
Query: 481 QSGRATE------KTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534
+SG + ++DV+S G+ +LE+ G+ P E NI L+
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP---ETYANIFAQLS---------A 221
Query: 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMH 570
I+D + + S D +C++ P+ RPT
Sbjct: 222 IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYA 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
++G GGFG V + G ++A K+++K R +R E +IL + R+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEK-----KRIKKRKGESMALNEKQILEKVNSRF 61
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLH 421
+V+L + + L+ + GG L ++ E + R + AA+ GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGR--AVFYAAEICCGLEDLH 119
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
+ RI++RD+K NILLD + R+SD GLA + E GT GY+APE ++
Sbjct: 120 QE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVK 174
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRP 507
+ R T D ++ G L+ E+++G+ P
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 314 IIGSGGFGTVYKLAM----DDGNVFALKRIDKL----NEGFDRFFERELEILGSIKHRYL 365
++G GG+G V+++ D G +FA+K + K N+ + E IL ++KH ++
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 366 VNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLH 421
V+L Y KL LI ++L GG L L ++ A I + L +LH
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHLH 117
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
II+RD+K NILLD +++DFGL K E +T GT Y+APE +
Sbjct: 118 QQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRP 507
+ D +S G L+ ++L+G P
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 314 IIGSGGFGTVY---KLA-MDDGNVFALKRIDKLNEGFDRFFER---------ELEILGSI 360
++G+G +G V+ K+ D G ++A+K + K ++ E ++L ++
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKA-----TIVQKAKTAEHTRTERQVLEAV 61
Query: 361 KHR-YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+ +LV L Y +KL LI D++ GG L L++R + + R+ I A+ +
Sbjct: 62 RRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI----AEIVL 116
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
L H II+RDIK NILLD ++DFGL+K EE GT Y+APE
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 479 YMQSGRA--TEKTDVYSFGVLVLEVLSGKRP 507
++ G + D +S GVL E+L+G P
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 68/252 (26%), Positives = 102/252 (40%), Gaps = 47/252 (18%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
+IG G FG V+ L D G V+A+K + K + E +IL ++V L
Sbjct: 8 VIGRGAFGEVW-LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 369 RGYCN-SPTSKL-LIYDFLPGGSLDEALHERSEQLDWD-ARLNII-MGAAKGLAYLHHDC 424
Y + L L+ +++PGG L L R + + AR I + A L +H
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETARFYIAELVLA--LDSVH--- 118
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAK--------LLEDEESHITT---------- 466
IHRDIK NIL+D + +++DFGL K +SH
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 467 ----------IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP-TDASFIEK 515
GT Y+APE ++ + D +S GV++ E+L G P + E
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 516 GLNIVGWLNFLI 527
I+ W L
Sbjct: 239 YNKIINWKESLR 250
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 61/234 (26%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTV-----YKLA-MDDGNVFALKRIDKLNEGFDRFFERE 353
+DI+ K E +G G FG V Y L+ D + A+K + + F+RE
Sbjct: 5 RDIVLKRE-------LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQRE 57
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH---------------ERS 398
E+L +++H ++V G C +++++++ G L++ L +
Sbjct: 58 AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 117
Query: 399 EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458
+L L+I A G+ YL S +HRD+ + N L+ NL ++ DFG+++
Sbjct: 118 GELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--- 171
Query: 459 DEESHITTIVAG----TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP 507
D S V G ++ PE + + T ++DV+SFGV++ E+ + GK+P
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 38/233 (16%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDKLNEGFDRFFERE 353
+DI+ K E +G G FG V+ L D + A+K + + +E + F+RE
Sbjct: 5 RDIVLKWE-------LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE 57
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL---------DEALHERSE----- 399
E+L ++H+++V G C L++++++ G L D + E
Sbjct: 58 AELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG 117
Query: 400 QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459
QL L I A G+ YL S +HRD+ + N L+ L ++ DFG+++ D
Sbjct: 118 QLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR---D 171
Query: 460 EESHITTIVAG----TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP 507
S V G ++ PE + + T ++D++SFGV++ E+ + GK+P
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 57/206 (27%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
++G G FG V+ D + +K+I +++ + + E ++L + H N+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP---NIIE 63
Query: 371 YCNS---PTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
Y + + +++ ++ PGG+L E + +R + LD D L+ + + L LHH +
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV---QILLALHHVHTK 120
Query: 427 RIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
I+HRD+K+ NILLD + + ++ DFG++K+L + T V GT Y++PE +
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPY 178
Query: 486 TEKTDVYSFGVLVLEVLSGKRPTDAS 511
+K+D+++ G ++ E+ S KR +A+
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 73/215 (33%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 314 IIGSGGFGTVYKLAMDD--GNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
IG G +G VYK A D G + ALK R+D EGF RE++IL + HR +VNL
Sbjct: 14 QIGEGTYGQVYK-ARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL- 71
Query: 370 GYCNSPTSKLLIYDFLPG----------------GSLDEALHERSEQLDWDARLNIIMGA 413
T K DF G L+ L SE D + +
Sbjct: 72 --KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE----DHIKSFMKQL 125
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
+GL Y H +HRDIK SNILL+ + +++DFGLA+L EES T T
Sbjct: 126 LEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 474 YLAPE-YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
Y PE + R DV+S G ++ E+ + K+P
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 71/203 (34%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 314 IIGSGGFGTVYKLA--MDDGNVFALK-----RIDKLNEGFDRFFERELEILGSIKHRYLV 366
+IG G FG V LA DG +A+K I K E ER + +L ++KH +LV
Sbjct: 2 VIGKGSFGKVL-LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLV 59
Query: 367 NLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
L Y KL + D++ GG L L + AR A L YLH S
Sbjct: 60 GLH-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---S 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAPEYMQSGR 484
II+RD+K NILLD ++DFGL K E E S T+ GT YLAPE ++
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 485 ATEKTDVYSFGVLVLEVLSGKRP 507
D + G ++ E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 314 IIGSGGFGTVYKLAMDDGNVF----ALKRIDKLNEGFD---RFFERELEILGSIKHRYLV 366
++G G FG V + N F ALK+ D + E D ER + L +H +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAW-EHPFLT 59
Query: 367 NLRGYCNSPTSKLLIY--DFLPGGSLDEALHERSEQLDWDARLNIIMGAA--KGLAYLHH 422
+L +C T + L + ++L GG L + +D A GL +LH
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLH- 113
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
II+RD+K N+LLD + +++DFG+ K + E +T GT Y+APE ++
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF-CGTPDYIAPEILKG 170
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP 507
+ E D +SFGVL+ E+L G+ P
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 36/270 (13%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGF---DRFFE---RELEILGSIKHRYL 365
+G+G F + Y+ A D G + A+K++ + + E +E+ ++ + H ++
Sbjct: 7 QLGTGAFSSCYQ-ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
+ + G + L +++ GGS+ L + +N +GL+YLH +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA-FKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 426 PRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTI------VAGTFGYLAPE 478
+IIHRD+K +N+L+D R++DFG A L + T + GT ++APE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA---AKGTGAGEFQGQLLGTIAFMAPE 178
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538
++ + DV+S G +++E+ + K P +A L ++ F I+ I
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI----FKIASATTAPSI-- 232
Query: 539 NCEGVQSESLD-ALLAVATQCVSSSPDDRP 567
E L L V +C+ P+DRP
Sbjct: 233 ------PEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 70/283 (24%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 314 IIGSGGFGTVYK--LAMDDGNV--FALKRIDKLNEGFDRF--FERELEILGSIKHRYLVN 367
I+G G FG+V + L+ DDG+ A+K + + F E + H ++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 368 LRGYC------NSPTSKLLIYDFLPGGSLDEAL-----HERSEQLDWDARLNIIMGAAKG 416
L G C ++I F+ G L L E+L L ++ A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT-FGYL 475
+ YL + IHRD+ + N +L ++ V+DFGL+K + + + +A ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534
A E + T K+DV++FGV + E+ + G+ P G+ ++L +R ++
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY------PGVENHEIYDYLRHGNRLKQ 236
Query: 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+C LD L + C + P DRPT ++ ++LE
Sbjct: 237 --PEDC-------LDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
++G GGFG V + G ++A K+++K R +R E +IL + R+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEK-----KRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLH 421
+V+L + + L+ + GG L ++ + R + AA+ GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEER--AVFYAAEITCGLEDLH 119
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
RI++RD+K NILLD R+SD GLA + + E+ I V GT GY+APE ++
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVK 174
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRP 507
+ R T D + G L+ E++ GK P
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 29/211 (13%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRIDKLN--EGFDRFFERELEILGSIK---HRYLVN 367
IG G +GTVYK ++ G ALK++ EG RE+ +L ++ H +V
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 368 LRGYCNSPTSK-----LLIYDFLPGGSLDEALH---ERSEQ--LDWDARLNIIMGAAKGL 417
L C+ P + L+++ + D+ L + + L + +++ +G+
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+LH S RI+HRD+K NIL+ + + +++DFGLA++ E +T++V T Y AP
Sbjct: 121 DFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVV-TLWYRAP 175
Query: 478 E-YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
E +QS AT D++S G + E L +RP
Sbjct: 176 EVLLQSSYAT-PVDMWSVGCIFAE-LFRRRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 56/195 (28%), Positives = 100/195 (51%), Gaps = 8/195 (4%)
Query: 315 IGSGGFGTVYKLAMD-DGNVFALKRID-KLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+G+G G V K+ G + A K I ++ REL++L Y+V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
S + + + GGSLD+ L E ++++ + + + +GLAYL +I+HRD
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRD 129
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVY 492
+K SNIL++ E ++ DFG++ L D + GT Y++PE +Q + ++D++
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 493 SFGVLVLEVLSGKRP 507
S G+ ++E+ G+ P
Sbjct: 187 SMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALK-----RIDKLNEGFDRFFERELEILGSIKHRYLV 366
+IG G FG V LA DG+ +A+K I K E ER + +L ++KH +LV
Sbjct: 2 VIGKGSFGKVL-LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG-AAKGLAYLHHDCS 425
L + + D++ GG L H + E+ + R A + YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLH---S 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYLAPEYMQSGR 484
II+RD+K NILLD ++DFGL K +E EE+ T+ GT YLAPE ++
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEP 172
Query: 485 ATEKTDVYSFGVLVLEVLSGKRP 507
D + G ++ E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 76/265 (28%), Positives = 115/265 (43%), Gaps = 34/265 (12%)
Query: 313 HIIGSGGFGTVYKLAMDDGN-VFALKRID----KLNEGFDRFFERELEILGSIKHRYLVN 367
H IG G FG VY N V A+K++ + NE + +E++ L +KH +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDII-KEVKFLQQLKHPNTIE 85
Query: 368 LRG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+G Y T+ L++ L GS + L + L I GA +GLAYLH
Sbjct: 86 YKGCYLKEHTAWLVMEYCL--GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY---MQSG 483
+IHRDIK+ NILL + +++DFG A S + GT ++APE M G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 484 RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543
+ K DV+S G+ +E+ K P +N + L + D P +
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPL------FNMNAMSALYHIAQND------SPTLQ-- 241
Query: 544 QSESLDALLAVATQCVSSSPDDRPT 568
+E D+ C+ P +RP
Sbjct: 242 SNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 20/207 (9%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + + + + VFA+K ++K L F E ++L + ++++ L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARLNI--IMGAAKGLAYLHHDCSP 426
+ L+ D+ GG L L + ++L D AR + ++ A + LH+
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFG-LAKLLEDEESHITTIVAGTFGYLAPEYMQS--- 482
+HRDIK NIL+D N R++DFG KL+ED +++ GT Y++PE +Q+
Sbjct: 124 --VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMED 180
Query: 483 --GRATEKTDVYSFGVLVLEVLSGKRP 507
G+ + D +S GV + E+L G+ P
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 73/289 (25%), Positives = 110/289 (38%), Gaps = 52/289 (17%)
Query: 315 IGSGGFGTVYK---LAMDDGNV---FALKRIDKLNEGFDRF-FERELEILGSIKHRYLVN 367
+G G FG VY+ D V A+K + + D F E I+ H+ +V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHE------RSEQLDWDARLNIIMGAAKGLAYLH 421
L G + ++ + + GG L L E R L L AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARV---SDFGLAK-LLEDEESHITTIVAGTFGYLAP 477
IHRDI + N LL RV +DFG+A+ + ++ P
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLS-------GKRPTDASFIEKGLNIVGWLNFLISED 530
E G T KTDV+SFGVL+ E+ S G+ + + F+
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV------------MEFVTGGG 238
Query: 531 RQREIIDP--NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
R +DP C G + + T C +P+DRP +++ ++
Sbjct: 239 R----LDPPKGCPG-------PVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 69/217 (31%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 307 ETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-RFFERELE-ILGSIKHR 363
E L D IG G FGTV K L G + A+KRI + + + +L+ ++ S
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 364 YLVNL------RGYCNSPTSKLLIYDFLPGGSLD---EALHERSEQ-LDWDARLNIIMGA 413
Y+V G C I L SLD + ++E + + + I +
Sbjct: 64 YIVKFYGALFREGDC-------WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVAT 116
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
K L YL + +IIHRD+K SNILLD N ++ DFG++ L D S T AG
Sbjct: 117 VKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SIAKTRDAGCRP 172
Query: 474 YLAPEYMQSGRATE---KTDVYSFGVLVLEVLSGKRP 507
Y+APE + ++DV+S G+ + EV +GK P
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD----------RFFERELEILGSIKH 362
++G G FG VY D G A+K++ FD E E+++L +++H
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVP-----FDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 363 RYLVNLRGYCNSPTS-KLLIY-DFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGL 417
+V G P KL I+ +++PGGS+ + L +E + I+ +G+
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGV 119
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI--VAGTFGYL 475
+YLH S I+HRDIK +NIL D ++ DFG +K ++ T I V GT ++
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+PE + K DV+S V+E+L+ K P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 76/267 (28%), Positives = 126/267 (47%), Gaps = 26/267 (9%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLR 369
IG G FG +Y LA D +K ID K+ ++E+ +L +KH +V
Sbjct: 7 KIGEGSFGKIY-LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
++ ++ GG L + ++ +R D L+ + + GL ++H +I
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKI 122
Query: 429 IHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE 487
+HRDIKS NI L N + A++ DFG+A+ L D T V GT YL+PE Q+
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNRPYNN 181
Query: 488 KTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547
KTD++S G ++ E+ + K P + + + + L I + I PN S
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEGNNLHQ-------LVLKICQGYFAP-ISPNF----SRD 229
Query: 548 LDALLAVATQCVSSSPDDRPTMHRVVQ 574
L +L+ +Q SP DRP++ +++
Sbjct: 230 LRSLI---SQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 44/111 (39%), Positives = 58/111 (52%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L L ++ +G I L L +L+ L L SN F GEIP LG L L L +N L+G I
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
P L + NL L + SNSL IP SLG + L + +N G +PS+
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423
|
Length = 968 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 312 DHIIGSGGFGTV----YKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLV 366
+ I+G+G FG + KL A+ + ++ R F E LG H +V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
L G + +++ +++ G+LD L + QL + ++ G A G+ YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL--APEYMQSGR 484
+H+ + + +L++ +L ++S F +L ED+ I T ++G L APE +Q
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 485 ATEKTDVYSFGVLVLEVLS-GKRP 507
+ +DV+SFG+++ EV+S G+RP
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 71/203 (34%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRFFERELEIL-GSIKHRYLVN 367
+IG G FG V LA DG +A+K + K LN + E +L ++KH +LV
Sbjct: 2 VIGKGSFGKVL-LAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 368 LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNI-IMGAAKGLAYLHHDCS 425
L Y T KL + DF+ GG L H + E+ + R A L YLH S
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLH---S 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAPEYMQSGR 484
I++RD+K NILLD ++DFGL K E +S TT GT YLAPE ++
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 485 ATEKTDVYSFGVLVLEVLSGKRP 507
D + G ++ E+L G P
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
++G GGFG V + G ++A KR++K R +R E +IL + ++
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEK-----KRIKKRKGESMALNEKQILEKVNSQF 61
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLH 421
+VNL + + L+ + GG L ++ + R + AA+ GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER--ALFYAAEILCGLEDLH 119
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
+ ++RD+K NILLD R+SD GLA + + ES + GT GY+APE +
Sbjct: 120 RE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLN 174
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRP 507
+ R T D + G L+ E++ G+ P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 55/194 (28%), Positives = 98/194 (50%), Gaps = 7/194 (3%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
IG G GTVY + + G A+K+++ + E+ ++ K+ +VN
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
++ ++L GGSL + + E +D + + L +LH S ++IHRDI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH---SNQVIHRDI 141
Query: 434 KSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYS 493
KS NILL + +++DFG + E+S +T+V GT ++APE + K D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 494 FGVLVLEVLSGKRP 507
G++ +E++ G+ P
Sbjct: 201 LGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 73/274 (26%), Positives = 118/274 (43%), Gaps = 37/274 (13%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G G +G VY + A+K I + + + + E+ + +KHR +V G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA--KGLAYLHHDCSPRIIH 430
+ + + +PGGSL L + L + + I +GL YLH + +I+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 431 RDIKSSNILLD---GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG-RAT 486
RDIK N+L++ G + ++SDFG +K L T GT Y+APE + G R
Sbjct: 132 RDIKGDNVLVNTYSGVV--KISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGY 188
Query: 487 EK-TDVYSFGVLVLEVLSGKRPTDASFIEKG-----LNIVGWLNFLISEDRQREIIDPNC 540
D++S G ++E+ +GK P FIE G + VG I P
Sbjct: 189 GAPADIWSLGCTIVEMATGKPP----FIELGEPQAAMFKVGMFK-----------IHPEI 233
Query: 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
S + +C PD R + H ++Q
Sbjct: 234 PESLSAEAKNFI---LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 314 IIGSGGFGTVYKLAMDD--GNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
+IG GG G VY LA D ALK+I + N + F RE +I + H +V +
Sbjct: 9 LIGKGGMGEVY-LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALH----------ERSEQLDWDARLNIIMGAAKGLA 418
C+ ++ G +L L E +E+ A L+I +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE--------------SHI 464
Y+H S ++HRD+K NILL E + D+G A + EE
Sbjct: 128 YVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 465 TTI---VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
TI + GT Y+APE + A+E TD+Y+ GV++ ++L+ P
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 311 DDHIIGSGGFGTVYKLAMD--DGNVFALKRID----KLNEGFDRFFERELEILGSIKHRY 364
D IG G FG VY A D V A+K++ + NE + +E+ L ++H
Sbjct: 19 DLREIGHGSFGAVY-FARDVRTNEVVAIKKMSYSGKQSNEKWQDII-KEVRFLQQLRHPN 76
Query: 365 LVNLRG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+ +G Y T+ L++ L GS + L + L I GA +GLAYLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL--GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH-- 132
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY---M 480
S IHRDIK+ NILL +++DFG A L+ S + GT ++APE M
Sbjct: 133 -SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAM 186
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRP 507
G+ K DV+S G+ +E+ K P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 314 IIGSGGFGTVYKL----AMDDGNVFALKRIDKL----NEGFDRFFERELEILGSIKHR-Y 364
++G+G +G V+ + D G ++A+K + K E +L ++ +
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 365 LVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYL 420
LV L Y +KL LI D++ GG + L++R + + R II+ L +L
Sbjct: 67 LVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILA----LEHL 121
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM 480
H I++RDIK NILLD ++DFGL+K EE T GT Y+APE +
Sbjct: 122 H---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 481 QSGRATEK-TDVYSFGVLVLEVLSGKRP 507
+ K D +S G+L+ E+L+G P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 307 ETLDDDHIIGSGGFGTVYK-LAMDDGNVF--ALKRIDKL-NEGFDRFFERELEILGSI-K 361
E + + +IG G FG V + + DG A+K + + +E R F ELE+L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEAL---------------HERSEQLDWDAR 406
H ++NL G C + + ++ P G+L + L H + L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-T 465
L A G+ YL + IHRD+ + N+L+ NL ++++DFGL++ EE ++
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175
Query: 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
T+ ++A E + T K+DV+SFGVL+ E++S
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 315 IGSGGFGTV-----YKLAMDDGNVF-ALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FG V Y L + + A+K + ++ + F RE E+L +++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERS------------EQLDWDARLNIIMGAAKG 416
G C +++++++ G L++ L +L L+I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG----TF 472
+ YL S +HRD+ + N L+ NL ++ DFG+++ D S V G
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---DVYSTDYYRVGGHTMLPI 186
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP 507
++ PE + + T ++DV+S GV++ E+ + GK+P
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 20/223 (8%)
Query: 312 DHIIGSGGFGTV-YKLAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVN- 367
++GSG GTV + DG FA+K +D ++E + E+ L + +V
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 368 ----LRGYCNSPTSKL---LIYDFLPGGSLDEALHERSEQ----LDWDARLNIIMGAAKG 416
+ +P + L L+ D+ G L + + R++ + +A L I +
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI----QV 152
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYL 475
L +HH S +IHRDIKS+NILL N ++ DFG +K+ S + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN 518
APE + ++K D++S GVL+ E+L+ KRP D +E+ ++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
|
Length = 496 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 36/210 (17%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNE------GFDRFFERELEILGSIKHRYLV 366
+G G + VYK A D G + A+K+I KL E G + RE+++L +KH ++
Sbjct: 8 LGEGTYAVVYK-ARDKETGRIVAIKKI-KLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA----------KG 416
L ++ L+++F+ L++ + ++S I++ A +G
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKDKS----------IVLTPADIKSYMLMTLRG 114
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L YLH S I+HRD+K +N+L+ + +++DFGLA+ +T V T Y A
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRA 170
Query: 477 PEYMQSGRA-TEKTDVYSFGVLVLEVLSGK 505
PE + R D++S G + E+L
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G GTV+ A+D G A+K+I+ + E+ ++ +K+ +VN
Sbjct: 27 IGQGASGTVFT-AIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ ++L GGSL + + E +D + + L +LH + ++IHRD
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVY 492
IKS N+LL + +++DFG + E+S +T+V GT ++APE + K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 493 SFGVLVLEVLSGKRP 507
S G++ +E++ G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 314 IIGSGGFGTVYKL----AMDDGNVFALKRIDKLN----EGFDRFFERELEILGSIKHR-Y 364
++G+G +G V+ + D G ++A+K + K E ++L I+ +
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLH 421
LV L + T LI D++ GG L L +R + + ++ I++ L +LH
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA----LEHLH 122
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
II+RDIK NILLD N ++DFGL+K ++E GT Y+AP+ ++
Sbjct: 123 ---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 482 SGRA--TEKTDVYSFGVLVLEVLSGKRP 507
G + D +S GVL+ E+L+G P
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 307 ETLDDD----HIIGSGGFGTVYKLAMD-DGNVFALKRID-KLNEGFDRFFERELEILGSI 360
E DDD +G+G G V+K++ G + A K I ++ REL++L
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGL 417
Y+V G S + + + GGSLD+ L + EQ+ + +I KGL
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVI----KGL 116
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
YL +I+HRD+K SNIL++ E ++ DFG++ L D + GT Y++P
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSP 171
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
E +Q + ++D++S G+ ++E+ G+ P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 68/220 (30%), Positives = 97/220 (44%), Gaps = 48/220 (21%)
Query: 312 DHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHR 363
D IG G FG V+ + D DG ALK K+ F R F REL++L KH
Sbjct: 5 DRPIGYGAFGVVWSVT-DPRDGKRVALK---KMPNVFQNLVSCKRVF-RELKMLCFFKHD 59
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLD--EALHERSEQLDWDARLNIIMGAA------- 414
+++ D L +D E ++ +E + D II+
Sbjct: 60 NVLSA-------------LDILQPPHIDPFEEIYVVTELMQSDLH-KIIVSPQPLSSDHV 105
Query: 415 --------KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
+GL YLH S I+HRDIK N+L++ N ++ DFGLA++ E +ES T
Sbjct: 106 KVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162
Query: 467 IVAGTFGYLAPE-YMQSGRATEKTDVYSFGVLVLEVLSGK 505
T Y APE M S T D++S G + E+L +
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 315 IGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHR---------- 363
IG G FG VY++ D ++A+K + K + + E+ +I R
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 364 --YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
++V L+ + + L+ D++ GG L L + + A+ I A+ + L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYI----AELVLALE 110
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYLAPEYM 480
H I++RD+K NILLD + DFGL+K L D ++ T GT YLAPE +
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVL 168
Query: 481 QSGRA-TEKTDVYSFGVLVLEVLSGKRP 507
+ T+ D +S GVLV E+ G P
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-15
Identities = 80/270 (29%), Positives = 123/270 (45%), Gaps = 36/270 (13%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRID----KLNEGFDRFFERELEILGSIKHRYLVNL 368
IG G FG VY A D V A+K++ + NE + +E++ L IKH +
Sbjct: 33 IGHGSFGAVY-FARDVRTNEVVAIKKMSYSGKQSNEKWQDII-KEVKFLQRIKHPNSIEY 90
Query: 369 RG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
+G Y T+ L++ L GS + L + L I GA +GLAYLH S
Sbjct: 91 KGCYLREHTAWLVMEYCL--GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHN 145
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY---MQSGR 484
+IHRDIK+ NILL + +++DFG A + S + GT ++APE M G+
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQ 200
Query: 485 ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544
K DV+S G+ +E+ K P +N + L + I+++ P +
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPL------FNMNAMSAL-YHIAQNES-----PTLQ--S 246
Query: 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+E D C+ P DRPT +++
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 315 IGSGGFGTVYK--LAMDDG-NVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+GSG FGTV K M A+K + D + RE ++ + + Y+V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
G C + S +L+ + G L++ L + + + ++ + G+ YL +
Sbjct: 63 GICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEET---NFV 117
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYMQSGRATE 487
HRD+ + N+LL A++SDFGL+K L +E++ G + + APE M + +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 488 KTDVYSFGVLVLEVLS-GKRPTD-------ASFIEKG 516
K+DV+SFGVL+ E S G++P IE G
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 32/278 (11%)
Query: 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL 365
L+ L IIG G FG V + G A+K I K + F E E ++ + H+ L
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQ-GEYTGQKVAVKNI-KCDVTAQAFLE-ETAVMTKLHHKNL 61
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL-NIIMGAAKGLAYLHHDC 424
V L G ++ + + G+L L R L +L + A+G+ YL
Sbjct: 62 VRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--- 117
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
S +++HRD+ + NIL+ + A+VSDFGLA++ + V T APE ++ +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKK 173
Query: 485 ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI-IDP--NCE 541
+ K+DV+S+GVL+ EV S R A + + L V E ++ ++P C
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGR---APYPKMSLKEV-------KECVEKGYRMEPPEGCP 223
Query: 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579
+ + T C + P RP+ H++ + LE E
Sbjct: 224 A-------DVYVLMTSCWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD----------RFFERELEILGSIKH 362
++G G FG VY +D G A K++ FD E E+++L +++H
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQ-----FDPESPETSKEVSALECEIQLLKNLQH 63
Query: 363 RYLVNLRGYCNSPTSKLL--IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+V G K L +++PGGS+ + L + R +G++YL
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYL 122
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI--VAGTFGYLAPE 478
H S I+HRDIK +NIL D ++ DFG +K L+ T I V GT +++PE
Sbjct: 123 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ K DV+S G V+E+L+ K P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G GTVY AMD G A+++++ + E+ ++ K+ +VN
Sbjct: 28 IGQGASGTVYT-AMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ ++L GGSL + + E +D + + L +LH S ++IHRD
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRD 141
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVY 492
IKS NILL + +++DFG + E+S +T+V GT ++APE + K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200
Query: 493 SFGVLVLEVLSGKRP 507
S G++ +E++ G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 50/158 (31%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 352 RELEILGSIKHRYLVNLRG--YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNI 409
REL++L Y+V G Y + S + + + GGSLD+ L +++ ++ + I
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEISICMEH--MDGGSLDQVL-KKAGRIPENILGKI 104
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+ +GL YL I+HRD+K SNIL++ E ++ DFG++ L D S + V
Sbjct: 105 SIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV- 159
Query: 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
GT Y++PE +Q T ++D++S G+ ++E+ G+ P
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDRFFERELEILGSIKHRYLVN 367
I G FG+VY LA G+ FA+K + K N+ + ER + ++ Y+
Sbjct: 4 ISKGAFGSVY-LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESP-YVAK 61
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
L S L+ ++L GG +L + L D I G+ LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---G 117
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE 487
IIHRDIK N+L+D +++DFGL++ + + + GT YLAPE + +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETILGVGDDK 172
Query: 488 KTDVYSFGVLVLEVLSGKRPTDASFIEK 515
+D +S G ++ E L G P A +
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 73/239 (30%), Positives = 114/239 (47%), Gaps = 29/239 (12%)
Query: 291 FHGDLPYSSKDIIKKLETLDDD-------HIIGSGGFGTVYKLA-MDDGNVFALKRIDKL 342
+G PY+S + LE+L D IG G +G VYK+ DG++ A+K +D +
Sbjct: 1 LYGLFPYNSSML--GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI 58
Query: 343 NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKL-----LIYDFLPGGSLDE---A 393
++ D E E IL S+ H +V G + L+ + GGS+ E
Sbjct: 59 SD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG 117
Query: 394 LHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453
L ++LD I+ GA GL +LH++ RIIHRD+K +NILL ++ DFG+
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV 174
Query: 454 AKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE-----KTDVYSFGVLVLEVLSGKRP 507
+ L T V GT ++APE + + + + DV+S G+ +E+ G P
Sbjct: 175 SAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD-----RFFERELEILGSIKHRYLVN 367
++G G FG VY D G A+K++ E + E E+++L ++ H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 368 LRGYCNSPTSKLL--IYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHH 422
G P + L + +PGGS+ + L +E + I+ +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLH- 123
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI--VAGTFGYLAPEYM 480
S I+HRDIK +NIL D ++ DFG +K L+ T + V GT +++PE +
Sbjct: 124 --SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRP 507
K D++S G V+E+L+ K P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRID----KLNEGFDRFFERELEILGSIKHRYLVNL 368
IG G FG VY A D + V A+K++ + NE + +E+ L ++H +
Sbjct: 23 IGHGSFGAVY-FARDVRNSEVVAIKKMSYSGKQSNEKWQDII-KEVRFLQKLRHPNTIQY 80
Query: 369 RG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
RG Y T+ L++ L GS + L + L + GA +GLAYLH S
Sbjct: 81 RGCYLREHTAWLVMEYCL--GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY---MQSGR 484
+IHRD+K+ NILL ++ DFG A ++ + GT ++APE M G+
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQ 190
Query: 485 ATEKTDVYSFGVLVLEVLSGKRP 507
K DV+S G+ +E+ K P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 43/221 (19%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+IG G +G VYK G + A+K +D + + E E IK Y + LR Y
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIED------EEE-----EIKEEYNI-LRKYS 60
Query: 373 NSPT-----------------SKL-LIYDFLPGGS---LDEALHERSEQLDWDARLNIIM 411
N P +L L+ + GGS L + L ++ ++L + I+
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471
+GLAYLH ++IHRDIK NILL N E ++ DFG++ L+ T + GT
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GT 176
Query: 472 FGYLAPEY---MQSGRAT--EKTDVYSFGVLVLEVLSGKRP 507
++APE + A+ ++DV+S G+ +E+ GK P
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 36/243 (14%)
Query: 353 ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-------------- 397
E+E++ I KH+ ++NL G C +I ++ G+L E L R
Sbjct: 67 EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126
Query: 398 -SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
EQL + ++ A+G+ YL S R IHRD+ + N+L+ + +++DFGLA+
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 457 LEDEESHITTIVAGT-FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIE 514
+ D + + T ++APE + T ++DV+SFG+L+ E+ + G P +E
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243
Query: 515 KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ L L+ E + + NC L + +C + P RPT ++V+
Sbjct: 244 E-------LFKLLREGHRMD-KPSNCT-------HELYMLMRECWHAVPTQRPTFKQLVE 288
Query: 575 ILE 577
L+
Sbjct: 289 ALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G FG V A D G A+K+I K + REL++L ++H +++L
Sbjct: 18 VGMGAFGLVCS-ARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
SP + L G L L R E+ L I+ +GL Y+H S ++
Sbjct: 77 IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL---RGLKYVH---SAGVV 130
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS-GRATEK 488
HRD+K SNIL++ N + ++ DFGLA++ ++ +T V+ + Y APE M + + +
Sbjct: 131 HRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYVSTRY-YRAPEIMLTWQKYDVE 186
Query: 489 TDVYSFGVLVLEVLSGK 505
D++S G + E+L GK
Sbjct: 187 VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 48/218 (22%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDR--FFER---ELEILGSIKHRYLV 366
IG G +G V A G A+K+I F+ F +R E++IL KH ++
Sbjct: 12 YIGEGAYGMVC-SATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEA-------------LHE--RSEQLDWDARLNIIM 411
I D + S + L++ +++ L D +
Sbjct: 67 G-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY 113
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH---ITTIV 468
+GL Y+H S ++HRD+K SN+LL+ N + ++ DFGLA++ + E H +T V
Sbjct: 114 QILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 469 AGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGK 505
A T Y APE M + + T+ D++S G ++ E+LS +
Sbjct: 171 A-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 37/208 (17%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFE------------RELEILGSIK 361
IG G +G V+K + G + A+K+ F E RE+ +L +K
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK----------FVESEDDPVIKKIALREIRMLKQLK 58
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
H LVNL L++++ L+E L + + II + + + H
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 422 -HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY- 479
H+C IHRD+K NIL+ + ++ DFG A++L T VA T Y APE
Sbjct: 118 KHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELL 172
Query: 480 ---MQSGRATEKTDVYSFGVLVLEVLSG 504
Q G DV++ G + E+L+G
Sbjct: 173 VGDTQYGPP---VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 314 IIGSGGFGTV----YKLAMDDGNVFALKRIDK----LNEGFDRFF--ERELEILGSIKHR 363
++G G FG V YK G ++A+K + K + + +R E S +H
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYL 420
+LVNL + + ++ GG L +H ++ + AA GL YL
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFS---EPRAVFYAACVVLGLQYL 117
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE-ESHITTIVAGTFGYLAPEY 479
H + +I++RD+K N+LLD +++DFGL K E T+ GT +LAPE
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEV 172
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ T D + GVL+ E+L G+ P
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 46/148 (31%), Positives = 78/148 (52%), Gaps = 15/148 (10%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +GTV+K + + ALKR+ D +EG RE+ +L +KH+ +V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG----AAKGLAYLHHDCSPR 427
+S L++++ D+ L + + + D I+ KGLA+ H S
Sbjct: 68 LHSDKKLTLVFEYC-----DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHN 119
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAK 455
++HRD+K N+L++ N E +++DFGLA+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-14
Identities = 50/136 (36%), Positives = 69/136 (50%), Gaps = 8/136 (5%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
R+ L L ++K SG I +LGK + L L+L +NN GEIP L + L L L SN L
Sbjct: 333 RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL 392
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI-------P 185
G IP LG +L + + NS S +P KL + ++SNN L G I P
Sbjct: 393 EGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMP 452
Query: 186 SDGVLTKFSESSFFGN 201
S +L+ + + FFG
Sbjct: 453 SLQMLS-LARNKFFGG 467
|
Length = 968 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
LD+ IG G G V +A D G A+K++D + E+ I+ +H
Sbjct: 19 SYLDNFVKIGEGSTGIV-CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 365 LVNLRGYCNSPTSKL------LIYDFLPGGSL-DEALHERSEQLDWDARLNIIMGAAKGL 417
+V + S L ++ +FL GG+L D H R ++ + + + K L
Sbjct: 78 IVEMYS------SYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKAL 128
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++LH + +IHRDIKS +ILL + ++SDFG + E ++V GT ++AP
Sbjct: 129 SFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAP 184
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
E + + D++S G++V+E++ G+ P
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFG-----TVYKLAMDDGNVFALKRIDKLNEGFDRF 349
LPY K + L +G+G FG T Y L+ D +K K+ +
Sbjct: 24 LPYDLKWEFPR-NNLSFGKTLGAGAFGKVVEATAYGLSKSDA---VMKVAVKMLKPTAHS 79
Query: 350 FER-----ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LD 402
ER EL+I+ + H +VNL G C L+I ++ G L L + E L
Sbjct: 80 SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLT 139
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
+ L+ AKG+A+L S IHRD+ + N+LL ++ DFGLA+ + ++ +
Sbjct: 140 LEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN 196
Query: 463 HITTIVAGT----FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
+ +V G ++APE + + T ++DV+S+G+L+ E+ S
Sbjct: 197 Y---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
++G GGFG V + G ++A K+++K R +R E IL + R+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEK-----KRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK--GLAYLHH 422
+V+L + + L+ + GG L ++ +D + I A GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQR 120
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
+ RI++RD+K NILLD R+SD GLA ++ E GT GY+APE + +
Sbjct: 121 E---RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP 507
+ T D + G L+ E++ G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 314 IIGSGGFGTVYKLAMDD-GNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + M + G V+A+K ++K L F E ++L + R++ NL
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARLNI--IMGAAKGLAYLHHDCSP 426
+ L+ D+ GG L L + ++L D AR + ++ A + L +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY---- 123
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS---- 482
+HRDIK N+LLD N R++DFG L + + + + GT Y++PE +Q+
Sbjct: 124 --VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 483 -GRATEKTDVYSFGVLVLEVLSGKRP 507
GR + D +S GV + E+L G+ P
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 31/233 (13%)
Query: 314 IIGSGGFGTVYKLAMDD--GNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
++G G FG V ++ + G+++A+K + K L + FFE E +IL ++ L
Sbjct: 8 LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD------ARLNIIMGAAKGLAYLHH 422
+ + L+ ++ PGG L L+ +Q D D A L + + + + Y
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY--- 123
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
+HRDIK N+L+D +++DFG A L + + + GT Y+APE + +
Sbjct: 124 ------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 483 GRATEKT------DVYSFGVLVLEVLSGKRP----TDASFIEKGLNIVGWLNF 525
K D +S GV+ E++ G+ P T A +N +L F
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKF 230
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 65/223 (29%), Positives = 97/223 (43%), Gaps = 29/223 (13%)
Query: 308 TLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDKLNE--GFDRFFERELEILGSIK 361
L D I +G G FG VYK + G V ALK+I NE GF RE++IL +K
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 362 HRYLVNL--RGYCNSPTS---KLLIYDFLPGGSLDEA--LHERSEQLDWDARLNIIMGAA 414
H +V L S + +Y P D + L S +L ++
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE-----------ESH 463
+G+ YLH I+HRDIK++NIL+D +++DFGLA+ +
Sbjct: 126 EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 464 ITTIVAGTFGYLAPEY-MQSGRATEKTDVYSFGVLVLEVLSGK 505
T +V T Y PE + R T D++ G + E+ + +
Sbjct: 183 YTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 65/272 (23%), Positives = 123/272 (45%), Gaps = 36/272 (13%)
Query: 314 IIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFD--RFFERELEILGSIKHRYLVNLRG 370
++G G +G V + DG + +K+++ N + E+E ++L +KH +V R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 371 YCNSPTSKL-LIYDFLPGGSLDEALHERSEQL-------DWDARLNIIMGAAKGLAYLHH 422
L ++ F GG L L E+ +L +W ++ A L YLH
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLHE 120
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
I+HRD+K+ N+ L +V D G+A++LE++ +T++ GT Y++PE +
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSN 176
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
K+DV++ G V E+ + K +F K +N + + II+
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKH----AFNAKDMNSLVY-----------RIIEGKLPP 221
Query: 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ + L + +S P+ RP++ +++
Sbjct: 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 38/283 (13%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKLNEG---FDRF-FERELEILGSIKHRYLVN 367
+G G FG VY+ + G I +NE +R F E ++ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNII-------MGA--AKGLA 418
L G ++ L++ + + G L L R + + + L M A A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAP 477
YL + + +HRD+ + N ++ +L ++ DFG+ + + E + ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537
E ++ G T K+DV+SFGV++ E+ T A +GL+ L F+I +D
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA-----TLAEQPYQGLSNEEVLKFVID----GGHLD 241
Query: 538 P--NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
NC D LL + C +P RPT +V L+
Sbjct: 242 LPENCP-------DKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 314 IIGSGGFGTVYK-------LAMDDGNVFALKRIDKLNEGFD-RFFERELEILGSI-KHRY 364
+IG G FG V K L MD A+KR+ + D R F ELE+L + H
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDA----AIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEAL---------------HERSEQLDWDARLNI 409
++NL G C L ++ P G+L + L + + L L+
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
A+G+ YL + IHRD+ + NIL+ N A+++DFGL++ E V
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVK 179
Query: 470 GTFG-----YLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
T G ++A E + T +DV+S+GVL+ E++S
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 63/228 (27%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRID---KLNEGFDRFFERELEILGSIKHRYLVNL 368
IG G +G VYK DG +A+K+ + G + RE+ +L +KH +V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 369 RGYCNSPTSKL--LIYDF-------------------LPGGSLDEALHERSEQLDWDARL 407
K L++D+ +P + L Q+ L
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW----QI-----L 118
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--DGNLEARV--SDFGLA-------KL 456
N G+ YLH S ++HRD+K +NIL+ +G V D GLA K
Sbjct: 119 N-------GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168
Query: 457 LEDEESHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLS 503
L D + V T Y APE + R T+ D+++ G + E+L+
Sbjct: 169 LADLDP-----VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 309 LDDDHIIGSGGFGTV-YKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVN 367
LD+ IG G G V G + A+K++D + E+ I+ +H +V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 368 LRGYCNSPTSKLLIYDFLPGGSL-DEALHER--SEQLDWDARLNIIMGAAKGLAYLHHDC 424
+ ++ +FL GG+L D H R EQ+ + + K L+ LH
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH--- 133
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
+ +IHRDIKS +ILL + ++SDFG + E ++V GT ++APE +
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLP 192
Query: 485 ATEKTDVYSFGVLVLEVLSGKRP 507
+ D++S G++V+E++ G+ P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 73/251 (29%), Positives = 113/251 (45%), Gaps = 43/251 (17%)
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-SEQL---DWDARLN 408
EL L + H +V S LLI ++ GG L++ + +R E L +++ L
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL- 173
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-HITTI 467
+ L +H S +++HRD+KS+NI L ++ DFG +K D S + +
Sbjct: 174 LFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLI 527
GT YLAPE + R ++K D++S GV++ E+L+ RP KG
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF------KG----------- 273
Query: 528 SEDRQREII--------DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579
QREI+ DP V S + ALL +S +P RPT Q+L +E
Sbjct: 274 --PSQREIMQQVLYGKYDPFPCPV-SSGMKALL---DPLLSKNPALRPTTQ---QLLHTE 324
Query: 580 VMTPCPSDFYD 590
+ + F D
Sbjct: 325 FLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 62/243 (25%), Positives = 112/243 (46%), Gaps = 36/243 (14%)
Query: 353 ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-------------- 397
E+E++ I KH+ ++NL G C +I ++ G+L E L R
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 398 -SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
EQ+ + ++ A+G+ YL S + IHRD+ + N+L+ N +++DFGLA+
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 457 LEDEESHITTIVAG-TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIE 514
+ + + + T ++APE + T ++DV+SFGVL+ E+ + G P +E
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
Query: 515 KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ F + ++ R NC + L + C + P RPT ++V+
Sbjct: 247 E--------LFKLLKEGHRMDKPANCT-------NELYMMMRDCWHAIPSHRPTFKQLVE 291
Query: 575 ILE 577
L+
Sbjct: 292 DLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNV--FALKRIDKL----NEGFDRFFERELEILG 358
K E + +G+G FG V + + A+KR +K + D F E +IL
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILN 86
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
I H + VNL G + L+ +F+ GG L R+++ D AA+ +
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVG---CFYAAQIVL 142
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
+ S I++RD+K N+LLD + +++DFG AK+++ T + GT Y+APE
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPE 198
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ + + D ++ G+ + E+L G P
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 63/199 (31%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 315 IGSGGFGTVYKL-AMDDGNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVNL 368
IG G FG V ++ D ++ALK I K +E ER +L + ++V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT--VLAQVNCPFIVPL 58
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ SP L+ F+ GG L L AR A+ L L + +
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT----AELLCALENLHKFNV 114
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEK 488
I+RD+K NILLD + DFGL K L ++ T GT YLAPE + T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 489 TDVYSFGVLVLEVLSGKRP 507
D ++ GVL+ E+L+G P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVF--ALKRIDKL-NEGFDRFFERELEILGSIKHR-YLVNL 368
+IG G FG V K DG A+KR+ + ++ R F ELE+L + H ++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEAL---------------HERSEQLDWDARLNIIMGA 413
G C L ++ P G+L + L + + L L+
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTF 472
A+G+ YL + IHRD+ + NIL+ N A+++DFGL++ +E ++ T+
Sbjct: 122 ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPV 175
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
++A E + T +DV+S+GVL+ E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 307 ETLDDDHIIGSGGFGTV-YKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL 365
E LD IG G G V G A+K++D + E+ I+ H +
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSL-DEALHER--SEQLDWDARLNIIMGAAKGLAYLHH 422
V++ ++ +FL GG+L D H R EQ+ + + + L+YLH
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH- 135
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
+ +IHRDIKS +ILL + ++SDFG + E ++V GT ++APE +
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISR 192
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP 507
+ D++S G++V+E++ G+ P
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 315 IGSGGFGTV-YKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+GSG +GTV L G A+K++ + +E F + REL +L +KH ++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 372 CNSPTSKLLIYDF---LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
S +DF +P D + E+L D ++ KGL Y+H + I
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGI 139
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG-RATE 487
IHRD+K N+ ++ + E ++ DFGLA+ +S +T V T Y APE + + T+
Sbjct: 140 IHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAPEVILNWMHYTQ 195
Query: 488 KTDVYSFGVLVLEVLSGK 505
D++S G ++ E+L+GK
Sbjct: 196 TVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 41/111 (36%), Positives = 58/111 (52%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L L + L+GPI + LG L L++L L+ N G IP + + +L L L N LSG I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
P + L NL L + SN+ + IP +L L RL + +N G IP +
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351
|
Length = 968 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 315 IGSGGFGTVYKLAMDDGNVFAL-KRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G G FG VYK + V A K ID +E + E++IL S H +V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
+ ++ +F GG++D + E L + + L YLH + +IIHRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129
Query: 434 KSSNILLDGNLEARVSDFGLA----KLLEDEESHITTIVAGTFGYLAPEYMQSGRATE-- 487
K+ NIL + + +++DFG++ + ++ +S I GT ++APE + + +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRP 184
Query: 488 ---KTDVYSFGVLVLEVLSGKRP 507
K DV+S G+ ++E+ + P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 314 IIGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEIL-GSIKHRYLVN 367
+IG G FG V LA + +A+K + K L + ++ E +L ++KH +LV
Sbjct: 2 VIGKGSFGKVL-LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 368 LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
L + KL + D++ GG L L L+ AR A L YLH S
Sbjct: 61 LH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAPEYMQSGRA 485
I++RD+K NILLD ++DFGL K E+ E + T+ GT YLAPE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 486 TEKTDVYSFGVLVLEVLSGKRP 507
D + G ++ E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + M ++A+K ++K L F E +L + +++ L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARLNIIMGAAKGLAYLHHDCSPRI 428
L+ D+ GG L L + ++L D AR I A+ + +H
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI----AEMVLAIHSIHQLHY 123
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS-----G 483
+HRDIK N+LLD N R++DFG + + + +++ GT Y++PE +Q+ G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 484 RATEKTDVYSFGVLVLEVLSGKRP 507
+ + D +S GV + E+L G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 74/266 (27%), Positives = 112/266 (42%), Gaps = 44/266 (16%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDK-----LNEGFDRFFERELEILGSIKHRYLVN 367
+G GG+G V+ LA D G + ALKR+ K LNE R E +IL + K +LV
Sbjct: 9 VGQGGYGQVF-LAKKKDTGEIVALKRMKKSLLFKLNE--VRHVLTERDILTTTKSEWLVK 65
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDE------ALHERSEQLDWDARLNII-MGAAKGLAYL 420
L L +++PGG L E AR + M A + L
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH------ARFYMAEMFEA--VDAL 117
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK-LLEDEESHITTIVAGTFGYLAPEY 479
H IHRD+K N L+D + +++DFGL+K ++ S V G+ Y+APE
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEV 169
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-NIVGWLNFLISEDRQREIIDP 538
++ D +S G ++ E L G P S + N+ W L QR + D
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-----QRPVYDD 224
Query: 539 NCEGVQSESLDALLAVATQCVSSSPD 564
+ E+ D + T+ ++
Sbjct: 225 PRFNLSDEAWDLI----TKLINDPSR 246
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 10/156 (6%)
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+ + L + +LI D++ G L + L + +L II + L L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAEVKKIIRQLVEALNDL 125
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLE-ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
H IIH DIK N+L D + + D+GL K++ + GT Y +PE
Sbjct: 126 H---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEK 177
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK 515
++ D ++ GVL E+L+GK P E+
Sbjct: 178 IKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 65/247 (26%), Positives = 112/247 (45%), Gaps = 44/247 (17%)
Query: 353 ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-------------- 397
E+E++ I KH+ ++NL G C +I ++ G+L E L R
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 398 -SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
EQL + ++ A+G+ YL S + IHRD+ + N+L+ + +++DFGLA+
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189
Query: 457 LEDEESHITTIVAGTFG-----YLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDA 510
+ HI T G ++APE + T ++DV+SFGVL+ E+ + G P
Sbjct: 190 IH----HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245
Query: 511 SFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMH 570
+E+ F + ++ R NC + L + C + P RPT
Sbjct: 246 VPVEE--------LFKLLKEGHRMDKPSNCT-------NELYMMMRDCWHAVPSQRPTFK 290
Query: 571 RVVQILE 577
++V+ L+
Sbjct: 291 QLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 65/255 (25%), Positives = 118/255 (46%), Gaps = 37/255 (14%)
Query: 353 ELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-------------- 397
E+E++ I KH+ ++NL G C ++ ++ G+L E L R
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 398 -SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
EQL + ++ A+G+ YL S + IHRD+ + N+L+ + +++DFGLA+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 457 LEDEESHITTIVAG-TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIE 514
+ + + + T ++APE + T ++DV+SFGVL+ E+ + G P +E
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243
Query: 515 KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ F + ++ R NC L + +C + P RPT ++V+
Sbjct: 244 E--------LFKLLKEGHRMDKPANCT-------HELYMIMRECWHAVPSQRPTFKQLVE 288
Query: 575 ILESEVMTPCPSDFY 589
L+ V+T +D Y
Sbjct: 289 DLD-RVLTVTSTDEY 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 66/302 (21%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKLNEG----FDRFFERELEILGSIKHRYLVN 367
IG G FG V++ + F + + L E F+RE ++ H +V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSE---------------------QLDWDAR 406
L G C L+++++ G L+E L RS L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA---------KLL 457
L I A G+AYL + +HRD+ + N L+ N+ +++DFGL+ K
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKG 516
E++ I ++ PE + R T ++DV+++GV++ E+ S G +P E+
Sbjct: 190 ENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 517 LNIVGWLNFLISEDRQREIIDPNC-EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575
+ V N L +C + E L + C S P DRP+ + +I
Sbjct: 242 IYYVRDGNVL------------SCPDNCPLE----LYNLMRLCWSKLPSDRPSFASINRI 285
Query: 576 LE 577
L+
Sbjct: 286 LQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 31/201 (15%)
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLN--EGFDRFFERE 353
+ D + K E L IG G FG V+K + ALK++ N EGF RE
Sbjct: 5 FPFCDEVSKYEKLA---KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE 61
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSK--------LLIYDF----LPGGSLDEALHERSEQL 401
++IL +KH +VNL C + + L+++F L G L ++ +
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG-----LLSNKNVKF 116
Query: 402 DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL---- 457
++ GL Y+H +I+HRD+K++NIL+ + +++DFGLA+
Sbjct: 117 TLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSK 173
Query: 458 EDEESHITTIVAGTFGYLAPE 478
+ + T V T Y PE
Sbjct: 174 NSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 315 IGSGGFGTVYKL-AMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G FG + + +DG + +K I+ K++ +E+ +L ++KH +V +
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHER-------SEQLDWDARLNIIMGAAKGLAYLH-HD 423
+ ++ D+ GG L + ++ + + LDW ++ LA H HD
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQI--------CLALKHVHD 119
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
+I+HRDIKS NI L + ++ DFG+A++L T + GT YL+PE ++
Sbjct: 120 --RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176
Query: 484 RATEKTDVYSFGVLVLEVLSGKRPTDA 510
K+D+++ G ++ E+ + K +A
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYLVNLR 369
+GSG +G+V + D + + KL+ F REL +L +KH ++ L
Sbjct: 23 VGSGAYGSV--CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 370 GYCNSPTS-----KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
TS ++ + L G L+ + + ++L + +I +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIV--KCQKLSDEHVQFLIYQLLRGLKYIH--- 135
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
S IIHRD+K SN+ ++ + E R+ DFGLA+ +DE +T VA T Y APE M +
Sbjct: 136 SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVA-TRWYRAPEIMLNWM 191
Query: 485 ATEKT-DVYSFGVLVLEVLSGK 505
+T D++S G ++ E+L GK
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILG-SIKHRYLVNL 368
++G G FG V + + G ++A+K + K L + E IL + H +L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 369 RGYC--NSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
YC +P + +F+ GG L H ++S + D L +LH
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLH---D 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH---ITTIVAGTFGYLAPEYMQS 482
II+RD+K N+LLD +++DFG+ K E T+ GT Y+APE +Q
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRPTDA 510
D ++ GVL+ E+L G P +A
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 9/202 (4%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDKLNEGFDRF--FERELEILGSIKHRYLVNLRG 370
++G G FG + + + +A+K I +L + +E +L +KH +V +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ ++ ++ GG L + + +R + D L + G+ ++H R++
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVL 122
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKT 489
HRDIKS NI L N + ++ DFG A+LL ++ T V GT Y+ PE ++ K+
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKS 181
Query: 490 DVYSFGVLVLEVLSGKRPTDAS 511
D++S G ++ E+ + K P A+
Sbjct: 182 DIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 45/279 (16%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-----------RELEILGSIKH 362
IG G F VYK + + DG V ALK++ + FE +E+++L + H
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKV--------QIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 363 RYLVNLRGYCNS--PTSKLLI-YDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKG 416
N+ Y S ++L I + G L + +Q + +
Sbjct: 62 ---PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L ++H S RI+HRDIK +N+ + ++ D GL + + + ++V GT Y++
Sbjct: 119 LEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536
PE + K+D++S G L+ E+ + + P F +N+ + D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKKIEKCD-----Y 225
Query: 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575
P SE L L++ C++ P+ RP + V+Q+
Sbjct: 226 PPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRI--DKLNEGFDRFFEREL 354
S D +KL +++ G +G VY+ A D G + ALK++ +K EGF RE+
Sbjct: 3 SVDEYEKLNRIEE------GTYGVVYR-ARDKKTGEIVALKKLKMEKEKEGFPITSLREI 55
Query: 355 EILGSIKHRYLVNLR----GYCNSPTSKL----LIYDFLPGGSLDEALHERSEQLDWDAR 406
IL ++H +V ++ G S L ++ +++ L + +
Sbjct: 56 NILLKLQHPNIVTVKEVVVG------SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEV 108
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
+++ G+A+LH + I+HRD+K+SN+LL+ ++ DFGLA+ T
Sbjct: 109 KCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ 165
Query: 467 IVAGTFGYLAPE-YMQSGRATEKTDVYSFGVLVLEVLSGK 505
+V T Y APE + + + D++S G + E+L+ K
Sbjct: 166 LVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGS 359
KL + +G+G FG V ++A G +A+K + K L + +E IL
Sbjct: 16 KLSDFEMGETLGTGSFGRV-RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 360 IKHRYLVN-LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAK 415
+ H ++VN + + + L+ +F+ GG L L + + A+ +++
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA--- 130
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
YLH S II+RD+K N+LLD +V+DFG AK + D T + GT YL
Sbjct: 131 -FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYL 182
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
APE +QS + D ++ GVL+ E ++G P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 73/303 (24%), Positives = 123/303 (40%), Gaps = 60/303 (19%)
Query: 312 DHIIGSGGFGTVYKLAMDDGNVFALK--------RIDKLNEGFD----RFFERELEILGS 359
+G G FG V K F LK + L E R E +L
Sbjct: 5 GKTLGEGEFGKVVK-----ATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ 59
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE---------------RSEQLDWD 404
+ H +++ L G C+ LLI ++ GSL L E S LD
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 405 ARLNIIMG--------AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
+ MG ++G+ YL +++HRD+ + N+L+ + ++SDFGL++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 457 LEDEESHITTIVAGT-FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIE 514
+ +E+S++ ++A E + T ++DV+SFGVL+ E+++ G P E
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 515 KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ N L+ + E + NC + + + C PD RPT + +
Sbjct: 237 RLFN-------LLKTGYRMERPE-NCS-------EEMYNLMLTCWKQEPDKRPTFADISK 281
Query: 575 ILE 577
LE
Sbjct: 282 ELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 22/202 (10%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYLVNLR 369
+GSG +G+V A D + + KL+ F REL +L +KH ++ L
Sbjct: 25 VGSGAYGSVCA-AFDTKTGLRVA-VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 370 GYCNSPTS-----KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
S + + L G L+ + + ++L D +I +GL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIH--- 137
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
S IIHRD+K SN+ ++ + E ++ DFGLA+ +DE +T VA T Y APE M +
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVA-TRWYRAPEIMLNWM 193
Query: 485 ATEKT-DVYSFGVLVLEVLSGK 505
+T D++S G ++ E+L+G+
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 42/277 (15%)
Query: 315 IGSGGFGTVYK-----LAMDDGNVFALKRIDKLNEGFD-RFFERELEILGSIKHRYLVNL 368
+G FG +YK MD + A+K + +N F++E ++ + H +V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERS----------------EQLDWDARLNIIMG 412
G +++++L G L E L RS LD L+I +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGT 471
A G+ YL S +H+D+ + NIL+ L ++SD GL++ + + + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 472 FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISED 530
++ PE + G+ + +D++SFGV++ E+ S G +P ++ + +V
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV---------- 239
Query: 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRP 567
R+R+++ P E + ++ T+C P RP
Sbjct: 240 RKRQLL-PCSEDCPPR----MYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G VYK A D ALK R+++ +EG RE+ +L ++H +V L+
Sbjct: 10 IGEGTYGVVYK-ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARL--NIIMGAAKGLAYLHHDCSPR 427
+S L++++L LD H + S + RL + +G+AY H S R
Sbjct: 69 VVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHR 122
Query: 428 IIHRDIKSSNILLDGNLEA-RVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA- 485
++HRD+K N+L+D A +++DFGLA+ T V T Y APE + R
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHY 181
Query: 486 TEKTDVYSFGVLVLEVLSGK 505
+ D++S G + E+++ K
Sbjct: 182 STPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGN-VFALKRIDKLNEGFDR----FFERELEILGS 359
K E D +IG G FG V + V+A+K + K E R FF E +I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF-EMIKRSDSAFFWEERDIMAH 99
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
++V L ++ +++PGG L + W AR L
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW-ARF-YTAEVVLALDA 157
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA-KLLEDEESHITTIVAGTFGYLAPE 478
+H S IHRD+K N+LLD + +++DFG K+ + T V GT Y++PE
Sbjct: 158 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPE 213
Query: 479 YMQSGRAT----EKTDVYSFGVLVLEVLSGKRP 507
++S + D +S GV + E+L G P
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 19/192 (9%)
Query: 329 DDGNVFALK--RIDKLNEGFDRF-FERELEILGSIKHRYLVNL--RGYCNSPTSKLLIYD 383
G+ A+K R D E R F RE + + H +V L G P +++
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--- 440
++PG +L E L L +++ LA H+ I+HRD+K NI++
Sbjct: 60 YVPGRTLREVLAADG-ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 441 DGNLEARVSDFGLAKLLED-EESHITTI-----VAGTFGYLAPEYMQSGRATEKTDVYSF 494
A+V DFG+ LL ++ + T+ V GT Y APE ++ T +D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 495 GVLVLEVLSGKR 506
G++ LE L+G+R
Sbjct: 176 GLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFE---RELEILG-SIKHRYLVNL 368
++G G FG V + G FA+K + K D E E +L + ++ +L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 369 RGYCNSPTSKLLIY--DFLPGGSLDEALHERSEQLDWDARLNIIMGAAK--GLAYLHHDC 424
YC T + L + +FL GG L + ++ +D A GL +LH
Sbjct: 62 --YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLH--- 113
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
S II+RD+K N++LD + +++DFG+ K ++ +T GT Y+APE +Q +
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-CGTPDYIAPEILQGLK 172
Query: 485 ATEKTDVYSFGVLVLEVLSGKRP 507
T D +SFGVL+ E+L G+ P
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 46/225 (20%)
Query: 311 DDHI---------IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRF---------F 350
D HI +G G +G V+K A+D V ALK+I FD F F
Sbjct: 2 DKHILRKYEILQKLGKGAYGIVWK-AIDRRTKEVVALKKI------FDAFRNATDAQRTF 54
Query: 351 ERELEILGSIK-HRYLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHE--RSEQLDWDA 405
RE+ L + H +V L + K L+++++ + LH R+ L+
Sbjct: 55 -REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVH 108
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL----EDEE 461
+ I+ K L Y+H S +IHRD+K SNILL+ + +++DFGLA+ L E+ E
Sbjct: 109 KRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165
Query: 462 SHITTIVAGTFGYLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
+ + T T Y APE + S R T+ D++S G ++ E+L GK
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G VYK A + G V ALK R+D EG RE+ +L + H +V L
Sbjct: 8 IGEGTYGVVYK-ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 371 YCNSPTSKLLIYDFL-----------PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
++ L+++FL P + L + + + +GLA+
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK-----------SYLFQLLQGLAF 115
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
H S R++HRD+K N+L++ +++DFGLA+ T V T Y APE
Sbjct: 116 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEI 171
Query: 480 MQSGR-ATEKTDVYSFGVLVLEVLSGK 505
+ + + D++S G + E+++ +
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 51/127 (40%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L L +KLSGPI + L +L L+L N+ GEIP + L+ L L SN +G I
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP----SDGVLTK 192
P L +L L L + SN S IP +LGK L ++S N L G IP S G L K
Sbjct: 325 PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
Query: 193 ---FSES 196
FS S
Sbjct: 385 LILFSNS 391
|
Length = 968 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 73/304 (24%), Positives = 128/304 (42%), Gaps = 55/304 (18%)
Query: 305 KLETLDDDHIIGSGGFGTVYK---LAMDDGN---VFALKRI-DKLNEGFDRFFERELEIL 357
+ L +G G FG V K + +D+ N A+K + D E E+E++
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 358 GSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---------------SEQL 401
I KH+ ++NL G C ++ ++ G+L + L R E L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 402 DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
++ A+G+ +L S + IHRD+ + N+L+ + +++DFGLA+ + +
Sbjct: 130 TQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 462 SHITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEK 515
+ T T G L APE + T ++DV+SFGVL+ E+ + G P +E+
Sbjct: 187 YYRKT----TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
Query: 516 GLNIVGWLNFLISEDRQREIIDP--NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573
L ++ ++ NC L + C P RPT ++V
Sbjct: 243 ----------LFKLLKEGYRMEKPQNCT-------QELYHLMRDCWHEVPSQRPTFKQLV 285
Query: 574 QILE 577
+ L+
Sbjct: 286 EDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 39/105 (37%), Positives = 61/105 (58%), Gaps = 8/105 (7%)
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
I + K L YLH S +IHRD+K SN+L++ N + ++ DFG++ L D S TI
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTID 163
Query: 469 AGTFGYLAPEYMQSGRATE----KTDVYSFGVLVLEVLSGKRPTD 509
AG Y+APE + + K+DV+S G+ ++E+ +G+ P D
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 313 HIIGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNL 368
+GSG +G+V A+D G A+K++ + +E F + REL +L ++H ++ L
Sbjct: 21 KQVGSGAYGSVCS-AIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79
Query: 369 RGYCNSPTSKLLIYDF---LPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDC 424
S S DF +P D L + L D ++ GL Y+H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCGLKYIH--- 134
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
S IIHRD+K N+ ++ + E ++ DFGLA+ + E +T V T Y APE + +
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVV-TRWYRAPEVILNWM 190
Query: 485 ATEKT-DVYSFGVLVLEVLSGK 505
+T D++S G ++ E+L+GK
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 10/203 (4%)
Query: 308 TLDDDHI-IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
+L +++I IG G G V +A + G A+K +D + E+ I+ +H+
Sbjct: 21 SLLENYIKIGEGSTGIVC-IAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
+V + ++ +FL GG+L + + + +L+ + + + L YLH
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH--- 134
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
S +IHRDIKS +ILL + ++SDFG + + ++V GT ++APE +
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTP 193
Query: 485 ATEKTDVYSFGVLVLEVLSGKRP 507
+ D++S G++V+E++ G+ P
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDKLNEGFDRFFE---RELEILG-SIKHRYLVNL 368
++G G FG V+ + N FA+K + K D E E +L + +H +L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 369 RGYCNSPTSKLLIY--DFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCS 425
YC T + L + ++L GG L H +S + D GL +LH S
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH---S 114
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAK--LLEDEESHITTIVAGTFGYLAPEYMQSG 483
I++RD+K NILLD + +++DFG+ K +L D + T GT Y+APE +
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPEILLGQ 171
Query: 484 RATEKTDVYSFGVLVLEVLSGKRP 507
+ D +SFGVL+ E+L G+ P
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 31/223 (13%)
Query: 301 DIIKKLETLDDDHI--IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFD-RFFERELEIL 357
DI+++ D + I +GSG +G VYK A +I KL G D ++E+ ++
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMV 60
Query: 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH---ERSE-QLDWDARLNIIMGA 413
KH +V G S + ++ GGSL + H SE Q+ + R +
Sbjct: 61 KECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---- 116
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA---- 469
+GLAYLH S +HRDIK +NILL N + +++DFG+A + IT +A
Sbjct: 117 -QGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKS 165
Query: 470 --GTFGYLAPEYM---QSGRATEKTDVYSFGVLVLEVLSGKRP 507
GT ++APE ++G + D+++ G+ +E+ + P
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 314 IIGSGGFGTVYKLAMDDG--NVFALKRIDK------------LNEGFDRFFERELEILGS 359
++G G FG V LA G ++A+K + K + E +R L + G
Sbjct: 2 VLGKGSFGKVL-LAELKGTDELYAVKVLKKDVILQDDDVECTMTE------KRVLALAG- 53
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKG 416
KH +L L + + +++ GG L + + AR I++G
Sbjct: 54 -KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG---- 108
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK--LLEDEESHITTIVAGTFGY 474
L +LH II+RD+K N+LLD +++DFG+ K +L T+ GT Y
Sbjct: 109 LQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDY 162
Query: 475 LAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA 510
+APE + D ++ GVL+ E+L+G+ P +
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 65/235 (27%), Positives = 94/235 (40%), Gaps = 54/235 (22%)
Query: 315 IGSGGFGTVYKLAMDDGN--VFALKRIDK-----LNEGFDRFFERELEILGSIKHRYLVN 367
+G G G V+ L G +FALK +DK N+ E+E IL ++ H +L
Sbjct: 9 LGKGDVGRVF-LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQE--ILATLDHPFLPT 65
Query: 368 LRGYCNSPTSKLLIY--DFLPGGSLDEALHERSEQL--DWDARLNIIMGAAK---GLAYL 420
L Y + T L D+ PGG L L + + + AR AA+ L YL
Sbjct: 66 L--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY----AAEVLLALEYL 119
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE------------------ES 462
H I++RD+K NILL + +SDF L+K + E
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 463 HITTIVA----------GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
T GT Y+APE + D ++ G+L+ E+L G P
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G VYK A D G + ALK+I + +EG RE+ +L + H +V L
Sbjct: 7 IGEGTYGVVYK-ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARL--NIIMGAAKGLAYLHHDCSPR 427
+S L+++FL LD + + S D L + + +G+AY H S R
Sbjct: 66 VVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHR 119
Query: 428 IIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
++HRD+K N+L+D G L +++DFGLA+ T V T Y APE + R
Sbjct: 120 VLHRDLKPQNLLIDREGAL--KLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQ 176
Query: 486 -TEKTDVYSFGVLVLEVLSGKRP 507
+ D++S G + E+++ +RP
Sbjct: 177 YSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALK--RIDKLNEGFDRFFERELEILGSIK---HRYLVNL 368
IG G +GTVYK G+ ALK R+ +G RE+ +L ++ H +V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-----LDWDARLNIIMGAAKGLAYLHHD 423
C + + L +D+ L ++ L + +++ +GL +LH +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE-YMQS 482
C I+HRD+K NIL+ + +++DFGLA++ + + +V T Y APE +QS
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVLLQS 182
Query: 483 GRATEKTDVYSFGVLVLEVLSGK 505
AT D++S G + E+ K
Sbjct: 183 TYAT-PVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 61/229 (26%), Positives = 111/229 (48%), Gaps = 24/229 (10%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSI 360
K+LE L G G + TVYK G + ALK I L+ EG RE+ ++ +
Sbjct: 3 KQLEKL------GEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKEL 55
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLA 418
KH +V L ++ +L+++++ L + + + LD + + KG+A
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
+ H + R++HRD+K N+L++ E +++DFGLA+ + + V T Y AP+
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD 170
Query: 479 YMQSGRA-TEKTDVYSFGVLVLEVLSGKRP-----TDASFIEKGLNIVG 521
+ R + D++S G ++ E+++G RP + + K I+G
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIFRIMG 218
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G+G +G VYK + G + A+K +D + E + + E+ +L H N+ Y
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHR--NIATYY 79
Query: 373 NSPTSK---------LLIYDFLPGGSL-DEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+ K L+ +F GS+ D + + L D I +GLA+LH
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH- 138
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
+ ++IHRDIK N+LL N E ++ DFG++ L+ T + GT ++APE +
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 195
Query: 483 GRATEKT-----DVYSFGVLVLEVLSGKRP 507
+ T D++S G+ +E+ G P
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +G VYK G + A+K R++ EG RE+ +L ++H +V L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERS----EQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
+ LI++FL S+D + S + +D + + + +G+ + H S R
Sbjct: 68 LMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRR 121
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE-YMQSGRAT 486
++HRD+K N+L+D +++DFGLA+ T V T Y APE + S R +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYS 180
Query: 487 EKTDVYSFGVLVLEVLSGKRP 507
D++S G + E+ + K+P
Sbjct: 181 TPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 26/202 (12%)
Query: 315 IGSGGFGTVY----KLAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNL 368
+G G FGTVY K A+ + + LK I +LN +E ++L + H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHE---------RSEQLDWDARLNIIMGAAKGLAY 419
+ +I ++ G LD L E ++ +W +L + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
+H RI+HRD+K+ NI L NL ++ DFG+++LL + T GT Y++PE
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPEA 176
Query: 480 MQSGRATEKTDVYSFGVLVLEV 501
++ K+D++S G ++ E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 46/238 (19%), Positives = 99/238 (41%), Gaps = 31/238 (13%)
Query: 348 RFFERELEILGSIKHRYLVNLRGY----CNSPTSKLLIYDFLPGGSLDEALHERSEQLDW 403
E E++ L I ++ + G+ + LI ++ G L E L ++ + L +
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSF 121
Query: 404 DARLNIIMGAAKGLAYLH-HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
+L++ + KGL L+ + P ++++ S + L+ N + ++ GL K+L
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178
Query: 463 -HITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI 519
++ +V Y + + + T K D+YS GV++ E+ +GK P + L
Sbjct: 179 KNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF------ENLTT 227
Query: 520 VGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ +I+++ + +C + + C S RP + ++ L
Sbjct: 228 KEIYDLIINKNNS-LKLPLDCPLE-------IKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 5/110 (4%)
Query: 394 LHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453
L +RS L D L I +GL YLH + RIIHRD+K+ NI ++ + + D G
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGA 203
Query: 454 AKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
A+ + + +AGT APE + + K D++S G+++ E+L+
Sbjct: 204 AQFPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 314 IIGSGGFGTVYKLAMDDGN--VFALKRIDKLNEGFDRFFE---RELEILG-SIKHRYLVN 367
++G G FG V LA G V+A+K + K D + E IL + KH +L
Sbjct: 2 VLGKGSFGKVM-LAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLH-HD 423
L + + +++ GG L + +RS + D + R AA+ L +LH H
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFD-EPRSRFY--AAEVTLALMFLHRHG 116
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAK--LLEDEESHITTIVAGTFGYLAPEYMQ 481
+I+RD+K NILLD +++DFG+ K +L TT GT Y+APE +Q
Sbjct: 117 ----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---TTTTFCGTPDYIAPEILQ 169
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRPTDA 510
D ++ GVL+ E+++G+ P +A
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 5/150 (3%)
Query: 67 KCDKNKRVITLSLTNHKLSGPISADLGKLD-QLKFLNLHSNNFYGEIPSELGNCTELQGL 125
+ + + +L L N+ ++ I +G L LK L+L N +PS L N L+ L
Sbjct: 111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK-IESLPSPLRNLPNLKNL 168
Query: 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
L N LS +P L NLSNL NLD+S N +SD +PP + L L ++SNN ++ +
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSIIELLS 226
Query: 186 SDGVLTKFSESSFFGNRGLCGKQINVTCKN 215
S L S N+ + N
Sbjct: 227 SLSNLKNLSGLELSNNKLEDLPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 53/240 (22%), Positives = 108/240 (45%), Gaps = 23/240 (9%)
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER--------SEQL 401
F +E++I+ +K+ ++ L G C S +I +++ G L++ L +R + +
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 402 DWDARLNIIMGAAK---GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK-LL 457
+ N++ A + G+ YL S +HRD+ + N L+ + +++DFG+++ L
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517
+ I ++A E + G+ T +DV++FGV + E+ + + S +
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240
Query: 518 NIVGWLNFLISEDRQREIID-PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
I F ++ RQ + P C + + +C S DRPT +++ L
Sbjct: 241 VIENTGEFFRNQGRQIYLSQTPLCPS-------PVFKLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 3e-11
Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G+G +G VYK + G + A+K +D + + ++E+ +L H N+ Y
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI-KQEINMLKKYSHHR--NIATYY 69
Query: 373 NSPTSK---------LLIYDFLPGGSLDEAL-HERSEQLDWDARLNIIMGAAKGLAYLHH 422
+ K L+ +F GS+ + + + + L + I +GL++LH
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
++IHRDIK N+LL N E ++ DFG++ L+ T + GT ++APE +
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 185
Query: 483 GRATE-----KTDVYSFGVLVLEVLSGKRP 507
+ K+D++S G+ +E+ G P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 315 IGSGGFGTV-YKLAMDDGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYLVNL 368
IG G +G V + A+K+I FD + RE+++L + H ++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI---ANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 369 RGYCNSPTSK------LLIYDFLPGGSLDEALHE--RSEQ-LDWDARLNIIMGAAKGLAY 419
+ P + ++Y+ + D LH+ RS Q L D + +GL Y
Sbjct: 70 KD-IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE- 478
+H S ++HRD+K SN+LL+ N + ++ DFGLA+ ++ +T V T Y APE
Sbjct: 124 IH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPEL 179
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGK 505
+ T DV+S G + E+L K
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 53/239 (22%), Positives = 98/239 (41%), Gaps = 38/239 (15%)
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN- 408
F +E++IL + + L G C +I +++ G L++ L + N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKH-VAETSGLACNS 124
Query: 409 --------IIMGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK-LL 457
+ M A G+ YL S +HRD+ + N L+ N +++DFG+++ L
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP-----TDAS 511
+ + ++A E + G+ T K+DV++FGV + E+L+ + TD
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
Query: 512 FIEKGLNIVGWLNFLISEDRQREIID--PNCEGVQSESLDALLAVATQCVSSSPDDRPT 568
IE +D ++ + PNC + + +C +DRPT
Sbjct: 242 VIEN-------AGHFFRDDGRQIYLPRPPNCP-------KDIYELMLECWRRDEEDRPT 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 17/213 (7%)
Query: 303 IKKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL-NEGFDRFFERELEI-LGS 359
+ LE L + IGSG G VYK+ G+V A+K++ + N+ ++ +L++ L S
Sbjct: 14 LNDLENLGE---IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS 70
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL-NIIMGAAKGLA 418
Y+V GY + + + + + + + L +R + + L + + K L
Sbjct: 71 HDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALH 128
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
YL +IHRD+K SNILLD + ++ DFG++ L D ++ T AG Y+APE
Sbjct: 129 YLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPE 184
Query: 479 YMQSGRATEK----TDVYSFGVLVLEVLSGKRP 507
+ K DV+S G+ ++E+ +G+ P
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 25/208 (12%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIK-HRYLVNL 368
+G G +G V + A+K+I + + + REL++L + H+ + L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 369 RGYCN---SPTSKLLIYDFLPGGSLDEALHE--RSEQLDWDARLN-IIMGAAKGLAYLHH 422
++L +Y+ L ++ LH+ RS Q DA I GL Y+H
Sbjct: 68 YDMDIVFPGNFNELYLYEEL----MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH- 122
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL----EDEESHITTIVAGTFGYLAPE 478
S ++HRD+K N+L++ + E ++ DFGLA+ + +T VA T Y APE
Sbjct: 123 --SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA-TRWYRAPE 179
Query: 479 YMQSGRA-TEKTDVYSFGVLVLEVLSGK 505
M S ++ T+ DV+S G ++ E+L K
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 25/233 (10%)
Query: 295 LPYSSKDII-----KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDR 348
P S K II +T + IG G +G V+K L +G+ A+K +D +++ D
Sbjct: 1 FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDE 59
Query: 349 FFERELEILGSIK-HRYLVNLRGYCNSPTSK-----LLIYDFLPGGS---LDEALHERSE 399
E E IL ++ H +V G K L+ + GGS L + +R E
Sbjct: 60 EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119
Query: 400 QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459
+++ I+ A GL +LH + + IHRD+K +NILL ++ DFG++ L
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 460 EESHITTIVAGTFGYLAPEYMQSGRATEKT-----DVYSFGVLVLEVLSGKRP 507
T V GT ++APE + + + T DV+S G+ +E+ G P
Sbjct: 177 TRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 63/245 (25%), Positives = 98/245 (40%), Gaps = 65/245 (26%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
+IG G FG V + D G+++A+K++ K E+ E +IL + +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRK-----SEMLEKEQVAHVRAERDILAEADNPW 62
Query: 365 LVNLRGYCN--SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L Y + LI ++LPGG + L + + + I + +H
Sbjct: 63 VVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAIDSIH- 118
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI--------------- 467
IHRDIK N+LLD ++SDFGL L ++SH T
Sbjct: 119 --KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSHALPSNFLDF 174
Query: 468 ------------------------VAGTFGYLAPE-YMQSGRATEKTDVYSFGVLVLEVL 502
GT Y+APE ++Q+G E D +S GV++ E+L
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEML 233
Query: 503 SGKRP 507
G P
Sbjct: 234 VGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 37/231 (16%)
Query: 315 IGSGGFGTVYKLAMD---DGNVFALKRI--DKLNEGFDRFFERELEIL---GSIKHRYLV 366
IG G +G V+K A D G ALKR+ EG RE+ +L + +H +V
Sbjct: 9 IGEGAYGKVFK-ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 367 NLRGYC-----NSPTSKLLIYDFLPGGSLDEALHERSEQ-----LDWDARLNIIMGAAKG 416
L C + T L+++ +D+ L ++ + + +++ +G
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFE-----HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L +LH S R++HRD+K NIL+ + + +++DFGLA++ + T V T Y A
Sbjct: 123 LDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRA 177
Query: 477 PE-YMQSGRATEKTDVYSFGVLVLEVLSGKRP-----TDASFIEKGLNIVG 521
PE +QS AT D++S G + E+ ++P +D + K L+++G
Sbjct: 178 PEVLLQSSYAT-PVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIG 226
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGN-VFALKRIDK---LNEGFDRFFERELEILGSI 360
K E D +IG G FG V + V+A+K + K + FF E +I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 361 KHRYLVNLRGYCNSPTSKLL--IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
++V L +C K L + +++PGG L + W A+ +
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYTAEVVL 153
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA-KLLEDEESHITTIVAGTFGYLAP 477
L S +IHRD+K N+LLD + +++DFG K+ E T V GT Y++P
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISP 212
Query: 478 EYMQS----GRATEKTDVYSFGVLVLEVLSGKRP 507
E ++S G + D +S GV + E+L G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFD-RFFERELEILGSIKHRYLVNLRGYC 372
IGSG +G VYK ++ G + A+K I KL G D ++E+ ++ KH +V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI-KLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 373 NSPTSKLLIYDFLPGGSLDEALH---ERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ +F GGSL + H SE Q+ + +R + +GL YLH S
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH---SKGK 127
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA------GTFGYLAPEYM-- 480
+HRDIK +NILL N +++DFG++ + IT +A GT ++APE
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 481 -QSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ G + D+++ G+ +E+ + P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 44/139 (31%), Positives = 58/139 (41%), Gaps = 25/139 (17%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE----------------- 115
+ L L ++ L G I LG L+ + L N+F GE+PSE
Sbjct: 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNL 440
Query: 116 LGNC-------TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ 168
G LQ LSL N G +P G+ L NLD+S N S +P LG L
Sbjct: 441 QGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLS 499
Query: 169 RLITFNVSNNFLVGAIPSD 187
L+ +S N L G IP +
Sbjct: 500 ELMQLKLSENKLSGEIPDE 518
|
Length = 968 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+G G + TVYK ++ +G + ALK I K EG RE +L +KH +V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 373 NSPTSKLLIYDFL-----------PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
++ + +++++ PGG LH + +L + +GLAY+H
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRL-------FMFQLLRGLAYIH 120
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE-DEESHITTIVAGTFGYLAPE-Y 479
I+HRD+K N+L+ E +++DFGLA+ +++ + +V T Y P+
Sbjct: 121 GQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGK 505
+ + + D++ G + +E+L G+
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 35/199 (17%)
Query: 392 EALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451
E L E LD + L+ AKG+++L S IHRD+ + NILL ++ DF
Sbjct: 202 EILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDF 258
Query: 452 GLAKLLEDEESHITTIVAGT----FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS---- 503
GLA+ + ++ ++ +V G ++APE + + T ++DV+S+G+L+ E+ S
Sbjct: 259 GLARDIRNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSS 315
Query: 504 --GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSS 561
P D+ F + +I E + ++ P C SE D + C +
Sbjct: 316 PYPGMPVDSKFYK-----------MIKEGYR--MLSPEC--APSEMYD----IMKSCWDA 356
Query: 562 SPDDRPTMHRVVQILESEV 580
P RPT ++VQ++E ++
Sbjct: 357 DPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT-F 472
A G+ YL S IHRD+ + N +L+ N+ V+DFGL+K + + + + +A
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531
++A E + T K+DV+SFGV + E+ + G+ P G+ ++L +R
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY------PGVENSEIYDYLRQGNR 232
Query: 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
++ P+C LD L ++ + C +P DRP+ + LE
Sbjct: 233 LKQ--PPDC-------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 56/219 (25%), Positives = 104/219 (47%), Gaps = 8/219 (3%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKH 362
K+ET +G G + TV+K + N+ ALK I + EG RE+ +L +KH
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L ++ S L++++L L + + + + + +GLAY H
Sbjct: 64 ANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE-YMQ 481
+++HRD+K N+L++ E +++DFGLA+ + V T Y P+ +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 178
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV 520
S + + D++ G + E+ SG+ S +E L+++
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTSKLLI---YDF-LPGGSLDEALHERSEQLDWD 404
E E+ LG + H ++ + S + +I YDF L DEA + L
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464
R I+ + Y+H ++IHRDIK NI L+ + + + DFG A E E
Sbjct: 269 TR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF 324
Query: 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
GT +PE + E TD++S G+++L++LS
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 314 IIGSGGFGTVYKL-AMDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
++G G FG V + G +A+K + K + + E +L + +H +L +L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA--AKGLAYLHHDCSPR 427
+ + +++ GG L H E++ + R GA L YLH S +
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SGK 115
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE 487
I++RD+K N++LD + +++DFGL K + + + T GT YLAPE ++
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-CGTPEYLAPEVLEDNDYGR 174
Query: 488 KTDVYSFGVLVLEVLSGKRP 507
D + GV++ E++ G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 60/267 (22%), Positives = 112/267 (41%), Gaps = 21/267 (7%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRI---DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G F VY+ + DG ALK++ D ++ +E+++L + H ++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ + G L + +Q + + + L H S R++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMH 129
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RDIK +N+ + ++ D GL + + + ++V GT Y++PE + K+D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSD 188
Query: 491 VYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID--PNCEGVQSESL 548
++S G L+ E+ + + P F +N L S ++ E D P SE L
Sbjct: 189 IWSLGCLLYEMAALQSP----FYGDKMN-------LYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 549 DALLAVATQCVSSSPDDRPTMHRVVQI 575
L+ C++ P+ RP + V +
Sbjct: 238 RQLV---NMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 37/101 (36%), Positives = 57/101 (56%), Gaps = 14/101 (13%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK--LLEDEESHITTIVAGT 471
A GL +LH S II+RD+K N++LD +++DFG+ K + + T GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGT 164
Query: 472 FGYLAPE---YMQSGRATEKTDVYSFGVLVLEVLSGKRPTD 509
Y+APE Y G++ D ++FGVL+ E+L+G+ P D
Sbjct: 165 PDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG-TF 472
A+G+ +L S + IHRD+ + NILL N ++ DFGLA+ + + ++ A
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531
++APE + T ++DV+SFGVL+ E+ S G P G+ I E+
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY------PGVQ--------IDEEF 285
Query: 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
R + + + + ++ C ++P+DRPT +V+IL
Sbjct: 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 8/219 (3%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKH 362
KLET +G G + TVYK + N+ ALK I + EG RE+ +L +KH
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L ++ S L++++L L + L + ++ + +GL Y H
Sbjct: 64 ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE-YMQ 481
+++HRD+K N+L++ E +++DFGLA+ + V T Y P+ +
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLG 178
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV 520
S + + D++ G + E+ +G+ S +E+ L+ +
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 35/281 (12%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKL----NEGFDRFFERELEILGSIKHRYLVNLRG 370
IG+G FG V G A + +L F +E++ + H ++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQ----LDWDARLNIIMG--AAKGLAYLHHDC 424
C LL+ +F P G L L RS + + M A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT-IVAGTFGYLAPEYMQS- 482
IH D+ N L +L ++ D+GLA E+ +IT A +LAPE ++
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 483 ------GRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535
T+K++++S GV + E+ + +P E+ L V ++ ++
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV-------VREQDIKL 230
Query: 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
P + S+ ++ Q P+ RPT V ++L
Sbjct: 231 PKPQLDLKYSDRWYEVM----QFCWLDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 56/242 (23%), Positives = 101/242 (41%), Gaps = 27/242 (11%)
Query: 344 EGFDRFFERELEILGSIKHRY-LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD 402
E F + E+ + G + + + + +L F P S + ++ L
Sbjct: 108 EFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL- 166
Query: 403 WDARLNI------IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
W + L + A+G+ +L S + IHRD+ + NILL N ++ DFGLA+
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD 223
Query: 457 LEDEESHITTIVAG-TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIE 514
+ + ++ A ++APE + T ++DV+SFGVL+ E+ S G P
Sbjct: 224 IYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP------- 276
Query: 515 KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ I+E+ + + D + + + C P +RPT +V+
Sbjct: 277 -------YPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
Query: 575 IL 576
IL
Sbjct: 330 IL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 13/152 (8%)
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLA 418
H +LV L + + + +F+ GG L + + + + AR I + L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 110
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYLAP 477
+LH II+RD+K N+LLD +++D+G+ K + ++ T+ GT Y+AP
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAP 165
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLSGKRPTD 509
E ++ D ++ GVL+ E+++G+ P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-10
Identities = 18/42 (42%), Positives = 27/42 (64%), Gaps = 1/42 (2%)
Query: 29 INSDGEALLSFRTAVVS-SDGFLNQWRPEDPDPCNWKGVKCD 69
+N D +ALL+F++++ G L+ W P DPC+W GV CD
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG 412
E +L + +H +L L+ + + ++ GG L H E++ + R G
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARF-YG 101
Query: 413 A--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
A L YLH S +++RDIK N++LD + +++DFGL K + + + T G
Sbjct: 102 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-CG 157
Query: 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
T YLAPE ++ D + GV++ E++ G+ P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT-IVAGTF 472
A GL +LH S II+RD+K N++LD +++DFG+ K E+ +TT GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA 510
Y+APE + + D ++FGVL+ E+L+G+ P +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
+ H S R++HRDIK +N+ + ++ D GL + + + ++V GT Y++PE
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
+ K+D++S G L+ E+ + + P F +N+ F + + ++ P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNL-----FSLCQKIEQCDYPPL 228
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575
SE L L+++ C+ PD RP + V QI
Sbjct: 229 PTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 13/216 (6%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK---LNEGFDRFFERELE 355
+D+ K E + +IG G FG V + V+A+K + K + FF E +
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
I+ ++V L ++ +++PGG L + W AR A+
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-ARFY----TAE 150
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
+ L S IHRD+K N+LLD + +++DFG + E GT Y+
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 210
Query: 476 APEYMQS----GRATEKTDVYSFGVLVLEVLSGKRP 507
+PE ++S G + D +S GV + E+L G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 351 ERELEILGSIKHRYLVNL-RGYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLN 408
RE++IL +I HR ++NL Y T ++ +P D + +RS L + +
Sbjct: 134 GREIDILKTISHRAIINLIHAYRWKSTVCMV----MPKYKCDLFTYVDRSGPLPLEQAIT 189
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA-KLLEDEESHITTI 467
I + LAYLH IIHRD+K+ NI LD A + DFG A KL ++
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+GT +PE + KTD++S G+++ E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDKLNEGFDRFFE---RELEILGSIKHRYLVNLR 369
++G G +G V K + + A+K+ K +E + E REL++L ++K +V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
L+++++ L E L E + + + I K + + H + I+
Sbjct: 67 EAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIV 122
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAK-LLEDEESHITTIVAGTFGYLAPEYMQSGRATEK 488
HRDIK N+L+ N ++ DFG A+ L E ++ T VA T Y +PE + +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPELLLGAPYGKA 181
Query: 489 TDVYSFGVLVLEVLSGK 505
D++S G ++ E+ G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 314 IIGSGGFGTVYK--LAMDDGNV--FALK--RIDKLNEGFDRFFERELEILGSIKHRYLVN 367
++G G FG+V + L +DG+ A+K + D + F RE + H ++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 368 LRGYCNSPTSK------LLIYDFLPGGSLDEAL-----HERSEQLDWDARLNIIMGAAKG 416
L G +K ++I F+ G L L E L + ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG-TFGYL 475
+ YL S IHRD+ + N +L+ N+ V+DFGL+K + + + + +L
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534
A E + T +DV++FGV + E+++ G+ P G+ N+LI +R ++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY------AGVENSEIYNYLIKGNRLKQ 236
Query: 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
P+C L+ + + QC S P RP+ + LE
Sbjct: 237 --PPDC-------LEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 36/222 (16%)
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-REL 354
+ D +KLE L G G + TVYK + +G + ALK I E F RE
Sbjct: 1 FGKADSYEKLEKL------GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREA 54
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLLIYDFL-----------PGGSLDEALHERSEQLDW 403
+L +KH +V L ++ + L+++++ PGG LH + +L
Sbjct: 55 SLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKL-- 107
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
+ +GL+Y+H I+HRD+K N+L+ E +++DFGLA+ + SH
Sbjct: 108 -----FLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSH 158
Query: 464 ITTIVAGTFGYLAPE-YMQSGRATEKTDVYSFGVLVLEVLSG 504
+ T Y P+ + S + D++ G + +E++ G
Sbjct: 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 8/219 (3%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRID-KLNEGFDRFFERELEILGSIKH 362
KLET +G G + TV+K + N+ ALK I + EG RE+ +L ++KH
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH 62
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V L ++ L++++L L + L + + +GL+Y H
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE-YMQ 481
+I+HRD+K N+L++ E +++DFGLA+ + V T Y P+ +
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLG 177
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV 520
S + D++ G ++ E+ +G+ S +++ L+++
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 12/202 (5%)
Query: 314 IIGSGGFGTVYKLAMDDGN-VFALKRIDK--LNEGFD-RFFERELEIL-GSIKHRYLVNL 368
+IG G + V + + ++A+K + K +N+ D + + E + + H +LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+ + + +++ GG L + + + + AR + L YLH I
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER---GI 117
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAPEYMQSGRATE 487
I+RD+K N+LLD +++D+G+ K E T+ GT Y+APE ++
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 488 KTDVYSFGVLVLEVLSGKRPTD 509
D ++ GVL+ E+++G+ P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 24/162 (14%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIK 361
KLET +G G + TVYK + G + ALK I +L EG RE +L +K
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLK 61
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK------ 415
H +V L ++ + L++++L D L + +D + M +
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYL-----DTDL---KQYMDDCGGG-LSMHNVRLFLFQL 112
Query: 416 --GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
GLAY H R++HRD+K N+L+ E +++DFGLA+
Sbjct: 113 LRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 42/125 (33%), Positives = 67/125 (53%), Gaps = 11/125 (8%)
Query: 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEAR 447
S DE E S LD D L A+G+ +L S IHRD+ + N+LL A+
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAK 252
Query: 448 VSDFGLAKLLEDEESHITTIVAGT----FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
+ DFGLA+ + ++ ++ +V G ++APE + T ++DV+S+G+L+ E+ S
Sbjct: 253 ICDFGLARDIMNDSNY---VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
Query: 504 -GKRP 507
GK P
Sbjct: 310 LGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 315 IGSGGFGTVYKLAMDDGNV---FALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G +G VYK DG +ALK+I+ G RE+ +L +KH +++L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 66
Query: 372 CNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY-----LHHDC 424
S + L++D+ R+ + + + + G K L Y +H+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 425 SPRIIHRDIKSSNILLDGNLEAR----VSDFGLAKLLEDEESHITTI--VAGTFGYLAPE 478
+ ++HRD+K +NIL+ G R ++D G A+L + + V TF Y APE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 479 YMQSGRA-TEKTDVYSFGVLVLEVLSGK 505
+ R T+ D+++ G + E+L+ +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIM 411
E +L + +H +L L+ Y +L + ++ GG L H E++ + R
Sbjct: 45 ESRVLQNTRHPFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARF-Y 100
Query: 412 GA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIV 468
GA L YLH S +++RD+K N++LD + +++DFGL K E +
Sbjct: 101 GAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 155
Query: 469 AGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
GT YLAPE ++ D + GV++ E++ G+ P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 315 IGSGGFGTVYKLAMDDGN---VFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G +G VYK DG +ALK+I+ G RE+ +L +KH ++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE--GTGISMSACREIALLRELKHPNVIALQKV 66
Query: 372 CNSPTSK--LLIYDF-------LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
S + + L++D+ + +++ QL +++ G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 423 DCSPRIIHRDIKSSNILLDGNLEAR----VSDFGLAKLLEDEESHITTI--VAGTFGYLA 476
+ ++HRD+K +NIL+ G R ++D G A+L + + V TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 477 PEYMQSGRA-TEKTDVYSFGVLVLEVLSGK 505
PE + R T+ D+++ G + E+L+ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 26/175 (14%)
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD------- 402
F +E++IL +K ++ L G C +I +++ G L++ L LD
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH--HLDDKEENGN 123
Query: 403 -------------WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449
+ + L++ + A G+ YL S +HRD+ + N L+ NL +++
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIA 180
Query: 450 DFGLAK-LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
DFG+++ L + I ++A E + G+ T +DV++FGV + E+L
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHI--TTIVAGT 471
+ L Y+H + + HRD+K NIL + + + ++ DFGLA++ D + I T VA T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-T 169
Query: 472 FGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGK 505
Y APE S + T D++S G + EVL+GK
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 62/240 (25%), Positives = 97/240 (40%), Gaps = 44/240 (18%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALK---RIDKLNEGFDRFFERELEILGSIKH 362
E + +IG G FG V + D G+V+A+K + D L + E +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++V + + LI +FLPGG + L ++ + L + I + +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQ 119
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGL----------------------------- 453
IHRDIK N+LLD ++SDFGL
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 454 -----AKLLEDEESHITTIVAGTFGYLAPE-YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
A+ + + GT Y+APE +MQ+G + D +S GV++ E+L G P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 45/226 (19%)
Query: 315 IGSGGFGTVYKLAMDDGNVF-----------ALKRI-DKLNEGFDRFFERELEILGSIKH 362
+G FG VYK G++F A+K + DK F+ E + ++H
Sbjct: 13 LGEDRFGKVYK-----GHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------------L 407
+V L G +I+ + L E L RS D + +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 408 NIIMGAAKGLAYL--HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
+I+ A G+ +L HH ++H+D+ + N+L+ L ++SD GL + E +
Sbjct: 128 HIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFR--EVYAADYY 180
Query: 466 TIVAGTF---GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP 507
++ + +++PE + G+ + +D++S+GV++ EV S G +P
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 314 IIGSGGFGTVY--KLAMDDGNVFALKRIDKL----NEGFDRFFERELEILGSIKHRYLVN 367
+IG G + V +L +D ++A+K + K +E D + + + +LV
Sbjct: 2 VIGRGSYAKVLLVRLKKND-QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 368 LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAYLHHD 423
L C TS+L L+ +++ GG L + + + + AR AA+ L +LH
Sbjct: 61 LHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY----AAEICIALNFLHER 115
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAPEYMQS 482
II+RD+K N+LLD + +++D+G+ K E T+ GT Y+APE ++
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRG 170
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRPTD 509
D ++ GVL+ E+++G+ P D
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 70/289 (24%), Positives = 129/289 (44%), Gaps = 46/289 (15%)
Query: 315 IGSGGFGTVYK-LAMD------DGNVFALKRIDKLNEGFDRF-FERELEILGSIKHRYLV 366
+G G FG VY+ A D + V A+K +++ +R F E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRV-AVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLN------IIMGA--AKGL 417
L G + L++ + + G L L R E + R I M A A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG---- 473
AYL+ + + +HRD+ + N ++ + ++ DFG+ + + + + + G G
Sbjct: 133 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPV 185
Query: 474 -YLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531
++APE ++ G T +D++SFGV++ E+ S ++P E+ L V +L D
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD- 244
Query: 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580
NC E + L+ + C +P RPT +V +L+ ++
Sbjct: 245 -------NCP----ERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 6/98 (6%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT-IVAGTF 472
+ GL +LH II+RD+K N++LD +++DFG+ K E +TT GT
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTP 165
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA 510
Y+APE + + D +++GVL+ E+L+G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 44/233 (18%)
Query: 314 IIGSGGFGTVYKLAMDD-GNVFALK---RIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + D G+++A+K + D L + E +IL ++V +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ LI +FLPGG + L ++ + L +A I + +H I
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQ---LGFI 123
Query: 430 HRDIKSSNILLDGNLEARVSDFGL----------------------------------AK 455
HRDIK N+LLD ++SDFGL A+
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAE 183
Query: 456 LLEDEESHITTIVAGTFGYLAPE-YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ + GT Y+APE +MQ+G + D +S GV++ E+L G P
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 61/281 (21%), Positives = 119/281 (42%), Gaps = 44/281 (15%)
Query: 315 IGSGGFGTVYK-----LAMDDGNV-FALKRIDKLNEGFDRF-FERELEILGSIKHRYLVN 367
+G G FG VY+ + D+ A+K +++ +R F E ++ ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN-------IIMGA--AKGLA 418
L G + L+I + + G L L +++ + I M A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG----- 473
YL+ + + +HRD+ + N ++ + ++ DFG+ + + + + + G G
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVR 186
Query: 474 YLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQ 532
+++PE ++ G T +DV+SFGV++ E+ + ++P E+ L V L D
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD-- 244
Query: 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573
NC D L + C +P RP+ ++
Sbjct: 245 ------NCP-------DMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 58/252 (23%), Positives = 105/252 (41%), Gaps = 39/252 (15%)
Query: 336 LKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH 395
LK + + FFE ++ + H++LV L G C + +++ +++ G LD LH
Sbjct: 35 LKVLGSDHRDSLAFFE-TASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLH 92
Query: 396 ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL-------DGNLEARV 448
+ +L++ A L YL +++H ++ NIL+ ++
Sbjct: 93 REKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149
Query: 449 SDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA--TEKTDVYSFGVLVLEVLS-GK 505
SD G+ + E + I ++APE +++G+A T D +SFG +LE+ S G+
Sbjct: 150 SDPGIPITVLSREERVERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
Query: 506 RPTDA-SFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPD 564
P S EK Q + P+C L + QC + P
Sbjct: 205 EPLSTLSSSEK----------ERFYQDQHRLPMPDC--------AELANLINQCWTYDPT 246
Query: 565 DRPTMHRVVQIL 576
RP+ +++ L
Sbjct: 247 KRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 34/207 (16%)
Query: 382 YDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440
Y + L + SE L L+ A+G+ +L S +HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 441 DGNLEARVSDFGLAKLLEDEESHITTIVAGTF---GYLAPEYMQSGRATEKTDVYSFGVL 497
++ DFGLA+ + + ++++ TF ++APE + T +DV+S+G+L
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSK--GSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 498 VLEVLS-GKRP-----TDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDAL 551
+ E+ S G P D++F K I + +E+ D
Sbjct: 329 LWEIFSLGGTPYPGMIVDSTFYNK---IKSGYRMAKPDHATQEVYD-------------- 371
Query: 552 LAVATQCVSSSPDDRPTMHRVVQILES 578
+ +C +S P+ RP+ + I+ES
Sbjct: 372 --IMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 37/277 (13%)
Query: 315 IGSGGFGTVYK----LAMDDGNVFA----LKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
+G G F ++K D G + LK +DK + + F ++ + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY-LHHDCS 425
G C +++ +++ GSLD L + ++ +L + AK LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV----AKQLAWALHFLED 118
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT----IVAGTFGYLAPEYMQ 481
+ H ++ + N+LL + + + K L D IT I+ ++ PE ++
Sbjct: 119 KGLTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVLPKEILLERIPWVPPECIE 177
Query: 482 SGRA-TEKTDVYSFGVLVLEVLSG-KRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
+ + + D +SFG + E+ SG +P A +K L EDR +
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL--------QFYEDRHQ------ 223
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
+ + L + QC+ PD RP+ +++ L
Sbjct: 224 ---LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 59/235 (25%), Positives = 98/235 (41%), Gaps = 64/235 (27%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE---------------RELEIL 357
+G G +G V K A D G + A+K++ K+ E + + REL+I+
Sbjct: 17 LGEGTYGKVEK-AYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 358 GSIKHRYLVNLR------GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN--- 408
IKH ++ L + N L+ D + + + +D RL
Sbjct: 75 NEIKHENIMGLVDVYVEGDFIN------LVMDIMAS--------DLKKVVDRKIRLTESQ 120
Query: 409 ---IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA----------K 455
I++ GL LH +HRD+ +NI ++ +++DFGLA
Sbjct: 121 VKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 456 LLEDEES----HITTIVAGTFGYLAPE-YMQSGRATEKTDVYSFGVLVLEVLSGK 505
L +DE +T+ V T Y APE M + + D++S G + E+L+GK
Sbjct: 178 LSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG 412
E +L + +H +L L+ + + ++ GG L H E++ + R G
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARF-YG 101
Query: 413 A--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
A L YLH + +++RD+K N++LD + +++DFGL K + + + T G
Sbjct: 102 AEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CG 158
Query: 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
T YLAPE ++ D + GV++ E++ G+ P
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 48/185 (25%), Positives = 88/185 (47%), Gaps = 43/185 (23%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK--------LLEDEESHIT 465
A G++YLH +IH+DI + N ++D L+ +++D L++ L D E+
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-- 181
Query: 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLN 524
++A E + + + +DV+SFGVL+ E+++ G+ P ++E ++
Sbjct: 182 -----PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP----YVE--IDPFEMAA 230
Query: 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPC 584
+L +D R NC D L AV C + P++RP+ ++VQ C
Sbjct: 231 YL--KDGYRLAQPINCP-------DELFAVMACCWALDPEERPSFSQLVQ---------C 272
Query: 585 PSDFY 589
+DF+
Sbjct: 273 LTDFH 277
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG-TF 472
AKG+ +L S + IHRD+ + NILL N ++ DFGLA+ + + ++ A
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP 507
++APE + T ++DV+SFGVL+ E+ S G P
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 28/220 (12%)
Query: 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALK--RIDKLNEGFDRFFERELEI 356
D +KLE IG G +G VYK A D G + ALK R++ EG RE+ +
Sbjct: 1 DAYEKLE------KIGEGTYGKVYK-ARDKNTGKLVALKKTRLEMDEEGIPPTALREISL 53
Query: 357 LGSIKHR-YLVNLRGY----CNSPTSKL-LIYDFLPG---GSLDEALHERSEQLDWDARL 407
L + Y+V L + L L++++L +D L
Sbjct: 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA-RVSDFGLAKLLEDE-ESHIT 465
+ + KG+A+ H ++HRD+K N+L+D +++D GL + +S+
Sbjct: 114 SFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 466 TIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSG 504
IV T Y APE + + D++S G + E+
Sbjct: 171 EIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 51/236 (21%), Positives = 102/236 (43%), Gaps = 37/236 (15%)
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN 408
FFE ++ + H+++V L G C +++ +F+ G LD +H +S+ L +
Sbjct: 51 FFETA-SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK 109
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL-------DGNLEARVSDFGLAKLLEDEE 461
+ A L+YL ++H ++ + NILL + ++SD G+ + +
Sbjct: 110 VAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ 166
Query: 462 SHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEV-LSGKRP-TDASFIEKGLN 518
+ I ++APE ++ + + D +SFG + E+ +G+ P D + EK
Sbjct: 167 ECVERI-----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF 221
Query: 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
G Q ++ P+C L + T C++ P+ RP +++
Sbjct: 222 YEG----------QCMLVTPSC--------KELADLMTHCMNYDPNQRPFFRAIMR 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 38/213 (17%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+IIG+G FG VY+ + +D A+K++ L + ++ REL I+ ++ H ++ L+ Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV--LQD--PQYKNRELLIMKNLNHINIIFLKDY 127
Query: 372 CNSPTSKL--------LIYDFLPGGSLDEALHERSEQLDWDARLNIIM----------GA 413
+ K ++ +F+P + +H+ + AR N +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIP-----QTVHK---YMKHYARNNHALPLFLVKLYSYQL 179
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA-RVSDFGLAKLLEDEESHITTIVAGTF 472
+ LAY+H S I HRD+K N+L+D N ++ DFG AK L + ++ I +
Sbjct: 180 CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF- 235
Query: 473 GYLAPEYM-QSGRATEKTDVYSFGVLVLEVLSG 504
Y APE M + T D++S G ++ E++ G
Sbjct: 236 -YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 62/269 (23%), Positives = 104/269 (38%), Gaps = 67/269 (24%)
Query: 315 IGSGGFGTV-YKLAMDDGNVFALKRI---DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G FG V +D ++A+K + D LN + E +IL + ++V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 371 YCNSPTSKLLIYDFLPGGSLD------EALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
+ + D++PGG + E E + + A L + + + + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF-YIAELTLAIESVHKMGF----- 122
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLA------------------------------ 454
IHRDIK NIL+D + +++DFGL
Sbjct: 123 ----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 455 -----------KLLEDEESH-----ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLV 498
K LE + + + GT Y+APE + T+ D +S GV++
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 499 LEVLSGKRPTDA-SFIEKGLNIVGWLNFL 526
E+L G+ P A + E L ++ W N L
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERE 353
S+ ++K+ + L IGSG G V A D G A+K++ + N+ + RE
Sbjct: 15 STFTVLKRYQQL---KPIGSGAQGIVCA-AFDTVLGINVAVKKLSRPFQNQTHAKRAYRE 70
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDF--------LPGGSLDEALHERSEQLDWDA 405
L +L + H+ +++L N T + + +F L +L + +H +LD +
Sbjct: 71 LVLLKCVNHKNIISL---LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM---ELDHER 124
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
++ G+ +LH S IIHRD+K SNI++ + ++ DFGLA+ + +
Sbjct: 125 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMM 179
Query: 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSG 504
T T Y APE + E D++S G ++ E++ G
Sbjct: 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 17/215 (7%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKL--AMDDGNVFALKRIDK--LNEGFDRFFERE 353
S+ ++K+ + L IGSG G V A+ D NV A+K++ + N+ + RE
Sbjct: 11 STFTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRE 66
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYD--FLPGGSLDEALHERSE-QLDWDARLNII 410
L ++ + H+ +++L +P L + +L +D L + + +LD + ++
Sbjct: 67 LVLMKCVNHKNIISLLNVF-TPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 125
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
G+ +LH S IIHRD+K SNI++ + ++ DFGLA+ S + T
Sbjct: 126 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV 180
Query: 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK 505
T Y APE + E D++S G ++ E++ K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 37/145 (25%), Positives = 57/145 (39%), Gaps = 13/145 (8%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV--NLRGY 371
++ G VY L + LK +G DR ERE+ IL + + L +
Sbjct: 5 LLKGGLTNRVYLL-GTKDEDYVLKINPSREKGADR--EREVAILQLLARKGLPVPKVLAS 61
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
S L+ +++ G +LDE E E + A A+ LA LH + H
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKEDI---AEQ-----LAELLAKLHQLPLLVLCHG 113
Query: 432 DIKSSNILLDGNLEARVSDFGLAKL 456
D+ NIL+D + D+ A
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAG--T 471
+GL Y+H S ++HRD+K +N+ ++ +L ++ DFGLA++++ SH + G T
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 472 FGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGK 505
Y +P + S T+ D+++ G + E+L+GK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 57/286 (19%), Positives = 102/286 (35%), Gaps = 43/286 (15%)
Query: 316 GSGGFGTVYKLAMDDGNVFALKRID---KLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+ K + A+K+I+ E + E+ ++H N+ Y
Sbjct: 11 EDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQ-EIITSRQLQHP---NILPYV 65
Query: 373 NSPTSK---LLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
S ++ + GS ++ L E L A I+ L Y+H
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GF 122
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG------YLAPEYMQ- 481
IHR +K+S+ILL G+ + +S + + + +L+PE +Q
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 482 --SGRATEKTDVYSFGVLVLEVLSGKRP---TDASF--IEK--GL--NIVGWLNFLISED 530
G EK+D+YS G+ E+ +G P A+ +EK G ++ + + ED
Sbjct: 183 NLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241
Query: 531 RQREIIDPNCEGVQSESLD---------ALLAVATQCVSSSPDDRP 567
+ N +S+D C+ P+ RP
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 74/313 (23%), Positives = 117/313 (37%), Gaps = 75/313 (23%)
Query: 315 IGSGGFGTVYKLAMDDGN-VFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G FG V + D N ++A+K + K L + E +IL + ++V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGLA--YLHHDCS 425
+ + D++PGG + L E L AR I A A +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYI---AELTCAIESVH---K 119
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLA------------------------------- 454
IHRDIK NIL+D + +++DFGL
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 455 ------KLLE-----DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
K LE + + + GT Y+APE + T+ D +S GV++ E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 504 GKRP-TDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSS 562
G+ P + E L ++ W L I P+ + E+ D +L +
Sbjct: 240 GQPPFLADTPAETQLKVINWETTL-------HI--PSQAKLSREASDLILRLCC-----G 285
Query: 563 PDDRPTMHRVVQI 575
+DR + +I
Sbjct: 286 AEDRLGKNGADEI 298
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF----DRFFERELEILGSIKHRYLVNLRG 370
IG+G FG V ++ G A + +L F E + S++H L+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGA--AKGLAYLHHDCSP 426
C T LL+ +F P G L L ++E + D M A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT-IVAGTFGYLAPEYMQSGRA 485
IH D+ N LL +L ++ D+GL+ E+ ++T + ++APE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 486 -------TEKTDVYSFGVLVLEVLS-GKRP 507
T++++V+S GV + E+ G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 41/211 (19%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE----RELEILGSIK-HRYLVNL 368
+G G FG+VY + G + A+K K+ + F + E RE++ L + H +V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIK---KMKKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 369 RGYCNSPTSKLLIYD----FLPGGSLDEALHERSEQL--DWDARL-------NIIMGAAK 415
K + + + ++ L+ QL D + +II +
Sbjct: 64 ---------KEVFRENDELYFVFEYMEGNLY----QLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
GLA++H HRD+K N+L+ G +++DFGLA+ + + T V T Y
Sbjct: 111 GLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYR 165
Query: 476 APE-YMQSGRATEKTDVYSFGVLVLEVLSGK 505
APE ++S + D+++ G ++ E+ + +
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 10/159 (6%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
I G FG VY L ++ ++A+K + K +N+ + E + L K ++V+L
Sbjct: 12 ISRGAFGKVY-LGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
S + L+ ++L GG + LH D + + I A L YLH II
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRH---GII 126
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
HRD+K N+L+ +++DFGL+K+ + E ++ I+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDIL 165
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYKLAMDD---GNVFALKRIDKLNEGFD------RFFER 352
++K+ + L IGSG G V A D G A+K KL+ F R + R
Sbjct: 14 VLKRYQNL---KPIGSGAQGIV--CAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAY-R 64
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF----LPGGSLDEALHERSEQLDWD-ARL 407
EL ++ + H+ N+ G N T + + +F L +D L + Q+D D R+
Sbjct: 65 ELVLMKLVNHK---NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQ-VIQMDLDHERM 120
Query: 408 N-IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
+ ++ G+ +LH S IIHRD+K SNI++ + ++ DFGLA+
Sbjct: 121 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 177
Query: 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK 505
+V T Y APE + E D++S G ++ E++ G
Sbjct: 178 VV--TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 68/259 (26%), Positives = 103/259 (39%), Gaps = 84/259 (32%)
Query: 314 IIGSGGFGTVYKLA--MDDGNVFALKRIDKLNEGFDR----FFERELEILGSIKHRYLVN 367
+IG G FG V +L D G ++A+K + K +E F + + E ++L ++V+
Sbjct: 8 VIGKGAFGEV-RLVQKKDTGKIYAMKTLLK-SEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 368 LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWD-----------ARLNIIMGAAK 415
L Y L LI +FLPGG L L + +D A + + A
Sbjct: 66 LY-YSFQDAQYLYLIMEFLPGGDLMTML------IKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA-------------KLLEDEES 462
L + IHRDIK NIL+D ++SDFGL+ KLL+ + +
Sbjct: 119 KLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 463 H----------ITTI-----------------------VAGTFGYLAPE-YMQSGRATEK 488
+ +I GT Y+APE ++Q G E
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE- 228
Query: 489 TDVYSFGVLVLEVLSGKRP 507
D +S G ++ E L G P
Sbjct: 229 CDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 34/122 (27%), Positives = 64/122 (52%), Gaps = 10/122 (8%)
Query: 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL-DGNL 444
P + + L S L + + A G+ +L S +HRD+ + N+L+ +G L
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKL 277
Query: 445 EARVSDFGLAKLLEDEESHITTIVAGTF---GYLAPEYMQSGRATEKTDVYSFGVLVLEV 501
++ DFGLA+ + + ++I+ TF ++APE + + T +DV+SFG+L+ E+
Sbjct: 278 -VKICDFGLARDIMRDSNYISK--GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
Query: 502 LS 503
+
Sbjct: 335 FT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 9e-07
Identities = 49/202 (24%), Positives = 85/202 (42%), Gaps = 27/202 (13%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-RELEILGSIKHRYLVNLRGYC 372
IG G F V K + G +A+K + K + ++ RE++ L L +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRR--------LSPHP 58
Query: 373 NSPTSKLLIYDFLPG----------GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
N +++D G +L E + R L + + K L ++H
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM-Q 481
+ I HRDIK NIL+ ++ +++DFG + + + + T T Y APE +
Sbjct: 119 N---GIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLT 172
Query: 482 SGRATEKTDVYSFGVLVLEVLS 503
G K D+++ G + E+LS
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 314 IIGSGGFGTVYKLAMDDGNV-FALKRIDK-----LNEGFDRFFERELEILGSIKHRYLVN 367
+I +G +G VY + + FA+K+I+K N+ F ER+ IL ++ ++V+
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERD--ILTFAENPFVVS 65
Query: 368 LRGYCNSPTSKLL--IYDFLPGGSLDEALHERSEQLDWD-ARLNIIMGAAKGLAYLHHDC 424
+ +C+ T + L + +++ GG L + L D AR+ L YLH
Sbjct: 66 M--FCSFETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDMARM-YFAETVLALEYLH--- 118
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAK---------LLE-----DEESHITTIVAG 470
+ I+HRD+K N+L+ +++DFGL+K L E D + V G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
T Y+APE + + D ++ G+++ E L G P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 19/169 (11%)
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
L I + + YLH + RIIHRDIK+ NI ++ + + DFG A D ++
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL 526
AGT APE + D++S G+++ E+ + D+ F + GL+ G +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKDGLD--GDCD-- 294
Query: 527 ISEDRQREII------DPNCEGVQSES-LDALLAVATQCVSSSPDDRPT 568
DRQ ++I PN + +++ LD + + S P RP
Sbjct: 295 --SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPL 341
|
Length = 391 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKL--AMDDGNVFALKRIDK--LNEGFDRFFERE 353
S+ ++K+ + L IGSG G V A+ + NV A+K++ + N+ + RE
Sbjct: 18 STFTVLKRYQNLKP---IGSGAQGIVCAAYDAILERNV-AIKKLSRPFQNQTHAKRAYRE 73
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDF--------LPGGSLDEALHERSEQLDWDA 405
L ++ + H+ N+ G N T + + +F L +L + + +LD +
Sbjct: 74 LVLMKCVNHK---NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHER 127
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
++ G+ +LH S IIHRD+K SNI++ + ++ DFGLA+ S +
Sbjct: 128 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM 182
Query: 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK 505
T T Y APE + E D++S G ++ E++ G
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 315 IGSGGFGTVYKLAMD-DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVN-LRG 370
IG+G FG V+ + F K I L E E+ ++ +KH+ +V +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 371 YCNSPTSKLLI-YDFLPGGSLDEALHERSE---QLDWDARLNIIMGAAKGLAYLHH---- 422
+ N KL I +F G L + + + +++ A ++I LAY H+
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 423 DCSPRIIHRDIKSSNILL-----------------DGNLEARVSDFGLAKLLEDEESHIT 465
R++HRD+K NI L +G A++ DFGL+K + E +
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS 200
Query: 466 TIVAGTFGYLAPEYM--QSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ GT Y +PE + ++ +K+D+++ G ++ E+ SGK P
Sbjct: 201 CV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 88 ISADLGKLDQLKFLN--LHSNNFYGEIPSELGNCT-ELQGLSLQSNYLSGSIPSELGNLS 144
+ +++ +L +L L NN +IP +G L+ L L N + S+PS L NL
Sbjct: 105 LRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLP 163
Query: 145 NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
NL NLD+S N LSD +P L L L ++S N
Sbjct: 164 NLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGN 196
|
Length = 394 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 35/112 (31%), Positives = 60/112 (53%), Gaps = 19/112 (16%)
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG----------NLEARVSDFGLAKLL 457
NI+ GA +GL YLH + IHR+IK+S+IL+ G +L + V + AK++
Sbjct: 105 NILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161
Query: 458 EDEESHITTIVAGTFGYLAPEYMQSGRA--TEKTDVYSFGVLVLEVLSGKRP 507
D T+++ +L+PE ++ K+D+YS G+ E+ +G+ P
Sbjct: 162 YDFPQFSTSVLP----WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 58/246 (23%), Positives = 108/246 (43%), Gaps = 33/246 (13%)
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEAL--HERSEQL-DWDAR 406
F +E++I+ +K ++ L C + +I +++ G L++ L HE E D
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 407 L----NIIMGA---AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK-LLE 458
+I A A G+ YL S +HRD+ + N L+ N +++DFG+++ L
Sbjct: 126 TISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS--GKRP----TDASF 512
+ I +++ E + G+ T +DV++FGV + E+L+ ++P +D
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242
Query: 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRV 572
IE G F + RQ + P D+L + C + +RP+ +
Sbjct: 243 IEN----TG--EFFRDQGRQVYLPKPAL------CPDSLYKLMLSCWRRNAKERPSFQEI 290
Query: 573 -VQILE 577
+LE
Sbjct: 291 HATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 51/244 (20%), Positives = 104/244 (42%), Gaps = 49/244 (20%)
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN 408
FFE ++ + H +L + G C + +++ +F+ G LD L + ++ ++
Sbjct: 63 FFETA-SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL------DGNLE-ARVSDFGLAKLLEDEE 461
+ A L+YL ++H ++ + NILL +G ++SD G++ E
Sbjct: 122 VAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE 178
Query: 462 SHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEV-------LSGKRPTDAS-F 512
+ I ++APE + G + + D +SFG +LE+ L + P++ F
Sbjct: 179 ERVERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233
Query: 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRV 572
EK + + +P+C+ L + +QC++ P RP+ +
Sbjct: 234 YEK----------------KHRLPEPSCK--------ELATLISQCLTYEPTQRPSFRTI 269
Query: 573 VQIL 576
++ L
Sbjct: 270 LRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 18/147 (12%)
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSL----DEALHERSEQLD-WDARLNIIMGAAKGLA 418
+V L Y S S L+ GG L + L+ E + W A + + + A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
LH + I+ RD+ +NILLD +++ F + E E+S V Y APE
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPE 152
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGK 505
TE D +S G ++ E+L+GK
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 1/74 (1%)
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRAT 486
IIHRDIK+ N+L++G + + DFG A S +AGT APE + T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 487 EKTDVYSFGVLVLE 500
D++S G+++ E
Sbjct: 341 PSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 32/120 (26%), Positives = 46/120 (38%), Gaps = 17/120 (14%)
Query: 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEAR 447
SL + L R L+ + + + L LH R KS NILL +
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELH---------RQAKSGNILL--TWDGL 49
Query: 448 VSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ G E+S +APE +Q TEK D+YS G+ + E L + P
Sbjct: 50 LKLDGSVAFKTPEQSRPDPYF------MAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 58/265 (21%), Positives = 97/265 (36%), Gaps = 67/265 (25%)
Query: 315 IGSGGFGTV-YKLAMDDGNVFALKRI---DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G FG V +D ++A+K + D L + E +IL + ++V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR--- 427
+ + D++PGG + L R+ I C+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL----------IRMGIFPEDLARFYIAELTCAVESVH 118
Query: 428 ---IIHRDIKSSNILLDGNLEARVSDFGLA------------------------------ 454
IHRDIK NIL+D + +++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 455 -----------KLLE-----DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLV 498
K LE + + + GT Y+APE + T+ D +S GV++
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 499 LEVLSGKRPTDA-SFIEKGLNIVGW 522
E+L G+ P A + +E + ++ W
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 30/111 (27%), Positives = 53/111 (47%), Gaps = 19/111 (17%)
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL--LDGN--LEARVSDFGL------AKLLE 458
I+ G K L Y+HH +HR +K+S+IL +DG L S+ + +++
Sbjct: 106 ILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162
Query: 459 DEESHITTIVAGTFGYLAPEYMQSGRA--TEKTDVYSFGVLVLEVLSGKRP 507
D + ++ +L+PE +Q K+D+YS G+ E+ +G P
Sbjct: 163 DFPKYSVKVLP----WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+N+ + + + L L L L L +N ++P +GN + L+ L L +N +S
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS-- 268
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSL 164
S LG+L+NL LD+S NSLS+ +P
Sbjct: 269 SISSLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 64/280 (22%), Positives = 116/280 (41%), Gaps = 34/280 (12%)
Query: 315 IGSGGFGTVY--KLAMDDGNVFALKRIDKLNEGFDR--FFERELEILGSIKHRYLVNLRG 370
IG+G FG V ++ D G + + K N F ++ + ++H ++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 371 YCNSPTSKLLIYDFLPGGSL-----DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
C LL++++ G L E H R+ QL R+ + A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA--GVTHMHKH-- 118
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT--IVAGTFGYLAPEYMQS- 482
+H D+ N L +L +V D+G+ +E +I T +LAPE +
Sbjct: 119 -NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 483 ------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536
T+ ++V++ GV + E+ + ++ + LN +I +D+Q ++
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-----LNHVI-KDQQVKLF 230
Query: 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
P E SE +L Q SP+ R T V ++L
Sbjct: 231 KPQLELPYSERWYEVL----QFCWLSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.004
Identities = 22/61 (36%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 97 QLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155
LK L+L SNN IP L+ L L N L+ P L +L +LD+S N+
Sbjct: 1 NLKSLDL-SNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 156 L 156
L
Sbjct: 60 L 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 594 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.67 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.49 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.45 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.44 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.43 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.42 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.38 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.28 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.28 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.25 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.21 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.1 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.06 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.03 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.01 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.01 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.92 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.86 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.83 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.83 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.81 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.79 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.76 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.67 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.67 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.63 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.55 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.54 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.53 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.51 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.5 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.31 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-60 Score=555.42 Aligned_cols=473 Identities=32% Similarity=0.563 Sum_probs=309.3
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+|+.|+|++|++++.+|..|.++++|+.|+|++|++.+.+|..+.++++|++|+|++|.+++.+|..|..+++|+.|+|
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 554 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence 34555555555555555555555555666666666555555555555556666666666665555555555556666666
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCcccccccCCCCCCCCCCCCCCccc
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQ 231 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~~~~c~~~~~~~~~~~~~~~~~~ 231 (594)
++|++++.+|..+.++++|+.|++++|++.+.+|..+.+..+....+.||+.+|+.+... ..++.
T Consensus 555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~------------~~~~c--- 619 (968)
T PLN00113 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS------------GLPPC--- 619 (968)
T ss_pred CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcccc------------CCCCC---
Confidence 666665555555555555666666666665555555455555555555665555432110 00000
Q ss_pred cCCCCCCCCceeeeehhhhhHHHHHHH-HhhhhceeecccccccccccccccCCCcceeEecCC--CCCCHHHHHHHhcC
Q 007668 232 NQGGKKNSGRLLISASATVGALLLVAL-MCFWGCFLYKKLGKNESKGLARDVGGGASIVMFHGD--LPYSSKDIIKKLET 308 (594)
Q Consensus 232 ~~~~~~~~~~~~i~~~~~~~~~ll~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 308 (594)
.. ..+.....+++ ++++++++++++ ++++.++++++..+.++. ....+......+... ..+..+++ ...
T Consensus 620 ~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 691 (968)
T PLN00113 620 KR-VRKTPSWWFYI-TCTLGAFLVLALVAFGFVFIRGRNNLELKRV---ENEDGTWELQFFDSKVSKSITINDI---LSS 691 (968)
T ss_pred cc-ccccceeeeeh-hHHHHHHHHHHHHHHHHHHHHhhhccccccc---ccccccccccccccccchhhhHHHH---Hhh
Confidence 00 01111222222 222333222222 222222222211111110 000011111111111 11233333 456
Q ss_pred CCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 309 LDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+...+.||+|+||.||+|.. .++..||||++...... ...|++.+++++|||||+++|+|.+....++||||+++
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 77888999999999999986 57899999998754332 23468889999999999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.++++. ++|..+.+++.|||+||+|||+.++++|+||||||+||+++.++.+++. ||........ ..
T Consensus 768 g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~ 837 (968)
T PLN00113 768 KNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TK 837 (968)
T ss_pred CcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CC
Confidence 999999953 8999999999999999999998777899999999999999998888875 6655433221 12
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC---CC
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG---VQ 544 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 544 (594)
..|+++|+|||++.+..++.++|||||||++|||+||+.||+.... .......|.+...........+|+.... ..
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 3578999999999999999999999999999999999999965432 2345667776655554455556655432 34
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
.....++.+++.+||+.||++||||+||++.|++....
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 45667889999999999999999999999999987654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=447.45 Aligned_cols=288 Identities=45% Similarity=0.825 Sum_probs=254.3
Q ss_pred CCCCCHHHHHHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEe
Q 007668 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373 (594)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 373 (594)
...|++.++.+++++|...+.||+|+||.||+|.+.+|..||||++.....+..++|..|++++++++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34689999999999999999999999999999999999999999887644431456999999999999999999999999
Q ss_pred CCC-ceEEEEEccCCCchhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 374 SPT-SKLLIYDFLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 374 ~~~-~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
+.+ +.+||||||++|+|.++++.... .++|..|++||.++|+||+|||+.+.+.|+|||||++|||+|+++++||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 998 49999999999999999997665 8999999999999999999999998889999999999999999999999999
Q ss_pred ccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 452 GLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 452 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
|+++..............||.+|+|||++..+..+.|+||||||++++|++||+.|.+.........+..|....+....
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 99965554122211111799999999999999999999999999999999999999887654555668999998888889
Q ss_pred cccccCCCCC-C-CCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 532 QREIIDPNCE-G-VQS-ESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 532 ~~~~~~~~~~-~-~~~-~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
..+++|+.+. . ... .....+..++.+|++.+|++||+|.||+++|+....
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 9999999986 3 333 577889999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=381.71 Aligned_cols=256 Identities=35% Similarity=0.579 Sum_probs=210.9
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchh--hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC-ceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG--FDRFFERELEILGSIKHRYLVNLRGYCNSPT-SKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e 383 (594)
+.+...+.||+|+||+||+|.++....||||++...... ..+.|.+|+.+|.+++|||||+++|+|.++. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 344455679999999999999996666999999863322 2568999999999999999999999999888 7999999
Q ss_pred ccCCCchhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eeeCCCCCCCeEecCCC-cEEEeecccccccccC
Q 007668 384 FLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPR-IIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDE 460 (594)
Q Consensus 384 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~~~~~~ 460 (594)
||++|+|.++++. +...+++..+++|+.|||+||.|||++ + |||||||++|||++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999998 477899999999999999999999965 5 99999999999999997 9999999999876543
Q ss_pred CceeeeeeecccCccCccccc--cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQ--SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
. ...+...||++|||||++. ...++.|+||||||+++|||+||+.||...... +......... .+.
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~-~Rp---- 265 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGG-LRP---- 265 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcC-CCC----
Confidence 2 2233367999999999999 568999999999999999999999999764321 1111111111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
..+......+..++.+||+.||+.||++.|++..|+...
T Consensus 266 ---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 266 ---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred ---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 122235578999999999999999999999999998653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=367.06 Aligned_cols=250 Identities=30% Similarity=0.511 Sum_probs=212.5
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecc-cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc-eEEEEEcc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS-KLLIYDFL 385 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~e~~ 385 (594)
++..+.||+|..|+|||+.++ +++.+|+|++.. .++...+++.+|+++++..+||+||.++|.|..+.. ..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 345588999999999999876 578899999953 455667899999999999999999999999998884 99999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++|||++.+... +.+++...-+|+.+|++||.|||+ ..+||||||||+|||++..|++||+|||.+..+... ..
T Consensus 161 DgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 161 DGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 999999999763 679999999999999999999996 369999999999999999999999999999877654 45
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
.+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||..... ...+....+ ..+.+...+..+.
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll---------~~Iv~~ppP~lP~ 304 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELL---------CAIVDEPPPRLPE 304 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHH---------HHHhcCCCCCCCc
Confidence 667899999999999999999999999999999999999999877511 112222222 2233333333444
Q ss_pred H-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 E-SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~-~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+ .+.++.+++..|+++||.+|||++|+++
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3 7789999999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=379.71 Aligned_cols=256 Identities=31% Similarity=0.488 Sum_probs=217.0
Q ss_pred CCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
.+...+.||+|.||+||.|.++....||+|.++.... ..+.|.+|+++|++|+|+|||+++|+|..+...+||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 3445688999999999999999888999999987543 356788999999999999999999999998899999999999
Q ss_pred Cchhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 388 GSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 388 gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
|+|.++|+. .+..+...+.+.++.|||+|++||+ ++++|||||.++|||++++..+||+|||+++...++......
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999996 5667999999999999999999999 559999999999999999999999999999966666555554
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...-+..|+|||.+..+.++.|||||||||+|||++| |+.||..+... +.+..+-...++. .+.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------ev~~~le~GyRlp---------~P~ 427 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------EVLELLERGYRLP---------RPE 427 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------HHHHHHhccCcCC---------CCC
Confidence 4445779999999999999999999999999999999 89998764322 2222222222221 234
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
.++..+.++|..||+.+|++|||++.+...|+.....
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 4567899999999999999999999999999875543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=374.90 Aligned_cols=247 Identities=26% Similarity=0.457 Sum_probs=212.9
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecc---cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.+|...++||+|+|+.+|++.. ..|+.||+|++.+ ......+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999987 8899999999976 24445677899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
|+|++++|.++++ +.+.+++.+++.+++||+.||.|||+ .+|+|||||..|++++++.++||+|||+|..+..++.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 9999999999998 56889999999999999999999994 5999999999999999999999999999998875543
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
. ..+.+|||-|+|||++.....+..+||||+||++|-|+.|++||+.....+. +......+ ..
T Consensus 174 r-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~~~---Y~------- 236 (592)
T KOG0575|consen 174 R-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKLNE---YS------- 236 (592)
T ss_pred c-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHhcC---cc-------
Confidence 3 4567899999999999999999999999999999999999999987533321 11111111 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+...+.+..+||.++|+++|.+|||+++|+.
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12244567889999999999999999999995
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=384.98 Aligned_cols=259 Identities=25% Similarity=0.438 Sum_probs=216.5
Q ss_pred cCCCccceeeeecceEEEEEEec------CCcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
.+....+.||+|+||+||+|... +...||||.++...+. ...+|++|++.++.++|||||+++|.|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34555688999999999998644 3567999999976555 7889999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcC---------C----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcE
Q 007668 380 LIYDFLPGGSLDEALHERS---------E----QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 446 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~---------~----~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 446 (594)
+|+|||..|+|.++|+.+. . +++..+.+.||.|||.|+.||- +..+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 9999999999999997421 2 2788999999999999999999 4599999999999999999999
Q ss_pred EEeecccccccccCCceeee-eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHH
Q 007668 447 RVSDFGLAKLLEDEESHITT-IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 447 ~l~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 524 (594)
||+|||+++.....+.+... ...-+.+|||||.+..+++|.+||||||||+|||+++ |+.||.+.--++..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI------- 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI------- 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-------
Confidence 99999999976554444332 3445789999999999999999999999999999999 99998764222211
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
..+-..++-+.++..+.++..||..||+.+|++||+++||-..|+......
T Consensus 716 --------e~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 716 --------ECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --------HHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 111222333456677889999999999999999999999999998865543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=349.86 Aligned_cols=200 Identities=31% Similarity=0.515 Sum_probs=180.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
..+|...+.||+|+||+||+|+++ ++..||||.+.+. .....+.+..|+.+++.++|||||++++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 456778888999999999999776 5799999999765 5666777899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC------CcEEEeecccccc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN------LEARVSDFGLAKL 456 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~~l~Dfgl~~~ 456 (594)
|||.+|+|.++++.+ +.+++.....++.|||.||++||+ .+||||||||+|||++.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999875 479999999999999999999995 599999999999999864 4589999999998
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDAS 511 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 511 (594)
+.+.. ...+.+|++-|||||++..++|+.|+|+||+|+++|++++|+.||+..
T Consensus 165 L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 165 LQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 87433 345678999999999999999999999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=342.57 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=210.2
Q ss_pred hcCCCccceeeeecceEEEEE-EecCCcEEEEEeec--ccchhhHHHHHHHHHHHhhCCCCeeeeeee-EEeCCCc-eEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKL-AMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRG-YCNSPTS-KLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~l 380 (594)
...|.+.++||+|.||+|||+ ...+|..+|.|.++ ..+....++...|+.++++|+|||||++++ .+.++.+ .++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 445777899999999999998 56789999999987 345556678999999999999999999998 4555555 789
Q ss_pred EEEccCCCchhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 381 IYDFLPGGSLDEALH---ERSEQLDWDARLNIIMGAAKGLAYLHHDCSP-RIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 381 v~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
||||+..|+|...++ +....+++..+++++.|++.||.++|..... -|+||||||.||+++.+|.+|++|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999987 3456699999999999999999999964322 388999999999999999999999999998
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
+...... ....+|||.||+||.+.+..|+.|+||||+||++|||..-++||.+.+.. + +...+..
T Consensus 178 l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~------~-L~~KI~q------- 242 (375)
T KOG0591|consen 178 LSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL------S-LCKKIEQ------- 242 (375)
T ss_pred hcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH------H-HHHHHHc-------
Confidence 8765433 45578999999999999999999999999999999999999999875321 1 1111111
Q ss_pred CCCCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 537 DPNCEGVQ-SESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 537 ~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
...+..+ .-++..+..|+..|+..||+.||+.-.++..+..
T Consensus 243 -gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 -GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1233334 6778899999999999999999985444444443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=353.46 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=202.2
Q ss_pred cCCCccceeeeecceEEEEEE-ecCCcEEEEEeecccch-------hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNE-------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
+.|...+.||+|+||.|-+|. .++|+.||||.+.+... .......+|+++|++|+|||||++.+++..++..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 467778999999999999985 55799999999975211 1123457999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC---CcEEEeeccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN---LEARVSDFGLAK 455 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~~l~Dfgl~~ 455 (594)
|+|+||++||.|.+.+-.+ +.+.+.....+++|++.|+.|||+ .||+||||||+|||+..+ ..+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999999763 557788889999999999999995 599999999999999765 779999999999
Q ss_pred ccccCCceeeeeeecccCccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGR---ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQ 532 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (594)
..+ +...+.+.+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||........ +. ..+..++.
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~----eQI~~G~y 399 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LK----EQILKGRY 399 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HH----HHHhcCcc
Confidence 876 344567789999999999997654 23478999999999999999999987543311 11 01111110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+- +......+.+..+||.+||..||++|||+.|+++
T Consensus 400 --~f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 400 --AFG---PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --ccc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 000 1123456678899999999999999999999885
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=372.23 Aligned_cols=272 Identities=27% Similarity=0.456 Sum_probs=226.1
Q ss_pred CCCCHHHHHHHhc---------CCCccceeeeecceEEEEEEecC----CcEEEEEeecc-cchhhHHHHHHHHHHHhhC
Q 007668 295 LPYSSKDIIKKLE---------TLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDK-LNEGFDRFFERELEILGSI 360 (594)
Q Consensus 295 ~~~~~~~~~~~~~---------~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l 360 (594)
.|++|+|--.+.. ...+.++||.|.||.||+|.++- ...||||.++. ..+.....|..|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 3566666555543 34467899999999999998763 45799999986 5566678899999999999
Q ss_pred CCCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 361 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
+||||++|.|+.......++|+|||++|+|+.+|+.+++++++.++..++++||.|+.||.+ +++|||||.++|||+
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILV 764 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILV 764 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheee
Confidence 99999999999999999999999999999999999999999999999999999999999994 599999999999999
Q ss_pred cCCCcEEEeecccccccccCCceeeeeeec--ccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccc
Q 007668 441 DGNLEARVSDFGLAKLLEDEESHITTIVAG--TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGL 517 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 517 (594)
+.+..+|++|||+++.+.++.....+...| +.+|.|||.+..+.++.++||||||+||||.++ |.+||..+-..+
T Consensus 765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-- 842 (996)
T KOG0196|consen 765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-- 842 (996)
T ss_pred ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--
Confidence 999999999999999876655333333333 469999999999999999999999999999999 999986543221
Q ss_pred hHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 007668 518 NIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPC 584 (594)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~ 584 (594)
.++..-.+.++. .+.+++..|.+||..||++|-.+||.+.+++..|+.+.-++.
T Consensus 843 ----VIkaIe~gyRLP---------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 843 ----VIKAIEQGYRLP---------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ----HHHHHHhccCCC---------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 112222222222 244566889999999999999999999999999998765543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=338.10 Aligned_cols=243 Identities=27% Similarity=0.394 Sum_probs=204.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.+.|+..++||+|+||+||.++.+ +++.+|+|++++. .....+...+|..++.+++||+||+++-.|+++...|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 568899999999999999999655 5889999999863 233456788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+||+.||.|..+|++ .+.+++..+.-++..|+.||.||| +.+||||||||+|||+|.+|+++|+|||+++......
T Consensus 104 ld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999976 467999999999999999999999 5599999999999999999999999999998654432
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
..+.+++||+.|||||++.+..++.++|-||+|+++|||++|.+||..... ..+.+...... ..
T Consensus 180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~k---------~~ 243 (357)
T KOG0598|consen 180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKGK---------LP 243 (357)
T ss_pred -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcCc---------CC
Confidence 234558999999999999999999999999999999999999999987432 22333332222 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPT 568 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs 568 (594)
..+.-...+..+++.+.++.||++|..
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 122223467889999999999999963
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=347.80 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=212.5
Q ss_pred cCCCccceeeeecceEEEEEE-ecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 381 (594)
+.|+..++||+|.||.||+|+ ..+|+.||+|++.-. .++......+||.+|++|+||||+++.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 445566899999999999995 567999999999753 456678889999999999999999999998776 689999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+|||+. +|.-++...+-.+++.++..+++|++.||+||| +.+|+|||||.+|||||++|.+||+|||+|+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999955 899999877778999999999999999999999 5699999999999999999999999999999888777
Q ss_pred ceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHH----------HHHHHhccc
Q 007668 462 SHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVG----------WLNFLISED 530 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~~ 530 (594)
....+..+-|..|.|||.+.+. .|+.++|+||.|||+.||++|++.+.+..+.++...+. |....+.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP-- 350 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP-- 350 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC--
Confidence 6666667789999999998874 69999999999999999999999998866554433221 2211111
Q ss_pred ccccccCCC------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPN------CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+.+. +.+.....+....+|+..+|..||++|.|+.++++
T Consensus 351 -~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 -HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred -cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00111111 11112233456889999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=341.49 Aligned_cols=253 Identities=31% Similarity=0.513 Sum_probs=204.6
Q ss_pred cCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC--ceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT--SKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 383 (594)
.++...+.||+|+||.||++...+ |+..|||.+...+....+.+.+|+.++++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 356677999999999999997765 8999999987654333567899999999999999999999854444 5889999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-CCcEEEeeccccccccc--C
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLED--E 460 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~~l~Dfgl~~~~~~--~ 460 (594)
|+++|+|.+++...+..+++..+.+.+.||++||+||| +++|+||||||+|||++. ++.+||+|||++..... .
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999986668999999999999999999999 569999999999999999 79999999999987663 2
Q ss_pred CceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.........||+.|||||++..+ ....++||||+||++.||+||++||.... ....+.-...... .
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----~~~~~~~~ig~~~--------~ 240 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----EEAEALLLIGRED--------S 240 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----chHHHHHHHhccC--------C
Confidence 22334457899999999999854 34469999999999999999999987530 1111111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
.+..+...+....+++.+|++.||++|||++++++-
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 123344456788999999999999999999999973
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=375.94 Aligned_cols=264 Identities=27% Similarity=0.446 Sum_probs=219.3
Q ss_pred cCCCccceeeeecceEEEEEEecC--Cc----EEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD--GN----VFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
+..+..+.||+|+||.||+|...+ |. .||||.+.+. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 455667899999999999997664 33 4899999874 5556788999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 007668 380 LIYDFLPGGSLDEALHER------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl 453 (594)
+++|||++|+|..+|++. ...++..+.+.++.|||+|+.||++ +++|||||.++|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999976 5669999999999999999999994 5999999999999999999999999999
Q ss_pred ccccccCCceeeee-eecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 454 AKLLEDEESHITTI-VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 454 ~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
|+.+...+.+.... ..-..+|||||.+..+.++.|+|||||||++||++| |..||......+ .........+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhCCc
Confidence 99665544443332 234579999999999999999999999999999999 889987643221 1122222332
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCccc
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDF 588 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~ 588 (594)
+. .+..++..+.++|.+||+.+|++||++..+++.++.......+.+|
T Consensus 923 L~---------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 923 LD---------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred cC---------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 11 2344557899999999999999999999999999988777666664
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.67 Aligned_cols=268 Identities=26% Similarity=0.440 Sum_probs=217.8
Q ss_pred CCHHHHHHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecc--cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC
Q 007668 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374 (594)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 374 (594)
.+.++++...+.+...+.||+|+||+||+|.+.+ .||||++.. .+....+.|+.|+.++++-||.||+-+.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3346666677788889999999999999999873 589999875 344456789999999999999999999999988
Q ss_pred CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
+.. .+|+.++++-+|+.++|.....++..+.+.||+|||+|+.||| .++|||||||+.||++.+++.|||+|||++
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccce
Confidence 776 9999999999999999987788999999999999999999999 569999999999999999999999999999
Q ss_pred cccccC-CceeeeeeecccCccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 455 KLLEDE-ESHITTIVAGTFGYLAPEYMQS---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 455 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
.....- ........-|...|||||++.. .+|++.+||||||+|+|||++|..||.....+.... .+.
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-------mVG-- 606 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-------MVG-- 606 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-------Eec--
Confidence 753321 1111122347889999999864 468999999999999999999999998543332111 111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
+....++..........++.+|+..||..++++||.+.+|+..|+....
T Consensus 607 --rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 607 --RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred --ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1112223333344566789999999999999999999999999988776
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=320.75 Aligned_cols=263 Identities=23% Similarity=0.342 Sum_probs=204.1
Q ss_pred cCCCccceeeeecceEEEEEEecC-CcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+.|+....+|+|+||.|||.+.++ |+.||||++... ++...+-..+|++++++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 456677899999999999998764 899999999764 34456778999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|++. ++.+-+.....-++.+.+.++++|++.|+.|+|. .+++||||||+|||++.++.+|++|||+|+.+... ..
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd 156 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD 156 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence 9966 5555555555668999999999999999999994 59999999999999999999999999999987732 22
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHH--------HHHhccc-ccc
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWL--------NFLISED-RQR 533 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~-~~~ 533 (594)
..+..+.|..|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+...-+....+... ...+... ...
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 3344567999999999887 68999999999999999999999988764332222221111 1111111 111
Q ss_pred cccCCCCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 534 EIIDPNCE------GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 534 ~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+.-|..+ .-.+..+..+.++++.|++.||++|++-++++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111 111233457889999999999999999988873
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=341.84 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=211.1
Q ss_pred HHhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecc---cchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCce
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 378 (594)
+...+|..++.||+|+|++|++|.. ..+..||||++.+ ..+.-.+++.+|-++|.+| .||.|++|+--|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3356888999999999999999964 4689999999975 3444457889999999999 899999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
|+|+||.++|+|.++|++. +.+++...+.++.+|+.||+||| +.|||||||||+|||+|+|++++|+|||.|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999999999874 67999999999999999999999 5699999999999999999999999999999876
Q ss_pred cCCce----------e--eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHH
Q 007668 459 DEESH----------I--TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 459 ~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
+.... . ...++||..|.+||++..+..++.+|+|+|||++|+|+.|.+||.+.++.....
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq-------- 297 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ-------- 297 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH--------
Confidence 43221 1 145899999999999999999999999999999999999999998865532111
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+++-.. ..++..+..+.+|+.+.|..||.+|+|.+++.+
T Consensus 298 -------kI~~l~y-~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 298 -------KIQALDY-EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred -------HHHHhcc-cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1111110 122333467889999999999999999988876
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=331.82 Aligned_cols=268 Identities=28% Similarity=0.436 Sum_probs=206.9
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhh--CCCCeeeeeeeEEeCCC----ceE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS--IKHRYLVNLRGYCNSPT----SKL 379 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~ 379 (594)
...+...++||+|+||.||||.+.+ +.||||++... ..+.|..|-++.+. |+|+||++++++-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4556677899999999999999974 89999988653 34578888877665 68999999999875555 889
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc------CCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD------CSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl 453 (594)
||++|.+.|+|.++|.. ..++|....+|+..+++||+|||++ .+++|+|||||++|||+++|++++|+|||+
T Consensus 285 LVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999986 4699999999999999999999986 378999999999999999999999999999
Q ss_pred ccccccCCce-eeeeeecccCccCccccccCCC------CccchhhhHHHHHHHHHhCCCCC--------Ccchhccc--
Q 007668 454 AKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRA------TEKTDVYSFGVLVLEVLSGKRPT--------DASFIEKG-- 516 (594)
Q Consensus 454 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~s~G~vl~elltg~~p~--------~~~~~~~~-- 516 (594)
|.++...... .....+||.+|||||++++.-. -.+.||||+|.|+||+++...-. ...++.+.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9988654432 2334789999999999987532 23689999999999999964332 22222211
Q ss_pred -chHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 517 -LNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 517 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
..+.+ ++..+..++.+..+...+... .....+.+.+..||..||+.|.|+.=|.+.+.++...
T Consensus 443 hPt~e~-mq~~VV~kK~RP~~p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 443 HPTLEE-MQELVVRKKQRPKIPDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCHHH-HHHHHHhhccCCCChhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 12222 233333333444444333322 4567789999999999999999998888777665443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=339.92 Aligned_cols=263 Identities=22% Similarity=0.367 Sum_probs=209.2
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhH-HHHHHHHHHHhhCC-CCeeeeeeeEEeCCC-ceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFD-RFFERELEILGSIK-HRYLVNLRGYCNSPT-SKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lv 381 (594)
.++|...+.||.|.||.||+|+. .+|+.||||++++.-...+ ..-.||+..++++. ||||+++.+.+.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45778889999999999999964 5689999999986433333 33568999999998 999999999998887 89999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
||||+ -+|+++++.+...+++..+..|++||++||+|+|++ |+.|||+||+|||+.....+||+|||+|+......
T Consensus 89 fE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC
Confidence 99995 499999999888899999999999999999999954 99999999999999998899999999999877655
Q ss_pred ceeeeeeecccCccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH----------HHHHHHhccc
Q 007668 462 SHITTIVAGTFGYLAPEYMQ-SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV----------GWLNFLISED 530 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~~ 530 (594)
++ +..+.|..|.|||++. ++-|+.+.|+||+|||++|+.+-++-|.+..+-+....+ .|.....-..
T Consensus 165 PY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 165 PY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred Cc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 43 4567899999999875 567899999999999999999999988775544332111 1111000000
Q ss_pred ----ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 ----RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.........+.......+.+..+++.+|+++||++|||++|+++
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 00111111112233346778999999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=344.03 Aligned_cols=249 Identities=23% Similarity=0.405 Sum_probs=211.0
Q ss_pred cCCCccceeeeecceEEEEEE-ecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
..|+.-..||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.++..|...++.++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467777899999999999984 5578899999998877777778999999999999999999999998889999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++|+|.|.+... .+++.++..|++++++||+||| ..+|+|||||.+|||++.++.+||+|||++..+..... ..
T Consensus 353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 999999999753 4899999999999999999999 45999999999999999999999999999987776554 45
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...+||++|||||+.....|++|+||||||++++||+-|.+||-....... . +.+......++ ..++
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA-----l--yLIa~ng~P~l------k~~~ 493 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----L--YLIATNGTPKL------KNPE 493 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH-----H--HHHhhcCCCCc------CCcc
Confidence 567899999999999999999999999999999999999999864222111 0 11111111111 1334
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+.+++.+||+.||++||+++|+++
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 55678999999999999999999999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=343.23 Aligned_cols=250 Identities=29% Similarity=0.508 Sum_probs=207.8
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.++..++.+...+-||.|+.|.||.|++. ++.||||+++..++. +|+.|++|+||||+.|.|+|.....+++
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkET-------dIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKET-------DIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhhhh-------hHHHHHhccCcceeeEeeeecCCceeEE
Confidence 34445566667789999999999999997 677899988765543 7888999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|||||+.|-|++.|+. +..++......|.++||.|++|||.+ .|||||||+-||||+.+..+||+|||-++...+.
T Consensus 190 iMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred eeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 9999999999999986 46688888999999999999999955 9999999999999999999999999999877654
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
. ....++||..|||||++...++++|+||||||||||||+||..||...... .+-| -+... .+.
T Consensus 266 S--TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIw---GVGsN----sL~--- 329 (904)
T KOG4721|consen 266 S--TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIW---GVGSN----SLH--- 329 (904)
T ss_pred h--hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEE---eccCC----ccc---
Confidence 2 234578999999999999999999999999999999999999998652111 0000 00000 011
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
...+..++..+.-|+++||+..|..||++.+++.-|+=
T Consensus 330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 12445666788999999999999999999999987763
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=347.66 Aligned_cols=267 Identities=28% Similarity=0.396 Sum_probs=213.8
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEecCC----cE-EEEEeecc---cchhhHHHHHHHHHHHhhCCCCeeeeeeeEE
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDDG----NV-FALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRGYC 372 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 372 (594)
.++-.-++....+.||+|+||.||+|.+..+ .. ||||..+. .......+|..|+++|++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3333445556669999999999999976642 23 89999884 3455678899999999999999999999999
Q ss_pred eCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 373 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
......++|||+++||+|.++|++....++..++.+++.++|.||+||| +.+++||||.++|+|++.++.+||+|||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999999987778999999999999999999999 5599999999999999999999999999
Q ss_pred cccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
+++.... .........-+.+|+|||.+..+.+++++|||||||++||+++ |..||.+.... +....+....
T Consensus 308 Ls~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~- 379 (474)
T KOG0194|consen 308 LSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNG- 379 (474)
T ss_pred cccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcC-
Confidence 9875431 1111111134679999999999999999999999999999999 88898775322 1111111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP 585 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 585 (594)
.+.. .+...+..+..++.+||..+|+.||+|.++.+.++.......+
T Consensus 380 ~r~~-------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 YRMP-------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ccCC-------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1111 1223456788899999999999999999999999987665544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.51 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=212.2
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhh--CCCCeeeeeeeEEeCC----CceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS--IKHRYLVNLRGYCNSP----TSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~~~l 380 (594)
.+....+.||+|.||.||+|.++ |+.||||++...++ +.+.+|.++... |||+||+.+++.-..+ ..++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 45677899999999999999998 88899999986544 456777777665 6999999999885333 35689
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD-----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
|++|++.|||+|+|.. ..++.+..++++..+|.||+|||.+ .++.|.|||||+.|||++.++.+.|+|+|+|-
T Consensus 287 vTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999999976 5699999999999999999999964 47899999999999999999999999999998
Q ss_pred ccccCCce---eeeeeecccCccCccccccCC------CCccchhhhHHHHHHHHHhC----------CCCCCcchhccc
Q 007668 456 LLEDEESH---ITTIVAGTFGYLAPEYMQSGR------ATEKTDVYSFGVLVLEVLSG----------KRPTDASFIEKG 516 (594)
Q Consensus 456 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg----------~~p~~~~~~~~~ 516 (594)
....+... .....+||.+|||||++...- .-..+||||||+|+||+... +.||.+.... +
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~-D 443 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS-D 443 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC-C
Confidence 77655322 234578999999999986531 12459999999999999873 3565542211 1
Q ss_pred chHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 517 LNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
.....++.++..++.+..+++++. ..+....+.++|+.||..+|..|.|+-.+.+.|.+....
T Consensus 444 -Ps~eeMrkVVCv~~~RP~ipnrW~--s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 444 -PSFEEMRKVVCVQKLRPNIPNRWK--SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred -CCHHHHhcceeecccCCCCCcccc--cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 112234455666667777777665 456678899999999999999999999999999876643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=345.56 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=203.3
Q ss_pred hcCCCccceeeeecceEEEEEEe------cCCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCC-
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT- 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~- 376 (594)
.++|...+.||+|+||.||+|.. .++..||+|+++... ....+.+.+|+.++.++ +||||++++++|....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45788889999999999999964 235689999987533 23346788999999999 8999999999987644
Q ss_pred ceEEEEEccCCCchhhhhhhcC----------------------------------------------------------
Q 007668 377 SKLLIYDFLPGGSLDEALHERS---------------------------------------------------------- 398 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 398 (594)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999987421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce-eeeeeecccCc
Q 007668 399 ---EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGY 474 (594)
Q Consensus 399 ---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y 474 (594)
..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 237788999999999999999995 59999999999999999999999999999865433221 12233467889
Q ss_pred cCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHH
Q 007668 475 LAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLA 553 (594)
Q Consensus 475 ~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (594)
+|||++.+..++.++||||||+++|||++ |..||....... ........... ...+...+..+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRLKDGTR---------MRAPENATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHHhcCCC---------CCCCCCCCHHHHH
Confidence 99999998899999999999999999997 999987532211 01111111110 0112233467899
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 554 VATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 554 l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
++.+||+.||++|||+.|+++.|++...
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.81 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=205.3
Q ss_pred hcCCCccceeeeecceEEEEEE-ecCCcEEEEEeecccch-hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.+.|...+.||.|..++||+|. ...++.||||++.-..- ...+.+.+|++.|+.++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3578888999999999999995 45689999999974322 225789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||.+||+.+.++.. ..-+++..+..|++++++||.|||++ |.||||||+.|||++.+|.+||+|||.+..+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999853 33499999999999999999999954 999999999999999999999999998765443222
Q ss_pred e---eeeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 463 H---ITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 463 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
. ....++||+.|||||++.+ ..|+.|+||||||+...||.+|..||......+ .+...+..........
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDPPTLLTS 255 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCCCCcccc
Confidence 1 1145689999999999644 468999999999999999999999997654321 1111111111100000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..-.+....+...+.+++..|++.||++|||++++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0000122344567999999999999999999999885
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=307.40 Aligned_cols=263 Identities=22% Similarity=0.392 Sum_probs=208.4
Q ss_pred cCCCccceeeeecceEEEEEE-ecCCcEEEEEeecc--cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
++|...+.+|+|.||.||+|. ..+|+.||||+++. ..++......+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356777899999999999995 55799999999975 344456778999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
||+ .+|...++.+...++..++..++.++++|++|||. ..|+||||||.|+|++.+|.+||+|||+++.+......
T Consensus 82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 995 49999999888889999999999999999999995 58999999999999999999999999999998765543
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH----------HHHHHHhccc--
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV----------GWLNFLISED-- 530 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~~-- 530 (594)
.... +-|..|.|||.+.+ +.|+..+|+||.|||+.||+.|.+-|.+...-++...+ +|.....-.+
T Consensus 158 ~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~ 236 (318)
T KOG0659|consen 158 QTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV 236 (318)
T ss_pred cccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence 3332 56999999998876 46999999999999999999988777654322221111 1211100000
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......+.........+....+|+.+|+..||.+|+|+.|+++
T Consensus 237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 00111111222233445566799999999999999999999886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.56 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=205.4
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc----ch-hhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL----NE-GFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 378 (594)
...|...+.||+|+||+|+.|.. .++..||+|.+.+. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 45788899999999999999955 46899999976542 11 23566779999999999 99999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC-CcEEEeeccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLL 457 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~~l~Dfgl~~~~ 457 (594)
++||||+.+|+|.+++.. .+++.+....++++|++.|++||| +.+|+||||||+|||++.+ +++||+|||++...
T Consensus 96 ~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999988 678999999999999999999999 5699999999999999999 99999999999977
Q ss_pred ccCCceeeeeeecccCccCccccccCC-CC-ccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSGR-AT-EKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... ..... +...
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~k-i~~~----- 238 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRK-IRKG----- 238 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHH-HhcC-----
Confidence 4 2223355678999999999999877 75 7899999999999999999999873221 11111 1111
Q ss_pred cCCCCCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHH
Q 007668 536 IDPNCEGVQSES-LDALLAVATQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 536 ~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~ev~ 573 (594)
....+... +.++..|+.+|+..||.+|+|+.+++
T Consensus 239 ----~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 ----EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11112222 67899999999999999999999998
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=327.86 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=205.7
Q ss_pred cCCCccceeeeecceEEEEEEec----CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
++|+..+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+..+.+++||||+++++++......++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999753 35689999987642 33456789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++......+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999999998766679999999999999999999995 599999999999999999999999999876543222
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
........++..|+|||.+.+..++.++||||||+++||+++ |..||....... ..... .... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~~-~~~~-~------- 226 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKAV-EDGF-R------- 226 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHH-HCCC-C-------
Confidence 111222335678999999999999999999999999999876 999986542211 11111 1110 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
...+...+..+.+++.+||+.+|++||+++++.+.|++.
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011223456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=322.04 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=204.7
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
++|+..+.||+|+||.||++.+.++..+|+|.+..... ..+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45777889999999999999998888999998865332 24578889999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+|+|.++++.....+++..+..++.|++.||.|||+ .+++||||||+||++++++.++++|||.++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 999999998655678999999999999999999995 59999999999999999999999999998865433322222
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........... ... +.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~~~i~~~~~---~~~------~~ 224 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVVEMISRGFR---LYR------PK 224 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHCCCC---CCC------CC
Confidence 2345678999999988889999999999999999999 89998653221 11111111110 111 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
.....+.+++.+||+.+|++||+++|+++.|.
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 22357899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.93 Aligned_cols=246 Identities=19% Similarity=0.343 Sum_probs=199.5
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeecccchhh---HHHHHHHHHHHhhCCCCeeeeeeeEEeC----CCceEEEEEc
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF---DRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLLIYDF 384 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e~ 384 (594)
...||+|++|.||+|.. +|+.||||+++...... .+.+.+|+.++.+++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999988 58899999997643322 4678899999999999999999999866 3467899999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++|+|.+++.++ ..+++.....++.+++.||.|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999999764 5689999999999999999999952 378899999999999999999999999988654322
Q ss_pred eeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....|+..|+|||++.+ ..++.++||||||+++|||++|+.||...... ........... .. .
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~-~~----~--- 242 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNN-SL----K--- 242 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCC-CC----C---
Confidence 22357899999999876 68899999999999999999999999764221 11222211111 11 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.+...+..+.+++.+||+.||++|||++|+++.|+..
T Consensus 243 ~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 243 LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1123456799999999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.28 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=211.7
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecc-cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
..|+..+.||+|.||.||||.. ..++.||+|++.- ..+...+.+++|+.++..++++||.+++|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3566779999999999999965 4688999999974 3334457789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+.+|++.+.++. +..+++..+..|++++..|+.|||. .+.+|||||+.|||+..+|.+|++|||.+..........
T Consensus 93 ~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 999999999975 3445888888899999999999995 499999999999999999999999999998777655443
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC-CCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC-EGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 543 (594)
.+++||+.|||||++.+..|+.|+||||||++.+||.+|.+|+...... +...++.... +..
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPPRL 231 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCCcc
Confidence 6788999999999999889999999999999999999999998664322 1222222222 234
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILES 578 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~ 578 (594)
...++..+.+++..|++.||+.||++.++++ ++++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 4577788999999999999999999999985 4444
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=328.00 Aligned_cols=264 Identities=23% Similarity=0.391 Sum_probs=215.0
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccch-hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
...+.+.+.||+|-||.|.......+..||||.++.... .....|.+|+++|.+++||||++++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 345667899999999999999998889999999986433 3458899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-
Q 007668 385 LPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~- 462 (594)
|++|+|..++.++..+ +.-....+|+.|||.|++||. +..+|||||.++|+|+++++++||+|||+++.+..++.
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999876433 466677889999999999999 56999999999999999999999999999996655444
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS--GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
+.....+-+.+|||||.+.-++++.++|||+||+.+||+++ ...||.....++ .++-....+.... ...+.+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~-~~~~l~-- 767 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQG-RQVVLS-- 767 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCC-cceecc--
Confidence 33445667889999999999999999999999999999988 678886543222 1111122222221 111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
-+..++..+.+++..||+.|-++||+++++...|++..
T Consensus 768 --~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 768 --RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred --CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 23345577899999999999999999999999988654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.88 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=203.3
Q ss_pred hcCCCccceeeeecceEEEEEEe------cCCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 377 (594)
.++|+..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|++++..+ +||||++++++|.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999863 235689999987532 33346788999999999 89999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcC-----------------------------------------------------------
Q 007668 378 KLLIYDFLPGGSLDEALHERS----------------------------------------------------------- 398 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 398 (594)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 399 ---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 399 ---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 247889999999999999999995 59999999999999999999999999999866543321
Q ss_pred e-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 464 I-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 464 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... +... ... .. .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~---~~~~-~~~-~~-~----- 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY---KMIK-EGY-RM-L----- 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH---HHHH-hCc-cC-C-----
Confidence 1 122335678999999999999999999999999999998 888886532211 111 1111 110 00 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.+...+.++.+++.+||+.||++|||++||++.|++.
T Consensus 338 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 -SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1112235789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=324.60 Aligned_cols=261 Identities=23% Similarity=0.376 Sum_probs=201.4
Q ss_pred cCCCccceeeeecceEEEEEEecC-----------------CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeee
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-----------------GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNL 368 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 368 (594)
.+|...+.||+|+||.||++...+ +..||+|.+... .......+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999997542 346999998754 23345678999999999999999999
Q ss_pred eeEEeCCCceEEEEEccCCCchhhhhhhcC------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 007668 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERS------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430 (594)
Q Consensus 369 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 430 (594)
++++.+....++||||+++|+|.+++.... ..+++..+.+++.||+.||+|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 999999999999999999999999986421 247888999999999999999995 59999
Q ss_pred CCCCCCCeEecCCCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh--CCCC
Q 007668 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS--GKRP 507 (594)
Q Consensus 431 ~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p 507 (594)
|||||+||+++.++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865443322 1223345789999999988899999999999999999987 5566
Q ss_pred CCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 508 TDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
|...... .............. ...... .+...+..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQG-RQVYLF----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhcc-cccccc----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6543211 11111111111110 011000 112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.33 Aligned_cols=246 Identities=28% Similarity=0.409 Sum_probs=209.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
++|...+.||+|+||.||||+.+ +.+.||+|.+.+. .+...+.+.+|+++++.++||||+.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56778899999999999999654 6789999999763 33345679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+.+ +|..++.. ++.++++.+..++.++..||.||| +.+|+|||+||+|||++..+.+|++|||+++.+.... .
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S 155 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence 9966 99999975 578999999999999999999999 5599999999999999999999999999999877643 4
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
..+...|||-|||||...++.|+..+|.||+||++||+++|++||.... +.+.+.....+. ...
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~----------v~~ 219 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDP----------VKP 219 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCC----------CCC
Confidence 4556789999999999999999999999999999999999999997632 222222222221 112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+...+..+.+++...+.+||.+|.|-.+++.
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 3366788999999999999999999887763
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=324.60 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=199.6
Q ss_pred CCccceeeeecceEEEEEEe-cCCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 309 LDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
|+..+.||+|+||+||++.. .+|+.||+|.+.... ......+.+|++++.+++|+||+++.+++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999975 578999999986432 22234678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 9999999888643 345899999999999999999999 45999999999999999999999999999986543221
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ ........... ....
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~---------~~~~ 224 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKED---------QEEY 224 (285)
T ss_pred -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcc---------cccC
Confidence 2334689999999999999999999999999999999999999976432111 00001111000 0112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
+...+..+.+|+.+||+.||++||+ ++++++
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 2334567899999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=323.90 Aligned_cols=248 Identities=33% Similarity=0.575 Sum_probs=194.7
Q ss_pred ccceeeeecceEEEEEEec-----CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 311 DDHIIGSGGFGTVYKLAMD-----DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 311 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
..+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+++++||||++++|++......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999887 3678999999653 333467899999999999999999999999988889999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++|+|.++++.. ...+++..+..|+.||++||+|||+. +++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999976 66799999999999999999999964 8999999999999999999999999999876332222
Q ss_pred -eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 464 -ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 464 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
......+...|+|||.+.+..++.++||||||+++||+++ |+.|+...... ........... ..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~~~~~~~~~~-~~------- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EIIEKLKQGQR-LP------- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HHHHHHHTTEE-TT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccc-ce-------
Confidence 2223456789999999998889999999999999999999 67887553211 11222211111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 576 (594)
.+...+..+.+++.+||+.+|++|||++++++.|
T Consensus 226 -~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122346789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=331.09 Aligned_cols=267 Identities=24% Similarity=0.352 Sum_probs=223.2
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 300 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
++++-...+++..++||-|.||.||.|.|+. .-.||||.++..... .++|..|+.+|+.++|||+|+++|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 5555555677788999999999999999875 567999999876554 67899999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
|+|+|||..|+|.++|++... .++.-.++.++.||+.|+.||. ++.+|||||.++|+|+.++..+|++|||+++.+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999997543 4777788999999999999999 569999999999999999999999999999998
Q ss_pred ccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
..+.........-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+.. +.+.+...-...++.
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkgyRM~--- 486 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKGYRMD--- 486 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhcccccc---
Confidence 8766555544444779999999999999999999999999999999 999986632 222222222222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP 585 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 585 (594)
.++.+++.+.+||+.||+++|.+||+++|+-+.+|.++....-
T Consensus 487 ------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 487 ------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred ------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 2345567899999999999999999999999999988765443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=318.30 Aligned_cols=254 Identities=25% Similarity=0.433 Sum_probs=207.2
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|+..+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+....++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 356788899999999999999988889999998875433 3567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.++++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999999753 4568999999999999999999995 599999999999999999999999999998765433222
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||++.++.++.++||||||+++|+|++ |..||....... ... .. .... . .+ .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~---~~-~~~~-~---~~----~ 225 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMS---AL-QRGY-R---MP----R 225 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHH---HH-HcCC-C---CC----C
Confidence 222345678999999988889999999999999999998 999986532211 111 11 1110 0 01 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
....+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 12234678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=298.34 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=208.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+.++.||+|.||.||.|+.+ ++..||+|++.+. ..+...++.+|+++-+.|+||||++++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 578999999999999999999755 5788999999863 334567899999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 382 YDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
+||.++|.+...|++. ..++++.....++.|+|.|+.|+| .+.|+||||||+|+|++.++..|++|||.+..-+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999999999843 456888899999999999999999 5699999999999999999999999999987543
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
.....+.+||..|.|||...+...+..+|+|++|++.||++.|.+||.....++. ++.. ...++..
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------YkrI----~k~~~~~--- 241 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKRI----RKVDLKF--- 241 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHHH----HHccccC---
Confidence 3345668899999999999999999999999999999999999999976542211 0100 0111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+...+....++|.+|+..+|.+|.+..|+++
T Consensus 242 ---p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 ---PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 2334467889999999999999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=317.79 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=206.8
Q ss_pred cCCCccceeeeecceEEEEEEecC----CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
++|+..+.||+|+||.||+|.+.. ...||+|.++.. .......+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998753 457999988753 333456788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++++|.+++......+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 99999999999998766789999999999999999999994 599999999999999999999999999998775222
Q ss_pred c-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 462 S-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 462 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
. .......++..|+|||.+.+..++.++||||||+++||+++ |..||...... ........... .
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~-----~-- 227 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAVEDGYR-----L-- 227 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHHHcCCC-----C--
Confidence 2 22222345678999999998899999999999999999998 99998543211 11111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
..+...+..+.+++.+|++.+|++||++.||++.|++.
T Consensus 228 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 --PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01123346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=316.89 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=204.7
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
++|+..+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 35677889999999999999888777899998875432 34678999999999999999999999998888999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+|+|.+++......+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||.++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 999999998655579999999999999999999995 59999999999999999999999999998865443322222
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...++..|+|||...+..++.++||||||+++|||++ |..||....... ........... ..+.
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~---------~~~~ 224 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQGLRL---------YRPH 224 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcCCCC---------CCCC
Confidence 2345678999999988889999999999999999999 999986533211 11111111110 0111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
..+..+.+++.+||+.+|++||++.++++.|+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 23467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.69 Aligned_cols=259 Identities=24% Similarity=0.421 Sum_probs=203.9
Q ss_pred HhcCCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCC
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 376 (594)
..++|...+.||+|+||.||+|... ++..||+|+++... ......+.+|+++++.+ +||||++++++|....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457888999999999999998642 34579999997533 23345688999999999 8999999999999999
Q ss_pred ceEEEEEccCCCchhhhhhhcC----------------------------------------------------------
Q 007668 377 SKLLIYDFLPGGSLDEALHERS---------------------------------------------------------- 398 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 398 (594)
..++||||+++|+|.++++...
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999986421
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee-ee
Q 007668 399 -----------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-TT 466 (594)
Q Consensus 399 -----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~-~~ 466 (594)
..+++..+.+++.||++||+|||+ .+|+||||||+|||+++++.++|+|||+++......... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 237888999999999999999994 599999999999999999999999999997654332211 12
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...++..|+|||++.+..++.++||||||+++|||++ |+.||....... . ..... ... . .... +.
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~---~~~~~-~~~-~----~~~~---~~ 338 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K---FYKMV-KRG-Y----QMSR---PD 338 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H---HHHHH-Hcc-c----CccC---CC
Confidence 2335678999999998899999999999999999997 999987542211 0 11111 110 0 0001 11
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
..+.++.+++.+||+.||++|||+.+|++.|++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 12467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.08 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=215.7
Q ss_pred CCCccceeeeecceEEEEEEecCC-cEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEE-e-----C-CCce
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDDG-NVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYC-N-----S-PTSK 378 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~-~-----~-~~~~ 378 (594)
+.++.++|.+|||+.||.|....+ ..+|+|++...++...+.+.+|+++|+.|+ |||||.+++.. . . ..+.
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 456778999999999999988776 999999998888888899999999999997 99999999932 1 1 2467
Q ss_pred EEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 379 LLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
+|.||||.+|+|-|++..+ ...|++.++++|+.++++|+++||.. +++|||||||.+|||++.+++.||||||.++-.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 8999999999999999854 23499999999999999999999986 889999999999999999999999999998743
Q ss_pred ccCCceee--------eeeecccCccCcccc---ccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHH
Q 007668 458 EDEESHIT--------TIVAGTFGYLAPEYM---QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 458 ~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
........ -...-|+.|+|||++ .+..+++|+|||++||+||-|+....||+...
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------------- 262 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------------- 262 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------
Confidence 22111000 012358999999986 46789999999999999999999999997631
Q ss_pred hcccccccccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCcc
Q 007668 527 ISEDRQREIIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSD 587 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 587 (594)
...|++....- ..+.++..+.+||..||++||++||++.+|+..+-++...++|..
T Consensus 263 -----~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 263 -----KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred -----ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 12233333322 235788999999999999999999999999999999988888765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=328.31 Aligned_cols=251 Identities=24% Similarity=0.414 Sum_probs=214.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecc--cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc-eEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS-KLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv 381 (594)
.++|...+++|+|+||.++.+.++ ++..+|+|.+.- ..+...+....|+.++++++|||||.+.+.|.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 356778899999999999998655 577899999864 334445578899999999999999999999999998 8999
Q ss_pred EEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 382 YDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+|++||++.+.+.+.. ..++++.+..|+.|++.|+.|||+ ..|+|||||+.||+++.+..++|+|||+|+....+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999998654 679999999999999999999995 49999999999999999999999999999998876
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
.. ....++||+.|+.||.+.+.+|..|+||||+||++|||++-+++|.+.+...- ...+.....
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---------------i~ki~~~~~ 223 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---------------ILKINRGLY 223 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---------------HHHHhhccC
Confidence 53 34557899999999999999999999999999999999999999987543211 111222223
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
...+..++.++..++..|++.+|+.||++.+++..
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 34567788999999999999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=297.23 Aligned_cols=237 Identities=27% Similarity=0.393 Sum_probs=201.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||.|+||.|..++.+ +|..+|+|++.+.. ....+...+|..+++.+.||+++++.+.+.+....++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 456778899999999999999765 58889999997633 23345678899999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|-|..++++ .+++++...+-+|.||+.||.||| +.+|++|||||+|||+|.+|.+||+|||.|++....
T Consensus 123 meyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999999986 467999999999999999999999 569999999999999999999999999999976543
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
+.+.+|||.|+|||++.+..+..++|-|||||++|||+.|.+||...+.. +.+......+.
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~~~v---------- 258 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILEGKV---------- 258 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHhCcc----------
Confidence 56689999999999999999999999999999999999999999875442 11111111110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCC
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDR 566 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~R 566 (594)
..+.-....+.+|+.+.++.|-.+|
T Consensus 259 ~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1233445678899999999999999
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=320.22 Aligned_cols=255 Identities=25% Similarity=0.465 Sum_probs=206.0
Q ss_pred hcCCCccceeeeecceEEEEEEecCC------cEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDG------NVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|+..+.||+|+||.||+|..... ..||+|.+.... ......+.+|++.+.+++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 34678889999999999999976432 579999887533 33456789999999999999999999999998899
Q ss_pred EEEEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC
Q 007668 379 LLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN 443 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 443 (594)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 99999999999999997532 457889999999999999999995 599999999999999999
Q ss_pred CcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHH
Q 007668 444 LEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVG 521 (594)
Q Consensus 444 ~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~ 521 (594)
+.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~ 237 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIE 237 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence 9999999999986543322 12233456789999999988899999999999999999998 999987543221 111
Q ss_pred HHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 522 WLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
. +... .....+...+.++.+|+.+||+.||++||+++||++.|++
T Consensus 238 ---~-i~~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 ---M-IRSR--------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---H-HHcC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 1111 1111233456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=315.50 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=206.5
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|+..+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|++++++++||||+++++++......++|+||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 356788899999999999999988888999999875433 3567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 9999999997543 568999999999999999999995 599999999999999999999999999998765332221
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
......+..|+|||++.+..++.++||||||+++|||++ |+.||....... ..... .... .. ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~-~~~~-~~-------~~ 225 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------VLQQV-DQGY-RM-------PC 225 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHH-HcCC-CC-------CC
Confidence 222223458999999998899999999999999999999 999986532111 01111 1110 00 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 22334678999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=328.58 Aligned_cols=241 Identities=22% Similarity=0.335 Sum_probs=196.0
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 388 (594)
+.||+|+||.||++... +|+.||+|+++... ......+.+|++++.+++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 68999999987532 223456788999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeee
Q 007668 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468 (594)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~ 468 (594)
+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 99999875 3568999999999999999999995 599999999999999999999999999987543222 122345
Q ss_pred ecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHH
Q 007668 469 AGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESL 548 (594)
Q Consensus 469 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (594)
.||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......... ...+....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~~----------~~~p~~~~ 219 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEE----------IRFPRTLS 219 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCC----------CCCCCCCC
Confidence 69999999999999999999999999999999999999996532211 111111110 01122345
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 549 DALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 549 ~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 6789999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=322.80 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=201.5
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++......++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 6788899999999999999876 5788999998753 233356788899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++.+..+. .....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||++..........
T Consensus 82 ~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 82 VEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9987766544 334568999999999999999999994 599999999999999999999999999998765433333
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHH---------HHHHHhcccccccc
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVG---------WLNFLISEDRQREI 535 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 535 (594)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||......+...... +.............
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 334568999999999998889999999999999999999999997643211110000 00000000000000
Q ss_pred cCCCCCC-------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 IDPNCEG-------VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 ~~~~~~~-------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+.... .....+..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 01123467999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.55 Aligned_cols=260 Identities=23% Similarity=0.385 Sum_probs=203.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|+..+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357888899999999999999766 5788999988753 33445679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 99999999999753 4689999999999999999999952 369999999999999999999999999987654322
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc---c----------
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE---D---------- 530 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~---------- 530 (594)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||......+ +.......... .
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcccc
Confidence 223468999999999999899999999999999999999999996532211 00000000000 0
Q ss_pred ---------------------ccccccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 ---------------------RQREIIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ---------------------~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+.....+. .......++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 11124567999999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=324.65 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=199.7
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 35778899999999999999765 68899999986432 223456889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999999763 568999999999999999999995 599999999999999999999999999998654322
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......... ..
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~----------~~ 216 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAGK----------LE 216 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC----------cC
Confidence 2346899999999999888999999999999999999999998753221 1111111111 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
.+......+.+++.+||+.||.+||+ ++++++
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 12223467889999999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.14 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=209.4
Q ss_pred hcCCCccceeeeecceEEEEEE-ecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-----CCceE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS-----PTSKL 379 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 379 (594)
-++|.+.+.+|+|||+-||.++ ..++..+|+|++.-......+...+|++..++++||||+++++++.. ..+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3578899999999999999986 56789999999987776667889999999999999999999988743 34489
Q ss_pred EEEEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 380 LIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
++++|...|+|.+.+.. .+..+++.++++|+.+|++||.+||+. .++++||||||.|||+.+++.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999874 345699999999999999999999976 45699999999999999999999999999875
Q ss_pred cccCCcee--------eeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHH
Q 007668 457 LEDEESHI--------TTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNF 525 (594)
Q Consensus 457 ~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 525 (594)
..-.-... ...-..|..|.|||.+. +...++++|||||||++|+|+.|..||+...+ .+.++.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla----- 252 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA----- 252 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE-----
Confidence 54211110 01123588999999885 45679999999999999999999999987554 333222
Q ss_pred HhcccccccccCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 526 LISEDRQREIIDPNCE-GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 526 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
..+..+... .....++..+.+++++|++.||.+||++.+++..++..
T Consensus 253 -------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 -------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111111111 01223678899999999999999999999999988754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=321.50 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=200.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|...+.||+|+||.||+|... ++..||+|.++... ......+.+|++++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 457888899999999999999765 68899999987432 2334567889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|++ |+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 997 59999987766678999999999999999999994 5999999999999999999999999999876443221
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHH----------HHHHHhccccc
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVG----------WLNFLISEDRQ 532 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~~~~ 532 (594)
......|++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+...... |.. .......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 237 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG-ITSNEEF 237 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc-cccchhh
Confidence 1223457999999998865 568999999999999999999999997643221111100 000 0000000
Q ss_pred ccccCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 REIIDPNCEG-----VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.... .......+..+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111000 01122356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.58 Aligned_cols=257 Identities=21% Similarity=0.414 Sum_probs=207.4
Q ss_pred cCCCccceeeeecceEEEEEEec------CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.+|...+.||+|+||.||++... ++..+++|.+........+.+.+|++.+++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35677789999999999998643 355689999877666556779999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 381 IYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
||||+++++|.+++..+. ..+++..++.++.||+.|++|||+ .+++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999997532 348999999999999999999995 59999999999999999999
Q ss_pred EEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHH
Q 007668 446 ARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWL 523 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 523 (594)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VI 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH
Confidence 99999999976543321 11223456788999999998899999999999999999999 999986532211 11
Q ss_pred HHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 524 NFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
... ... .........+..+.+++.+||+.+|++|||+++|+++|++...
T Consensus 236 ~~~-~~~--------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 ECI-TQG--------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHH-hCC--------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111 111 1111122234678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=317.97 Aligned_cols=254 Identities=25% Similarity=0.441 Sum_probs=209.9
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
..+|+..+.||+|+||.||+|...++..+|+|.+..........+.+|+++++.++||||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45678889999999999999999889999999998766655678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.++++.. ...+++..+..++.||+.|++|||+ .+++||||+|+||++++++.++|+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999753 4568999999999999999999995 59999999999999999999999999999866443221
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... ....... .. ..
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~---~~~~~~~--~~-------~~ 225 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVY---DQITAGY--RM-------PC 225 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHH---HHHHhCC--cC-------CC
Confidence 223345678999999988899999999999999999998 89998653211 111 1111110 00 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
+...+..+.+++.+|++.||++|||++++++.|++
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 22334678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.98 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=202.9
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
.+|+..+.||+|+||.||++..+++..+|+|.+..... ....+.+|++++++++||||+++++++......++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999888888899998865332 24568889999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+++|.+++..+...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++...........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999998766679999999999999999999995 59999999999999999999999999998765433222112
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ .. ... ... .... .+.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~~-~~~-----~~~~---~~~ 224 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV---ESV-SAG-----YRLY---RPK 224 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH---HHH-HcC-----CcCC---CCC
Confidence 2224568999999998899999999999999999999 888986532111 11 111 000 0001 112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 576 (594)
..+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2456799999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=329.44 Aligned_cols=245 Identities=25% Similarity=0.365 Sum_probs=205.7
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
-|..++.||.|+-|.|-.|++. +|+.+|||.+.+. .......+.+|+-+|+-+.||||+++++++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4667889999999999999764 6999999999764 33345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++|-|.+++..+ +.+++.+..++++||..|+.|+| ..+|+|||+||+|+|+|..+++||+|||+|..-..+.
T Consensus 93 yv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred ecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence 99999999999874 56888889999999999999999 4599999999999999999999999999998654432
Q ss_pred eeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
...+.+|++.|.+||++.+..| +.++||||.|||||.|+||+.||++.+...- +..+ ..+. + +
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L------LlKV-~~G~----f-----~ 230 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL------LLKV-QRGV----F-----E 230 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH------HHHH-HcCc----c-----c
Confidence 3455689999999999999987 6789999999999999999999997543321 1111 1111 1 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+...+.+..+|+.+|+..||++|.|++||++
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 12344577999999999999999999999986
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=327.97 Aligned_cols=244 Identities=25% Similarity=0.343 Sum_probs=199.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 457888899999999999999775 58899999987532 22345688999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999999763 568899999999999999999995 599999999999999999999999999998664332
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ ...
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~-~~~--------- 232 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILA-GRL--------- 232 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhc-CCc---------
Confidence 2356899999999999989999999999999999999999998653211 11111111 100
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPT-----MHRVV 573 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~ 573 (594)
..+......+.+++.+||+.||++||+ +++++
T Consensus 233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 011123356889999999999999997 56665
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.64 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=204.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
..|...+.||+|+||.||+|... .++.||+|.+.... .....+.+|++++.+++||||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34677789999999999999765 48889999887543 23567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999754 3458999999999999999999995 599999999999999999999999999998765433222
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+ ......... ..+ ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~~------~~~---~~ 226 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKG------YRM---ER 226 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHCC------CCC---CC
Confidence 222334668999999998899999999999999999998 89998653221 111111110 001 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
+...+..+.+++.+|++.+|++|||+.++.+.|++.
T Consensus 227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 223346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=326.96 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=202.5
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+|+..+.||+|+||.||+|... +++.||+|++.... ......+..|++++..++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999999999876 58899999987532 2234568889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 9999999999975 3568999999999999999999995 5999999999999999999999999999986543
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
......||+.|+|||++.+..++.++|||||||++|||++|..||......+.. ....... .....+.....
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~--~~~~~~~~~~~ 225 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLKYWK--ETLQRPVYDDP 225 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHHhcc--ccccCCCCCcc
Confidence 223356899999999999889999999999999999999999999764322110 0000000 00001111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+..+.+++.+|++.+|++||+++++++
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 1234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=318.87 Aligned_cols=258 Identities=21% Similarity=0.402 Sum_probs=207.5
Q ss_pred cCCCccceeeeecceEEEEEEec------CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|...+.||+|+||.||++... ++..+|+|.+..........+.+|++++.+++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46778899999999999998742 345689999887666566789999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEE
Q 007668 381 IYDFLPGGSLDEALHERS------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l 448 (594)
|+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999987432 248999999999999999999995 59999999999999999999999
Q ss_pred eecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHH
Q 007668 449 SDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... .....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECI 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH
Confidence 999999865433221 1122345778999999998899999999999999999998 899986532211 11111
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
.. .... ..+...+..+.+++.+||+.+|.+|||+.||.+.|+.....
T Consensus 236 ~~-~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 TQ-GRVL--------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred Hc-CCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11 1100 01112345789999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.93 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=204.8
Q ss_pred cCCCccceeeeecceEEEEEEec-CCc----EEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.+|+..+.||+|+||.||+|.+. +++ .||+|.++... ....+.+.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999754 333 38999987533 34456788999999999999999999999764 5679
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||+++|+|.++++.....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 999999999999998766779999999999999999999995 59999999999999999999999999999876543
Q ss_pred Cceee-eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESHIT-TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
..... ....++..|+|||.+.+..++.++||||||+++|||++ |..||+.....+ .... .... ...
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~~~~-~~~~-~~~---- 230 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSI-LEKG-ERL---- 230 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH-HhCC-CCC----
Confidence 32221 22234678999999999999999999999999999998 999986532211 1111 1111 000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
..+......+.+++.+||+.+|++||++.+++..+......
T Consensus 231 ---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 01112335688999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=327.76 Aligned_cols=245 Identities=23% Similarity=0.293 Sum_probs=199.8
Q ss_pred hcCCCccceeeeecceEEEEEEecC--CcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.++|...+.||+|+||.||+|...+ +..||+|++... .....+.+.+|++++..++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4678889999999999999997543 368999998643 22334568889999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999763 568999999999999999999995 59999999999999999999999999999865432
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
.....||+.|+|||++.+..++.++|||||||++|||++|..||...... ..........
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~---------- 244 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGI---------- 244 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCC----------
Confidence 23456899999999999888999999999999999999999999753221 0111111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
...+......+.+++.+|++.||++|+ +++++++
T Consensus 245 ~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 001122335678999999999999995 7888765
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.14 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=206.0
Q ss_pred HHhcCCCccceeeeecceEEEEEEecC------CcEEEEEeecccc-hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCC
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCNSP 375 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 375 (594)
...++|.+.+.||+|+||.||+|.... +..||||++.... ....+.+.+|++++.++. ||||++++++|.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 345688889999999999999987532 3469999997533 333567899999999996 99999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcC---------------------------------------------------------
Q 007668 376 TSKLLIYDFLPGGSLDEALHERS--------------------------------------------------------- 398 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 398 (594)
...++||||+++|+|.++++...
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 99999999999999999886421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 399 --------------------------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 399 --------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
..+++..+..++.||++||+|||+ .+|+||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEE
Confidence 237888899999999999999994 599999999999999
Q ss_pred cCCCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-- 348 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-- 348 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence 99999999999999865433221 1223346788999999998899999999999999999997 9999865322110
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
. ... ..... . . ..+...+..+.+++.+||+.+|++||++.+|.++|++...
T Consensus 349 ~---~~~-~~~~~-~----~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 F---YNK-IKSGY-R----M---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H---HHH-HhcCC-C----C---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 011 11110 0 0 1122344678999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=317.50 Aligned_cols=254 Identities=22% Similarity=0.433 Sum_probs=204.8
Q ss_pred cCCCccceeeeecceEEEEEEecC------CcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
++|...+.||+|+||.||+|...+ +..||+|.++..... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999997643 478999998764443 4578999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcE
Q 007668 380 LIYDFLPGGSLDEALHERS-------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 446 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 446 (594)
+||||+++++|.++++... ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999997532 347889999999999999999994 599999999999999999999
Q ss_pred EEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHH
Q 007668 447 RVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 447 ~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 524 (594)
+|+|||++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIE 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHH
Confidence 9999999976533221 11223345788999999999999999999999999999998 999986532221 111
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
... ... ....+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 236 ~~~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CIT-QGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHH-cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111 111 111122344678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.77 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=202.3
Q ss_pred CCCccceeeeecceEEEEEEec-C-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-D-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.|...+.||+|+||.||+|... + +..||+|.+..........+.+|+++++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4778899999999999999654 3 5778888776555555567888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 386 PGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 386 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
++|+|.++++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 3458899999999999999999994 5999999999999999999999999999987654322
Q ss_pred -eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 -HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.......||++|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~---------~~ 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGK---------YD 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC---------CC
Confidence 1233456999999999999999999999999999999999999998653221 1111111111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+...+..+.+++.+||+.+|++||++++++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112233467899999999999999999998864
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=312.33 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=204.7
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
++|+..+.||+|+||.||+|...++..||+|.+..... ..+.+.+|++++++++||||+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 46888899999999999999888777899999875333 34578999999999999999999998754 55789999999
Q ss_pred CCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 387 GGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 387 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
+|+|.++++.. ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||.+...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999753 3458999999999999999999994 5999999999999999999999999999986654332222
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....++..|+|||+..+..++.++||||||+++||+++ |..||....... ......... .....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~---------~~~~~ 225 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGY---------RMPCP 225 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHHhcCC---------CCCCc
Confidence 23346778999999988899999999999999999999 888886532211 011110000 00112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
...+..+.+++.+|++.+|++||+++++++.|+...
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 334567899999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=324.11 Aligned_cols=242 Identities=26% Similarity=0.353 Sum_probs=194.8
Q ss_pred eeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 315 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
||+|+||.||++... +++.||+|.+... .......+.+|++++.+++||||+++++++.+....++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999765 5788999998753 233345678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeec
Q 007668 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (594)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~g 470 (594)
.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||+++....... ......|
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 155 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG 155 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence 9999763 568999999999999999999995 5999999999999999999999999999875433222 2334568
Q ss_pred ccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHH
Q 007668 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDA 550 (594)
Q Consensus 471 t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (594)
|+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... ...+......
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~----------~~~~~~~~~~ 219 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP----------LRFPDGFDRD 219 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC----------CCCCCcCCHH
Confidence 99999999999999999999999999999999999999653221 1111111110 0112234467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 551 LLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 551 l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
+.+++.+||+.||++||++..+.+.|+
T Consensus 220 ~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 889999999999999987544444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=323.20 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=216.6
Q ss_pred HHhcCCCccceeeeecceEEEEEEecC---C--cEEEEEeecc-cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMDD---G--NVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
-+.+..+..++||.|-||.||+|...+ | -.||||.-+. .+....+.|..|+.+|+.++||||++++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 334556667899999999999996543 3 3588898876 4445577899999999999999999999999764 5
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++|||.++-|.|..+++.+...++......+++||+.||+||| +..+|||||.++|||+....-+|++|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 78999999999999999988888999999999999999999999 669999999999999999999999999999999
Q ss_pred ccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
.++..+......-+..|||||.+.-++++.++|||.|||.+||+++ |..||.+-...+. ...+-
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---------------I~~iE 606 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---------------IGHIE 606 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce---------------EEEec
Confidence 8877766665666789999999999999999999999999999998 9999876322111 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
.....+.++.+++.+..|+.+||..+|.+||++.|+...|+....
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 112223456677889999999999999999999999988876443
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=311.38 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=204.0
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|+..+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 346778899999999999999988888999999876433 24578999999999999999999998854 5678999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.++++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999754 3458999999999999999999995 499999999999999999999999999998765433222
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||...+..++.++||||||+++|||++ |..||...... .......... . ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~------~---~~~ 224 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQVERGY------R---MPC 224 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC------C---CCC
Confidence 222335678999999988889999999999999999999 88888653211 1111111100 0 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
+...+..+.+++.+|++.+|++|||++++.+.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 22345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=308.89 Aligned_cols=247 Identities=26% Similarity=0.456 Sum_probs=200.4
Q ss_pred ceeeeecceEEEEEEecCCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCchh
Q 007668 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 391 (594)
++||+|+||.||+|...++..+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4789999999999998889999999987543 333456889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecc
Q 007668 392 EALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471 (594)
Q Consensus 392 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt 471 (594)
+++......+++..+..++.|++.||.|+|+ .+++||||+|+||+++.++.++++|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 9997666678999999999999999999994 5999999999999999999999999999875443222111222346
Q ss_pred cCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHH
Q 007668 472 FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDA 550 (594)
Q Consensus 472 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (594)
..|+|||++.++.++.++||||||+++|++++ |..||........ ........ . . ..+...+..
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-------~~~~~~~~-~----~---~~~~~~~~~ 222 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-------REQVEKGY-R----M---SCPQKCPDD 222 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHHcCC-C----C---CCCCCCCHH
Confidence 78999999998899999999999999999998 9999865422110 01111110 0 0 111223467
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 551 LLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 551 l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
+.+++.+|++.+|++||++.|++++|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=315.67 Aligned_cols=256 Identities=20% Similarity=0.364 Sum_probs=202.6
Q ss_pred HhcCCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
..++|+..+.||+|+||.||+|... .+..||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567889999999999999998653 35679999886432 2334568899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEE
Q 007668 378 KLLIYDFLPGGSLDEALHERS---------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l 448 (594)
.++|+||+++++|.++++... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999987522 236788899999999999999995 59999999999999999999999
Q ss_pred eecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHH
Q 007668 449 SDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
+|||++.......... .....++..|+|||++.++.++.++||||||+++|||++ |..||...... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRFV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence 9999987654332211 112345778999999998899999999999999999999 78888653221 111111
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
.... ....+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 235 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111 111122234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=309.17 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=195.8
Q ss_pred CCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc-----eEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS-----KLLI 381 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~lv 381 (594)
.|...+++|.|+||.||+|...+ ++.||||+.-.... .-.+|+++|+.++|||||+++-+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46667999999999999997664 68999999865433 34579999999999999999988854322 3489
Q ss_pred EEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC-CcEEEeeccccccc
Q 007668 382 YDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLL 457 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~~l~Dfgl~~~~ 457 (594)
||||+. +|.+.++. ....++.-.+.-+.+||.+||+||| +.+|+||||||+|+|+|.+ |.+||+|||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999977 89998874 2466888888889999999999999 4699999999999999955 99999999999999
Q ss_pred ccCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccch-HHHHH-----------H
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN-IVGWL-----------N 524 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~~~-----------~ 524 (594)
..+++..... -|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+....++.. +...+ +
T Consensus 177 ~~~epniSYi--cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPNISYI--CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCceeEE--EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 8877765544 48999999998764 69999999999999999999999987643222111 11100 0
Q ss_pred HHhcccccccccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 525 FLISEDRQREIIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+.....+....+.. .......+..+|+.++++.+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 000001111111111111 23345578999999999999999999999874
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.69 Aligned_cols=241 Identities=22% Similarity=0.340 Sum_probs=194.7
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 388 (594)
+.||+|+||.||++... +|..||+|.+... .......+.+|+++++.++||||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999764 6899999998753 2223456778999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeee
Q 007668 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468 (594)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~ 468 (594)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........ .....
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccccc
Confidence 999888653 568999999999999999999995 5999999999999999999999999999875432221 12335
Q ss_pred ecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHH
Q 007668 469 AGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESL 548 (594)
Q Consensus 469 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (594)
.||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... ...+....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~----------~~~p~~~~ 219 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE----------IRFPRTLS 219 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCC----------CCCCCCCC
Confidence 68999999999998899999999999999999999999986532211 011111100 01122344
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 549 DALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 549 ~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 6788999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.41 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=195.6
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 388 (594)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999754 6899999999753 2233456788999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeee
Q 007668 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468 (594)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~ 468 (594)
+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 155 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTF 155 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccccc
Confidence 99998865 3568999999999999999999994 5999999999999999999999999999875432221 22345
Q ss_pred ecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHH
Q 007668 469 AGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESL 548 (594)
Q Consensus 469 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (594)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ...+....
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~----------~~~p~~~~ 219 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMED----------IKFPRTLS 219 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCC----------ccCCCCCC
Confidence 6899999999999889999999999999999999999999653211 1111111100 01122344
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 549 DALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 549 ~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+.+++.+||+.||++|| ++.|+++
T Consensus 220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 6788999999999999997 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=307.88 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=205.3
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.+|++.+.||+|.||+|-+|.. ..|+.||||.+++.. ++..-.+.+|+++|+.|+||||+.++++|...+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3566778999999999999854 779999999998643 333446889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||..+|.|+|++.++ +.+++.+..+++.||..|+.|+|. .+++|||||.+|||+|.++++||+|||++-.+..+.
T Consensus 133 EYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k- 207 (668)
T KOG0611|consen 133 EYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK- 207 (668)
T ss_pred EecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcccc-
Confidence 999999999999874 679999999999999999999995 499999999999999999999999999998876543
Q ss_pred eeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
..++++|++-|.+||++.+.+| ++.+|-||+|++||-|+.|..||++..- ...++. +..+..++ |
T Consensus 208 -fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvrQ-Is~GaYrE---P--- 273 (668)
T KOG0611|consen 208 -FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVRQ-ISRGAYRE---P--- 273 (668)
T ss_pred -HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHHH-hhcccccC---C---
Confidence 3467899999999999999887 6789999999999999999999987421 111111 11121111 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+.+....-||++||..+|++|.|+.+|..
T Consensus 274 ----~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 274 ----ETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ----CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 12245678999999999999999999875
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=308.94 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=198.1
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
+.||+|+||.||+|... +++.+|+|.+... .......+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999765 6889999987643 334456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee-eeee
Q 007668 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT-TIVA 469 (594)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~-~~~~ 469 (594)
.++++.....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++|||++........... ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 99998766678999999999999999999994 5999999999999999999999999999876443211111 1112
Q ss_pred cccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHH
Q 007668 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESL 548 (594)
Q Consensus 470 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (594)
++..|+|||.+.++.++.++||||||+++||+++ |..||........ ....... .. . ..+...+
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~-~~----~---~~~~~~~ 222 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQG-VR----L---PCPELCP 222 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcC-CC----C---CCcccCC
Confidence 3457999999998899999999999999999998 8888864322110 0011000 00 0 1122334
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 549 DALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 549 ~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
..+.+++.+|++.+|++|||+.+|.++|+.
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=313.23 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=200.5
Q ss_pred HHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---------hh-----hHHHHHHHHHHHhhCCCCeeee
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---------EG-----FDRFFERELEILGSIKHRYLVN 367 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~-----~~~~~~~E~~~l~~l~h~niv~ 367 (594)
.+..++|+..+.||+|.||.|-+|... +++.||||++.+.. .. ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445788999999999999999999654 68999999996421 11 1247889999999999999999
Q ss_pred eeeEEeC--CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 368 LRGYCNS--PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 368 l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
++++..+ .+..|||+||+..|.+...--. ...++..+.+.++.++..||.|||.+ +|+||||||+|+|++++|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 9999865 4668999999999887765322 22389999999999999999999954 9999999999999999999
Q ss_pred EEEeecccccccccCCce----eeeeeecccCccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCcchhcccc
Q 007668 446 ARVSDFGLAKLLEDEESH----ITTIVAGTFGYLAPEYMQSGR----ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 517 (594)
+||+|||.+..+...... .....+|||.|+|||...++. .+.+.||||+||.||.|+.|+.||-+.++.+.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l- 327 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL- 327 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH-
Confidence 999999999877332111 112367999999999887633 46789999999999999999999976543211
Q ss_pred hHHHHHHHHhcccccccccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 518 NIVGWLNFLISEDRQREIIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
...++...+.- ..++....+.+|++++|.+||++|.+..+|..-
T Consensus 328 --------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 328 --------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred --------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 12222222221 223456789999999999999999999998753
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=317.58 Aligned_cols=262 Identities=20% Similarity=0.328 Sum_probs=197.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++.+++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467888999999999999999876 68899999987532 2234467889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|++ ++|.+++..+...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++....... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 995 68888887666778999999999999999999995 599999999999999999999999999987543222 1
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc---ccc-----c
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED---RQR-----E 534 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-----~ 534 (594)
......|++.|+|||++.+ ..++.++||||+||++|||++|+.||....... ............. ... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhcc
Confidence 1233457999999998865 457889999999999999999999997532110 0000000000000 000 0
Q ss_pred ccCC-CCC----C-CC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDP-NCE----G-VQ-----SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~-~~~----~-~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..++ ... . .. ......+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 000 0 00 012246789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=308.72 Aligned_cols=252 Identities=28% Similarity=0.455 Sum_probs=202.5
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
++|...+.||+|++|.||++...++..+|+|.+..... ..+.+.+|++++++++|||++++++++.. ...++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 45778899999999999999988877899998765332 34678899999999999999999998754 56789999999
Q ss_pred CCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 387 GGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 387 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
+++|.++++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999754 3458999999999999999999995 5999999999999999999999999999976644332222
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....++..|+|||...+..++.++||||||+++|||++ |+.||....... ... ... .. ... ..+
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~-~~-----~~~---~~~ 225 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLE---QVE-RG-----YRM---PCP 225 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHH-cC-----CCC---CCC
Confidence 22345678999999988899999999999999999999 899986532211 111 111 10 000 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.82 Aligned_cols=244 Identities=24% Similarity=0.374 Sum_probs=203.2
Q ss_pred HHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCce
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 378 (594)
...++|....+||+|.||+|+.+..+ +++.+|||.+++.. ....+..+.|.+++... +||.+++++..|..+++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34678999999999999999999766 57899999998742 23356677888887776 599999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||+.||++..+.+ .+.+++..+.-++..|+.||+|||++ +|||||||.+|||+|.+|++||+|||+++..-
T Consensus 445 ~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999999554443 46799999999999999999999965 99999999999999999999999999998644
Q ss_pred cCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
... ..+.+++||+.|||||++.+..|+.++|-|||||+||||+.|..||.+..+++. .+..+.++.
T Consensus 520 ~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------FdsI~~d~~------- 585 (694)
T KOG0694|consen 520 GQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------FDSIVNDEV------- 585 (694)
T ss_pred CCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCCC-------
Confidence 222 246778999999999999999999999999999999999999999987655432 122222221
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
.++.-.+.+...++++++.++|++|..+
T Consensus 586 ---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1333445778899999999999999976
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.18 Aligned_cols=260 Identities=23% Similarity=0.383 Sum_probs=201.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|+..+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 357888999999999999999776 5788999988753 33345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 99999999999753 4689999999999999999999952 379999999999999999999999999987654321
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc------------
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR------------ 531 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 531 (594)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ...........
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE---LMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH---HHhcCcccCCccccccCcccCCc
Confidence 22346899999999999888999999999999999999999998753221100 00000000000
Q ss_pred --------------------cccccCCCCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 --------------------QREIIDPNCEGV-QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 --------------------~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+.....+.. ......++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000000000000 0113456889999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=310.25 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=205.0
Q ss_pred cCCCccceeeeecceEEEEEEecC-C---cEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-G---NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
++|+..+.||+|+||.||+|.... + ..+|+|.+... .....+.+..|++++++++|||++++.+++......++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467778999999999999997652 3 37899988753 333456788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++++|.+++......+++..+..++.|++.|++|||+ .+++||||||+||++++++.++++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 99999999999998766779999999999999999999995 599999999999999999999999999998665332
Q ss_pred ceeee--eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 462 SHITT--IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 462 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
..... ....+..|+|||++..+.++.++||||||+++||+++ |+.||...... .......... ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~~~-----~~~ 230 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAINDGF-----RLP 230 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhcCC-----CCC
Confidence 22111 1223457999999988889999999999999999998 99998653221 1111111110 001
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.....+..+.+++.+|++.+|++||++.+|++.|++.
T Consensus 231 ----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1123346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=323.40 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=198.2
Q ss_pred CCCccceeeeecceEEEEEEe----cCCcEEEEEeecccc----hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCce
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 378 (594)
+|+..+.||+|+||.||++.. .++..||+|++.+.. ....+.+..|++++.++ +||||+++.+++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 367789999999999999865 357899999987522 22345678899999999 599999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||+++|+|.+++..+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999999753 568999999999999999999995 599999999999999999999999999998665
Q ss_pred cCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
...........||+.|+|||++.+. .++.++||||||+++|||++|+.||......... ......... .+
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~-------~~ 227 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK-------CD 227 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc-------CC
Confidence 4433333446799999999998765 4788999999999999999999999653222111 111111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
+. .+......+.+++.+||+.||++|| +++++++
T Consensus 228 ~~---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 PP---FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CC---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11 1223446788999999999999999 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=315.65 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=193.4
Q ss_pred cCCCccceeeeecceEEEEEEec--CCcEEEEEeecccc--hhhHHHHHHHHHHHhhC---CCCeeeeeeeEEe-----C
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLN--EGFDRFFERELEILGSI---KHRYLVNLRGYCN-----S 374 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~ 374 (594)
++|+..+.||+|+||.||+|... ++..||+|+++... ......+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36788899999999999999763 46889999886432 22234566777777665 6999999999884 3
Q ss_pred CCceEEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 007668 375 PTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (594)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl 453 (594)
....++|+||++ ++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 455789999996 6899988753 3458999999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-hHHHHHHHHhcccc-
Q 007668 454 AKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-NIVGWLNFLISEDR- 531 (594)
Q Consensus 454 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~- 531 (594)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.. .+............
T Consensus 157 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 157 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 98654332 223456899999999998889999999999999999999999999764322110 00000000000000
Q ss_pred -----cccccCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 -----QREIIDPNCE----GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 -----~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+.+... .........+.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000111100 011123456789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=313.82 Aligned_cols=262 Identities=28% Similarity=0.458 Sum_probs=203.3
Q ss_pred cCCCccceeeeecceEEEEEEe-----cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--CCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 379 (594)
++|...+.||+|+||.||++.. .++..||+|++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677789999999999999864 3578999999987666666789999999999999999999998744 34678
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+|+||+++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 9999999999999998766679999999999999999999995 5999999999999999999999999999987654
Q ss_pred CCceee--eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcc----c-----chHHHHHHHHhc
Q 007668 460 EESHIT--TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK----G-----LNIVGWLNFLIS 528 (594)
Q Consensus 460 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~----~-----~~~~~~~~~~~~ 528 (594)
...... ....++..|+|||++.+..++.++||||||+++|||++|..|+......- + ............
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 332211 11223456999999988889999999999999999999887754321110 0 000000000000
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.. .........+..+.+++.+||+.+|++|||++||++.|+.+
T Consensus 241 ~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 241 NN--------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 00011223346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=308.42 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=204.4
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+.|...+.||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+|++++++++. ....++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 356778899999999999999998999999999875443 3467889999999999999999999874 45689999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||++++++.++++|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999998753 356899999999999999999999 4599999999999999999999999999997665333222
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||++.+..++.++||||||+++||+++ |+.||...... .......... .. ..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~------~~---~~ 224 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP------EVIQNLERGY------RM---PR 224 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH------HHHHHHHcCC------CC---CC
Confidence 223345778999999998889999999999999999999 99998653211 1111111000 00 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 12234579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=321.96 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=203.2
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|...+.||+|+||.||++... +++.||+|+++... ....+.+.+|+.++..++||||+++.+++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 35788899999999999999765 68899999997532 234566889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++......+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999998766779999999999999999999994 5999999999999999999999999999987655443
Q ss_pred eeeeeeecccCccCccccc------cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 463 HITTIVAGTFGYLAPEYMQ------SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
.......||+.|+|||++. ...++.++||||||+++|||++|+.||...... ...............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~- 230 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKF- 230 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCC-
Confidence 3334456899999999986 456789999999999999999999999653221 111111111110000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+ .....+..+.+++.+|++ +|++|||++++++
T Consensus 231 -~----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 231 -P----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -C----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 111234668899999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=298.03 Aligned_cols=264 Identities=22% Similarity=0.271 Sum_probs=202.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEE--eCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYC--NSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~~~l 380 (594)
.+.|...+.|++|.||.||+|+.+ +++.||+|+++-. ..+..-.-.+|+.++.+.+|||||.+..+. .+-+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356777789999999999999654 6889999999743 334445568899999999999999998886 34567899
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||++. +|...+......+...++..+..|+++|++|||. ..|+|||||++|+|++..|.+||+|||+|+.++..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999955 8999998877889999999999999999999995 48999999999999999999999999999998865
Q ss_pred CceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC--
Q 007668 461 ESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID-- 537 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 537 (594)
.. ..+..+-|..|.|||.+.+ ..|+.++|+||+|||+.|++++++-|.+..+.++.+.+-..-..-.+........
T Consensus 231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 33 3445567999999999876 4699999999999999999999998877544433222211100000000000000
Q ss_pred ----CCCC--------CCCHH--HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 538 ----PNCE--------GVQSE--SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 538 ----~~~~--------~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
-... ..... .+..-.+|+..++..||.+|.|+.|.++
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000 00001 2355678999999999999999999874
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=325.91 Aligned_cols=257 Identities=20% Similarity=0.207 Sum_probs=195.3
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+|...+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5799999999999999999965 4688999996432 34678999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
. ++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++...........
T Consensus 166 ~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 240 (391)
T PHA03212 166 K-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY 240 (391)
T ss_pred C-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence 4 7888888653 568999999999999999999995 5999999999999999999999999999975443322233
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-hHHHHHHHHh---c-------------
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-NIVGWLNFLI---S------------- 528 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~---~------------- 528 (594)
....||+.|+|||++.+..++.++|||||||++|||++|+.|+.......+. .......... .
T Consensus 241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~ 320 (391)
T PHA03212 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN 320 (391)
T ss_pred ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence 4457999999999999889999999999999999999999886432111100 0000000000 0
Q ss_pred ------ccccccccCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 ------EDRQREIIDPNCEG---VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ------~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.........+.... .....+.++.+++.+||+.||++|||++|+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000000 01123457889999999999999999999985
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=313.25 Aligned_cols=254 Identities=22% Similarity=0.408 Sum_probs=204.4
Q ss_pred cCCCccceeeeecceEEEEEEec------CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.+|...+.||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677899999999999998632 356899999887666667789999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcE
Q 007668 381 IYDFLPGGSLDEALHERS--------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 446 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 446 (594)
++||+++++|.++++... ..+++..+..++.|++.|++|||+ .+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 999999999999997542 348899999999999999999994 599999999999999999999
Q ss_pred EEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHH
Q 007668 447 RVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 447 ~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 524 (594)
+|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHH
Confidence 999999987654332211 122345778999999998899999999999999999998 899985432211 111
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
........ ..+...+..+.+++.+||+.||++||+++||.+.|++
T Consensus 236 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11111100 1112234668899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=312.03 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=202.5
Q ss_pred cCCCccceeeeecceEEEEEEec-CCc----EEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|...+.||+|+||+||+|.+. +++ .+++|.+.... ......+..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45677899999999999999764 344 47778775432 2234567888889999999999999999864 45778
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
++||+++|+|.+++......+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 999999999999998767789999999999999999999995 58999999999999999999999999999866443
Q ss_pred Cce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
... ......++..|+|||.+.++.++.++||||||+++||+++ |..||....... ..+ .+.... ....+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~----~~~~~~--~~~~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPD----LLEKGE--RLAQP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHHCCC--cCCCC
Confidence 321 1223456789999999998899999999999999999998 999986542211 111 111111 00111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
......+.+++.+||..+|++|||+.|+++.|+.+...+
T Consensus 234 ------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 234 ------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred ------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 112356788999999999999999999999998866544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=320.60 Aligned_cols=241 Identities=26% Similarity=0.412 Sum_probs=194.4
Q ss_pred ceeeeecceEEEEEEe----cCCcEEEEEeecccc----hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 313 HIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+.||+|+||.||++.. .+++.||+|.++... ......+.+|+++++.++||||+++++++..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999875 357899999987532 22345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 9999999998753 567888899999999999999995 5999999999999999999999999999875433222 2
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......... ...+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~----------~~~~ 220 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGK----------LNLP 220 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC----------CCCC
Confidence 23356899999999999888999999999999999999999999764221 1111111110 0112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 545 SESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
......+.+++.+|++.+|++|| +++++++
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 22346788999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=308.42 Aligned_cols=254 Identities=28% Similarity=0.459 Sum_probs=206.8
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|...+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++......++|+||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 457888899999999999999988888999999875433 3567899999999999999999999999888999999999
Q ss_pred CCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.+++.... ..+++..+..++.|++.|++|||+ .+++|+||||+||++++++.++++|||++..........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 9999999997643 468999999999999999999995 499999999999999999999999999998765432222
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... .......... .. ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~~~--~~-------~~ 225 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVERGY--RM-------PR 225 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCC--CC-------CC
Confidence 222334678999999998899999999999999999999 99998653211 1111111100 00 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11224678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=312.59 Aligned_cols=254 Identities=23% Similarity=0.437 Sum_probs=201.9
Q ss_pred cCCCccceeeeecceEEEEEEe-----cCCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
..|+..+.||+|+||.||+|.. .++..+|+|.+.... ......+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677789999999999999974 346789999997533 3334678899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC
Q 007668 381 IYDFLPGGSLDEALHER----------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 444 (594)
||||+++++|.+++..+ ...+++..+..++.|++.||+|||+ .+++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 99999999999998532 1247889999999999999999995 5999999999999999999
Q ss_pred cEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHH
Q 007668 445 EARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGW 522 (594)
Q Consensus 445 ~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 522 (594)
.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||...... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~-- 236 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVI-- 236 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH--
Confidence 999999999986543322 11223345678999999988889999999999999999999 88898653211 111
Q ss_pred HHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 523 LNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
.... .... ...+......+.+++.+|++.||++||++.++.+.|+.
T Consensus 237 -~~~~-~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 237 -EMVR-KRQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHH-cCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 1110 01122334678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=312.81 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=202.3
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchh---hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEG---FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+...+||+|+||.||.++.+ +|+.+|+|++++.... ..+.+..|-.+|...++|+||+++-.|.+...+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 568899999999999999999765 5999999999875433 345678899999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc--
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-- 459 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~-- 459 (594)
|||++||++..+|.. .+.+++......+.+.+.|+..+|+ .|+|||||||+|+|||..|++||+|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999976 4679999999999999999999995 5999999999999999999999999999853211
Q ss_pred --------------------CC-ce---ee--------------------eeeecccCccCccccccCCCCccchhhhHH
Q 007668 460 --------------------EE-SH---IT--------------------TIVAGTFGYLAPEYMQSGRATEKTDVYSFG 495 (594)
Q Consensus 460 --------------------~~-~~---~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G 495 (594)
.+ .. .. ...+|||.|+|||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 00 00 00 125799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCcchhccc-chHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHH
Q 007668 496 VLVLEVLSGKRPTDASFIEKG-LNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT---MHR 571 (594)
Q Consensus 496 ~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~e 571 (594)
||+|||+.|.+||.+...... ..+..|........ ....+.+..+||.+|+. ||++|.. ++|
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-------------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-------------EVDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-------------cCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 999999999999987654432 22333322211111 11222678899999999 9999996 555
Q ss_pred HH
Q 007668 572 VV 573 (594)
Q Consensus 572 v~ 573 (594)
|.
T Consensus 442 IK 443 (550)
T KOG0605|consen 442 IK 443 (550)
T ss_pred Hh
Confidence 54
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=323.99 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=203.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36788899999999999999766 68999999987532 233567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC-
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE- 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~- 461 (594)
||+++++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999865 678999999999999999999995 599999999999999999999999999998665433
Q ss_pred ---------------------------ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhc
Q 007668 462 ---------------------------SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIE 514 (594)
Q Consensus 462 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 514 (594)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11123356899999999999999999999999999999999999999764321
Q ss_pred ccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 007668 515 KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT-MHRVVQ 574 (594)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~ 574 (594)
. ......... .....+. ....+..+.+++.+|++ ||++||+ ++++++
T Consensus 237 ~------~~~~i~~~~--~~~~~p~----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 237 E------TYNKIINWK--ESLRFPP----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred H------HHHHHhccC--CcccCCC----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 1 111111100 0000011 11135678899999998 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=321.61 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=202.4
Q ss_pred hcCCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC-C
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP-T 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 376 (594)
.++|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+..|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346888899999999999998532 34789999987532 22345678899999999 899999999988644 5
Q ss_pred ceEEEEEccCCCchhhhhhhcC----------------------------------------------------------
Q 007668 377 SKLLIYDFLPGGSLDEALHERS---------------------------------------------------------- 398 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 398 (594)
..++++||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999999986421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee-eeeeecccCcc
Q 007668 399 --EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYL 475 (594)
Q Consensus 399 --~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~ 475 (594)
..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.++|+|||++..+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 258999999999999999999995 599999999999999999999999999998764332221 22344577899
Q ss_pred CccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHH
Q 007668 476 APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAV 554 (594)
Q Consensus 476 aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 554 (594)
|||++.+..++.++|||||||++|||++ |..||......+. ......... .. ..+.....++.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~-~~-------~~~~~~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGT-RM-------RAPEYATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccC-CC-------CCCccCCHHHHHH
Confidence 9999999999999999999999999998 9999865322110 011111110 00 0112334678999
Q ss_pred HHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 555 ATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 555 ~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
+.+||+.+|++||++.|+++.|++.+.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=321.84 Aligned_cols=262 Identities=22% Similarity=0.370 Sum_probs=194.1
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-----CceE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSKL 379 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 379 (594)
+|+..+.||+|+||.||+|... ++..||+|++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677899999999999999754 6899999998742 222345688999999999999999999987533 2478
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||++ ++|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 689888865 3468999999999999999999995 5999999999999999999999999999976432
Q ss_pred CCc--eeeeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH---------HHHHHH
Q 007668 460 EES--HITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV---------GWLNFL 526 (594)
Q Consensus 460 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~---------~~~~~~ 526 (594)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ .+....
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 221 11234568999999999865 67899999999999999999999999653321110000 000000
Q ss_pred hccc------ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 527 ISED------RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 527 ~~~~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ....................+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 00000000000001123356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.90 Aligned_cols=247 Identities=25% Similarity=0.445 Sum_probs=197.2
Q ss_pred eeeeecceEEEEEEec---CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCc
Q 007668 314 IIGSGGFGTVYKLAMD---DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ...++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999998764 35579999887543 3345678999999999999999999998854 56889999999999
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee--e
Q 007668 390 LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT--I 467 (594)
Q Consensus 390 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~--~ 467 (594)
|.+++......+++..+.+++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++............ .
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999998666779999999999999999999995 49999999999999999999999999999865443322211 1
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (594)
..++..|+|||.+....++.++||||||+++||+++ |..||...... ........... ...+..
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~---------~~~~~~ 222 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVMSFIEQGKR---------LDCPAE 222 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHHCCCC---------CCCCCC
Confidence 223578999999988889999999999999999996 99998653221 11111111110 011223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 547 SLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 547 ~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.+.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.54 Aligned_cols=255 Identities=27% Similarity=0.472 Sum_probs=204.7
Q ss_pred cCCCccceeeeecceEEEEEEec----CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.+|+..+.||+|+||.||+|... .+..+|+|.++.. .....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999764 2347999988753 233456789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++++|.+++......+++.++..++.|++.|+.|||+ .+++||||||+||+++.++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999998766778999999999999999999995 599999999999999999999999999998765433
Q ss_pred ceeeee--eecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 462 SHITTI--VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 462 ~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
...... ..++..|+|||.+.++.++.++||||||+++||+++ |..||......+ .. ........ .+
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~---~~~~~~~~-----~~ 229 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI---KAIEEGYR-----LP 229 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH---HHHhCCCc-----CC
Confidence 222211 223568999999998899999999999999999887 999986532111 11 11111100 01
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.....+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 ----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=313.81 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=201.9
Q ss_pred CCCccceeeeecceEEEEEEecC------CcEEEEEeecccch-hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
+|...+.||+|+||.||+|...+ +..||+|++..... ...+.+.+|+.++..++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 45667899999999999997643 57899999975433 334668899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 381 IYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
++||+++++|.+++..+ ...+++..+..++.|++.||+|+|+ .+|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 99999999999998531 1347888999999999999999994 59999999999999999999
Q ss_pred EEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHH
Q 007668 446 ARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWL 523 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 523 (594)
+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..||...... .+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence 99999999886543322 11223345789999999988889999999999999999998 88887653221 112
Q ss_pred HHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 524 NFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
....... ....+...+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 237 ~~i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2111111 111223345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.39 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=207.6
Q ss_pred cCCCccceeeeecceEEEEEEec-CCc----EEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|+..+.||+|+||+||+|.+. ++. .||+|.+... .....+.+.+|+.++..++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 46778899999999999999753 444 4899988753 334456788999999999999999999998754 5679
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
++||+++|+|.++++.....+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 999999999999998766779999999999999999999994 59999999999999999999999999999876543
Q ss_pred Cceee-eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESHIT-TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
..... ....++..|+|||...+..++.++||||||+++|||++ |..||....... ...+.. ....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~------ 229 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGER------ 229 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCc------
Confidence 32211 12234678999999998899999999999999999998 899986532211 111111 1100
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCcc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSD 587 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 587 (594)
...+...+..+.+++.+||+.||++||++.++++.|+.....+.+.+
T Consensus 230 --~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~~ 276 (279)
T cd05109 230 --LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFV 276 (279)
T ss_pred --CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCeE
Confidence 01112334678899999999999999999999999998877665543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=313.06 Aligned_cols=260 Identities=23% Similarity=0.425 Sum_probs=203.1
Q ss_pred CCCccceeeeecceEEEEEEe-----cCCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKL 379 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 379 (594)
.|...+.||+|+||.||.+.. .++..||+|.++... ......+.+|++++++++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 456778999999999999864 357889999987543 33456799999999999999999999998765 5678
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||+++++|.+++.+....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 9999999999999997655678999999999999999999995 5999999999999999999999999999987654
Q ss_pred CCce--eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhc---------ccchHHHHHHHHhc
Q 007668 460 EESH--ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIE---------KGLNIVGWLNFLIS 528 (594)
Q Consensus 460 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~ 528 (594)
.... ......++..|+|||.+.+..++.++||||||+++|||++++.|....... ............ .
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL-E 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH-H
Confidence 3321 112345677899999998888999999999999999999987764321110 000001111110 0
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.. .........+..+.+++.+|++.+|++|||++++++.|++.
T Consensus 241 ~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EG--------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cC--------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 00111223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=307.49 Aligned_cols=257 Identities=19% Similarity=0.354 Sum_probs=206.7
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecc---cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.+|+..+.||+|+||.||+|... +++.||+|.+.. ........+.+|++++++++||||+++++++.+....++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999764 689999998764 23334557889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988853 23458899999999999999999995 5999999999999999999999999999887654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.... .....|+..|+|||.+.+..++.++|+||+|+++|||++|+.||..... ....+........ .+.
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~------~~~ 227 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCD------YPP 227 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCC------CCC
Confidence 3221 1234578899999999888899999999999999999999999854321 1111211111100 111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.........+.+++.+||+.+|++||++.+|++.++++
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11233456799999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.29 Aligned_cols=238 Identities=28% Similarity=0.400 Sum_probs=193.4
Q ss_pred ceeeeecceEEEEEEe----cCCcEEEEEeecccch--hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 313 HIIGSGGFGTVYKLAM----DDGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.++...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 3578999999975322 233457789999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++........ ...
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 99999998653 568999999999999999999995 5999999999999999999999999999886543322 233
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (594)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ...+..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~~----------~~~p~~ 220 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKAK----------LGMPQF 220 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcCC----------CCCCCC
Confidence 456899999999999888999999999999999999999999753221 1111111110 011223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHH
Q 007668 547 SLDALLAVATQCVSSSPDDRPTMHR 571 (594)
Q Consensus 547 ~~~~l~~l~~~cl~~dP~~RPs~~e 571 (594)
....+.+++.+||+.||++||++.+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3467889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.70 Aligned_cols=260 Identities=20% Similarity=0.358 Sum_probs=204.9
Q ss_pred HhcCCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568889999999999999998654 24579999886433 2234567889999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEE
Q 007668 378 KLLIYDFLPGGSLDEALHERS---------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l 448 (594)
.++||||+++|+|.++++... ...++..+..++.|++.||.|||+ ++|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997421 335678889999999999999994 59999999999999999999999
Q ss_pred eecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHH
Q 007668 449 SDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||.....+ +.....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH
Confidence 9999988654322211 122235678999999998899999999999999999999 78888653221 122222
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
.... ....+......+.+++.+|++.+|++|||+.++++.|++....
T Consensus 235 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 235 MDGG---------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 1111 1111122346799999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=323.28 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=192.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+++++.++|+||+++++++......++|+||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34556689999999999999765 6899999998653 333456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++|+|.+.. ..++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++........ .
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 9999987542 34677788999999999999995 5999999999999999999999999999986543221 1
Q ss_pred eeeeecccCccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 465 TTIVAGTFGYLAPEYMQS-----GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||...... ............ .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~---------~ 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWASLMCAICMS---------Q 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHhcc---------C
Confidence 233568999999998743 23456899999999999999999999732211 111111100000 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...........+.+++.+||+.||++|||+.|+++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112234467899999999999999999999986
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=304.84 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=204.2
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|++|.||+|... +++.|++|.+... .......+.+|++++++++|||++++++++.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999765 6889999988642 344466788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++++|.++++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999864 4568999999999999999999995 59999999999999999999999999998866543322
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....|++.|+|||+..+..++.++||||||+++|||++|+.||...... ........ ...+..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~---------~~~~~~ 221 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKIIR---------GVFPPV 221 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc---------CCCCCC
Confidence 23345889999999999888999999999999999999999998754321 11111111 111112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 22445679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=306.73 Aligned_cols=240 Identities=21% Similarity=0.370 Sum_probs=191.4
Q ss_pred ceeeeecceEEEEEEecC-------------CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 313 HIIGSGGFGTVYKLAMDD-------------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
+.||+|+||.||+|...+ ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997542 2358899887655555667888999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc-------EEEeecc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-------ARVSDFG 452 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~~l~Dfg 452 (594)
+|+||+++|+|..+++.....+++..+..++.||++||+||| +.+|+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998876667999999999999999999999 459999999999999986654 8999999
Q ss_pred cccccccCCceeeeeeecccCccCccccc-cCCCCccchhhhHHHHHHHHH-hCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQ-SGRATEKTDVYSFGVLVLEVL-SGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+......+. ... . ..
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~-~-~~ 224 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------ERF-Y-EG 224 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------HHH-H-hc
Confidence 98755432 2235788999999886 467899999999999999998 58888754321110 000 0 00
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
. .. ........+.+++.+||+.||++||++.++++.++
T Consensus 225 ~-~~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 225 Q-CM--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred C-cc--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00 01112356889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.56 Aligned_cols=242 Identities=22% Similarity=0.341 Sum_probs=194.8
Q ss_pred ceeeeecceEEEEEEe-cCCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCC
Q 007668 313 HIIGSGGFGTVYKLAM-DDGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 388 (594)
+.||+|+||.||++.. .++..||+|.+... .......+..|++++..++||||+++.+++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 46889999998753 2223456778999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeee
Q 007668 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468 (594)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~ 468 (594)
+|.+++.. ...+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~~ 156 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTF 156 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccccc
Confidence 99998865 3568999999999999999999994 14999999999999999999999999999875432222 12335
Q ss_pred ecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHH
Q 007668 469 AGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESL 548 (594)
Q Consensus 469 ~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (594)
.||+.|+|||++.+..++.++||||||+++|||++|+.||.....+. ......... ...+....
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~i~~~~----------~~~p~~~~ 220 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEE----------IRFPRTLS 220 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHHHhcCC----------CCCCCCCC
Confidence 68999999999998899999999999999999999999996532211 111111100 01122334
Q ss_pred HHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 549 DALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 549 ~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+.+++.+||+.||++|+ +++++++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 6789999999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=317.28 Aligned_cols=240 Identities=24% Similarity=0.375 Sum_probs=190.2
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhh-CCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGS-IKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||+|... +++.||+|.++... ....+.+..|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 57889999987532 2223445566666665 4899999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9999998753 468999999999999999999995 599999999999999999999999999997643322 22334
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ . ...+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~---~-------~~~~~~~ 219 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILND---R-------PHFPRWI 219 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcC---C-------CCCCCCC
Confidence 568999999999998899999999999999999999999997543211 11111110 0 1112223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTMH-RVV 573 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~-ev~ 573 (594)
...+.+++.+||+.+|++||++. +++
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 46688999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.46 Aligned_cols=265 Identities=24% Similarity=0.401 Sum_probs=199.8
Q ss_pred CCccceeeeecceEEEEEEe-----cCCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceEE
Q 007668 309 LDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLL 380 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 380 (594)
|...+.||+|+||+||.+.. .++..||+|.++... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 36778999999999987542 357889999987543 23456788999999999999999999988653 35789
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999999975 358999999999999999999995 59999999999999999999999999999866543
Q ss_pred Ccee--eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESHI--TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......- ....................+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhhc
Confidence 2211 122335667999999988889999999999999999999999975432110 0000000000000000000000
Q ss_pred CC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 539 NC-EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 539 ~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.. ...+...+..+.+++.+||+.+|++|||++++++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 00 112233457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.02 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=199.7
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.|+..+.||+|+||+||++... +++.||+|++.... ......+.+|++++++++||||+++.+.+..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3667789999999999999764 68899999986532 2223557789999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
|+++|+|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 99999999988653 3468999999999999999999995 5999999999999999999999999999986543222
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.....|+..|+|||++.+..++.++||||+|+++||+++|+.||........ ...+...+. .....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~---------~~~~~ 223 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVK---------EDQEE 223 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhh---------hcccc
Confidence 1234689999999999988899999999999999999999999975322110 000111110 01111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
.+...+..+.+++.+||+.||++|| +++++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 2233456789999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=314.33 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=201.8
Q ss_pred cCCCccceeeeecceEEEEEEecC-C--cEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-G--NVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 381 (594)
++|+..+.||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568888999999999999997654 3 34788888753 333456788999999999 799999999999999999999
Q ss_pred EEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcE
Q 007668 382 YDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 446 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 446 (594)
+||+++++|.++++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 99999999999997532 348899999999999999999995 599999999999999999999
Q ss_pred EEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHH
Q 007668 447 RVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNF 525 (594)
Q Consensus 447 ~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 525 (594)
||+|||++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYEK 230 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence 999999986432111 1111223567999999998889999999999999999998 999986542211 1111
Q ss_pred HhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 526 LISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
.... ... ..+...+..+.+++.+|++.+|.+|||++++++.|+.+...
T Consensus 231 ~~~~------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 231 LPQG------YRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HhcC------CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1110 000 11223446789999999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=334.34 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=201.8
Q ss_pred HhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC-----
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----- 376 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 376 (594)
..++|...+.||+|+||+||++.. .+++.||||++... .......+.+|+..+..++|+|++++.+.+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 356899999999999999999965 46899999998643 3344566888999999999999999887764332
Q ss_pred ---ceEEEEEccCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEee
Q 007668 377 ---SKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (594)
Q Consensus 377 ---~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~D 450 (594)
..++||||+++|+|.++++.+ ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEe
Confidence 257999999999999998753 3468999999999999999999994 5999999999999999999999999
Q ss_pred cccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 451 FGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 451 fgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...+......
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~~ 260 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLAG 260 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcC
Confidence 999986643221 222345799999999999999999999999999999999999999975322 1122221111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ....+...+..+.+++.+||+.||++||++.++++
T Consensus 261 ~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 261 R---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred C---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1 11122234467899999999999999999999876
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.57 Aligned_cols=252 Identities=26% Similarity=0.451 Sum_probs=203.9
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
.+|+..+.||+|+||.||++...++..+|+|.+..... ....+.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677899999999999999887788999998875332 24578899999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+++|.+++......++++.+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++............
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 999999998766678999999999999999999995 49999999999999999999999999998765433222222
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...++.+|+|||.+.++.++.++||||||+++|||++ |..||....... ...... .. .....+.
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~-~~--~~~~~~~------ 224 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETIN-AG--FRLYKPR------ 224 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHh-CC--CCCCCCC------
Confidence 2335678999999998899999999999999999998 999986532211 111110 00 0111111
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
..+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=307.42 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=196.6
Q ss_pred CccceeeeecceEEEEEEecCCc---EEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC------Cce
Q 007668 310 DDDHIIGSGGFGTVYKLAMDDGN---VFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TSK 378 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 378 (594)
...+.||+|+||.||+|...+.. .+|+|.++.. .....+.+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45689999999999999876532 5899988653 333456788999999999999999999987432 246
Q ss_pred EEEEEccCCCchhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 007668 379 LLIYDFLPGGSLDEALHE-----RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl 453 (594)
++++||+++|+|.+++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988742 22348999999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCCceee-eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 454 AKLLEDEESHIT-TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 454 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
++.......... ....+++.|+|||...+..++.++||||||+++|||++ |+.||...... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~~ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDYLRQGNR 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcCCC
Confidence 987654332211 22345778999999998899999999999999999999 78888652211 11111111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
. .........+.+++.+||+.+|++|||+.++++.|++.
T Consensus 233 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 L---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 01122345689999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=301.85 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=201.5
Q ss_pred CCCccceeeeecceEEEEEEe-cCCcEEEEEeecc--cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-----CCceE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNS-----PTSKL 379 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 379 (594)
.|...+.||+|+||.|+.+.. .+|+.||||++.. .+....+...+|++.++.++|+||+.+.+.+.- -...|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 444568899999999999854 4689999999974 344456778899999999999999999998743 56679
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+|+|+| +.+|...++. ...++.....-+++||++||.|+| +.+|+||||||+|++++.+..+||+|||+|+....
T Consensus 103 iV~elM-etDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred EehhHH-hhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccc
Confidence 999999 6689998875 345999999999999999999999 77999999999999999999999999999998754
Q ss_pred CC-ceeeeeeecccCccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHH--------HHHhcc
Q 007668 460 EE-SHITTIVAGTFGYLAPEYMQ-SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWL--------NFLISE 529 (594)
Q Consensus 460 ~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~ 529 (594)
.. ....+..+-|..|.|||++. ...|+.+.||||.|||+.||++|++-|.+...-.+..++... -..+..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 21 22235567799999999865 468999999999999999999999988775433222221111 001111
Q ss_pred ccccccc-------CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 DRQREII-------DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~~~~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+..+..+ ...+....+...+...+|+.+||..||.+|+|++|+++
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111100 00111122344567889999999999999999999986
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.26 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=200.0
Q ss_pred CCccceeeeecceEEEEEEecC----CcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc-----
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS----- 377 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 377 (594)
|...+.||+|+||.||+|.... +..||+|+++.. .......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999997653 367999998753 23334678999999999999999999998866554
Q ss_pred -eEEEEEccCCCchhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 378 -KLLIYDFLPGGSLDEALHER-----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 378 -~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
.++|+||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 68999999999999998532 2358999999999999999999995 59999999999999999999999999
Q ss_pred ccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcc
Q 007668 452 GLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 452 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
|+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC
Confidence 9998665433221 112234678999999988899999999999999999999 88888653211 111111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
. ....+......+.+++.+|++.||++|||+.|+++.|++.
T Consensus 232 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1112233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.77 Aligned_cols=262 Identities=22% Similarity=0.362 Sum_probs=205.9
Q ss_pred HHHHhcCCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEe
Q 007668 302 IIKKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCN 373 (594)
Q Consensus 302 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~ 373 (594)
.....++|...+.||+|+||.||+|.+. .+..||+|+++... ....+.+.+|++++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4445567888899999999999999764 34679999997542 223456889999999997 999999999999
Q ss_pred CCCceEEEEEccCCCchhhhhhhcC-------------------------------------------------------
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHERS------------------------------------------------------- 398 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 398 (594)
.....++|+||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 007668 399 ------------------------------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSS 436 (594)
Q Consensus 399 ------------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~ 436 (594)
..+++..+..++.||+.||.||| +.+++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 13677888999999999999999 459999999999
Q ss_pred CeEecCCCcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhc
Q 007668 437 NILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIE 514 (594)
Q Consensus 437 NIll~~~~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~ 514 (594)
||++++++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986543221 11223356789999999998889999999999999999998 88898653211
Q ss_pred ccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 515 KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
+ ........... + ..+...+..+.+++.+||+.+|++||+++|+++.|++.+
T Consensus 349 ~-----~~~~~~~~~~~------~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E-----QFYNAIKRGYR------M---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H-----HHHHHHHcCCC------C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 00111111100 0 011223467999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=310.12 Aligned_cols=244 Identities=26% Similarity=0.349 Sum_probs=193.7
Q ss_pred eeeecceEEEEEEec-CCcEEEEEeecccch---hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 315 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
||+|+||+||++... +++.||+|.+..... ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999998765 688999999865322 1234577899999999999999999999999999999999999999
Q ss_pred hhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 391 DEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 391 ~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
.+.+.. ....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 988753 33568999999999999999999995 59999999999999999999999999999765543322 233
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....... +.... ...+...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~---------~~~~~-~~~~~~~ 224 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQR---------ILNDS-VTYPDKF 224 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHh---------hcccC-CCCcccC
Confidence 5689999999999999999999999999999999999999975322110 0000011 11110 1122345
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 548 LDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
+..+.+++.+||+.||++|| +++++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 56789999999999999999 6667664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.32 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=205.1
Q ss_pred HhcCCCccceeeeecceEEEEEEecC------CcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCC
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 376 (594)
..++|+..+.||+|+||.||++...+ ...+|+|.+... .......+.+|++++.++ +||||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34567888999999999999997642 367999988753 233345688999999999 7999999999999999
Q ss_pred ceEEEEEccCCCchhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec
Q 007668 377 SKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 441 (594)
..+++|||+++|+|.++++.+ ...+++..++.++.|++.||+|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 999999999999999998642 3468999999999999999999995 5999999999999999
Q ss_pred CCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchH
Q 007668 442 GNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNI 519 (594)
Q Consensus 442 ~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~ 519 (594)
+++.++|+|||+++......... .....++..|+|||.+.+..++.++||||||+++||+++ |..||......+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 99999999999998765433211 122335678999999988899999999999999999998 999986532211
Q ss_pred HHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 520 VGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.......... ...+......+.+++.+|++.+|++|||++|+++.|++.+
T Consensus 243 --~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 --LFKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111100 0112233467889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=308.89 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=194.6
Q ss_pred eeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 315 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
||+|+||.||++... +|+.||+|.+.... ......+..|++++++++||||+++.+++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999765 58999999986421 12234566799999999999999999999999999999999999999
Q ss_pred hhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeee
Q 007668 391 DEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469 (594)
Q Consensus 391 ~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~ 469 (594)
.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9988653 3358999999999999999999995 599999999999999999999999999988665432 223346
Q ss_pred cccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHH
Q 007668 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLD 549 (594)
Q Consensus 470 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (594)
|+..|+|||++.+..++.++||||+||++|||++|+.||....... ............ .........+.
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~~~~ 224 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLED---------EVKFEHQNFTE 224 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcc---------ccccccccCCH
Confidence 8999999999998889999999999999999999999986532211 111111111111 11101123446
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 550 ALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 550 ~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
++.+++.+||+.||++||+++|+++.+.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 7899999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.51 Aligned_cols=262 Identities=25% Similarity=0.357 Sum_probs=197.7
Q ss_pred CCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC-----ceE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-----SKL 379 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 379 (594)
+|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 367789999999999999976 47899999998653 2233467889999999999999999999997766 789
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+|+||+. ++|.+.+.. ...+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999996 578877754 3568999999999999999999995 5999999999999999999999999999986554
Q ss_pred CCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHH----------H------
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVG----------W------ 522 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~----------~------ 522 (594)
..........++..|+|||.+.+. .++.++||||+||++|||++|+.||............. +
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333333344678999999998764 47899999999999999999999997643221111000 0
Q ss_pred HHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 523 LNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+.......................+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000000000000000000111223467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=308.86 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=200.9
Q ss_pred hcCCCccceeeeecceEEEEEEecC------CcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|...+.||+|++|.||+|...+ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568888999999999999997754 5678999886433 33456789999999999999999999999998899
Q ss_pred EEEEEccCCCchhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC---cEEEe
Q 007668 379 LLIYDFLPGGSLDEALHERS------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVS 449 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~~l~ 449 (594)
++|+||+++++|.+++.... ..+++..+.+++.||+.||+|||+ .+++||||||+||+++.++ .++++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999997542 258999999999999999999995 5999999999999998654 59999
Q ss_pred ecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHh
Q 007668 450 DFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLI 527 (594)
Q Consensus 450 Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 527 (594)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHH
Confidence 999998663322111 112223568999999998899999999999999999997 999987532221 111111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
..... ..+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 236 ~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11110 111223467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=317.43 Aligned_cols=236 Identities=24% Similarity=0.377 Sum_probs=190.5
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||+|... +++.||+|++.+. .....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999765 5789999998753 223345667788888776 699999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTST 155 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cccc
Confidence 9999988753 568999999999999999999995 5999999999999999999999999999875432221 2234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......... . ..+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~----~------~~~~~~ 219 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILNDE----V------VYPTWL 219 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCC----C------CCCCCC
Confidence 56899999999999889999999999999999999999999764321 1111111111 0 011223
Q ss_pred HHHHHHHHHHcccCCCCCCCCH
Q 007668 548 LDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
...+.+++.+|++.||++||++
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCC
Confidence 4678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.60 Aligned_cols=252 Identities=21% Similarity=0.336 Sum_probs=200.3
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 567888999999999999999765 5889999998642 222345578899999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 122 MEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999865 357888899999999999999995 599999999999999999999999999998765433
Q ss_pred ceeeeeeecccCccCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSG----RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ........... ..
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~--~~-- 266 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKN--SL-- 266 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCC--cC--
Confidence 2223345799999999998653 4788999999999999999999999763221 11111111110 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDD--RPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~ 574 (594)
..+ .....+..+.+++.+|++.+|++ |||++|+++
T Consensus 267 -~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 -TFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -CCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 011 01123567889999999999988 999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=305.98 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=200.5
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+|+..+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++.+++||||+++++++......++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999976 468899999987544444566888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.++++.. ..+++..+..++.|++.||+|||+ .+|+||||+|+||+++.++.++|+|||++........ ..
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 89 GGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 999999998753 568999999999999999999995 5999999999999999999999999999986643221 12
Q ss_pred eeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....|+..|+|||.+. ...++.++||||||+++|||++|+.|+......... . .... .....+...
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~-----~~~~---~~~~~~~~~- 232 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F-----LMSK---SNFQPPKLK- 232 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--e-----eeec---CCCCCCCCc-
Confidence 2345889999999874 345788999999999999999999998543211100 0 0000 000111111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
.....+..+.+++.+||+.+|++|||++++++.
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 112344678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=314.73 Aligned_cols=247 Identities=22% Similarity=0.381 Sum_probs=194.9
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
++||+|+||.||++... +++.||+|.+++. .....+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999765 5889999999753 223345678899999888 799999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++...... .....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 9999988653 579999999999999999999995 599999999999999999999999999987432211 12234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcc--cchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK--GLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
..||+.|+|||++.+..++.++||||||+++|||++|+.||+.....+ ......+.......... ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~p~ 226 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---------RIPR 226 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---------CCCC
Confidence 568999999999999999999999999999999999999997432211 11111222211111111 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC------HHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPT------MHRVV 573 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs------~~ev~ 573 (594)
..+..+.+++.+|++.||++||+ +++++
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 33467889999999999999997 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.98 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=193.2
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHH---hhCCCCeeeeeeeEEeCCCceEEE
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEIL---GSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999999765 68999999997532 22334566676654 567899999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|...++. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999988864 469999999999999999999995 599999999999999999999999999987543222
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~~~---------- 218 (324)
T cd05589 156 D-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDEV---------- 218 (324)
T ss_pred C-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC----------
Confidence 1 2234568999999999999899999999999999999999999997643221 1111111110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
..+...+..+.+++.+||+.||++||+ +.++++
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011223466889999999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=303.97 Aligned_cols=246 Identities=26% Similarity=0.406 Sum_probs=196.2
Q ss_pred eeeeecceEEEEEEe---cCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCC
Q 007668 314 IIGSGGFGTVYKLAM---DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 388 (594)
.||+|+||.||+|.+ .++..+|+|+++... ....+.+.+|+.+++.++||||+++++++. ....++|+||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999864 357889999886432 334567899999999999999999999885 45678999999999
Q ss_pred chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee--e
Q 007668 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT--T 466 (594)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~--~ 466 (594)
+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........... .
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999753 568999999999999999999995 5999999999999999999999999999987654432211 1
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...++..|+|||.+....++.++||||||+++|||++ |..||...... .+..... .... + ..+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~i~-~~~~-----~---~~~~ 221 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQMIE-SGER-----M---ECPQ 221 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-CCCC-----C---CCCC
Confidence 2234578999999988889999999999999999998 99998754221 1111111 1110 0 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
..+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 3446789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=312.02 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=204.5
Q ss_pred hcCCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 377 (594)
.++|...+.||+|+||.||++... .+..+|+|.++... ....+.+.+|+++++++ +||||+++++++.....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457888999999999999998642 34579999887543 33346788999999999 79999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
.++|+||+++|+|.++++... ..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++++|||++..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997543 348999999999999999999995 5999999999999999999999999999986
Q ss_pred cccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 457 LEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 457 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
....... ......++..|+|||.+.+..++.++||||+|+++|||++ |..||........ .. .......
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~----~~~~~~~--- 261 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FY----KLIKEGY--- 261 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HH----HHHHcCC---
Confidence 6443221 1222345778999999998899999999999999999998 9999865322110 00 0111110
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.. ..+......+.+++.+|++.+|++|||+.|+++.|++.
T Consensus 262 --~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 --RM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 01112346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.83 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=202.1
Q ss_pred HHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
+.+++.+.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..+...++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445667777789999999999999755 5778999998776655667899999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-CCcEEEeecccccccc
Q 007668 382 YDFLPGGSLDEALHERSEQL--DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLE 458 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~~l~Dfgl~~~~~ 458 (594)
+||+++++|.++++.....+ ++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 99999999999998654445 888899999999999999994 59999999999999976 6799999999987654
Q ss_pred cCCceeeeeeecccCccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSG--RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
..... .....|++.|+|||++.+. .++.++||||||+++|+|++|+.||....... ...+... .
T Consensus 161 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~----------~ 226 (268)
T cd06624 161 GINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVG----------M 226 (268)
T ss_pred cCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhh----------h
Confidence 32221 2223578999999998654 37889999999999999999999986432110 0000000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+..+......+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00011122334467899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.99 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=191.3
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||++... +++.||+|.+++. .......+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999765 5789999998753 223345677888888776 799999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 9999888653 568999999999999999999995 5999999999999999999999999999875432221 1234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcc--cchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK--GLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
..||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+......... ...+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------~~~p~ 226 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------IRIPR 226 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------CCCCC
Confidence 568999999999999999999999999999999999999996422111 1111112211111111 11223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
.....+.+++.+||+.||++||++
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 344678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=306.89 Aligned_cols=254 Identities=28% Similarity=0.482 Sum_probs=203.3
Q ss_pred CCCccceeeeecceEEEEEEecC-C---cEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD-G---NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.|...+.||+|+||.||+|.... + ..||+|.+... .....+.|..|+.++++++||||+++.+++.+....++|+
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678999999999999997653 2 36999998753 3444568999999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++++|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 9999999999998766779999999999999999999995 5999999999999999999999999999876543322
Q ss_pred eee--eeee--cccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 463 HIT--TIVA--GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 463 ~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
... .... .+..|+|||.+.+..++.++||||||+++||+++ |..||...... ....++ .....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i---~~~~~------ 229 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI---EQDYR------ 229 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH---HcCCc------
Confidence 111 1111 2457999999998899999999999999999887 99998653221 111111 11100
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
. ..+...+..+.+++.+||+.+|++||++++++..|++.
T Consensus 230 --~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 --L-PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --C-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01123346688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=306.36 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=204.0
Q ss_pred cCCCccceeeeecceEEEEEEecC----CcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
++|...+.||+|+||.||+|...+ ...||+|...... ....+.+.+|++++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778999999999999997643 2468999887544 4455678999999999999999999999875 457899
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+||+++|+|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++|||++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 99999999999998765678999999999999999999995 599999999999999999999999999998665443
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
........++..|+|||.+....++.++||||||+++||+++ |..||......+ ...+ .......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~---~~~~~~~-------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGR---IENGERL-------- 227 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHH---HHcCCcC--------
Confidence 222223334568999999988889999999999999999986 999986543211 1111 1111100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
..+...+..+.+++.+|+..+|++|||+.++++.|++...
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1122334679999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=304.14 Aligned_cols=253 Identities=25% Similarity=0.449 Sum_probs=204.3
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|...+.||+|+||.||++...++..+|+|.+..... ..+.+.+|++++++++|+||+++.+++.+ ...++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 357888899999999999999988888899998875432 35678899999999999999999999887 7789999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.+++... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999753 4458899999999999999999995 499999999999999999999999999998665433222
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||++..+.++.++|+||||+++|++++ |+.||...... ....+ ....... ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~--------~~ 224 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA----LERGYRM--------PR 224 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----HhCCCCC--------CC
Confidence 222345678999999998889999999999999999999 89998653211 11111 0111000 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12334678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.55 Aligned_cols=241 Identities=21% Similarity=0.331 Sum_probs=192.8
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCC-CeeeeeeeEEeCCCceEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKH-RYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~ 382 (594)
+|+..+.||+|+||.||+|... +++.||+|++... .....+.+..|.+++..++| ++|+++.+++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677899999999999999765 4678999998753 22334567889999999976 46888999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999999998753 568999999999999999999995 5999999999999999999999999999875332221
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......... ..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~----------~~ 219 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHN----------VS 219 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC----------CC
Confidence 2334568999999999999999999999999999999999999997543211 111111100 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
.+......+.+++.+|++.||++|++.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 122334678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=302.91 Aligned_cols=256 Identities=20% Similarity=0.379 Sum_probs=207.5
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++.+....++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 56888899999999999999876 7899999988642 2233567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
||+++++|.+++.. ....+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998863 23458999999999999999999995 5999999999999999999999999999876543
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........... . .
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-~--------~ 224 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK-C--------D 224 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc-C--------C
Confidence 3221 2234578899999999888899999999999999999999999854321 11111111110 0 0
Q ss_pred CCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 540 CEGVQ-SESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 540 ~~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
....+ ......+.+++.+|++.+|++|||+.+|+++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111 24456789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.98 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=193.2
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 47899999987532 22345577788888866 799999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 9999988753 568999999999999999999995 5999999999999999999999999999875432222 2234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ......... .. .+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~~~~----~~------~p~~~ 219 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESILHDD----VL------YPVWL 219 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC----CC------CCCCC
Confidence 568999999999998899999999999999999999999997643221 111111111 00 11123
Q ss_pred HHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 007668 548 LDALLAVATQCVSSSPDDRP-------TMHRVVQ 574 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RP-------s~~ev~~ 574 (594)
...+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 36788999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=319.79 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=194.9
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.|...+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4677899999999999999654 57899999997532 2334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~- 462 (594)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999998753 468899999999999999999995 5999999999999999999999999999754321000
Q ss_pred ---------------------------------------------eeeeeeecccCccCccccccCCCCccchhhhHHHH
Q 007668 463 ---------------------------------------------HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVL 497 (594)
Q Consensus 463 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~v 497 (594)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123469999999999998889999999999999
Q ss_pred HHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHH--cccCCCCCCCCHHHHHH
Q 007668 498 VLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQ--CVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 498 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~ev~~ 574 (594)
+|||++|+.||........ .......... . ..+ .....+.++.+++.+ |+..+|..||+++|+++
T Consensus 238 l~elltG~~Pf~~~~~~~~------~~~i~~~~~~--~---~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET------QLKVINWENT--L---HIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH------HHHHHccccc--c---CCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999976432110 0001100000 0 000 011234567788877 55666777999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.11 Aligned_cols=240 Identities=24% Similarity=0.369 Sum_probs=191.0
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhh-CCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGS-IKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||+|... +++.||+|.++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 47889999987532 2233456667777775 4899999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 9999999753 568999999999999999999995 5999999999999999999999999999875432221 2234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........ .+. .+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~i~~~-------~~~---~~~~~ 219 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE------LFQSIRMD-------NPC---YPRWL 219 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-------CCC---CCccC
Confidence 568999999999998899999999999999999999999997532211 11111100 011 11123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTMH-RVV 573 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~-ev~ 573 (594)
...+.+++.+||+.||++||++. ++.
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 45688999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=309.56 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=202.7
Q ss_pred CCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
+|...+.||+|+||.||+|... ....+|+|.+.... ......+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667789999999999999753 23568888887543 2334678899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCC
Q 007668 381 IYDFLPGGSLDEALHER-----------------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSN 437 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N 437 (594)
|+||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 99999999999988642 1347899999999999999999995 599999999999
Q ss_pred eEecCCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcc
Q 007668 438 ILLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEK 515 (594)
Q Consensus 438 Ill~~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 515 (594)
|++++++.++|+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998654332211 122345678999999988889999999999999999998 999986543221
Q ss_pred cchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 516 GLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
+. ... ... .. .. .+.....++.+++.+|++.+|++||+++|+++.|++++.
T Consensus 238 ---~~---~~~-~~~-~~----~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 ---LF---NLL-KTG-YR----ME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HH---HHH-hCC-CC----CC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 111 110 00 00 112334678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=302.05 Aligned_cols=249 Identities=25% Similarity=0.429 Sum_probs=204.5
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|...+.||+|+||.||++... |+.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++|+||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 346778899999999999999875 78899999976544 4667899999999999999999999999889999999999
Q ss_pred CCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999997643 368999999999999999999995 5999999999999999999999999999986643221
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
...++..|+|||.+.++.++.++||||||+++||+++ |..||......+ . .. ...... . . ..
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~-~~~~~~-~----~---~~ 220 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V---VP-HVEKGY-R----M---EA 220 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---H---HH-HHhcCC-C----C---CC
Confidence 2234668999999988889999999999999999997 999986532211 0 01 111110 0 0 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
+...+..+.+++.+|++.+|++|||+.|++++|++
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 22334678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.23 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=201.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCc--EEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGN--VFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 380 (594)
+++|+..+.||+|+||.||+|... ++. .+|+|.++.. .....+.+.+|++++.++ +||||+++++++......++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888899999999999999865 343 4678877643 333456788999999999 89999999999999999999
Q ss_pred EEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 381 IYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
|+||+++++|.++++... ..+++..++.++.|++.|++|||+ .+++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 999999999999997432 357899999999999999999994 59999999999999999999
Q ss_pred EEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHH
Q 007668 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 524 (594)
++|+|||++........ .....++..|+|||++.+..++.++||||||+++|||+| |..||...... ....
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE 234 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHH
Confidence 99999999864321111 111234668999999988889999999999999999998 99998653221 1111
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
.... . ... ..+......+.+++.+|++.+|++||+++++++.|++++..
T Consensus 235 ~~~~-~-----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 KLPQ-G-----YRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHhc-C-----CcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1110 0 000 01112345688999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.08 Aligned_cols=251 Identities=23% Similarity=0.365 Sum_probs=198.4
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||.||++... +++.||||++.... ......+.+|++++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36788899999999999999765 58899999997532 233456788999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999999764 468999999999999999999995 5999999999999999999999999999875432110
Q ss_pred e-------------------------------------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCC
Q 007668 463 H-------------------------------------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK 505 (594)
Q Consensus 463 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~ 505 (594)
. ......||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011246899999999999889999999999999999999999
Q ss_pred CCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 007668 506 RPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT---MHRVVQ 574 (594)
Q Consensus 506 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev~~ 574 (594)
.||....... .......... ....+. ....+..+.+++.+|+. +|.+|++ ++|+++
T Consensus 237 ~Pf~~~~~~~------~~~~i~~~~~--~~~~~~----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQE------TYRKIINWKE--TLQFPD----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHH------HHHHHHcCCC--ccCCCC----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9997542211 1111111000 000000 11234567889999997 9999998 887765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.38 Aligned_cols=255 Identities=25% Similarity=0.450 Sum_probs=202.9
Q ss_pred hcCCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456888899999999999999753 46789999987532 33456789999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCC
Q 007668 379 LLIYDFLPGGSLDEALHERS---------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSN 437 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N 437 (594)
++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999997421 247888999999999999999995 599999999999
Q ss_pred eEecCCCcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcc
Q 007668 438 ILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEK 515 (594)
Q Consensus 438 Ill~~~~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~ 515 (594)
|++++++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875433221 11112234678999999998899999999999999999998 88887543221
Q ss_pred cchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 516 GLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
....... ... ....+...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 -----~~~~~~~-~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIYYVR-DGN--------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHHh-cCC--------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111 111 111122344679999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=307.28 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=203.3
Q ss_pred hcCCCccceeeeecceEEEEEEecC------CcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|++++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3567788999999999999987643 4689999986532 23345788999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEe
Q 007668 379 LLIYDFLPGGSLDEALHERS---------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~ 449 (594)
++|+||+++|+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 99999999999999986421 247889999999999999999994 599999999999999999999999
Q ss_pred ecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHh
Q 007668 450 DFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLI 527 (594)
Q Consensus 450 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 527 (594)
|||+++....... .......++..|+|||.+.++.++.++||||||+++||+++ |..||....... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VLKFVI 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HHHHHh
Confidence 9999876543322 11223346789999999988889999999999999999998 899986432211 111111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
... ....+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 236 -~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 -DGG--------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111 011122235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=305.25 Aligned_cols=257 Identities=18% Similarity=0.351 Sum_probs=206.7
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.+|+..+.||+|+||.||++.. .++..+|||.+... .......+.+|+++++.++||||+++++++.+++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677789999999999999975 57899999988642 2233467889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
||+++++|.+++.. ....+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 23458999999999999999999995 5999999999999999999999999999876654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.....+ ......... ....+.
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~------~~~~~~ 227 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE------QCDYPP 227 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhh------cCCCCC
Confidence 3321 22345889999999998888999999999999999999999998643211 111111111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
. ........+.+++.+|++.+|++|||+.+|++++++.
T Consensus 228 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 L--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 1223456799999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=318.09 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=198.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||.||++... +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 467888999999999999999775 5788999998642 222345688899999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 122 MEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 9999999999999653 58889999999999999999994 599999999999999999999999999998765433
Q ss_pred ceeeeeeecccCccCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSG----RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .............
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~---- 266 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSL---- 266 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCccc----
Confidence 3333456799999999998754 3788999999999999999999999753221 1111111111000
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDD--RPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~ 574 (594)
..+ .....+..+.+++.+|++.++.+ ||++.|+++
T Consensus 267 -~~p-~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 267 -NFP-EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred -CCC-CcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 001 11123466788999999855543 889999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.69 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=209.5
Q ss_pred CCccceeeeecceEEEEEEec-CC----cEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DG----NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
+...++||+|+||+||||.+- +| -+||+|++... ..+...++.+|+-+|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345689999999999999653 33 36899988753 3445678999999999999999999999998766 78999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
+||+.|+|.|+++.+...+.....+.|..|||+||.|||++ .+|||||.++|||++.-..+||.|||+++....++.
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999999888999999999999999999999965 999999999999999999999999999998876654
Q ss_pred eeee-eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 463 HITT-IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 463 ~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
.... ...-.+.|||-|.+....++.++|||||||.+||++| |..|++....++..++.. ..++
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle------~geR--------- 918 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE------KGER--------- 918 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh------cccc---------
Confidence 3332 2233568999999999999999999999999999999 999998754433222111 1111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
...++....++.-++.+||..|++.||+++++...+.+...
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 11344556789999999999999999999999998877543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.55 Aligned_cols=241 Identities=22% Similarity=0.350 Sum_probs=194.0
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||+||+|... +++.||+|.+++.. ......+..|.+++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999766 47899999997532 23345677888888887 699999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 9999988753 569999999999999999999994 5999999999999999999999999999875322221 2233
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......... . ..+...
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~~~---~-------~~~~~~ 219 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILEDE---V-------RYPRWL 219 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHcCC---C-------CCCCcC
Confidence 56899999999999999999999999999999999999999753221 1111111110 0 011223
Q ss_pred HHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTM-----HRVVQ 574 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~-----~ev~~ 574 (594)
+..+.+++.+||+.||++||++ .++++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 4678999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.78 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=197.1
Q ss_pred CCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+|...+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++.+++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567778999999999999965 56889999988643 3334567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~ 150 (279)
T cd06619 82 DGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A 150 (279)
T ss_pred CCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence 999997542 46888899999999999999995 599999999999999999999999999997654322 2
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-hHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-NIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....|+..|+|||++.+..++.++||||||+++|+|++|+.||......... ............. .+... .
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~--~ 222 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLP--V 222 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCC--C
Confidence 2346899999999999889999999999999999999999998753322111 1111111111110 01110 1
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+.+++.+|++.+|++||+++|+++
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 123456899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=303.23 Aligned_cols=250 Identities=27% Similarity=0.417 Sum_probs=194.7
Q ss_pred ceeeeecceEEEEEEecC----CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEe-CCCceEEEEEccC
Q 007668 313 HIIGSGGFGTVYKLAMDD----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCN-SPTSKLLIYDFLP 386 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~~~ 386 (594)
+.||+|+||.||+|...+ +..+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997542 457999988643 3334567889999999999999999999875 4556789999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee--
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-- 464 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~-- 464 (594)
+|+|.+++.......++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999998765667888899999999999999995 599999999999999999999999999997654322111
Q ss_pred -eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 465 -TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSG-KRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 465 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.....++..|+|||.+.+..++.++||||||+++|||++| ..||..... ............ ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~~---------~~ 222 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGRR---------LL 222 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCCC---------CC
Confidence 1123457789999999888999999999999999999995 555543211 111111111110 00
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.+...+..+.+++.+||+.+|++||++.|+++.|++..
T Consensus 223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=301.32 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=205.0
Q ss_pred cCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
++|+..+.||+|+||.||+|...+ +..+++|.+..... .+.+.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568888999999999999998775 78999999875433 568999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++......+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 9999999998766789999999999999999999995 4999999999999999999999999999887654322 22
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....|+..|+|||++.+..++.++||||||+++|+|++|+.||.......... .... ...+. ...+.
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~-----~~~~~-~~~~~ 223 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPN-----KPPPT-LSDPE 223 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhcc-----CCCCC-CCchh
Confidence 33457889999999998899999999999999999999999987532211100 0000 00001 11223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.+++.+|++.+|++|||+.||++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 34467899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=302.68 Aligned_cols=247 Identities=29% Similarity=0.482 Sum_probs=203.4
Q ss_pred ceeeeecceEEEEEEecC----CcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMDD----GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||++.... +..+|+|.+...... ..+.+.+|++.+..++|+|++++++++......++|+||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999997764 788999999864433 367889999999999999999999999999999999999999
Q ss_pred Cchhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 388 GSLDEALHER--------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 388 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 4779999999999999999999994 5999999999999999999999999999987664
Q ss_pred CCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 460 EES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 460 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~-------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRKG-------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcC--------
Confidence 432 11233457889999999988889999999999999999999 69998764211 111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
.....+...+..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 -YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122333577999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=302.38 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=201.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch-----hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|...+.||+|++|.||++... ++..+|+|.+..... ...+.+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999754 689999998864321 123568889999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999998753 468899999999999999999995 59999999999999999999999999998765432
Q ss_pred Cceee--eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESHIT--TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
..... ....|+..|+|||.+.+..++.++||||+|+++||+++|+.||...... ...... ....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~-~~~~-------- 223 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAIFKI-ATQP-------- 223 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHHHHH-hccC--------
Confidence 22111 2345788999999999888999999999999999999999998653211 000010 0000
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
.....+......+.+++.+||+.+|++|||+.++++.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011223345678999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=307.26 Aligned_cols=261 Identities=21% Similarity=0.370 Sum_probs=200.3
Q ss_pred cCCCccceeeeecceEEEEEEecC---------------CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeee
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD---------------GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRG 370 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g 370 (594)
.+|...+.||+|+||.||++...+ ...||+|.++.. .......+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999986542 235899988753 3334567899999999999999999999
Q ss_pred EEeCCCceEEEEEccCCCchhhhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeE
Q 007668 371 YCNSPTSKLLIYDFLPGGSLDEALHERS-----------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439 (594)
Q Consensus 371 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIl 439 (594)
++......++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 9999999999999999999999986432 237889999999999999999995 59999999999999
Q ss_pred ecCCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCCcchhccc
Q 007668 440 LDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS--GKRPTDASFIEKG 516 (594)
Q Consensus 440 l~~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~~~ 516 (594)
+++++.+||+|||++.......... .....++..|+|||+..++.++.++||||||+++|||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 9999999999999997654332211 122345678999999988889999999999999999998 566765432211
Q ss_pred chHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 517 LNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
............. ..... ..+...+..+.+++.+|++.+|++|||+.+|++.|++
T Consensus 241 --~~~~~~~~~~~~~-~~~~~----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 --VIENTGEFFRNQG-RQIYL----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHhhhhcc-ccccC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111000 00000 0111234679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=314.02 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=198.1
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||.||++... +++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46788899999999999999765 5889999998742 2233456888999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999999998766679999999999999999999995 5999999999999999999999999999876654433
Q ss_pred eeeeeeecccCccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 463 HITTIVAGTFGYLAPEYMQS-----GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... .............. +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~~ 230 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ-FP 230 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc-CC
Confidence 33334568999999999863 45788999999999999999999998653221 11111111111000 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPD--DRPTMHRVVQI 575 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~--~RPs~~ev~~~ 575 (594)
+ .....+..+.+++.+|+..+++ .||+++++++-
T Consensus 231 ~----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 P----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1 1122446678888887765333 37788887753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=307.34 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=205.5
Q ss_pred hcCCCccceeeeecceEEEEEEecC-----CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-CCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 378 (594)
.++|...+.||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4577888999999999999998766 788999988753 33345678899999999999999999998765 5678
Q ss_pred EEEEEccCCCchhhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 379 LLIYDFLPGGSLDEALHERS-------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
++++||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 89999999999999987532 458999999999999999999995 59999999999999999999999999
Q ss_pred ccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcc
Q 007668 452 GLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 452 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... .+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------EMAAYLKDG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------HHHHHHHcC
Confidence 9998664433221 122345678999999988889999999999999999999 99998653221 111111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.... .....+..+.+++.+||+.+|++|||+.++++.|+...
T Consensus 236 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 236 YRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1100 11123457899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.54 Aligned_cols=241 Identities=22% Similarity=0.337 Sum_probs=193.0
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 382 (594)
+|...+.||+|+||.||+|... +++.||+|.+.+.. ....+.+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677899999999999999765 57899999987532 22234566778887777 5899999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999998753 568999999999999999999995 5999999999999999999999999999875432221
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......... ..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~~~~i~~~~----------~~ 219 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHN----------VA 219 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC----------CC
Confidence 2234568999999999999999999999999999999999999997643221 111111110 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
.+...+.++.+++.+|++.+|++|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 122344678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=306.96 Aligned_cols=239 Identities=20% Similarity=0.347 Sum_probs=188.9
Q ss_pred eeeeecceEEEEEEecC-------------------------CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeee
Q 007668 314 IIGSGGFGTVYKLAMDD-------------------------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL 368 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 368 (594)
.||+|+||.||+|.+.. ...||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999986421 23588998876555455678889999999999999999
Q ss_pred eeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC----
Q 007668 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---- 444 (594)
Q Consensus 369 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---- 444 (594)
++++.+....++||||+++|+|..++......+++..+..++.||++||+|||+ .+|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence 999999999999999999999999997766779999999999999999999994 5999999999999997543
Q ss_pred ---cEEEeecccccccccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHH-hCCCCCCcchhcccchH
Q 007668 445 ---EARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVL-SGKRPTDASFIEKGLNI 519 (594)
Q Consensus 445 ---~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~ell-tg~~p~~~~~~~~~~~~ 519 (594)
.++++|||++....... ...++..|+|||.+.+ ..++.++||||||+++||++ +|+.||........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--- 230 (274)
T ss_pred ccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---
Confidence 37999999876443221 2346788999998865 56899999999999999995 68998865322110
Q ss_pred HHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 520 VGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
..+ .... . .. +......+.+++.+||+.+|++|||++++++.|+
T Consensus 231 ~~~----~~~~---~----~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ERF----YEKK---H----RL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHH----HHhc---c----CC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111 0000 0 00 1112246889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=313.91 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=190.9
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhh-CCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGS-IKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||+|... +|+.||+|.++... ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999765 58899999987532 2233456677777765 4899999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++...... .....
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 9999998763 568999999999999999999995 599999999999999999999999999987532222 12334
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ......... .+. .+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~~-------~~~---~~~~~ 219 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRVD-------TPH---YPRWI 219 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-------CCC---CCCCC
Confidence 56899999999999999999999999999999999999999753221 111111100 011 11223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTMH-RVV 573 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~-ev~ 573 (594)
..++.+++.+||+.||++||++. ++.
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 46788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=316.80 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=194.5
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||+||++... +++.||+|++.+.. ......+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46788899999999999999765 58899999997532 223456888999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999999763 568999999999999999999994 5999999999999999999999999999875432110
Q ss_pred ----------------------------------eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 007668 463 ----------------------------------HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPT 508 (594)
Q Consensus 463 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 508 (594)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012357999999999999999999999999999999999999999
Q ss_pred CcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHccc--CCCCCCCCHHHHHH
Q 007668 509 DASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVS--SSPDDRPTMHRVVQ 574 (594)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~RPs~~ev~~ 574 (594)
....... ......... ....+.+. . .....+.+++.+++. .++..||+++|+++
T Consensus 237 ~~~~~~~------~~~~i~~~~-~~~~~p~~-~----~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 237 CSETPQE------TYKKVMNWK-ETLIFPPE-V----PISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCHHH------HHHHHHcCc-CcccCCCc-C----CCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 7532211 111111100 00011111 1 123456677766443 33445789999976
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=311.96 Aligned_cols=263 Identities=22% Similarity=0.365 Sum_probs=199.6
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++..+...++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 357888899999999999999765 57889999987432 2334567889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++ +|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9975 8888887666678999999999999999999995 59999999999999999999999999998764432221
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH----------HHHHHHhccccc
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV----------GWLNFLISEDRQ 532 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~~~~ 532 (594)
.....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+..... .|... ......
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 238 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI-SSNDEF 238 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh-cchhhh
Confidence 223457899999998865 46889999999999999999999999764322111111 01000 000000
Q ss_pred ccccCCCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 REIIDPNCE-----GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...-.+... ........++.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 011123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=311.73 Aligned_cols=258 Identities=27% Similarity=0.415 Sum_probs=204.0
Q ss_pred hcCCCccceeeeecceEEEEEEec--------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 375 (594)
.++|...+.||+|+||.||++... +...+|+|.++... ......+.+|++++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357888999999999999998653 23569999987532 33345688899999999 799999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
...++|+||+++|+|.+++..+. ..+++..++.++.|++.||+|||+ .+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence 99999999999999999997532 248899999999999999999995 599999999999999
Q ss_pred cCCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
+.++.++|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 999999999999987654322111 111224568999999998889999999999999999998 88888653221
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
....... .... ...+......+.+++.+|++.+|++|||+.+|++.|++...
T Consensus 250 --~~~~~~~-~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 250 --ELFKLLK-EGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred --HHHHHHH-cCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1111111 1100 01122344678899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.79 Aligned_cols=237 Identities=24% Similarity=0.351 Sum_probs=188.3
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHH-HHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||+||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999775 68999999987532 122234445544 56789999999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 999999875 3568999999999999999999995 599999999999999999999999999987543222 12234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......... . ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~---~-------~~~~~~ 219 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNKP---L-------RLKPNI 219 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC---C-------CCCCCC
Confidence 56899999999999989999999999999999999999999753221 1111111110 0 011223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTMH 570 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~ 570 (594)
+..+.+++.+|++.||++||+++
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCC
Confidence 46789999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=310.80 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=205.4
Q ss_pred hcCCCccceeeeecceEEEEEEec--------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 375 (594)
.++|...+.||+|+||.||++... ++..||+|.+... .....+.+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457788899999999999998642 3457999988753 233456788999999999 899999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
...++||||+++|+|.+++.... ..+++..+..++.||++||+|||+ .+++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 99999999999999999997531 347889999999999999999995 599999999999999
Q ss_pred cCCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
++++.++|+|||+++......... .....+++.|+|||++.+..++.++||||||+++||+++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 999999999999998765433221 222345678999999988889999999999999999998 7888754321
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
............. ..+...+..+.+++.+||+.+|++|||+.|+++.|++....
T Consensus 246 -~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 -EELFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -HHHHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111111111100 01123446789999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=311.73 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=209.4
Q ss_pred hcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchh---hHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEG---FDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 380 (594)
.+.|...+.||+|.||.||++..+. |+.+|+|.+.+.... ....+.+|+++|+++. |||||.+.+.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3467778999999999999997765 999999999764332 3468999999999998 9999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC----CCcEEEeecccccc
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG----NLEARVSDFGLAKL 456 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~~l~Dfgl~~~ 456 (594)
|||++.+|.|.+.+... .+++.....++.||+.++.||| +.+|+||||||+|+|+.. ++.++++|||++..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999875 3999999999999999999999 469999999999999963 35799999999998
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
... .......+||+.|+|||++.+..++..+||||+|+++|.|++|.+||.+........ .+..... ..-
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-~f~ 258 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-DFT 258 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-CCC
Confidence 876 445667789999999999999999999999999999999999999998754322111 1111111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+ +.....+....+++..|+..||.+|+|+.++++
T Consensus 259 ~----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 259 S----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred C----CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1 123345677899999999999999999999998
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=298.63 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=199.6
Q ss_pred ceeeeecceEEEEEEecCCcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCchh
Q 007668 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 391 (594)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++||||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999998877999999988764333 4567899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee-eeeec
Q 007668 392 EALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT-TIVAG 470 (594)
Q Consensus 392 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~-~~~~g 470 (594)
+++......+++..+..++.+++.|++|||+ .+++||||+|+||+++.++.++|+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 9997665678999999999999999999995 4999999999999999999999999999876542221111 11223
Q ss_pred ccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHH
Q 007668 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLD 549 (594)
Q Consensus 471 t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (594)
+..|+|||.+.++.++.++|+||||+++|||++ |..||....... ..... ... ... ..+...+.
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~~-~~~-~~~-------~~~~~~~~ 222 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI-ESG-YRM-------PAPQLCPE 222 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHHH-hcC-CCC-------CCCccCCH
Confidence 567999999988899999999999999999999 888875532211 11111 000 000 01223346
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 550 ALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 550 ~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
.+.+++.+|++.+|++|||+.|+++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 7999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=300.33 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=196.6
Q ss_pred ceeeeecceEEEEEEecC----CcEEEEEeecccch-hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMDD----GNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||+|.... +..+|+|.+..... ...+.+.+|++++++++||||+++++++. ....++|+||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999996532 26899999875443 34567899999999999999999999876 4567999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee-
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT- 466 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~- 466 (594)
|+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++...........
T Consensus 80 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999764 378999999999999999999995 59999999999999999999999999999866543322111
Q ss_pred -eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 467 -IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 467 -~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
...++..|+|||...+..++.++||||||+++||+++ |..||...... ....+. ...... ..+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~---~~~~~~---------~~~ 220 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML---ESGERL---------PRP 220 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH---HcCCcC---------CCC
Confidence 1223568999999998899999999999999999998 99998653221 111111 111100 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
...+..+.+++.+|++.+|++||++.++.+.|++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 22346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=307.10 Aligned_cols=262 Identities=21% Similarity=0.395 Sum_probs=203.9
Q ss_pred hcCCCccceeeeecceEEEEEEecC-----------------CcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeee
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-----------------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVN 367 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 367 (594)
.++|...+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578888999999999999987543 2458999887533 334567899999999999999999
Q ss_pred eeeEEeCCCceEEEEEccCCCchhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCC
Q 007668 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERS----------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSN 437 (594)
Q Consensus 368 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~N 437 (594)
+++++......++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999997543 268999999999999999999995 599999999999
Q ss_pred eEecCCCcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCCcchhc
Q 007668 438 ILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS--GKRPTDASFIE 514 (594)
Q Consensus 438 Ill~~~~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~ 514 (594)
|+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876543322 12223446778999999988889999999999999999998 66777543211
Q ss_pred ccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 515 KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
................... ..+...+.++.+++.+|++.||++|||+.||++.|++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 ---QVIENAGHFFRDDGRQIYL-----PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHHhccccccccccC-----CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1111111111111111111 1112234679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=301.01 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=201.8
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+|+..+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.+++.++||||+++++++.+....++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3677899999999999999765 6889999988642 3334567888999999999999999999999999999999999
Q ss_pred CCCchhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.+++.. ....+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++++|||++........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999998865 34458999999999999999999995 5999999999999999999999999999876643322 2
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
.....|++.|+|||++.+..++.++|+||||+++|+|++|..||...... ....... ... ....+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~-~~~--------~~~~~ 221 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLILKVC-QGS--------YKPLP 221 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHHHHh-cCC--------CCCCC
Confidence 23356889999999999888999999999999999999999999753211 1111111 110 11112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
...+..+.+++.+||+.||++|||+.|+++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2334668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=307.16 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=202.8
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+|+..+.||+|+||.||+|.. .++..||+|.+..........+.+|+.+++.++||||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677889999999999999975 468899999987655555677889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++.+ ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++......... .
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~ 173 (296)
T cd06654 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (296)
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-c
Confidence 99999999864 358899999999999999999994 59999999999999999999999999998765433221 2
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .+.... . .... .. ..+.
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~~~~-~-~~~~-----~~-~~~~ 240 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIA-T-NGTP-----EL-QNPE 240 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHHHHh-c-CCCC-----CC-CCcc
Confidence 23458899999999998889999999999999999999999996543211 111100 0 0000 00 1123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.+++.+||..+|++|||+.|+++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 34467889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.35 Aligned_cols=243 Identities=22% Similarity=0.359 Sum_probs=192.3
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||++... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999765 57889999997532 23345678899998888 699999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 9999988653 569999999999999999999995 599999999999999999999999999987532221 12234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++||||||+++|||++|+.||+............+.......... ..+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~p~~~ 226 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---------RIPRFL 226 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---------CCCCCC
Confidence 56899999999999999999999999999999999999999653222221212222211111110 112223
Q ss_pred HHHHHHHHHHcccCCCCCCCCH
Q 007668 548 LDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
+..+.+++.+||+.||++||++
T Consensus 227 ~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 227 SVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CHHHHHHHHHHhccCHHHcCCC
Confidence 4668899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=313.04 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=198.8
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||.||++... +++.+|+|.+.+. .......+.+|+.++..++|+||+++.+++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999999999999766 4678999998642 2223445888999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.++++.....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999998766679999999999999999999995 5999999999999999999999999999876544333
Q ss_pred eeeeeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 463 HITTIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ............ ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~-~~--- 227 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKE-RF--- 227 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCc-cc---
Confidence 3333457999999999986 34678999999999999999999999975321 111111111110 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDD--RPTMHRVVQI 575 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~~ 575 (594)
..+......+..+.+++.+|+..++++ |++++|+++-
T Consensus 228 -~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 -QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111111233467888999988654444 6788888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=303.17 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=194.7
Q ss_pred ceeeeecceEEEEEEecC-Cc--EEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMDD-GN--VFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||+|...+ +. .+|+|.++.. .......+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 33 4688888753 233456788999999999 799999999999999999999999999
Q ss_pred CchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 388 GSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 388 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
|+|.++++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.++++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 247899999999999999999995 599999999999999999999999999
Q ss_pred cccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
++........ ......+..|+|||++....++.++||||||+++|||++ |..||...... ...........
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~ 229 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLPQGYR 229 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHhCCCC
Confidence 9863221111 111223567999999988889999999999999999997 99998653211 11111111100
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
. ..+......+.+++.+|++.+|.+|||+.++++.|++++
T Consensus 230 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 L---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 011223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=296.40 Aligned_cols=265 Identities=22% Similarity=0.290 Sum_probs=200.8
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCe-eeeeeeEEeCCC-----
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRY-LVNLRGYCNSPT----- 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~----- 376 (594)
...|...+.||+|.||+||+|.. .+|+.||+|+++-.. ++......+|+.+++.++|+| |+++.+++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34455567899999999999965 468899999997543 345667899999999999999 999999998877
Q ss_pred -ceEEEEEccCCCchhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 377 -SKLLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 377 -~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
..++|+||+ .-+|..++.... ..++...+..+++||+.||+|||+ .+|+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 788999999 559999998654 357778899999999999999995 599999999999999999999999999
Q ss_pred cccccccCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
+|+.+.-... ..+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+..+.+....+-..-..-.++.
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9997653222 13345679999999999876 789999999999999999999988877554322111110000000000
Q ss_pred cccc-----cCCCCC------CCCHH---HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 532 QREI-----IDPNCE------GVQSE---SLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 532 ~~~~-----~~~~~~------~~~~~---~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
...+ .+.... ..... ......+++.+|++.+|.+|.|++.+++.
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000 000000 01111 11368899999999999999999999874
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=286.93 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=201.3
Q ss_pred cCCCccceeeeecceEEEEE-EecCCcEEEEEeecc--cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKL-AMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+.|+..+.||+|.|+.||+. ...+|+.+|+|.+.. .+....+.+.+|+++-+.|+||||+++...+.+....++|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 46777789999999999996 445688999988753 333356789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec---CCCcEEEeecccccccccC
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~~l~Dfgl~~~~~~~ 460 (594)
+|+|++|..-+-.+ ..+++...-..++||+++|.|+|. .+|||||+||+|+++- ..--+|++|||++....
T Consensus 91 ~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred cccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999998877654 457888888999999999999995 5999999999999995 33458999999999887
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
........+|||+|||||++...+++..+|||+.||+||-|+.|..||.+.... +.+....... .-++++
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~------rlye~I~~g~---yd~~~~- 234 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYEQIKAGA---YDYPSP- 234 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH------HHHHHHhccc---cCCCCc-
Confidence 334456678999999999999999999999999999999999999999763211 1111111111 111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.-....++..+|+.+|+..||.+|.|+.|.+.
T Consensus 235 --~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 235 --EWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 12234466889999999999999999998873
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.52 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=199.3
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEE-eCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC-NSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~ 384 (594)
.++|...+.||+|+||.||++... |..+|+|.++... ..+.+.+|+.++++++|+|++++++++ .+....++|+||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 346788899999999999999765 7889999886533 245788999999999999999999976 455678999999
Q ss_pred cCCCchhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++++|.++++.... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.++++|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999999986443 48999999999999999999995 599999999999999999999999999987544322
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......... ... + .
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~-~~~-----~---~ 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEK-GYK-----M---D 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhc-CCC-----C---C
Confidence 12234668999999998889999999999999999998 9999864321 111111111 100 0 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
.....+..+.+++.+|++.+|++|||++++++.|++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112334678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=335.79 Aligned_cols=259 Identities=27% Similarity=0.373 Sum_probs=202.7
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999765 5899999998753 2334567899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhc----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 383 DFLPGGSLDEALHER----------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 383 e~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
||+++|+|.+++... ....++..+++++.||++||+|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988631 1336677889999999999999995 599999999999999999999999999
Q ss_pred cccccccCCc-----------------eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcc
Q 007668 453 LAKLLEDEES-----------------HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK 515 (594)
Q Consensus 453 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~ 515 (594)
++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01112468999999999999999999999999999999999999986532111
Q ss_pred cchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhcccC
Q 007668 516 GLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRP-TMHRVVQILESEVM 581 (594)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~~~~ 581 (594)
.. +.. .+.++.........+..+.+++.+|++.||++|| +++++.+.|+..+.
T Consensus 239 ---i~-~~~---------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ---IS-YRD---------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---hh-hhh---------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 000 0001000001123346688999999999999996 57777777776543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.89 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=200.7
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 376 (594)
++....++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445678999999999999999999766 5788999998642 2223456788999999999999999999999999
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
..++||||+++|+|.+++.. ..++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999999999865 347888899999999999999994 5999999999999999999999999999987
Q ss_pred cccCCceeeeeeecccCccCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSG----RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQ 532 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (594)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~ 265 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNS 265 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCc
Confidence 654433333456799999999998753 3788999999999999999999999764221 111111111110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007668 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDD--RPTMHRVVQ 574 (594)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~ 574 (594)
.. .+ .....+..+.+++.+|++.++.+ ||+++|+++
T Consensus 266 ~~-----~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 266 LT-----FP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred cc-----CC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 01 01 11234567889999999844433 678888876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=306.66 Aligned_cols=261 Identities=28% Similarity=0.474 Sum_probs=205.6
Q ss_pred cCCCccceeeeecceEEEEEEec-----CCcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeC--CCce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-----DGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNS--PTSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 378 (594)
+.|...+.||+|+||.||++.+. ++..+|||.+...... ..+.+.+|++.++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999754 3678999999765443 46789999999999999999999999877 5578
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||+++++|.+++......+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999998766679999999999999999999995 599999999999999999999999999998765
Q ss_pred cCCcee--eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc---------hHHHHHHHHh
Q 007668 459 DEESHI--TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL---------NIVGWLNFLI 527 (594)
Q Consensus 459 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~ 527 (594)
...... .....++..|+|||...+..++.++||||||+++|||++|+.|+......... ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 332211 11233466799999998889999999999999999999999997653221100 0011111111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
... .. ..+...+..+.+++.+|++.+|++|||+.||+++|++.
T Consensus 241 ~~~--------~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGE--------RL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCC--------cC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000 00 11123346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=318.00 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=195.6
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36788899999999999998654 68899999986532 223456888999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999999975 3568899999999999999999994 5999999999999999999999999999864321100
Q ss_pred e----------------------------------------------eeeeeecccCccCccccccCCCCccchhhhHHH
Q 007668 463 H----------------------------------------------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGV 496 (594)
Q Consensus 463 ~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~ 496 (594)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHH
Q 007668 497 LVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDR---PTMHRVV 573 (594)
Q Consensus 497 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~ev~ 573 (594)
++|||++|..||......+. ......... .. ..+. ....+..+.+++.+|++ +|.+| +++.|++
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~--~~---~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET------YRKIINWRE--TL---YFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH------HHHHHccCC--cc---CCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 99999999999965332110 111111000 00 0010 11234568899999997 67765 5888877
Q ss_pred H
Q 007668 574 Q 574 (594)
Q Consensus 574 ~ 574 (594)
+
T Consensus 304 ~ 304 (377)
T cd05629 304 S 304 (377)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.66 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=201.2
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+|+..+.||+|+||.||++... ++..+|+|.+... .......+.+|++++.+++||||+++++++.+++..++|+||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 5788899999999999999765 5788899988643 3334566889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.++++.. ..+++..+..++.|+++||.|||+. .+++||||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~ 155 (308)
T cd06615 82 DGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 155 (308)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---c
Confidence 999999999764 6689999999999999999999952 489999999999999999999999999987553321 2
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc--------------
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR-------------- 531 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------- 531 (594)
....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...+.........
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCC
Confidence 23468899999999988889999999999999999999999986532211 1111100000000
Q ss_pred ----------cccccCCCCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 532 ----------QREIIDPNCEGV-QSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 532 ----------~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
....+....+.. .......+.+++.+|++.+|++|||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 11244568999999999999999999998864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=301.39 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=201.8
Q ss_pred cCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+.|++.+.||+|+||.||+|.... +..+|+|.+........+.+.+|+++++.++||||+++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 567788999999999999997754 8899999988766666677889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|..++.+....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++....... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 9999999887666679999999999999999999994 599999999999999999999999999887543321 112
Q ss_pred eeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 466 TIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
....+++.|+|||++. ...++.++||||||+++|||++|+.||...... .......... .+..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~------~~~~ 235 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE------PPTL 235 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhcCC------CccC
Confidence 3345789999999984 345688999999999999999999998653211 1111111100 0000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+...+..+.+++.+||+.+|++||+++++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 -SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 112234467889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.68 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=199.4
Q ss_pred ceeeeecceEEEEEEecC--C--cEEEEEeecccch-hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMDD--G--NVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999997643 2 3689999987555 556789999999999999999999999988 888999999999
Q ss_pred CchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee--
Q 007668 388 GSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-- 464 (594)
Q Consensus 388 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~-- 464 (594)
++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998654 568999999999999999999994 599999999999999999999999999998765432211
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .......... . ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~-------~-~~~ 222 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGE-------R-LER 222 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC-------c-CCC
Confidence 112346789999999998899999999999999999999 999986432211 1111111000 0 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1233467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=312.63 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=198.8
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|...+.||+|+||.||++... +++.||+|.+.+. .......+.+|..++..++|+||+++.+++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46788899999999999999765 5788999998652 2223455788999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999998756678999999999999999999994 5999999999999999999999999999987655443
Q ss_pred eeeeeeecccCccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 463 HITTIVAGTFGYLAPEYMQS-----GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
.......||+.|+|||++.+ +.++.++||||||+++|||++|+.||...... ........... +..+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~-~~~~p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEE-RFQFP 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCC-cccCC
Confidence 33334569999999999875 46788999999999999999999999653221 11111111110 00011
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDD--RPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~ 574 (594)
. .....+..+.+++.+|+..++++ |++++++++
T Consensus 231 ~----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 231 S----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred C----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 1 11223467888999999866544 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.82 Aligned_cols=243 Identities=23% Similarity=0.332 Sum_probs=190.0
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHH-HHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||++... +++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999765 56789999987532 122233444444 56788999999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++... ..+++.....++.||++||.|||+ .+|+||||||+||+++.++.++|+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 9999999753 557888888999999999999995 5999999999999999999999999999875432221 2334
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... . ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~-~---------~~~~~~ 219 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKP-L---------QLKPNI 219 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhCC-c---------CCCCCC
Confidence 56999999999999999999999999999999999999999753221 1111111110 0 011233
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTMHRVVQIL 576 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 576 (594)
...+.+++.+|++.||.+||++.+.+..+
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 46788999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.29 Aligned_cols=261 Identities=20% Similarity=0.373 Sum_probs=201.0
Q ss_pred cCCCccceeeeecceEEEEEEec-----------------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeee
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-----------------DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNL 368 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 368 (594)
++|+..+.||+|+||.||++... ++..+|+|++... .......+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999997532 2346899998754 33345678999999999999999999
Q ss_pred eeEEeCCCceEEEEEccCCCchhhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCe
Q 007668 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERS----------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNI 438 (594)
Q Consensus 369 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NI 438 (594)
++++......++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999987532 247788999999999999999995 4999999999999
Q ss_pred EecCCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh--CCCCCCcchhcc
Q 007668 439 LLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS--GKRPTDASFIEK 515 (594)
Q Consensus 439 ll~~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt--g~~p~~~~~~~~ 515 (594)
+++.++.++++|||++..+....... .....++..|+|||...++.++.++||||||+++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999998654332211 122334678999999888889999999999999999998 677875432211
Q ss_pred cchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 516 GLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
............. .....+ .+...+..+.+++.+||+.||++||++.||.+.|++
T Consensus 242 ---~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQG-RQVYLP----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhcc-ccccCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111110 011111 112234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.79 Aligned_cols=240 Identities=23% Similarity=0.417 Sum_probs=191.2
Q ss_pred ceeeeecceEEEEEEecC--------CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 313 HIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 234888887665555566788899999999999999999999998999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc--------EEEeecccccc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--------ARVSDFGLAKL 456 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~~l~Dfgl~~~ 456 (594)
+++|+|.++++.+...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999998766678999999999999999999995 59999999999999987665 69999998875
Q ss_pred cccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCC-CCCCcchhcccchHHHHHHHHhccccccc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGK-RPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
.... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+....... ..... ... .
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~~~--~~~--~ 222 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQFY--EDR--H 222 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHHHH--Hcc--c
Confidence 4432 22457889999999986 45799999999999999999985 5554321111 00100 000 0
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
..+......+.+++.+||+.+|++|||++++++.|+
T Consensus 223 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 -------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111223356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=301.73 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=198.7
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456688999999999999776 4778899988765555567788999999999999999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
++|.+++......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||++........ ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence 99999887656679999999999999999999995 5999999999999999999999999999876543221 1233
Q ss_pred eecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 468 VAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 468 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
..++..|+|||++. +..++.++|||||||++|||++|+.||....... ........... .. .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~-~~------~ 229 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSEPP-TL------A 229 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcCCC-CC------C
Confidence 46899999999874 3457789999999999999999999986532110 00011111000 00 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+...+..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223467899999999999999999998874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.30 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=205.0
Q ss_pred cCCCccceeeeecceEEEEEEecC-Cc----EEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GN----VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.+|...+.||+|+||.||+|...+ |. .+|+|.+.... ......+.+|++.+.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467778999999999999997643 32 58999887543 3345678899999999999999999999987 78899
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||+++|+|.+++......+++..+..++.||+.||+|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 999999999999998766679999999999999999999995 59999999999999999999999999999876543
Q ss_pred Cceee-eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESHIT-TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
..... ....++..|+|||.+....++.++|+||||+++||+++ |+.||+..... +..........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~------- 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPDLLEKGER------- 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhCCCC-------
Confidence 32211 11223568999999988889999999999999999999 99998764221 11111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
...+......+.+++.+||..+|++||++.++++.|++...
T Consensus 230 --~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 --LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01111233568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=314.69 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=200.3
Q ss_pred hcCCCccceeeeecceEEEEEEe------cCCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC-C
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP-T 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 376 (594)
.++|...+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45788999999999999999863 357889999997533 23345688899999999 689999999988654 4
Q ss_pred ceEEEEEccCCCchhhhhhhcC----------------------------------------------------------
Q 007668 377 SKLLIYDFLPGGSLDEALHERS---------------------------------------------------------- 398 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 398 (594)
..++|+||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 5789999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce-eeeeee
Q 007668 399 --------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVA 469 (594)
Q Consensus 399 --------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~ 469 (594)
..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.++|+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 236888899999999999999995 59999999999999999999999999999865432221 112233
Q ss_pred cccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHH
Q 007668 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESL 548 (594)
Q Consensus 470 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (594)
++..|+|||.+.+..++.++||||||+++||+++ |..||....... .... ........ . .+....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~-~~~~~~~~-----~---~~~~~~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCR-RLKEGTRM-----R---APDYTT 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----HHHH-HHhccCCC-----C---CCCCCC
Confidence 5678999999988899999999999999999997 899986532110 0001 11111100 0 111123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 549 DALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 549 ~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
..+.+++..||+.+|++|||+.|+++.|+..+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 568999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=298.50 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=205.6
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
++|...+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56788899999999999999765 57889999988655555678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++......+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........ ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 9999999998765679999999999999999999995 4999999999999999999999999999876553221 12
Q ss_pred eeeecccCccCccccccC---CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSG---RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||.......... ..... .+.+....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-------~~~~~----~~~~~~~~ 227 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-------LISKS----NFPPPKLK 227 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhc----cCCCcccc
Confidence 334678899999998776 78999999999999999999999986532211100 00000 00111111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+||+.+|++|||+.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23345577999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.34 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=202.6
Q ss_pred hcCCCccceeeeecceEEEEEEec--------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 375 (594)
.++|...+.||+|+||.||++... ....+|+|.++... ......+..|++++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357788899999999999998642 24568999887532 23345688899999999 699999999999998
Q ss_pred CceEEEEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
...++|+||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 89999999999999999997532 348899999999999999999995 599999999999999
Q ss_pred cCCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
++++.++|+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..||.......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999998664322211 111224567999999988889999999999999999999 888886532211
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
....... .... ..+......+.+++.+|++.+|++|||+.|+++.|++...
T Consensus 245 ---~~~~~~~-~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 ---LFKLLRE-GHRM--------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ---HHHHHHc-CCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111111 1100 1112334578899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=299.50 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=191.1
Q ss_pred ceeeeecceEEEEEEecC---CcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCC
Q 007668 313 HIIGSGGFGTVYKLAMDD---GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 388 (594)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999997653 4578999887543 233457888999999999999999999999999999999999999
Q ss_pred chhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 389 SLDEALHER----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 389 sL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+|.++++.. ....++..+..++.|++.|++|||+ .+++||||||+||+++.++.++++|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999753 2346778888999999999999995 599999999999999999999999999987544332221
Q ss_pred e-eeeecccCccCccccccC-------CCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 465 T-TIVAGTFGYLAPEYMQSG-------RATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 465 ~-~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
. ....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+. ........ ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~-~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV------LTYTVREQ-QLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH------HHHHhhcc-cCCC
Confidence 1 234567889999998642 35789999999999999996 9999865322211 01111111 1111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
.++.. .......+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~---~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL---KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc---CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1123345788999999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=316.77 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=204.5
Q ss_pred ceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCchh
Q 007668 313 HIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 391 (594)
-+||+|.||+||.|+..+ ...+|||.+........+-+.+|+...++++|.|||+++|.|.+++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 469999999999997654 5678999998766666777899999999999999999999999999889999999999999
Q ss_pred hhhhhcCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeecccccccccCCceeeeee
Q 007668 392 EALHERSEQL--DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHITTIV 468 (594)
Q Consensus 392 ~~l~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~~~~~~~~~~~~ 468 (594)
++++..-+++ .+.+.--..+||++||.|||++ .|||||||-+|||++ -.|.+||+|||-++++..-.+ .+.++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence 9999877776 7788888999999999999965 999999999999996 788999999999988764433 34557
Q ss_pred ecccCccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHH
Q 007668 469 AGTFGYLAPEYMQSG--RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546 (594)
Q Consensus 469 ~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (594)
-||..|||||++..+ .|+.++|||||||.+.||.||++||...... ... .+.+. ..... ++.+++
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp----qAA--MFkVG----myKvH---P~iPee 803 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP----QAA--MFKVG----MYKVH---PPIPEE 803 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh----hHh--hhhhc----ceecC---CCCcHH
Confidence 799999999999865 5899999999999999999999998653221 111 11111 11112 235677
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 547 SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 547 ~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+.+...++.+|+.+||..||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7888999999999999999999999985
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=299.46 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=200.4
Q ss_pred CCCccceeeeecceEEEEEEecCCcEEEEEeecccc------hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367789999999999999988889999999886422 12235688999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999753 468899999999999999999995 489999999999999999999999999987653211
Q ss_pred -----ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 462 -----SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 462 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
........|+..|+|||++.+..++.++||||||+++|+|++|..||....... ..... .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~-~~~~---~-- 225 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AMFYI-GAHR---G-- 225 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HHHHh-hhcc---C--
Confidence 111223458899999999998889999999999999999999999996532110 00000 0000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+......+.+++.+|++.+|++||++.|+++
T Consensus 226 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 --LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011122334567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=298.24 Aligned_cols=250 Identities=30% Similarity=0.505 Sum_probs=202.2
Q ss_pred CCccceeeeecceEEEEEEecC-----CcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++..+.||+|+||.||++...+ +..||+|.+...... ..+.+..|++.+..++|+||+++++++.+....+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3466899999999999997764 478999999765433 4678899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
||+++++|.+++...... +++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++++|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999865444 8999999999999999999994 599999999999999999999999999998766543
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
........+++.|+|||.+.+..++.++||||+|+++++|++ |..||...... ...........
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~~~~~~~~~~~--------- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------EVLEYLKKGYR--------- 222 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHhcCCC---------
Confidence 322222336789999999988889999999999999999998 78887652111 11111111110
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 576 (594)
...+...+..+.+++.+|++.+|++|||+.|+++.|
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011122456789999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=319.52 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=193.5
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4778899999999999999764 57899999987532 2334578899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC--
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-- 461 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~-- 461 (594)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999999754 568899999999999999999995 599999999999999999999999999975321100
Q ss_pred --------------------------------------------ceeeeeeecccCccCccccccCCCCccchhhhHHHH
Q 007668 462 --------------------------------------------SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVL 497 (594)
Q Consensus 462 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~v 497 (594)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123468999999999999899999999999999
Q ss_pred HHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 007668 498 VLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT---MHRVVQ 574 (594)
Q Consensus 498 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev~~ 574 (594)
+|||++|+.||........ ........ .....+. ....+....+++.+|+ .+|++|++ +.|+++
T Consensus 238 l~elltG~~Pf~~~~~~~~------~~~i~~~~--~~~~~p~----~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLET------QMKVINWQ--TSLHIPP----QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHhCCCCCCCCCHHHH------HHHHHccC--CCcCCCC----cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999976422110 01111100 0000011 1123456777777765 49999997 777654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.68 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=203.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|++.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356788899999999999999775 5889999998766655567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 99999999998766779999999999999999999995 5999999999999999999999999999876543222 2
Q ss_pred eeeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 465 TTIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.....|++.|+|||.+. ...++.++||||||+++|||++|+.||....... ......... .+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~~ 227 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILKSE------PPT 227 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhcCC------CCC
Confidence 23356899999999874 3456789999999999999999999986532111 011111000 000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ..+...+..+.+++.+||+.+|++||++.++++
T Consensus 228 ~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 L-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred c-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0 112234467889999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=312.70 Aligned_cols=237 Identities=25% Similarity=0.349 Sum_probs=187.7
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHH-HHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
++||+|+||.||+|... +++.||+|.+.+.. ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999775 57899999987532 222334555554 57889999999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTST 155 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cccc
Confidence 999988865 3568888999999999999999995 5999999999999999999999999999875332221 2234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||.+.+..++.++|||||||++|||++|..||...... .......... ...+...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~----------~~~~~~~ 219 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDNILHKP----------LQLPGGK 219 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHHHhcCC----------CCCCCCC
Confidence 56899999999999889999999999999999999999999653211 1111111110 0112233
Q ss_pred HHHHHHHHHHcccCCCCCCCCHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTMH 570 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~ 570 (594)
...+.+++.+|++.||++||++.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCC
Confidence 46788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=314.88 Aligned_cols=241 Identities=25% Similarity=0.363 Sum_probs=189.9
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHH-HHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||++... +|+.+|+|++... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999754 6899999998653 2223344555554 46779999999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||+++....... ....
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTT 155 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cccc
Confidence 999988865 4568999999999999999999995 5999999999999999999999999999875432221 2234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..+ ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~~~---~~~-------~~~~ 219 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILHKP---LVL-------RPGA 219 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHcCC---ccC-------CCCC
Confidence 56899999999999999999999999999999999999998653211 1111111110 011 1123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+..+.+++.+|++.+|++||++++.++
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 466889999999999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.91 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=203.3
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788889999999999999975 478999999997655555677889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++.+ ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~ 172 (297)
T cd06656 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (297)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-c
Confidence 99999999864 457899999999999999999995 59999999999999999999999999998765443221 2
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....+++.|+|||.+.+..++.++||||||+++|++++|..||.......... . ..... .+. ...+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~-~~~~~-----~~~-~~~~~ 239 (297)
T cd06656 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------L-IATNG-----TPE-LQNPE 239 (297)
T ss_pred CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------e-eccCC-----CCC-CCCcc
Confidence 23457889999999998889999999999999999999999996532211100 0 00000 000 01123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.+++.+||+.+|++||+++++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 34466889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.36 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=194.8
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|++++.+++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999999765 58899999986532 2234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC--
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-- 461 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~-- 461 (594)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999763 568889999999999999999995 599999999999999999999999999975331000
Q ss_pred ----------------------------------------ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHH
Q 007668 462 ----------------------------------------SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEV 501 (594)
Q Consensus 462 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~el 501 (594)
........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001134699999999999999999999999999999999
Q ss_pred HhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHH
Q 007668 502 LSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRP---TMHRVVQ 574 (594)
Q Consensus 502 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~ev~~ 574 (594)
++|+.||......+. ......... ....+. ....+..+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 238 l~G~~Pf~~~~~~~~------~~~i~~~~~--~~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 238 LVGQPPFLADTPAET------QLKVINWET--TLHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhCCCCCCCCCHHHH------HHHHhccCc--cccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999976432211 111110000 000011 1123456777888876 4999999 7888774
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.00 Aligned_cols=263 Identities=22% Similarity=0.356 Sum_probs=199.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++..+...++|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 467888999999999999999765 57899999987432 3334567789999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|++ ++|.+++......+++..+..++.||++||.||| +.+++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 996 5899988776667899999999999999999999 459999999999999999999999999998764432211
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH----------HHHHHHhccccc
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV----------GWLNFLISEDRQ 532 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~~~~ 532 (594)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... .|... ......
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 238 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI-LSNEEF 238 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh-hccccc
Confidence 222356889999998765 35788999999999999999999999754322110000 00000 000000
Q ss_pred ccccCCCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 REIIDPNC-----EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.. ..........+.+++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 0011123456889999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=304.13 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=197.5
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
|+..+.||+|+||.||++... +++.||+|.+.... ......+..|+.++++++|+|++++.+.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566789999999999998665 68899999886432 22234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999998643 3458999999999999999999994 5999999999999999999999999999876543322
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....|+..|+|||++.+..++.++||||+|+++|+|++|+.||......... .. ....... ... ..
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~-~~~~~~~--~~~-------~~ 224 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EE-VERLVKE--VQE-------EY 224 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HH-HHhhhhh--hhh-------hc
Confidence 12346899999999999889999999999999999999999999753211000 00 0000000 000 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
.......+.+++.+||+.||++||| ++|+++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2223466889999999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=299.28 Aligned_cols=248 Identities=27% Similarity=0.451 Sum_probs=199.1
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccchh---------hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEG---------FDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
+|.....||+|++|.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667889999999999999764 5789999988643221 22568889999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++|+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999999764 568899999999999999999995 59999999999999999999999999998866
Q ss_pred ccCCce-----eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccc
Q 007668 458 EDEESH-----ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQ 532 (594)
Q Consensus 458 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 532 (594)
...... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........ .... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~---- 225 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKI-G---- 225 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHH-h----
Confidence 532111 11224578899999999988899999999999999999999999975321100 0000 0
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... +..+......+.+++.+||+.||++||++.|+++
T Consensus 226 -~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 -ENAS---PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -ccCC---CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111 1122334567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.07 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=197.2
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++|+|++++.+++...+..++|+||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999764 68899999986532 22234578899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999988753 346999999999999999999999 45999999999999999999999999999876543221
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....|+..|+|||.+.+..++.++|+||+|+++|||++|..||......... ... ....... .. ..
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~-~~~~~~~--~~-------~~ 224 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEV-DRRVLET--EE-------VY 224 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH-HHhhhcc--cc-------cc
Confidence 22346899999999998889999999999999999999999999754221110 000 1111100 00 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
.......+.+++.+|++.||++||+ +.++++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2233456889999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.83 Aligned_cols=238 Identities=22% Similarity=0.386 Sum_probs=190.2
Q ss_pred ceeeeecceEEEEEEecCCc-----------EEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 313 HIIGSGGFGTVYKLAMDDGN-----------VFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999876533 5778876654333 6788999999999999999999999988 778999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-------cEEEeecccc
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-------EARVSDFGLA 454 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~~l~Dfgl~ 454 (594)
+||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .++++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765579999999999999999999994 5999999999999999887 7999999999
Q ss_pred cccccCCceeeeeeecccCccCccccccC--CCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSG--RATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
...... ....++..|+|||++.+. .++.++||||||+++|||++ |..|+...... .+........
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~------~~~~~~~~~~- 223 (259)
T cd05037 156 ITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS------EKERFYQDQH- 223 (259)
T ss_pred cccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch------hHHHHHhcCC-
Confidence 865431 123467789999998876 78999999999999999999 56676543211 1111111000
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
. .+ ......+.+++.+||..+|++|||+.++++.|+
T Consensus 224 --~-----~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 --R-----LP---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --C-----CC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 011167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.88 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=201.7
Q ss_pred cCCCccceeeeecceEEEEEEec-CCc----EEEEEeecccch-hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|...+.||+|+||.||+|... ++. .+|+|.+..... .....+.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677789999999999999764 343 478888865432 3344688999999999999999999998754 4679
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
++||+++|+|.+++..+...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCc
Confidence 999999999999998766678999999999999999999995 59999999999999999999999999999876533
Q ss_pred Ccee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ...+ ...... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~---~-- 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDL----LEKGER---L-- 230 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHCCCC---C--
Confidence 3211 122345678999999998899999999999999999998 899986532211 1111 111100 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
..+......+.+++.+||..+|++||+++++++.|+.+...
T Consensus 231 ---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112335688999999999999999999999999886444
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=297.76 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=202.7
Q ss_pred cCCCccceeeeecceEEEEEEec------CCcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
++|+..+.||+|+||.||+|... +...+++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56778899999999999999864 3467899988754433 4567999999999999999999999999989999
Q ss_pred EEEEccCCCchhhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 380 LIYDFLPGGSLDEALHERS--------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
+|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997533 158999999999999999999995 59999999999999999999999999
Q ss_pred ccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhccc
Q 007668 452 GLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 452 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
|++...............++..|+|||.+.+...+.++||||||+++|++++ |..||...... ..+.... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~~~~~~~-~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------EVLNRLQ-AG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------HHHHHHH-cC
Confidence 9987544333222333456788999999988889999999999999999999 78887542211 1111111 11
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
..... .....+..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 235 ~~~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 11223467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=296.64 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=203.4
Q ss_pred CCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|+||.||.+.. .+++.+++|.+... +....+.+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477789999999999998864 45889999988643 344456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++++|.+++... ...+++..+..++.|++.|++|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999764 4568999999999999999999995 4999999999999999999999999999986654332
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
......|++.|+|||...+...+.++||||||+++|||++|..||...... ......... .....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~---------~~~~~ 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQG---------NYTPV 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcC---------CCCCC
Confidence 223346899999999998888899999999999999999999998653221 111111111 11111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
.......+.+++.+|++.+|++||+++++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 23344678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=295.15 Aligned_cols=244 Identities=26% Similarity=0.414 Sum_probs=207.1
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
|++.+.||+|+||.|||+.++ .|+.+|||++...+. .+++..|+.+|.+.+.|+||+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD--LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD--LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch--HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 455678999999999999665 599999998875443 56788999999999999999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+..|.++.+.+++++.++..+++.-+.||+|||.. .-+|||||+.|||++.+|.+|++|||.+..+.+.- ....+
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKRNT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKRNT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-HhhCc
Confidence 999999998889999999999999999999999954 78999999999999999999999999998665432 23456
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC---CCC
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE---GVQ 544 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 544 (594)
+.||+.|||||++..-.|..++||||+|+...||.-|++||.+-... +...++....+ ..+
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPPTF~KP 252 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPPTFKKP 252 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCCCCCCh
Confidence 78999999999999999999999999999999999999998753221 11111221111 134
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+.-+.++.+++++|+-+.|++|-|+.++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 556778999999999999999999988764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.11 Aligned_cols=252 Identities=31% Similarity=0.503 Sum_probs=198.7
Q ss_pred CCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhH--HHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFD--RFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
|+..+.||+|+||+||++.... ++.+|+|.+........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 3457899999999999998765 56899999987544332 23456999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++.. ...+++..+..++.|+++||.+||+. +++|+||||+||+++.++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred ccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence 99999999983 46689999999999999999999964 999999999999999999999999999876422 22233
Q ss_pred eeeecccCccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQ-SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....++..|+|||.+. +...+.++||||+|+++|+|++|..||......+..... ............. ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~------~~ 226 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKILKRPLPSSSQ------QS 226 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHHHTHHHHHTT------SH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhccccccccccc------cc
Confidence 4456899999999998 888999999999999999999999999865211111111 1111000000000 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011278999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=298.24 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=200.8
Q ss_pred CCCccceeeeecceEEEEEEecC--CcEEEEEeeccc----------chhhHHHHHHHHHHHhh-CCCCeeeeeeeEEeC
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRIDKL----------NEGFDRFFERELEILGS-IKHRYLVNLRGYCNS 374 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~ 374 (594)
.|+..+.||+|+||.||+|.... +..+|+|.+... .......+..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999998765 688999987532 12223456778888765 799999999999999
Q ss_pred CCceEEEEEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 375 PTSKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
....++|+||+++++|.+++.. ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999998753 34568999999999999999999995 248999999999999999999999999
Q ss_pred ccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 452 GLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 452 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
|.+....... ......|+..|+|||...++.++.++||||||+++|||++|+.||...... ........ ..
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~~~-~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKIVE-AV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHHhh-cc
Confidence 9998765433 233456889999999999888999999999999999999999998653221 11111111 11
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
.. +. ........+.+++.+||+.||++||++.|+.++++
T Consensus 230 ~~----~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YE----PL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CC----cC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 00 11123467899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.33 Aligned_cols=241 Identities=20% Similarity=0.335 Sum_probs=192.4
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 382 (594)
+|+..+.||+|+||.||+|... +++.||+|.+.+.. ....+.+..|.+++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999765 68899999987532 223455778888888885 577888999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999998653 569999999999999999999995 5999999999999999999999999999875433221
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ......... ..
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~~~----------~~ 219 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIMEHN----------VS 219 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC----------CC
Confidence 2233568999999999998899999999999999999999999997643211 111111110 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
.+...+..+.+++.+|++.+|++|++.
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 122334678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=299.79 Aligned_cols=248 Identities=28% Similarity=0.482 Sum_probs=196.0
Q ss_pred ceeeeecceEEEEEEecC-------CcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 313 HIIGSGGFGTVYKLAMDD-------GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+++++.++||||+++++++......++|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 468999999999997643 2578999876532 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-----cEEEeeccc
Q 007668 385 LPGGSLDEALHER------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-----EARVSDFGL 453 (594)
Q Consensus 385 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~~l~Dfgl 453 (594)
+++++|.++++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 2347899999999999999999994 5899999999999999877 899999999
Q ss_pred ccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 454 AKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 454 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
+........ .......++..|+|||++.++.++.++||||||+++|||++ |+.||...... ... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~---~~~~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVL---QHVTAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHH---HHHhcCC-
Confidence 876543221 11122345778999999999999999999999999999998 99998643221 111 1111100
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
....+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001122345678999999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.18 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=203.3
Q ss_pred cCCCccceeeeecceEEEEEEec--------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 376 (594)
.+|++.+.||+|+||.||++... .+..||+|.++.. .....+.+.+|++++.++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788899999999999998642 1236899988753 233456789999999999 7999999999999999
Q ss_pred ceEEEEEccCCCchhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec
Q 007668 377 SKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 441 (594)
..++++||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 999999999999999998753 2348899999999999999999995 5999999999999999
Q ss_pred CCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchH
Q 007668 442 GNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNI 519 (594)
Q Consensus 442 ~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~ 519 (594)
.++.++|+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.....+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE----- 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 99999999999997654322211 112234567999999998899999999999999999998 88888653221
Q ss_pred HHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 520 VGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
........... ...+......+.+++.+|++.+|++|||+.|+++.|+....
T Consensus 244 -~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 -ELFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred -HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11121111110 01112334678899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=303.44 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=203.1
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+|+..+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+..++.++|||++++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4678889999999999999865 568999999987655555677889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++.. ..+++..+..++.|++.|++|||+ .+++||||+|+||+++.++.++|+|||++......... .
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 172 (296)
T cd06655 99 AGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R 172 (296)
T ss_pred CCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence 99999999864 358999999999999999999995 59999999999999999999999999998765543322 2
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....|+..|+|||.+.+..++.++||||||+++|++++|+.||........ ..... ...... ...+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~-~~~~~~------~~~~~ 239 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIA-TNGTPE------LQNPE 239 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcCCcc------cCCcc
Confidence 234578899999999988899999999999999999999999876432111 00000 000000 01122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.+++.+||+.||++||++.+++.
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 34467889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=306.42 Aligned_cols=195 Identities=26% Similarity=0.400 Sum_probs=159.3
Q ss_pred cceeeeecceEEEEEEec---CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--CCceEEEEEccC
Q 007668 312 DHIIGSGGFGTVYKLAMD---DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKLLIYDFLP 386 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~ 386 (594)
...||+|+||+||+|... ++..+|+|.+..... ...+.+|++++++++||||+++++++.. ....++|+||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999765 467899998875432 3457889999999999999999998854 455789999985
Q ss_pred CCchhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe----cCCCcEEEeecccc
Q 007668 387 GGSLDEALHER--------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLA 454 (594)
Q Consensus 387 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~~l~Dfgl~ 454 (594)
++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888876531 2348899999999999999999995 599999999999999 45678999999999
Q ss_pred cccccCCce--eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcch
Q 007668 455 KLLEDEESH--ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASF 512 (594)
Q Consensus 455 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 512 (594)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876543221 1234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=283.55 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=202.3
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc-----chh---hHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL-----NEG---FDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~---~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 375 (594)
.+.|.-.+.+|+|..++|.+... .+|..+|+|++... .+. ..+.-..|+.+++++ .||+|+++.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 56777889999999999998754 46888999988631 111 124456799999998 699999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
...++|+|.|+.|.|.|++.+ .-.+++....+|++|+.+|+.||| ...||||||||+|||++++.+++|+|||+++
T Consensus 96 sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceee
Confidence 999999999999999999975 466999999999999999999999 5599999999999999999999999999999
Q ss_pred ccccCCceeeeeeecccCccCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQS------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
.+.+++. ....+|||+|+|||.+.. ..|+..+|+|+.||++|.|+.|.+||...... ..++....
T Consensus 172 ~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm------lMLR~Ime- 242 (411)
T KOG0599|consen 172 QLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM------LMLRMIME- 242 (411)
T ss_pred ccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH------HHHHHHHh-
Confidence 8876653 345789999999998853 36788999999999999999999998653211 11111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+. .+.-.|. -.+.+....+|+.+|++.||.+|.|++|+++
T Consensus 243 Gk-yqF~spe----Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 243 GK-YQFRSPE----WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cc-cccCCcc----hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11 1111122 2345567899999999999999999999985
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.98 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=189.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--------C
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--------T 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~ 376 (594)
..+|...+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++.+++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 357888999999999999999764 58899999886532 2345799999999999999998876321 2
Q ss_pred ceEEEEEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeecc
Q 007668 377 SKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFG 452 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfg 452 (594)
..++||||+++ ++.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999975 67776642 34568999999999999999999994 5999999999999998654 79999999
Q ss_pred cccccccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc--
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE-- 529 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 529 (594)
+++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|.+||.+....+. +..........
T Consensus 217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCH
Confidence 9987654322 223468999999999865 4689999999999999999999999976422111 00000000000
Q ss_pred -------cccccccCCCCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 -------DRQREIIDPNCE------GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 -------~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.-+... ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000000000 011123467899999999999999999999884
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=302.53 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=200.0
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+|+..+.||+|+||.||++... ++..||+|.+... .......+.+|++++.+++||||+++++++......++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777899999999999999876 6899999988653 3333467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 386 PGGSLDEALHER--SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 386 ~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
++++|..++... ...+++..+..++.|++.||.|||+ +.+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 999999988753 2368999999999999999999995 2489999999999999999999999999987654322
Q ss_pred eeeeeecccCccCccccccCC------CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGR------ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
.....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||....... ..... ..+.+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~---------~~~~~ 224 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQL---------SAIVD 224 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHH---------HHHhh
Confidence 12235788999999986543 4889999999999999999999986532111 00000 01111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+......+.+++.+|++.+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111223345677899999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=300.79 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=204.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|+..+.||+|+||+||++... ++..||+|.+... .....+.+.+|+++++.++||||+++++++......++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677789999999999998765 5888999987653 234467789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++++|.+++... +.+++..+..++.+++.||.|||+ ..+++||||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 85 MDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred CCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 9999999998763 568999999999999999999995 2489999999999999999999999999987543222
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhccc-----chHHHHHHHHhcccccccccCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG-----LNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.....|+..|+|||++.+..++.++||||||+++|++++|..||........ .....+........ .+.
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 232 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------PPR 232 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------CCC
Confidence 1234689999999999888899999999999999999999999976443211 11112222211111 011
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
+ .....+..+.+++.+|++.||++|||+.|+++.
T Consensus 233 ~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 233 L--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred C--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1 111245678999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=297.70 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=188.6
Q ss_pred eeeeecceEEEEEEecC---CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCc
Q 007668 314 IIGSGGFGTVYKLAMDD---GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
.||+|+||.||+|...+ ...+|+|.+... .......+.+|++.++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997544 346888877643 23345678899999999999999999999999999999999999999
Q ss_pred hhhhhhhcC----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee-
Q 007668 390 LDEALHERS----EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI- 464 (594)
Q Consensus 390 L~~~l~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~- 464 (594)
|.+++.... ...++.....++.||+.|++|||+ .+|+||||||+||++++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997543 225678889999999999999995 599999999999999999999999999987543322211
Q ss_pred eeeeecccCccCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 465 TTIVAGTFGYLAPEYMQS-------GRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
.....++..|+|||+... ..++.++||||||+++|||++ |..||......+ ......... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-CccCC
Confidence 122345678999998643 456889999999999999999 778876532111 011111111 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
++ .........+.+++..|+ .||++|||++||++.|.
T Consensus 232 ~~---~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KP---QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC---cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 122334466778888998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=301.57 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=196.1
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|++|.||+|... ++..||+|+++.. .....+.+.+|+.++.+++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3667789999999999999765 6899999998643 233346788899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHER--SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
++ ++|.+++... ...+++..+..++.||+.||+|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 6888888643 2568999999999999999999994 5999999999999999999999999999876543221
Q ss_pred eeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc-----------cc
Q 007668 463 HITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS-----------ED 530 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~ 530 (594)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ .......... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhH
Confidence 12233568899999987654 578899999999999999999999875322110 0000000000 00
Q ss_pred cccccc----CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREII----DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+ ...........+.++.+++.+||+.||++|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 00000011123467789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=299.54 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=201.2
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+|...+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+|++++.+++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5677889999999999999765 58899999887533 333467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++... .+++..+..++.|++.|+.|||+ .+++||||+|+||++++++.++++|||+++....... ..
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KR 155 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cc
Confidence 999999999754 78999999999999999999994 5999999999999999999999999999987654322 12
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ... ..... ..+.... .
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~-~~~~~-----~~~~~~~--~ 221 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLF-LIPKN-----NPPSLEG--N 221 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHH-Hhhhc-----CCCCCcc--c
Confidence 23457889999999998889999999999999999999999986532110 000 01111 1111111 1
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+.+++.+|+..+|++|||++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 14567899999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.37 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=191.6
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhC---CCCeeeeeeeEEeC-----CC
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSI---KHRYLVNLRGYCNS-----PT 376 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~ 376 (594)
+|+..+.||+|+||+||+|... +++.||+|.++... ......+.+|++++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677899999999999999765 68899999887432 22234566677776665 79999999998754 34
Q ss_pred ceEEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
..++|+||++ ++|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 4789999997 4888888753 3458999999999999999999995 599999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc--cccc-
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS--EDRQ- 532 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~- 532 (594)
....... .....|+..|+|||++.+..++.++||||+||++|||++|++||......+. .......... ....
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhhCc
Confidence 6643221 2234679999999999988999999999999999999999999865322211 0000000000 0000
Q ss_pred ------ccccCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 ------REIIDPNC----EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ------~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+.+.. ....+.....+.+++.+|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00001000 0111233456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=309.93 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=195.0
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC-----
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----- 376 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 376 (594)
..++|...+.||+|+||.||++... +|..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999764 5889999998643 2334566788999999999999999999885443
Q ss_pred -ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 377 -SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 377 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
..++||||+++ +|.+.++. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46899999965 56666642 47889999999999999999995 599999999999999999999999999997
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc---------hHHHH----
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL---------NIVGW---- 522 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~---------~~~~~---- 522 (594)
...... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......... ....+
T Consensus 172 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 543322 123346899999999999999999999999999999999999999754221100 00000
Q ss_pred ---HHHHhccc-cc-----ccc----cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 523 ---LNFLISED-RQ-----REI----IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 523 ---~~~~~~~~-~~-----~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
........ .. .+. ..+............+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00 000 000000011122456889999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.82 Aligned_cols=257 Identities=18% Similarity=0.182 Sum_probs=193.9
Q ss_pred CCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
.|.+.+.||+|+||.||++.... ++.||||.... ..+.+|++++++++|+||+++++++......++|+|++
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~- 242 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY- 242 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-
Confidence 68888999999999999997764 78899995332 24568999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-eee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-HIT 465 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~-~~~ 465 (594)
.++|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++|+|||+++....... ...
T Consensus 243 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 578999887666679999999999999999999995 5999999999999999999999999999986543222 122
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhc-c-cc---hHHHHHHH---Hhcccc------
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIE-K-GL---NIVGWLNF---LISEDR------ 531 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~-~-~~---~~~~~~~~---~~~~~~------ 531 (594)
....||..|+|||++.+..++.++|||||||++|||++|..|+...... . .. .+...+.. ......
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 3456999999999999999999999999999999999988664321111 0 00 01111110 000000
Q ss_pred --------cccccCCCCCC-C---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 --------QREIIDPNCEG-V---QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 --------~~~~~~~~~~~-~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+.... . .......+.+|+.+||+.||++|||+.|+++
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00000000000 0 0012246889999999999999999999986
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=294.75 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=199.4
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-CCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e 383 (594)
+|+..+.||+|++|.||++... +++.+|+|++... .....+.+.+|++++++++|+|++++++.+.. ....++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3677899999999999999765 5788999998643 23345568889999999999999999998764 445789999
Q ss_pred ccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
|+++++|.+++... ...+++.++..++.+++.|++|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999763 3458999999999999999999995 5999999999999999999999999999986643322
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......|++.|+|||++.+..++.++||||+|++++++++|+.||+..... ........ . ....
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~-~--------~~~~ 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIE-G--------KLPP 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-c--------CCCC
Confidence 223345789999999999999999999999999999999999998753211 11111111 1 0111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+......+.+++.+|++.+|++|||+.++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 22345567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=298.93 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=198.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
++|...+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++......++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46677789999999999999764 58899999987654444556888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++... +.+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++........ ..
T Consensus 89 ~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06645 89 GGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-KR 163 (267)
T ss_pred CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-cc
Confidence 999999998753 568999999999999999999995 4999999999999999999999999999876543221 12
Q ss_pred eeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....|+..|+|||.+. ...++.++||||+|+++|+|++|..||......... . .. ... ....+...
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~----~~-~~~---~~~~~~~~- 232 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F----LM-TKS---NFQPPKLK- 232 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--H----hh-hcc---CCCCCccc-
Confidence 3346899999999874 456888999999999999999999998543211100 0 00 000 00011111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01123356889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.75 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=211.4
Q ss_pred CCCccceeeeecceEEEEEE-ecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
-|+..+.||+|.|+.|-.|+ .-+|+.||||++.+. +......+..|++.|+.++|||||+++++.......|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 46667889999999998885 347999999999863 444567788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
=.+|+|+|++.++...+.++-..+++.||+.|+.|+| ..++|||||||+||.+- .-|-+|++|||++-.+.++..
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 9999999999998888999999999999999999999 45999999999999885 567899999999988776543
Q ss_pred eeeeeecccCccCccccccCCCC-ccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRAT-EKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
..+.+|+..|-|||++.+..|+ +++||||+|||||.|++|+.||...+..+ .+..++|-.. .
T Consensus 175 -L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDCKY-t 237 (864)
T KOG4717|consen 175 -LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDCKY-T 237 (864)
T ss_pred -hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcccc-c
Confidence 3557899999999999998875 67999999999999999999997654332 2333444332 3
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
++...+.++.+||..||..||.+|.+.+||..
T Consensus 238 vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 238 VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 66778889999999999999999999999875
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.99 Aligned_cols=259 Identities=20% Similarity=0.235 Sum_probs=196.8
Q ss_pred cCCCccceeeeecceEEEEEEec---CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD---DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.+|...+.||+|+||.||++... .+..||+|.+... +...+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 46888999999999999998653 3577999987653 235679999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
++. ++|.+++. ....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++|+|||++.........
T Consensus 167 ~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 167 KYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 995 68888884 34679999999999999999999995 59999999999999999999999999999765543322
Q ss_pred -eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc-----------
Q 007668 464 -ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR----------- 531 (594)
Q Consensus 464 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 531 (594)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 22345799999999999999999999999999999999999999865432211100000000000000
Q ss_pred ------cccccCCCC--CC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 532 ------QREIIDPNC--EG--VQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 532 ------~~~~~~~~~--~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
......+.. +. ........+.+++.+|+..||++|||+.|++..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00 001223568899999999999999999998863
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.04 Aligned_cols=246 Identities=28% Similarity=0.425 Sum_probs=201.5
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999765 58899999887432 344567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++++|||++......... .
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~ 158 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-R 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-c
Confidence 99999999864 458899999999999999999994 59999999999999999999999999999766443221 2
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....++..|+|||++.+..++.++||||||+++|||++|..|+......... . .... ...+....
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~-~~~~--------~~~~~~~~ 223 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------F-LIPK--------NNPPTLTG 223 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------h-hhhc--------CCCCCCch
Confidence 2345788999999998888999999999999999999999998653221100 0 0000 01112334
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 56678999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=294.58 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=201.7
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999998654 6889999998642 333456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++++|.+.+... ...+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 9999999998764 3358999999999999999999995 59999999999999999999999999999765433211
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....|++.|+|||+..++..+.++||||||++++++++|+.||...... ..+...... .....
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~---------~~~~~ 221 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRG---------SYPPV 221 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcC---------CCCCC
Confidence 22345788999999999888999999999999999999999998643211 111111111 11112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+......+.+++.+|++.+|++||++.+|++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2334567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=321.66 Aligned_cols=282 Identities=18% Similarity=0.239 Sum_probs=199.5
Q ss_pred HHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCC------CeeeeeeeEEeCC-
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKH------RYLVNLRGYCNSP- 375 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~~~~~- 375 (594)
....+|.+.+.||+|+||+||+|... .++.||||+++.... ..+.+..|++++..++| ++++++++++...
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 34578999999999999999999764 578899999865322 23455667777777654 4588999988654
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-----------
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----------- 444 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----------- 444 (594)
...++|||++ +++|.+++..+ ..+++..+..++.||+.||.|||++ .+|+||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccccc
Confidence 4678999988 77898888754 5699999999999999999999952 4999999999999998665
Q ss_pred -----cEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchH
Q 007668 445 -----EARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI 519 (594)
Q Consensus 445 -----~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 519 (594)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+....
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998764322 12345789999999999999999999999999999999999999976432211111
Q ss_pred H---------HHHHHH--------hcc-cccccccCCC--------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007668 520 V---------GWLNFL--------ISE-DRQREIIDPN--------CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 520 ~---------~~~~~~--------~~~-~~~~~~~~~~--------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 573 (594)
. .|.... ... .......++. ...........+.+|+.+||+.||++|||++|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 0 010000 000 0000000000 0000001134578999999999999999999999
Q ss_pred H--HHhcccCC-CCCccccccCCC
Q 007668 574 Q--ILESEVMT-PCPSDFYDSNSD 594 (594)
Q Consensus 574 ~--~L~~~~~~-~~~~~~~~~~~~ 594 (594)
+ .+...... ..-.+|+++.+|
T Consensus 437 ~Hp~~~~~~~~~~~~~~~~~~~~~ 460 (467)
T PTZ00284 437 THPYVLKYYPECRQHPNYPDNRSM 460 (467)
T ss_pred cCccccccCCccccCCCCCCcccc
Confidence 7 55543321 123446655543
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=303.52 Aligned_cols=194 Identities=26% Similarity=0.405 Sum_probs=158.4
Q ss_pred cceeeeecceEEEEEEec---CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEe--CCCceEEEEEccC
Q 007668 312 DHIIGSGGFGTVYKLAMD---DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN--SPTSKLLIYDFLP 386 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~~~ 386 (594)
...||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++. .....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999865 357899998875432 345788999999999999999999884 3556789999986
Q ss_pred CCchhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe----cCCCcEEEeecccc
Q 007668 387 GGSLDEALHER--------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLA 454 (594)
Q Consensus 387 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~~l~Dfgl~ 454 (594)
++|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4777776421 2348899999999999999999994 599999999999999 46678999999999
Q ss_pred cccccCCce--eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcc
Q 007668 455 KLLEDEESH--ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDAS 511 (594)
Q Consensus 455 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~ 511 (594)
+........ ......||+.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 1234568999999999876 45799999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=293.87 Aligned_cols=247 Identities=26% Similarity=0.408 Sum_probs=200.2
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-----hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999876 78999999886533 22456789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+||+++++|.+++... ..+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999999754 468999999999999999999995 599999999999999999999999999987654433
Q ss_pred ceeeeeeecccCccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGR-ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
......|+..|+|||.+.... ++.++|+||||+++|++++|+.||...... ..... ..... ..
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~-~~~~~-------~~ 220 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFK-IGRSK-------EL 220 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHH-HHhcc-------cC
Confidence 123345789999999987766 899999999999999999999998654211 00000 00000 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+......+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122233467889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=294.41 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=201.8
Q ss_pred CCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--CCceEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKLLIY 382 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~ 382 (594)
+|+..+.||.|+||.||++.. .++..+|+|.+... .....+.+..|++++++++||||+++++++.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778999999999999965 46789999988642 33345678899999999999999999998753 44578999
Q ss_pred EccCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 383 DFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDC--SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 383 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
||+++++|.+++... ...+++..++.++.||+.||.|||..+ +.+++|+||+|+||++++++.++++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998753 456999999999999999999999432 458999999999999999999999999999876
Q ss_pred ccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... . .
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~--------~ 224 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLASKI-K--------E 224 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHHHHH-h--------c
Confidence 544321 22346899999999999888999999999999999999999998764311 111111 1 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+......+.+++.+|++.+|++||++++|++
T Consensus 225 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 225 GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1111233345578999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=310.04 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=196.0
Q ss_pred HHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-----
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP----- 375 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 375 (594)
...++|...+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999754 5889999998753 233345678899999999999999999987543
Q ss_pred -CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 376 -TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 376 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 346899999965 67666643 48899999999999999999995 59999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH--------------
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV-------------- 520 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-------------- 520 (594)
+...... ......||..|+|||++.+..++.++||||||+++|||++|+.||......+.....
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8654322 223356899999999999889999999999999999999999999754321110000
Q ss_pred --HHHHHHhccc-ccccc-----cCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 521 --GWLNFLISED-RQREI-----IDPNC----EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 521 --~~~~~~~~~~-~~~~~-----~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......... ..... ..... ..........+.+++.+|++.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000000 00000 00000 0011123456889999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=300.29 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=199.3
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.|+..+.||+|+||.||+|... ++..||+|.+... .....+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3455678999999999999754 5788999988743 2334567899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++.. ..+++..+..++.|+++|+.|||+ .+++|+||+|+||++++++.++++|||++........ ..
T Consensus 85 ~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 85 GGGSALDLLKP--GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 99999999864 468999999999999999999995 5999999999999999999999999999976553321 12
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....|+..|+|||++.+..++.++||||||+++|||++|+.|+....... .... ... ...+....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~-~~~--------~~~~~~~~ 223 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------VLFL-IPK--------NSPPTLEG 223 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh------HHhh-hhc--------CCCCCCCc
Confidence 23457889999999998889999999999999999999999986432211 0000 000 01111223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 34567899999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.59 Aligned_cols=244 Identities=27% Similarity=0.404 Sum_probs=200.9
Q ss_pred CCCccceeeeecceEEEEEE-ecCCcEEEEEeecccch---hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.|.+.+.||.|+||.||.|. ..+.+.||||++.-... .....+..|+..+.+++|||.+.+.|+|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46667899999999999995 45788999999963222 224568889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|| -||-.|.+.-+.+++.+..+..|+.+.+.||+||| +.+.||||||+.|||+++.|.||++|||.+....+.
T Consensus 107 YC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 99 67999999877788999999999999999999999 559999999999999999999999999999876653
Q ss_pred eeeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
..++|||.|||||++. .+.|+-++||||+|+...||.-.++|+-.++.. ...+.....+.. .+
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-----SALYHIAQNesP-------tL 245 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNESP-------TL 245 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-----HHHHHHHhcCCC-------CC
Confidence 3468999999999985 478999999999999999999999996544321 111111111111 11
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+-+..+.+++..|+++-|.+|||.+++++
T Consensus 246 --qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 --QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 13345567899999999999999999998874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.46 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=201.2
Q ss_pred CCCccceeeeecceEEEEEE-ecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-C-----CeeeeeeeEEeCCCceEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-H-----RYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~l 380 (594)
+|.+.++||+|.||.|.|+. ..+++.||||++++... ...+...|+.+|..|+ | -|+|+++++|...++.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78889999999999999995 55699999999987543 4566778999999996 3 599999999999999999
Q ss_pred EEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC--CCcEEEeeccccccc
Q 007668 381 IYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--NLEARVSDFGLAKLL 457 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~~l~Dfgl~~~~ 457 (594)
|+|.+ ..+|+++++.+ ...++...++.|+.||+.||.+||+ .+|||+||||+|||+.+ ...+||+|||.++..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99988 66999999864 3459999999999999999999995 59999999999999974 447999999999875
Q ss_pred ccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHH-------------
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLN------------- 524 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~------------- 524 (594)
..... ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+..+.+....+..+.
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 53321 3445889999999999999999999999999999999988887766554432221110
Q ss_pred --HHhcc--cccc-----c-----------------ccCCCCC----C----CCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007668 525 --FLISE--DRQR-----E-----------------IIDPNCE----G----VQSESLDALLAVATQCVSSSPDDRPTMH 570 (594)
Q Consensus 525 --~~~~~--~~~~-----~-----------------~~~~~~~----~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 570 (594)
..+.. ...+ . ..+...+ . .....-..+.+++++|+..||.+|+|+.
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 00000 0000 0 0000011 0 1113446789999999999999999999
Q ss_pred HHHH
Q 007668 571 RVVQ 574 (594)
Q Consensus 571 ev~~ 574 (594)
++++
T Consensus 498 qal~ 501 (586)
T KOG0667|consen 498 QALN 501 (586)
T ss_pred HHhc
Confidence 9886
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=305.12 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=193.0
Q ss_pred ccceeeee--cceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 311 DDHIIGSG--GFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 311 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
..++||+| +|++||++.. .+|+.||+|++... .....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999865 46899999998753 2334567888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce-
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH- 463 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~- 463 (594)
++|+|.+++..+ ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999754 3458999999999999999999995 59999999999999999999999999865433211110
Q ss_pred -----eeeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc--------
Q 007668 464 -----ITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS-------- 528 (594)
Q Consensus 464 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 528 (594)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccch
Confidence 0112346778999999875 4588999999999999999999999975321110 0000000000
Q ss_pred -cc-----ccccccC------------------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 -ED-----RQREIID------------------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 -~~-----~~~~~~~------------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+ ......+ .............+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 0000000 0000112234567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=309.56 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=195.3
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++..++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5778899999999999999765 58899999987532 2334568889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~- 462 (594)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999999753 568999999999999999999994 5999999999999999999999999999875432110
Q ss_pred ---------------------------------eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 007668 463 ---------------------------------HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTD 509 (594)
Q Consensus 463 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 509 (594)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred cchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 510 ASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
...... ......... ....+.+. ...+..+.+++.+|+. ||++|++...+-+.++
T Consensus 238 ~~~~~~------~~~~i~~~~-~~~~~p~~-----~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 238 SETPQE------TYRKVMNWK-ETLVFPPE-----VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCHHH------HHHHHHcCC-CceecCCC-----CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 543221 111111100 00011111 1133567788888764 9999996443333333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=300.20 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=201.7
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|...+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++|||++++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999764 68999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+ +++|.+++......+++..+..++.||++||+|||+ .+++|+||||+||+++.++.++++|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 999999998766779999999999999999999995 599999999999999999999999999998765543322
Q ss_pred eeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc------------c
Q 007668 465 TTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED------------R 531 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------~ 531 (594)
.....|+..|+|||.+.+. .++.++||||+|+++|||++|.+||....... ............ .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcch
Confidence 3345689999999998654 46899999999999999999988775432111 000000000000 0
Q ss_pred cccccCCC-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 QREIIDPN-----CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+..+. +..........+.+++.+|++.+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000 00111223478899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=295.79 Aligned_cols=251 Identities=23% Similarity=0.396 Sum_probs=196.5
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC------C
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP------T 376 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~ 376 (594)
+...|+..+.||+|+||.||+|... +++.||+|.+..... ....+..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4566778889999999999999765 578899998865432 345688899999998 699999999998642 4
Q ss_pred ceEEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
..++||||+++++|.+++... ...+++..+..++.|++.|++|||+ .+|+|+||||+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999998863 3468999999999999999999995 499999999999999999999999999987
Q ss_pred ccccCCceeeeeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
....... ......|+..|+|||++. +..++.++||||||+++|||++|+.||....... ... .....
T Consensus 160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~--~~~~~ 231 (272)
T cd06637 160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF--LIPRN 231 (272)
T ss_pred ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH--HHhcC
Confidence 6543221 223456899999999986 3457889999999999999999999986432111 000 01111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..... .....+..+.+++.+||+.+|.+|||+.|+++
T Consensus 232 ~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PAPRL-------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC-------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111 11123457889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=307.86 Aligned_cols=191 Identities=25% Similarity=0.296 Sum_probs=164.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
..+|...+.||+|+||.||+|... +++.||+|..... ....|+.++++++||||+++++++......++|+||
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999775 4678999975432 234689999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+ .++|.+++......+++..+..|+.||+.||.|||+ .+|+||||||+|||++.++.++|+|||+++...... .
T Consensus 139 ~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~ 212 (357)
T PHA03209 139 Y-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--A 212 (357)
T ss_pred c-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc--c
Confidence 9 568999888767789999999999999999999995 599999999999999999999999999987543221 1
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPT 508 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~ 508 (594)
.....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 23356899999999999999999999999999999999965553
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=310.33 Aligned_cols=261 Identities=20% Similarity=0.284 Sum_probs=195.4
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC------
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------ 375 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 375 (594)
..++|...+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578899999999999999999754 5888999998753 233345678899999999999999999987443
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 356899999965 67777643 47889999999999999999994 599999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH---------HHH---
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV---------GWL--- 523 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~---------~~~--- 523 (594)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+..... .+.
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 654322 123346899999999999999999999999999999999999999754321110000 000
Q ss_pred ----HHHhccccc----------ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 524 ----NFLISEDRQ----------REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 524 ----~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......... ....-+............+.+++.+|++.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000 000000000111122356889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=295.77 Aligned_cols=252 Identities=27% Similarity=0.453 Sum_probs=203.9
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+|+..+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4667789999999999999776 58899999987643 344567889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++......+++..+..++.|++.|++|||+ ..+++|+||+|+||++++++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 157 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence 9999999998655778999999999999999999994 169999999999999999999999999998765432221
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||....... .............. .+..+.
T Consensus 158 -~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~ 226 (265)
T cd06605 158 -TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP---------PPRLPS 226 (265)
T ss_pred -cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC---------CCCCCh
Confidence 1567889999999998899999999999999999999999986542211 11111222111111 111111
Q ss_pred H-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 E-SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~-~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ....+.+++.+||..+|++|||+.+++.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1 5567899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=293.14 Aligned_cols=248 Identities=24% Similarity=0.379 Sum_probs=193.3
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-----hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--CCceE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKL 379 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 379 (594)
+|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++||||+++.+++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5788899999999999999764 58899999886421 2234568889999999999999999998865 35678
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+++||+++++|.+++... ..+++.....++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 83 l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 999999999999999753 458999999999999999999994 5999999999999999999999999999876532
Q ss_pred CCc--eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 460 EES--HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 460 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||...... .. ...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~-~~~~~~-----~~~~ 227 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA-IFKIAT-----QPTN 227 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH-HHHHhc-----CCCC
Confidence 111 1112245788999999999888999999999999999999999998653211 00 010000 0001
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+ ..+......+.+++ +||..+|++||+++||++
T Consensus 228 ~---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 P---QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 12233345566777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=293.46 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=197.7
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
++|+..+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++++++|||++++.+++... ..++|+||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5678889999999999999874 57889999886532 245788999999999999999999998654 5799999999
Q ss_pred CCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 387 GGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 387 ~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
+++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999997543 358999999999999999999994 599999999999999999999999999987543221
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
.....+..|+|||.+.++.++.++||||||+++|||++ |+.||......+ ...... .. . ..+ ..
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~-~~-~--~~~-----~~ 219 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVE-KG-Y--RME-----PP 219 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHh-CC-C--CCC-----CC
Confidence 11234568999999988899999999999999999998 999986532211 111111 11 0 001 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 2334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=298.51 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=199.4
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
++|+..+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|||++++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35778899999999999999876 58999999886432 2334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++++|..++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9999888877654 3468999999999999999999995 5999999999999999999999999999987654332
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccch-HHHHHH-------HHhcccc-cc
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN-IVGWLN-------FLISEDR-QR 533 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~~~~-------~~~~~~~-~~ 533 (594)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ...... ....... ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1223457889999999875 457899999999999999999999997543221110 000000 0000000 00
Q ss_pred cccCCCCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 534 EIIDPNCEG------VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 534 ~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+.... .....+..+.+++.+||+.+|++||++.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000010000 01123467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=331.17 Aligned_cols=258 Identities=23% Similarity=0.378 Sum_probs=198.9
Q ss_pred HHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--CCce
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSK 378 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 378 (594)
....+|.+.+.||+|+||+||++... ++..+|+|.+... .......+..|+.++.+++||||+++++++.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999765 4678899988642 33345678999999999999999999998744 4568
Q ss_pred EEEEEccCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcC----CCCeeeCCCCCCCeEecC---------
Q 007668 379 LLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDC----SPRIIHRDIKSSNILLDG--------- 442 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~ivH~Dlk~~NIll~~--------- 442 (594)
++||||+++|+|.+++... ...+++..++.|+.||+.||+|||+.. ..+|+||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 8999999999999999752 356999999999999999999999641 135999999999999964
Q ss_pred --------CCcEEEeecccccccccCCceeeeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcch
Q 007668 443 --------NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASF 512 (594)
Q Consensus 443 --------~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 512 (594)
...+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2348999999998654322 1233568999999999854 458899999999999999999999996432
Q ss_pred hcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH--HHHhc
Q 007668 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV--QILES 578 (594)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~--~~L~~ 578 (594)
. ....... +... +.++ ....+..+.+|+..||+.+|++||++.|++ ..+..
T Consensus 248 ~-----~~qli~~-lk~~-------p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 248 N-----FSQLISE-LKRG-------PDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred c-----HHHHHHH-HhcC-------CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 1 1111111 1111 0000 112346789999999999999999999998 34543
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.19 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=202.4
Q ss_pred CCCccceeeeecceEEEEEEecC--C--cEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD--G--NVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.+...++||+|.||.|++|.|.. | ..||||.++..... ....|.+|+.+|.+|+|||+++++|++.+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34456889999999999997763 4 35899999865444 57889999999999999999999999987 6778999
Q ss_pred EccCCCchhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|..+.|+|.+.|++ ....+-......++.|||.|++||. ++++|||||.++|+|+-....+||+|||+.+-+...+
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999997 4556888999999999999999999 5699999999999999989999999999999876544
Q ss_pred cee-ee-eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 462 SHI-TT-IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 462 ~~~-~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.+. .. ...-.+.|+|||.+..+.++.++|||+|||.+|||+| |..||-+-.... .++.+-..
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q------IL~~iD~~--------- 331 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ------ILKNIDAG--------- 331 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH------HHHhcccc---------
Confidence 322 21 1223568999999999999999999999999999999 788986643221 11111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....-++.++.+++++++.||..+|++|||+..+.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 111234567789999999999999999999999973
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=292.00 Aligned_cols=251 Identities=28% Similarity=0.480 Sum_probs=205.9
Q ss_pred CCCccceeeeecceEEEEEEecC-CcEEEEEeecccch-hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+|...+.||+|++|.||++...+ ++.||+|++..... .....+.+|++.+.+++|+|++++++++......++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 57778999999999999998764 89999999876543 44677999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++... ..+++..+..++.|+++|++|||+ +.+++||||+|+||+++.++.++|+|||.+......... .
T Consensus 82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-~ 157 (264)
T cd06623 82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-C 157 (264)
T ss_pred CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-c
Confidence 999999999764 668999999999999999999994 169999999999999999999999999999876543322 1
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... .........
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~---------~~~~~~~~~ 225 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQAIC---------DGPPPSLPA 225 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHHHh---------cCCCCCCCc
Confidence 2345789999999999889999999999999999999999998664321 1111111111 111111222
Q ss_pred H-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 E-SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~-~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. .+..+.+++.+|++.+|++||++.|+++
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 2 5578999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.66 Aligned_cols=260 Identities=21% Similarity=0.323 Sum_probs=198.2
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccch-----hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
+|+..+.||+|++|.||+|... +++.||+|++..... .....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999765 689999999975432 2345677899999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+ +++|.+++......+++..+..++.||++||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 999999997654479999999999999999999995 599999999999999999999999999998765432
Q ss_pred ceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc--------ccc
Q 007668 462 SHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE--------DRQ 532 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~ 532 (594)
.. .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||......+. ........... ...
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 RK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred cc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhcccc
Confidence 21 122346788999998854 4678999999999999999999877764322110 00000000000 000
Q ss_pred ccc------cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 REI------IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ~~~------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... ...............+.+++.+||+.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000 000000111233567899999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.47 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=199.1
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEe----
Q 007668 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCN---- 373 (594)
Q Consensus 300 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~---- 373 (594)
+.+....++|+..+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344456788999999999999999999664 578899998765322 345688899999999 6999999999873
Q ss_pred -CCCceEEEEEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEe
Q 007668 374 -SPTSKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (594)
Q Consensus 374 -~~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~ 449 (594)
.+...++||||+++++|.++++. ....+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEc
Confidence 34567999999999999998763 33568899999999999999999995 599999999999999999999999
Q ss_pred ecccccccccCCceeeeeeecccCccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHH
Q 007668 450 DFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS-----GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 450 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 524 (594)
|||++........ ......|+..|+|||++.. ..++.++||||+|+++|||++|+.|+....... ....
T Consensus 167 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~~~~ 240 (286)
T cd06638 167 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----ALFK 240 (286)
T ss_pred cCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----HHhh
Confidence 9999876543221 1223468999999998753 457889999999999999999999986532111 0000
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
..........+ +......+.+++.+||+.+|++|||+.|+++.
T Consensus 241 --~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 --IPRNPPPTLHQ------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --ccccCCCcccC------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000000111 11223568899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=299.35 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=195.7
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|+||.||+|... +|+.+|+|+++... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999765 68899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++ ++|.+++......+++..+..++.||++||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 96 58888887656679999999999999999999995 59999999999999999999999999999865432211
Q ss_pred eeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhc-ccc----------hHHHHHHHHhcccc-
Q 007668 465 TTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIE-KGL----------NIVGWLNFLISEDR- 531 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~-~~~----------~~~~~~~~~~~~~~- 531 (594)
.....++..|+|||.+.+. .++.++||||||+++|||++|..|+...... ... ....|.........
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 1233568899999988764 4689999999999999999999886432111 000 00001000000000
Q ss_pred cccccCCC--CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 QREIIDPN--CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
........ +.......+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000000 00111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=309.08 Aligned_cols=240 Identities=26% Similarity=0.332 Sum_probs=185.1
Q ss_pred eeeecceEEEEEEec-CCcEEEEEeecccch---hhHHHHHHHHHHHhhC---CCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEILGSI---KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 315 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
||+|+||+||+|... +++.||+|++..... .....+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999765 589999999864221 1223345566666554 699999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.++|+|||++........ ....
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 999999875 4568999999999999999999995 5999999999999999999999999999875433222 1234
Q ss_pred eecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHH
Q 007668 468 VAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (594)
..||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ......... .. .++ ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~~-~~------~~~--~~~ 220 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAFG-KV------RFP--KNV 220 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHcC-CC------CCC--Ccc
Confidence 5689999999998754 4799999999999999999999998653221 111111111 00 011 112
Q ss_pred HHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 007668 547 SLDALLAVATQCVSSSPDDRPT----MHRVVQ 574 (594)
Q Consensus 547 ~~~~l~~l~~~cl~~dP~~RPs----~~ev~~ 574 (594)
....+.+++.+||+.||++||+ +.++++
T Consensus 221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3456889999999999999995 555443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=294.89 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=196.5
Q ss_pred CCccceeeeecceEEEEEEec----CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC------
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------ 376 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 376 (594)
|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999754 3688999988753 2334567889999999999999999999875432
Q ss_pred ceEEEEEccCCCchhhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 377 SKLLIYDFLPGGSLDEALHER-----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
..++++||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 236889999999999887531 2247899999999999999999995 59999999999999999999999999
Q ss_pred ccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcc
Q 007668 452 GLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 452 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
|+++......... .....++..|++||.+....++.++||||||+++|||++ |+.||...... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS------EIYNYLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH------HHHHHHHcC
Confidence 9998664332211 122335678999999998889999999999999999999 88887653221 111111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
... .........+.+++.+|++.+|++|||+.|+++.|++.
T Consensus 232 ~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 01122346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=291.83 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=187.7
Q ss_pred eeeeecceEEEEEEecCCc---EEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCc
Q 007668 314 IIGSGGFGTVYKLAMDDGN---VFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
.||+|+||.||++...++. .+++|.+.... ....+.+.+|+..++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999755433 45666665432 3345789999999999999999999999999999999999999999
Q ss_pred hhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC-ceee
Q 007668 390 LDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-SHIT 465 (594)
Q Consensus 390 L~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~-~~~~ 465 (594)
|.+++++. ....++..+..++.||++||+|||+ .+++||||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999753 2346777788999999999999995 599999999999999999999999999986432211 1112
Q ss_pred eeeecccCccCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 466 TIVAGTFGYLAPEYMQS-------GRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
....++..|+|||++.+ ..++.++||||||+++|||++ |..||...... ......... ......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD-QQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh-cccccCC
Confidence 23457889999998753 245789999999999999997 56677542211 111111211 1122233
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
+... ......+.+++..|| .+|++||++++|++.|.
T Consensus 232 ~~~~---~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE---LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC---CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3322 224466788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=292.31 Aligned_cols=252 Identities=23% Similarity=0.443 Sum_probs=200.5
Q ss_pred CCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc------hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467789999999999999975 568999999986432 1234678899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeeccccccccc
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLED 459 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~~~~~ 459 (594)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999999753 468999999999999999999995 5999999999999998765 599999999877654
Q ss_pred CCce---eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 460 EESH---ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 460 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
.... ......|+..|+|||.+.+..++.++||||+|+++|+|++|..||........ ......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~-----~~- 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIAS-----AT- 227 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhc-----cC-
Confidence 3211 12234678999999999888899999999999999999999999864322111 111000000 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+......+.+++.+|++.+|++||++.|+++
T Consensus 228 --~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 --TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011233345577999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=300.39 Aligned_cols=246 Identities=23% Similarity=0.387 Sum_probs=198.7
Q ss_pred ccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCc
Q 007668 311 DDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 311 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
....||+|+||.||++... ++..||+|.+........+.+.+|+..+++++||||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3467999999999999764 588999999876555556778999999999999999999999999999999999999999
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeee
Q 007668 390 LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469 (594)
Q Consensus 390 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~ 469 (594)
|.+++.. ..+++..+..++.||+.||.|||+ .+++||||||+||++++++.++|+|||++......... .....
T Consensus 106 L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~ 179 (292)
T cd06658 106 LTDIVTH--TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLV 179 (292)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cceee
Confidence 9998854 458999999999999999999995 59999999999999999999999999998765433221 23356
Q ss_pred cccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHH
Q 007668 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLD 549 (594)
Q Consensus 470 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (594)
|+..|+|||...+..++.++||||||+++|||++|+.||........ ... . ...+.+... .......
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~-~-----~~~~~~~~~-~~~~~~~ 246 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MRR-I-----RDNLPPRVK-DSHKVSS 246 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-H-----HhcCCCccc-cccccCH
Confidence 89999999999888899999999999999999999999865321110 000 0 011111111 1112345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 550 ALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 550 ~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
.+.+++.+|++.||++|||++|+++.
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 68899999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=291.26 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=195.5
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-----hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--Cce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 378 (594)
.+|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 36788899999999999999764 58899999885321 12345788899999999999999999988664 457
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 7999999999999998754 458889999999999999999995 499999999999999999999999999987654
Q ss_pred cCCc--eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 459 DEES--HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 459 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
.... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~-~~~~~-------- 223 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AAI-FKIAT-------- 223 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HHH-HHHhc--------
Confidence 2211 1122345888999999998888999999999999999999999998643111 000 00000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+.....+......+.+++.+|+. +|++||+++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011111234455678899999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=292.72 Aligned_cols=253 Identities=26% Similarity=0.478 Sum_probs=197.9
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccch----------hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE----------GFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 376 (594)
+|...+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|++++++++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667789999999999999654 688999998753211 11246788999999999999999999999999
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
..++|+||+++++|.++++.. ..+++..+..++.||+.||.|||+ .+++||||+|+||+++.++.++++|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999999765 578999999999999999999995 5999999999999999999999999999976
Q ss_pred cccCCce-eeeeeecccCccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccc
Q 007668 457 LEDEESH-ITTIVAGTFGYLAPEYMQSGR--ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533 (594)
Q Consensus 457 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (594)
....... ......|+..|+|||.+.... ++.++||||||+++||+++|..||...... ..... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~--~~~~~~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFK--LGNKRSA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHH--hhccccC
Confidence 5432211 122345789999999987654 789999999999999999999998642211 11111 0011111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..++.. .....+..+.+++.+|++.+|++|||+++|++
T Consensus 231 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPIPPD---VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCCcc---ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 12234577899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=287.85 Aligned_cols=248 Identities=29% Similarity=0.438 Sum_probs=204.4
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
|+..+.||+|++|.||++... ++..+++|++..........+.+|++.+++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667789999999999999876 6889999999876555567899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
++|.+++......+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.+........ ...
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 99999998765679999999999999999999994 5999999999999999999999999999987665432 234
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ....... .....
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~------~~~~~ 223 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT-NGPPGLR------NPEKW 223 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh-cCCCCcC------ccccc
Confidence 56889999999998888999999999999999999999998653211 01111000 1011110 11112
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 467899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=288.26 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=204.0
Q ss_pred hcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchh---hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEG---FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
...|+..+.||+|.-|+||.+..++ +..+|+|++.+..-. ...+...|.++|+.++||.++.+++.++.+.-.++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 3456667889999999999998876 488999999864332 345677899999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 382 YDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+||+|..+.+++ ++.+++..++-++..|+-||.||| -.|||+|||||+|||+.++|++.|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999864 456999999999999999999999 459999999999999999999999999987543210
Q ss_pred --------------------------------C-c----------------------eeeeeeecccCccCccccccCCC
Q 007668 461 --------------------------------E-S----------------------HITTIVAGTFGYLAPEYMQSGRA 485 (594)
Q Consensus 461 --------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 485 (594)
. . .....++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 00123579999999999999999
Q ss_pred CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC--CCCCCCCHHHHHHHHHHHHHcccCCC
Q 007668 486 TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID--PNCEGVQSESLDALLAVATQCVSSSP 563 (594)
Q Consensus 486 ~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP 563 (594)
+.++|-|+|||++|||+.|..||.+....+. ...++. ..+++. +..+..+.+||++.|.+||
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCC-CcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999987644321 111111 122222 2556789999999999999
Q ss_pred CCCCC----HHHHHH
Q 007668 564 DDRPT----MHRVVQ 574 (594)
Q Consensus 564 ~~RPs----~~ev~~ 574 (594)
++|.. ++||.+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99998 777764
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=295.78 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=202.5
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+|...+.||+|+||.||++... .++.||+|.+.... ......+.+|+++++.++||||+++++.+..+...++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999765 47889999887543 2234567889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~- 462 (594)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999999999764 568999999999999999999995 5999999999999999999999999998864211100
Q ss_pred -------------eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 463 -------------HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 463 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
.......|+..|+|||.+.+..++.++|+||||+++||+++|..||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~~ 231 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVISD 231 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc
Confidence 0111235788999999998888999999999999999999999998643211 111111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
. ...+. .....+..+.+++.+|++.+|++||++.++.+.|+..+.
T Consensus 232 ~----~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 232 D----IEWPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred c----cCCCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 1 01111 111344668999999999999999998888888877543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.40 Aligned_cols=242 Identities=26% Similarity=0.424 Sum_probs=194.7
Q ss_pred CccceeeeecceEEEEEEec-CCcEEEEEe--eccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc--eEEEE
Q 007668 310 DDDHIIGSGGFGTVYKLAMD-DGNVFALKR--IDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS--KLLIY 382 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~--~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lv~ 382 (594)
...++||+|+|-+||||... +|..||=-. +... ++...+.|..|+.+|+.|+||||++++.++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999764 466666222 2222 23334789999999999999999999999977655 66899
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|.|..|+|..++++. +..+...+..|++||++||.|||.+ .++|+|||||-.||+|+ .-|.|||+|+|+|.......
T Consensus 123 EL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999999874 5688899999999999999999998 89999999999999998 56899999999999766433
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc---cccccCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR---QREIIDP 538 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 538 (594)
...+.|||.|||||++. ..|.+.+||||||++++||+|+..||..= .+.++.++.+..... +..+-|
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQIYKKV~SGiKP~sl~kV~d- 270 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQIYKKVTSGIKPAALSKVKD- 270 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHHHHHHHHcCCCHHHhhccCC-
Confidence 22378999999999988 78999999999999999999999998541 122333333333322 122222
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+++.++|.+|+.. .++|||+.|++.
T Consensus 271 ----------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ----------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 4688999999999 899999999986
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=291.67 Aligned_cols=251 Identities=29% Similarity=0.455 Sum_probs=200.7
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccch--hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|+||.||+|... ++..||+|.++.... ...+.+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677899999999999999764 688999999875443 3567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++++|.+++... ..+++..+..++.++++|+.|||+ .+++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999763 458899999999999999999995 599999999999999999999999999998765433222
Q ss_pred ee---eeecccCccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 465 TT---IVAGTFGYLAPEYMQSGR---ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 465 ~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.. ...++..|+|||++.+.. .+.++||||||+++||+++|+.||...... ...... .... ..+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~-----~~~ 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFH-VGAG-----HKP 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHH-HhcC-----CCC
Confidence 11 345788999999988766 889999999999999999999998643211 000000 1111 011
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+. .......+.+++.+|++.+|++|||+.+++.
T Consensus 226 ~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 PIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 1122466789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.76 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=196.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|+..+.||+|++|.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 467888899999999999999765 68899999986532 2223456789999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|++ ++|.+++......+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||+++........
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 997 49999887666678999999999999999999994 59999999999999999999999999998754322111
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhc-ccchHH----------HHHHHHhcccc
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIE-KGLNIV----------GWLNFLISEDR 531 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~-~~~~~~----------~~~~~~~~~~~ 531 (594)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... +..... .|.........
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 122346889999998865 45789999999999999999999998654311 000000 00000000000
Q ss_pred ccc---cc-CCCCCCCCHH--HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 QRE---II-DPNCEGVQSE--SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ~~~---~~-~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... .. .......... ....+.+++.+|++.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 00 0000000001 1256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.60 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=200.6
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|+||.||+|... +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778899999999999999776 5789999988743 333456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++.+..+... ...+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.++|+|||++..........
T Consensus 82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 998777665543 4568999999999999999999995 499999999999999999999999999998766544323
Q ss_pred eeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHH-H--------HHHhccccccc
Q 007668 465 TTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGW-L--------NFLISEDRQRE 534 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~ 534 (594)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....... . ...........
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3345678899999999887 789999999999999999999999875322111000000 0 00000000000
Q ss_pred --ccCCCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 --IIDPNCE-----GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 --~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+.... ..+...+..+.+++.+||+.+|++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 011123577999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=290.73 Aligned_cols=247 Identities=23% Similarity=0.415 Sum_probs=199.4
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|++++++++||||+++++.+......++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677899999999999998654 6888999998653 333456788999999999999999999999989999999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC-CcEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~~l~Dfgl~~~~~~~~~ 462 (594)
+++++|.+++... ...+++..+..++.+++.|++|||+ .+++|+||+|+||+++++ +.++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999864 3458999999999999999999995 599999999999999854 4689999999987654322
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.....|+..|+|||.+.+...+.++||||||+++|+|++|+.||...... .......... ...
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~---------~~~ 220 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSGT---------FAP 220 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhcC---------CCC
Confidence 12345788999999999888999999999999999999999998653221 1111111110 111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+......+.+++.+||+.+|++|||+.|+++
T Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11223467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.19 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=200.4
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC--
Q 007668 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP-- 375 (594)
Q Consensus 300 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-- 375 (594)
.++.++.++|...+.||+|+||.||++.. .+++.+|+|.+..... ....+.+|+.++.++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 45556678899999999999999999976 4688999998865332 345678899999998 799999999998653
Q ss_pred ---CceEEEEEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEe
Q 007668 376 ---TSKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (594)
Q Consensus 376 ---~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~ 449 (594)
...++|+||+++++|.++++. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEe
Confidence 357899999999999998863 34568999999999999999999995 599999999999999999999999
Q ss_pred ecccccccccCCceeeeeeecccCccCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHH
Q 007668 450 DFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG-----RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 450 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 524 (594)
|||++......... .....|+..|+|||.+... .++.++||||||+++|||++|+.||........ +..
T Consensus 171 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~--- 244 (291)
T cd06639 171 DFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFK--- 244 (291)
T ss_pred ecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHH---
Confidence 99998865432211 1234578999999987543 368899999999999999999999865322110 000
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......... .+......+.+++.+|++.+|++||++.|+++
T Consensus 245 --~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 --IPRNPPPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HhcCCCCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0001000111 12233457899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.39 Aligned_cols=244 Identities=23% Similarity=0.370 Sum_probs=197.3
Q ss_pred cceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 312 DHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
...||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..+...++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999764 6899999998765545566788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeec
Q 007668 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (594)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~g 470 (594)
.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++........ ......|
T Consensus 106 ~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~ 179 (297)
T cd06659 106 TDIVSQ--TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVG 179 (297)
T ss_pred HHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceec
Confidence 998754 458999999999999999999995 5999999999999999999999999999875543322 1233568
Q ss_pred ccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHH
Q 007668 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDA 550 (594)
Q Consensus 471 t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (594)
+..|+|||++.+..++.++||||||+++|||++|+.||........ .... ..... +. ..........
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~~~~-----~~-~~~~~~~~~~ 246 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKRL-RDSPP-----PK-LKNAHKISPV 246 (297)
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-hccCC-----CC-ccccCCCCHH
Confidence 9999999999988899999999999999999999999864321110 1110 00000 00 0011223456
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 007668 551 LLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 551 l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+.+++.+|++.+|++||+++++++
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhh
Confidence 889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=306.29 Aligned_cols=258 Identities=25% Similarity=0.349 Sum_probs=193.5
Q ss_pred HhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC------
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP------ 375 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 375 (594)
..++|...+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 356888999999999999999975 467899999987532 22345677899999999999999999887432
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
...+++++++ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 4468999988 7899888753 469999999999999999999995 599999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHH---------
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNF--------- 525 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~--------- 525 (594)
..... .....||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......+.. ..+...
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~ 240 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIMEVVGTPSPEVL 240 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCCHHHH
Confidence 65432 223468999999999876 56899999999999999999999998653221110 000000
Q ss_pred -HhcccccccccC--CCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 526 -LISEDRQREIID--PNCE-----GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 526 -~~~~~~~~~~~~--~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+........+. +..+ .........+.+++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 0000 000112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=290.46 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=203.2
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|+..+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+......++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36788899999999999999754 67889999986432 22456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHER--SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
+++++|.++++.. ...+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999754 2468999999999999999999995 5999999999999999999999999999876654332
Q ss_pred e---eeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 463 H---ITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 463 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
. ......|+..|+|||++... .++.++|+||||+++|||++|+.||....... .... ..... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~----~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLML----TLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHH----HhcCC------CC
Confidence 2 22345689999999998776 78999999999999999999999986542211 0011 11110 01
Q ss_pred CCCCC--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 NCEGV--QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..... ....+..+.+++.+|++.||++||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111 1244577899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=294.22 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=200.0
Q ss_pred CCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 309 LDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
|...+.||+|++|.||++.. .+++.+|+|++........+.+.+|+.+++.++||||+++++++......++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44557999999999999975 46889999998765555566788999999999999999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++++|||.+......... ...
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~ 174 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKS 174 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-ccc
Confidence 999999876 568999999999999999999995 59999999999999999999999999988765433222 223
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... . .+... .....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-~-----~~~~~-~~~~~ 241 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-L-----PPKLK-NLHKV 241 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-C-----CCCCc-ccccC
Confidence 45899999999998888999999999999999999999998653211 111111111 0 01111 11124
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 548 LDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+.+++.+||+.+|++|||+.++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 467999999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=292.64 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=198.2
Q ss_pred CCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc-chhhHHHHHHHHHHHhhCC---CCeeeeeeeEEeCCCceEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL-NEGFDRFFERELEILGSIK---HRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~ 382 (594)
.|+..+.||+|+||.||+|.. .++..+|+|.+... .......+.+|++++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366678999999999999976 56899999988653 2333567888999999986 999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++++|.++++. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999999865 368999999999999999999995 5999999999999999999999999999987654432
Q ss_pred eeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. .....|+..|+|||.+.++ .++.++||||||+++|+|++|..||....... .... ... ...+.+.
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~-~~~-----~~~~~~~ 223 (277)
T cd06917 157 K-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-IPK-----SKPPRLE 223 (277)
T ss_pred c-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc-ccc-----CCCCCCC
Confidence 2 2334688999999988654 46899999999999999999999997542211 1100 000 0111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ......+.+++.+||+.||++||++.|+++
T Consensus 224 ~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 D--NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 114567899999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=299.46 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=198.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35778899999999999999876 58999999886432 2235678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++++|.++... ...+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 9999988887654 3458999999999999999999995 5999999999999999999999999999886544332
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-hHHHHHH-------HHhccccc-c
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-NIVGWLN-------FLISEDRQ-R 533 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~~~~~~-------~~~~~~~~-~ 533 (594)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. .+..+.. ........ .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2223457889999999875 45788999999999999999999988643211100 0000000 00000000 0
Q ss_pred cccCCCCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 534 EIIDPNCE------GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 534 ~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+... ...+..+..+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 011233567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=295.93 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=196.2
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
+.|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++.+++.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999765 68899999886432 223456889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||++ |++.+.+......+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++.......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~- 169 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN- 169 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence 9996 67878776555679999999999999999999995 599999999999999999999999999987654321
Q ss_pred eeeeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
...++..|+|||++. .+.++.++||||||+++|||++|+.||....... .... ..... .+.
T Consensus 170 ----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~~~~-----~~~ 233 (307)
T cd06607 170 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQND-----SPT 233 (307)
T ss_pred ----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-HhcCC-----CCC
Confidence 245788999999874 4568899999999999999999999986532111 0000 00000 001
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ........+.+++.+||+.+|++||++.+++.
T Consensus 234 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 234 L--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred C--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 12234567899999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.78 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=199.4
Q ss_pred CCCccceeeeecceEEEEEEecC-CcEEEEEeecccch---hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+|+..+.||+|++|.||++...+ ++.+|+|.+..... ...+.+..|++++..++||||+++++.+.+....++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 57788999999999999997764 89999999875432 244568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
|+++++|.+++... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998753 356899999999999999999999 45999999999999999999999999999875532211
Q ss_pred e----------------------------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhc
Q 007668 463 H----------------------------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIE 514 (594)
Q Consensus 463 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 514 (594)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235788999999999888999999999999999999999998654321
Q ss_pred ccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 007668 515 KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT----MHRVVQ 574 (594)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~ev~~ 574 (594)
. .+... .. ... ..+ ........+.+++.+|++.+|++||| ++|+++
T Consensus 239 ~-----~~~~~-~~-~~~------~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 E-----TFSNI-LK-KEV------TFP-GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H-----HHHHH-hc-CCc------cCC-CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11111 10 000 011 11114577999999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=295.64 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=198.5
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5778899999999999999765 58999999986532 2334668899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 99999999999764 578999999999999999999995 59999999999999999999999999999876543
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ....... ... . ..
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~------~---~~ 217 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKIL-EGK------V---RF 217 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-cCC------c---cC
Confidence 22345889999999998888899999999999999999999998653211 0011111 110 0 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRP-----TMHRVV 573 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~ 573 (594)
+......+.+++.+||+.+|.+|| +++|++
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 122346788999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=290.10 Aligned_cols=263 Identities=29% Similarity=0.419 Sum_probs=202.0
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e 383 (594)
+|...+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+. ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5677889999999999999875 57889999887532 23456789999999999999999999998543 46789999
Q ss_pred ccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 384 FLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 384 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+++++|.+++.. ....+++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999988753 34558899999999999999999995 59999999999999999999999999998755432
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
.. ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+....... .............. .. +...
T Consensus 159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~-~~-~~~~- 231 (287)
T cd06621 159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYIVNMPN-PE-LKDE- 231 (287)
T ss_pred cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHHHhcCCc-hh-hccC-
Confidence 21 234578899999999988999999999999999999999999976422111 11111111111110 00 1100
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhccc
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILESEV 580 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~~~ 580 (594)
..........+.+++.+||+.+|++|||+.|+++ .+.+..
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 0111224567899999999999999999999987 444433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=293.85 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=204.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.+.|+..+.||+|++|.||+|... ++..+++|++..... ..+.+.+|++.+++++|+|++++++++......++|+||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 456777889999999999999876 688999999876444 456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++++|.+++..+...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 99999999998765579999999999999999999994 5999999999999999999999999998876543322 1
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ..... ...... .. ..
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~~-----~~-~~ 239 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLIT-TKGIPP-----LK-NP 239 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hcCCCC-----Cc-ch
Confidence 2234578899999999888899999999999999999999999865322110 00000 010000 00 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+.+++.+|++.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 124467899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=293.69 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=201.9
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+|...+.||+|+||.||++.. .++..||+|.+........+.+.+|+.++++++||||+++++++......++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5778889999999999999975 467889999987554445667889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++.+ ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......... .
T Consensus 99 ~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~ 172 (293)
T cd06647 99 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (293)
T ss_pred CCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-c
Confidence 99999999875 357899999999999999999995 59999999999999999999999999988765543322 2
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....|++.|+|||.+....++.++||||||+++|++++|+.||.......... ...... .+.. ....
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~------~~~~-~~~~ 239 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TPEL-QNPE 239 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCC------CCCC-CCcc
Confidence 23458889999999988889999999999999999999999997532211100 000000 0001 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.+++.+||+.+|++||++.+++.
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 34467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=289.87 Aligned_cols=246 Identities=28% Similarity=0.431 Sum_probs=199.4
Q ss_pred CCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
-|+..+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|+..+++++||||+++++++..+...++|+||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 456678999999999999975 468899999876432 233467889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||++......... .
T Consensus 85 ~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 158 (277)
T cd06641 85 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-R 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchhh-h
Confidence 99999999864 458999999999999999999995 59999999999999999999999999998765433211 2
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....|+..|+|||.+.+...+.++||||||+++|+|++|..|+...... ...... ... ..+....
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~--------~~~~~~~ 223 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLI-PKN--------NPPTLEG 223 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHH-hcC--------CCCCCCc
Confidence 2345788999999998888899999999999999999999998653211 111111 111 0111222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 34467889999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=294.64 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=195.4
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||.|++|.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3677889999999999999765 68899999886432 22335788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+. ++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++++|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 95 6888888643 3568999999999999999999995 59999999999999999999999999998765432211
Q ss_pred eeeeeecccCccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc-------------
Q 007668 464 ITTIVAGTFGYLAPEYMQSGR-ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE------------- 529 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 529 (594)
.....++..|+|||.+.+.. ++.++||||||+++|||+||+.||......+. ........-..
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHHH
Confidence 22234688999999887644 58899999999999999999999865332211 11100000000
Q ss_pred --cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 --DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 --~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....................+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000011123356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=294.90 Aligned_cols=262 Identities=25% Similarity=0.357 Sum_probs=198.6
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceEEEEE
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLIYD 383 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e 383 (594)
|+..+.||+|++|.||+|... +++.+|+|++... .......+.+|++++++++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456789999999999999776 4889999999865 334456788999999999999999999999887 78999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|++ ++|.+++......+++..+..++.||++||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 997 48998887655679999999999999999999995 59999999999999999999999999999876554322
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc-------
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI------- 535 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 535 (594)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........................
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2333456889999997764 45789999999999999999999998764322111100000000000000000
Q ss_pred -cCC------CCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 -IDP------NCEGVQSE-SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 -~~~------~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+ ........ .+..+.+++.+|++.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00000011 2567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=294.94 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=198.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 380 (594)
.++|+..+.||+|+||.||+|... +++.+|+|.++... ......+.+|++++.+++||||+++.+++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 356788899999999999999876 58899999987533 22334577899999999999999999998776 88999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||++ ++|.+++......+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999996 59999987665679999999999999999999995 49999999999999999999999999999876543
Q ss_pred CceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchH-H---------HHHHHHh-c
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI-V---------GWLNFLI-S 528 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-~---------~~~~~~~-~ 528 (594)
.. ......+++.|+|||.+.+. ..+.++|+||+|+++|||++|..||......+.... . .|..... .
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 21 12234578899999988754 468999999999999999999999875322111000 0 0100000 0
Q ss_pred --c-cccccccCCCCCC-CCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 --E-DRQREIIDPNCEG-VQSE-SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 --~-~~~~~~~~~~~~~-~~~~-~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ..........+.. .+.. ....+.+++.+||+.+|++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000000000000 1111 3566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=292.96 Aligned_cols=265 Identities=21% Similarity=0.271 Sum_probs=195.9
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++.+|...+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++|+||+++.+++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567888999999999999999654 68899999986532 333446788999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+. +++.+.+......+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9995 67777776555568888999999999999999995 5999999999999999999999999999875432221
Q ss_pred eeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHH----------HHhc-cc
Q 007668 463 HITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLN----------FLIS-ED 530 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~-~~ 530 (594)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||+........-...|.. .... ..
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred C-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1 1223468899999998754 57889999999999999999999997532210000000000 0000 00
Q ss_pred ccccccCCCCCCC------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPNCEGV------QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
............. .......+.+++.+|++.||++|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000 0012356889999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=289.79 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=199.5
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|...+.||+|+||.||+|... +|..+|+|.+... .....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999765 5788999998653 223345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~~~~~~~~ 462 (594)
+++++|.+++.... ..+++..+..++.|+++||+|||+ .+++|+||+|+||++++++ .++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999987543 358999999999999999999995 5999999999999999875 469999999987654322
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
. .....|++.|+|||+..+..++.++||||||+++||+++|..||..... ..+....... ....
T Consensus 158 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~---------~~~~ 221 (257)
T cd08225 158 L-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG---------YFAP 221 (257)
T ss_pred c-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc---------cCCC
Confidence 1 2234588999999999888899999999999999999999999865321 1111111111 1111
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
........+.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12233467999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=291.76 Aligned_cols=252 Identities=25% Similarity=0.436 Sum_probs=198.7
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCC------
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT------ 376 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------ 376 (594)
+.++|+..+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999875 578899998875443 346789999999999 6999999999996644
Q ss_pred ceEEEEEccCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 007668 377 SKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl 453 (594)
..++|+||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 478999999999999998742 357899999999999999999999 45999999999999999999999999999
Q ss_pred ccccccCCceeeeeeecccCccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc
Q 007668 454 AKLLEDEESHITTIVAGTFGYLAPEYMQS-----GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528 (594)
Q Consensus 454 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 528 (594)
+........ ......|+..|+|||++.. ..++.++||||||+++|++++|+.||....... ... . . .
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~---~-~-~ 231 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALF---K-I-P 231 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHH---H-h-h
Confidence 876543222 1233458899999998753 346789999999999999999999986432110 000 0 0 0
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... .+... ........+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~-----~~~~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNP-----PPTLK-SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccC-----CCCCC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 01111 12234567899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=291.47 Aligned_cols=247 Identities=28% Similarity=0.378 Sum_probs=200.9
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677899999999999999776 58999999987532 2345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999764 578999999999999999999995 499999999999999999999999999988665432
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ...+....... .. ...
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~-------~~~ 221 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--AD-------VLY 221 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--cc-------ccC
Confidence 123345788999999998888999999999999999999999998764321 01111111110 11 112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTM--HRVV 573 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~--~ev~ 573 (594)
+...+..+.+++.+||+.||++||++ +|++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22334788999999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=291.65 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=191.7
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHH-HhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEI-LGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|+||.||++... +|+.||+|++.... ......+..|+.. ++..+||||+++++++......++|+||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 5778899999999999999765 68999999987532 2233455556665 6667899999999999999999999999
Q ss_pred cCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
++ |+|.+++.. ....+++..+..++.||+.||+|||++ .+++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 96 688887753 235689999999999999999999952 389999999999999999999999999988654322
Q ss_pred ceeeeeeecccCccCcccccc----CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 462 SHITTIVAGTFGYLAPEYMQS----GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
......|+..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... .......... ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~------~~ 225 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEE------PS 225 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhc------CC
Confidence 1222457889999998865 45688999999999999999999998642111 0001111110 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+..+ ....+..+.+++.+||+.+|++||+++++++
T Consensus 226 ~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1124467899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=294.40 Aligned_cols=264 Identities=27% Similarity=0.370 Sum_probs=198.7
Q ss_pred HHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC----
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT---- 376 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---- 376 (594)
...++|+..+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678889999999999999999876 58899999987532 233456788999999999999999999987654
Q ss_pred ------ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEee
Q 007668 377 ------SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (594)
Q Consensus 377 ------~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~D 450 (594)
..++|+||+++ ++.+.+......+++..+..++.||+.||+|||+ .+|+||||+|+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCc
Confidence 78899999975 7777776655679999999999999999999995 5999999999999999999999999
Q ss_pred cccccccccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 451 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 451 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
||++...............++..|+|||.+.+ ...+.++||||||+++|||++|+.||......... . .+......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~--~-~~~~~~~~ 236 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL--E-LISRLCGS 236 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH--H-HHHHHhCC
Confidence 99998765443222223346788999998764 45789999999999999999999998753221110 0 01110000
Q ss_pred cc---cccc--------cC------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 DR---QREI--------ID------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~---~~~~--------~~------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. ...+ .+ ..........+..+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000 00 0000011123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=292.23 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=195.8
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
|+..+.||.|++|.||+|... +|..||+|++.... ....+.+.+|++++++++|||++++++++.+....++|+||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456789999999999999764 78999999886432 233456888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+ ++|.+++.... ..+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 4 68999887543 468999999999999999999995 59999999999999999999999999999765432211
Q ss_pred eeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHH------------hcccc
Q 007668 465 TTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL------------ISEDR 531 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~~~~ 531 (594)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ........ ...+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhh
Confidence 1223468899999987654 568899999999999999999999865322110 00000000 00000
Q ss_pred ---cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 ---QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...................+.+++.+|++.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000111112233467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.51 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=204.3
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|...+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+++++.++|||++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677789999999999999765 58899999987543 24566788999999999999999999999988999999999
Q ss_pred cCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+++++|.+++... ...+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999864 3679999999999999999999995 499999999999999999999999999998765443
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||+..... ......... ...
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~---------~~~ 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKG---------QYP 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcC---------CCC
Confidence 2233346889999999998888999999999999999999999998653211 111111111 111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+......+.+++.+||+.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 122234467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=292.07 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=201.9
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeec--ccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 382 (594)
-..|++.++||+||.+.||++...+.+.+|+|++. ..+.+....|..|+..|.+|+ |.+||++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 34678889999999999999999988999998875 345556678999999999995 999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||= +.+|..+|+++....+.-.+..+.+|++.++.++|++ ||||.||||.|+|+- +|.+||+|||+|..+..+..
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 965 7799999997666555347888999999999999976 999999999999986 56999999999998877655
Q ss_pred eee-eeeecccCccCccccccC-----------CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 463 HIT-TIVAGTFGYLAPEYMQSG-----------RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 463 ~~~-~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
... ...+||+-||+||.+... .++.++||||+|||||+|+.|+.||.... ..|.
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~a------- 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIA------- 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHH-------
Confidence 433 457899999999988532 25688999999999999999999986532 1121
Q ss_pred ccccccCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPNC----EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
++..+.+|.- +..++ ..++.++++.||..||++|||..|+++
T Consensus 581 Kl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2233444422 11111 234999999999999999999999985
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.12 Aligned_cols=245 Identities=28% Similarity=0.398 Sum_probs=195.6
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
|...+.||+|+||.||+|... ++..+|+|.+... .......+.+|++++++++|||++++++++.+....++|+||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566789999999999999764 6889999998643 222345688899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++ |++.+.+......+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 96 58888877666679999999999999999999995 59999999999999999999999999988754432
Q ss_pred eeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
....|+..|+|||.+. .+.++.++||||||+++|||++|+.||....... .......... ..
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~--------~~ 243 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES--------PT 243 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccC--------CC
Confidence 2235788999999874 4568899999999999999999999986532110 0111111110 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 576 (594)
.........+.+++.+|++.+|.+||++.++++..
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 11223446789999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=319.95 Aligned_cols=263 Identities=28% Similarity=0.428 Sum_probs=213.0
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEec--------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeee
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRG 370 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g 370 (594)
.++...+++...+.||+|.||.|++|... ....||||.++.. .....+.+..|+++|..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45555666677789999999999998643 1457999999863 334567899999999998 5999999999
Q ss_pred EEeCCCceEEEEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 007668 371 YCNSPTSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKS 435 (594)
Q Consensus 371 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~ 435 (594)
+|.+....++|.||++.|+|.++++.+. ..++..+.+.+++|||.|++||+ +.++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 9999999999999999999999998765 34889999999999999999999 55899999999
Q ss_pred CCeEecCCCcEEEeecccccccccCCceeeeeeec--ccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcch
Q 007668 436 SNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG--TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASF 512 (594)
Q Consensus 436 ~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~ 512 (594)
+|||++.+..+||+|||+++...+...+......| ..+|||||.+....++.++||||||++|||++| |..||....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999776666554333332 557999999999999999999999999999999 888886521
Q ss_pred hcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.. ...+.......+. ..+..+..++.++|+.||+.+|++||++.++.+.++.++
T Consensus 527 ~~-----~~l~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PT-----EELLEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cH-----HHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 01 1111111111111 123344578999999999999999999999999999854
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=290.11 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=198.9
Q ss_pred HHHHHHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeC--
Q 007668 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNS-- 374 (594)
Q Consensus 299 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~-- 374 (594)
..++..+...|+..+.||+|+||.||+|... +++.+|+|.+..... ....+..|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3444556678888899999999999999764 578899998765432 345688899999998 69999999999843
Q ss_pred ----CCceEEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEe
Q 007668 375 ----PTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449 (594)
Q Consensus 375 ----~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~ 449 (594)
....+++|||+++|+|.+++... ...+++..+..++.||+.|++|||+ .+++|+||+|+||++++++.++|+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEe
Confidence 45678999999999999998753 3458888899999999999999995 599999999999999999999999
Q ss_pred ecccccccccCCceeeeeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHH
Q 007668 450 DFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 450 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~ 524 (594)
|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|..||..........
T Consensus 164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------ 236 (282)
T cd06636 164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------ 236 (282)
T ss_pred eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------
Confidence 9999876542221 122346889999999875 3467889999999999999999999986532111000
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...... .+.. .....+..+.+++.+||+.||++||++.|+++
T Consensus 237 -~~~~~~-----~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -LIPRNP-----PPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hHhhCC-----CCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000 0110 11234567999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=283.06 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=204.0
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccch--hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLIY 382 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 382 (594)
+|...+.||+|++|.||+|... ++..|++|++..... ...+.+.+|++.+++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999876 688999999875442 4467789999999999999999999999888 8899999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999997643 79999999999999999999995 5999999999999999999999999999987665432
Q ss_pred e-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 H-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. ......++..|+|||...+...+.++||||||+++++|++|..||..... ....... ... .....
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~-~~~-------~~~~~ 223 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYK-IGS-------SGEPP 223 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHh-ccc-------cCCCc
Confidence 1 12334578899999999888899999999999999999999999876430 0000000 000 00111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+......+.+++.+|++.+|++||++.++++
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 122333578999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=286.15 Aligned_cols=242 Identities=27% Similarity=0.386 Sum_probs=194.8
Q ss_pred eeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 315 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
||.|++|.||++... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999876 48899999986532 23456789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeec
Q 007668 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (594)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~g 470 (594)
.+++... ..+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999764 458999999999999999999995 599999999999999999999999999998765432 1223467
Q ss_pred ccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHH
Q 007668 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDA 550 (594)
Q Consensus 471 t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (594)
+..|+|||.+.+..++.++|+||+|+++|++++|..||.....+ ............ .....+......
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~--------~~~~~~~~~~~~ 222 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGN--------GKLEFPNYIDKA 222 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccC--------CCCCCCcccCHH
Confidence 89999999998888999999999999999999999998764321 111111111100 011112222567
Q ss_pred HHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 551 LLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 551 l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
+.+++.+||+.+|++||+ ++|+++
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 999999999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=295.25 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=194.6
Q ss_pred CCCccceeeeecceEEEEEEecC---CcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD---GNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKL 379 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 379 (594)
+|...+.||+|+||.||+|.... +..||+|.+.... ......+.+|++++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36777899999999999998754 7899999998633 33446678899999999999999999999887 7899
Q ss_pred EEEEccCCCchhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC----CCcEEEeec
Q 007668 380 LIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG----NLEARVSDF 451 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~~l~Df 451 (594)
+|+||+++ ++.+.+... ...+++..+..++.||+.||+|||+ .+++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 676666422 2368899999999999999999994 59999999999999998 999999999
Q ss_pred ccccccccCCc--eeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-------hHHH
Q 007668 452 GLAKLLEDEES--HITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-------NIVG 521 (594)
Q Consensus 452 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-------~~~~ 521 (594)
|++........ .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986643322 11233467889999998765 45789999999999999999999998754332200 0000
Q ss_pred HHHHHh------------cccccc---cccCCCCC--CC----C--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 522 WLNFLI------------SEDRQR---EIIDPNCE--GV----Q--SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 522 ~~~~~~------------~~~~~~---~~~~~~~~--~~----~--~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+...- ..+... ........ .. . ......+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000000 00000000 00 0 023456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=287.58 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=193.4
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCC--CceEEEEE
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCNSP--TSKLLIYD 383 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~e 383 (594)
|+..+.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999754 68899999987532 222334457888898885 99999999999877 88999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|++ +++.+.+......+++..+..++.|++.||.|||+ .+++||||+|+||+++. +.++|+|||++.........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 996 58888887655679999999999999999999995 59999999999999999 99999999999866443221
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHh-----------cccc
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLI-----------SEDR 531 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~ 531 (594)
....++..|+|||.+.+ +.++.++||||+||++|||++|..||......+ ...+..... ....
T Consensus 156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcccc
Confidence 22457889999997654 557889999999999999999999996543221 111111100 0000
Q ss_pred cccccCCC-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 QREIIDPN-----CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+. ........+..+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 00111234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=302.43 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=201.8
Q ss_pred CCCccceeeeecceEEEEEEecCCcE-EEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDDGNV-FALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
.|.+...||-|+||.||+|..++... .|.|++....+...+.+.-|+++++.++||+||++++.|.-.+.+++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 34556779999999999998775444 46677776666667888999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
||-.+..+-+-+..+++.++..+++|++.||.||| +..|+|||||+.|||++-+|.++++|||.+..... ......
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKRD 188 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh-HHhhhc
Confidence 99999988877788999999999999999999999 45999999999999999999999999998864322 223345
Q ss_pred eeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 467 IVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.+.|||+|||||+.. ..+|+.++||||||+.|.||..+.+|....+... .+-.....+ |...
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR------VllKiaKSe-------PPTL 255 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE-------PPTL 255 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH------HHHHHhhcC-------CCcc
Confidence 678999999999864 5689999999999999999999999965532211 111111111 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
-.+..-+..+.+++.+||..||+.||+++++++
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 123344577999999999999999999998874
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=282.53 Aligned_cols=247 Identities=27% Similarity=0.432 Sum_probs=202.3
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccch--hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|++|.||++... +++.|++|.+..... .....+.+|++++++++|||++++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667899999999999999765 578999999976543 3456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++++|.+++... ..+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998764 678999999999999999999994 59999999999999999999999999999876654332
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
.....++..|+|||...+...+.++|||++|+++|+|++|..|+...... ....... .. .. ...+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~--~~-~~-------~~~~ 220 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIV--QD-DH-------PPLP 220 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHh--cc-CC-------CCCC
Confidence 23345789999999998888899999999999999999999998643211 1111110 00 01 1112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+.+++.+|++.+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 233467889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=288.06 Aligned_cols=249 Identities=26% Similarity=0.413 Sum_probs=199.9
Q ss_pred eeeecceEEEEEEecC-CcEEEEEeecccch---hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 315 IGSGGFGTVYKLAMDD-GNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 315 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
||+|+||.||++...+ |+.+|+|.+..... ...+.+.+|++++.+++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998774 89999999875433 3456788899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-------e
Q 007668 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-------H 463 (594)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~-------~ 463 (594)
.+++... ..+++..+..++.||++||+|||+ .+++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 9999764 378999999999999999999995 5999999999999999999999999999876543311 1
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
......++..|+|||.......+.++||||||+++|++++|..||...... ........ ... ..+.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~------~~~~- 222 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN-GKI------EWPE- 222 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCc------CCCc-
Confidence 223345788999999998888999999999999999999999998754321 11111111 000 0010
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
.......+.+++.+|++.+|++|||+.++.+.|+..+.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 01124678999999999999999999888888876544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=289.78 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=199.9
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccch--hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
|...+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456688999999999999765 688999999875432 34567888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++ ++.+.+..+...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 65 8888887765679999999999999999999995 599999999999999999999999999998765443 122
Q ss_pred eeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc---cccccc------
Q 007668 466 TIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE---DRQREI------ 535 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------ 535 (594)
....++..|+|||.+.+. ..+.++||||+|+++|+|++|+.||......+.... ....... ......
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhhhh
Confidence 234578899999998776 789999999999999999999999865432111000 0000000 000000
Q ss_pred --------cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 --------IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 --------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+.............+.+++.+||+.||.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000001122334578999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.06 Aligned_cols=262 Identities=21% Similarity=0.334 Sum_probs=196.5
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+|+..+.||+|++|.||+|... +|..||+|.+.... ......+.+|++++++++||||+++++++.+.+..++|+||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4677899999999999999875 58899999987543 223456778999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 386 PGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 386 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
++ +|.+++.... ..+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++++|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 75 8888886543 458999999999999999999995 59999999999999999999999999999765432211
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchH-HHHH--------HHHhcccccc
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI-VGWL--------NFLISEDRQR 533 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-~~~~--------~~~~~~~~~~ 533 (594)
.....++..|+|||.+.+ ..++.++||||||+++|++++|+.||......+.... .... ..........
T Consensus 157 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 157 -FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred -cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 122346889999998765 3568899999999999999999999875432211000 0000 0000000000
Q ss_pred cccCC----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 534 EIIDP----NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 534 ~~~~~----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+.. ......+.....+.+++.+|++.||++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 000011223466889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=287.43 Aligned_cols=241 Identities=24% Similarity=0.367 Sum_probs=185.7
Q ss_pred eeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHH---hhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEIL---GSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
+||+|+||.||++... +++.+|+|.+.+.. ......+.+|..++ ...+|||++.+.+++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 58899999886532 11223344444433 34479999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+|+|.+++..+ ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||++........ .
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---~ 153 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---c
Confidence 99999998754 569999999999999999999995 5999999999999999999999999999875543221 2
Q ss_pred eeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...|+..|+|||.+.+ ..++.++||||+|+++|||++|..||......... ....... ..+. ..+.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~------~~~~---~~~~ 220 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTL------TVNV---ELPD 220 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhh------cCCc---CCcc
Confidence 2458999999998864 56789999999999999999999999653221110 0111000 0011 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+..+.+++.+|++.||++|| |++|+++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 3457789999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.87 Aligned_cols=266 Identities=24% Similarity=0.349 Sum_probs=203.6
Q ss_pred CCccceeeeecceEEEEEE-ecCCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC------CceEE
Q 007668 309 LDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TSKLL 380 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 380 (594)
+...+.||+|+||.||+|+ ...|+.||||.+++.. ....+...+|+++|++++|||||+++++-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3456889999999999998 4579999999998633 33456788999999999999999999885443 35679
Q ss_pred EEEccCCCchhhhhhh--cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec--CCC--cEEEeecccc
Q 007668 381 IYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNL--EARVSDFGLA 454 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~~l~Dfgl~ 454 (594)
|||||++|||...+.+ +..-+++.+.+.++.+++.||.|||++ +|+||||||.||++- .+| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999985 344599999999999999999999975 999999999999994 334 4799999999
Q ss_pred cccccCCceeeeeeecccCccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQ-SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (594)
+...++. ....++||..|++||.+. ++.|+..+|.|||||++||++||..||..........-+.|....-.+....
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9887655 567788999999999999 5889999999999999999999999998755443322233332222111111
Q ss_pred cccCCC----------CC---CCCHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHhcc
Q 007668 534 EIIDPN----------CE---GVQSESLDALLAVATQCVSSSPDDRP--TMHRVVQILESE 579 (594)
Q Consensus 534 ~~~~~~----------~~---~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~ev~~~L~~~ 579 (594)
....+. ++ .........+.+.+..++..+|++|- ...+....+..+
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 111111 11 12334445677888899999999999 655555554443
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.94 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=195.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 380 (594)
.++|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++.+++|+|++++++++.+. ...++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999999999999765 58999999986432 22234567899999999999999999998654 45799
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||++ ++|.+++......+++..+..++.||+.||+|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 999996 58888887655679999999999999999999995 59999999999999999999999999999876543
Q ss_pred CceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc--cc-----
Q 007668 461 ESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED--RQ----- 532 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~----- 532 (594)
... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+... ......... ..
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD---LIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChhhchhhh
Confidence 221 122345788999999865 457899999999999999999999987543221100 000000000 00
Q ss_pred -----cc-ccCC-CCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 -----RE-IIDP-NCEG---VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 -----~~-~~~~-~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. .... .... ........+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0000 0000 01123566789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=288.76 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=195.4
Q ss_pred hcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccc-hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|+..+.||+|+||.||+|...+ ++.||||.++... ......+..|+.++.+.. ||||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4677888999999999999998875 8999999987532 223455667777776664 999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||++ +++.+.+......+++..+..++.||+.|++|||+ ..+++||||+|+||++++++.++|+|||++........
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9984 57777776545679999999999999999999995 24899999999999999999999999999876543222
Q ss_pred eeeeeeecccCccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGR----ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
. ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ............ .
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~-~----- 237 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP-P----- 237 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC-C-----
Confidence 1 2234788999999987553 788999999999999999999998652211 111111111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+ .......++.+++.+||+.||++||++.++++
T Consensus 238 ~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 238 SLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 01123467899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=288.91 Aligned_cols=251 Identities=28% Similarity=0.404 Sum_probs=192.9
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. ||||+++++++..+...++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999998765 58999999987532 234567889999999996 99999999999999999999999
Q ss_pred cCCCchhhh---hhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 385 LPGGSLDEA---LHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 385 ~~~gsL~~~---l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
++. ++.++ +.. ....+++..+..++.+++.||+|||+ +.+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 854 55443 322 23569999999999999999999995 348999999999999999999999999999765432
Q ss_pred CceeeeeeecccCccCccccccC---CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSG---RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
.. .....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||..... ............ .
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~------~ 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGD------P 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCCC------C
Confidence 21 1223578899999998766 689999999999999999999999865321 111111111100 0
Q ss_pred CCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 538 PNCE-GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+... ......+..+.+++.+|++.+|++|||+++|++
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 111235567999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=283.40 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=201.5
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|++++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999998654 6789999998753 233355678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+++++|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.++++|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 9999999998652 356899999999999999999999 4599999999999999999999999999998765441
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....++..|+|||...+..++.++|+||+|+++|||++|+.||....... .. . ... ....+
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~---~-~~~--------~~~~~ 219 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LR---Y-KVQ--------RGKYP 219 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---H-HHh--------cCCCC
Confidence 222457889999999998889999999999999999999999987543211 00 0 011 11112
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.........+.+++.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 223355577999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.35 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=195.0
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc----
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS---- 377 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 377 (594)
..++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3467888999999999999999765 68899999886432 2233456789999999999999999999866543
Q ss_pred ----eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 007668 378 ----KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (594)
Q Consensus 378 ----~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl 453 (594)
.++|+||++ ++|.+.+......+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 489999996 58888887655679999999999999999999995 4999999999999999999999999999
Q ss_pred ccccccCCce---eeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 454 AKLLEDEESH---ITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 454 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.....................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9866433221 11234578899999987654 4788999999999999999999998654322111111110000000
Q ss_pred cccc---------cccCCC-CC-CC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 DRQR---------EIIDPN-CE-GV-----QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~~~---------~~~~~~-~~-~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ....+. .. .. .......+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 000000 00 00 0011345779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=286.59 Aligned_cols=243 Identities=23% Similarity=0.383 Sum_probs=196.7
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCchh
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 391 (594)
..||+|+||.||++... +++.||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 67999999999999764 68999999987555555677899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecc
Q 007668 392 EALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471 (594)
Q Consensus 392 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt 471 (594)
+++.. ..+++..+..++.|++.|++|||+ .+++||||+|+||+++.++.++|+|||++........ ......|+
T Consensus 106 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 106 DIVTH--TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 98753 358999999999999999999995 5999999999999999999999999998876543322 12334588
Q ss_pred cCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHH
Q 007668 472 FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDAL 551 (594)
Q Consensus 472 ~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 551 (594)
..|+|||.+.+..++.++||||+|+++|+|++|..||....... ..... .. ...+.... .......+
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~------~~~~~-~~-----~~~~~~~~-~~~~~~~l 246 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMI-RD-----NLPPKLKN-LHKVSPSL 246 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-Hh-----hCCcccCC-cccCCHHH
Confidence 99999999988889999999999999999999999986532111 01110 00 01111111 11234568
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 007668 552 LAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 552 ~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+++.+||+.+|.+||++.++++
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhc
Confidence 89999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=286.43 Aligned_cols=243 Identities=24% Similarity=0.354 Sum_probs=191.6
Q ss_pred eeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 315 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
||+|+||+||++... +|+.+|+|.+.... ......+..|++++++++||||+++.+++...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999998654 68899999886422 22344567899999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeee
Q 007668 391 DEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469 (594)
Q Consensus 391 ~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~ 469 (594)
.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 99997643 368999999999999999999995 599999999999999999999999999987654322 122345
Q ss_pred cccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHH
Q 007668 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLD 549 (594)
Q Consensus 470 gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (594)
++..|+|||++.+..++.++||||+|+++|+|++|+.||.......... . .. .. . .......+.....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-~~----~~----~-~~~~~~~~~~~~~ 223 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-LK----RR----T-LEMAVEYPDKFSP 223 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-HH----hc----c-ccccccCCccCCH
Confidence 7889999999988889999999999999999999999986543211100 0 00 00 0 0001112233456
Q ss_pred HHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 550 ALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 550 ~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
.+.+++.+||+.+|++|| ++.++++
T Consensus 224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 789999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=289.32 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=193.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
++|+..+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888899999999999999765 68899999886532 2334568889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-CCcEEEeecccccccccCC
Q 007668 384 FLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~~l~Dfgl~~~~~~~~ 461 (594)
|++ ++|.+++.... ..+++..+..++.||+.||+|||+ .+++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 57888775432 336888889999999999999995 59999999999999984 5679999999997654322
Q ss_pred ceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc--cccc------
Q 007668 462 SHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS--EDRQ------ 532 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~------ 532 (594)
.. .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+.. ......... ....
T Consensus 158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 RT-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred cc-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChhhccccccc
Confidence 11 122356889999998865 45789999999999999999999998653221110 000000000 0000
Q ss_pred ---ccc----cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 ---REI----IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ---~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... ............+..+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000011223456889999999999999999999986
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.12 Aligned_cols=264 Identities=25% Similarity=0.343 Sum_probs=196.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC--CceE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP--TSKL 379 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~ 379 (594)
.++|+..+.||+|+||.||+|... +++.+|+|++... .......+.+|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888899999999999999765 5789999988642 223345677899999999 999999999998643 3579
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+|+||++ ++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 86 lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 9999996 5999888653 68899999999999999999994 5999999999999999999999999999986644
Q ss_pred CCc----eeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccch-HHHH---------H-
Q 007668 460 EES----HITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN-IVGW---------L- 523 (594)
Q Consensus 460 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~~---------~- 523 (594)
... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+... +... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 322 12233568999999998765 457889999999999999999999986532211100 0000 0
Q ss_pred -HHHhcccccccccCC---CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 524 -NFLISEDRQREIIDP---NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 524 -~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
............... ............+.+++.+||+.+|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000 0011111245678999999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=289.44 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=202.4
Q ss_pred CCccceeeeecceEEEEEEe----cCCcEEEEEeecccc----hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceE
Q 007668 309 LDDDHIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 379 (594)
|+..+.||+|++|.||++.. .+++.||||.++... ....+.+.+|++++.++ +||||+++.+.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 66778999999999999864 357889999987532 22345688899999999 5999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||+++|+|.+++... ..+++..+..++.|+++||.|||+ .+++||||+|+||+++.++.++++|||++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999999998753 568899999999999999999994 5999999999999999999999999999887654
Q ss_pred CCceeeeeeecccCccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGR--ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
..........|+..|+|||...+.. .+.++||||||+++|||++|..||....... ............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~-------- 227 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS-------- 227 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc--------
Confidence 4333233456899999999987655 7889999999999999999999985421110 111111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
....+......+.+++.+||+.+|++|||++++.+.|+....
T Consensus 228 --~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 228 --KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred --CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 011122334678899999999999999999999988877543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=297.85 Aligned_cols=265 Identities=24% Similarity=0.384 Sum_probs=196.4
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-----Cce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 378 (594)
.++|...+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 35788899999999999999965 46899999998643 233455678899999999999999999887543 347
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||++ +++.+.+.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 89999996 488877753 468999999999999999999995 599999999999999999999999999987654
Q ss_pred cCCce--eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc---ccc
Q 007668 459 DEESH--ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE---DRQ 532 (594)
Q Consensus 459 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 532 (594)
..... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ .......... +..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence 32221 1123468899999998654 5688999999999999999999999965322110 0000000000 000
Q ss_pred ccccC-------------CCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhcc
Q 007668 533 REIID-------------PNC--EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI--LESE 579 (594)
Q Consensus 533 ~~~~~-------------~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~--L~~~ 579 (594)
..+.+ +.. ....+.....+.+++.+||+.+|++|||+.|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000 000 00011234668999999999999999999999874 5543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.99 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=196.2
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC------
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------ 375 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 375 (594)
..++|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3567888999999999999999764 6899999998642 233345677899999999999999999987543
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
...++|+||+. ++|.+.+... +++..+..++.|++.||+|||. .+++||||||+||+++.++.++|+|||++.
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 34689999995 5888887543 8899999999999999999995 599999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-hH--------HHHHH--
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-NI--------VGWLN-- 524 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~--------~~~~~-- 524 (594)
....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... .+ ..+..
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 6544322 22345788999999999999999999999999999999999998653221100 00 00000
Q ss_pred -----HHhcccc------cccccCCCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 525 -----FLISEDR------QREIIDPNC-----EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 525 -----~~~~~~~------~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....... ....+.... ..........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000000 000000000 0011234566889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=285.72 Aligned_cols=255 Identities=21% Similarity=0.256 Sum_probs=182.0
Q ss_pred cCCCccceeeeecceEEEEEEecCC----cEEEEEeecccchhh-----------HHHHHHHHHHHhhCCCCeeeeeeeE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDG----NVFALKRIDKLNEGF-----------DRFFERELEILGSIKHRYLVNLRGY 371 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~ 371 (594)
++|.+.+.||+|+||.||+|...++ ..+|+|......... ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4688889999999999999987654 455666443222111 0112233344566789999999987
Q ss_pred EeCCC----ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEE
Q 007668 372 CNSPT----SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEAR 447 (594)
Q Consensus 372 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~ 447 (594)
+.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEE
Confidence 65443 2357777763 366666543 2346788899999999999999995 5999999999999999999999
Q ss_pred EeecccccccccCCce------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchH--
Q 007668 448 VSDFGLAKLLEDEESH------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI-- 519 (594)
Q Consensus 448 l~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-- 519 (594)
|+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999999876432211 11234699999999999999999999999999999999999999976422111000
Q ss_pred -HHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007668 520 -VGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 520 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~ 577 (594)
.++........ . . ....+..+.+++..|++.+|++||+++++++.++
T Consensus 247 ~~~~~~~~~~~~----~---~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFIKRLHEGK----I---K----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhhhhh----h---c----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111111100 0 0 1122467899999999999999999999998874
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=279.15 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=190.7
Q ss_pred HHHHHhcCCCcccee--eeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCC
Q 007668 301 DIIKKLETLDDDHII--GSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (594)
Q Consensus 301 ~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 376 (594)
++....+.|+..+.+ |+|+||.||++... ++..+|+|.+....... .|+.....+ +|||++++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344445666666666 99999999998754 67889999876532211 122222222 7999999999999999
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeeccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAK 455 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~ 455 (594)
..++||||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++||||+|+||+++.++ .++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 999999999999999999764 379999999999999999999995 5899999999999999888 99999999987
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
...... ...|+..|+|||++.+..++.++||||+|+++|||++|+.||.....+ ......+.... . .
T Consensus 159 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~----~-- 225 (267)
T PHA03390 159 IIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-Q----K-- 225 (267)
T ss_pred ecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-c----c--
Confidence 654322 235789999999999889999999999999999999999999743221 11112221111 0 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPT-MHRVVQ 574 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~ 574 (594)
........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 ----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00112245567999999999999999996 688763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=287.02 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=196.3
Q ss_pred CCCccceeeeecceEEEEEEe----cCCcEEEEEeecccc----hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCce
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 378 (594)
+|+..+.||+|+||.||++.. .+|..||+|++.... ....+.+.+|++++.++ +|+||+++.+.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999875 368899999987532 22346688899999999 599999999999988889
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999999764 568899999999999999999995 599999999999999999999999999998765
Q ss_pred cCCceeeeeeecccCccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSG--RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
...........|+..|+|||.+.+. ..+.++||||||+++|+|++|..||...... ..............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~------ 228 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE------ 228 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC------
Confidence 4433333345689999999998753 4678999999999999999999998642111 11111111111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
...+......+.+++.+|++.+|++|| ++++++.
T Consensus 229 ----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111223446788999999999999997 5566543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=280.88 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=195.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-----chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--Cce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 378 (594)
++|...+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46788899999999999999764 5899999987431 223345788999999999999999999998654 457
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 8999999999999998753 458899999999999999999995 499999999999999999999999999998654
Q ss_pred cCCc--eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 459 DEES--HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 459 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
.... .......|+..|+|||.+.+...+.++|+||||+++|++++|+.||....... . ...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~-~~~~~~-~~----- 225 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-----A-IFKIAT-QP----- 225 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-----H-HHHHHc-CC-----
Confidence 2111 11123458899999999988889999999999999999999999986532110 0 000000 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+......+.+++.+|++ +|..||++.++++
T Consensus 226 --~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111233455779999999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=288.40 Aligned_cols=261 Identities=20% Similarity=0.282 Sum_probs=192.2
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCc-----
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTS----- 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~----- 377 (594)
++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35788899999999999999765 68999999876532 223456888999999995 6999999999876665
Q ss_pred eEEEEEccCCCchhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-CCcEEEeecc
Q 007668 378 KLLIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFG 452 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~~l~Dfg 452 (594)
.++||||+++ +|.+++... ...+++..+..++.||+.||.|||+ .+++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 788887643 2358999999999999999999995 59999999999999998 8899999999
Q ss_pred cccccccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc-
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED- 530 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 530 (594)
++..+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........ ............
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCCh
Confidence 98765432211 122346889999998765 4578999999999999999999999865321110 000000000000
Q ss_pred -cccccc-------CCCC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 -RQREII-------DPNC-----EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 -~~~~~~-------~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...... -+.. ....+.....+.+++.+||+.+|++||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000 0011224467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=282.53 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=193.7
Q ss_pred CCccceeeeecceEEEEEEecC-CcEEEEEeecccc--hhhHHHHHHHHHHHhhC---CCCeeeeeeeEEeCCCc-----
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN--EGFDRFFERELEILGSI---KHRYLVNLRGYCNSPTS----- 377 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~----- 377 (594)
|+..+.||+|+||.||+|..+. ++.||+|++.... ......+.+|+.++.++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567899999999999998764 8999999997432 22234566788777665 69999999999987776
Q ss_pred eEEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
.+++|||+. ++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 899999996 58988887543 358999999999999999999995 5999999999999999999999999999977
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc-----
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR----- 531 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 531 (594)
....... ....++..|+|||.+.+..++.++||||||+++|||++|..||......+. .............
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcCC
Confidence 6443221 223478899999999988999999999999999999999999875332211 1111110000000
Q ss_pred --------cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 --------QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 --------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...................+.+++.+||+.||++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000011112234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=285.43 Aligned_cols=245 Identities=24% Similarity=0.366 Sum_probs=201.8
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
+.|+.-++||+|+||.||-.+.+ +|+.+|.|++.+. ......-...|.+++.+++.+.||.+--.++..+.+++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 46778899999999999987655 5888999988642 2223445778999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
..|.||+|.-+|...+ ..+++...+-.+.+|+.||.+||+ ..||+||+||+|||+|+.|+++|+|.|+|..+....
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999998754 359999999999999999999995 599999999999999999999999999999887655
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.. ...+||.+|||||++..+.|+...|-||+||++|||+.|+.||....+.. ..+.....+.....
T Consensus 342 ~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------k~eEvdrr~~~~~~ 407 (591)
T KOG0986|consen 342 PI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------KREEVDRRTLEDPE 407 (591)
T ss_pred cc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------hHHHHHHHHhcchh
Confidence 43 33479999999999999999999999999999999999999997532211 11111111111222
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPT 568 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs 568 (594)
.++...+.+..++....|+.||++|..
T Consensus 408 ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 408 EYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hcccccCHHHHHHHHHHHccCHHHhcc
Confidence 355667788899999999999999984
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=287.30 Aligned_cols=245 Identities=26% Similarity=0.402 Sum_probs=194.2
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.|+..+.||+|+||.||+|... ++..+|+|.+... .......+.+|+++++.++|+|++++.+++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3566688999999999999765 5788999988642 22334567889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+. |++.+.+......+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++++|||++.......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 169 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-- 169 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCcc--
Confidence 996 68888876656678999999999999999999995 599999999999999999999999999987654322
Q ss_pred eeeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
...|+..|+|||.+. .+.++.++||||||+++|+|++|+.|+....... ...... .... +..
T Consensus 170 ---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~-~~~~-----~~~ 234 (308)
T cd06634 170 ---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QNES-----PAL 234 (308)
T ss_pred ---cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHh-hcCC-----CCc
Confidence 235788999999874 3567889999999999999999999975432110 001111 0000 000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
........+.+++.+||+.+|++||++.++++.
T Consensus 235 --~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred --CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 122344678899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.02 Aligned_cols=265 Identities=20% Similarity=0.244 Sum_probs=186.8
Q ss_pred hcCCCccceeeeecceEEEEEEecC--CcEEEEEe--------------ec---ccchhhHHHHHHHHHHHhhCCCCeee
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD--GNVFALKR--------------ID---KLNEGFDRFFERELEILGSIKHRYLV 366 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~niv 366 (594)
.++|...+.||+|+||+||++..+. +...++|. +. .........+.+|++++.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999986542 22222221 10 11222345688999999999999999
Q ss_pred eeeeEEeCCCceEEEEEccCCCchhhhhhhc----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC
Q 007668 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442 (594)
Q Consensus 367 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 442 (594)
++++++......++|++++ .++|.+++... ...........++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 9999999999999999998 45777776532 1223456677899999999999995 59999999999999999
Q ss_pred CCcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCC-CCcchhcccchHHH
Q 007668 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP-TDASFIEKGLNIVG 521 (594)
Q Consensus 443 ~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p-~~~~~~~~~~~~~~ 521 (594)
++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|..+ +..........+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999987765443333446799999999999999999999999999999999998754 33221111111111
Q ss_pred HHHHHh-ccccc-------ccc-----cCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 522 WLNFLI-SEDRQ-------REI-----IDPNCEGVQ-----SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 522 ~~~~~~-~~~~~-------~~~-----~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...... ..+.. ... ++....... ......+.+++.+||+.||++|||+.|+++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 110000 00000 000 000000000 012245678899999999999999999985
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=277.75 Aligned_cols=245 Identities=25% Similarity=0.330 Sum_probs=190.4
Q ss_pred ceeeeecceEEEEEEec-CCcEEEEEeecccch---hhHHHHHHHHHH-HhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEI-LGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999764 588999999875322 112334445444 4455899999999999999999999999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
++|.++++.. ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++..... ...
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999999753 468999999999999999999995 5999999999999999999999999998875433 122
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..|+..|+|||.+.+..++.++||||||+++|||++|..||....... ......... .. .. .......
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~--~~---~~~~~~~ 220 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRR-IN--WP---EEVKEFC 220 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcc-cC--CC---CcccccC
Confidence 457889999999988888999999999999999999999986532211 111111000 00 00 0111234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 548 LDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 548 ~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 5678999999999999999988877776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=311.80 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=187.7
Q ss_pred HHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-----
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP----- 375 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 375 (594)
.+-..+|...++||+||||.|||++.+ ||+.||||++.-. +......+.+|+..+++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 344567888899999999999999876 8999999999743 344456788999999999999999876443110
Q ss_pred --------------------------------------------------------------------------------
Q 007668 376 -------------------------------------------------------------------------------- 375 (594)
Q Consensus 376 -------------------------------------------------------------------------------- 375 (594)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhh
Q 007668 376 ----------------------------------TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421 (594)
Q Consensus 376 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH 421 (594)
...|+=||||+...+.++++.+...-.....++++++|++||+|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1125668888888888887653221146778899999999999999
Q ss_pred hcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc------c-----------CCceeeeeeecccCccCccccccC-
Q 007668 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE------D-----------EESHITTIVAGTFGYLAPEYMQSG- 483 (594)
Q Consensus 422 ~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~- 483 (594)
+ +|+|||||||.||++++++.+||+|||+++... . ......+..+||.-|+|||++.+.
T Consensus 715 ~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 D---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred h---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 5 599999999999999999999999999998721 0 011123456899999999998764
Q ss_pred --CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccC
Q 007668 484 --RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSS 561 (594)
Q Consensus 484 --~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 561 (594)
.|+.|+|+||+|+|++||+. ||....+. +..+.. ++...-|..+.+.......=.++|.+|++.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-----a~iL~~------LR~g~iP~~~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-----ASILTN------LRKGSIPEPADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHH-----HHHHHh------cccCCCCCCcccccccchHHHHHHHHHhcC
Confidence 49999999999999999997 56543221 111111 111100111122333334456899999999
Q ss_pred CCCCCCCHHHHHH
Q 007668 562 SPDDRPTMHRVVQ 574 (594)
Q Consensus 562 dP~~RPs~~ev~~ 574 (594)
||.+|||+.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=292.95 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=199.8
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC-----ceE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-----SKL 379 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 379 (594)
+|+..+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|+++++.++||||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677899999999999999876 48999999987643 344567899999999999999999999987765 789
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+|+||++ ++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999997 5888888653 479999999999999999999994 5999999999999999999999999999987654
Q ss_pred CCc--eeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH-HHHHH----H---hc
Q 007668 460 EES--HITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV-GWLNF----L---IS 528 (594)
Q Consensus 460 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-~~~~~----~---~~ 528 (594)
... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+..... ..... . ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 431 112334578899999999887 7899999999999999999999999764322110000 00000 0 00
Q ss_pred ccccccccC-------CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 EDRQREIID-------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ~~~~~~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......+. ..+.......+..+.+++.+||+.+|++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000000000 0000111224567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=290.34 Aligned_cols=265 Identities=25% Similarity=0.309 Sum_probs=194.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC------
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------ 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 376 (594)
.++|+..+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 568889999999999999999765 58899999886432 222346778999999999999999999875433
Q ss_pred --ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 377 --SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 377 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
..++|+||++. ++...+......+++..+..++.|+++||+|||. .+++|+||||+||++++++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 35899999964 7777776656679999999999999999999994 59999999999999999999999999999
Q ss_pred cccccCCce----------eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHH
Q 007668 455 KLLEDEESH----------ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWL 523 (594)
Q Consensus 455 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 523 (594)
......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 765432211 1123457888999998765 45789999999999999999999998754322111100000
Q ss_pred ----------HHHhcccccccccCCCCCC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 524 ----------NFLISEDRQREIIDPNCEG----VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 524 ----------~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.................+. ........+.+++.+|++.+|++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000000001100 01122356889999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=264.23 Aligned_cols=251 Identities=24% Similarity=0.424 Sum_probs=198.5
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+++.....||.|..|.|+++..+ .|..+|||.+.+. +....+.+...++++.+- .+|+||+.+|||..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34445578999999999999766 4889999999863 444566778888887665 48999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
.| ..-+..+++.-.+.+++.-+-++...+..||.||.+ +.+|+|||+||+|||+|+.|++|++|||++-++.+..
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-- 246 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-- 246 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc--
Confidence 98 445666666556678888888999999999999998 4699999999999999999999999999998776543
Q ss_pred eeeeeecccCccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQS---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
..+..+|-+.|||||.+.- ..|+.++||||||+.++||.||+.||..-..+ ...+..++.++. |.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkvln~eP------P~L 315 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKVLNEEP------PLL 315 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHHHhcCC------CCC
Confidence 3444578999999999864 36888999999999999999999999763221 111222222211 222
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
++ ....+..+.+++..||++|+.+||.+.++++
T Consensus 316 ~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 PG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred Cc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 21 2236788999999999999999999998875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=285.16 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=192.6
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
|...+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++|||++++.+++.+....++|+||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999764 68899999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+. |++.+.+......+++..+..++.||+.|++|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence 95 68888887666679999999999999999999995 59999999999999999999999999988643321
Q ss_pred eeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
....|+..|+|||++. .+.++.++||||||+++|||++|..|+...... .......... ....
T Consensus 175 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~-~~~~------ 240 (313)
T cd06633 175 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQND-SPTL------ 240 (313)
T ss_pred -CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-CCCC------
Confidence 2345788999999974 456888999999999999999999998653211 1111111100 0011
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
........+.+++.+|++.+|.+||++.++++
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223356889999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=292.00 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=192.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC------Cc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TS 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 377 (594)
.+|...+.||+|+||.||+|... +|+.||+|++... .......+.+|+++++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 67888899999999999999764 6899999998652 222345678899999999999999999988644 34
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++|+||+.. +|.+.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 95 ~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 5899999964 666654 2458999999999999999999995 59999999999999999999999999998764
Q ss_pred ccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHH---------HHHHh
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGW---------LNFLI 527 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~---------~~~~~ 527 (594)
.... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ....
T Consensus 168 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (342)
T cd07879 168 DAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL- 242 (342)
T ss_pred CCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh-
Confidence 3321 22356889999999876 4688999999999999999999999976432111000000 0000
Q ss_pred ccccc-------ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhcc
Q 007668 528 SEDRQ-------REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILESE 579 (594)
Q Consensus 528 ~~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~~ 579 (594)
..... .......+....+.....+.+++.+||+.||++||+++|++. .++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 000000000011123456889999999999999999999984 35543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=281.28 Aligned_cols=241 Identities=24% Similarity=0.374 Sum_probs=186.1
Q ss_pred eeeeecceEEEEEEec-CCcEEEEEeecccch---hhHHHHHHHHH---HHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 314 IIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELE---ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
.||+|+||.||++... +++.||+|.+..... .....+..|.. .++...||+|+++.+++.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 588999998865321 11222333433 4445689999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+|+|.+++.. ...+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.++|+|||++........ .
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 9999998865 4569999999999999999999995 5999999999999999999999999999876543221 2
Q ss_pred eeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........... .... ...+.. .+.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~------~~~~~~---~~~ 220 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT------LTMAVE---LPD 220 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHh------hccCCC---CCC
Confidence 34689999999998754 688999999999999999999999976422111000 0000 001111 122
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+..+.+++.+|+..+|++|| ++.++++
T Consensus 221 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2356799999999999999999 8999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=293.18 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=195.6
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-----Cce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 378 (594)
.+|...+.||+|+||.||++... ++..||+|.+... .......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 46788899999999999999754 6899999998753 222345677899999999999999999987543 347
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 85 YIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 99999995 688888865 3569999999999999999999995 599999999999999999999999999998664
Q ss_pred cCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH-HH--------HHHHhc
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV-GW--------LNFLIS 528 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-~~--------~~~~~~ 528 (594)
... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ .. ......
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 432 12233457889999998765 46889999999999999999999998653211100000 00 000000
Q ss_pred cc------ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 529 ED------RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 529 ~~------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
.. ......++.........+..+.+++.+||+.+|++|||++|+++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00 000000011111112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=293.57 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=195.8
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC----CCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 379 (594)
++|+..+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++.+++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888899999999999999754 68999999987532 2335667889999999999999999988753 34578
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+|+||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 85 lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999995 6899988653 459999999999999999999995 5999999999999999999999999999976543
Q ss_pred CCce---eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc-------
Q 007668 460 EESH---ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS------- 528 (594)
Q Consensus 460 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 528 (594)
.... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~~~~~ 236 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPSEEVL 236 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCChhHhh
Confidence 2211 1123468899999998765 46889999999999999999999999654221110 00000000
Q ss_pred ----ccccccc---cCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 ----EDRQREI---IDPN----CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ----~~~~~~~---~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....... .... +.......+..+.+++.+|++.+|++|||+++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000 0000 00011234577999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=287.31 Aligned_cols=257 Identities=21% Similarity=0.329 Sum_probs=190.0
Q ss_pred ceeeee--cceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSG--GFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
..||+| +||+||++... +|+.||+|.+... .....+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999764 7899999998643 233346788999999999999999999999999999999999999
Q ss_pred Cchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee--
Q 007668 388 GSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI-- 464 (594)
Q Consensus 388 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~-- 464 (594)
+++.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998754 2458999999999999999999994 599999999999999999999999998654332111100
Q ss_pred ----eeeeecccCccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHH-------------
Q 007668 465 ----TTIVAGTFGYLAPEYMQSG--RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNF------------- 525 (594)
Q Consensus 465 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~------------- 525 (594)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||........ .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccch
Confidence 0112345679999998763 478999999999999999999999975422110 0000000
Q ss_pred -------------------HhcccccccccCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 526 -------------------LISEDRQREIIDPNCE-GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 526 -------------------~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...........+..+. .........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000000000001111 112345677999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=290.69 Aligned_cols=247 Identities=22% Similarity=0.348 Sum_probs=204.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
+..|.+...||+|.|+.|..|.+. ++..||+|.+.+. +......+.+|+++|..++|||||+++.+...+...|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456778899999999999999655 5899999999863 3334455899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||..+|.+.+++..++. ..+.....++.|+.+|++|||. ..|||||||++|||++.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc--
Confidence 99999999999987654 4448888999999999999995 59999999999999999999999999999988743
Q ss_pred eeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
......+|++.|.|||++.+..+ ++++|+||+|+++|-|+.|..||++....... +...... -
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~rvl~gk-----~ 272 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PRVLRGK-----Y 272 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------chheeee-----e
Confidence 33456789999999999998765 78999999999999999999999874322110 0000000 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+.-.+.++.+++++++-.+|.+|++++++..
T Consensus 273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 122233456889999999999999999999875
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=284.74 Aligned_cols=257 Identities=18% Similarity=0.250 Sum_probs=190.4
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCc
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+....+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455566666666554 6899999998753 33445679999999999999999999999999999999999999999
Q ss_pred hhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc------
Q 007668 390 LDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES------ 462 (594)
Q Consensus 390 L~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~------ 462 (594)
|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999854 3458899999999999999999995 4999999999999999999999999998875432211
Q ss_pred eeeeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHH----hccc------
Q 007668 463 HITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL----ISED------ 530 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~------ 530 (594)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ......... ....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhc
Confidence 01122346788999999875 357899999999999999999999987532110 000000000 0000
Q ss_pred -cccc----ccCCC-----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 -RQRE----IIDPN-----CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 -~~~~----~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ..++. ...........+.+++.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 00000 00122344567889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=280.40 Aligned_cols=260 Identities=21% Similarity=0.322 Sum_probs=195.3
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeecccch-hhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEEcc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-GFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
|...+.||+|++|+||+|... +++.||+|++..... .......+|+..+.+++ |||++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999876 478899999875322 22334567899999999 999999999999999999999999
Q ss_pred CCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+|+|.+.+.... ..+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999887653 468999999999999999999995 4999999999999999999999999999986543322
Q ss_pred eeeeecccCccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccch----------HHHHHHHHhcccccc
Q 007668 465 TTIVAGTFGYLAPEYMQ-SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN----------IVGWLNFLISEDRQR 533 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~----------~~~~~~~~~~~~~~~ 533 (594)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||......+... ...|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 12245788999999875 4457899999999999999999999986542211100 000111110001111
Q ss_pred cccCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 534 EIIDPNC----EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 534 ~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+.... ..........+.+++.+|++.+|++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1111000 0011122467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=284.47 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=200.4
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv 381 (594)
++|...+.||+|+||.||++... ++..||+|.+... .....+.+.+|++++.+++ ||||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 35778899999999999999765 6899999988652 2334567888999999998 99999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999999764 479999999999999999999995 599999999999999999999999999988665432
Q ss_pred c-------------------eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHH
Q 007668 462 S-------------------HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGW 522 (594)
Q Consensus 462 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~ 522 (594)
. .......|+..|+|||...+...+.++||||+|++++++++|+.||...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~ 230 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------LT 230 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------HH
Confidence 1 1223346789999999998888999999999999999999999998754211 00
Q ss_pred HHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHH
Q 007668 523 LNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTM----HRVV 573 (594)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~ev~ 573 (594)
...... ... ..+......+.+++.+||+.+|++||++ ++++
T Consensus 231 ~~~~~~---~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 231 FQKILK---LEY-------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHHHHh---cCC-------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 111110 000 1122234678999999999999999999 6655
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=282.05 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=198.3
Q ss_pred CCccceeeeecceEEEEEEecC-CcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
|+..+.||+|++|.||+|...+ ++.+|+|.+.... ....+.+..|++++++++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999997764 8999999987642 334567888999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
+ ++|.+++......+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++......... .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence 7 58999998755679999999999999999999995 49999999999999999999999999999866543221 2
Q ss_pred eeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-hH---------HHHHHHHhc---ccc
Q 007668 466 TIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-NI---------VGWLNFLIS---EDR 531 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~---------~~~~~~~~~---~~~ 531 (594)
....++..|+|||.+.+. .++.++||||||+++||+++|+.||......... .+ ..|...... ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 223457789999998766 7899999999999999999999998653321110 00 000000000 000
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.............+.....+.+++.+|++.+|++||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000011122567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.81 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=201.2
Q ss_pred hcCCCccceeeeecceEEEEEE-ecCCcEEEEEeecc--cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
+-++.....||.|.||.||-+. ..+|+..|+|-++- .....-....+|+.++..++|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3467778899999999999974 56799999998863 22333456889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
|||++|+|.+.+.- +...++.....+..|++.|++|||++ |||||||||.||+++.+|-+|++|||.|..+.....
T Consensus 1314 EyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 99999999999853 45577777788899999999999965 999999999999999999999999999987765432
Q ss_pred ee---eeeeecccCccCccccccC---CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHH-HHhcccccccc
Q 007668 463 HI---TTIVAGTFGYLAPEYMQSG---RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLN-FLISEDRQREI 535 (594)
Q Consensus 463 ~~---~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 535 (594)
.. .....||+.|||||++.+. .-..+.||||+|||+.||+||++||.....+ |.- +.+..+
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~g----- 1457 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAG----- 1457 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhcc-----
Confidence 21 2346799999999999764 3466899999999999999999998653222 111 111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..++..+.+=.+++..|+..||++|.++.|+++
T Consensus 1458 ---h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1458 ---HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ---CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 223344556777889999999999999988886654
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=278.66 Aligned_cols=247 Identities=21% Similarity=0.356 Sum_probs=194.0
Q ss_pred CCCccceeeeecceEEEEEEecC-CcEEEEEeeccc-----chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
+|...+.||+|+||.||++.... +..+++|.++.. .......+..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778999999999999987654 444556655431 222334577899999999999999999999999999999
Q ss_pred EEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 382 YDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
+||+++++|.+.+.. ....+++..+..++.|++.||.|||+ .+++|+||+|+||++++ +.++++|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 34569999999999999999999995 59999999999999975 569999999987654
Q ss_pred cCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... ......|++.|+|||...+..++.++|+||||+++|+|++|..|+..... ........ ..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~---------~~ 220 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV---------EG 220 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH---------cC
Confidence 3322 22334578899999999888889999999999999999999999864321 11111111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+...+..+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111223445578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.48 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=193.0
Q ss_pred CCC-ccceeeeecceEEEEEEec-CCcEEEEEeecccchhh--------------HHHHHHHHHHHhhCCCCeeeeeeeE
Q 007668 308 TLD-DDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGF--------------DRFFERELEILGSIKHRYLVNLRGY 371 (594)
Q Consensus 308 ~~~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g~ 371 (594)
+|. ..+.||+|+||.||+|... +++.||+|.++...... ...+.+|++++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 443 3577999999999999755 68999999886432211 1247789999999999999999999
Q ss_pred EeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 372 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
+......++||||++ |+|.+++.. ...+++.....++.|++.||+|||+ .+++||||+|+||+++.++.++++||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCc
Confidence 999999999999996 689988864 3568999999999999999999994 59999999999999999999999999
Q ss_pred ccccccccCC-------------ceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccc
Q 007668 452 GLAKLLEDEE-------------SHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517 (594)
Q Consensus 452 gl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 517 (594)
|++....... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||......+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~- 242 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ- 242 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9997654111 0111223467889999998764 468999999999999999999999875432211
Q ss_pred hHHHHHHHHhccccc---------------ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 518 NIVGWLNFLISEDRQ---------------REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 518 ~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+......... .....+............+.+++.+|++.+|++|||++|++.
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 --LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred --HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111000000000 000000001111223466889999999999999999999986
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=285.69 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=196.3
Q ss_pred HHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-CCce
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSK 378 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 378 (594)
....++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|++++.+++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345678999999999999999999654 7899999988642 22334667889999999999999999998865 5578
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||+ +++|.++++. ..+++.....++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++....
T Consensus 86 ~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 8999998 5689888764 457888889999999999999994 599999999999999999999999999987543
Q ss_pred cCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchH---------HHHHHHHhc
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI---------VGWLNFLIS 528 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~---------~~~~~~~~~ 528 (594)
... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... .++......
T Consensus 160 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 160 PQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred CCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 221 22356889999998765 5689999999999999999999999865432111000 011111111
Q ss_pred ccccccccCCCC-CC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 529 EDRQREIIDPNC-EG-----VQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 529 ~~~~~~~~~~~~-~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
............ .. ........+.+++.+|++.+|++|||+++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 100000000000 00 011234678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=269.57 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=198.2
Q ss_pred HhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccch---hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
..++|+..++||+|.||+|..++- ..++.+|+|++++... .....-..|-+++...+||.+..+.-.|...+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 357888899999999999999854 4689999999987422 223445668899999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||..||.|.-++.. ...+++....-.-..|..||.||| +.+||.||+|.+|.|+|.||++||+|||+++.--..
T Consensus 246 VMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999999975 456888888888999999999999 569999999999999999999999999999854332
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
...+.+++|||.|+|||++....|+.++|-|.+|||+|||++|+.||....-+....++ --.-
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI----------------l~ed 384 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI----------------LMED 384 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH----------------Hhhh
Confidence 23456789999999999999999999999999999999999999999763222111111 0000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPT 568 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs 568 (594)
...+...+++...|+...+.+||.+|..
T Consensus 385 ~kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 385 LKFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred ccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 1133344566788899999999999983
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=286.72 Aligned_cols=265 Identities=25% Similarity=0.340 Sum_probs=196.0
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-
Q 007668 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSP- 375 (594)
Q Consensus 300 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~- 375 (594)
.++....++|...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++.+++||||+++.+++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45556678999999999999999999965 568999999987532 22345678899999999999999999987532
Q ss_pred -----CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEee
Q 007668 376 -----TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (594)
Q Consensus 376 -----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~D 450 (594)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEec
Confidence 3457788876 7899888764 358999999999999999999995 5999999999999999999999999
Q ss_pred cccccccccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccch-HHHH------
Q 007668 451 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN-IVGW------ 522 (594)
Q Consensus 451 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~~------ 522 (594)
||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... +...
T Consensus 164 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 164 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred cccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9998764332 223457889999998865 568889999999999999999999986532211100 0000
Q ss_pred -HHHHhccccc-------ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 523 -LNFLISEDRQ-------REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 523 -~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......... ..................+.+++.+|++.||++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000000 000000000001123456889999999999999999999885
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=262.39 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=201.4
Q ss_pred CHHHHHHHhcCCCccceeeeecceEEEEE-EecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCC
Q 007668 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKL-AMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSP 375 (594)
Q Consensus 298 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 375 (594)
.++++.+-++ +.||+|+|+.|-.. ...+|..+|||++.+........+.+|++++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3566666654 78999999999875 56789999999998876666778899999999985 99999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc---EEEeecc
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFG 452 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~~l~Dfg 452 (594)
..+|||||-|.||.|..+++++ ..+++.+..++.++|+.||.+|| .+||.|||+||+|||...... +||+||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 9999999999999999999874 67999999999999999999999 569999999999999975544 7999998
Q ss_pred cccccc--cCCce----eeeeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhc-ccch--
Q 007668 453 LAKLLE--DEESH----ITTIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIE-KGLN-- 518 (594)
Q Consensus 453 l~~~~~--~~~~~----~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~-~~~~-- 518 (594)
+..-.. .+-+. ...+.+|+..|||||+.. .-.|+.+.|.||+|||+|-|++|.+||.+.=.. .+.+
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG 304 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG 304 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence 875432 22111 123457889999999763 235788999999999999999999999764221 1110
Q ss_pred ----HHHHHH-HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 519 ----IVGWLN-FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 519 ----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+-.- ..+.++ ..+..|.. -...+.+..+++...+..||..|.++.++++
T Consensus 305 e~Cr~CQ~~LFesIQEG-kYeFPdkd----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 305 EVCRVCQNKLFESIQEG-KYEFPDKD----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccHHHHHHHHHHHhcc-CCcCChhh----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000000 001111 11111111 1244566788999999999999999998886
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=284.30 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=190.3
Q ss_pred CCCccceeeeecceEEEEEEecC---CcEEEEEeeccc--chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeC----CCc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD---GNVFALKRIDKL--NEGFDRFFERELEILGSI-KHRYLVNLRGYCNS----PTS 377 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~ 377 (594)
+|+..+.||+|+||.||++.... +..||+|++... .....+.+.+|++++.++ +||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 36677899999999999997653 678999988742 222345678899999999 59999999987532 245
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++++||++ ++|.+.+.. ...+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 678889885 689888864 4568999999999999999999995 59999999999999999999999999999865
Q ss_pred ccCCce---eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchH---------HHHHH
Q 007668 458 EDEESH---ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI---------VGWLN 524 (594)
Q Consensus 458 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~---------~~~~~ 524 (594)
...... ......|+..|+|||...+ ..++.++||||+|+++|++++|+.||........... ..+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 1123468999999998765 4689999999999999999999999875332110000 00000
Q ss_pred HHhcccc------cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 525 FLISEDR------QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 525 ~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....... ...................+.+++.+|++.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0000000001111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=285.37 Aligned_cols=264 Identities=26% Similarity=0.361 Sum_probs=195.8
Q ss_pred HhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC-----
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----- 376 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 376 (594)
..++|+..+.||+|+||.||++.. .++..||||++... .......+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 356788899999999999999964 46899999998642 2233456889999999999999999999886543
Q ss_pred -ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 377 -SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 377 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.++++|||++.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 358999999 7789888764 468999999999999999999995 599999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhccc-chH--------HHHHHH
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG-LNI--------VGWLNF 525 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-~~~--------~~~~~~ 525 (594)
...... ....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||........ ... ..+...
T Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 167 QTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 654322 22357889999999875 4588999999999999999999999875321100 000 000000
Q ss_pred Hhcccc------cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhc
Q 007668 526 LISEDR------QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILES 578 (594)
Q Consensus 526 ~~~~~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~ 578 (594)
...... ...................+.+++.+|++.||++|||+.+++. .++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 000000 0000000000011223456889999999999999999999983 4444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=288.07 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=191.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC----------
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP---------- 375 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---------- 375 (594)
.+|...+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 46788899999999999999764 5889999998765555567788999999999999999999776443
Q ss_pred ----CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEee
Q 007668 376 ----TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSD 450 (594)
Q Consensus 376 ----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~D 450 (594)
...++|+||++ ++|.+++.. ..+++..+..++.||+.||.|||+ .+++||||||+||+++ +++.++++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECC
Confidence 34689999996 588888753 458999999999999999999995 4999999999999997 556789999
Q ss_pred cccccccccCCce--eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHH------
Q 007668 451 FGLAKLLEDEESH--ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVG------ 521 (594)
Q Consensus 451 fgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~------ 521 (594)
||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999765432111 1122357889999998654 567889999999999999999999997543211100000
Q ss_pred ---HHHHHhcc--cccc-cccCCC--CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 522 ---WLNFLISE--DRQR-EIIDPN--CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 522 ---~~~~~~~~--~~~~-~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
........ .... ....+. ..........++.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000 0000 000000 00011123466889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=270.90 Aligned_cols=236 Identities=28% Similarity=0.376 Sum_probs=192.0
Q ss_pred eeeecceEEEEEEec-CCcEEEEEeecccch---hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 315 IGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 315 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
||+|+||.||++... +++.+|+|.+..... .....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999765 488999999875322 2355788999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeec
Q 007668 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470 (594)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~g 470 (594)
.+++... ..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCG 155 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcC
Confidence 9999754 468999999999999999999995 5999999999999999999999999999986644321 1233457
Q ss_pred ccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHH
Q 007668 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDA 550 (594)
Q Consensus 471 t~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (594)
+..|+|||...+...+.++|+||||+++|++++|+.||..... ......... . .. ..+......
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~--~~-------~~~~~~~~~ 219 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-D--PL-------RFPEFLSPE 219 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-C--CC-------CCCCCCCHH
Confidence 8899999999888889999999999999999999999965322 111111111 0 00 111222467
Q ss_pred HHHHHHHcccCCCCCCCCHHH
Q 007668 551 LLAVATQCVSSSPDDRPTMHR 571 (594)
Q Consensus 551 l~~l~~~cl~~dP~~RPs~~e 571 (594)
+.+++.+||..||++||++++
T Consensus 220 l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHhcCCHhhCCCccc
Confidence 889999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=264.32 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=169.3
Q ss_pred HHhcCCCccceeeeecceEEEEEEecC-----CcEEEEEeecccch--hhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-C
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNS-P 375 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~ 375 (594)
.....|+....||+|.||.||+|.-.+ ...+|+|+++.... +......+|+..++.++||||+.++.++.+ +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 345678888999999999999994332 23689999986432 334567899999999999999999999866 7
Q ss_pred CceEEEEEccCCCchhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC----CcEE
Q 007668 376 TSKLLIYDFLPGGSLDEALHE----RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN----LEAR 447 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~~ 447 (594)
...++++||.+. +|...++- ....++...+..|++||+.|+.|||++ =|+||||||.|||+..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 788999999965 88888863 235689999999999999999999965 69999999999999877 8999
Q ss_pred EeecccccccccCCce--eeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcc
Q 007668 448 VSDFGLAKLLEDEESH--ITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDAS 511 (594)
Q Consensus 448 l~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~ 511 (594)
|+|||+++.+...-.. ....++-|..|.|||.+.+. .||++.|||+.|||..||+|-.+-|...
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999988754322 22346679999999998774 6999999999999999999987776553
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=287.22 Aligned_cols=259 Identities=26% Similarity=0.372 Sum_probs=193.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc-----
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS----- 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 377 (594)
.++|+..+.||+|++|.||+|... ++..||+|++... .....+.+.+|+.++++++|||++++.+++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 457888899999999999999775 5789999988643 22234567789999999999999999987765544
Q ss_pred -eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 378 -KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 378 -~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||+|+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999998 6799998864 468999999999999999999994 5999999999999999999999999999986
Q ss_pred cccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccch-HHH--------HHHHH
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN-IVG--------WLNFL 526 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~-~~~--------~~~~~ 526 (594)
.... .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||.......... +.. +....
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 5432 223357889999998765 467899999999999999999999986532211000 000 00000
Q ss_pred hcccc------cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 527 ISEDR------QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 527 ~~~~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..... ......+.........+..+.+++.+|++.+|++|||+.||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 0000000000111123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=265.54 Aligned_cols=251 Identities=27% Similarity=0.373 Sum_probs=195.2
Q ss_pred CccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHH-HhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 310 DDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEI-LGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
+....||.|+||+|+|..++ .|+.+|||+++... +..++++..|.+. ++.-++||||+++|.+..++..++.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 34478999999999997654 68999999998643 3567788888886 45557999999999999999999999999
Q ss_pred CCchhhhhh----hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 387 GGSLDEALH----ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 387 ~gsL~~~l~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
..|++.+.. .....+++.-+-.|......||.||.+. ..|+|||+||+|||++..|.+|++|||++..+...-
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 557666543 1345688988889999999999999984 589999999999999999999999999987665432
Q ss_pred eeeeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
..+.-+|-..|||||.+.. ..|+.++||||+|+.|||+.||+.||..... +.+.+..++......-..+.
T Consensus 223 -AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdpp~l~~~~-- 294 (361)
T KOG1006|consen 223 -AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDPPILLFDK-- 294 (361)
T ss_pred -HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCCCeecCcc--
Confidence 2233468889999999864 3488999999999999999999999876321 22222233322221111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+++..+.+++-.|+.+|-+.||.+.++.+
T Consensus 295 --~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 295 --ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 12346678999999999999999999998875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.57 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=211.1
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecc---cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC
Q 007668 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP 375 (594)
Q Consensus 300 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 375 (594)
.++.-..++|.+.++||+|+||.|..++++ .++.||.|++.+ ........|..|-++|..-+.+=|+++.-.|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 344445678999999999999999999775 588999999987 3344467799999999999999999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
..+|+|||||+||+|-.++.+.+ .+++....-++..|.-||..+| +.|+|||||||+|||+|..|++||+|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999998876 8999999999999999999999 5699999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCccccc----c-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQ----S-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
.+..+..-.....+|||.|++||++. + +.|++.+|-||+||++|||+.|..||+... ++.-+......+
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk 297 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHK 297 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchh
Confidence 88877766677788999999999985 2 578999999999999999999999998742 222222222221
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT---MHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ev~~ 574 (594)
..-. ++ .....+....+||.+.+. +|+.|.. ++++..
T Consensus 298 ~~l~-----FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 298 ESLS-----FP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhcC-----CC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1111 11 012245667788887776 7788887 777753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=298.15 Aligned_cols=146 Identities=29% Similarity=0.457 Sum_probs=130.3
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++..++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467888899999999999999776 68899999987532 23346788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
|||+++++|.+++... ..+++..++.++.||+.||+|||. .+|+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999753 468899999999999999999995 499999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=259.37 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=192.4
Q ss_pred hcCCCcc-ceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhh-CCCCeeeeeeeEEe----CCCce
Q 007668 306 LETLDDD-HIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGS-IKHRYLVNLRGYCN----SPTSK 378 (594)
Q Consensus 306 ~~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~----~~~~~ 378 (594)
+++|++. ++||-|-.|.|..... .+|+.+|+|++.... ...+|++..-. -.|||||++++++. ....+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455443 6799999999998754 468999999887532 35678876433 36999999999874 45667
Q ss_pred EEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec---CCCcEEEeecccc
Q 007668 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLA 454 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~~l~Dfgl~ 454 (594)
++|||+|+||.|...+++++ ..+++.+.-.|+.||+.|+.||| +..|.||||||+|+|.+ .+-.+||+|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccc
Confidence 89999999999999998764 45999999999999999999999 56999999999999997 3456899999999
Q ss_pred cccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
+...... ...+.+-|+.|.|||++....|+...|+||+||++|-|++|.+||...... .+.--.+..+..+. .+
T Consensus 212 K~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gq-y~ 285 (400)
T KOG0604|consen 212 KETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQ-YE 285 (400)
T ss_pred cccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccC-cc
Confidence 8755322 233445699999999999999999999999999999999999999764321 11111111111110 01
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+ +.-...+.+..++|+.+|+.+|.+|.|+.|++.
T Consensus 286 FP~----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 286 FPE----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCC----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111 123456677889999999999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=237.06 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=198.2
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecc--cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+|..-++||+|.||+||||+.+ +++.||+|+++- .+++......+|+-+++.++|+|||++++..+.+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3455678999999999999765 478899999864 4555667789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+ ..+|..+...-.+.++.+....++.|+++||.++| +..+.|||+||+|.+++.+|+.|++|||+++.++-...-
T Consensus 83 c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc- 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC- 157 (292)
T ss_pred h-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence 9 55888888777788999999999999999999999 459999999999999999999999999999988754322
Q ss_pred eeeeecccCccCccccccCC-CCccchhhhHHHHHHHHHhCCCC-CCcchhcccchHHHHHHHHhcccccccc---cCC-
Q 007668 465 TTIVAGTFGYLAPEYMQSGR-ATEKTDVYSFGVLVLEVLSGKRP-TDASFIEKGLNIVGWLNFLISEDRQREI---IDP- 538 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~- 538 (594)
....+-|..|.+|.++.+.. |+...|+||.||++.|+.....| |.+...+++...+-|.-....++....+ .|-
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 22234589999999998754 88999999999999999984444 5554333332222222211122111111 110
Q ss_pred ---CCC------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 ---NCE------GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ---~~~------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+ ..-+.....=.+++.+.+.-+|.+|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 000 011112223457888888889999999998775
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=263.28 Aligned_cols=221 Identities=22% Similarity=0.217 Sum_probs=176.5
Q ss_pred ecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhh
Q 007668 318 GGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE 396 (594)
Q Consensus 318 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 396 (594)
|.+|.||++... +++.+|+|++..... +.+|...+....|||++++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999998654 688999999876432 33455555566799999999999999999999999999999999875
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecccCccC
Q 007668 397 RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476 (594)
Q Consensus 397 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~a 476 (594)
. ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++++|||.+....... ....++..|+|
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 4 458999999999999999999995 599999999999999999999999999876554321 22345778999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHH
Q 007668 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVAT 556 (594)
Q Consensus 477 PE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 556 (594)
||...+..++.++||||+|+++|||++|..|+....... ...... ..+......+.+++.
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~---~~~~~~~~~~~~li~ 210 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTL---NIPEWVSEEARSLLQ 210 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cccccc---CCcccCCHHHHHHHH
Confidence 999988889999999999999999999998865321100 000000 112233467889999
Q ss_pred HcccCCCCCCCCHHH
Q 007668 557 QCVSSSPDDRPTMHR 571 (594)
Q Consensus 557 ~cl~~dP~~RPs~~e 571 (594)
+|++.||++||++.+
T Consensus 211 ~~l~~dp~~R~~~~~ 225 (237)
T cd05576 211 QLLQFNPTERLGAGV 225 (237)
T ss_pred HHccCCHHHhcCCCc
Confidence 999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=257.98 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=204.1
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEecC------CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEe
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCN 373 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 373 (594)
++....++++...++-+|.||.||+|.+++ .+.|.||.++.. ++-....+..|.-.+....|||+.++.+++.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 333444567777889999999999996654 445677877653 3333456778888888899999999999985
Q ss_pred C-CCceEEEEEccCCCchhhhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 374 S-PTSKLLIYDFLPGGSLDEALHE-------RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 374 ~-~~~~~lv~e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
+ ....+.+|.++.-|+|..++.. ..+.++..+...++.|++.|++||| +.+|||.||.++|++|++..+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence 4 5567889999999999999982 2345778889999999999999999 459999999999999999999
Q ss_pred EEEeecccccccccCCceee-eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHH
Q 007668 446 ARVSDFGLAKLLEDEESHIT-TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWL 523 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 523 (594)
+||+|=.+++..-+.+.+-. ..--.+..||+||.+....|+.++||||||+++|||+| |+.||..-.. ....
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------fEm~ 508 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------FEME 508 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------HHHH
Confidence 99999999987655443221 11224679999999999999999999999999999999 9999854322 2223
Q ss_pred HHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 524 NFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
.+.....+..+ +.+++.+++.++.-||..+|++||++++++.-|.+
T Consensus 509 ~ylkdGyRlaQ---------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 509 HYLKDGYRLAQ---------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHhccceecC---------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 33333443333 33455789999999999999999999999988764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=290.29 Aligned_cols=260 Identities=17% Similarity=0.238 Sum_probs=171.4
Q ss_pred HhcCCCccceeeeecceEEEEEEecC-----CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeE------Ee
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY------CN 373 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~ 373 (594)
..++|...+.||+|+||.||+|.+.+ +..||+|++...... +....| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45788999999999999999998754 689999987653221 111111 1112222222222211 24
Q ss_pred CCCceEEEEEccCCCchhhhhhhcCCC-------------------CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCC
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHERSEQ-------------------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIK 434 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 434 (594)
.....++|+||+++++|.++++..... .....+..++.||+.||+|||+ .+|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 567789999999999999998753211 1223456799999999999995 599999999
Q ss_pred CCCeEecC-CCcEEEeecccccccccCCceeeeeeecccCccCccccccC----------------------CCCccchh
Q 007668 435 SSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG----------------------RATEKTDV 491 (594)
Q Consensus 435 ~~NIll~~-~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 491 (594)
|+|||++. ++.+||+|||+++..............++++|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 67999999999987654444444556789999999965322 23456799
Q ss_pred hhHHHHHHHHHhCCCCCCcchh-------cccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCC
Q 007668 492 YSFGVLVLEVLSGKRPTDASFI-------EKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPD 564 (594)
Q Consensus 492 ~s~G~vl~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 564 (594)
|||||++|||+++..|++.... ..+.+...|........ ..+ ..... ...........+|+.+|++.||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~-~~~~~-~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRA-SPD-LRRGF-EVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcccc-chh-hhhhh-hhccccchHHHHHHHHHccCCcc
Confidence 9999999999998777553211 11112222222111100 000 00000 00011123456899999999999
Q ss_pred CCCCHHHHHH
Q 007668 565 DRPTMHRVVQ 574 (594)
Q Consensus 565 ~RPs~~ev~~ 574 (594)
+|||++|+++
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999986
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=277.90 Aligned_cols=257 Identities=20% Similarity=0.281 Sum_probs=181.0
Q ss_pred hcCCCccceeeeecceEEEEEEe-----------------cCCcEEEEEeecccchhhHHH--------------HHHHH
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-----------------DDGNVFALKRIDKLNEGFDRF--------------FEREL 354 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~ 354 (594)
.++|...++||+|+||.||+|.. .+++.||||++........+. ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999864 245679999987543332222 34467
Q ss_pred HHHhhCCCCee-----eeeeeEEeC--------CCceEEEEEccCCCchhhhhhhcC-----------------------
Q 007668 355 EILGSIKHRYL-----VNLRGYCNS--------PTSKLLIYDFLPGGSLDEALHERS----------------------- 398 (594)
Q Consensus 355 ~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------- 398 (594)
.++.+++|.++ ++++++|.. ....++||||+++++|.++++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 677787743 356799999999999999987421
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecccCccCcc
Q 007668 399 EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478 (594)
Q Consensus 399 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE 478 (594)
..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 124677889999999999999995 59999999999999999999999999999765433222222234588999999
Q ss_pred ccccCCC----------------------CccchhhhHHHHHHHHHhCCC-CCCcchhc------ccchHHHHHHHHhcc
Q 007668 479 YMQSGRA----------------------TEKTDVYSFGVLVLEVLSGKR-PTDASFIE------KGLNIVGWLNFLISE 529 (594)
Q Consensus 479 ~~~~~~~----------------------~~~~Dv~s~G~vl~elltg~~-p~~~~~~~------~~~~~~~~~~~~~~~ 529 (594)
.+..... ..+.||||+||++|+|++|.. |+...... ...+...|.....
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~-- 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG-- 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc--
Confidence 8754321 134799999999999999875 65432111 1111122211100
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSP---DDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~ev~~ 574 (594)
.. .+ +. ..........+++.+++..+| .+|+|++|+++
T Consensus 459 ~~----~~--~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QK----YD--FS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cC----CC--cc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00 00 11 112334668899999999766 68999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=265.27 Aligned_cols=254 Identities=28% Similarity=0.467 Sum_probs=195.0
Q ss_pred CCCccceeeeecceEEEEEE-ecCCcEEEEEeecc---c----chhhHHHHHHHHHHHhhCCCCeeeeeeeEEe-CCCce
Q 007668 308 TLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDK---L----NEGFDRFFERELEILGSIKHRYLVNLRGYCN-SPTSK 378 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~---~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~ 378 (594)
+|-..++||+|+|+.||||. +...+.||||+-.- + .+.+.+...+|.++.+.|+||.||++++|+. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 45566889999999999995 45567788885431 1 1223456788999999999999999999984 56678
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec---CCCcEEEeeccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAK 455 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~~l~Dfgl~~ 455 (594)
+-|+||++|.+|+=+++.+ ..+++.+...|+.||+.||.||.+. +++|+|-||||.|||+- .-|.+||+|||+++
T Consensus 544 CTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 8999999999999998764 5689999999999999999999987 89999999999999995 45789999999999
Q ss_pred ccccCCce------eeeeeecccCccCccccccC----CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHH
Q 007668 456 LLEDEESH------ITTIVAGTFGYLAPEYMQSG----RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNF 525 (594)
Q Consensus 456 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 525 (594)
.+.++... .+...+||..|++||.+.-+ .++.|+||||+|||+|.++.|+.||+......+ +.+. +.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--ILqe-NT 698 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--ILQE-NT 698 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HHhh-hc
Confidence 88654332 23457899999999987533 578899999999999999999999986433211 1110 11
Q ss_pred HhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007668 526 LISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 573 (594)
.+...... + | ..+..+.+...+|++||+..-++|....++.
T Consensus 699 IlkAtEVq--F-P----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 699 ILKATEVQ--F-P----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhcceecc--C-C----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111111 1 1 1223456788999999999998888776654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=255.86 Aligned_cols=260 Identities=24% Similarity=0.376 Sum_probs=195.2
Q ss_pred CCccceeeeecceEEEEEEec-CCcEEEEEeec--ccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--------CCc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS--------PTS 377 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~~ 377 (594)
|....+||+|.||.||+|..+ +|+.||+|++. ...++......+|++++..++|+|++.+++.|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444578999999999999765 46778988764 3455566778899999999999999999998833 334
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
+++||++++. +|.-.+......++..++.++++++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||+++.+
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 7899999955 8999988777789999999999999999999995 59999999999999999999999999999876
Q ss_pred ccCCc---eeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccc
Q 007668 458 EDEES---HITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533 (594)
Q Consensus 458 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (594)
...+. ...+..+-|..|.+||.+.+ +.++++.|||+.|||+.||+||.+-+.+.-+......++.+-..+..+...
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 54332 11233456999999998876 579999999999999999999998877654443332222111111111000
Q ss_pred ---------------------cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 534 ---------------------EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 534 ---------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+...+- .-....+|+.+++..||.+|+.+.+++.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~--kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYV--KDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhccccc--CChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00111111000 0125678999999999999999998874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=255.37 Aligned_cols=238 Identities=28% Similarity=0.391 Sum_probs=192.3
Q ss_pred cceEEEEEEecC-CcEEEEEeecccchhh-HHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhh
Q 007668 319 GFGTVYKLAMDD-GNVFALKRIDKLNEGF-DRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE 396 (594)
Q Consensus 319 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 396 (594)
+||.||+|...+ ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998874 8999999997654433 67899999999999999999999999998999999999999999999875
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecccCccC
Q 007668 397 RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476 (594)
Q Consensus 397 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~a 476 (594)
.. .+++..+..++.+++.+++|||+ .+++|+||+|+||++++++.++++|||.+....... ......++..|++
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 43 38999999999999999999995 499999999999999999999999999998765432 2233457889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHH
Q 007668 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVAT 556 (594)
Q Consensus 477 PE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 556 (594)
||.......+.++|||++|++++++++|..||...... .............. ..........+.+++.
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-----~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~i~ 222 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-----LELFKKIGKPKPPF-------PPPEWKISPEAKDLIR 222 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHhccCCCC-------ccccccCCHHHHHHHH
Confidence 99998888999999999999999999999998652111 11111111110000 0000014467899999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 007668 557 QCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 557 ~cl~~dP~~RPs~~ev~~ 574 (594)
+|+..+|++||++.++++
T Consensus 223 ~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 223 KLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHccCCchhccCHHHHhh
Confidence 999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=276.42 Aligned_cols=239 Identities=24% Similarity=0.288 Sum_probs=191.2
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 383 (594)
++.|.....+|.|+|+.|-++.. .+++..+||++.+.. ..-.+|+.++... +|||++++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56778888899999999988754 467889999987652 2344577665555 79999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe-cCCCcEEEeecccccccccCCc
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL-DGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
.+.++-+.+.+.... .....+..|+.+|+.|+.|||. .|||||||||+|||+ ++.++++|+|||.++....+
T Consensus 397 ~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999998888886532 2226777899999999999995 599999999999999 59999999999999877665
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....+-|..|.|||+.....+++++|+||||++||+|++|+.||.....+ ..+. ..+..+ .
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~------------~~i~~~---~ 530 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH------------TRIQMP---K 530 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH------------HhhcCC---c
Confidence 11223488999999999999999999999999999999999998653322 0000 011111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+....+....+|+.+||+.||.+||+|.++..
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 22455677899999999999999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=262.63 Aligned_cols=242 Identities=24% Similarity=0.333 Sum_probs=195.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhh---HHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGF---DRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 380 (594)
..+|....+||+|+||+|-.+..+ +.+.+|||++++...-. .+--..|-+++... +-|.++++..++...+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457888999999999999998655 46789999998632211 12234466666655 57899999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+.+|+|..++++ -+.+.+....-.|..||-||-+|| +.+|++||||..|||++.+|++||+|||+++.--.+
T Consensus 428 VMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999976 456788888889999999999999 569999999999999999999999999999854332
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
...+.+++||+.|+|||++..++|+..+|-|||||+||||+.|++||++..+++. ...+.+..
T Consensus 504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---------------F~aI~ehn- 566 (683)
T KOG0696|consen 504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---------------FQAIMEHN- 566 (683)
T ss_pred -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---------------HHHHHHcc-
Confidence 2345678999999999999999999999999999999999999999998644321 11111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPT 568 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs 568 (594)
..++...+.+...+.+..+..+|.+|..
T Consensus 567 vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 567 VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1245556677888999999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=267.46 Aligned_cols=243 Identities=27% Similarity=0.416 Sum_probs=195.3
Q ss_pred cceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCC
Q 007668 312 DHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 388 (594)
+++||.|.||+||-|.++ +|+.||||++.+. ......++.+|+.++..++||.||.+--.|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 589999999999999765 6999999999763 2333578999999999999999999999999999999999999555
Q ss_pred chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---CCcEEEeecccccccccCCceee
Q 007668 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
-|.-.+....+++++....-++.||+.||.|||.. +|+|+||||+|||+.. -.++||+|||+|+.++.. ...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SFR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--hhh
Confidence 55555666678899998899999999999999954 9999999999999963 347999999999988753 344
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
..++||+.|+|||++..+.|...-|+||.|||+|--++|.-||.....- .+.++-+.+ +..+. .-.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaF---------MyPp~---PW~ 789 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAF---------MYPPN---PWS 789 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhcccc---------ccCCC---chh
Confidence 5678999999999999999999999999999999999999998653211 111111111 11111 123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 573 (594)
+.+....+||...++..-++|-|...-+
T Consensus 790 eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 790 EISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 4456678899999999999999876544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=275.39 Aligned_cols=253 Identities=24% Similarity=0.387 Sum_probs=202.9
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEe-----
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCN----- 373 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~----- 373 (594)
.+...++.|.+.+.||+|.+|.||++.. ++++..|+|++... ...++++..|.+++... .|||++.++|++.
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3344567888999999999999999965 46888888876643 33466788899998877 6999999999983
Q ss_pred CCCceEEEEEccCCCchhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
.++.++||||||.+||..|+++. .+..+.|..+..|++.++.|+.+||. ..++|||||-.|||++.++.+|+.|||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeee
Confidence 46778999999999999999984 35679999999999999999999995 499999999999999999999999999
Q ss_pred cccccccCCceeeeeeecccCccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHh
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQS-----GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLI 527 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 527 (594)
.+...... .....+..||+.|||||++.. ..|+.++|+||+|++..||.-|.+|+-++....
T Consensus 169 vSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr------------ 235 (953)
T KOG0587|consen 169 VSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR------------ 235 (953)
T ss_pred eeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh------------
Confidence 99866532 333456789999999999853 356788999999999999999999976543211
Q ss_pred cccccccccCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 528 SEDRQREIIDPNCEG---VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 528 ~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+.++.+. -+..-...+.++|..|+..|-++||++.++++
T Consensus 236 ----aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 ----ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ----hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111111111 23445678999999999999999999988774
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=233.05 Aligned_cols=197 Identities=26% Similarity=0.448 Sum_probs=166.4
Q ss_pred CCccceeeeecceEEEEEEe-cCCcEEEEEeecc-cchhhHHHHHHHHHH-HhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 309 LDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDK-LNEGFDRFFERELEI-LGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+.....||+|++|.|-+.++ .+|...|+|++.. .+.+..+...+|+.+ ++...+|.+|.++|........++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34456799999999988755 4799999999974 455567778888887 45568999999999999999999999999
Q ss_pred CCCchhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 386 PGGSLDEALH---ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 386 ~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
..||+.+-+ .++..+++..+-+|+..+.+||.|||++ ..++|||+||+|||++.+|++|++|||.+-.+.+.-.
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 558877655 4678899999999999999999999984 6899999999999999999999999999987664322
Q ss_pred eeeeeeecccCccCcccccc----CCCCccchhhhHHHHHHHHHhCCCCCCc
Q 007668 463 HITTIVAGTFGYLAPEYMQS----GRATEKTDVYSFGVLVLEVLSGKRPTDA 510 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~vl~elltg~~p~~~ 510 (594)
.+...|-..|||||.+.. ..|+-++||||+|+.+.||.+++.||+.
T Consensus 205 --kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 205 --KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred --HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 222357889999998853 4789999999999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=253.02 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=195.6
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCC-C-----CeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-H-----RYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~ 378 (594)
.++|.+...+|+|.||.|-+...+ .+..||||+++.... +.+...-|++++.++. + --+|++.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 568888999999999999997443 478999999887544 4556777999999993 2 1367788889999999
Q ss_pred EEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---------------
Q 007668 379 LLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--------------- 442 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------------- 442 (594)
++|+|.+ |-|+.+++..+ ...++...+..|++|+++++++||+ .+++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999988 77999999863 4569999999999999999999994 59999999999999932
Q ss_pred -----CCcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc
Q 007668 443 -----NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517 (594)
Q Consensus 443 -----~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 517 (594)
+..++++|||.|+...... ...+.|..|.|||++.+-.++.++||||+||||.|+.||..-|..-...+..
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 2358999999998755433 4456799999999999999999999999999999999999887653211111
Q ss_pred hHHHHHHHHhcc-----------------cc-----------cccccCCCCC-----CCCHHHHHHHHHHHHHcccCCCC
Q 007668 518 NIVGWLNFLISE-----------------DR-----------QREIIDPNCE-----GVQSESLDALLAVATQCVSSSPD 564 (594)
Q Consensus 518 ~~~~~~~~~~~~-----------------~~-----------~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~ 564 (594)
..+...+.+ +. .+...++..+ .....+-..+.+|+.+|+..||.
T Consensus 319 ---aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 319 ---AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred ---HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 111111110 00 0111111100 01234456799999999999999
Q ss_pred CCCCHHHHHH
Q 007668 565 DRPTMHRVVQ 574 (594)
Q Consensus 565 ~RPs~~ev~~ 574 (594)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=276.19 Aligned_cols=243 Identities=27% Similarity=0.416 Sum_probs=187.4
Q ss_pred CCCccceeeeecceE-EEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGT-VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
-|...+++|.|+.|+ ||+|... |+.||||++-... .....+|++.+..- +|||||++++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355567899999876 5778775 7899999886532 34678899998887 5999999999999999999999999
Q ss_pred CCCchhhhhhhcCCC---CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-----CCcEEEeeccccccc
Q 007668 386 PGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-----NLEARVSDFGLAKLL 457 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~~l~Dfgl~~~~ 457 (594)
.-+|.+++...... ..-...+.+..|++.|+++|| +.+||||||||+||||+. ...++|+|||+++..
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 55999999763111 111345778999999999999 569999999999999975 257999999999988
Q ss_pred ccCCcee--eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 458 EDEESHI--TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSG-KRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 458 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
..+.... .....||.+|+|||++....-+.++||||+|||+|+.++| .+||+.....+ .+..........
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-------~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-------ANILTGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-------hhhhcCccceee
Confidence 7655432 3457799999999999998888999999999999999995 99998753321 111111111111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 573 (594)
+ ... .+. +..+||.+|++++|..||++.+|+
T Consensus 735 L-----~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 L-----EPL-PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred e-----ccC-chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1 101 111 678999999999999999999997
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=241.03 Aligned_cols=248 Identities=22% Similarity=0.385 Sum_probs=197.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 380 (594)
.++|+..++||+|+|++|..+.+. +.+.+|+|++++. ......-.+.|-.+..+- +||.+|-+..++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 568889999999999999998765 5678999998762 222234466677776665 79999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|.||+++|+|.=++++ ...++++...-.-..|.-||.|||+ .||+.||||..|||+|..|++|++|+|+.+.--.+
T Consensus 329 vieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999999999988875 3568999988899999999999994 59999999999999999999999999999854322
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcc-cchHHHHHHHHhcccccccccCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK-GLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
...+.+++||+.|+|||++.+..|+..+|-|++|++++||+.|+.||+....++ ..+-.+++-.++-+...+
T Consensus 405 -gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------ 477 (593)
T KOG0695|consen 405 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------ 477 (593)
T ss_pred -CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc------
Confidence 233567899999999999999999999999999999999999999998643322 122333333333333222
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRP 567 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP 567 (594)
.+...+.....+++.-+++||.+|.
T Consensus 478 ---iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 ---IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1223334566788899999999987
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-31 Score=258.31 Aligned_cols=244 Identities=25% Similarity=0.356 Sum_probs=200.3
Q ss_pred HhcCCCccceeeeecceEEEEEEecCCcE-EEEEeecc---cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNV-FALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
+..++.....||-|+||.|=.+....... +|+|.+++ .+....+.+..|-.+|...+.|.||+++.-|.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 34566666789999999999987765443 78887765 344445668889999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
.||-|-||.+...++.+ +.++..+..-++..+.+|+.||| +.+||+|||||+|.+++.+|-+||.|||+|+.+...
T Consensus 498 LmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999999874 56888888889999999999999 569999999999999999999999999999988765
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
. .+-+++||+.|.|||++.....+.++|.||+|+++|||++|.+||.+..... -++..+..-...+
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk------tYn~ILkGid~i~------ 639 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK------TYNLILKGIDKIE------ 639 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH------HHHHHHhhhhhhh------
Confidence 4 4567899999999999999999999999999999999999999998754322 2222222211111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPT 568 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs 568 (594)
.+........+++++..+.+|.+|..
T Consensus 640 --~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 --FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred --cccccchhHHHHHHHHHhcCcHhhhc
Confidence 22334456788999999999999996
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=231.25 Aligned_cols=210 Identities=36% Similarity=0.622 Sum_probs=183.6
Q ss_pred eeeecceEEEEEEecC-CcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCchhh
Q 007668 315 IGSGGFGTVYKLAMDD-GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDE 392 (594)
Q Consensus 315 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 392 (594)
||+|.+|.||++...+ ++.+++|++...... ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998765 899999998865432 34678999999999999999999999999899999999999999999
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-CCcEEEeecccccccccCCceeeeeeecc
Q 007668 393 ALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAGT 471 (594)
Q Consensus 393 ~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt 471 (594)
++......+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 997654568999999999999999999995 49999999999999998 89999999999986654321 12224578
Q ss_pred cCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHH
Q 007668 472 FGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDA 550 (594)
Q Consensus 472 ~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (594)
..|++||..... ..+.+.|+|++|++++++ ..
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------~~ 189 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------PE 189 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------HH
Confidence 899999999877 888999999999999999 35
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 551 LLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 551 l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
+.+++.+|++.+|++||++.++++.
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHHHhhC
Confidence 7899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-31 Score=241.58 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=196.6
Q ss_pred CCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-----CceEE
Q 007668 309 LDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSKLL 380 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 380 (594)
.+-++.||-|+||.||.+.. ++|+.||.|++... +-...+.+.+|+.++..++|.|++..+++..-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34568999999999998854 57999999998753 333467788999999999999999988765332 34567
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
++|.| ..+|...+-. ...++.+.+..+++||++||.||| +.+|.||||||.|.|++.+...||+|||+++....+
T Consensus 135 ~TELm-QSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHH-Hhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 88887 4477777654 466888999999999999999999 679999999999999999999999999999987766
Q ss_pred CceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHH--------HHHhcccc
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWL--------NFLISEDR 531 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 531 (594)
+....+.-+-|-+|.|||++.+. .|+.+.||||.||+..|++..+.-|......+...++... .....++.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 66555555678999999999874 6999999999999999999988887664433322221110 11112222
Q ss_pred cccccCCCCCC----------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007668 532 QREIIDPNCEG----------VQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576 (594)
Q Consensus 532 ~~~~~~~~~~~----------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 576 (594)
...++...... .+.....+-..+..+++..||++|.+.++.+..+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11222111110 1112334567888899999999999999887654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=248.56 Aligned_cols=201 Identities=26% Similarity=0.402 Sum_probs=169.1
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccch---hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
-|...+.||-|+||+|..+..- +...+|.|.+++.+. ......+.|-++|..-+.+-||+|+-.|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4666788999999999998544 466789999976432 234557889999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc-----
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE----- 458 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~----- 458 (594)
|++||++..+|.+. +.+.+...+-++..+..|+.+.| +.|+|||||||+|||||.+|++||+|||+++-+.
T Consensus 710 YIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999999998763 56777777888899999999999 6699999999999999999999999999986332
Q ss_pred ----cCCcee--------------------------------eeeeecccCccCccccccCCCCccchhhhHHHHHHHHH
Q 007668 459 ----DEESHI--------------------------------TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVL 502 (594)
Q Consensus 459 ----~~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ell 502 (594)
.++... ....+||+.|+|||++....++..+|-||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 100000 01247999999999999999999999999999999999
Q ss_pred hCCCCCCcch
Q 007668 503 SGKRPTDASF 512 (594)
Q Consensus 503 tg~~p~~~~~ 512 (594)
.|+.||.+.-
T Consensus 866 ~g~~pf~~~t 875 (1034)
T KOG0608|consen 866 VGQPPFLADT 875 (1034)
T ss_pred hCCCCccCCC
Confidence 9999997643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=222.65 Aligned_cols=255 Identities=18% Similarity=0.297 Sum_probs=191.2
Q ss_pred hcCCCccceeeeecceEEEEEE-ecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCC--CceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSP--TSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv 381 (594)
.++|++.+.+|+|.++.||.|. ..+.++++||.++... .+.+.+|+.++..|+ ||||+++++...++ ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3567778899999999999995 4568889999988654 357899999999997 99999999998664 456799
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeecccccccccC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~~~~ 460 (594)
+||+.+.+...+. +.++..++...+.+++.||.|+| ++||.|||+||+|+++| ....++++|+|+|.++.+.
T Consensus 114 FE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999988776664 34777888999999999999999 66999999999999999 4567999999999988765
Q ss_pred CceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcc--hhcccchHHHHH-----HHHhccccc
Q 007668 461 ESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDAS--FIEKGLNIVGWL-----NFLISEDRQ 532 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~--~~~~~~~~~~~~-----~~~~~~~~~ 532 (594)
... ...+.+..|--||.+-. ..++..-|+|||||++..|+..+.||-.. +.++-..++..+ ...+....
T Consensus 187 ~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~- 263 (338)
T KOG0668|consen 187 KEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ- 263 (338)
T ss_pred cee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc-
Confidence 433 22345778899998764 56788999999999999999999997432 111111111100 00000000
Q ss_pred ccccCCCCCC-----------------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 REIIDPNCEG-----------------VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ~~~~~~~~~~-----------------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
-.+||...+ ...-.+++..+++.+.+..|-.+|||++|.+.
T Consensus 264 -i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 264 -IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred -cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 001111110 11122467889999999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=227.81 Aligned_cols=199 Identities=31% Similarity=0.505 Sum_probs=173.4
Q ss_pred CCccceeeeecceEEEEEEecC-CcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
|...+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999998875 889999999865544 56788999999999999999999999999899999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+++|.+++......+++..+..++.+++.++.+||+ .+++|+|++++||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 999999997644338999999999999999999995 49999999999999999999999999999877654311223
Q ss_pred eeecccCccCcccc-ccCCCCccchhhhHHHHHHHHHhCCCCCCc
Q 007668 467 IVAGTFGYLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGKRPTDA 510 (594)
Q Consensus 467 ~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 510 (594)
...++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34578899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=229.15 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=189.4
Q ss_pred CCCccceeeeecceEEEEEE-ecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEe------CCCce
Q 007668 308 TLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCN------SPTSK 378 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------~~~~~ 378 (594)
+|.....+|.|.- .|..+. .-.++.||+|++... +....+...+|...+..+.|+|+++++.++. +..+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 5556677888887 455443 235889999988642 3334567889999999999999999999873 34566
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
|+|||+| .++|...++ ..++-.++..+.+|++.|++||| +.+|+||||||+||++..+..+||.|||+++.-.
T Consensus 97 y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccC
Confidence 8999999 669999887 34677888999999999999999 6699999999999999999999999999998654
Q ss_pred cCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHH------------
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL------------ 526 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~------------ 526 (594)
.+ ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. .+.+|.+..
T Consensus 170 ~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 170 TD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCHHHHH
Confidence 43 44566778999999999999889999999999999999999998776421 111221110
Q ss_pred ---------hc--cc----ccccc-cCCCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 527 ---------IS--ED----RQREI-IDPNCEG---VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 527 ---------~~--~~----~~~~~-~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+. ++ ...+. .|..+.. .+.-......+++.+||-.+|++|-+++++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 00 00111 1111111 11122345778999999999999999999987
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=244.36 Aligned_cols=199 Identities=23% Similarity=0.340 Sum_probs=169.5
Q ss_pred HHhcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchh---h-----HHHHHHHHHHHhhCC---CCeeeeeeeE
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEG---F-----DRFFERELEILGSIK---HRYLVNLRGY 371 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~-----~~~~~~E~~~l~~l~---h~niv~l~g~ 371 (594)
+....|+..+.+|+|+||.|+.+.++. ...|+||.+++.+.- + ...+..|+++|.+++ |+||++++.+
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 344568889999999999999997664 567889988763221 1 123567999999997 9999999999
Q ss_pred EeCCCceEEEEEccC-CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEee
Q 007668 372 CNSPTSKLLIYDFLP-GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (594)
Q Consensus 372 ~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~D 450 (594)
|++.+.+|+++|-.. +.+|.+++.. ...+++.....|++||+.|+++||+ .+|||||||-+||.++.+|-+||+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence 999999999999874 5589999865 4669999999999999999999995 5999999999999999999999999
Q ss_pred cccccccccCCceeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCC
Q 007668 451 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTD 509 (594)
Q Consensus 451 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~ 509 (594)
||.+.....+ ....++||.+|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999875543 3456789999999999998887 566899999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=230.19 Aligned_cols=131 Identities=24% Similarity=0.388 Sum_probs=110.7
Q ss_pred cCCCccceeeeecceEEEEEE-ecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC--------CCeeeeeeeEEe----
Q 007668 307 ETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIK--------HRYLVNLRGYCN---- 373 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~---- 373 (594)
.+|...++||.|.|++||.+- ..+.+.||+|+.+.. ..+.+....||+++.+++ ..+||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 478888999999999999984 556788999987653 445677888999999884 358999999984
Q ss_pred CCCceEEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 441 (594)
.+.+.++|+|++ |.+|..+|... -+-++...+..|++||+.||.|||.+| +|+|-||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 467789999999 77899988754 344999999999999999999999977 999999999999993
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-28 Score=247.66 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=198.7
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|.....+|.|.||.|||++. ..++..|+|.++-.........+.|+-+++..+||||+.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35677889999999999999965 46889999999865554456678899999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+.+|+|.+.-+. .+.+++.++..+++...+|++||| +.+-+|||||-.||++++.+.+|++|||.+..+...- ..
T Consensus 94 cgggslQdiy~~-TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 94 CGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred cCCCcccceeee-cccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 999999998875 367899999999999999999999 5688999999999999999999999999987665322 23
Q ss_pred eeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
...+.||++|||||+.. .+.|.+++|||+.|+...|+---+.|.-.....+. -+.... ..+++.-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-------l~LmTk----S~~qpp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-------LFLMTK----SGFQPPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-------HHHhhc----cCCCCCcc
Confidence 45578999999999863 46789999999999999999887777322111110 011111 11111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 573 (594)
.....-...+-++++.|+..+|++||+++.++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11223345688999999999999999987665
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=214.38 Aligned_cols=253 Identities=18% Similarity=0.314 Sum_probs=189.7
Q ss_pred hcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeE-EeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGY-CNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lv~ 382 (594)
.+.|++.+.+|+|.||.+-.+.++. .+.+|+|-+...-. ..++|.+|..---.| .|.||+.-++. |...+.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4568888999999999999998774 67788888775433 367888888764455 58999987664 56667777999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec--CCCcEEEeecccccccccC
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~~l~Dfgl~~~~~~~ 460 (594)
||++.|+|...+... .+.+....+++.|+++|+.||| +..+||||||.+|||+- +..++|++|||+.+..+.-
T Consensus 102 E~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 999999999998653 3778888999999999999999 56999999999999993 4458999999998865432
Q ss_pred CceeeeeeecccCccCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSG-----RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
... .--+..|.|||..... ...+.+|||.||+++|.++||+.||..... .......|.++.....
T Consensus 177 V~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~rk~----- 246 (378)
T KOG1345|consen 177 VKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKRKN----- 246 (378)
T ss_pred ehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhcccC-----
Confidence 221 1225578999976432 357789999999999999999999984332 2334444544432221
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 576 (594)
++.+......+..++++.++-+.++|++|=-..++..+.
T Consensus 247 --~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 --PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred --ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 233333445567788999999999999995555555444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=235.19 Aligned_cols=260 Identities=20% Similarity=0.234 Sum_probs=195.6
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCC------CCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK------HRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~~~~~ 379 (594)
.+|.+....|+|-|++|.+|... .|+.||||++.+.. ...+.=..|+++|++|. --|.++++..|...+++|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 46777788999999999999654 47899999998643 33455677999999995 357889999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCC--CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC-CcEEEeecccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKL 456 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~--l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~~l~Dfgl~~~ 456 (594)
||+|-+ .-+|.+.|+..+.. +....+..+++|+.-||..|... +|+|.||||.|||+++. ..+||||||.|..
T Consensus 511 lVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~ 586 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASF 586 (752)
T ss_pred EEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccc
Confidence 999987 66999999865443 77889999999999999999954 99999999999999854 5689999999987
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH---------------H
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV---------------G 521 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~---------------~ 521 (594)
....+.. .+.-+..|.|||++.+-+|+...|+||.||.||||.||+.-|.+.-...-..+. +
T Consensus 587 ~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgq 663 (752)
T KOG0670|consen 587 ASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQ 663 (752)
T ss_pred ccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcc
Confidence 7655432 222356799999999999999999999999999999999887653211110000 0
Q ss_pred HHHHHhcc---------------cc--cccccCC------------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 007668 522 WLNFLISE---------------DR--QREIIDP------------NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRV 572 (594)
Q Consensus 522 ~~~~~~~~---------------~~--~~~~~~~------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 572 (594)
+....+.. +. ....+.| +++.........+.+|+.+|+..||++|.|..++
T Consensus 664 F~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqA 743 (752)
T KOG0670|consen 664 FKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQA 743 (752)
T ss_pred hhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHH
Confidence 00110000 00 0001111 1223334456678999999999999999999988
Q ss_pred HH
Q 007668 573 VQ 574 (594)
Q Consensus 573 ~~ 574 (594)
+.
T Consensus 744 L~ 745 (752)
T KOG0670|consen 744 LK 745 (752)
T ss_pred hc
Confidence 74
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=225.37 Aligned_cols=262 Identities=25% Similarity=0.307 Sum_probs=193.5
Q ss_pred HHhcCCCccceeeeecceEEEEEEec----CCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCce
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 378 (594)
...+.|...++||+|.|++||++... .++.||+|.+...+. ...+.+|++++..+. +.||+++.+++..++..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 33467888899999999999998654 367899999876544 345889999999985 99999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeeccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLL 457 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~ 457 (594)
.+|+||++.....++... ++...+...++.+..||+++| +.|||||||||+|+|.+ ..+.-.|.|||++...
T Consensus 111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHH
Confidence 999999999998888754 678889999999999999999 55999999999999998 5677899999999722
Q ss_pred ccCC--------------c-----------------------------eeeeeeecccCccCcccccc-CCCCccchhhh
Q 007668 458 EDEE--------------S-----------------------------HITTIVAGTFGYLAPEYMQS-GRATEKTDVYS 493 (594)
Q Consensus 458 ~~~~--------------~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s 493 (594)
.... . ......+||+||.|||++.. ...+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 1000 0 00112469999999999865 45788999999
Q ss_pred HHHHHHHHHhCCCCCCcchhccc-----chHHHHHH---HHhcccc---------------------cc-cccCC-----
Q 007668 494 FGVLVLEVLSGKRPTDASFIEKG-----LNIVGWLN---FLISEDR---------------------QR-EIIDP----- 538 (594)
Q Consensus 494 ~G~vl~elltg~~p~~~~~~~~~-----~~~~~~~~---~~~~~~~---------------------~~-~~~~~----- 538 (594)
.|+|++.+++++.||-....+-+ ..+..+.. .....+. .. +.+.+
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 99999999999999754322111 00000000 0000000 00 00000
Q ss_pred -CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 -NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 -~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+..+..+.+++.+|+..||.+|-|++|.+.
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 001112223457899999999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=263.81 Aligned_cols=195 Identities=16% Similarity=0.211 Sum_probs=139.1
Q ss_pred hCCC-CeeeeeeeEE-------eCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 007668 359 SIKH-RYLVNLRGYC-------NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430 (594)
Q Consensus 359 ~l~h-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 430 (594)
.++| +||++++++| .+....+.++||+ +++|.+++......+++..++.++.||++||+|||+ .+|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeee
Confidence 3455 5777787776 2334567889987 669999998655669999999999999999999994 59999
Q ss_pred CCCCCCCeEecCC-------------------CcEEEeecccccccccCC---------------ceeeeeeecccCccC
Q 007668 431 RDIKSSNILLDGN-------------------LEARVSDFGLAKLLEDEE---------------SHITTIVAGTFGYLA 476 (594)
Q Consensus 431 ~Dlk~~NIll~~~-------------------~~~~l~Dfgl~~~~~~~~---------------~~~~~~~~gt~~y~a 476 (594)
|||||+|||++.. +.+|++|||+++...... ........||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 9999999999654 445666666665321100 000112357889999
Q ss_pred ccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHH
Q 007668 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVAT 556 (594)
Q Consensus 477 PE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 556 (594)
||++.+..++.++|||||||++|||++|..|+..... ..... .. ...++.. .........++.
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~-~~--------~~~~~~~----~~~~~~~~~~~~ 246 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL-RH--------RVLPPQI----LLNWPKEASFCL 246 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH-HH--------hhcChhh----hhcCHHHHHHHH
Confidence 9999999999999999999999999999888643211 00000 00 0111110 111234568889
Q ss_pred HcccCCCCCCCCHHHHHH
Q 007668 557 QCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 557 ~cl~~dP~~RPs~~ev~~ 574 (594)
+||+++|.+||++.|+++
T Consensus 247 ~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhCCCChhhCcChHHHhh
Confidence 999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-25 Score=203.19 Aligned_cols=167 Identities=23% Similarity=0.269 Sum_probs=126.8
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~ 467 (594)
|+|.++++.+...+++..+..|+.||+.||+|||++ + ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 789999987667799999999999999999999964 3 999999999999999 99988654422
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (594)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... .............. ++.........
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~~~ 135 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMPAD---DPRDRSNLESV 135 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhccC---CccccccHHHH
Confidence 25799999999999999999999999999999999999998653221 11111111110000 00000111222
Q ss_pred HH--HHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 548 LD--ALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 548 ~~--~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.. .+.+++.+||+.+|++||++.|+++.+...
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 23 689999999999999999999999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-25 Score=201.75 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=188.5
Q ss_pred CccceeeeecceEEEEEEecCCcEEEEEeec--ccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
....+|.+...|+.|+|+++.+ .+++|++. ..+....+.|..|.-.++-+.||||.+++|.|..+....++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 3445688899999999999854 45556654 34445567899999999999999999999999999999999999999
Q ss_pred CchhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEe--ecccccccccCCcee
Q 007668 388 GSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS--DFGLAKLLEDEESHI 464 (594)
Q Consensus 388 gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~--Dfgl~~~~~~~~~~~ 464 (594)
|+|+..+++... ..+..+..+++.+||+|++|||+- .+-|.---|.++.|++|++.+++|+ |--++.. +.
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq----e~-- 344 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----EV-- 344 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee----cc--
Confidence 999999997533 377888999999999999999974 4445556789999999999988875 3222211 11
Q ss_pred eeeeecccCccCccccccCCC---CccchhhhHHHHHHHHHhCCCCCCcch-hcccchHHHHHHHHhcccccccccCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRA---TEKTDVYSFGVLVLEVLSGKRPTDASF-IEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~G~vl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
...=.+.||+||.++..+. -.++|+|||++++||+.|...||.... .+.+. .+.-+.++..+
T Consensus 345 --gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------kialeglrv~i---- 410 (448)
T KOG0195|consen 345 --GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------KIALEGLRVHI---- 410 (448)
T ss_pred --ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------hhhhccccccC----
Confidence 1112678999999987653 457999999999999999999986532 22221 11222233333
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
++..+..+.+|+.-|++.||.+||.+..|+-.||.+.
T Consensus 411 ---ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 ---PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 3344577899999999999999999999999998753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=214.36 Aligned_cols=169 Identities=20% Similarity=0.182 Sum_probs=130.4
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEec--CCcEEEEEeeccc-----chhhHHHHHHHHHHHhhCCCCeeeeeeeEEe
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVNLRGYCN 373 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 373 (594)
.+......|...+.||+|+||+||+|... +++.+|||++... .....+.+.+|++++.+++|+|+++.+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 33444578999999999999999999765 5778899987532 222356799999999999999998533222
Q ss_pred CCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC-CCCCeEecCCCcEEEeecc
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI-KSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~~l~Dfg 452 (594)
...++||||+++++|... ... . ...++.+++++|.|||+ .+|+|||| ||+|||++.++.++|+|||
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 457999999999999732 111 1 14678999999999995 59999999 9999999999999999999
Q ss_pred cccccccCCceee-------eeeecccCccCccccccC
Q 007668 453 LAKLLEDEESHIT-------TIVAGTFGYLAPEYMQSG 483 (594)
Q Consensus 453 l~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 483 (594)
+++.+........ ....+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9997654331111 245678899999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=207.90 Aligned_cols=260 Identities=20% Similarity=0.284 Sum_probs=194.1
Q ss_pred CCCccceeeeecceEEEEEEecCC--cEEEEEeecccchhhHHHHHHHHHHHhhCCC----CeeeeeeeEE-eCCCceEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDDG--NVFALKRIDKLNEGFDRFFERELEILGSIKH----RYLVNLRGYC-NSPTSKLL 380 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 380 (594)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999986654 4788887766433323368889999888863 6888888888 47777899
Q ss_pred EEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC-----CcEEEeecccc
Q 007668 381 IYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-----LEARVSDFGLA 454 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~~l~Dfgl~ 454 (594)
||+.+ +.+|.++..... +.++..+..+|+.|++.+|.++| +.|++||||||.|+++... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 889999886544 77999999999999999999999 4599999999999999754 46999999999
Q ss_pred c--ccccCCce------e-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHH
Q 007668 455 K--LLEDEESH------I-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNF 525 (594)
Q Consensus 455 ~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 525 (594)
+ .+...... . .....||.+|.+++...+.+.+.+.|+||++.++.|+..|..||........ .. .+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~-~~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KS-KFEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HH-HHHH
Confidence 8 43222211 1 1345699999999999999999999999999999999999999865332111 01 0000
Q ss_pred HhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 526 LISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
......... .. ...+..+.++...+-..+..++|....+...++.....
T Consensus 252 ----~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 252 ----DPRKLLTDR-FG---DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ----Hhhhhcccc-cc---CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 001111110 11 11224455566666668999999999999998776554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=235.88 Aligned_cols=171 Identities=33% Similarity=0.626 Sum_probs=119.8
Q ss_pred CcchHHHHHHHHHhccCCCCCCcCCCCCCCCCCccceeEeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCcc
Q 007668 29 INSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF 108 (594)
Q Consensus 29 ~~~~~~~L~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 108 (594)
.+.|..||++||+.+.++.+.+.+|+ ...+||.|.||+|+...+|+.|+|++|++++.++..|..+++|+.|+|++|++
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~ 105 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQL 105 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCC-CCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCcc
Confidence 55789999999999987777889996 45789999999998778999999999999999999999999999999999999
Q ss_pred CCCCCCCcC-CCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC
Q 007668 109 YGEIPSELG-NCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187 (594)
Q Consensus 109 ~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 187 (594)
++.+|..+. ++++|++|+|++|++++.+|. ..+++|++|+|++|.+++.+|..+.++++|++|+|++|.+.+..|..
T Consensus 106 ~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 106 SGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred CCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 888887654 677777777777766655443 23444444444444444444444444444444444444444433322
Q ss_pred -cccccCCcccccCCC
Q 007668 188 -GVLTKFSESSFFGNR 202 (594)
Q Consensus 188 -~~l~~l~~l~l~~N~ 202 (594)
..+++|+.|++++|.
T Consensus 184 ~~~l~~L~~L~L~~n~ 199 (968)
T PLN00113 184 LTNLTSLEFLTLASNQ 199 (968)
T ss_pred hhhCcCCCeeeccCCC
Confidence 344444444444443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=185.16 Aligned_cols=262 Identities=16% Similarity=0.209 Sum_probs=201.5
Q ss_pred CCCccceeeeecceEEEEEE-ecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.|.++++||+|+||..+.|. +-+++.||||.-...+ ..-++..|.+..+.|. .+.|...+-|..++....||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 67889999999999999995 5679999999654322 2346788999888884 789988888888888889999988
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-----CCcEEEeecccccccccC
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-----NLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~~l~Dfgl~~~~~~~ 460 (594)
|.||.|+..-.+..++..++..||.|++.-++|+|+ ..+|.|||||+|.||.. ...+.++|||+|+.+.+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 889999998888899999999999999999999995 48999999999999963 345899999999988765
Q ss_pred Ccee------eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 461 ESHI------TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 461 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
.... .....||.+||+-....+++.+.+.|.=|+|-++++.+.|..||.+..........+ . +.+....-
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe---K-IGe~Kr~T 258 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE---K-IGETKRST 258 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH---H-hccccccC
Confidence 4332 244679999999999999999999999999999999999999998754332211111 0 11111100
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
. +...-...+.++..-+.-.-+.+-.+-|..+-+...+...+...
T Consensus 259 ~----i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 259 P----IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred C----HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 0 11112234455666666666778888899888887777665543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=214.75 Aligned_cols=162 Identities=35% Similarity=0.583 Sum_probs=125.9
Q ss_pred cCCCcchHHHHHHHHHhccCCCCCCcCCCCCCCCCC-----ccceeEeCCC-----CcEEEEEcccCCCCCCCCccccCc
Q 007668 26 SRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPC-----NWKGVKCDKN-----KRVITLSLTNHKLSGPISADLGKL 95 (594)
Q Consensus 26 ~~~~~~~~~~L~~~k~~~~~~~~~l~~w~~~~~~~c-----~w~gv~c~~~-----~~l~~L~L~~n~l~~~~~~~~~~l 95 (594)
..+...|..||+.+|..+..+.. .+|+ .++| .|.||.|+.. ..++.|+|++|+|+|.+|..+.++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~---g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCC---CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 34567899999999999865432 4795 3456 7999999521 248888888888888888888888
Q ss_pred ccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEe
Q 007668 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNV 175 (594)
Q Consensus 96 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l 175 (594)
++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+.+|++|+.|+|++|++++.+|..+..+
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~-------- 513 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR-------- 513 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc--------
Confidence 888888888888888888888888888888888888888888888888888888888888888777766432
Q ss_pred ecccccccCCCCcccccCCcccccCCCCCCCCccccccc
Q 007668 176 SNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCK 214 (594)
Q Consensus 176 ~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~~~~c~ 214 (594)
+.++..+++.+|+.+|+.|....|.
T Consensus 514 --------------~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 514 --------------LLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred --------------cccCceEEecCCccccCCCCCCCCc
Confidence 1234456788999999877554553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-20 Score=190.78 Aligned_cols=257 Identities=29% Similarity=0.418 Sum_probs=195.8
Q ss_pred CCccceeeeecceEEEEEEecCCcEEEEEeecccchh---hHHHHHHHHHHHhhCCCC-eeeeeeeEEeCCCceEEEEEc
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG---FDRFFERELEILGSIKHR-YLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lv~e~ 384 (594)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999877 78899988753332 467899999999999988 799999999777778999999
Q ss_pred cCCCchhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~~~~~~~ 461 (594)
+.++++.+.+.... ..++......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776543 268899999999999999999995 4899999999999999888 79999999998655433
Q ss_pred ce-----eeeeeecccCccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCcchhc-ccchHHHHHHHHhcccc-
Q 007668 462 SH-----ITTIVAGTFGYLAPEYMQS---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIE-KGLNIVGWLNFLISEDR- 531 (594)
Q Consensus 462 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~- 531 (594)
.. ......|+..|+|||.+.+ .......|+|++|++++++++|..|+...... ........... ....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE--LPTPS 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh--cCCcc
Confidence 22 2355679999999999987 57889999999999999999999996654321 00000100000 0000
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
........ ........+.+++..|+..+|..|.+..+....
T Consensus 235 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPS---NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCcc---ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 002223568899999999999999998887763
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=218.05 Aligned_cols=247 Identities=22% Similarity=0.221 Sum_probs=185.2
Q ss_pred CCCccceeeeecceEEEEEEecCCcEEEEEeecccch-hhHHHHHHHHHH--HhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE-GFDRFFERELEI--LGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++...+.||.+.|=+|.++++++|. |+||++.+..+ -.-+.|.++++- ...++|||.+++.-.-......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999999888 88998865442 223334433332 5556899999998887777778899999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc--ccccCCc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK--LLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~--~~~~~~~ 462 (594)
. ..+|+|.+..+ .-+...+...|+.|++.|+.-+| ..||+|||||.+|||++.-+-+.|+||..-+ ++..+++
T Consensus 103 v-khnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred H-hhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 8 55999999753 45777788899999999999999 4599999999999999999999999998664 3344444
Q ss_pred eeeeeeecc----cCccCccccccC-----------CCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHH
Q 007668 463 HITTIVAGT----FGYLAPEYMQSG-----------RATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 463 ~~~~~~~gt----~~y~aPE~~~~~-----------~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
.....+..| ..|+|||.+... ..+++.||||+||++.||++ |++||..+..- .+.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~---------aYr 248 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL---------AYR 248 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH---------hHh
Confidence 444444444 379999987541 15788999999999999999 68888654211 111
Q ss_pred hc-----ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 527 IS-----EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 527 ~~-----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.. +..+.++-| ..+.+++..|++.||++|.++++.++.-.+.+
T Consensus 249 ~~~~~~~e~~Le~Ied-----------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIED-----------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred ccCccCHHHHHHhCcC-----------ccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 11 111122222 25889999999999999999999998765543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.7e-22 Score=178.05 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=196.8
Q ss_pred cCCCccceeeeecceEEEEEE-ecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCC-CeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH-RYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.+|...+.||.|+||.+|.|. ..+|+.||||.-..... .-++..|.++.+.|++ ..|..+..|..+.....+|||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 568888999999999999984 56799999997654322 3467789999999975 6777777788888888999998
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec---CCCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+ +.||.++..-....++..+++-.+-|++.-++|+|. .+++||||||+|.|.. .-..+.++|||+++.+.+..
T Consensus 93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~ 168 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR 168 (341)
T ss_pred c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence 8 889999998777889999999999999999999995 4899999999999996 33468999999999876544
Q ss_pred ceee------eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 462 SHIT------TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 462 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
.... ....||.+|.+-....+.+.+.+.|+=|+|.+|.++-.|..||.+...... .+... .+.+......
T Consensus 169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyE-kI~EkK~s~~ 244 (341)
T KOG1163|consen 169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYE-KISEKKMSTP 244 (341)
T ss_pred ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHH-HHHHhhcCCC
Confidence 3222 335799999998888877888999999999999999999999987433211 11111 1111111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
+.. .-...+.++.-.+.-|-...-++-|...-+-+.+.-.
T Consensus 245 ie~----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 245 IEV----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HHH----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 111 1123345677778888888888889877666655443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-22 Score=217.04 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=186.6
Q ss_pred CccceeeeecceEEEEEEec-CCcEEEEEeec----c-cc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 310 DDDHIIGSGGFGTVYKLAMD-DGNVFALKRID----K-LN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
...+++|.|++|.|+..... .....+.|... . .. ......+..|+-+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35688999999977765433 33334444332 1 11 111222566777788899999998888877777777779
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++ +|..++... ..++..++..+++|+..|++|+|. .||.|||+|++|++++.++.+||+|||.+..+...-.
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999998753 468888899999999999999994 5999999999999999999999999999987654322
Q ss_pred ---eeeeeeecccCccCccccccCCCCcc-chhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 463 ---HITTIVAGTFGYLAPEYMQSGRATEK-TDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 463 ---~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
......+|+..|+|||++.+.+|.+. .||||.|+++..|.+|+.||.....++.... .........+ ..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------~~~~~~~~~~-~~ 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------TNNYSDQRNI-FE 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------hhcccccccc-cc
Confidence 44566789999999999999988765 8999999999999999999876544332210 0000000000 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.........+.....++.+|++.+|.+|-|+++|++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 111123344566788999999999999999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=196.31 Aligned_cols=218 Identities=28% Similarity=0.438 Sum_probs=169.3
Q ss_pred HhhCCCCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 007668 357 LGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSS 436 (594)
Q Consensus 357 l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~ 436 (594)
|+.+.|.|+.+++|.+.++...+.|.+|++.|+|.|.+......++|.....++++|+.||+|+|. ++...|+.++++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 456899999999999999999999999999999999999878889999999999999999999996 444499999999
Q ss_pred CeEecCCCcEEEeeccccccccc-CCceeeeeeecccCccCccccccC-------CCCccchhhhHHHHHHHHHhCCCCC
Q 007668 437 NILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAPEYMQSG-------RATEKTDVYSFGVLVLEVLSGKRPT 508 (594)
Q Consensus 437 NIll~~~~~~~l~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~vl~elltg~~p~ 508 (594)
|++++....+|++|||+...... ..........-..-|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999876642 111111112235579999998753 2577899999999999999999999
Q ss_pred Ccchhccc-chHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 509 DASFIEKG-LNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 509 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
+....... ..++.++.. .....+.|...... +....+..++..||..+|++||+++.|-..++.....
T Consensus 159 ~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 87443322 222322211 12223333333222 3444789999999999999999999999999876654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=175.49 Aligned_cols=141 Identities=15% Similarity=0.157 Sum_probs=108.9
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeecccchh--h------------------------HHHHHHHHHHHhhCCCCee
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG--F------------------------DRFFERELEILGSIKHRYL 365 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 365 (594)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999889999999999753211 0 1123459999999987776
Q ss_pred eeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 366 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
.....+.. ...++||||++++++...... ...+++.....++.|++.+|.|+|+ +.+|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-CCc
Confidence 44333322 234899999998877655332 3568999999999999999999942 34999999999999998 478
Q ss_pred EEEeecccccccc
Q 007668 446 ARVSDFGLAKLLE 458 (594)
Q Consensus 446 ~~l~Dfgl~~~~~ 458 (594)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=168.95 Aligned_cols=142 Identities=16% Similarity=0.191 Sum_probs=111.7
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeecccchh--------------------------hHHHHHHHHHHHhhCCCCee
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG--------------------------FDRFFERELEILGSIKHRYL 365 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 365 (594)
...||+|++|.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999998888999999998753211 01234678999999999987
Q ss_pred eeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 366 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
.....+... ..++||||++++++...... ...++......++.|++.++.++|+ ..+|+||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCC
Confidence 554444333 24899999988865443222 2457888899999999999999996 15999999999999999 889
Q ss_pred EEEeeccccccccc
Q 007668 446 ARVSDFGLAKLLED 459 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~ 459 (594)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=175.47 Aligned_cols=178 Identities=12% Similarity=0.185 Sum_probs=134.2
Q ss_pred HHHHHHH--hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHH---------HHHHHHHHHhhCCCCeeee
Q 007668 299 SKDIIKK--LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDR---------FFERELEILGSIKHRYLVN 367 (594)
Q Consensus 299 ~~~~~~~--~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~ 367 (594)
+.++... ..+|...+++|+|+||.||.+.. ++..+|+|.++.......+ .+.+|++.+.+++||+|..
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 4455444 36888999999999999999766 5778999999753222222 2689999999999999999
Q ss_pred eeeEEeCC--------CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeE
Q 007668 368 LRGYCNSP--------TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNIL 439 (594)
Q Consensus 368 l~g~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIl 439 (594)
+..++... ...++||||++|.+|.+... ++. ....+++.++..+|+ .+++|||++|+||+
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nil 167 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFI 167 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEE
Confidence 98885432 35789999999999988732 222 245699999999995 59999999999999
Q ss_pred ecCCCcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh
Q 007668 440 LDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503 (594)
Q Consensus 440 l~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt 503 (594)
++.++ ++++|||.......+... ..+.....+..++|+|+||+.+..+..
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99888 999999988755322111 013334456678999999998876653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-19 Score=171.09 Aligned_cols=230 Identities=22% Similarity=0.313 Sum_probs=147.6
Q ss_pred CCccceeeeecceEEEEEEecC-CcEEEEEeecccc---hhhHHHHHHHHHHHhhCCC-----------CeeeeeeeE--
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN---EGFDRFFERELEILGSIKH-----------RYLVNLRGY-- 371 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-----------~niv~l~g~-- 371 (594)
+...+.||.|+++.||.+...+ ++.+|+|.+.... ....+.+.+|.-....+.+ ..++++--.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4456899999999999998764 8999999886422 2234566776655554322 222222111
Q ss_pred ------EeCC---C-----ceEEEEEccCCCchhhhhh---hcCCC---CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 007668 372 ------CNSP---T-----SKLLIYDFLPGGSLDEALH---ERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431 (594)
Q Consensus 372 ------~~~~---~-----~~~lv~e~~~~gsL~~~l~---~~~~~---l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 431 (594)
+... . ..+++|+-+ .++|.+++. ..... +....+..+..|+.+.+++||. .|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 1111 1 235678877 668888754 22222 3445567777999999999995 599999
Q ss_pred CCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecccCccCccccccC--------CCCccchhhhHHHHHHHHHh
Q 007668 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG--------RATEKTDVYSFGVLVLEVLS 503 (594)
Q Consensus 432 Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~s~G~vl~ellt 503 (594)
||+|+|++++.+|.++|+||+.....+.... . ...+..|.+||..... .++.+.|.|++|+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee---c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987765543211 1 2345789999976442 46889999999999999999
Q ss_pred CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 007668 504 GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDR 566 (594)
Q Consensus 504 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 566 (594)
|..||+....+..... .+..+. +.+..+..||..+|+++|++|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986533321110 222334 667889999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=175.67 Aligned_cols=197 Identities=20% Similarity=0.264 Sum_probs=139.5
Q ss_pred CCCeeeeeeeEEeC---------------------------CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHH
Q 007668 361 KHRYLVNLRGYCNS---------------------------PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA 413 (594)
Q Consensus 361 ~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 413 (594)
+|||||++.++|.+ +...|+||... .-+|.+++.. ...+.....-|+.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~--~~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT--RHRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc--CCCchHHHHHHHHHH
Confidence 59999999887633 34567888877 4488888864 335666677799999
Q ss_pred HHHHHHhhhcCCCCeeeCCCCCCCeEec--CCC--cEEEeecccccccccCC---ceee--eeeecccCccCccccccCC
Q 007668 414 AKGLAYLHHDCSPRIIHRDIKSSNILLD--GNL--EARVSDFGLAKLLEDEE---SHIT--TIVAGTFGYLAPEYMQSGR 484 (594)
Q Consensus 414 a~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~~l~Dfgl~~~~~~~~---~~~~--~~~~gt~~y~aPE~~~~~~ 484 (594)
++|+.|||.+ ||.|||+|++|||+. +|. ...++|||++-...... .+.. ....|.-.-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999955 999999999999994 443 46889999875332211 1111 1234777899999987532
Q ss_pred ------CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHc
Q 007668 485 ------ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQC 558 (594)
Q Consensus 485 ------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 558 (594)
.-.|+|.|+.|.+.||+++...||....+. ..+... .....++..++..+..+.+++...
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-------------Yqe~qLPalp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-------------YQESQLPALPSRVPPVARQLVFDL 493 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-------------hhhhhCCCCcccCChHHHHHHHHH
Confidence 245899999999999999999999762211 111111 111223334455667789999999
Q ss_pred ccCCCCCCCCHHHHHHHHh
Q 007668 559 VSSSPDDRPTMHRVVQILE 577 (594)
Q Consensus 559 l~~dP~~RPs~~ev~~~L~ 577 (594)
++.||++|++..-....|+
T Consensus 494 L~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 494 LKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hcCCccccCCccHHHhHHH
Confidence 9999999999766655553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.9e-19 Score=162.04 Aligned_cols=189 Identities=16% Similarity=0.092 Sum_probs=140.0
Q ss_pred CccceeeeecceEEEEEEecCCcEEEEEeecccchh----hHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEEc
Q 007668 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG----FDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.....|++|+||+||.+.. ++.+++.+.+...... ....+.+|+++|.++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997655 6788887777653331 1235889999999995 5888888886 346999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC-CCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI-KSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++.+|...+.. . ...++.|++++|.++|. .||+|||| ||.|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998765421 1 13578899999999995 49999999 799999999999999999999865543210
Q ss_pred ----e--------eeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcchhc
Q 007668 464 ----I--------TTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIE 514 (594)
Q Consensus 464 ----~--------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~ 514 (594)
. ..-...++.|++|+...- ..--...+-++-|.-+|.++|+..|.....+.
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 0 001124677788875432 22335678899999999999999997654443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=162.06 Aligned_cols=137 Identities=23% Similarity=0.282 Sum_probs=106.7
Q ss_pred CCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhC-----CCCeeeeeeeEEeCCC---c-eE
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI-----KHRYLVNLRGYCNSPT---S-KL 379 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~ 379 (594)
++..+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45678999999999996 3334444 79988765444567899999999999 5799999999998764 2 23
Q ss_pred EEEEc--cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeeeCCCCCCCeEecC----CCcEEEeecc
Q 007668 380 LIYDF--LPGGSLDEALHERSEQLDWDARLNIIMGAAKGL-AYLHHDCSPRIIHRDIKSSNILLDG----NLEARVSDFG 452 (594)
Q Consensus 380 lv~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~~l~Dfg 452 (594)
+|+|| ..+|+|.+++.+. .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +..++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5579999999652 35555 35677888777 99995 49999999999999973 3479999954
Q ss_pred cc
Q 007668 453 LA 454 (594)
Q Consensus 453 l~ 454 (594)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=189.83 Aligned_cols=251 Identities=20% Similarity=0.182 Sum_probs=182.7
Q ss_pred HHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC---CCeeeeeeeEEeCCCceE
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK---HRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~ 379 (594)
+.--+.|.+.+.||+|+||+||+|...+|+.||+|+=+..+.. +|..-.+++.+|+ -+.|+.+...+.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3334577788999999999999999999999999987664432 2222334455555 233444444445567778
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-------CCCcEEEeecc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-------GNLEARVSDFG 452 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-------~~~~~~l~Dfg 452 (594)
+|+||.+.|+|.+++. ..+.++|.-++.+..|+++.+.+||. .+||||||||+|.|+. +...++|+|||
T Consensus 771 lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999998 45679999999999999999999995 4999999999999994 23458999999
Q ss_pred cccccccC-CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 453 LAKLLEDE-ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 453 l~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
.+..+..- +.......++|-.+--+|...++.++..+|-|.++.+++-|+.|+.-- ...+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------------~~~g~- 908 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------------VKNGS- 908 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------------hcCCc-
Confidence 98765432 223556678899999999999999999999999999999999987531 00000
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
...++..++.+... ...-+++..+|+.|-..=|...++...|++.+.
T Consensus 909 -~~~~~~~~~Ry~~~--~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 909 -SWMVKTNFPRYWKR--DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -ceeccccchhhhhH--HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 11111111111111 223456666777776677778888888777553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.2e-20 Score=187.88 Aligned_cols=234 Identities=28% Similarity=0.368 Sum_probs=183.8
Q ss_pred eeeeecceEEEEEE----ecCCcEEEEEeecccchhh--HHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEEccC
Q 007668 314 IIGSGGFGTVYKLA----MDDGNVFALKRIDKLNEGF--DRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
.+|+|.||.|+.+. ...|..+|.|..++.+... ......|..++...+ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999742 3457788988887532221 114455777888887 9999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+|.+...+... ..++..........++-++.++| +.+++|||+|++||+++.+|++++.|||+++..-..+..
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99999998763 45666677777888999999999 569999999999999999999999999999876654433
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (594)
+||..|||||++. ....++|-||||++++||+||..||... ... .+.......+.+
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~----------~Il~~~~~~p~~ 209 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMK----------RILKAELEMPRE 209 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----------HHH----------HHhhhccCCchh
Confidence 7999999999998 5678899999999999999999998651 011 111112234566
Q ss_pred HHHHHHHHHHHcccCCCCCCCCH--HHHHHHHhc
Q 007668 547 SLDALLAVATQCVSSSPDDRPTM--HRVVQILES 578 (594)
Q Consensus 547 ~~~~l~~l~~~cl~~dP~~RPs~--~ev~~~L~~ 578 (594)
......+++..++..+|..|.-. ..+.+..+.
T Consensus 210 l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h 243 (612)
T KOG0603|consen 210 LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH 243 (612)
T ss_pred hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence 77788899999999999999865 344444433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=157.99 Aligned_cols=142 Identities=15% Similarity=0.187 Sum_probs=110.6
Q ss_pred CCCccceeeeecceEEEEEE--ecCCcEEEEEeecccchh------------------------hHHHHHHHHHHHhhCC
Q 007668 308 TLDDDHIIGSGGFGTVYKLA--MDDGNVFALKRIDKLNEG------------------------FDRFFERELEILGSIK 361 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 361 (594)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778999999999999997 568999999998743210 1123678999999997
Q ss_pred CC--eeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eeeCCCCCCCe
Q 007668 362 HR--YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR-IIHRDIKSSNI 438 (594)
Q Consensus 362 h~--niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivH~Dlk~~NI 438 (594)
+. .+.+++++ ...++||||+++++|...... ...........++.||+.++++||+ .+ ++||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence 53 33444443 235899999999888776533 2345566678999999999999995 48 99999999999
Q ss_pred EecCCCcEEEeecccccccc
Q 007668 439 LLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 439 ll~~~~~~~l~Dfgl~~~~~ 458 (594)
+++ ++.++++|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=155.37 Aligned_cols=134 Identities=20% Similarity=0.280 Sum_probs=112.6
Q ss_pred ceeeeecceEEEEEEecCCcEEEEEeecccch--------hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE--------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+.||+|++|.||+|.. .|..+++|+...... .....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 577889997653211 1124578899999999999998888787777888999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
+++++|.+.+.... + .+..++.+++.+|.++|+ .+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 788999999999999995 5999999999999999 78999999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.3e-17 Score=152.69 Aligned_cols=131 Identities=20% Similarity=0.301 Sum_probs=106.3
Q ss_pred eeeeecceEEEEEEecCCcEEEEEeecccc---h-----hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 314 IIGSGGFGTVYKLAMDDGNVFALKRIDKLN---E-----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.||+|+||.||+|.+ ++..+++|+..... . .....+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 56788999865321 1 11355778999999999887666555666666779999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
++++|.+.+..... .++.+++.+|.++| +.+++|||++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998754211 78999999999999 45999999999999999 789999999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=150.77 Aligned_cols=139 Identities=17% Similarity=0.136 Sum_probs=109.1
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchh----------------------hHHHHHHHHHHHhhCCCCe
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG----------------------FDRFFERELEILGSIKHRY 364 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n 364 (594)
..|...+.||+|+||.||++...+|+.||||++...... ....+..|...+..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 346778999999999999999888999999987542210 1123677888898887774
Q ss_pred --eeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC
Q 007668 365 --LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442 (594)
Q Consensus 365 --iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 442 (594)
+.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+ .+++||||+|+||++++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 444443 2345899999999998876431 2346788999999999995 59999999999999999
Q ss_pred CCcEEEeeccccccccc
Q 007668 443 NLEARVSDFGLAKLLED 459 (594)
Q Consensus 443 ~~~~~l~Dfgl~~~~~~ 459 (594)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.8e-18 Score=172.03 Aligned_cols=172 Identities=24% Similarity=0.390 Sum_probs=129.8
Q ss_pred ceEEEEEccCCCchhhhhhh--cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 377 SKLLIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
..++.|+++...+|.+++.. .....++.....++.|++.|+.| . +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 45789999999999999963 34568889999999999999999 2 8999999999999999999999999999
Q ss_pred cccccCC-----ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhc
Q 007668 455 KLLEDEE-----SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLIS 528 (594)
Q Consensus 455 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 528 (594)
....... ....+...||..||+||.+.+..|+.++||||+|++++|++. -..+++..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------------- 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------------- 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------------
Confidence 8776554 233455679999999999999999999999999999999998 22222110
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 007668 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRV 572 (594)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 572 (594)
.....+-|..+++.....-+.=..|+.+++.+.|.+||++.++
T Consensus 467 -~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 -ATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -HhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 0111111222221111111223578889999999999955444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=172.56 Aligned_cols=138 Identities=21% Similarity=0.288 Sum_probs=111.7
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeeccc-c------hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL-N------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
..|...+.||+|+||+||+|.+.+...++.+++.+. . ....+.+.+|++++..++|++++....++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 344667899999999999998765544333333221 1 112356889999999999999998888887777889
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
+||||+++++|.+++. ....++.+++++|.|||+ .+++||||||+||++ +++.++|+|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999999885 356799999999999995 599999999999999 5779999999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.2e-17 Score=175.74 Aligned_cols=214 Identities=26% Similarity=0.351 Sum_probs=148.3
Q ss_pred cCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+|+..+.|..|+||.||.+.++. .+.+|.| +.+.+- +.+- ++..-..|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-------------------
Confidence 467888999999999999998774 5677874 333211 1110 23333444444
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc---
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES--- 462 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~--- 462 (594)
|+....++. .+.++... +.+++|+| +.+|+|||+||+|.+|+.-|++|++|||+++.......
T Consensus 136 --gDc~tllk~-~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 --GDCATLLKN-IGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred --chhhhhccc-CCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 555555543 23333332 67899999 67999999999999999999999999999875432111
Q ss_pred -----------eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 463 -----------HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 463 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
.....++||+.|+|||++..+.|+..+|-|++|+|+||.+-|..||.+.-.++- +..++.+..
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~visd~i 275 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVISDDI 275 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhhhhc
Confidence 011346899999999999999999999999999999999999999987633321 111111110
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+.+..+....+..+++.+.++.+|.+|.-....++
T Consensus 276 -------~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 276 -------EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred -------cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 111223334477899999999999999985444433
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=7e-18 Score=145.16 Aligned_cols=129 Identities=25% Similarity=0.397 Sum_probs=87.7
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
..+++.|.|++|+|+ .+|+.+..|.+|+.|++++|+|+ .+|..++.+++|+.|+++-|++. .+|..|+.+|.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 356777777777777 66777777777777777777777 67777777777777777777777 6777777777777777
Q ss_pred ccCCcCCC-CCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCC
Q 007668 151 ISSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 151 l~~N~l~~-~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
|++|++.. .+|+.|..+..|+.|+|+.|.+.-.+++.+.+++|+.|.+..|.
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCc
Confidence 77777653 35555555555555555555555555555555555555555554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.9e-15 Score=132.80 Aligned_cols=134 Identities=24% Similarity=0.254 Sum_probs=113.5
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCC--CeeeeeeeEEeCCCceEEEEEccCCCc
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH--RYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999998765 7889998865433 4578899999999976 588999988888788999999998887
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 390 LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 390 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
+... +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7654 5566778899999999999964335799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.3e-15 Score=138.66 Aligned_cols=138 Identities=20% Similarity=0.276 Sum_probs=98.4
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeecccchhh---HHH---------------------HHHHHHHHhhCCCCe--e
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF---DRF---------------------FERELEILGSIKHRY--L 365 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~---------------------~~~E~~~l~~l~h~n--i 365 (594)
.+.||+|+||.||+|...+++.||||++....... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999886532111 111 134555666654332 3
Q ss_pred eeeeeEEeCCCceEEEEEccCCCchhhh-hhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC
Q 007668 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEA-LHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (594)
Q Consensus 366 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 444 (594)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. +.+|+||||||+||+++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CC
Confidence 444433 245899999999654322 21111 11 5677899999999999995 15999999999999999 88
Q ss_pred cEEEeeccccccccc
Q 007668 445 EARVSDFGLAKLLED 459 (594)
Q Consensus 445 ~~~l~Dfgl~~~~~~ 459 (594)
.++++|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-17 Score=141.76 Aligned_cols=132 Identities=27% Similarity=0.438 Sum_probs=124.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccccccc-CCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS-GSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L 149 (594)
..+|+.|++.+|+|+ .+|..++.+++|+.|++.-|++. ..|..|+.++.|+.|||++|++. ..+|..|..|+.|+.|
T Consensus 55 l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral 132 (264)
T KOG0617|consen 55 LKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL 132 (264)
T ss_pred hhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence 578999999999999 89999999999999999999999 99999999999999999999987 4689999999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c 205 (594)
+|+.|.+. ++|..++++++|+.|.+..|.+-..+.+.+.+.+|++|.+.||+..-
T Consensus 133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~v 187 (264)
T KOG0617|consen 133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTV 187 (264)
T ss_pred HhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeee
Confidence 99999999 59999999999999999999999888888999999999999998543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.2e-14 Score=138.43 Aligned_cols=136 Identities=19% Similarity=0.211 Sum_probs=105.0
Q ss_pred cceee-eecceEEEEEEecCCcEEEEEeecccc-------------hhhHHHHHHHHHHHhhCCCCee--eeeeeEEeCC
Q 007668 312 DHIIG-SGGFGTVYKLAMDDGNVFALKRIDKLN-------------EGFDRFFERELEILGSIKHRYL--VNLRGYCNSP 375 (594)
Q Consensus 312 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~ 375 (594)
...|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999998775 6778998875311 1223567889999999998775 6677764332
Q ss_pred Cc----eEEEEEccCC-CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEee
Q 007668 376 TS----KLLIYDFLPG-GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (594)
Q Consensus 376 ~~----~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~D 450 (594)
.. .++|+||+++ .+|.+++.. ..++.. .+.+|+.++.+||+ .||+||||||.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence 22 2499999997 689888754 234543 36789999999995 5999999999999999888999999
Q ss_pred ccccccc
Q 007668 451 FGLAKLL 457 (594)
Q Consensus 451 fgl~~~~ 457 (594)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.2e-16 Score=168.29 Aligned_cols=255 Identities=24% Similarity=0.319 Sum_probs=189.6
Q ss_pred cCCCccceeeeecceEEEEEEecC--CcEEEEEeecccc--hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD--GNVFALKRIDKLN--EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv 381 (594)
..|...+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 356667789999999998876543 3456666665432 223344555777767776 99999999999999999999
Q ss_pred EEccCCCchhhhh-hhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeeccccccccc
Q 007668 382 YDFLPGGSLDEAL-HERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLED 459 (594)
Q Consensus 382 ~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~~~~~ 459 (594)
.+|..++++.+.+ +......+....-..+.|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||++..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999999 5433245666677899999999999993 23999999999999999999 999999999987766
Q ss_pred --CCceeeeeeec-ccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 460 --EESHITTIVAG-TFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 460 --~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++......+ ....|.... ....
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~~~-- 251 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GRFT-- 251 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---cccc--
Confidence 33344455678 9999999999874 557889999999999999999999876543321 111111110 0000
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
............++..+++..+|+.|.+.+++..
T Consensus 252 -----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 -----QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----cCccccCChhhhhcccccccCCchhccccccccc
Confidence 0111223345678888999999999999888754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.9e-16 Score=157.86 Aligned_cols=138 Identities=22% Similarity=0.303 Sum_probs=123.8
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCCh---hhhCCCCCce
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPS---ELGNLSNLLN 148 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~ 148 (594)
.+|++|+|++|+|+...+..|..|..|++|+|++|.+...-...|..+++|++|||++|.|+..+.+ .|..|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 6899999999999987888999999999999999999977777899999999999999999977765 4788999999
Q ss_pred EeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCccc
Q 007668 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 149 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~~ 210 (594)
|+|.+|+|..+.-.+|.++++|++|||.+|.|.++-+.. ..+ +|+.|.+..-.++|+|++.
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~ 458 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLK 458 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHH
Confidence 999999999877789999999999999999999888876 445 9999999999999999863
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-13 Score=142.45 Aligned_cols=142 Identities=18% Similarity=0.224 Sum_probs=101.2
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeecccchhh----------------------------------------HHHHH
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF----------------------------------------DRFFE 351 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~ 351 (594)
.+.||.|++|.||+|.+++|+.||||+.+...... +-.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 47899999999999999999999999986421100 00244
Q ss_pred HHHHHHhhCC-----CCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHH-HHHHhhhcCC
Q 007668 352 RELEILGSIK-----HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK-GLAYLHHDCS 425 (594)
Q Consensus 352 ~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-~L~~LH~~~~ 425 (594)
+|++.+.+++ ++++.-..-+.......++||||++|++|.+.........+ +..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~--- 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR--- 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh---
Confidence 5666555552 34433222233334557999999999999988753222222 3456666666 4677884
Q ss_pred CCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 426 ~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
.|++|+|++|.||+++.++.++++|||++..+..
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 4999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-15 Score=145.14 Aligned_cols=141 Identities=18% Similarity=0.224 Sum_probs=129.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccc-ccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS-NYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 149 (594)
+...+.|+|..|+|+.+.+.+|+.+++|+.||||+|+|+.+-|+.|.+|.+|..|-+.+ |+|+....+.|.+|.+|+.|
T Consensus 66 P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 66 PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRL 145 (498)
T ss_pred CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHH
Confidence 46789999999999988888999999999999999999999999999999999888877 99995555679999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCcccc
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQINV 211 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~~~ 211 (594)
.+.-|++.-+....|..|++|..|.+..|.+..+.... ..+..++.+.+..|++.|+|.++-
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w 208 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW 208 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence 99999999888899999999999999999999777744 789999999999999999998874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6e-15 Score=143.25 Aligned_cols=126 Identities=29% Similarity=0.434 Sum_probs=116.3
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhh-CCCCCceEe
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELG-NLSNLLNLD 150 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 150 (594)
++|+.||...|-++ .+|+.++.+.+|..|+|..|+|. .+| +|+++..|++|+++.|+|. .+|.... ++++|..||
T Consensus 183 ~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLD 258 (565)
T KOG0472|consen 183 KRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLD 258 (565)
T ss_pred HHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeee
Confidence 57888999998888 88999999999999999999999 788 8999999999999999999 7777654 999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
|..|+++. .|..+.-+++|+.||+|+|.|++.++..+++ .|+.|.+.|||.
T Consensus 259 LRdNklke-~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 259 LRDNKLKE-VPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred cccccccc-CchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence 99999996 9999999999999999999999999999999 999999999984
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1e-14 Score=147.73 Aligned_cols=131 Identities=22% Similarity=0.218 Sum_probs=82.2
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.++++|+|+.|+++..-...+.+|+.|+.|+||+|.|...-++.+.-.++|++|+||+|+|+...+.+|..|..|++|+|
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 34556666666666444455566666666666666666555566666666666666666666555556666666666666
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCC----cccccCCcccccCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD----GVLTKFSESSFFGNR 202 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~----~~l~~l~~l~l~~N~ 202 (594)
++|+|+.+-...|..+++|+.|||++|.|+..+.+. ..|++|+.|.|.||+
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 666666555556666667777777777766655532 446667777777775
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-14 Score=140.60 Aligned_cols=91 Identities=19% Similarity=0.233 Sum_probs=68.2
Q ss_pred CccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccc
Q 007668 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSF 198 (594)
Q Consensus 120 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l 198 (594)
++|++|+|++|+|+.+-+.+|.++.+|++|+|..|+|..+-...|.++..|+.|+|.+|+|+.+.|.. ..+..|.+|++
T Consensus 274 ~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l 353 (498)
T KOG4237|consen 274 PNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNL 353 (498)
T ss_pred ccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeeh
Confidence 55566666666666555555666666666666666665545556778889999999999999988876 77889999999
Q ss_pred cCCCCCCCCccc
Q 007668 199 FGNRGLCGKQIN 210 (594)
Q Consensus 199 ~~N~~~c~~~~~ 210 (594)
-+|||.|+|.+.
T Consensus 354 ~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 354 LSNPFNCNCRLA 365 (498)
T ss_pred ccCcccCccchH
Confidence 999999999863
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=8e-15 Score=142.37 Aligned_cols=124 Identities=31% Similarity=0.424 Sum_probs=106.1
Q ss_pred EcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCC
Q 007668 78 SLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS 157 (594)
Q Consensus 78 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 157 (594)
.+++|.++ .+|..+..+++|..|+|++|-+. .+|..++.+..|+.||||+|+|. .+|..+..+..|+.+-.++|++.
T Consensus 418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~ 494 (565)
T KOG0472|consen 418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG 494 (565)
T ss_pred HhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc
Confidence 33333443 45556677888999999999888 88888999999999999999998 88888888778888888889999
Q ss_pred CCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 158 DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 158 ~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
.+.|..+.+|.+|.+|||.+|.|..+||..+++.+|+.|.+.|||+.
T Consensus 495 ~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 495 SVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 87777799999999999999999999999999999999999999975
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-14 Score=146.15 Aligned_cols=129 Identities=29% Similarity=0.420 Sum_probs=84.6
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccccccc------------------
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS------------------ 133 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~------------------ 133 (594)
+++..|+||+|+|..+....|-+|+.|-+||||+|+|. .+|+.+..|..|++|+||+|.+.
T Consensus 126 Kn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 126 KNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred cCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 45666677777776333345566677777777777776 56666666666777777666543
Q ss_pred -------CCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCC
Q 007668 134 -------GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 134 -------~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
..+|.++..|.+|..+|||.|.+. .+|+.+-++++|+.|+||+|+|+...-..+.+.+|++|+++.|+
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQ 279 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQ 279 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccch
Confidence 235566666667777777777776 36777777777777777777776655555556666666666665
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.3e-13 Score=126.87 Aligned_cols=197 Identities=21% Similarity=0.287 Sum_probs=137.2
Q ss_pred HHhhCCCCeeeeeeeEEeC-----CCceEEEEEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 007668 356 ILGSIKHRYLVNLRGYCNS-----PTSKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427 (594)
Q Consensus 356 ~l~~l~h~niv~l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ 427 (594)
-+-++.|-|||++..|+.+ .....++.|||+.|++..+|++ ....+......+|+-||..||.|||.. .+.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 3556679999999999854 3346789999999999999985 344578888899999999999999985 899
Q ss_pred eeeCCCCCCCeEecCCCcEEEeecccccccccCC----ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh
Q 007668 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE----SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503 (594)
Q Consensus 428 ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt 503 (594)
|+|+++..+-|++..++-+|+.- +......... ......-.+-++|.+||+-..-..+.++|||+||+..+||.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999888888752 2111111100 000111235789999999887788889999999999999988
Q ss_pred CCCCCCcchhc--ccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 504 GKRPTDASFIE--KGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 504 g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+..-...+... ....+. ........ ..=..++.+|++..|..||+|.+++.
T Consensus 278 lEiq~tnseS~~~~ee~ia----------~~i~~len----------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIA----------NVIIGLEN----------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhh----------hheeeccC----------ccccCcCcccccCCCCCCcchhhhhc
Confidence 76542111000 000000 00000000 01135677999999999999998763
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.7e-13 Score=122.39 Aligned_cols=122 Identities=29% Similarity=0.365 Sum_probs=48.0
Q ss_pred CcEEEEEcccCCCCCCCCcccc-CcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhh-hCCCCCceE
Q 007668 72 KRVITLSLTNHKLSGPISADLG-KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNL 149 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L 149 (594)
.++++|+|++|.|+ .+. .++ .+.+|+.|+|++|.|+ .++ .+..+++|++|+|++|+|+ .++..+ ..+++|++|
T Consensus 19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 36788889998888 443 454 5788888999999888 454 5788888889999999888 565544 468888889
Q ss_pred eccCCcCCCCCC-ccccccCCCcEEEeecccccccCCC----CcccccCCcccc
Q 007668 150 DISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIPS----DGVLTKFSESSF 198 (594)
Q Consensus 150 ~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~----~~~l~~l~~l~l 198 (594)
+|++|+|...-. ..+..+++|+.|+|.+|+++..... ...+|+|+.|+.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 999888876322 4567788888888888888755331 155667766654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.1e-14 Score=144.34 Aligned_cols=131 Identities=23% Similarity=0.303 Sum_probs=91.6
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccC-CCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFY-GEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.+|+.|.+++|+|. .+-..++.|+.|+.+++.+|+|. .-+|..+..|..|+.||||+|+++ ..|..+..-.++-.|+
T Consensus 55 qkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLN 132 (1255)
T KOG0444|consen 55 QKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLN 132 (1255)
T ss_pred hhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEE
Confidence 35666666666666 45556666677777777777664 236666677777777777777777 7777777777777777
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
||+|+|..+...-|.+|..|-.||||+|+|...||....+..|++|.|++||..
T Consensus 133 LS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~ 186 (1255)
T KOG0444|consen 133 LSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLN 186 (1255)
T ss_pred cccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhh
Confidence 777777764444566777777777777777777777777777777777777743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=135.20 Aligned_cols=247 Identities=23% Similarity=0.274 Sum_probs=181.4
Q ss_pred CCCccceeee--ecceEEEEEEe---cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceE
Q 007668 308 TLDDDHIIGS--GGFGTVYKLAM---DDGNVFALKRIDKL--NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 308 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 379 (594)
.|.....+|. |.+|.||.+.. .++..+|+|+-+.. .......=.+|+....++ .|+|.++....+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556688999 99999999865 46888999984432 122223334566666666 4999999888899999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeeeCCCCCCCeEecCC-CcEEEeecccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK----GLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLA 454 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~~l~Dfgl~ 454 (594)
+-+|.+ +.+|..+.+.....++....+....+..+ |+.++| +..++|-|+||.||+...+ ...+++|||+.
T Consensus 195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence 999987 57999988876666777788888888888 999999 5699999999999999998 88999999999
Q ss_pred cccccCCce----eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 455 KLLEDEESH----ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 455 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
..+.+..-. ......|...|++||... +.++...|+|++|.+..+..++..+..... ...|...
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~~----- 338 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQL----- 338 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC------CCCcccc-----
Confidence 888765421 112235788999999876 478889999999999999999877643210 0111110
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+...+.+.- ......++...+.+|++.+|..|++.+.+..
T Consensus 339 r~~~ip~e~----~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGYIPLEF----CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccCchhh----hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 011111111 1122344556899999999999999888764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.4e-11 Score=125.63 Aligned_cols=169 Identities=15% Similarity=0.256 Sum_probs=127.6
Q ss_pred EecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHH
Q 007668 327 AMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR 406 (594)
Q Consensus 327 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~ 406 (594)
...++.+|.|...+..+........+-++.++.+|||||++++..+...+..|+|+|-+.- |..++.+ +.....
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~----l~~~~v 106 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE----LGKEEV 106 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH----hHHHHH
Confidence 3446888888888766665556678888999999999999999999999999999998743 5555544 235566
Q ss_pred HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecccCccCccccccCCCC
Q 007668 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRAT 486 (594)
Q Consensus 407 ~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 486 (594)
...++||+.||.+||+.| +++|++|....|+++..|+.||++|.++.....-.. ......---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 778999999999999754 899999999999999999999999988765432221 011111122456666544322
Q ss_pred ccchhhhHHHHHHHHHhCCC
Q 007668 487 EKTDVYSFGVLVLEVLSGKR 506 (594)
Q Consensus 487 ~~~Dv~s~G~vl~elltg~~ 506 (594)
-..|.|.||++++|++.|..
T Consensus 182 ~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cchhhhhHHHHHHHHhCccc
Confidence 34699999999999999943
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.8e-12 Score=133.56 Aligned_cols=144 Identities=14% Similarity=0.169 Sum_probs=95.0
Q ss_pred hcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccch----------------------------------hhHH--
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNE----------------------------------GFDR-- 348 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~----------------------------------~~~~-- 348 (594)
+..|+. +.||.|++|.||+|.+++ |+.||||+.+.... ...+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 789999999999999988 99999999874210 0111
Q ss_pred ----HHHHHHHHHhhCC----CCeeeeeeeEEe-CCCceEEEEEccCCCchhhhh--hhcCC---CCCHHHHHHHHHHHH
Q 007668 349 ----FFERELEILGSIK----HRYLVNLRGYCN-SPTSKLLIYDFLPGGSLDEAL--HERSE---QLDWDARLNIIMGAA 414 (594)
Q Consensus 349 ----~~~~E~~~l~~l~----h~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l--~~~~~---~l~~~~~~~i~~~ia 414 (594)
.+.+|+..+.+++ +.+.+.+-.++. -....++||||++|+.+.+.- ...+. .+.......++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1344554444442 333343333332 245678999999999998753 22211 122222333333332
Q ss_pred HHHHHhhhcCCCCeeeCCCCCCCeEecCCC----cEEEeecccccccccC
Q 007668 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLAKLLEDE 460 (594)
Q Consensus 415 ~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~~l~Dfgl~~~~~~~ 460 (594)
..|++|+|++|.||+++.++ .+++.|||++..+...
T Consensus 278 ----------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 ----------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ----------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 23999999999999999888 9999999999877643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-11 Score=112.81 Aligned_cols=130 Identities=20% Similarity=0.167 Sum_probs=95.3
Q ss_pred ceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeee-eeeeEEeCCCceEEEEEccCCCchh
Q 007668 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV-NLRGYCNSPTSKLLIYDFLPGGSLD 391 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~gsL~ 391 (594)
+.++.|.++.||++... +..+++|....... ....+..|++++..+.+.+++ +++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 57899999999998865 77899998765432 123467899999888655544 344433 23458999999998876
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 392 EALHERSEQLDWDARLNIIMGAAKGLAYLHHDC--SPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 392 ~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
+.- .....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 531 011345778999999999641 12369999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-12 Score=117.84 Aligned_cols=118 Identities=30% Similarity=0.363 Sum_probs=42.2
Q ss_pred cccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcC-CCCccceeecccccccCCCChhhhCCCCCceEeccCCcCC
Q 007668 79 LTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELG-NCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS 157 (594)
Q Consensus 79 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 157 (594)
|+.+.|. ..+ .+.+..++++|+|++|.|+ .+. .++ .+.+|+.|+||+|.|+ .++ .+..+++|++|++++|+|+
T Consensus 4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIE-QIA-QYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred ccccccc-ccc-ccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 4455555 333 3455668999999999999 564 565 6899999999999999 565 4888999999999999999
Q ss_pred CCCCccc-cccCCCcEEEeecccccccCC--CCcccccCCcccccCCCC
Q 007668 158 DYIPPSL-GKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 158 ~~~~~~~-~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~l~~N~~ 203 (594)
. ++..+ ..+++|+.|+|++|+|...-. ....+++|+.|++.|||.
T Consensus 78 ~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 78 S-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred c-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 7 54445 479999999999999986543 237899999999999985
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.4e-13 Score=145.01 Aligned_cols=130 Identities=28% Similarity=0.378 Sum_probs=114.8
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCC-CCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
...|+.|.|.+|.|+...-+.+.++++|+.|+|++|+|. .+| ..+.++..|++|+||+|+++ .+|..+..++.|++|
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL 435 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTL 435 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHH
Confidence 357889999999999777778899999999999999999 566 45889999999999999999 899999999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
...+|+|.. .| .+..+++|+.+||+.|+|+...-.. ...++|++|+|+||.++
T Consensus 436 ~ahsN~l~~-fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 436 RAHSNQLLS-FP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhcCCceee-ch-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 999999995 77 8999999999999999998654333 33489999999999974
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5e-13 Score=125.33 Aligned_cols=127 Identities=22% Similarity=0.260 Sum_probs=110.8
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.-|++|||++|.|+ .+.++..-+|.++.|+||+|.|. .+- .+..|++|+.||||+|.++ .+..+=..|-++++|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 46899999999999 88888888999999999999998 554 4889999999999999999 67777778899999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccC--CCCcccccCCcccccCCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI--PSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~--~~~~~l~~l~~l~l~~N~~~ 204 (594)
+.|.|.. -..+..|-+|..||+++|+|.... ...+.+|.|+.+.|.+||..
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 9999985 256788889999999999997653 35589999999999999853
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.1e-11 Score=135.96 Aligned_cols=90 Identities=36% Similarity=0.601 Sum_probs=86.7
Q ss_pred cCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEee
Q 007668 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176 (594)
Q Consensus 97 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 176 (594)
.++.|+|++|.++|.+|..+..|++|+.|+|++|.|+|.+|..+..+++|+.|+|++|+|++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 58899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCC
Q 007668 177 NNFLVGAIPS 186 (594)
Q Consensus 177 ~N~l~~~~~~ 186 (594)
+|++++.+|.
T Consensus 499 ~N~l~g~iP~ 508 (623)
T PLN03150 499 GNSLSGRVPA 508 (623)
T ss_pred CCcccccCCh
Confidence 9999998875
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.3e-10 Score=105.50 Aligned_cols=136 Identities=14% Similarity=0.155 Sum_probs=97.7
Q ss_pred ceeeeecceEEEEEEecC-------CcEEEEEeeccc-------------c---------hhhHHHH----HHHHHHHhh
Q 007668 313 HIIGSGGFGTVYKLAMDD-------GNVFALKRIDKL-------------N---------EGFDRFF----ERELEILGS 359 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~~ 359 (594)
..||.|.-+.||.|...+ +..+|||..+.. . ....+.+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999997553 478999977421 0 0112223 379999988
Q ss_pred CCC--CeeeeeeeEEeCCCceEEEEEccCCCchhh-hhhhcCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeeCCCCC
Q 007668 360 IKH--RYLVNLRGYCNSPTSKLLIYDFLPGGSLDE-ALHERSEQLDWDARLNIIMGAAKGLAYL-HHDCSPRIIHRDIKS 435 (594)
Q Consensus 360 l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlk~ 435 (594)
+.. -++.+++++ ...++||||+.++.+.. .++. ..++......+..+++.+|..+ | ..+++||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence 853 455555554 46789999997654432 2221 2345556677889999999999 6 45999999999
Q ss_pred CCeEecCCCcEEEeecccccccc
Q 007668 436 SNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 436 ~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
.||+++ ++.++++|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-10 Score=103.21 Aligned_cols=132 Identities=25% Similarity=0.354 Sum_probs=100.7
Q ss_pred ceeeeecceEEEEEEecCCcEEEEEe-ecc-cc-h-----hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 313 HIIGSGGFGTVYKLAMDDGNVFALKR-IDK-LN-E-----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~-~~-~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
..+++|+-+.+|.+.+.+.. +++|. +.+ .. + -....-.+|++++.+++--.|...+=+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999776444 44443 322 11 1 1234567799999998766666556666788888999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
+++-.|.+.+... ...++..+-.-+.-|| ..+|+|+||.++||.+.++. +.++|||++..-
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999898753 2567778888888999 45999999999999998764 999999999753
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.7e-10 Score=100.49 Aligned_cols=143 Identities=20% Similarity=0.245 Sum_probs=105.3
Q ss_pred ccceeeeecceEEEEEEecCCcEEEEEe-ecc-c------chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 311 DDHIIGSGGFGTVYKLAMDDGNVFALKR-IDK-L------NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 311 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~-~------~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
...++-||+-+.|+++.+. |+...||. +.+ . ..-..+...+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999887 55555553 322 1 1112456778999999887555555555666777778999
Q ss_pred EccCC-CchhhhhhhcCCCCCHH-HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC---cEEEeeccccccc
Q 007668 383 DFLPG-GSLDEALHERSEQLDWD-ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVSDFGLAKLL 457 (594)
Q Consensus 383 e~~~~-gsL~~~l~~~~~~l~~~-~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~~l~Dfgl~~~~ 457 (594)
||+++ -++.+++......-..+ .....+..|-+.+.-||. .+++|+||..+||++..++ .+.++|||++..-
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99966 37888887644333333 337889999999999995 5999999999999997554 3589999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.5e-10 Score=109.42 Aligned_cols=142 Identities=22% Similarity=0.305 Sum_probs=110.7
Q ss_pred ceeeeecceEEEEEEecCCcEEEEEeecccch-hhHHHHHHHHHHHhhCCC--CeeeeeeeEEeCCC---ceEEEEEccC
Q 007668 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE-GFDRFFERELEILGSIKH--RYLVNLRGYCNSPT---SKLLIYDFLP 386 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lv~e~~~ 386 (594)
+.|+.|..+.||++...+|..+++|....... .....+..|++++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999887778999998765332 134568899999999976 34566777765542 5689999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------------
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC------------------------------------------ 424 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------ 424 (594)
+.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988886632 34677788888889999998888420
Q ss_pred -----------CCCeeeCCCCCCCeEecC--CCcEEEeecccccc
Q 007668 425 -----------SPRIIHRDIKSSNILLDG--NLEARVSDFGLAKL 456 (594)
Q Consensus 425 -----------~~~ivH~Dlk~~NIll~~--~~~~~l~Dfgl~~~ 456 (594)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999997763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-09 Score=107.32 Aligned_cols=260 Identities=16% Similarity=0.186 Sum_probs=159.8
Q ss_pred CccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeE------E-eCCCceEEE
Q 007668 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGY------C-NSPTSKLLI 381 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~------~-~~~~~~~lv 381 (594)
...+.||+|+.+.+|-.- +-..-+.|+..........+. +..|... .||-+-.=+.+ . .......+.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 456889999999999632 111224466655444322222 2223332 45543321111 0 112224567
Q ss_pred EEccCCCc-hhhhhh-----hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 382 YDFLPGGS-LDEALH-----ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 382 ~e~~~~gs-L~~~l~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
|..+++-- ..++.. ++....+|...+++++.+|.+.+.||+. |.+-+|+.++|+|+++++.+.+.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 77765542 222221 2234589999999999999999999965 89999999999999999999999865443
Q ss_pred ccccCCceeeeeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhC-CCCCCcchhccc-----chHHHHHH
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSG-KRPTDASFIEKG-----LNIVGWLN 524 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~-----~~~~~~~~ 524 (594)
.. .........+|...|.+||.-. +-..+...|-|.+|+++++++.| ++||.+-..... ...+....
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 32 2223344567899999999754 33557789999999999999996 999976432211 11111111
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHHhcc
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSS--PDDRPTMHRVVQILESE 579 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPs~~ev~~~L~~~ 579 (594)
+....+.......+.......-..+.+.-+..+|+... |.-|||++-++..|.+.
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 12222222222222222122334467888888999764 56899999988877653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.4e-11 Score=124.60 Aligned_cols=245 Identities=20% Similarity=0.243 Sum_probs=175.7
Q ss_pred HhcCCCccceeeeecceEEEEEEec--CCcEEEEEeecccchh--hHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEG--FDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 379 (594)
.+.+|.....||.|.|+.|++...+ ++..|++|.+.+.... .+..-..|+.+...+ .|.+++.....+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457778889999999999987543 6788999988763322 222334566665555 5889999888888888888
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC-CcEEEeecccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLE 458 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~~l~Dfgl~~~~~ 458 (594)
+=-||++++++...+. -...++...++++..|++.++.++| ++.++|+|++|+||++..+ +..++.|||.+..+.
T Consensus 343 ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred CchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccc
Confidence 9999999998887763 2345778889999999999999999 6799999999999999876 888999999987422
Q ss_pred cCCceeeeeeecccCcc--CccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 459 DEESHITTIVAGTFGYL--APEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
-. .....+.-+++ +|+......+..+.|+++||.-+.|..++..--... .....+.
T Consensus 419 ~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------------------~~~~~i~ 476 (524)
T KOG0601|consen 419 FS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG------------------VQSLTIR 476 (524)
T ss_pred ee----cccccccccccccchhhccccccccccccccccccccccccCcccCccc------------------ccceeee
Confidence 11 11112233444 555566677889999999999999999987542210 0111122
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L 576 (594)
...++..+... ..+..+.+.+..+++..||.+.+.....
T Consensus 477 ~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 477 SGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred cccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccc
Confidence 22222222222 5677888899999999999988876543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.6e-11 Score=128.78 Aligned_cols=36 Identities=22% Similarity=0.074 Sum_probs=19.5
Q ss_pred CCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 169 RLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 169 ~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
+|+.|+|++|+|+.++.....+++|+.|++++|++.
T Consensus 423 ~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 423 GLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred hhhhhhhccCcccccChHHhhccCCCeEECCCCCCC
Confidence 344455555555544333455666666666666644
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.7e-11 Score=87.03 Aligned_cols=59 Identities=34% Similarity=0.492 Sum_probs=27.5
Q ss_pred cCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCc
Q 007668 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155 (594)
Q Consensus 97 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 155 (594)
+|++|+|++|+|+...+..|.++++|++|+|++|.|+...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44444444444443333344444444444444444443333444444444444444444
|
... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.8e-10 Score=125.85 Aligned_cols=119 Identities=25% Similarity=0.343 Sum_probs=81.0
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
+.+++.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|+
T Consensus 198 p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~ 268 (754)
T PRK15370 198 PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLD 268 (754)
T ss_pred ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence 356888888888888 5565543 57888888888887 5665553 46788888888887 6676654 4678888
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
|++|+|+. +|..+. ++|+.|+|++|+|++.+... .++|+.|++++|..
T Consensus 269 Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l--p~sL~~L~Ls~N~L 316 (754)
T PRK15370 269 LFHNKISC-LPENLP--EELRYLSVYDNSIRTLPAHL--PSGITHLNVQSNSL 316 (754)
T ss_pred CcCCccCc-cccccC--CCCcEEECCCCccccCcccc--hhhHHHHHhcCCcc
Confidence 88888875 565543 47788888888777654322 13455555555543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.1e-09 Score=106.87 Aligned_cols=168 Identities=21% Similarity=0.331 Sum_probs=126.8
Q ss_pred cceEEEEEE-ecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEe----CCCceEEEEEccCC-Cchhh
Q 007668 319 GFGTVYKLA-MDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN----SPTSKLLIYDFLPG-GSLDE 392 (594)
Q Consensus 319 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~e~~~~-gsL~~ 392 (594)
-..+.||+. ..||..|++|+++.........-..-++..+++.|+|||++.+++. .....++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 456788885 4589999999995433333323344577889999999999998875 34556899999875 46766
Q ss_pred hhhh--------------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 393 ALHE--------------RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 393 ~l~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
.-.. .+...++..++.++.|+..||.++|+ .|+..+-|.+++|+++++.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5431 12347788999999999999999994 599999999999999999999999888776655
Q ss_pred cCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 507 (594)
.+.. |-+ +-..+-|.-.||.+++.|.||..-
T Consensus 445 ~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 4330 111 123467999999999999998643
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-10 Score=86.50 Aligned_cols=61 Identities=36% Similarity=0.530 Sum_probs=55.4
Q ss_pred CccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccc
Q 007668 120 TELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180 (594)
Q Consensus 120 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l 180 (594)
|+|++|+|++|+|+...+..|..+++|++|+|++|+|+.+.|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999966667899999999999999999988888999999999999999986
|
... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.3e-10 Score=125.25 Aligned_cols=117 Identities=25% Similarity=0.369 Sum_probs=68.2
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 241 ~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~L 311 (754)
T PRK15370 241 DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNV 311 (754)
T ss_pred ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHh
Confidence 46788888888888 5666553 47888888888887 5666554 47788888888777 4554432 24555555
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
++|+|+. +|..+. ++|+.|++++|.|++++... .++|+.|++++|+
T Consensus 312 s~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l--~~sL~~L~Ls~N~ 357 (754)
T PRK15370 312 QSNSLTA-LPETLP--PGLKTLEAGENALTSLPASL--PPELQVLDVSKNQ 357 (754)
T ss_pred cCCcccc-CCcccc--ccceeccccCCccccCChhh--cCcccEEECCCCC
Confidence 5555554 333221 34445555555544433221 1344444444443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.9e-11 Score=127.78 Aligned_cols=127 Identities=31% Similarity=0.372 Sum_probs=102.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
..+|+.|+|++|+|.......+.+|+.|+.|+||+|+|+ .+|..+.++..|++|...+|+|. .+| .+..++.|+.+|
T Consensus 382 ~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred ccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 578999999999999555568899999999999999999 89999999999999999999999 888 799999999999
Q ss_pred ccCCcCCCCC-CccccccCCCcEEEeecccccccCC-CCcccccCCcccccCC
Q 007668 151 ISSNSLSDYI-PPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGN 201 (594)
Q Consensus 151 l~~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~l~~N 201 (594)
||.|+|+... |... .-++|++|||++|.-..... ....++++...++.-|
T Consensus 459 lS~N~L~~~~l~~~~-p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEAL-PSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred cccchhhhhhhhhhC-CCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 9999998643 3332 23899999999998532211 1234444444444444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.4e-11 Score=121.63 Aligned_cols=124 Identities=28% Similarity=0.400 Sum_probs=64.2
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEecc
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 152 (594)
.|+.|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.|. .+|..++.+.+|+.|.+.
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 3445555555555 4444444333 455555555555 45555555555555555555555 455555555555555555
Q ss_pred CCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCC
Q 007668 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 153 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
.|++.. +|..+..| .|..||++.|+++.++-....|..|++|.|.+||
T Consensus 198 Rn~l~~-lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 198 RNHLED-LPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred hhhhhh-CCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCC
Confidence 555554 44444433 3555555555555554444555555555555555
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.3e-08 Score=93.59 Aligned_cols=127 Identities=19% Similarity=0.258 Sum_probs=82.9
Q ss_pred EEEEEEecCCcEEEEEeeccc---------------c-----------hhhHHHHHHHHHHHhhCCCC--eeeeeeeEEe
Q 007668 322 TVYKLAMDDGNVFALKRIDKL---------------N-----------EGFDRFFERELEILGSIKHR--YLVNLRGYCN 373 (594)
Q Consensus 322 ~Vy~~~~~~~~~vavK~~~~~---------------~-----------~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~ 373 (594)
.||.|...+|..+|+|..+.. . ........+|.+.|.++..- ++.+++.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999999999999977421 0 00123467899999999765 455666442
Q ss_pred CCCceEEEEEccC--CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 374 SPTSKLLIYDFLP--GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 374 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
...+||||++ +..+..+.... ++......++.+++..+..+++ ..|++|+|+++.||+++++ .+.++||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEEEec
Confidence 4579999998 55555443321 1133455677788886666432 4599999999999999987 9999999
Q ss_pred ccccccc
Q 007668 452 GLAKLLE 458 (594)
Q Consensus 452 gl~~~~~ 458 (594)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9886544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.6e-10 Score=108.65 Aligned_cols=105 Identities=22% Similarity=0.224 Sum_probs=91.4
Q ss_pred CcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEE
Q 007668 94 KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITF 173 (594)
Q Consensus 94 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l 173 (594)
..+.|++||||+|.|+ .+.++..-+|.++.|++|+|.|+ .+-+ +..|++|+.||||+|.++. +.++-..|-+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHh-hhhhHhhhcCEeee
Confidence 3567999999999999 78888889999999999999999 5554 8999999999999999996 67777889999999
Q ss_pred EeecccccccCCCCcccccCCcccccCCCC
Q 007668 174 NVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 174 ~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
.|+.|.|... .....+-+|..|++.+|+.
T Consensus 358 ~La~N~iE~L-SGL~KLYSLvnLDl~~N~I 386 (490)
T KOG1259|consen 358 KLAQNKIETL-SGLRKLYSLVNLDLSSNQI 386 (490)
T ss_pred ehhhhhHhhh-hhhHhhhhheeccccccch
Confidence 9999999743 3456788899999999985
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.5e-11 Score=125.35 Aligned_cols=127 Identities=24% Similarity=0.288 Sum_probs=109.4
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChh-hhCCCCCceEec
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDI 151 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l 151 (594)
.|.+.+.+.|.|+ .+..++.-++.|+.|||++|+++... .+..|+.|++|||++|.++ .+|.. ...+ +|+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 6788899999999 88889999999999999999999443 7899999999999999999 67753 3344 4999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCC--CcccccCCcccccCCCCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS--DGVLTKFSESSFFGNRGLCG 206 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~--~~~l~~l~~l~l~~N~~~c~ 206 (594)
++|.++.. ..+.+|.+|+.|||++|-|.+...- ++.+..|..|+|.|||.-|.
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 99999853 4578999999999999999876543 37889999999999998776
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.6e-09 Score=126.02 Aligned_cols=128 Identities=17% Similarity=0.248 Sum_probs=104.7
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 578899999988777889999999999999999875444788766 7899999999987655466653 367899999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeec-ccccccCCCCcccccCCcccccCCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSN-NFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~-N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
++|.|+. +|.++..+++|+.|+|++ |+|++++.....+++|+.+++++++.+
T Consensus 854 s~n~i~~-iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~L 906 (1153)
T PLN03210 854 SRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGAL 906 (1153)
T ss_pred CCCCCcc-ChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCccc
Confidence 9999986 888899999999999988 678877766688889999998877544
|
syringae 6; Provisional |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=4.3e-10 Score=122.42 Aligned_cols=249 Identities=21% Similarity=0.211 Sum_probs=169.5
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
..+.+.+.+-+-+|.++.++.+.-. .|...+.|...... ....+....+-.+.-..++|-++...--+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456666677888999999876433 23333444332211 1111222222223333456777766555556677889
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc-
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED- 459 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~- 459 (594)
+++|..+++|...++... ..+.+.....+..+..+++|||. ..+.|+|++|.|.+...+++.+++|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999999998643 34444445566677889999994 4689999999999999999999999984322110
Q ss_pred --------------------CC---------ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCc
Q 007668 460 --------------------EE---------SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA 510 (594)
Q Consensus 460 --------------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 510 (594)
.. ........||+.|.+||...+......+|.|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 00 0112335689999999999999999999999999999999999999977
Q ss_pred chhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007668 511 SFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMH 570 (594)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 570 (594)
...++.. + -..-.+..++..+........+++...+..+|.+|-.+.
T Consensus 1038 ~tpq~~f-----------~--ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIF-----------E--NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhhh-----------h--ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 5433211 0 011122334445566667788899999999999998876
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.7e-10 Score=115.76 Aligned_cols=133 Identities=21% Similarity=0.223 Sum_probs=101.0
Q ss_pred CCcEEEEEcccCCCCCCCCccccCccc---CCeeecccCccCC----CCCCCcCCC-CccceeecccccccCC----CCh
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQ---LKFLNLHSNNFYG----EIPSELGNC-TELQGLSLQSNYLSGS----IPS 138 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~ 138 (594)
..+|+.|+|++|.+.+..+..+..+.+ |+.|+|++|++++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 568999999999998766666666666 9999999999873 233345666 8999999999999843 344
Q ss_pred hhhCCCCCceEeccCCcCCCC----CCccccccCCCcEEEeecccccccCC-----CCcccccCCcccccCCCC
Q 007668 139 ELGNLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAIP-----SDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~~~-----~~~~l~~l~~l~l~~N~~ 203 (594)
.+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++... ....+++|+.|++++|+.
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l 233 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL 233 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence 567778999999999999842 23345566799999999999874422 224578899999999863
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.9e-09 Score=116.23 Aligned_cols=98 Identities=28% Similarity=0.332 Sum_probs=71.6
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+ .+|..+ ++|+.|+|
T Consensus 222 ~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~L 289 (788)
T PRK15387 222 AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWI 289 (788)
T ss_pred cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCchh-hhhhch---hhcCEEEC
Confidence 46788888888888 45542 578888888888888 56643 357888888888887 566533 46778888
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 185 (594)
++|+|+. +|. .+++|+.|+|++|+|++++.
T Consensus 290 s~N~Lt~-LP~---~p~~L~~LdLS~N~L~~Lp~ 319 (788)
T PRK15387 290 FGNQLTS-LPV---LPPGLQELSVSDNQLASLPA 319 (788)
T ss_pred cCCcccc-ccc---cccccceeECCCCccccCCC
Confidence 8888886 554 24678888888888887543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.8e-09 Score=121.99 Aligned_cols=128 Identities=18% Similarity=0.222 Sum_probs=83.9
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+|+.|++.++.++ .+|..| .+.+|+.|+|++|+|. .+|..+..+++|+.|+|++|.....+|. +..+++|+.|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEe
Confidence 34666666666666 556555 4567777777777776 5666677777777777776654435664 666777777777
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
++|.....+|..+.++++|+.|++++|..-+.+|....+++|+.|++++|..
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSR 716 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence 7765545577777777777777777754333334333567777777777653
|
syringae 6; Provisional |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.9e-08 Score=94.76 Aligned_cols=140 Identities=17% Similarity=0.146 Sum_probs=98.8
Q ss_pred ceeeeecceEEEEEEecCCcEEEEEeecccchh-----------hHHHHHHHHHHHhhCCCCe--eeeeeeEEeC-----
Q 007668 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG-----------FDRFFERELEILGSIKHRY--LVNLRGYCNS----- 374 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~----- 374 (594)
+.+-......|+++.+ +|+.+.||+....... ....+.+|.+.+.++...+ +++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555555777655 5778999976432211 1124778999888874322 2344555432
Q ss_pred CCceEEEEEccCCC-chhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-------CCc
Q 007668 375 PTSKLLIYDFLPGG-SLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-------NLE 445 (594)
Q Consensus 375 ~~~~~lv~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~ 445 (594)
....++|+|++++. +|.+++... ....+...+..++.+++..+.-||+ .||+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence 23467999999886 898887532 2345566778899999999999995 59999999999999975 468
Q ss_pred EEEeecccccc
Q 007668 446 ARVSDFGLAKL 456 (594)
Q Consensus 446 ~~l~Dfgl~~~ 456 (594)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999997753
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.6e-09 Score=113.58 Aligned_cols=131 Identities=35% Similarity=0.474 Sum_probs=98.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcc-cCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLD-QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
...++.|++.+|.++ .++.....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....+++|+.|
T Consensus 115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L 191 (394)
T COG4886 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL 191 (394)
T ss_pred ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence 346788888888888 6666666674 8888888888887 66667788888888888888888 677666677888888
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c 205 (594)
++++|+++. +|.....+..|++|.+++|++...+.....+.++..+.+.+|+..+
T Consensus 192 ~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 192 DLSGNKISD-LPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred eccCCcccc-CchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee
Confidence 888888885 6665556666888888888665566656677777777777776554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.2e-10 Score=118.68 Aligned_cols=125 Identities=28% Similarity=0.356 Sum_probs=94.2
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEecc
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 152 (594)
..+..||+.|++. .+|..+..+-.|+.|.|++|.|. .+|..+.+|..|++|||+.|+++ .+|..+..|+ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 4556777888887 77777777777788888888777 77777778888888888888877 7777777765 7777777
Q ss_pred CCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCC
Q 007668 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 153 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
+|+++. +|..++.++.|..||.+.|++...++..+.+.+|+.|.+..|.
T Consensus 152 NNkl~~-lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~ 200 (722)
T KOG0532|consen 152 NNKLTS-LPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNH 200 (722)
T ss_pred cCcccc-CCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhh
Confidence 777774 7777777777777777777777777766777777777766665
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.8e-10 Score=114.73 Aligned_cols=132 Identities=25% Similarity=0.267 Sum_probs=91.9
Q ss_pred CcEEEEEcccCCCCC----CCCccccCc-ccCCeeecccCccCCC----CCCCcCCCCccceeecccccccCC----CCh
Q 007668 72 KRVITLSLTNHKLSG----PISADLGKL-DQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGS----IPS 138 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 138 (594)
++|++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++. ++.
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~ 187 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence 458889999888873 233345566 8888999998888742 334566777888889988888742 334
Q ss_pred hhhCCCCCceEeccCCcCCCCC----CccccccCCCcEEEeecccccccCCC-C-c----ccccCCcccccCCCC
Q 007668 139 ELGNLSNLLNLDISSNSLSDYI----PPSLGKLQRLITFNVSNNFLVGAIPS-D-G----VLTKFSESSFFGNRG 203 (594)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~l~l~~N~l~~~~~~-~-~----~l~~l~~l~l~~N~~ 203 (594)
.+..+++|+.|+|++|.+++.. +..+..+++|++|++++|+++..... . . ..++|+.|++++|..
T Consensus 188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i 262 (319)
T cd00116 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262 (319)
T ss_pred HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCC
Confidence 4556678888899888887432 34456778888888888888752111 1 1 236888888888864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.1e-10 Score=97.50 Aligned_cols=137 Identities=20% Similarity=0.209 Sum_probs=95.2
Q ss_pred eCCCCcEEEEEcccCCCCCCCCcc---ccCcccCCeeecccCccCCCCCCCcCC-CCccceeecccccccCCCChhhhCC
Q 007668 68 CDKNKRVITLSLTNHKLSGPISAD---LGKLDQLKFLNLHSNNFYGEIPSELGN-CTELQGLSLQSNYLSGSIPSELGNL 143 (594)
Q Consensus 68 c~~~~~l~~L~L~~n~l~~~~~~~---~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l 143 (594)
|.+...+..++|+++.|- .+++. +....+|+..+|++|.|. ..|..|.. .+.++.|+|++|.|+ .+|..+..+
T Consensus 23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam 99 (177)
T KOG4579|consen 23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM 99 (177)
T ss_pred hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence 444566777888888777 45544 344556777788888888 56666654 458888888888888 788888888
Q ss_pred CCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCc
Q 007668 144 SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 144 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~ 208 (594)
+.|+.|+++.|.|.. .|..+..|.+|-.|+..+|.+..++-....-.......+.+|||--+++
T Consensus 100 ~aLr~lNl~~N~l~~-~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 100 PALRSLNLRFNPLNA-EPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred HHhhhcccccCcccc-chHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCc
Confidence 888888888888885 7777778888888888888887554432111222234445555544444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-09 Score=113.25 Aligned_cols=127 Identities=31% Similarity=0.446 Sum_probs=105.1
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEecc
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 152 (594)
+|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....+++|+.|++++|+++ .+|.....+..|++|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 8999999999999 77788999999999999999999 78877778999999999999999 888876666779999999
Q ss_pred CCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 153 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
+|++.. .+..+.++.++..|.+.+|++...+.....++++++|++++|..
T Consensus 218 ~N~~~~-~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 218 NNSIIE-LLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred CCccee-cchhhhhcccccccccCCceeeeccchhccccccceeccccccc
Confidence 996443 56667777778888888888776555556777788888877763
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.8e-08 Score=91.22 Aligned_cols=134 Identities=19% Similarity=0.142 Sum_probs=95.2
Q ss_pred CccceeeeecceEEEEEEecCCcEEEEEeeccc--------------------c--hhhHHHHHHHHHHHhhCCCC--ee
Q 007668 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--------------------N--EGFDRFFERELEILGSIKHR--YL 365 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~h~--ni 365 (594)
.+++.||.|.-+.||.|..++|.++|||.=+.. + .......++|.++|.+|... .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 456899999999999999999999999943210 0 01234577899999998654 66
Q ss_pred eeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 366 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
.+.+++ +...+||||+++--|...-- +.+..-.++..|++-+.-+-. .|+||+|+++-||++++||.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCC
Confidence 666643 56689999998866665431 222233344444444444442 38999999999999999999
Q ss_pred EEEeecccccc
Q 007668 446 ARVSDFGLAKL 456 (594)
Q Consensus 446 ~~l~Dfgl~~~ 456 (594)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999975543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.2e-09 Score=70.17 Aligned_cols=40 Identities=45% Similarity=1.111 Sum_probs=30.2
Q ss_pred cchHHHHHHHHHhccC-CCCCCcCCCCCC-CCCCccceeEeC
Q 007668 30 NSDGEALLSFRTAVVS-SDGFLNQWRPED-PDPCNWKGVKCD 69 (594)
Q Consensus 30 ~~~~~~L~~~k~~~~~-~~~~l~~w~~~~-~~~c~w~gv~c~ 69 (594)
+.|++||++||.++.. +.+.+.+|+... .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 5789999999999985 568999998764 899999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=99.68 Aligned_cols=148 Identities=17% Similarity=0.231 Sum_probs=98.3
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchh----------------------------------h------
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG----------------------------------F------ 346 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------------------~------ 346 (594)
..|+ .+.|+.++-|.||+|.+++|+.||||+.+..-.. .
T Consensus 126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3443 3789999999999999999999999987531000 0
Q ss_pred HHHHHHHHHHHhhCC-----CCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhh
Q 007668 347 DRFFERELEILGSIK-----HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421 (594)
Q Consensus 347 ~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH 421 (594)
+-.+.+|+.-+.+++ .+++.-.-=|++-.....++|||++|..+.+...-.....+...+..-..++.--.-+-|
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhc
Confidence 012444555555542 344443333444456778999999999999985432234553333222222211122223
Q ss_pred hcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 422 ~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|++|.|..|.||+++.++++.+.|||+...+.+.
T Consensus 285 -----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 -----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred -----CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999999877653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=5.5e-09 Score=109.85 Aligned_cols=150 Identities=21% Similarity=0.377 Sum_probs=103.2
Q ss_pred HHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee--------eeeecccCccCcccccc
Q 007668 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT--------TIVAGTFGYLAPEYMQS 482 (594)
Q Consensus 411 ~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~ 482 (594)
.+++.|+.|+|. ++++||++|.|++|.++.++..||+.|+.+........... ....-...|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345599999997 68999999999999999999999999998765433211111 11234568999999999
Q ss_pred CCCCccchhhhHHHHHHHHHhCCCC-CCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccC
Q 007668 483 GRATEKTDVYSFGVLVLEVLSGKRP-TDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSS 561 (594)
Q Consensus 483 ~~~~~~~Dv~s~G~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 561 (594)
...+.++|+||+|+++|.+..|..+ +...... +.. .......+..........+.++.+=+.+++..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----~~~--------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----LSY--------SFSRNLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc----chh--------hhhhcccccccccccccCcHHHHHHHHHHhcC
Confidence 8899999999999999999965544 3221100 000 00011111111223344556788888899999
Q ss_pred CCCCCCCHHHHHH
Q 007668 562 SPDDRPTMHRVVQ 574 (594)
Q Consensus 562 dP~~RPs~~ev~~ 574 (594)
++.-||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998777653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.63 E-value=8.1e-09 Score=102.39 Aligned_cols=163 Identities=23% Similarity=0.243 Sum_probs=88.1
Q ss_pred chHHHHHHHHHhccCCCCCCcCCCCCCCCCCccceeEeCCCCcEEEEEcccCCCCCCCCc-cccCcccCCeeecccCccC
Q 007668 31 SDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISA-DLGKLDQLKFLNLHSNNFY 109 (594)
Q Consensus 31 ~~~~~L~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~ 109 (594)
....++...++...+. +.+.+|.. .|. -|+..++|+.|+|+.|++.-.... .-..+++|+.|.|+.+.|+
T Consensus 140 ~~~k~~~~v~~LdLS~-NL~~nw~~----v~~----i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls 210 (505)
T KOG3207|consen 140 EYSKILPNVRDLDLSR-NLFHNWFP----VLK----IAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLS 210 (505)
T ss_pred hhhhhCCcceeecchh-hhHHhHHH----HHH----HHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCC
Confidence 3455566666555443 34555631 111 133456777777777777622221 1224567777777777665
Q ss_pred C-CCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCC--ccccccCCCcEEEeecccccccC-C
Q 007668 110 G-EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIP--PSLGKLQRLITFNVSNNFLVGAI-P 185 (594)
Q Consensus 110 ~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~l~l~~N~l~~~~-~ 185 (594)
. .+-.....+|+|+.|+|..|............+..|++|||++|++.. .+ ...+.++.|+.|+++.+.+..+- |
T Consensus 211 ~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~ 289 (505)
T KOG3207|consen 211 WKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEP 289 (505)
T ss_pred HHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhhccccCcchhcCC
Confidence 2 122223455667777777664222333334445566677777766654 33 34556666666666666665431 1
Q ss_pred C------CcccccCCcccccCCCC
Q 007668 186 S------DGVLTKFSESSFFGNRG 203 (594)
Q Consensus 186 ~------~~~l~~l~~l~l~~N~~ 203 (594)
. ...+++|+.|++..|+.
T Consensus 290 d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 290 DVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred CccchhhhcccccceeeecccCcc
Confidence 1 14566666666666664
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-08 Score=101.53 Aligned_cols=132 Identities=24% Similarity=0.154 Sum_probs=96.9
Q ss_pred CCcEEEEEcccCCCCCC--CCccccCcccCCeeecccCccCCCCCCCc-CCCCccceeecccccccCC-CChhhhCCCCC
Q 007668 71 NKRVITLSLTNHKLSGP--ISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGS-IPSELGNLSNL 146 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L 146 (594)
..+++.|||+.|-+... +-.....||+|+.|+|+.|++........ ..++.|+.|.|+.+.|+-. +-..+..+|+|
T Consensus 145 ~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl 224 (505)
T KOG3207|consen 145 LPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSL 224 (505)
T ss_pred CCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcH
Confidence 36899999999988732 22455678999999999999873332222 2578899999999988821 22335677899
Q ss_pred ceEeccCCcCCCCCCccccccCCCcEEEeecccccccC--CCCcccccCCcccccCCC
Q 007668 147 LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI--PSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 147 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~--~~~~~l~~l~~l~l~~N~ 202 (594)
+.|+|..|...........-+..|+.|||++|++.... +..+.++.|..|+++.+.
T Consensus 225 ~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tg 282 (505)
T KOG3207|consen 225 EVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTG 282 (505)
T ss_pred HHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccC
Confidence 99999999644344455667788999999999998776 444788888888888765
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.54 E-value=9e-08 Score=85.71 Aligned_cols=123 Identities=21% Similarity=0.182 Sum_probs=88.2
Q ss_pred EEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCC
Q 007668 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (594)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 154 (594)
..++|.+.++. .+...=..+.+...+||++|.+. .++ .|..+++|.+|.|++|+|+.+-|.--.-+++|..|.|.+|
T Consensus 22 ~e~~LR~lkip-~ienlg~~~d~~d~iDLtdNdl~-~l~-~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnN 98 (233)
T KOG1644|consen 22 RELDLRGLKIP-VIENLGATLDQFDAIDLTDNDLR-KLD-NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNN 98 (233)
T ss_pred ccccccccccc-chhhccccccccceecccccchh-hcc-cCCCccccceEEecCCcceeeccchhhhccccceEEecCc
Confidence 45667776666 22221122457788999999987 444 6888899999999999999666665566788999999999
Q ss_pred cCCCCC-CccccccCCCcEEEeecccccccCCC----CcccccCCcccccC
Q 007668 155 SLSDYI-PPSLGKLQRLITFNVSNNFLVGAIPS----DGVLTKFSESSFFG 200 (594)
Q Consensus 155 ~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~----~~~l~~l~~l~l~~ 200 (594)
+|...- -..+..+|+|++|.+-+|+.+....- ...+++|+.|++.+
T Consensus 99 si~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~k 149 (233)
T KOG1644|consen 99 SIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQK 149 (233)
T ss_pred chhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhh
Confidence 887532 23467788899999989988765442 25678888888764
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2e-08 Score=105.68 Aligned_cols=127 Identities=28% Similarity=0.306 Sum_probs=59.3
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEecc
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 152 (594)
.+..+++..|.|. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|.|+. +.. +..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~-i~~-l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITK-LEG-LSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccc-ccc-hhhccchhhheec
Confidence 3444445555554 22333445555555555555555 333224445555555555555552 221 3444445555555
Q ss_pred CCcCCCCCCccccccCCCcEEEeecccccccCCC-CcccccCCcccccCCCCCC
Q 007668 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-DGVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 153 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~l~~N~~~c 205 (594)
+|.|+.+ ..+..+++|+.+++++|+++...+. ...+.+++.+.+.+|....
T Consensus 149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~ 200 (414)
T KOG0531|consen 149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIRE 200 (414)
T ss_pred cCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhc
Confidence 5555531 2233355555555555555443332 2344455555555554433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.53 E-value=8.9e-07 Score=83.60 Aligned_cols=106 Identities=25% Similarity=0.323 Sum_probs=80.8
Q ss_pred HHHHHHHHHHHhhCCC--CeeeeeeeEEeCC----CceEEEEEccCCC-chhhhhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 007668 347 DRFFERELEILGSIKH--RYLVNLRGYCNSP----TSKLLIYDFLPGG-SLDEALHERSEQLDWDARLNIIMGAAKGLAY 419 (594)
Q Consensus 347 ~~~~~~E~~~l~~l~h--~niv~l~g~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~ 419 (594)
.....+|...+..+.. =.+.+.+++.... ...++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 3457778887777743 2344555555442 2347999999885 79998875222 6667788999999999999
Q ss_pred hhhcCCCCeeeCCCCCCCeEecCCC---cEEEeecccccc
Q 007668 420 LHHDCSPRIIHRDIKSSNILLDGNL---EARVSDFGLAKL 456 (594)
Q Consensus 420 LH~~~~~~ivH~Dlk~~NIll~~~~---~~~l~Dfgl~~~ 456 (594)
||+ .||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 995 5999999999999999876 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.1e-08 Score=85.53 Aligned_cols=111 Identities=23% Similarity=0.259 Sum_probs=91.0
Q ss_pred CCcEEEEEcccCCCCCCCCccc-cCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADL-GKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
..+|+.++|++|.+. .+|+.| .+++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 468999999999999 566655 45679999999999999 89999999999999999999999 889988889999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 185 (594)
+..+|.+.. +|-.+-.-..+-..++.+|.+.+..+
T Consensus 129 ds~~na~~e-id~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 129 DSPENARAE-IDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cCCCCcccc-CcHHHhccccHHHHHhcCCcccccCc
Confidence 999999986 55444333344445567788876544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2e-08 Score=105.61 Aligned_cols=132 Identities=27% Similarity=0.269 Sum_probs=98.8
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++++.|+|.+|+|. .+...+..+++|++|+|++|+|+... .+..++.|+.|++++|.|+ .+.. +..+++|+.++
T Consensus 94 ~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~-~~~~-~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLIS-DISG-LESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhheeccCcch-hccC-Cccchhhhccc
Confidence 478889999999998 44444778899999999999998443 4777888999999999998 4443 66688899999
Q ss_pred ccCCcCCCCCC-ccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCcc
Q 007668 151 ISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 151 l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
+++|+++.+-+ . ...+.+|+.+++.+|.+..+ .....+..+..+++..|...+-.++
T Consensus 169 l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i-~~~~~~~~l~~~~l~~n~i~~~~~l 226 (414)
T KOG0531|consen 169 LSYNRIVDIENDE-LSELISLEELDLGGNSIREI-EGLDLLKKLVLLSLLDNKISKLEGL 226 (414)
T ss_pred CCcchhhhhhhhh-hhhccchHHHhccCCchhcc-cchHHHHHHHHhhcccccceeccCc
Confidence 99999987444 2 57888899999999988744 3334455566667788876554433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.4e-06 Score=79.04 Aligned_cols=135 Identities=13% Similarity=0.135 Sum_probs=98.6
Q ss_pred eeecceEEEEEEecCCcEEEEEeeccc-----c-hhhHHHHHHHHHHHhhCCC--CeeeeeeeEEe-C----CCceEEEE
Q 007668 316 GSGGFGTVYKLAMDDGNVFALKRIDKL-----N-EGFDRFFERELEILGSIKH--RYLVNLRGYCN-S----PTSKLLIY 382 (594)
Q Consensus 316 G~G~~g~Vy~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~-~----~~~~~lv~ 382 (594)
|+||-+.|++....+ ..+-+|+-... . +.....|.+|...+.++.. -.+.+++ ++. . ...-+||+
T Consensus 27 ~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 678888999877654 46888876521 1 2345679999999998853 2244444 332 1 22346999
Q ss_pred EccCC-Cchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc--EEEeeccccc
Q 007668 383 DFLPG-GSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--ARVSDFGLAK 455 (594)
Q Consensus 383 e~~~~-gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~~l~Dfgl~~ 455 (594)
|-+++ -+|.+++.+. ..+.+...+..++.+++..+.-||+ .|+.|+|+.+.||+++.++. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 4888887543 2346777888999999999999995 59999999999999986666 9999997655
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.6e-06 Score=79.19 Aligned_cols=137 Identities=16% Similarity=0.192 Sum_probs=83.6
Q ss_pred ceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCe--eeeeeeEEeCCCceEEEEEccCCCc-
Q 007668 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY--LVNLRGYCNSPTSKLLIYDFLPGGS- 389 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gs- 389 (594)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++........+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 67899999999983 25567788776422 2345788999998886433 4566777777777889999998863
Q ss_pred hhhhh---------------------hhc-CCCCCHHHHH-HHHH----------HHHH-HHHHhhhc-CCCCeeeCCCC
Q 007668 390 LDEAL---------------------HER-SEQLDWDARL-NIIM----------GAAK-GLAYLHHD-CSPRIIHRDIK 434 (594)
Q Consensus 390 L~~~l---------------------~~~-~~~l~~~~~~-~i~~----------~ia~-~L~~LH~~-~~~~ivH~Dlk 434 (594)
+.+.+ |.- .......... ++.. .+.+ ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 22111 110 0011111100 0000 0001 11122111 13467899999
Q ss_pred CCCeEecCCCcEEEeeccccc
Q 007668 435 SSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 435 ~~NIll~~~~~~~l~Dfgl~~ 455 (594)
|.||++++++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999887 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.5e-06 Score=77.75 Aligned_cols=151 Identities=17% Similarity=0.220 Sum_probs=97.2
Q ss_pred HHHHHHHhcCCCccc---eeeeecceEEEEEEecCCcEEEEEeecccchhhH------------------------HHHH
Q 007668 299 SKDIIKKLETLDDDH---IIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFD------------------------RFFE 351 (594)
Q Consensus 299 ~~~~~~~~~~~~~~~---~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~ 351 (594)
.+.+.....+..+.+ .|+.|.-+.||+|...++..+|||+.+....... .-..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 344444444444444 4667888899999988899999998864221111 1133
Q ss_pred HHHHHHhhCC--CCeeeeeeeEEeCCCceEEEEEccCCCc-hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 007668 352 RELEILGSIK--HRYLVNLRGYCNSPTSKLLIYDFLPGGS-LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428 (594)
Q Consensus 352 ~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 428 (594)
.|..-|.++. +-.+.+.+++. ...|||||+.... -.-.|.. -.+.......+..++++.+.-|-. ..++
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~--~a~L 188 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYK--EAGL 188 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHH--hcCc
Confidence 4666666663 33444445442 3479999996541 1112221 222333556677778788777774 3599
Q ss_pred eeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 429 vH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
||+||+.-|||+. ++.+.|+|||-+....
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999999 8899999999876544
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.5e-06 Score=86.89 Aligned_cols=144 Identities=19% Similarity=0.251 Sum_probs=95.4
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeecccchh-------------------------------h------HHHHHHHH
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEG-------------------------------F------DRFFEREL 354 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------~------~~~~~~E~ 354 (594)
.+.||.-+.|.||+|++++|+.||||+=+..-+. . +-.|..|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 4789999999999999999999999976431000 0 01244555
Q ss_pred HHHhhC----CCCee---eeeee-EEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 007668 355 EILGSI----KHRYL---VNLRG-YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426 (594)
Q Consensus 355 ~~l~~l----~h~ni---v~l~g-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 426 (594)
+-..++ +|-+. |.+=. |+.-.....|+||||+|..+.|.-.-....++...+..-+.++..-+-+-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~----- 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT----- 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc-----
Confidence 443333 44441 11212 223345678999999999888875433344666655555444433333334
Q ss_pred CeeeCCCCCCCeEec----CCCcEEEeecccccccccC
Q 007668 427 RIIHRDIKSSNILLD----GNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 427 ~ivH~Dlk~~NIll~----~~~~~~l~Dfgl~~~~~~~ 460 (594)
|++|+|=.|.||+++ .++++.+.|||+.......
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 899999999999998 3678999999998866543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 594 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-62 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-61 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-34 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-25 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-25 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-24 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-24 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-24 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-24 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-24 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-24 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-24 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-24 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-24 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-24 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-22 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-22 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-21 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-21 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-21 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-21 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-21 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-21 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-21 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-21 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-21 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-21 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-21 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-21 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-20 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-18 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-17 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-15 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-15 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-11 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-09 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-128
Identities = 116/279 (41%), Positives = 189/279 (67%), Gaps = 7/279 (2%)
Query: 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRI-DKLNEGFDRFFERELEILGSIKHRYLVNL 368
+ +I+G GGFG VYK + DG + A+KR+ ++ +G + F+ E+E++ HR L+ L
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCS 425
RG+C +PT +LL+Y ++ GS+ L ER E LDW R I +G+A+GLAYLH C
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
P+IIHRD+K++NILLD EA V DFGLAKL++ +++H+TT V GT G++APEY+ +G++
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 212
Query: 486 TEKTDVYSFGVLVLEVLSGKRPTDASFI--EKGLNIVGWLNFLISEDRQREIIDPNCEG- 542
+EKTDV+ +GV++LE+++G+R D + + + + ++ W+ L+ E + ++D + +G
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 272
Query: 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581
+ E ++ L+ VA C SSP +RP M VV++LE + +
Sbjct: 273 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 342 bits (880), Expect = e-114
Identities = 107/273 (39%), Positives = 157/273 (57%), Gaps = 8/273 (2%)
Query: 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
D +IG G FG VYK + DG ALKR + FE E+E L +H +LV+L
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLI 101
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSP 426
G+C+ +LIY ++ G+L L+ + W+ RL I +GAA+GL YLH
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA-- 159
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYLAPEYMQSGRA 485
IIHRD+KS NILLD N +++DFG++K E +++H++T+V GT GY+ PEY GR
Sbjct: 160 -IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL 218
Query: 486 TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG-VQ 544
TEK+DVYSFGV++ EVL + S + +N+ W + + +I+DPN ++
Sbjct: 219 TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR 278
Query: 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
ESL A +C++ S +DRP+M V+ LE
Sbjct: 279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-111
Identities = 91/284 (32%), Positives = 152/284 (53%), Gaps = 21/284 (7%)
Query: 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRF-------FERELEILGSIKH 362
+ +G GGFG VYK +++ V A+K+ L D F++E++++ +H
Sbjct: 34 VGGNKMGEGGFGVVYKGYVNNTTV-AVKK---LAAMVDITTEELKQQFDQEIKVMAKCQH 89
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYL 420
LV L G+ + L+Y ++P GSL + L L W R I GAA G+ +L
Sbjct: 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAPEY 479
H + IHRDIKS+NILLD A++SDFGLA+ + ++ +T+ + GT Y+APE
Sbjct: 150 HENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQ-REIIDP 538
+ G T K+D+YSFGV++LE+++G D + ++ + E++ + ID
Sbjct: 207 L-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEIEDEEKTIEDYIDK 263
Query: 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582
S S++A+ +VA+QC+ + RP + +V Q+L+ +
Sbjct: 264 KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-82
Identities = 74/312 (23%), Positives = 128/312 (41%), Gaps = 34/312 (10%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE-GFDRFFER 352
+ ++++ + L + G FG V+K + + V A+K ++ + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDKQSW--QNEY 67
Query: 353 ELEILGSIKHRYLVNLRGYC----NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN 408
E+ L +KH ++ G + LI F GSL + L + + W+ +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCH 125
Query: 409 IIMGAAKGLAYLHHD-------CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
I A+GLAYLH D P I HRDIKS N+LL NL A ++DFGLA E +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 462 SHI-TTIVAGTFGYLAPEYMQSG-----RATEKTDVYSFGVLVLEVLSGKRPTDASFIEK 515
S T GT Y+APE ++ A + D+Y+ G+++ E+ S D E
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 516 GLNIVGWLNF---------LISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDR 566
L + ++ ++R ++ + + + L +C + R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ--KHAGMAMLCETIEECWDHDAEAR 303
Query: 567 PTMHRVVQILES 578
+ V + +
Sbjct: 304 LSAGCVGERITQ 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 3e-64
Identities = 75/283 (26%), Positives = 132/283 (46%), Gaps = 26/283 (9%)
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
S +I + ++ + ++G G FG V K A A+K+I +E + F EL L
Sbjct: 1 SLHMID-YKEIEVEEVVGRGAFGVVCK-AKWRAKDVAIKQI--ESESERKAFIVELRQLS 56
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKG 416
+ H +V L G C +P L+ ++ GGSL LH E ++ + ++G
Sbjct: 57 RVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLE-ARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
+AYLH +IHRD+K N+LL ++ DFG A + T G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWM 170
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535
APE + +EK DV+S+G+++ EV++ ++P D + + + R
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPP 224
Query: 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ N + +++L+ T+C S P RP+M +V+I+
Sbjct: 225 LIKNL----PKPIESLM---TRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-63
Identities = 81/278 (29%), Positives = 138/278 (49%), Gaps = 21/278 (7%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKH 362
L+ IG+G FGTV++ A G+ A+K + + F RE+ I+ ++H
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHR-AEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKGLAYL 420
+V G P + ++ ++L GSL LH EQLD RL++ AKG+ YL
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM 480
H+ +P I+HR++KS N+L+D +V DFGL++L + AGT ++APE +
Sbjct: 154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVL 211
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540
+ + EK+DVYSFGV++ E+ + ++P LN + + +R I N
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPW------GNLNPAQVV-AAVGFKCKRLEIPRNL 264
Query: 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ + A++ C ++ P RP+ ++ +L
Sbjct: 265 ----NPQVAAII---EGCWTNEPWKRPSFATIMDLLRP 295
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-63
Identities = 81/301 (26%), Positives = 144/301 (47%), Gaps = 37/301 (12%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFD---- 347
+ P S + ++ + IG GGFG V+K L D V A+K + + +
Sbjct: 7 EFPKSRLPTLA-DNEIEYEKQIGKGGFGLVHKGRLVKDKSVV-AIKSLILGDSEGETEMI 64
Query: 348 ---RFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD 404
+ F+RE+ I+ ++ H +V L G ++P ++ +F+P G L L +++ + W
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-----ARVSDFGLAKLLED 459
+L +++ A G+ Y+ + +P I+HRD++S NI L E A+V+DFGL++
Sbjct: 123 VKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 460 EESHITTIVAGTFGYLAPE--YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517
+ H + + G F ++APE + TEK D YSF +++ +L+G+ P F E
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP----FDEYSY 233
Query: 518 NIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ ++N + E R I +C L ++ C S P RP +V+ L
Sbjct: 234 GKIKFINMIREEGL-RPTIPEDC----PPRLRNVI---ELCWSGDPKKRPHFSYIVKELS 285
Query: 578 S 578
Sbjct: 286 E 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 2e-62
Identities = 74/327 (22%), Positives = 127/327 (38%), Gaps = 47/327 (14%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
+ S + L+ L +IG G +G VYK ++D+ V A+K N + F E
Sbjct: 2 EAAASEPSL--DLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFANR---QNFINE 55
Query: 354 LEI--LGSIKHRYLVNLRGYC-----NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR 406
I + ++H + + LL+ ++ P GSL + L + DW +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSS 113
Query: 407 LNIIMGAAKGLAYLHHD------CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE-- 458
+ +GLAYLH + P I HRD+ S N+L+ + +SDFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 459 -----DEESHITTIVAGTFGYLAPEYMQS-------GRATEKTDVYSFGVLVLEVLSGKR 506
EE + GT Y+APE ++ A ++ D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 507 PTDASFIEKGLNI-----VGW------LNFLISEDRQREIIDPNCEGVQSESLDALLAVA 555
+ VG + L+S ++QR P S ++ +L
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF-PEAWKENSLAVRSLKETI 292
Query: 556 TQCVSSSPDDRPTMHRVVQILESEVMT 582
C + R T + + +M
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-59
Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 32/283 (11%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKH 362
+ L+ + G ++K GN +K + + R F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWK-GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 363 RYLVNLRGYCNSPTSKLL--IYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAY 419
++ + G C SP + I ++P GSL LHE + +D + + A+G+A+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
LH P I + S ++++D ++ AR+S + + ++APE
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEA 179
Query: 480 MQ---SGRATEKTDVYSFGVLVLEVLSGKRP-TDASFIEKGLNIVGWLNFLISEDRQREI 535
+Q D++SF VL+ E+++ + P D S +E G+ + + R
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA--------LEGLRPT 231
Query: 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
I P S + L+ C++ P RP +V ILE
Sbjct: 232 IPPGI----SPHVSKLM---KICMNEDPAKRPKFDMIVPILEK 267
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 7e-59
Identities = 73/283 (25%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
++G G FG K + G V +K + + +E R F +E++++ ++H ++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
I +++ GG+L + Q W R++ A G+AYLH S IIHR
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT-------------TIVAGTFGYLAPE 478
D+ S N L+ N V+DFGLA+L+ DE++ V G ++APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRPT---DASFIEKGLNIVGWLNFLISEDRQREI 535
+ EK DV+SFG+++ E++ ++ GLN+ G+L
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---------DRY 243
Query: 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
PNC + + +C P+ RP+ ++ LE+
Sbjct: 244 CPPNC-------PPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 32/286 (11%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI----DKLNEGFDRFFERELEILGSI 360
L + IIG GGFG VY+ V A+K D+ +E ++ +
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
KH ++ LRG C + L+ +F GG L+ L + ++ D +N + A+G+ YL
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYL 121
Query: 421 HHDCSPRIIHRDIKSSNILLD--------GNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
H + IIHRD+KSSNIL+ N +++DFGLA+ AG +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAY 178
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQ 532
++APE +++ ++ +DV+S+GVL+ E+L+G+ P F +G++ + + ++ ++
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP----F--RGIDGLAVA-YGVAMNKL 231
Query: 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
I C E L+ C + P RP+ ++ L +
Sbjct: 232 ALPIPSTC----PEPFAKLM---EDCWNPDPHSRPSFTNILDQLTT 270
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-57
Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 41/292 (14%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKH 362
E L+ +IG G FG VY G V A++ I ++ NE + F+RE+ +H
Sbjct: 31 PFEQLEIGELIGKGRFGQVYH-GRWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V G C SP +I G +L + + LD + I KG+ YLH
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH- 147
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL----LEDEESHITTIVAGTFGYLAPE 478
+ I+H+D+KS N+ D N + ++DFGL + I G +LAPE
Sbjct: 148 --AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 479 YMQSGRA---------TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN---IVGWLNFL 526
++ ++ +DV++ G + E+ + + P F K I+ +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----F--KTQPAEAII----WQ 254
Query: 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ + + + + +L C + ++RPT +++ +LE
Sbjct: 255 MGTGMKPNLSQIGM----GKEISDIL---LFCWAFEQEERPTFTKLMDMLEK 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-55
Identities = 74/279 (26%), Positives = 136/279 (48%), Gaps = 24/279 (8%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRY 364
+ IGSG FGTVYK G+V A+K + + F+ E+ +L +H
Sbjct: 24 GQITVGQRIGSGSFGTVYK-GKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
++ GY +P ++ + G SL LH + + ++I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAPE---YM 480
+ IIHRD+KS+NI L + ++ DFGLA SH ++G+ ++APE
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRP-TDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
S + ++DVY+FG+++ E+++G+ P ++ + ++ + +VG R + P+
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG-----------RGSLSPD 246
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
V+S + + +C+ D+RP+ R++ +E
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-55
Identities = 71/312 (22%), Positives = 112/312 (35%), Gaps = 36/312 (11%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
LP + I + + IG G +G V+ V A+K E F E E
Sbjct: 26 GLPLLVQRTI--AKQIQMVKQIGKGRYGEVWMGKWRGEKV-AVKVFFTTEEA-SWFRETE 81
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSK----LLIYDFLPGGSLDEALHERSEQLDWDARLNI 409
+ ++H ++ T LI D+ GSL + L + LD + L +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKL 139
Query: 410 IMGAAKGLAYLH-----HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464
+ GL +LH P I HRD+KS NIL+ N ++D GLA + + +
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 465 ---TTIVAGTFGYLAPE------YMQSGRATEKTDVYSFGVLVL-EVLSGKRPTD----- 509
GT Y+ PE ++ D+YSFG L+L EV
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARRCVSGGIVEEY 258
Query: 510 --ASFIEKGLNI-VGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDR 566
+ + ++ + R E L + + T+C + +P R
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWS--SDECLRQMGKLMTECWAHNPASR 316
Query: 567 PTMHRVVQILES 578
T RV + L
Sbjct: 317 LTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 2e-54
Identities = 72/306 (23%), Positives = 124/306 (40%), Gaps = 48/306 (15%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
+ +G G +G V++ + NV A+K +E F E EL ++H ++
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENV-AVKIFSSRDEK-SWFRETELYNTVMLRHENIL 65
Query: 367 NLRGYCNSPTSK----LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+ LI + GSL + L + LD + L I++ A GLA+LH
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHI 123
Query: 423 D-----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI---TTIVAGTFGY 474
+ P I HRD+KS NIL+ N + ++D GLA + + + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 475 LAPE------YMQSGRATEKTDVYSFGVLVLEVLSGKR----------------PTDASF 512
+APE + + ++ D+++FG+++ EV P D SF
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRV 572
+ + ++ D+QR I +L +L + +C +P R T R+
Sbjct: 244 ED--------MRKVVCVDQQRPNIPNRWF--SDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 573 VQILES 578
+ L
Sbjct: 294 KKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-54
Identities = 71/312 (22%), Positives = 124/312 (39%), Gaps = 38/312 (12%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFEREL 354
LP + I T+ IG G FG V++ V A+K E R + RE
Sbjct: 32 LPLLVQRTI--ARTIVLQESIGKGRFGEVWRGKWRGEEV-AVKIFSSREE---RSWFREA 85
Query: 355 EI--LGSIKHRYLVNLRGYC----NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN 408
EI ++H ++ + T L+ D+ GSL + L+ + + + +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIK 143
Query: 409 IIMGAAKGLAYLHHD-----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
+ + A GLA+LH + P I HRD+KS NIL+ N ++D GLA +
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 464 IT---TIVAGTFGYLAPE------YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDAS--- 511
I GT Y+APE M+ + ++ D+Y+ G++ E+
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 512 ----FIEKGLN-IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDR 566
+ + V + ++ E + R I + E+L + + +C ++ R
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS--CEALRVMAKIMRECWYANGAAR 321
Query: 567 PTMHRVVQILES 578
T R+ + L
Sbjct: 322 LTALRIKKTLSQ 333
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 55/164 (33%), Positives = 76/164 (46%), Gaps = 8/164 (4%)
Query: 30 NSDGEALLSFRTAVVSSDGFLNQWRPE-DPDPCNWKGVKCD---KNKRVITLSLTNHKLS 85
D +ALL + + + L+ W P D W GV CD + RV L L+ L
Sbjct: 5 PQDKQALLQIKKDL-GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 86 G--PISADLGKLDQLKFLNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
PI + L L L FL + NN G IP + T+L L + +SG+IP L
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ L+ LD S N+LS +PPS+ L L+ N + GAIP
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 2/130 (1%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
++++ ++L+G I L+ L F++L N G+ G+ Q + L N L+ +
Sbjct: 179 MTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSES 196
+G NL LD+ +N + +P L +L+ L + NVS N L G IP G L +F S
Sbjct: 238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS 296
Query: 197 SFFGNRGLCG 206
++ N+ LCG
Sbjct: 297 AYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 19/62 (30%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L N+++ G + L +L L LN+ NN GEIP GN + +N
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306
Query: 136 IP 137
P
Sbjct: 307 SP 308
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-45
Identities = 51/153 (33%), Positives = 74/153 (48%)
Query: 74 VITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
++T+ G S + FL++ N G IP E+G+ L L+L N +S
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKF 193
GSIP E+G+L L LD+SSN L IP ++ L L ++SNN L G IP G F
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729
Query: 194 SESSFFGNRGLCGKQINVTCKNDSGGSTTDSQS 226
+ F N GLCG + +++ G +S
Sbjct: 730 PPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRS 762
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-33
Identities = 46/117 (39%), Positives = 64/117 (54%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
++ L L + L G I +L + L+ L L N+ GEIPS L NCT L +SL +
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
N L+G IP +G L NL L +S+NS S IP LG + LI +++ N G IP+
Sbjct: 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-33
Identities = 46/115 (40%), Positives = 66/115 (57%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+++L L+ + LSG I + LG L +L+ L L N GEIP EL L+ L L N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+G IPS L N +NL + +S+N L+ IP +G+L+ L +SNN G IP+
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 43/118 (36%), Positives = 56/118 (47%), Gaps = 1/118 (0%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L N+ +G I L +L L+L N G IPS LG+ ++L+ L L N L G
Sbjct: 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGE 457
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTK 192
IP EL + L L + N L+ IP L L ++SNN L G IP G L
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-31
Identities = 50/113 (44%), Positives = 67/113 (59%), Gaps = 2/113 (1%)
Query: 76 TLSLTNHKLSGPISADLGK--LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
TL L+++ SGPI +L + + L+ L L +N F G+IP L NC+EL L L NYLS
Sbjct: 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
G+IPS LG+LS L +L + N L IP L ++ L T + N L G IPS
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 41/113 (36%), Positives = 54/113 (47%), Gaps = 3/113 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L ++ +KLSG S + +LK LN+ SN F G IP LQ LSL N +G
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGE 284
Query: 136 IPSEL-GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
IP L G L LD+S N +PP G L + +S+N G +P D
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMD 337
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 48/223 (21%), Positives = 78/223 (34%), Gaps = 61/223 (27%)
Query: 26 SRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVI---------- 75
S+++ + L+SF+ V+ L W + +PC + GV C + +V
Sbjct: 7 SQSLYREIHQLISFK-DVLPDKNLLPDWSS-NKNPCTFDGVTCR-DDKVTSIDLSSKPLN 63
Query: 76 ----------------------------------------TLSLTNHKLSGPISAD--LG 93
+L L+ + LSGP++ LG
Sbjct: 64 VGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 94 KLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSGSIPSEL---GNLSNLLNL 149
LKFLN+ SN S L+ L L +N +SG+ L +L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
IS N +S + + + L +VS+N IP G +
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSA 224
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 46/132 (34%), Positives = 69/132 (52%), Gaps = 5/132 (3%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCT-ELQGLSLQSNYLS 133
+L+L+++ SG + D L K+ LK L+L N F GE+P L N + L L L SN S
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 134 GSIPSELGN--LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVL 190
G I L + L L + +N + IPP+L L++ ++S N+L G IPS G L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 191 TKFSESSFFGNR 202
+K + + N
Sbjct: 442 SKLRDLKLWLNM 453
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 4/112 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL L + L+G I + L L +++L +N GEIP +G L L L +N SG+
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGN 529
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
IP+ELG+ +L+ LD+++N + IP ++ K + ++ NF+ G
Sbjct: 530 IPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-28
Identities = 40/113 (35%), Positives = 63/113 (55%), Gaps = 4/113 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
L++++++ GPI L L++L+L N F GEIP L G C L GL L N+ G
Sbjct: 251 LLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPS 186
++P G+ S L +L +SSN+ S +P +L K++ L ++S N G +P
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-28
Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ L+++ +K+SG + + + L+FL++ SNNF IP LG+C+ LQ L + N
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNK 234
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
LSG + + L L+ISSN IPP L+ L +++ N G IP
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDF 288
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 32/148 (21%), Positives = 57/148 (38%), Gaps = 23/148 (15%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+ +SL+N++L+G I +G+L+ L L L +N+F G IP+ELG+C L L L +
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547
Query: 130 NYLSGSIPSELGNLSNLL----------------------NLDISSNSLSDYIPPSLGKL 167
N +G+IP+ + S + + + L +L
Sbjct: 548 NLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
Query: 168 QRLITFNVSNNFLVGAIPSD-GVLTKFS 194
N+++ G
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMM 635
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 14/68 (20%), Positives = 27/68 (39%), Gaps = 8/68 (11%)
Query: 142 NLSNLLNLDISSNSLSDY---IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK-----F 193
+ ++D+SS L+ + SL L L + +SN+ + G++
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDL 107
Query: 194 SESSFFGN 201
S +S G
Sbjct: 108 SRNSLSGP 115
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 7e-41
Identities = 75/298 (25%), Positives = 132/298 (44%), Gaps = 50/298 (16%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY- 371
+IGSGGFG V+K DG + +KR+ NE ERE++ L + H +V+ G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVHYNGCW 73
Query: 372 --------------CNSPTSKLLIY-DFLPGGSLDEALHER-SEQLDWDARLNIIMGAAK 415
S T L I +F G+L++ + +R E+LD L + K
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
G+ Y+H S ++I+RD+K SNI L + ++ DFGL L+++ + GT Y+
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLRYM 188
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535
+PE + S ++ D+Y+ G+++ E+L E + ++ R I
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVCDT----AFET--------SKFFTDLRDGII 236
Query: 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNS 593
+ + LL + +S P+DRP +IL + + + + ++
Sbjct: 237 --SDI---FDKKEKTLL---QKLLSKKPEDRPNTS---EILRTLTVWKKSPEKNERHT 283
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 34/286 (11%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G FG + +DG + +K I+ +++ RE+ +L ++KH +V R
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHER-----SEQLDWDARLNIIMGAAKGLAYLHHDCS 425
S ++ D+ GG L + ++ + E D + I + L ++H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA----LKHVH---D 143
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
+I+HRDIKS NI L + ++ DFG+A++L + GT YL+PE ++
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPY 202
Query: 486 TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545
K+D+++ G ++ E+ + K F + ++ L I + S
Sbjct: 203 NNKSDIWALGCVLYELCTLKHA----F--EAGSMKN-LVLKIISGSFPPV--SLH---YS 250
Query: 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDS 591
L +L+ +Q +P DRP+ V ILE + F
Sbjct: 251 YDLRSLV---SQLFKRNPRDRPS---VNSILEKGFIAKRIEKFLSP 290
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 61/284 (21%), Positives = 117/284 (41%), Gaps = 29/284 (10%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE---RELEILGSIKHRYLVNL 368
IG G F VY+ + DG ALK++ + + +E+++L + H ++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 369 RGYCNSPTSKLLIY-DFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDC 424
++L I + G L + +Q + + L ++H
Sbjct: 98 YASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--- 153
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
S R++HRDIK +N+ + ++ D GL + + + ++V GT Y++PE +
Sbjct: 154 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 212
Query: 485 ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544
K+D++S G L+ E+ + + P F +N+ L I + P
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYS-LCKKIEQCD----YPPLPSDHY 263
Query: 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILE-SEVMTPCPSD 587
SE L L+ C++ P+ RP V + + ++ M C +
Sbjct: 264 SEELRQLV---NMCINPDPEKRPD---VTYVYDVAKRMHACTAS 301
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 79/323 (24%), Positives = 128/323 (39%), Gaps = 63/323 (19%)
Query: 293 GDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVF---ALKRIDKLNEGF 346
G+ P + I+K+ E ++GSG FGTVYK + V A+K +L E
Sbjct: 1 GEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREAT 56
Query: 347 DRF----FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD 402
E ++ S+ + ++ L G C + T LI +P G L + + E + +
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG 115
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
LN + AKG+ YL R++HRD+ + N+L+ +++DFGLAKLL EE
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 463 HITTIVAGT---FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518
G ++A E + T ++DV+S+GV V E+++ G +P D
Sbjct: 173 EYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--------- 221
Query: 519 IVGWLNFLISEDRQREIID-----------PNCEGVQSESLDALLAVATQCVSSSPDDRP 567
G EI P C + + +C D RP
Sbjct: 222 --GIPA--------SEISSILEKGERLPQPPIC-------TIDVYMIMRKCWMIDADSRP 264
Query: 568 TMHRVVQILESEVMTPCPSDFYD 590
++ M P +
Sbjct: 265 KFRELIIEFSK--MARDPQRYLV 285
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 73/280 (26%), Positives = 127/280 (45%), Gaps = 29/280 (10%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG+G +G K DG + K +D + E + E+ +L +KH +V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 371 -YCNSPTSKLLIY-DFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLH--HD 423
+ + L I ++ GG L + + +++ LD + L ++ L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
++HRD+K +N+ LDG ++ DFGLA++L + S T V GT Y++PE M
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 484 RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543
EK+D++S G L+ E+ + P A + L I E + R I P
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFTAF------SQKE-LAGKIREGKFRRI--PYR--- 239
Query: 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
S+ L+ ++ T+ ++ RP+ V +ILE+ ++
Sbjct: 240 YSDELNEII---TRMLNLKDYHRPS---VEEILENPLILE 273
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-38
Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 34/277 (12%)
Query: 312 DHIIGSGGFGTVYKLAMD--DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVN 367
D IG G F TVYK +D A + KL + + F+ E E+L ++H +V
Sbjct: 31 DIEIGRGSFKTVYK-GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 368 LRGYCNSPTSK---LLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
S +++ + + G+L L +R + + + KGL +LH
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 424 CSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
+P IIHRD+K NI + G ++ D GLA L S ++ GT ++APE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVI-GTPEFMAPEMYEE 204
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
E DVY+FG+ +LE+ + + P + E + ++ + D
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP----YSE--CQNAAQIYRRVTSGVKPASFD----K 253
Query: 543 VQSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574
V + ++ C+ + D+R + H Q
Sbjct: 254 VAIPEVKEIIE---GCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 79/307 (25%), Positives = 140/307 (45%), Gaps = 33/307 (10%)
Query: 292 HGDLPYSSKD--IIKKLETLDDDHIIGSGGFGTVYK-----LAMDDGNVFALKRIDKLNE 344
H Y+ +D I ++ L +G G FG+V L + G + A+K++
Sbjct: 7 HHAQLYACQDPTIFEE-RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP 65
Query: 345 GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLD 402
R F+RE++IL ++ ++V RG P + L+ ++LP G L + L +LD
Sbjct: 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
L KG+ YL S R +HRD+ + NIL++ +++DFGLAKLL ++
Sbjct: 126 ASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
Query: 463 HITTIVAGTF--GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNI 519
+ G + APE + + ++DV+SFGV++ E+ + + S + L +
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRM 240
Query: 520 VGWLNFLISEDRQREIID--------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHR 571
+G + + R E+++ P C + L+ C + SP DRP+
Sbjct: 241 MGCERDVPALSRLLELLEEGQRLPAPPAC----PAEVHELM---KLCWAPSPQDRPSFSA 293
Query: 572 VVQILES 578
+ L+
Sbjct: 294 LGPQLDM 300
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 65/297 (21%), Positives = 118/297 (39%), Gaps = 55/297 (18%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG- 370
++G G FG V K A + D +A+K+I E E+ +L S+ H+Y+V
Sbjct: 13 VLGQGAFGQVVK-ARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 371 ---------YCNSPTSKLLIY---DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+ K ++ ++ G+L + +H + D + + L+
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALS 130
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE--------------DEESHI 464
Y+H S IIHRD+K NI +D + ++ DFGLAK + ++
Sbjct: 131 YIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 465 TTIVAGTFGYLAPEYMQ-SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWL 523
T+ + GT Y+A E + +G EK D+YS G++ E++ + L +
Sbjct: 188 TSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL--- 241
Query: 524 NFLISEDRQREI-IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579
R I P+ + + + ++ + P+ RP +L S
Sbjct: 242 -------RSVSIEFPPDFDDNKMKVEKKII---RLLIDHDPNKRPG---ARTLLNSG 285
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 50/295 (16%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLV------ 366
+G GGFG V++ D +A+KRI N E RE++ L ++H +V
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 367 ---NLRGYCNSPTSKLLIY---DFLPGGSLDEALHER--SEQLDWDARLNIIMGAAKGLA 418
N + K+ +Y +L + ++ R E+ + L+I + A+ +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA--------- 469
+LH S ++HRD+K SNI + +V DFGL ++ +E T +
Sbjct: 133 FLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 470 --GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLI 527
GT Y++PE + + K D++S G+++ E+L + + L V
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDV------- 240
Query: 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582
R + P + ++ +S SP +RP + I+E+ V
Sbjct: 241 -----RNLKFPPLFTQKYPCEYVMV---QDMLSPSPMERPE---AINIIENAVFE 284
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 74/279 (26%), Positives = 113/279 (40%), Gaps = 40/279 (14%)
Query: 313 HIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFDRF-FERELEILGSIKHRYLVNLR 369
IG G FG V+ L D+ V A+K + + F +E IL H +V L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLV-AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
G C ++ + + GG L +L L ++ AA G+ YL S I
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY--LAPEYMQSGRATE 487
HRD+ + N L+ ++SDFG+++ D + + APE + GR +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 488 KTDVYSFGVLVLEVLS-GKRP------TDA-SFIEKGLNIVGWLNFLISEDRQREIIDPN 539
++DV+SFG+L+ E S G P F+EKG G L
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG----GRLPC-----------PEL 339
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
C DA+ + QC + P RP+ + Q L+S
Sbjct: 340 CP-------DAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 69/302 (22%), Positives = 129/302 (42%), Gaps = 32/302 (10%)
Query: 296 PYSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGN------VFALKRIDKLNEGFD 347
+K L +G G FG V + N V +LK N D
Sbjct: 11 TEVDPTHFEK-RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD 69
Query: 348 RFFERELEILGSIKHRYLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDA 405
++E+EIL ++ H +V +G C LI +FLP GSL E L + +++
Sbjct: 70 --LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
+L + KG+ YL S + +HRD+ + N+L++ + ++ DFGL K +E ++ + T
Sbjct: 128 QLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184
Query: 466 TIVAGTF--GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIV-- 520
+ APE + + +DV+SFGV + E+L+ + + +
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 521 -GWLNF-LISEDRQREIID--PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
L++ ++ + + PNC + + L+ +C P +R + +++
Sbjct: 245 GQMTVTRLVNTLKEGKRLPCPPNC----PDEVYQLM---RKCWEFQPSNRTSFQNLIEGF 297
Query: 577 ES 578
E+
Sbjct: 298 EA 299
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-37
Identities = 80/327 (24%), Positives = 129/327 (39%), Gaps = 63/327 (19%)
Query: 293 GDLP-YSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVF---ALKRIDKLNEGF 346
G+ P + I+K+ E ++GSG FGTVYK + V A+K +L E
Sbjct: 1 GEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREAT 56
Query: 347 DRF----FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD 402
E ++ S+ + ++ L G C + T LI +P G L + + E + +
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG 115
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
LN + AKG+ YL R++HRD+ + N+L+ +++DFGLAKLL EE
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 463 HITTIVAGT---FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518
G ++A E + T ++DV+S+GV V E+++ G +P D
Sbjct: 173 EYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--------- 221
Query: 519 IVGWLNFLISEDRQREIID-----------PNCEGVQSESLDALLAVATQCVSSSPDDRP 567
G EI P C + + +C D RP
Sbjct: 222 --GIPA--------SEISSILEKGERLPQPPIC-------TIDVYMIMVKCWMIDADSRP 264
Query: 568 TMHRVVQILESEVMTPCPSDFYDSNSD 594
++ M P + D
Sbjct: 265 KFRELIIEFSK--MARDPQRYLVIQGD 289
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-36
Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 36/292 (12%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEIL 357
+S I+ K+ ++G G GT+ M D A+KRI F +RE+++L
Sbjct: 16 TSVVIVGKIS-FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLL 71
Query: 358 -GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKG 416
S +H ++ + + + L +L E + ++ + ++ G
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 417 LAYLHHDCSPRIIHRDIKSSNILL-----DGNLEARVSDFGLAKLLEDEES--HITTIVA 469
LA+LH S I+HRD+K NIL+ G ++A +SDFGL K L + V
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 470 GTFGYLAPEYMQS---GRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNF 525
GT G++APE + T D++S G + V+S G P S + N
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANI 240
Query: 526 LISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
L+ + + E + L+ + ++ P RP+ +L+
Sbjct: 241 LL---GACSLDCLHPEKHEDVIARELI---EKMIAMDPQKRPSAK---HVLK 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-36
Identities = 71/298 (23%), Positives = 127/298 (42%), Gaps = 54/298 (18%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVF-ALKRIDKLNEGFDRF----FEREL 354
+K+ L D +G G FG+V + M + A+K L +G ++ RE
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQGTEKADTEEMMREA 387
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA 414
+I+ + + Y+V L G C + +L+ + GG L + L + E++ ++ +
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
G+ YL +HR++ + N+LL A++SDFGL+K L ++S+ T AG +
Sbjct: 447 MGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503
Query: 475 --LAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531
APE + + + ++DV+S+GV + E LS G++P
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-----------KMKG------- 545
Query: 532 QREIID-----------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
E++ P C L A+ + C +DRP V Q + +
Sbjct: 546 -PEVMAFIEQGKRMECPPEC-------PPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 74/294 (25%), Positives = 130/294 (44%), Gaps = 49/294 (16%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVFALKRIDKLNEGFD---RFFERELEILGSIKHRY 364
+G G FG+V L + G V A+K KL + R FERE+EIL S++H
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVK---KLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 365 LVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V +G C S + LI ++LP GSL + L + E++D L KG+ YL
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG- 131
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYM 480
+ R IHRD+ + NIL++ ++ DFGL K+L ++ G + APE +
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI-----VGWLNFLISEDRQREI 535
+ + +DV+SFGV++ E+ + + + E I + +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV--------FHL 241
Query: 536 ID-----------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
I+ C + + ++ T+C +++ + RP+ + ++
Sbjct: 242 IELLKNNGRLPRPDGC----PDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 288
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 70/288 (24%), Positives = 123/288 (42%), Gaps = 54/288 (18%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF-ALKRIDKLNEGFD----RFFERELEILGSIKHRY 364
D +G G FG+V + M + A+K L +G + RE +I+ + + Y
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
+V L G C + +L+ + GG L + L + E++ ++ + G+ YL
Sbjct: 72 IVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYMQS 482
+HRD+ + N+LL A++SDFGL+K L ++S+ T AG + + APE +
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 483 GRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID---- 537
+ + ++DV+S+GV + E LS G++P E++
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYK-----------KMKG--------PEVMAFIEQ 228
Query: 538 -------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
P C L A+ + C +DRP V Q + +
Sbjct: 229 GKRMECPPEC-------PPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 74/293 (25%), Positives = 131/293 (44%), Gaps = 49/293 (16%)
Query: 314 IIGSGGFGTVYK-----LAMDDGNVFALKRIDKLNEGFD---RFFERELEILGSIKHRYL 365
+G G FG+V L + G V A+K KL + R FERE+EIL S++H +
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVK---KLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 366 VNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
V +G C S + LI ++LP GSL + L + E++D L KG+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-- 162
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYMQ 481
+ R IHRD+ + NIL++ ++ DFGL K+L ++ + G + APE +
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI-----VGWLNFLISEDRQREII 536
+ + +DV+SFGV++ E+ + + + E I + +I
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV--------FHLI 273
Query: 537 D-----------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ C + + ++ T+C +++ + RP+ + ++
Sbjct: 274 ELLKNNGRLPRPDGC----PDEIYMIM---TECWNNNVNQRPSFRDLALRVDQ 319
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 70/308 (22%), Positives = 117/308 (37%), Gaps = 52/308 (16%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK--LAMDDGNVF--ALK--RIDKLNEGF 346
G+ P S + + L +G G FG V + G A+K + D L++
Sbjct: 4 GEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 347 DRF-FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDA 405
F RE+ + S+ HR L+ L G +P ++ + P GSL + L +
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
+ A+G+ YL S R IHRD+ + N+LL ++ DFGL + L + H
Sbjct: 123 LSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 466 TIVAGTFGY--LAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGW 522
+ APE +++ + +D + FGV + E+ + G+ P G
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----------GL 228
Query: 523 LNFLISEDRQREIID------------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMH 570
+I+ +C + V QC + P+DRPT
Sbjct: 229 NG--------SQILHKIDKEGERLPRPEDC-------PQDIYNVMVQCWAHKPEDRPTFV 273
Query: 571 RVVQILES 578
+ L
Sbjct: 274 ALRDFLLE 281
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-35
Identities = 49/266 (18%), Positives = 91/266 (34%), Gaps = 47/266 (17%)
Query: 312 DHIIGSGGFGTVYKLAMD---DGNVFALKR-IDKLNEGFDRFFERELEILGSIKHRYLVN 367
I GG G +Y LA+D +G LK + + E + L + H +V
Sbjct: 85 KGCIAHGGLGWIY-LALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 368 LR--GYCNSPTSKLLIY---DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+ + Y +++ G SL + ++ L + ++ L+YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH- 199
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ- 481
S +++ D+K NI+L + ++ D G + + GT G+ APE
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE--IV 249
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541
T TD+Y+ G + + + ++ + + +
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNGRYV-------------------DGLPEDDPV 290
Query: 542 GVQSESLDALLAVATQCVSSSPDDRP 567
+S LL A P R
Sbjct: 291 LKTYDSYGRLLRRAI---DPDPRQRF 313
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 69/292 (23%), Positives = 112/292 (38%), Gaps = 38/292 (13%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+G GGF V L DG+ +ALKRI + +RE ++ H ++ L YC
Sbjct: 37 LGEGGFSYVD-LVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 373 NSPTSK----LLIYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCS 425
L+ F G+L + ++ L D L +++G +GL +H +
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA--------GTFGYLAP 477
HRD+K +NILL + + D G + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 478 EYMQSGR---ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534
E E+TDV+S G ++ ++ G+ P D F + G L +++
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK------GDSVALAVQNQLSI 266
Query: 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPS 586
P S +L LL ++ P RP + ++ LE + P P
Sbjct: 267 PQSPRH----SSALWQLLN---SMMTVDPHQRPHIPLLLSQLE-ALQPPAPG 310
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 36/296 (12%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGN------VFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
+ +IG G FG VY +D+ V +L RI + E F E I+ H
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEGIIMKDFSHPN 151
Query: 365 LVNLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+++L G C S S L++ ++ G L + + + + AKG+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA-- 209
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL-----APE 478
S + +HRD+ + N +LD +V+DFGLA+ + D+E T L A E
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALE 266
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537
+Q+ + T K+DV+SFGVL+ E+++ G P +N +L +R +
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DVNTFDITVYL--LQGRRLLQP 318
Query: 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNS 593
C D L V +C + RP+ +V + + T + N+
Sbjct: 319 EYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 367
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 63/284 (22%), Positives = 114/284 (40%), Gaps = 50/284 (17%)
Query: 314 IIGSGGFGTVYK--LAMDDGNVF-ALK--RIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
+GSG FGTV K M A+K + + + E ++ + + Y+V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G C + S +L+ + G L++ L + + + ++ + G+ YL
Sbjct: 84 IGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE---ESNF 138
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYMQSGRAT 486
+HRD+ + N+LL A++SDFGL+K L +E++ G + + APE + + +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 487 EKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID-------- 537
K+DV+SFGVL+ E S G++P G E+
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYR-----------GMKG--------SEVTAMLEKGERM 239
Query: 538 ---PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
C + + C + ++RP V L +
Sbjct: 240 GCPAGC-------PREMYDLMNLCWTYDVENRPGFAAVELRLRN 276
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 33/285 (11%)
Query: 313 HIIGSGGFGTVYKLAMDDGN--------VFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
+G G FG V D N V ALK +++E++IL ++ H +
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG--WKQEIDILRTLYHEH 94
Query: 365 LVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++ +G C + L+ +++P GSL + L + L +G+AYLH
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH- 151
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF--GYLAPEYM 480
+ IHRD+ + N+LLD + ++ DFGLAK + + + G + APE +
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 481 QSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIV---GWLNF-LISEDRQREI 535
+ + +DV+SFGV + E+L+ L + L + E
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269
Query: 536 ID--PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ C + L+ C + RPT ++ IL++
Sbjct: 270 LPRPDKC----PAEVYHLM---KNCWETEASFRPTFENLIPILKT 307
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 62/271 (22%), Positives = 108/271 (39%), Gaps = 46/271 (16%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G FG V++ D G A+K++ + F EL + +V L G
Sbjct: 64 PRVGRGSFGEVHR-MKDKQTGFQCAVKKVR-----LEVFRVEELVACAGLSSPRIVPLYG 117
Query: 371 YCNSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ I+ + L GGSL + + ++ L D L + A +GL YLH + RI+
Sbjct: 118 -AVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLH---TRRIL 172
Query: 430 HRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTI----VAGTFGYLAPEYMQSGR 484
H D+K+ N+LL + A + DFG A L+ + + + + GT ++APE +
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 485 ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLN-------FLISEDRQREIID 537
K D++S ++L +L+G P W I+ + I
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCHP--------------WTQYFRGPLCLKIASEPP--PIR 276
Query: 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPT 568
+ A+ + + P R +
Sbjct: 277 EIPPSCAPLTAQAIQ----EGLRKEPVHRAS 303
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 64/295 (21%), Positives = 115/295 (38%), Gaps = 57/295 (19%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGN------VFALKRIDKLNEGFDRFFERELEILGSIKHR 363
++GSG FGTV+K + + + ++ + +GS+ H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA--VTDHMLAIGSLDHA 75
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
++V L G C + L+ +LP GSL + + + L LN + AKG+ YL
Sbjct: 76 HIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-- 132
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT---FGYLAPEYM 480
++HR++ + N+LL + +V+DFG+A LL ++ + + ++A E +
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESI 189
Query: 481 QSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID-- 537
G+ T ++DV+S+GV V E+++ G P G E+ D
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYA-----------GLRL--------AEVPDLL 230
Query: 538 ---------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
C + V +C + RPT + P
Sbjct: 231 EKGERLAQPQIC-------TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 4e-34
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G F VY A + G A+K IDK G + + E++I +KH ++ L
Sbjct: 19 LGKGSFAGVY-RAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD-WDARLNIIMGAAKGLAYLHHDCSPRI 428
Y L+ + G ++ L R + +AR + + G+ YLH S I
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLH---SHGI 133
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-TE 487
+HRD+ SN+LL N+ +++DFGLA L+ T+ GT Y++PE + + A
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYISPE-IATRSAHGL 191
Query: 488 KTDVYSFGVLVLEVLSGKRPTDASFIE 514
++DV+S G + +L G+ P D ++
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVK 218
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 74/297 (24%), Positives = 128/297 (43%), Gaps = 37/297 (12%)
Query: 307 ETLDDDHIIGSGGFGTVYK-LAMDDGN------VFALKRIDKLNEGFDRFFERELEILGS 359
D +IG G FG VY +D + +L RI ++ + F RE ++
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA--FLREGLLMRG 78
Query: 360 IKHRYLVNLRGYCNSPT-SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+ H ++ L G P ++ ++ G L + + ++ + A+G+
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL--- 475
YL + +HRD+ + N +LD + +V+DFGLA+ + D E ++ L
Sbjct: 139 YLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVK 193
Query: 476 --APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQ 532
A E +Q+ R T K+DV+SFGVL+ E+L+ G P ++ +FL +
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR------HIDPFDLTHFL--AQGR 245
Query: 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFY 589
R C D+L V QC + P RPT +V +E ++++ D Y
Sbjct: 246 RLPQPEYC-------PDSLYQVMQQCWEADPAVRPTFRVLVGEVE-QIVSALLGDHY 294
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
++G G +G VY + + A+K I + + + + E+ + +KH+ +V G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87
Query: 373 NSPTSKLLIY-DFLPGGSLDEALHERSEQLDWDARL--NIIMGAAKGLAYLHHDCSPRII 429
S + I+ + +PGGSL L + L + + +GL YLH +I+
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIV 144
Query: 430 HRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR--AT 486
HRDIK N+L++ + ++SDFG +K L T GT Y+APE + G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYG 203
Query: 487 EKTDVYSFGVLVLEVLSGKRP 507
+ D++S G ++E+ +GK P
Sbjct: 204 KAADIWSLGCTIIEMATGKPP 224
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 54/218 (24%), Positives = 81/218 (37%), Gaps = 44/218 (20%)
Query: 312 DHIIGSGGFGTVYKLAMDDGNVFALKRID--KL-------NEGFDRFFERELEILGSIKH 362
++G GG G VY A D +RI KL + F +RE G ++
Sbjct: 39 RRLVGRGGMGDVY-EAEDT----VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 363 RYLVNLRGYCNSPTSKLLIYD-------------FLPGGSLDEALHERSEQLDWDARLNI 409
++V I+D + G L L + L + I
Sbjct: 94 PHVVP-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAI 139
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+ L H HRD+K NIL+ + A + DFG+A DE+
Sbjct: 140 VRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196
Query: 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
GT Y+APE AT + D+Y+ ++ E L+G P
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 75/289 (25%), Positives = 118/289 (40%), Gaps = 54/289 (18%)
Query: 312 DHIIGSGGFGTVYK---LAMDDGNVF-ALKRIDKLNEGFD----RFFERELEILGSIKHR 363
+ IIGSG G V +V A+K L G+ R F E I+G H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
++ L G +++ +++ GSLD L Q + ++ G G+ YL
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS-- 168
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL--APEYMQ 481
+HRD+ + N+L+D NL +VSDFGL+++LED+ T G APE +
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 482 SGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID--- 537
+ +DV+SFGV++ EVL+ G+RP N R++I
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYW-----------NMTN--------RDVISSVE 268
Query: 538 --------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
C AL + C RP ++V +L++
Sbjct: 269 EGYRLPAPMGCP-------HALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 50/197 (25%), Positives = 77/197 (39%), Gaps = 11/197 (5%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFD--RFFERELEILGSI-KHRYLVNLRG 370
+G G +G V+K + +DG ++A+KR G E+ + +H V L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
L + L G SL + L + LA+LH S ++H
Sbjct: 125 AWEEG-GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVH 180
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
D+K +NI L ++ DFGL L + G Y+APE +Q D
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELLQGS-YGTAAD 237
Query: 491 VYSFGVLVLEVLSGKRP 507
V+S G+ +LEV
Sbjct: 238 VFSLGLTILEVACNMEL 254
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 49/292 (16%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVFALKRIDKLNEGFD----RFFERELEILGSIKHRYL 365
+IG+G FG VYK L G I L G+ F E I+G H +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
+ L G + ++I +++ G+LD+ L E+ + + ++ G A G+ YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---N 165
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY--LAPEYMQSG 483
+HRD+ + NIL++ NL +VSDFGL+++LED+ T G APE +
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 484 RATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID----- 537
+ T +DV+SFG+++ EV++ G+RP N E++
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERPYW-----------ELSN--------HEVMKAINDG 266
Query: 538 ------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
+C A+ + QC RP +V IL+ + P
Sbjct: 267 FRLPTPMDCP-------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 73/301 (24%), Positives = 125/301 (41%), Gaps = 36/301 (11%)
Query: 302 IIKKLETLDDDHIIGSGGFGTVYK-LAMDDGN------VFALKRIDKLNEGFDRFFEREL 354
I + + +IG G FG VY +D+ V +L RI + E F E
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ--FLTEG 77
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLL-IYDFLPGGSLDEALHERSEQLDWDARLNIIMGA 413
I+ H +++L G C L + ++ G L + + + +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
AKG+ YL S + +HRD+ + N +LD +V+DFGLA+ + D+E + ++ T
Sbjct: 138 AKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGA 192
Query: 474 YL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLI 527
L A E +Q+ + T K+DV+SFGVL+ E+++ G P +N +L
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DVNTFDITVYL- 245
Query: 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSD 587
+R + C D L V +C + RP+ +V + + T
Sbjct: 246 -LQGRRLLQPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
Query: 588 F 588
+
Sbjct: 298 Y 298
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 38/212 (17%)
Query: 315 IGSGGFGTVYKLAMD---DGNVFALK--RID-KLNEGFDRFFERELEILGSIKHRYLVNL 368
+G GG TVY A D + V A+K I + E + FERE+ + H+ +V+
Sbjct: 19 LGGGGMSTVYL-AEDTILNIKV-AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS- 75
Query: 369 RGYCNSPTSKLLIYD-------------FLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
+ D ++ G +L E + L D +N
Sbjct: 76 ------------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILD 122
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
G+ + H RI+HRDIK NIL+D N ++ DFG+AK L + T V GT Y
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+PE + E TD+YS G+++ E+L G+ P
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 312 DHIIGSGGFGTVYKLAMD---DGNVFALK--RID-KLNEGFDRFFERELEILGSIKHRYL 365
I+G GG V+ A D +V A+K R D + F F RE + ++ H +
Sbjct: 17 GEILGFGGMSEVHL-ARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 366 VNLRGYCNSPTSKLLIY----DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
V + + T + +++ G +L + +H + + +I A + L + H
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH 133
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT--IVAGTFGYLAPEY 479
+ IIHRD+K +NI++ +V DFG+A+ + D + +T V GT YL+PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ ++DVYS G ++ EVL+G+ P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 66/198 (33%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG VY LA + ALK + K G + RE+EI ++H ++ L
Sbjct: 17 LGKGKFGNVY-LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
GY + T LI ++ P G++ L + S+ + I A L+Y H S R+I
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRVI 131
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKT 489
HRDIK N+LL E +++DFG + GT YL PE ++ EK
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDL--CGTLDYLPPEMIEGRMHDEKV 188
Query: 490 DVYSFGVLVLEVLSGKRP 507
D++S GVL E L GK P
Sbjct: 189 DLWSLGVLCYEFLVGKPP 206
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 54/288 (18%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF--ALKRIDKLNEGFD----RFFERELEILGSIKHR 363
D ++G+G FG V L + A+K L G+ R F E I+G H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
++ L G +++ +++ GSLD L + Q + ++ G A G+ YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS-- 164
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL--APEYMQ 481
+HRD+ + NIL++ NL +VSDFGL ++LED+ T G +PE +
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 482 SGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID--- 537
+ T +DV+S+G+++ EV+S G+RP N +++I
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYW-----------EMSN--------QDVIKAVD 264
Query: 538 --------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+C AL + C ++RP ++V IL+
Sbjct: 265 EGYRLPPPMDCP-------AALYQLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 40/286 (13%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G FG V+ V A+K + + F + E +++ ++H LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV 247
Query: 372 C-NSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRII 429
P ++ +++ GSL + L + + L +++ A G+AY+ +
Sbjct: 248 VSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKT 489
HRD++++NIL+ NL +V+DFGLA+L+ED E + APE GR T K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 490 DVYSFGVLVLEVLS-GKRP------TDA-SFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541
DV+SFG+L+ E+ + G+ P + +E+G R P C
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---------------YRMPCPPEC- 406
Query: 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSD 587
ESL L+ QC P++RPT + LE + P
Sbjct: 407 ---PESLHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-32
Identities = 30/299 (10%), Positives = 69/299 (23%), Gaps = 53/299 (17%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
+ G V+ L D FALK + +
Sbjct: 69 PLRVGDRSVVF-LVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 369 RGYCN--------------------------SPTSKLLIYDFLPG-----GSLDEALHER 397
R + + LL+ S + ++
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 398 SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457
A + + A L S ++H N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242
Query: 458 EDEESHITTIVAGTFGYLAPEYMQSGRA--TEKTDVYSFGVLVLEVLSGKRPTDASFIEK 515
+ + Y E++ + A T + + G+ + V P
Sbjct: 243 --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL---VT 297
Query: 516 GLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
W + + +C + + + L+ + ++ R ++
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPL-PDFVKTLI---GRFLNFDRRRRLLPLEAME 352
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 315 IGSGGFGTVYKLA-MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G GGF ++++ D VFA K + K L E+ I S+ H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ ++ + SL E R + +AR + G YLH R+IH
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVIH 164
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-TEKT 489
RD+K N+ L+ +LE ++ DFGLA +E + + GT Y+APE + S + + +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPE-VLSKKGHSFEV 222
Query: 490 DVYSFGVLVLEVLSGKRPTDASFIE 514
DV+S G ++ +L GK P + S ++
Sbjct: 223 DVWSIGCIMYTLLVGKPPFETSCLK 247
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 14/222 (6%)
Query: 301 DIIKKLETLDD---DHIIGSGGFGTVYKLA-MDDGNVFALKRIDK---LNEGFDRFFERE 353
+++ + +G GGF ++++ D VFA K + K L E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA 413
+ I S+ H+++V G+ ++ + SL E R + +AR +
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQI 124
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
G YLH R+IHRD+K N+ L+ +LE ++ DFGLA +E + + GT
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPN 180
Query: 474 YLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIE 514
Y+APE + S + + + DV+S G ++ +L GK P + S ++
Sbjct: 181 YIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 74/311 (23%), Positives = 125/311 (40%), Gaps = 54/311 (17%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEIL 357
+ + +K L + I+G G GTV G A+KR+ F E+++L
Sbjct: 8 NFEQSLKNLVVSEK--ILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLL 62
Query: 358 G-SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDE------ALHERSEQLDWDARLNII 410
S H ++ + + + L +L + E + ++++
Sbjct: 63 TESDDHPNVIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-------------GNLEARVSDFGLAKLL 457
A G+A+LH S +IIHRD+K NIL+ NL +SDFGL K L
Sbjct: 122 RQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 458 EDEESHITTI---VAGTFGYLAPEYMQSG-------RATEKTDVYSFGVLVLEVLS-GKR 506
+ +S T +GT G+ APE ++ R T D++S G + +LS GK
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 507 PTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDR 566
P + + I G + E+ + + +E+ D L+ +Q + P R
Sbjct: 239 PFGDKYSRESNIIRGIFSL-------DEMKCLHDRSLIAEATD-LI---SQMIDHDPLKR 287
Query: 567 PTMHRVVQILE 577
PT ++L
Sbjct: 288 PTAM---KVLR 295
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 72/304 (23%), Positives = 110/304 (36%), Gaps = 67/304 (22%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF--ALKRIDKLNEGFDRF----FERELEILGSIKHR 363
+ I+G G FG VY+ G A+K + F E I+ ++ H
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 364 YLVNLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++V L G PT +I + P G L L L + + K +AYL
Sbjct: 74 HIVKLIGIIEEEPT--WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 130
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL-----AP 477
S +HRDI NIL+ ++ DFGL++ +EDE+ + L +P
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-----YYKASVTRLPIKWMSP 183
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536
E + R T +DV+ F V + E+LS GK+P N +++I
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGKQPFF-----------WLEN--------KDVI 224
Query: 537 D-----------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP 585
C L + T+C P DRP +V L +
Sbjct: 225 GVLEKGDRLPKPDLCP-------PVLYTLMTRCWDYDPSDRPRFTELVCSLSD--VYQME 275
Query: 586 SDFY 589
D
Sbjct: 276 KDIA 279
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 76/317 (23%), Positives = 121/317 (38%), Gaps = 65/317 (20%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVF---ALKRIDKLNEGFD- 347
G + S++D + E ++ IG G FG V++ + M N A+K
Sbjct: 1 GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK---TCKNCTSD 57
Query: 348 ---RFFERELEILGSIKHRYLVNLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDW 403
F +E + H ++V L G +P +I + G L L R LD
Sbjct: 58 SVREKFLQEALTMRQFDHPHIVKLIGVITENPV--WIIMELCTLGELRSFLQVRKYSLDL 115
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
+ + + LAYL S R +HRDI + N+L+ N ++ DFGL++ +ED
Sbjct: 116 ASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-- 170
Query: 464 ITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGL 517
+ G L APE + R T +DV+ FGV + E+L G +P
Sbjct: 171 ---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-------- 219
Query: 518 NIVGWLNFLISEDRQREIID-----------PNCEGVQSESLDALLAVATQCVSSSPDDR 566
G N ++I PNC L ++ T+C + P R
Sbjct: 220 ---GVKN--------NDVIGRIENGERLPMPPNC-------PPTLYSLMTKCWAYDPSRR 261
Query: 567 PTMHRVVQILESEVMTP 583
P + L + +
Sbjct: 262 PRFTELKAQLSTILEEE 278
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-32
Identities = 76/286 (26%), Positives = 125/286 (43%), Gaps = 40/286 (13%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G FG V+ V A+K + + F + E +++ ++H LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQLYAV 330
Query: 372 C-NSPTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
P ++ +++ GSL + L + L +++ A G+AY+ +
Sbjct: 331 VSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKT 489
HRD++++NIL+ NL +V+DFGLA+L+ED E + APE GR T K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 490 DVYSFGVLVLEVLS-GKRP------TDA-SFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541
DV+SFG+L+ E+ + G+ P + +E+G R P C
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---------------YRMPCPPEC- 489
Query: 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSD 587
ESL L+ QC P++RPT + LE + P
Sbjct: 490 ---PESLHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 72/288 (25%), Positives = 118/288 (40%), Gaps = 52/288 (18%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGF--DRFFERELEILGSIKHRYLVNLR 369
IGSG FG V+ ++ V A+K + EG + F E E++ + H LV L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKV-AIK---TIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
G C L+ +F+ G L + L + + L + + +G+AYL +I
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY--LAPEYMQSGRATE 487
HRD+ + N L+ N +VSDFG+ + + D++ T+ F +PE R +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 488 KTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID--------- 537
K+DV+SFGVL+ EV S GK P + N E+++
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYE-----------NRSN--------SEVVEDISTGFRLY 225
Query: 538 --PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
+ + C P+DRP R+++ L +
Sbjct: 226 KPRLAS-------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFEREL 354
S+ L L D I+G G V++ G++FA+K + D RE
Sbjct: 2 GSQSTSNHLWLLSD--ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-MREF 58
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKL--LIYDFLPGGSLDEAL--HERSEQLDWDARLNII 410
E+L + H+ +V L T++ LI +F P GSL L + L L ++
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITT 466
G+ +L I+HR+IK NI+ DG +++DFG A+ LED+E +
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS 174
Query: 467 IVAGTFGYLAPEYMQSGRA--------TEKTDVYSFGVLVLEVLSGKRP 507
+ GT YL P+ + D++S GV +G P
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG VY LA + + ALK + K EG + RE+EI ++H ++ +
Sbjct: 22 LGKGKFGNVY-LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
Y + L+ +F P G L + L + + + + A L Y H ++I
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCH---ERKVI 136
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-TEK 488
HRDIK N+L+ E +++DFG + T GT YL PE M G+ EK
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPE-MIEGKTHDEK 192
Query: 489 TDVYSFGVLVLEVLSGKRPTDASFIEK 515
D++ GVL E L G P D+ +
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 23/214 (10%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
++GSG F V+ L G +FALK I K D E E+ +L IKH +V L
Sbjct: 16 VLGSGAFSEVF-LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
S T L+ + GG L + + ER +E+ DA +I + YLH I
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEK---DAS-LVIQQVLSAVKYLH---ENGI 127
Query: 429 IHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
+HRD+K N+L + N + ++DFGL+K+ ++ ++T GT GY+APE +
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLAQKPY 184
Query: 486 TEKTDVYSFGVLVLEVLSGKRP----TDASFIEK 515
++ D +S GV+ +L G P T++ EK
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK 218
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 54/246 (21%), Positives = 104/246 (42%), Gaps = 37/246 (15%)
Query: 292 HGDLPYSSKDIIKKLETLDDDHI---IGSGGFGTVYKLAMDDGNVFALKRIDK------- 341
+ +L Y +K + +K + ++D I + G F + L D +ALK+ +K
Sbjct: 13 YSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKII-LCEKDNKFYALKKYEKSLLEKKR 71
Query: 342 ----------LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLD 391
+ F+ EL+I+ IK+ Y + G + +IY+++ S+
Sbjct: 72 DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL 131
Query: 392 EALHERSEQLDWDARLNIIMGAAK-------GLAYLHHDCSPRIIHRDIKSSNILLDGNL 444
+ I +Y+H++ I HRD+K SNIL+D N
Sbjct: 132 KFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNG 189
Query: 445 EARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRAT---EKTDVYSFGVLVLEV 501
++SDFG ++ + D++ + GT+ ++ PE S ++ K D++S G+ + +
Sbjct: 190 RVKLSDFGESEYMVDKKIK-GS--RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVM 245
Query: 502 LSGKRP 507
P
Sbjct: 246 FYNVVP 251
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 36/276 (13%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
H +G G +G VY+ + A+K + + + F + E ++ IKH LV L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGV 284
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
C +I +F+ G+L + L E + Q + L + + + YL IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
R++ + N L+ N +V+DFGL++L+ + + APE + + + K+D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 491 VYSFGVLVLEVLS-GKRP----TDA---SFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
V++FGVL+ E+ + G P + +EK R C
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------------RMERPEGC-- 444
Query: 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
E + L+ C +P DRP+ + Q E+
Sbjct: 445 --PEKVYELM---RACWQWNPSDRPSFAEIHQAFET 475
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 27/229 (11%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFEREL 354
S+ L L D I+G G V++ G++FA+K + D RE
Sbjct: 2 GSQSTSNHLWLLSD--ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-MREF 58
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKL--LIYDFLPGGSLDEAL--HERSEQLDWDARLNII 410
E+L + H+ +V L T++ LI +F P GSL L + L L ++
Sbjct: 59 EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITT 466
G+ +L I+HR+IK NI+ DG +++DFG A+ LED+E +
Sbjct: 119 RDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS 174
Query: 467 IVAGTFGYLAPEYMQSGRA--------TEKTDVYSFGVLVLEVLSGKRP 507
+ GT YL P+ + D++S GV +G P
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-31
Identities = 72/298 (24%), Positives = 111/298 (37%), Gaps = 65/298 (21%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGNVF---ALKRIDKLNEGFD----RFFERELEILGSIKHR 363
IG G FG V++ + M N A+K F +E + H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 364 YLVNLRGYC-NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++V L G +P +I + G L L R LD + + + LAYL
Sbjct: 452 HIVKLIGVITENPV--WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE- 508
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL-----AP 477
S R +HRDI + N+L+ N ++ DFGL++ +ED + G L AP
Sbjct: 509 --SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-----YYKASKGKLPIKWMAP 561
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536
E + R T +DV+ FGV + E+L G +P G N ++I
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-----------GVKN--------NDVI 602
Query: 537 D-----------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
PNC L ++ T+C + P RP + L + +
Sbjct: 603 GRIENGERLPMPPNCP-------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 48/281 (17%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+GSG FG V +V A+K I + + D FF+ E + + + H LV G
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQ-EAQTMMKLSHPKLVKFYGV 71
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
C+ ++ +++ G L L + L+ L + +G+A+L S + IHR
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY--LAPEYMQSGRATEKT 489
D+ + N L+D +L +VSDFG+ + + D++ + V F APE + + K+
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 490 DVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID----------- 537
DV++FG+L+ EV S GK P D + N E++
Sbjct: 187 DVWAFGILMWEVFSLGKMPYD-----------LYTN--------SEVVLKVSQGHRLYRP 227
Query: 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
S+++ ++ C P+ RPT +++ +E
Sbjct: 228 HLA----SDTIYQIM---YSCWHELPEKRPTFQQLLSSIEP 261
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 58/291 (19%), Positives = 118/291 (40%), Gaps = 50/291 (17%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKH--RYLVNLRG 370
IGSGG V+++ + ++A+K ++ + + E+ L ++ ++ L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 371 YCNSPTSKLLIYDFL--PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y + IY + L+ L ++ + +D R + + + +H I
Sbjct: 96 YEITDQY---IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGI 148
Query: 429 IHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHI--TTIVAGTFGYLAPE------- 478
+H D+K +N L+ G L ++ DFG+A ++ + + + + V GT Y+ PE
Sbjct: 149 VHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSS 205
Query: 479 ----YMQSGRATEKTDVYSFGVLVLEVLSGKRP--TDASFIEKGLNIVGWLNFLISEDRQ 532
+ + K+DV+S G ++ + GK P + I K I+ D
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---------DPN 256
Query: 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
EI P+ + + L +L C+ P R ++ ++L +
Sbjct: 257 HEIEFPD---IPEKDLQDVL---KCCLKRDPKQRISIP---ELLAHPYVQI 298
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 64/281 (22%), Positives = 114/281 (40%), Gaps = 48/281 (17%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G+G FG V +V A+K I + + D F E E +++ ++ H LV L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE-EAKVMMNLSHEKLVQLYGV 87
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
C +I +++ G L L E + L + + + YL S + +HR
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY--LAPEYMQSGRATEKT 489
D+ + N L++ +VSDFGL++ + D+E T+ V F PE + + + K+
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 490 DVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID----------- 537
D+++FGVL+ E+ S GK P + + N E +
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYE-----------RFTN--------SETAEHIAQGLRLYRP 243
Query: 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ + + C D+RPT ++ +
Sbjct: 244 HLAS-------EKVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 67/270 (24%), Positives = 115/270 (42%), Gaps = 14/270 (5%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID-KLNEGFDRFFERELEILGSIK 361
K + + +G+G G V+K G V A K I ++ REL++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLH 421
Y+V G S + + + GGSLD+ L ++ ++ + + KGL YL
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
+I+HRD+K SNIL++ E ++ DFG++ L D S + V GT Y++PE +Q
Sbjct: 149 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQ 203
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRP----TDASFIEKGLNIVGWLNFLISEDRQREIID 537
+ ++D++S G+ ++E+ G+ P V +
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 538 PNCEGVQSESLDALLAVATQCVSSSPDDRP 567
N G+ S A+ + V+ P P
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 68/199 (34%), Positives = 102/199 (51%), Gaps = 16/199 (8%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRF--FERELEILGSIKHRYLVNLRG 370
IG G FG V+K +D V A+K ID L E D ++E+ +L Y+ G
Sbjct: 30 IGKGSFGEVFK-GIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 371 -YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y +KL +I ++L GGS + L A I+ KGL YLH S +
Sbjct: 88 SYLKD--TKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREILKGLDYLH---SEKK 140
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEK 488
IHRDIK++N+LL + E +++DFG+A L D + T V GT ++APE ++ K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 199
Query: 489 TDVYSFGVLVLEVLSGKRP 507
D++S G+ +E+ G+ P
Sbjct: 200 ADIWSLGITAIELARGEPP 218
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 58/291 (19%), Positives = 117/291 (40%), Gaps = 50/291 (17%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKH--RYLVNLRG 370
IGSGG V+++ + ++A+K ++ + + E+ L ++ ++ L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 371 YCNSPTSKLLIYDFL--PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y + IY + L+ L ++ + +D R + + + +H I
Sbjct: 77 YEITDQY---IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGI 129
Query: 429 IHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHI--TTIVAGTFGYLAPE------- 478
+H D+K +N L+ G L ++ DFG+A ++ + + + + V GT Y+ PE
Sbjct: 130 VHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSS 186
Query: 479 ----YMQSGRATEKTDVYSFGVLVLEVLSGKRP--TDASFIEKGLNIVGWLNFLISEDRQ 532
+ + K+DV+S G ++ + GK P + I K I+ D
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---------DPN 237
Query: 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
EI P + + + D L C+ P R ++ ++L +
Sbjct: 238 HEIEFP--DIPEKDLQDVLK----CCLKRDPKQRISIP---ELLAHPYVQI 279
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-29
Identities = 70/279 (25%), Positives = 128/279 (45%), Gaps = 44/279 (15%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G+G FG V+ V A+K + + + F E ++ +++H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA-EANVMKTLQHDKLVKLHAV 251
Query: 372 C-NSPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
P +I +F+ GSL + L + ++ A+G+A++ I
Sbjct: 252 VTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY--LAPEYMQSGRATE 487
HRD++++NIL+ +L +++DFGLA+++ED E T F APE + G T
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTI 364
Query: 488 KTDVYSFGVLVLEVLS-GKRP----TDA---SFIEKGLNIVGWLNFLISEDRQREIIDPN 539
K+DV+SFG+L++E+++ G+ P ++ +E+G R N
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---------------YRMPRPEN 409
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
C E L ++ +C + P++RPT + +L+
Sbjct: 410 C----PEELYNIM---MRCWKNRPEERPTFEYIQSVLDD 441
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 59/196 (30%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+G G +G+VYK A+ G + A+K++ + +E+ I+ ++V G
Sbjct: 37 LGEGSYGSVYK-AIHKETGQIVAIKQVP-VESDLQEI-IKEISIMQQCDSPHVVKYYG-S 92
Query: 373 NSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
+ L ++ ++ GS+ + + R++ L D I+ KGL YLH R IHR
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHR 149
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDV 491
DIK+ NILL+ A+++DFG+A L D + T++ GT ++APE +Q D+
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADI 208
Query: 492 YSFGVLVLEVLSGKRP 507
+S G+ +E+ GK P
Sbjct: 209 WSLGITAIEMAEGKPP 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 60/292 (20%), Positives = 114/292 (39%), Gaps = 57/292 (19%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGNVF-------ALKRIDKLNEGFDRFFERELEILGSIKHR 363
+ +G G F ++K + + G+ LK +DK + + F ++ + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
+LV G C +L+ +F+ GSLD L + ++ +L + A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE-- 130
Query: 424 CSPRIIHRDIKSSNILLDG--------NLEARVSDFGLAKLLEDEESHITTIVAGTFGY- 474
+IH ++ + NILL ++SD G++ + ++
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQ 178
Query: 475 -----LAPEYMQSGRA-TEKTDVYSFGVLVLEVLS-GKRP-TDASFIEKGLNIVGWLNFL 526
+ PE +++ + TD +SFG + E+ S G +P + K L F
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-------LQFY 231
Query: 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
EDR + E L + C+ PD RP+ +++ L S
Sbjct: 232 --EDRHQLPAPKAAE---------LANLINNCMDYEPDHRPSFRAIIRDLNS 272
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 41/309 (13%), Positives = 83/309 (26%), Gaps = 66/309 (21%)
Query: 308 TLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFER------ELEILGS 359
TL ++G A D G F + ++ L +L
Sbjct: 79 TLVRGTVLGQEDPYAYL-EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137
Query: 360 IKHRYLVNLRGYCNSPTSKL------LIYDFLP--------------------GGSLDEA 393
IK++ + P + + + E
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 394 LHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450
L + L ARL + + + LA LH ++H ++ +I+LD ++
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 451 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-----TEKTDVYSFGVLVLEVLSGK 505
F A + G+ T D ++ G+ + +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 506 RPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDD 565
P + E I +C+ + + + ALL + +D
Sbjct: 315 LPNTDD----------------AALGGSEWIFRSCKNI-PQPVRALL---EGFLRYPKED 354
Query: 566 RPTMHRVVQ 574
R + ++
Sbjct: 355 RLLPLQAME 363
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 67/307 (21%), Positives = 118/307 (38%), Gaps = 44/307 (14%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVF---ALK--RIDKLNEGF 346
+L +D++ L I+G G FG+V + + A+K ++D ++
Sbjct: 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 347 DRFFERELEILGSIKHRYLVNLRGYC-----NSPTSKLLIYDFLPGGSLDEAL-----HE 396
F E + H ++ L G C ++I F+ G L L
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 397 RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
+ + L ++ A G+ YL + +HRD+ + N +L ++ V+DFGL+K
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 457 LEDEESHITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDA 510
+ + + G + A E + T K+DV++FGV + E+ + G P
Sbjct: 197 IYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY-- 250
Query: 511 SFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMH 570
G+ ++L R +C LD L + C + P DRPT
Sbjct: 251 ----PGVQNHEMYDYL--LHGHRLKQPEDC-------LDELYEIMYSCWRTDPLDRPTFS 297
Query: 571 RVVQILE 577
+ LE
Sbjct: 298 VLRLQLE 304
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 21/223 (9%)
Query: 298 SSKDIIKKLETL----------DDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEG 345
S ++I++KL ++ IG G GTVY AMD G A+++++ +
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYT-AMDVATGQEVAIRQMNLQQQP 59
Query: 346 FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWD 404
E+ ++ K+ +VN +L ++ ++L GGSL + + E
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464
A + + L +LH S ++IHRDIKS NILL + +++DFG + E+S
Sbjct: 119 AA--VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+T+V GT ++APE + K D++S G++ +E++ G+ P
Sbjct: 174 STMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 59/291 (20%), Positives = 107/291 (36%), Gaps = 46/291 (15%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLR 369
++ GGF VY A D G +ALKR+ E +R +E+ + + H +V
Sbjct: 34 RVLAEGGFAFVY-EAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 370 GYC-------NSPTSKLLIYDFLPGGSLDEALHERSEQ--LDWDARLNIIMGAAKGLAYL 420
++ ++ L+ L G L E L + + L D L I + + ++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA----------- 469
H P IIHRD+K N+LL ++ DFG A + + +
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 470 GTFGYLAPE---YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL 526
T Y PE + EK D+++ G ++ + + P + +
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----------- 260
Query: 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
I + Q +L+ + +P++R ++ VV L+
Sbjct: 261 IVNGKYSIPPHDT----QYTVFHSLIR---AMLQVNPEERLSIAEVVHQLQ 304
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 60/297 (20%), Positives = 111/297 (37%), Gaps = 58/297 (19%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSI-KHRYLVNLRG 370
IGSG FG+V+K + DG ++A+KR K ++ RE+ + +H ++V
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 371 YCNSPTSKLLIY-DFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLHHDCSP 426
+ +LI ++ GGSL +A+ E ++++ +GL Y+H S
Sbjct: 79 -AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SM 134
Query: 427 RIIHRDIKSSNILLDGN-------------------LEARVSDFGLAKLLEDEESHITTI 467
++H DIK SNI + + ++ D G + +
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE--- 191
Query: 468 VAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL 526
G +LA E +Q K D+++ + V+ + N W
Sbjct: 192 --GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--------NGDQWHEI- 240
Query: 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
R+ P V S+ LL + P+ RP+ + +++ V+
Sbjct: 241 ------RQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPS---AMALVKHSVLLS 285
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 4e-29
Identities = 41/337 (12%), Positives = 97/337 (28%), Gaps = 78/337 (23%)
Query: 287 SIVMFHGDLPYSSKDII-KKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLN 343
S +++ P+ + + ++ TL ++G A D G F +
Sbjct: 52 STSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYL-EATDQETGESFEVHVPYFTE 110
Query: 344 EGFDRFFER----------------------------ELEILGSIKHRYLVNLRGYCNSP 375
++ +++ + + ++ +R
Sbjct: 111 RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDM 170
Query: 376 TSK--LLIYDFLPG--GSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
+Y + + E L + L ARL + + + LA LH +
Sbjct: 171 WVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS------ 482
+H ++ +I+LD ++ F + + G+ PE
Sbjct: 228 VHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGARVVSS-VSRGFEPPELEARRATISY 282
Query: 483 -----GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537
T D ++ G+++ + P + E I
Sbjct: 283 HRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD----------------AALGGSEWIF 326
Query: 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+C+ + + + ALL + +DR + ++
Sbjct: 327 RSCKNI-PQPVRALL---EGFLRYPKEDRLLPLQAME 359
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY 364
LD IG G G V A + G A+K +D + E+ I+ +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCL-AREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 365 LVNLRG-YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
+V + Y +L ++ +FL GG+L + + + + A + + LAYLH
Sbjct: 104 VVEMYKSYLVG--EELWVLMEFLQGGALTDIVSQVRLNEEQIAT--VCEAVLQALAYLH- 158
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
+ +IHRDIKS +ILL + ++SDFG + + ++V GT ++APE +
Sbjct: 159 --AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP 507
+ D++S G++V+E++ G+ P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 67/297 (22%), Positives = 115/297 (38%), Gaps = 60/297 (20%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGF---DRFFERELEILGSIKHRYLVNL 368
H +G G +G VY+ + A+K L E + F + E ++ IKH LV L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLK-EAAVMKEIKHPNLVQL 74
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
G C +I +F+ G+L + L E +++ L + + + YL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL-----APEYMQS 482
IHRD+ + N L+ N +V+DFGL++L+ + A APE +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-----TAHAGAKFPIKWTAPESLAY 186
Query: 483 GRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID---- 537
+ + K+DV++FGVL+ E+ + G P G ++ +
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYP-----------GIDL--------SQVYELLEK 227
Query: 538 -------PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSD 587
C + + + C +P DRP+ + Q E+ SD
Sbjct: 228 DYRMERPEGC-------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG-Y 371
+G G FG VYK A + G + A K I+ +E + E+EIL + H Y+V L G Y
Sbjct: 27 LGDGAFGKVYK-AKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 372 CNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ KL ++ +F PGG++D + E L + + L +LH S RIIH
Sbjct: 86 YHD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIH 140
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE-----YMQSGRA 485
RD+K+ N+L+ + R++DFG++ + + GT ++APE M+
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTPY 199
Query: 486 TEKTDVYSFGVLVLEVLSGKRP 507
K D++S G+ ++E+ + P
Sbjct: 200 DYKADIWSLGITLIEMAQIEPP 221
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 67/321 (20%), Positives = 121/321 (37%), Gaps = 45/321 (14%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVF---ALK--RIDKLNEGFD 347
+L +D++ + ++G G FG+V + + F A+K + D +
Sbjct: 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI 69
Query: 348 RFFERELEILGSIKHRYLVNLRGYC------NSPTSKLLIYDFLPGGSLDEAL-----HE 396
F RE + H ++ L G ++I F+ G L L E
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 397 RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456
L + ++ A G+ YL S IHRD+ + N +L ++ V+DFGL++
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 457 LEDEESHITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDA 510
+ + + G L A E + T +DV++FGV + E+++ G+ P
Sbjct: 187 IYSGDYY----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY-- 240
Query: 511 SFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMH 570
G+ N+L R P C ++ + + QC S+ P RP+
Sbjct: 241 ----AGIENAEIYNYL--IGGNRLKQPPEC-------MEEVYDLMYQCWSADPKQRPSFT 287
Query: 571 RVVQILESEVMTPCPSDFYDS 591
+ LE+ +
Sbjct: 288 CLRMELENILGHLSVLSTSQD 308
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-29
Identities = 66/279 (23%), Positives = 109/279 (39%), Gaps = 48/279 (17%)
Query: 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG V GN A+K I K + F E ++ ++H LV L G
Sbjct: 199 QTIGKGEFGDVML-GDYRGNKVAVKCI-KNDATAQAFLA-EASVMTQLRHSNLVQLLGVI 255
Query: 373 -NSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ +++ GSL + L R L D L + + + YL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT-FGY--LAPEYMQSGRATE 487
RD+ + N+L+ + A+VSDFGL K ++ APE ++ + +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 488 KTDVYSFGVLVLEVLS-GKRP----TDA---SFIEKGLNIVGWLNFLISEDRQREIIDPN 539
K+DV+SFG+L+ E+ S G+ P +EKG +
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---------------YKMDAPDG 410
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
C ++ ++ C RPT ++ + LE
Sbjct: 411 C----PPAVYDVM---KNCWHLDAATRPTFLQLREQLEH 442
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-29
Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 26/232 (11%)
Query: 291 FHGDLPYSSKDII-KKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK-- 341
F GDL + I K L + +GSG +G V L D A+K I K
Sbjct: 16 FQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVL-LCRDKVTHVERAIKIIRKTS 74
Query: 342 LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---S 398
++ + E+ +L + H ++ L + + L+ + GG L + + R +
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 399 EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAK 455
E DA II G+ YLH I+HRD+K N+LL + + ++ DFGL+
Sbjct: 135 EV---DAA-VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ E+++ + + GT Y+APE ++ + EK DV+S GV++ +L+G P
Sbjct: 188 VFENQKK-MKERL-GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 52/283 (18%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G+G FG V+ V A+K + + + D F E ++ ++H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA-EANLMKQLQHQRLVRLYAV 76
Query: 372 C-NSPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
P +I +++ GSL + L S +L + L++ A+G+A++ I
Sbjct: 77 VTQEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYI 131
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY--LAPEYMQSGRATE 487
HRD++++NIL+ L +++DFGLA+L+ED E T F APE + G T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 488 KTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID--------- 537
K+DV+SFG+L+ E+++ G+ P G N E+I
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYP-----------GMTN--------PEVIQNLERGYRMV 230
Query: 538 --PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
NC E L L+ C P+DRPT + +LE
Sbjct: 231 RPDNC----PEELYQLM---RLCWKERPEDRPTFDYLRSVLED 266
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 57/291 (19%), Positives = 116/291 (39%), Gaps = 50/291 (17%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKH--RYLVNLRG 370
IGSGG V+++ + ++A+K ++ + + E+ L ++ ++ L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 371 YCNSPTSKLLIYDFL--PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
Y + IY + L+ L ++ + +D R + + + +H I
Sbjct: 124 YEITDQY---IYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH---QHGI 176
Query: 429 IHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHI--TTIVAGTFGYLAPE------- 478
+H D+K +N L+ G L ++ DFG+A ++ + + + + V G Y+ PE
Sbjct: 177 VHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSS 233
Query: 479 ----YMQSGRATEKTDVYSFGVLVLEVLSGKRP--TDASFIEKGLNIVGWLNFLISEDRQ 532
+ + K+DV+S G ++ + GK P + I K I+ D
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---------DPN 284
Query: 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
EI P + + + D L C+ P R ++ ++L +
Sbjct: 285 HEIEFP--DIPEKDLQDVLK----CCLKRDPKQRISIP---ELLAHPYVQI 326
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDK---------LNEGFDRFFERELEILGSIK 361
I+G G V + +A+K ID + +E++IL +
Sbjct: 23 EILGRGVSSVVR-RCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81
Query: 362 -HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGL 417
H ++ L+ + T L++D + G L + L E+ SE+ + R I+ + +
Sbjct: 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK---ETR-KIMRALLEVI 137
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
LH I+HRD+K NILLD ++ +++DFG + L+ E + + GT YLAP
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC-GTPSYLAP 192
Query: 478 E------YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
E ++ D++S GV++ +L+G P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 64/305 (20%), Positives = 122/305 (40%), Gaps = 51/305 (16%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSIKH 362
+G G FG VY+ + D+ A+K +NE F E ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRERIEFLNEASVMKEFNC 87
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------LNIIMGA 413
++V L G + L+I + + G L L + + + +
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
A G+AYL+ + + +HRD+ + N ++ + ++ DFG+ + + + + G G
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKG 200
Query: 474 YL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLI 527
L +PE ++ G T +DV+SFGV++ E+ + ++P +GL+ L F+
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------QGLSNEQVLRFV- 253
Query: 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPS- 586
+ NC D L + C +P RP+ ++ ++ E+
Sbjct: 254 -MEGGLLDKPDNC-------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305
Query: 587 DFYDS 591
FY S
Sbjct: 306 SFYYS 310
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 69/220 (31%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFER--------ELE 355
D I IG G FG V + D ++A+K ++K + ER EL+
Sbjct: 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-----QKCVERNEVRNVFKELQ 67
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLD-WDARL---NII 410
I+ ++H +LVNL Y + ++ D L GG L L +++ +L ++
Sbjct: 68 IMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFICELV 125
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
M L YL + RIIHRD+K NILLD + ++DF +A +L E T +AG
Sbjct: 126 MA----LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAG 176
Query: 471 TFGYLAPEYMQSGRATEKT---DVYSFGVLVLEVLSGKRP 507
T Y+APE S + + D +S GV E+L G+RP
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 60/245 (24%), Positives = 105/245 (42%), Gaps = 32/245 (13%)
Query: 283 GGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID 340
GGG + M D+ + + + +IG G F V ++ G FA+K +D
Sbjct: 8 GGGGILDMADDDVLFEDVYELCE--------VIGKGPFSVVR-RCINRETGQQFAVKIVD 58
Query: 341 K----LNEGFDR-FFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH 395
+ G +RE I +KH ++V L +S ++++F+ G L +
Sbjct: 59 VAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV 118
Query: 396 ERSEQLDW----DARLNI--IMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEA 446
+R++ A + I+ A L Y H IIHRD+K +LL + +
Sbjct: 119 KRADAGFVYSEAVASHYMRQILEA---LRYCH---DNNIIHRDVKPHCVLLASKENSAPV 172
Query: 447 RVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKR 506
++ FG+A L + V GT ++APE ++ + DV+ GV++ +LSG
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231
Query: 507 PTDAS 511
P +
Sbjct: 232 PFYGT 236
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 56/231 (24%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFER 352
+ S++D + ++ +G G VY +ALK + K + +
Sbjct: 43 IDGSNRDALSDFFEVES--ELGRGATSIVY-RCKQKGTQKPYALKVLKKTVD--KKIVRT 97
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNI 409
E+ +L + H ++ L+ +PT L+ + + GG L + + E+ SE+ DA +
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSER---DAA-DA 153
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITT 466
+ + +AYLH I+HRD+K N+L + +++DFGL+K++E + + T
Sbjct: 154 VKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKT 209
Query: 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517
+ GT GY APE ++ + D++S G++ +L G P ++ +
Sbjct: 210 VC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 10/197 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
+GSG FG V++ ++ G VF K I+ + E+ I+ + H L+NL
Sbjct: 59 LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+LI +FL GG L + + ++ +N + A +GL ++H I+H D
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 174
Query: 433 IKSSNILLDGNLEARV--SDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
IK NI+ + + V DFGLA L +E I + T + APE + TD
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTD 232
Query: 491 VYSFGVLVLEVLSGKRP 507
+++ GVL +LSG P
Sbjct: 233 MWAIGVLGYVLLSGLSP 249
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLR 369
++G G FG V D +A+K I+K RE+E+L + H ++ L
Sbjct: 29 MLGKGSFGEVL-KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+S ++ + GG L + + +R SE DA II G+ Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---DAA-RIIKQVFSGITYMH---KH 140
Query: 427 RIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
I+HRD+K NILL + + + ++ DFGL+ + + + GT Y+APE ++ G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIAPEVLR-G 197
Query: 484 RATEKTDVYSFGVLVLEVLSGKRP 507
EK DV+S GV++ +LSG P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 5e-28
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 312 DHIIGSGGFGTVYKLA--MDDGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNL 368
+G+GGFG V D G A+K+ + L+ + E++I+ + H +V+
Sbjct: 19 KERLGTGGFGYVL-RWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 369 ------RGYCNSPTSKLLIYDFLPGGSLDEAL--HERSEQLDWDARLNIIMGAAKGLAYL 420
LL ++ GG L + L E L ++ + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEAR---VSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H RIIHRD+K NI+L + + D G AK L+ E T V GT YLAP
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFV-GTLQYLAP 192
Query: 478 EYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
E ++ + T D +SFG L E ++G RP
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEI 356
+ + D +G G F K + FA+K I K E ++E+
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRK-CVHKKSNQAFAVKIISKRME---ANTQKEITA 58
Query: 357 LGSIK-HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMG 412
L + H +V L + L+ + L GG L E + ++ SE +A I+
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET---EAS-YIMRK 114
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVA 469
++++H ++HRD+K N+L + NLE ++ DFG A+L + + T
Sbjct: 115 LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC- 170
Query: 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
T Y APE + E D++S GV++ +LSG+ P
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRF 349
+ +S+ + + ++G G FG V L D G A+K I K +
Sbjct: 17 VQHSTAIFSDRYKG---QRVLGKGSFGEVI-LCKDKITGQECAVKVISKRQVKQKTDKES 72
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDAR 406
RE+++L + H ++ L + L+ + GG L + + R SE DA
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV---DAA 129
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESH 463
II G+ Y+H +I+HRD+K N+LL + R+ DFGL+ E +
Sbjct: 130 -RIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK- 184
Query: 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ + GT Y+APE + G EK DV+S GV++ +LSG P
Sbjct: 185 MKDKI-GTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLN-EGFDRFFEREL 354
S+K I + TL++ IG G +G V +A+ A K+I K E DRF ++E+
Sbjct: 2 STKGDINQYYTLEN--TIGRGSWGEVK-IAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEI 57
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIM 411
EI+ S+ H ++ L T L+ + GG L E + + E DA I+
Sbjct: 58 EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES---DAA-RIMK 113
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIV 468
+AY H + HRD+K N L + ++ DFGLA + + + T V
Sbjct: 114 DVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV 169
Query: 469 AGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
GT Y++P+ ++ G + D +S GV++ +L G P
Sbjct: 170 -GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G F V + G +A I+ L+ + ERE I +KH +V L
Sbjct: 18 ELGKGAFSVVR-RCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ LI+D + GG L E + R SE DA + I + + + H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA---DAS-HCIQQILEAVLHCH---QM 129
Query: 427 RIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
++HR++K N+LL +++DFGLA +E E+ GT GYL+PE ++
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKD 188
Query: 484 RATEKTDVYSFGVLVLEVLSGKRP 507
+ D+++ GV++ +L G P
Sbjct: 189 PYGKPVDLWACGVILYILLVGYPP 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-28
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDK--------LNEGFDRFFERELEILGSIK- 361
+IG G V + G+ FA+K ++ E RE IL +
Sbjct: 100 DVIGRGVSSVVR-RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLA 418
H +++ L S + L++D + G L + L E+ SE+ + R +I+ + ++
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK---ETR-SIMRSLLEAVS 214
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
+LH + I+HRD+K NILLD N++ R+SDFG + LE E + + GT GYLAPE
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPE 269
Query: 479 ------YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
++ D+++ GV++ +L+G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNL 368
+G G F V + G FA K I+ L+ + ERE I ++H +V L
Sbjct: 12 EELGKGAFSVVR-RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCS 425
+ L++D + GG L E + R SE DA + I + +AY H S
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---DAS-HCIQQILESIAYCH---S 123
Query: 426 PRIIHRDIKSSNILLDGNLEA---RVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
I+HR++K N+LL + +++DFGLA + D E+ GT GYL+PE ++
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKK 181
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP 507
++ D+++ GV++ +L G P
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPP 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 36/231 (15%)
Query: 302 IIKKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK-------------L 342
+ KK + + +GSG +G V L + + A+K I K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVL-LCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN 85
Query: 343 NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SE 399
E F E+ +L S+ H ++ L L+ +F GG L E + R E
Sbjct: 86 IEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE 145
Query: 400 QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKL 456
DA NI+ G+ YLH I+HRDIK NILL + L ++ DFGL+
Sbjct: 146 C---DAA-NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ + + GT Y+APE ++ + EK DV+S GV++ +L G P
Sbjct: 199 FSKDYK-LRDRL-GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 18/223 (8%)
Query: 296 PYSSKDIIKKLETLDDD------HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD 347
P+ + + K ++ I+G G FG V+K + G A K I
Sbjct: 72 PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDK 130
Query: 348 RFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLD-WDAR 406
+ E+ ++ + H L+ L S +L+ +++ GG L + + + S L D
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI 190
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHI 464
+ +G+ ++H I+H D+K NIL ++ DFGLA+ + E +
Sbjct: 191 -LFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-L 245
Query: 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
GT +LAPE + + TD++S GV+ +LSG P
Sbjct: 246 KVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 51/302 (16%), Positives = 105/302 (34%), Gaps = 48/302 (15%)
Query: 303 IKKLETLDDDHII------GSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEI 356
+K L L+ I+ + + + ++
Sbjct: 55 VKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
Query: 357 LGSIKHRYLVNLRGYCNSPTSKLLIY---DFLPGGSLDEALHER--SEQLDWDARLNIIM 411
+ + V + K+ +Y +L + ++ R E + L+I +
Sbjct: 115 MDPFSTKNTVG---QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA-- 469
A+ + +LH S ++HRD+K SNI + +V DFGL ++ +E T +
Sbjct: 172 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 470 ---------GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV 520
GT Y++PE + + K D++S G+++ E+L
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM----------- 277
Query: 521 GWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580
+I++ R + P + ++ +S SP +RP I+E+ +
Sbjct: 278 -ERVRIITDVRNLKF--PLLFTQKYPQEHMMV---QDMLSPSPTERPEAT---DIIENAI 328
Query: 581 MT 582
Sbjct: 329 FE 330
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 18/60 (30%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 313 HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRF-FERELEILGSIKHRYLVNLRG 370
+G GGFG V++ D +A+KRI N R RE++ L ++H +V
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 40/219 (18%), Positives = 71/219 (32%), Gaps = 27/219 (12%)
Query: 312 DHIIGSGGFGTVYK------LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL 365
H++G G F VY+ + F LK N + +E L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLH 421
+ +L+ + G+L A++ + + ++ M + +H
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 422 HDCSPRIIHRDIKSSNILL-----------DGNLEARVSDFGLAKLLE-DEESHITTIVA 469
IIH DIK N +L D + + D G + ++ + I T
Sbjct: 190 ---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 470 GTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRP 507
T G+ E M S + + D + V +L G
Sbjct: 247 ETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVN---- 367
+G+G +G VYK G + A+K +D + + ++E+ +L HR +
Sbjct: 32 VGNGTYGQVYK-GRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 368 -LRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQL---DWDARLNIIMGAAKGLAYLHH 422
++ +L L+ +F GS+ + + +W A I +GL++LH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH- 146
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
++IHRDIK N+LL N E ++ DFG++ L+ T + GT ++APE +
Sbjct: 147 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 203
Query: 483 GRATE-----KTDVYSFGVLVLEVLSGKRP 507
+ K+D++S G+ +E+ G P
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE--RELEILGSIKHRYLVNLRG 370
IGSG V A A+KRI+ L + E +E++ + H +V+
Sbjct: 23 IGSGATAVVQA-AYCAPKKEKVAIKRIN-LEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 371 -YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL-------NIIMGAAKGLAYLH 421
+ +L L+ L GGS+ + + + + + + I+ +GL YLH
Sbjct: 81 SFVVK--DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF-G---YLAP 477
IHRD+K+ NILL + +++DFG++ L V TF G ++AP
Sbjct: 139 ---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195
Query: 478 EYMQSGRA-TEKTDVYSFGVLVLEVLSGKRP 507
E M+ R K D++SFG+ +E+ +G P
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 28/230 (12%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEG 345
G P+ + + + + +GSG F V K + G +A K I K G
Sbjct: 1 GMEPFKQQKVEDFYDIGE---ELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRG 56
Query: 346 FDR-FFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQL 401
R ERE+ IL + H ++ L + T +LI + + GG L + L ++ SE+
Sbjct: 57 VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE- 115
Query: 402 DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLL 457
+A + I G+ YLH + +I H D+K NI+L ++ DFGLA +
Sbjct: 116 --EAT-SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
ED + GT ++APE + + D++S GV+ +LSG P
Sbjct: 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILG-SIKHRYLVNLR 369
IG G + + + FA+K IDK E+EIL +H ++ L+
Sbjct: 28 EDIGVGSYSVCKR-CIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLK 82
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ ++ + + GG L + + + SE+ +A ++ K + YLH +
Sbjct: 83 DVYDDGKYVYVVTELMKGGELLDKILRQKFFSER---EAS-AVLFTITKTVEYLH---AQ 135
Query: 427 RIIHRDIKSSNILL---DGNLEA-RVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
++HRD+K SNIL GN E+ R+ DFG AK L E + T T ++APE ++
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLER 194
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP 507
D++S GVL+ +L+G P
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 74/296 (25%), Positives = 107/296 (36%), Gaps = 50/296 (16%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGF---DRF-FERELEILGSIKH 362
+G G FG VY+ + D + A+K L E D F E I+ H
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALIISKFNH 92
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL------NIIMGAAKG 416
+ +V G + ++ + + GG L L E + + L ++ A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARV---SDFGLAKLLEDEESHITTIVAGTFG 473
YL IHRDI + N LL RV DFG+A+ + G
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCA 205
Query: 474 YL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLI 527
L PE G T KTD +SFGVL+ E+ S G P + L F+
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY------PSKSNQEVLEFV- 258
Query: 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
R NC + + TQC P+DRP +++ +E P
Sbjct: 259 -TSGGRMDPPKNC-------PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 40/277 (14%)
Query: 268 KKLGKNESKGLARD----VGGGASIVMFHGDLPYSSKDIIKKLETLDDD----HIIGSGG 319
+ +GK + + L + + + V DL + + K L D+ +GSG
Sbjct: 90 ELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPK--ALRDEYIMSKTLGSGA 147
Query: 320 FGTVYKLAMD--DGNVFALKRIDK--------LNEGFDRFFERELEILGSIKHRYLVNLR 369
G V LA + A++ I K E E+EIL + H ++ ++
Sbjct: 148 CGEVK-LAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ ++ ++ + + GG L + + E + + YLH
Sbjct: 207 NFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEA---TCK-LYFYQMLLAVQYLH---EN 258
Query: 427 RIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
IIHRD+K N+LL + + +++DFG +K+L E S + T+ GT YLAPE + S
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPTYLAPEVLVSV 316
Query: 484 RA---TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517
D +S GV++ LSG P + L
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 16/221 (7%)
Query: 296 PYSSKDIIKKLETLDD----DHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRF 349
Y + + K + + D +G+G FG V++ + GN FA K + +E
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKET 200
Query: 350 FERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSL-DEALHERSEQLDWDARLN 408
+E++ + ++H LVNL ++IY+F+ GG L ++ E ++ + +A
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV-E 259
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHITT 466
+ KGL ++H +H D+K NI+ + DFGL L+ ++S
Sbjct: 260 YMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VK 314
Query: 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ GT + APE + TD++S GVL +LSG P
Sbjct: 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 53/240 (22%), Positives = 100/240 (41%), Gaps = 41/240 (17%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID-KLNEGFDRFFERELEI-LGSI 360
K + L+ +G G +G V K G + A+KRI +N + +L+I + ++
Sbjct: 5 KADDLEPIMELGRGAYGVVEK-MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63
Query: 361 KHRYLVNLRG-------------YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL 407
+ V G ++ K G ++ E + L
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI------------L 111
Query: 408 NIIMGAA-KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466
I + K L +LH +IHRD+K SN+L++ + ++ DFG++ L D
Sbjct: 112 GKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKD 167
Query: 467 IVAGTFGYLAPE----YMQSGRATEKTDVYSFGVLVLEVLSGKRP--TDASFIEKGLNIV 520
I AG Y+APE + + K+D++S G+ ++E+ + P + + ++ +V
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 65/301 (21%), Positives = 116/301 (38%), Gaps = 64/301 (21%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEG---FDRF-FERELEILGSIKH 362
+G FG VYK A + A+K L + R F E + ++H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------------L 407
+V L G +I+ + G L E L RS D + +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467
+++ A G+ YL S ++H+D+ + N+L+ L ++SD GL + + +
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD----YY 184
Query: 468 VAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP----TDASFIEKGL 517
L APE + G+ + +D++S+GV++ EV S G +P ++ +E
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE--- 241
Query: 518 NIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+I +RQ +C + AL+ +C + P RP + L
Sbjct: 242 --------MI-RNRQVLPCPDDC----PAWVYALM---IECWNEFPSRRPRFKDIHSRLR 285
Query: 578 S 578
+
Sbjct: 286 A 286
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 66/282 (23%), Positives = 108/282 (38%), Gaps = 56/282 (19%)
Query: 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF-DRFFERELEILGSIKHRYLVNLRGY 371
IG G FG V GN A+K + + F E ++ ++H LV L G
Sbjct: 27 QTIGKGEFGDVML-GDYRGNKVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 372 CNSPTSKLLI-YDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRII 429
L I +++ GSL + L R L D L + + + YL +
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 139
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY--LAPEYMQSGRATE 487
HRD+ + N+L+ + A+VSDFGL K + +T G APE ++ + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EAS---STQDTGKLPVKWTAPEALREKKFST 193
Query: 488 KTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID--------- 537
K+DV+SFG+L+ E+ S G+ P ++++
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYP-----------RIPL--------KDVVPRVEKGYKMD 234
Query: 538 --PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
C A+ V C RP+ ++ + LE
Sbjct: 235 APDGCP-------PAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDR-FFERELEILGSIKHRYLV 366
+GSG F V K G +A K I K G R ERE+ IL I+H ++
Sbjct: 13 LGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHD 423
L + T +LI + + GG L + L E+ +E +A + G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED---EAT-QFLKQILDGVHYLH-- 125
Query: 424 CSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
S RI H D+K NI+L N ++ DFG+A +E I GT ++APE
Sbjct: 126 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF-GTPEFVAPEI 182
Query: 480 MQSGRATEKTDVYSFGVL--VLEVLSGKRP 507
+ + D++S GV+ +L LSG P
Sbjct: 183 VNYEPLGLEADMWSIGVITYIL--LSGASP 210
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 24/221 (10%)
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFER 352
Y ++ + ++G G FG V D +A+K I+K R
Sbjct: 15 YFQGTFAERYNIVC---MLGKGSFGEVL-KCKDRITQQEYAVKVINKASAKNKDTSTILR 70
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNI 409
E+E+L + H ++ L +S ++ + GG L + + +R SE DA I
Sbjct: 71 EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH---DAA-RI 126
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITT 466
I G+ Y+H I+HRD+K NILL + + + ++ DFGL+ + +
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKD 182
Query: 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ GT Y+APE ++ G EK DV+S GV++ +LSG P
Sbjct: 183 RI-GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 73/296 (24%), Positives = 106/296 (35%), Gaps = 50/296 (16%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSIKH 362
+G G FG VY+ + D + A+K L E F E I+ H
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALIISKFNH 133
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL------NIIMGAAKG 416
+ +V G + ++ + + GG L L E + + L ++ A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARV---SDFGLAKLLEDEESHITTIVAGTFG 473
YL IHRDI + N LL RV DFG+A+ + G
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCA 246
Query: 474 YL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLI 527
L PE G T KTD +SFGVL+ E+ S G P + L F+
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY------PSKSNQEVLEFV- 299
Query: 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
R NC + + TQC P+DRP +++ +E P
Sbjct: 300 -TSGGRMDPPKNC-------PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 63/311 (20%), Positives = 119/311 (38%), Gaps = 64/311 (20%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF---FERELEILGSIKHR 363
+G G FG V+ L + + A+K L E + F+RE E+L ++H+
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEASESARQDFQREAELLTMLQHQ 103
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR--------------LNI 409
++V G C L++++++ G L+ L A L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
A G+ YL +HRD+ + N L+ L ++ DFG+++ + +
Sbjct: 164 ASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRV 216
Query: 470 GTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP----TDASFIEKGLNI 519
G L PE + + T ++DV+SFGV++ E+ + GK+P ++ I+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID----- 271
Query: 520 VGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579
+ + C + A+ C P R ++ V L++
Sbjct: 272 -----CI--TQGRELERPRACP-------PEVYAIMRGCWQREPQQRHSIKDVHARLQA- 316
Query: 580 VMTPCPSDFYD 590
+ P + D
Sbjct: 317 -LAQAPPVYLD 326
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 62/300 (20%), Positives = 116/300 (38%), Gaps = 63/300 (21%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF---FERELEILGSIKHR 363
+G G FG V+ L+ + A+K L + F+RE E+L +++H
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAARKDFQREAELLTNLQHE 77
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------------LN 408
++V G C +++++++ G L++ L L+
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
I A G+ YL S +HRD+ + N L+ NL ++ DFG+++ + + +
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----R 190
Query: 469 AGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP----TDASFIEKGLN 518
G L PE + + T ++DV+SFGV++ E+ + GK+P ++ IE
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC--- 247
Query: 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ C + V C P R + + +IL +
Sbjct: 248 ---------ITQGRVLERPRVCP-------KEVYDVMLGCWQREPQQRLNIKEIYKILHA 291
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G G FG V++ + + K + ++E+ IL +HR +++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV-KKEISILNIARHRNILHLHESFE 71
Query: 374 SPTSKLLIYDFLPGGSLDEALHER----SEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
S ++I++F+ G + E ++ +E+ + + + + L +LH S I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNER---EIV-SYVHQVCEALQFLH---SHNIG 124
Query: 430 HRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE 487
H DI+ NI+ + + +FG A+ L+ ++ + Y APE Q +
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPEYYAPEVHQHDVVST 182
Query: 488 KTDVYSFGVLVLEVLSGKRP 507
TD++S G LV +LSG P
Sbjct: 183 ATDMWSLGTLVYVLLSGINP 202
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 22/217 (10%)
Query: 305 KLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID-KLNEGFDRFFERELEI-LGSI 360
E L D IG G +G+V K + G + A+KRI ++E + +L++ + S
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNK-MVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN------IIMGAA 414
Y+V G + + + S D+ LD + I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLD--DVIPEEILGKITLATV 135
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
K L +L + +IIHRDIK SNILLD + ++ DFG++ L D S T AG Y
Sbjct: 136 KALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPY 191
Query: 475 LAPEYMQSGRA----TEKTDVYSFGVLVLEVLSGKRP 507
+APE + + ++DV+S G+ + E+ +G+ P
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G F V + G FA K I+ L+ + ERE I ++H +V L
Sbjct: 36 ELGKGAFSVVR-RCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ L++D + GG L E + R SE DA + I + +AY H S
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA---DAS-HCIQQILESIAYCH---SN 147
Query: 427 RIIHRDIKSSNILLDGNLEA---RVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
I+HR++K N+LL + +++DFGLA + D E+ GT GYL+PE ++
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKD 205
Query: 484 RATEKTDVYSFGVLVLEVLSGKRP 507
++ D+++ GV++ +L G P
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPP 229
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDR-FFERELEILGSIKHRYLV 366
+GSG F V K + G +A K I K G R ERE+ IL + H ++
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHD 423
L + T +LI + + GG L + L ++ SE+ +A + I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE---EAT-SFIKQILDGVNYLH-- 132
Query: 424 CSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
+ +I H D+K NI+L ++ DFGLA +ED + GT ++APE
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEI 189
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ + D++S GV+ +LSG P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 15/224 (6%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRID-KLNEGFDRF 349
G L + ++ L++ +GSG G V+K G+V A+K++ N+ ++
Sbjct: 11 GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWK-MRFRKTGHVIAVKQMRRSGNKEENKR 69
Query: 350 FERELEIL-GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN 408
+L+++ S Y+V G + T + + + G ++ +
Sbjct: 70 ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK 128
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
+ + K L YL +IHRD+K SNILLD + ++ DFG++ L D
Sbjct: 129 MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRS 184
Query: 469 AGTFGYLAPEYMQSGRATE-----KTDVYSFGVLVLEVLSGKRP 507
AG Y+APE + T+ + DV+S G+ ++E+ +G+ P
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDR-FFERELEILGSIKHRYLV 366
+GSG F V K + G +A K I K G R ERE+ IL I+H ++
Sbjct: 19 LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHD 423
L + T +LI + + GG L + L E+ +E+ +A + G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE---EAT-EFLKQILNGVYYLH-- 131
Query: 424 CSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
S +I H D+K NI+L ++ DFGLA ++ + GT ++APE
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEI 188
Query: 480 MQSGRATEKTDVYSFGVL--VLEVLSGKRP 507
+ + D++S GV+ +L LSG P
Sbjct: 189 VNYEPLGLEADMWSIGVITYIL--LSGASP 216
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 24/233 (10%)
Query: 290 MFHGDLPYSSKDIIKKLETLDD----DHIIGSGGFGTVYKLAMD--DGNVFALKRIDK-- 341
M H S ++ + T+DD +GSG FG V+ L + G +K I+K
Sbjct: 1 MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVH-LVEERSSGLERVIKTINKDR 59
Query: 342 LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQL 401
++ E E+E+L S+ H ++ + + ++ + GG L E + +
Sbjct: 60 SQVPMEQI-EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARG 118
Query: 402 DW----DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLA 454
++ LAY H S ++H+D+K NIL + ++ DFGLA
Sbjct: 119 KALSEGYVA-ELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
Query: 455 KLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+L + +E H T GT Y+APE + T K D++S GV++ +L+G P
Sbjct: 175 ELFKSDE-HSTNAA-GTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 9e-26
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALK-----RIDKLNEGFDRFFERE-LEILGSIKHRYL 365
IIG GGFG VY D G ++A+K RI ER L ++ + ++
Sbjct: 196 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 366 VNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLH 421
V + Y KL I D + GG L L + + D R II+G L ++H
Sbjct: 255 VCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMH 309
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
+ +++RD+K +NILLD + R+SD GLA ++ H V GT GY+APE +Q
Sbjct: 310 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQ 363
Query: 482 SGRATEKT-DVYSFGVLVLEVLSGKRP 507
G A + + D +S G ++ ++L G P
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 46/210 (21%), Positives = 84/210 (40%), Gaps = 23/210 (10%)
Query: 315 IGSG--GFGTVYKLAMD--DGNVFALKRID--KLNEGFDRFFERELEILGSIKHRYLVNL 368
IG G TV A G ++RI+ + F + EL + H +V
Sbjct: 33 IGKGFEDLMTVNL-ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 369 RG-YCNSPTSKL-LIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCS 425
R + ++L ++ F+ GS + + + ++ A I+ G K L Y+HH
Sbjct: 92 RATFIAD--NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM-- 147
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI------VAGTFGYLAPEY 479
+HR +K+S+IL+ + + +S + + +L+PE
Sbjct: 148 -GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 480 MQSGRA--TEKTDVYSFGVLVLEVLSGKRP 507
+Q K+D+YS G+ E+ +G P
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
I+G G F TV LA +A+K ++K + E + RE +++ + H + V L
Sbjct: 37 ILGEGSFSTVV-LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWD-ARL---NIIMGAAKGLAYLHHDC 424
+ G L + + + D R I+ L YLH
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSA----LEYLH--- 147
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI-VAGTFGYLAPEYMQSG 483
IIHRD+K NILL+ ++ +++DFG AK+L E GT Y++PE +
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 484 RATEKTDVYSFGVLVLEVLSGKRP 507
A + +D+++ G ++ ++++G P
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPP 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 30/223 (13%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK--------LNEGFDRFFERELEILGSIKHR 363
+GSG G V LA + A+K I K E E+EIL + H
Sbjct: 17 TLGSGACGEVK-LAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYL 420
++ ++ + ++ ++ + + GG L + + E + + YL
Sbjct: 76 CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEA---TCK-LYFYQMLLAVQYL 130
Query: 421 HHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
H IIHRD+K N+LL + + +++DFG +K+L + + T+ GT YLAP
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLC-GTPTYLAP 185
Query: 478 EYMQSGRA---TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517
E + S D +S GV++ LSG P + L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 32/226 (14%)
Query: 302 IIKKLETLDD-----DHIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFER 352
+ +E ++ +G G F V + + G +A K + K +
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQ-CISKSTGQEYAAKFLKKRRRGQDCRAEILH 77
Query: 353 ELEILGSIKHR-YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER-----SEQLDWDAR 406
E+ +L K ++NL + + +LI ++ GG + SE D
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN---DVI 134
Query: 407 LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESH 463
+I +G+ YLH I+H D+K NILL + ++ DFG+++ +
Sbjct: 135 -RLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE- 189
Query: 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVL--VLEVLSGKRP 507
+ I+ GT YLAPE + T TD+++ G++ +L L+ P
Sbjct: 190 LREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYML--LTHTSP 232
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 77/295 (26%), Positives = 121/295 (41%), Gaps = 57/295 (19%)
Query: 312 DHIIGSGGFGTVYK--LAMDDGNVF-ALKRIDKLNEGFD----RFFERELEILGSI-KHR 363
+IG G FG V K + D + A+KR + E R F ELE+L + H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLN 408
++NL G C L ++ P G+L + L + + L L+
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
A+G+ YL + IHRD+ + NIL+ N A+++DFGL++ +E + V
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY----V 196
Query: 469 AGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGW 522
T G L A E + T +DV+S+GVL+ E++S G P G+
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY------CGMTCAEL 250
Query: 523 LNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
L R NC D + + QC P +RP+ +++ L
Sbjct: 251 YEKL--PQGYRLEKPLNC-------DDEVYDLMRQCWREKPYERPSFAQILVSLN 296
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHR 363
++G GGFG V+ G ++A K+++K R +R E +IL + R
Sbjct: 192 VLGRGGFGEVF-ACQMKATGKLYACKKLNK-----KRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDW----DARL---NIIMGAAK 415
++V+L Y + L L+ + GG + ++ E A I+
Sbjct: 246 FIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS---- 300
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
GL +LH II+RD+K N+LLD + R+SD GLA L+ ++ GT G++
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFM 356
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
APE + D ++ GV + E+++ + P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 55/245 (22%), Positives = 103/245 (42%), Gaps = 34/245 (13%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRG 370
++G G V ++ +A+K I+K RE+E+L + HR ++ L
Sbjct: 20 VLGEGAHARVQ-TCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
+ L+++ + GGS+ +H+R +E +A ++ A L +LH +
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL---EAS-VVVQDVASALDFLH---NKG 131
Query: 428 IIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESH-------ITTIVAGTFGYLAP 477
I HRD+K NIL + ++ DF L ++ + T G+ Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAP 190
Query: 478 EYMQSGRATEKT-----DVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQ 532
E +++ D++S GV++ +LSG P F+ + + GW Q
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP----FVGRCGSDCGWDRGEACPACQ 246
Query: 533 REIID 537
+ +
Sbjct: 247 NMLFE 251
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 53/248 (21%), Positives = 93/248 (37%), Gaps = 57/248 (22%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDK-----LNEGFDRFFERELEILGSIKHRYL 365
IG G +G V +A++ + A+K ++K +N + E+ ++ + H +
Sbjct: 32 GAIGQGSYGVVR-VAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG------------- 412
L L+ + GG L + L+ + ++++
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 413 -------------------AAK-------GLAYLHHDCSPRIIHRDIKSSNILL--DGNL 444
+ L YLH + I HRDIK N L + +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSF 207
Query: 445 EARVSDFGLAKLL---EDEESHITTIVAGTFGYLAPEYMQSGRA--TEKTDVYSFGVLVL 499
E ++ DFGL+K + E + T AGT ++APE + + K D +S GVL+
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 500 EVLSGKRP 507
+L G P
Sbjct: 268 LLLMGAVP 275
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 72/312 (23%), Positives = 129/312 (41%), Gaps = 60/312 (19%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF---ALKRIDKLNEGFDRF----FERELEILGS 359
+G G FG V + D A+K L + E+E++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEMEMMKM 96
Query: 360 I-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSL---------------DEALHERSEQLDW 403
I KH+ ++NL G C +I ++ G+L + EQ+ +
Sbjct: 97 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
++ A+G+ YL S + IHRD+ + N+L+ N +++DFGLA+ + + + +
Sbjct: 157 KDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 464 ITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGL 517
T G L APE + T ++DV+SFGVL+ E+ + G P G+
Sbjct: 214 ----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY------PGI 263
Query: 518 NIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ L ++ R NC + L ++ C + P RPT ++V+ L+
Sbjct: 264 PVEELFKLL--KEGHRMDKPANC----TNELYMMM---RDCWHAVPSQRPTFKQLVEDLD 314
Query: 578 SEVMTPCPSDFY 589
++T ++ Y
Sbjct: 315 -RILTLTTNEEY 325
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + + + VFA+K ++K L F E ++L + +++ L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 370 GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWD-ARL---NIIMGAAKGLAYLHHDC 424
Y + L L+ D+ GG L L + ++L + AR +++ + +H
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA----IDSVH--- 192
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
+HRDIK NIL+D N R++DFG L ++ + +++ GT Y++PE +Q+
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 485 ATEKT-----DVYSFGVLVLEVLSGKRP 507
+ D +S GV + E+L G+ P
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/309 (21%), Positives = 114/309 (36%), Gaps = 72/309 (23%)
Query: 313 HIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSIKH 362
IG G FG V++ L + A+K L E F+RE ++ +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAALMAEFDN 109
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------------- 406
+V L G C L+++++ G L+E L S
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 407 -------LNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459
L I A G+AYL + +HRD+ + N L+ N+ +++DFGL++ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 460 EESHITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP----TD 509
+ A + PE + R T ++DV+++GV++ E+ S G +P
Sbjct: 227 AD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
Query: 510 ASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTM 569
I ++ D NC L + C S P DRP+
Sbjct: 283 EEVIY----------YV--RDGNILACPENC-------PLELYNLMRLCWSKLPADRPSF 323
Query: 570 HRVVQILES 578
+ +IL+
Sbjct: 324 CSIHRILQR 332
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHR 363
++G GGFG V G ++A K+++K R +R E +IL + R
Sbjct: 191 VLGKGGFGEVC-ACQVRATGKMYACKKLEK-----KRIKKRKGEAMALNEKQILEKVNSR 244
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK---GLAY 419
++V+L Y L L+ + GG L ++ + +AR + AA+ GL
Sbjct: 245 FVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR--AVFYAAEICCGLED 301
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
LH RI++RD+K NILLD + R+SD GLA + + ++ GT GY+APE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEV 356
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+++ R T D ++ G L+ E+++G+ P
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G F V + M G V+A+K ++K L G F E ++L + R++ L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 370 GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWD-ARL---NIIMGAAKGLAYLHHDC 424
+ + L L+ ++ GG L L + E++ + AR I+M + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA----IDSVH--- 179
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
+HRDIK NILLD R++DFG L + + + + GT YL+PE +Q+
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 485 ATEKTDVY-------SFGVLVLEVLSGKRP 507
T Y + GV E+ G+ P
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE---RELEILGSIKHRYLVNLR 369
IG G FG VY A D + V A+K++ + + ++ +E+ L ++H + R
Sbjct: 62 IGHGSFGAVYF-ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
G + L+ ++ G + D L + L + GA +GLAYLH S +I
Sbjct: 121 GCYLREHTAWLVMEYCLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMI 176
Query: 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE---YMQSGRAT 486
HRD+K+ NILL ++ DFG A ++ + + V GT ++APE M G+
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILAMDEGQYD 231
Query: 487 EKTDVYSFGVLVLEVLSGKRP 507
K DV+S G+ +E+ K P
Sbjct: 232 GKVDVWSLGITCIELAERKPP 252
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 32/227 (14%)
Query: 296 PYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERE 353
P K + L ++G G G V + G ALK + + +E
Sbjct: 19 PEPKKYAVTDDYQLSKQ-VLGLGVNGKVLE-CFHRRTGQKCALKLLYDSPK-----ARQE 71
Query: 354 LEILGSI-KHRYLVNLRGYC----NSPTSKLLIYDFLPGGSLDEALHER-----SEQLDW 403
++ ++V + + L+I + + GG L + ER +E+
Sbjct: 72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER--- 128
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDE 460
+A I+ + +LH S I HRD+K N+L + + +++DFG AK
Sbjct: 129 EAA-EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+ T T Y+APE + + + D++S GV++ +L G P
Sbjct: 185 A--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 59/300 (19%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF---ALKRIDKLNEGFDRF----FERELEILGS 359
+G G FG V + D A+K L + E+E++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEMEMMKM 142
Query: 360 I-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS---------------EQLDW 403
I KH+ ++NL G C +I ++ G+L E L R EQ+ +
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
++ A+G+ YL S + IHRD+ + N+L+ N +++DFGLA+ + + + +
Sbjct: 203 KDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 464 ITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGL 517
T G L APE + T ++DV+SFGVL+ E+ + G P G+
Sbjct: 260 ----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY------PGI 309
Query: 518 NIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ L ++ R NC + L + C + P RPT ++V+ L+
Sbjct: 310 PVEELFKLL--KEGHRMDKPANCT-------NELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 39/212 (18%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+IG+G FG V++ + + + A+K++ DK RF REL+I+ +KH +V+L+ +
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAF 100
Query: 372 CNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA----------K 415
S K L+ +++P E ++ A+L M +
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVP-----ETVYRA---SRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
LAY+H S I HRDIK N+LLD ++ DFG AK+L E +++ I + Y
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYY 207
Query: 475 LAPEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
APE + + T D++S G ++ E++ G+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 74/318 (23%), Positives = 127/318 (39%), Gaps = 61/318 (19%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF---ALKRIDKLNEGFDRF----FERELEILGS 359
+G G FG V L D N A+K L E+E++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKM 130
Query: 360 I-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGA---- 413
I KH+ ++NL G C +I ++ G+L E L R L++ +
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 414 ----------AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
A+G+ YL S + IHRD+ + N+L+ + +++DFGLA+ + + +
Sbjct: 191 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 464 ITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGL 517
T G L APE + T ++DV+SFGVL+ E+ + G P G+
Sbjct: 248 ----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGV 297
Query: 518 NIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ L ++ R NC + L ++ C + P RPT ++V+ L+
Sbjct: 298 PVEELFKLL--KEGHRMDKPSNC----TNELYMMM---RDCWHAVPSQRPTFKQLVEDLD 348
Query: 578 S--EVMTPCPSDFYDSNS 593
+ + +Y +
Sbjct: 349 RIVALTSNQEMGYYHHHH 366
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 314 IIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+IG G FG V + V+A+K + K + FF E +I+ ++V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 370 GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDCS 425
Y L ++ +++PGG L + W AR +++ L +H S
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-ARFYTAEVVLA----LDAIH---S 186
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS--- 482
IHRD+K N+LLD + +++DFG + E GT Y++PE ++S
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 483 -GRATEKTDVYSFGVLVLEVLSGKRP 507
G + D +S GV + E+L G P
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 32/222 (14%)
Query: 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILG 358
II + ++G G G V + + FALK + + RE+E+
Sbjct: 58 AIIDDYKVTSQ--VLGLGINGKVLQ-IFNKRTQEKFALKMLQDCPK-----ARREVELHW 109
Query: 359 SI-KHRYLVNLRG-YCNSPTSKLLIY---DFLPGGSLDEALHER-----SEQLDWDARLN 408
+ ++V + Y N + + + L GG L + +R +E+ +A
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER---EAS-E 165
Query: 409 IIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHIT 465
I+ + + YLH S I HRD+K N+L N +++DFG AK S +T
Sbjct: 166 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LT 221
Query: 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
T T Y+APE + + + D++S GV++ +L G P
Sbjct: 222 TPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 77/352 (21%), Positives = 143/352 (40%), Gaps = 70/352 (19%)
Query: 264 CFLYKKLGKNESK-GLARDVGGGASIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGT 322
+ YK+ K + + + G + + LPY+ K + L +G+G FG
Sbjct: 3 DYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPR-NNLQFGKTLGAGAFGK 61
Query: 323 VYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSI-KHRYLVNLRGY 371
V + L +D + A+K L EL+I+ + +H +VNL G
Sbjct: 62 VVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118
Query: 372 C--NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN-----------IIMGA--AKG 416
C P L+I ++ G L L +S L+ D + + A+G
Sbjct: 119 CTHGGPV--LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG 176
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL- 475
+A+L S IHRD+ + N+LL A++ DFGLA+ + ++ ++ + L
Sbjct: 177 MAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKGNARLP 229
Query: 476 ----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP-----TDASFIEKGLNIVGWLNF 525
APE + T ++DV+S+G+L+ E+ S G P ++ F +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK----------L 279
Query: 526 LISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ +D + +++ +++ C + P RPT ++ L+
Sbjct: 280 V--KDGYQMAQPAFA----PKNIYSIM---QACWALEPTHRPTFQQICSFLQ 322
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 68/305 (22%), Positives = 120/305 (39%), Gaps = 68/305 (22%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSI- 360
+G+G FG V + L D + A+K L EL++L +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTEREALMSELKVLSYLG 84
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN------------ 408
H +VNL G C L+I ++ G L L + +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 409 ---IIMGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
+ AKG+A+L S IHRD+ + NILL ++ DFGLA+ ++++ ++
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 464 ITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP-----TDASF 512
V L APE + + T ++DV+S+G+ + E+ S G P D+ F
Sbjct: 202 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRV 572
+ + ++ R + + + ++ C + P RPT ++
Sbjct: 258 YK----------MI--KEGFRMLSPEHA----PAEMYDIM---KTCWDADPLKRPTFKQI 298
Query: 573 VQILE 577
VQ++E
Sbjct: 299 VQLIE 303
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 74/306 (24%), Positives = 120/306 (39%), Gaps = 64/306 (20%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSIK 361
+G G FG V K L G A+K L E E +L +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVN 84
Query: 362 HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA-------- 413
H +++ L G C+ LLI ++ GSL L E + +
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 414 ---------------AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458
++G+ YL +++HRD+ + NIL+ + ++SDFGL++ +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 459 DEESHITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASF 512
+E+S+ V + G + A E + T ++DV+SFGVL+ E+++ G P
Sbjct: 202 EEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY---- 253
Query: 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRV 572
G+ N L + R NC SE + L+ QC PD RP +
Sbjct: 254 --PGIPPERLFNLL--KTGHRMERPDNC----SEEMYRLM---LQCWKQEPDKRPVFADI 302
Query: 573 VQILES 578
+ LE
Sbjct: 303 SKDLEK 308
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 40/213 (18%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+IG+G FG VY+ D G + A+K++ DK RF REL+I+ + H +V LR
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRY 114
Query: 371 YCNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA---------- 414
+ S K L+ D++P E ++ +R +
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVP-----ETVYRV---ARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA-RVSDFGLAKLLEDEESHITTIVAGTFG 473
+ LAY+H S I HRDIK N+LLD + ++ DFG AK L E +++ I +
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 221
Query: 474 YLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
Y APE + + T DV+S G ++ E+L G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 72/302 (23%), Positives = 108/302 (35%), Gaps = 63/302 (20%)
Query: 312 DHIIGSGGFGTVYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSI- 360
+G G FG V + + A+K L EG EL+IL I
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIG 88
Query: 361 KHRYLVNLRGYC---NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN--------- 408
H +VNL G C P ++I +F G+L L + +
Sbjct: 89 HHLNVVNLLGACTKPGGPL--MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 409 ----IIMGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
I AKG+ +L S + IHRD+ + NILL ++ DFGLA+ + +
Sbjct: 147 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 463 HITTIVAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP-TDASFIEK 515
+ V L APE + T ++DV+SFGVL+ E+ S G P E+
Sbjct: 204 Y----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 516 GLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575
+ ++ R + C P RPT +V+
Sbjct: 260 FCRRL--------KEGTRMRAPDYTT-------PEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 576 LE 577
L
Sbjct: 305 LG 306
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 37/261 (14%), Positives = 70/261 (26%), Gaps = 49/261 (18%)
Query: 312 DHIIGSGGFGTVYKLAMDD--GNVFALKRID---KLNEGFDRFFERELEILGSIKHRYLV 366
G ++ A+D AL +D L + + L I +
Sbjct: 36 LIFHGGVPPLQFWQ-ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+ ++ L++ +++ GGSL E + + A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRAT 486
+ S + VS G L + A
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPD-------AN 180
Query: 487 EKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546
+ D+ G + +L + P + + GL D + I+P + +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEP--ADIDRD 231
Query: 547 SLDALLAVATQCVSSSPDDRP 567
+ AVA + V R
Sbjct: 232 IPFQISAVAARSVQGDGGIRS 252
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 79/362 (21%), Positives = 135/362 (37%), Gaps = 83/362 (22%)
Query: 267 YKKLGKNESKGLARDVGGGASIVMFHGDLPYSSKDIIKKLE----TLDDDHIIGSGGFGT 322
YKK + ES+ V G + F+ D D K E L+ ++GSG FG
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYD--LKWEFPRENLEFGKVLGSGAFGK 60
Query: 323 VYK-----LAMDDGNVF-ALKRIDKLNEGFDRF----FERELEILGSI-KHRYLVNLRGY 371
V ++ ++ A+K L E D EL+++ + H +VNL G
Sbjct: 61 VMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 117
Query: 372 C--NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLN--------------------I 409
C + P LI+++ G L L + E+ D +
Sbjct: 118 CTLSGPI--YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175
Query: 410 IMGA--AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467
AKG+ +L +HRD+ + N+L+ ++ DFGLA+ + +
Sbjct: 176 CFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS----NY 228
Query: 468 VAGTFGYL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP-----TDASFIEKG 516
V L APE + G T K+DV+S+G+L+ E+ S G P DA+F +
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK-- 286
Query: 517 LNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
+ ++ + +E + ++ C + RP+ + L
Sbjct: 287 --------LI--QNGFKMDQPFYA----TEEIYIIM---QSCWAFDSRKRPSFPNLTSFL 329
Query: 577 ES 578
Sbjct: 330 GC 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 18/121 (14%), Positives = 45/121 (37%), Gaps = 10/121 (8%)
Query: 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF--------YGEIPSELGNCTELQGLS 126
+ + N + L L +++ +N+ N + ++ ++Q +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 127 LQSNYL-SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
+ N L + + + L + L L+ N L P+ G +L + N++ N +
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPA 370
Query: 186 S 186
+
Sbjct: 371 N 371
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 28/224 (12%), Positives = 60/224 (26%), Gaps = 46/224 (20%)
Query: 21 IIINKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWK------------GVKC 68
I ++++ D AL A+ + + NW GV
Sbjct: 20 IKLSRTAEYIKDYLALKEIWDALNGKNWSQQGF--GTQPGANWNFNKELDMWGAQPGVSL 77
Query: 69 DKNKRVITLSLTNHKLSGPISAD----------------------------LGKLDQLKF 100
+ N RV LSL SG + + +
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 101 LNLHSNNFYGEIPSELG--NCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSD 158
++ + ++L + S+ SI + SN+++
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT- 196
Query: 159 YIPPSLGKLQRLITFNVSNNFLVGAIP-SDGVLTKFSESSFFGN 201
++ ++ +L +L F + N+ V + +
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 21/118 (17%), Positives = 45/118 (38%), Gaps = 11/118 (9%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ------ 128
++ L +KL+ L L ++L N+F + P++ N + L+G ++
Sbjct: 492 SIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQ 550
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
N P + +L L I SN + + + + ++ +N + S
Sbjct: 551 GNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-20
Identities = 23/107 (21%), Positives = 42/107 (39%), Gaps = 4/107 (3%)
Query: 81 NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL 140
N+ + P+ L K+ +L L N G++P G+ +L L+L N ++ +
Sbjct: 315 NNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFC 373
Query: 141 GNLSNLLNLDISSNSLSDYIPPSL--GKLQRLITFNVSNNFLVGAIP 185
G + NL + N L IP + + + S N +
Sbjct: 374 GFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDG 419
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 27/132 (20%), Positives = 46/132 (34%), Gaps = 17/132 (12%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-------YGEIPSELGNCTEL 122
K V +++L+N+++S L +NL N + N L
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 123 QGLSLQSNYLSGSIPSEL--GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN--- 177
+ L+ N L+ + + L L+ +D+S NS S P L F + N
Sbjct: 491 TSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRD 548
Query: 178 ---NFLVGAIPS 186
N + P
Sbjct: 549 AQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 5e-20
Identities = 16/148 (10%), Positives = 43/148 (29%), Gaps = 20/148 (13%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+I + + I + + SNN + + T+L+ + ++
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPF 218
Query: 133 SG-------------------SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITF 173
+ + NL +L ++++ + +P L L +
Sbjct: 219 VAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLI 278
Query: 174 NVSNNFLVGAIPSDGVLTKFSESSFFGN 201
NV+ N + +++
Sbjct: 279 NVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 19/133 (14%), Positives = 42/133 (31%), Gaps = 16/133 (12%)
Query: 77 LSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYG-------EIPSELGNCTELQGLSLQ 128
LS ++KL P D + + ++ N + + ++L
Sbjct: 382 LSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSD-------YIPPSLGKLQRLITFNVSNNFLV 181
+N +S S L ++++ N L++ + L + ++ N L
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
Query: 182 GAIPSDGVLTKFS 194
+ D T
Sbjct: 502 K-LSDDFRATTLP 513
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 17/109 (15%), Positives = 32/109 (29%), Gaps = 11/109 (10%)
Query: 86 GPISADLGKLDQLKFLNLHSNNFYGEIPSEL--GNCTELQGLSLQSNYLSGSIPSELGNL 143
+ + L ++L N ++ + L G+ L N S P++ N
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535
Query: 144 SNL------LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
S L D N P + L + +N + +
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE 583
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 17/109 (15%), Positives = 32/109 (29%), Gaps = 10/109 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLH------SNNFYGEIPSELGNCTELQGLSLQS 129
+ L+ + S LK + N E P + C L L + S
Sbjct: 517 GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
N + + ++ N+ LDI N + + + +
Sbjct: 576 NDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 17/107 (15%), Positives = 31/107 (28%), Gaps = 4/107 (3%)
Query: 102 NLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS---- 157
N + + + L + + GLSL+ SG +P +G L+ L L + S+
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 158 DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204
+ P + FS+
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSD 169
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 8/82 (9%), Positives = 23/82 (28%), Gaps = 3/82 (3%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
++ + L L + SN+ ++ ++ + L ++ N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISID 603
Query: 137 PSELGNLSNLLNLDISSNSLSD 158
S + + + D
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQD 625
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 44/218 (20%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD--RFFERELEI---LGSIKHRYLV 366
+ G G FGTV + G A+K++ RF REL+I L + H +V
Sbjct: 30 MAGQGTFGTVQL-GKEKSTGMSVAIKKV------IQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 367 NLRGYCNSPTSK-------LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA----- 414
L+ Y + + ++ +++P + LH R +
Sbjct: 83 QLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRC---CRNYYRRQVAPPPILIKVF 134
Query: 415 -----KGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIV 468
+ + LH S + HRDIK N+L++ + ++ DFG AK L E ++ I
Sbjct: 135 LFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 469 AGTFGYLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
+ Y APE + + T D++S G + E++ G+
Sbjct: 194 --SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM--DDGNVFALKRIDK-----LNEGFDRFFERELEIL 357
LD +G+G FG V L + GN +A+K +DK L + E+ IL
Sbjct: 39 QLDQFDRIKTLGTGSFGRVM-LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR--IL 95
Query: 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAA 414
++ +LV L ++ ++ +++ GG + L + AR I++
Sbjct: 96 QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT-- 153
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
YLH S +I+RD+K N+L+D +V+DFG AK ++ T + GT
Sbjct: 154 --FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEA 204
Query: 475 LAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
LAPE + S + D ++ GVL+ E+ +G P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-22
Identities = 22/112 (19%), Positives = 39/112 (34%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ + L S +L+ L+L + + L L L N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
LS+L L +L+ +G L+ L NV++N + +
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 23/113 (20%), Positives = 46/113 (40%), Gaps = 3/113 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSG 134
L L+ + + +S++ L+QL+ L+ +N S + L L + +
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPS 186
+ LS+L L ++ NS + P +L+ L ++S L P+
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 26/116 (22%), Positives = 37/116 (31%), Gaps = 2/116 (1%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ LS G S LK+L+L N + S +L+ L Q + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 133 SGSIP-SELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
S +L NL+ LDIS L L ++ N D
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-19
Identities = 22/113 (19%), Positives = 36/113 (31%), Gaps = 2/113 (1%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L + + D +L L FL+L P+ + + LQ L++ N
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQR-LITFNVSNNFLVGAIPS 186
L++L LD S N + L L N++ N
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 3/119 (2%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
C + IT I +L K L+L N + ELQ L L
Sbjct: 3 CVEVVPNITYQCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ +LS+L L ++ N + + L L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 26/149 (17%), Positives = 47/149 (31%), Gaps = 10/149 (6%)
Query: 81 NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQ----GLSLQSNYLSGSI 136
N S + L L+ L+L SN ++L ++ L L N ++
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSE 195
P + L L + +N S + + L L + L KF +
Sbjct: 194 PGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN----LEKFDK 248
Query: 196 SSFFGNRGLCGKQINVTCKNDSGGSTTDS 224
S+ G L ++ + + D
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 22/119 (18%), Positives = 38/119 (31%), Gaps = 9/119 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ SL + + D + L L + F +L + L G
Sbjct: 286 SFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTLKLKSLK-----RLTFTSNKGG 338
Query: 136 IPSELGNLSNLLNLDISSNSLS--DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+L +L LD+S N LS S L ++S N ++ + L +
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 397
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 21/121 (17%), Positives = 35/121 (28%), Gaps = 12/121 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGE------IPSELGNCTEL 122
K R+ L+L N+ S + + L L+ L F E S L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 123 QGLSLQSNYLSGS---IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
+ YL I L+N+ + + S ++ + N
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK 315
Query: 180 L 180
Sbjct: 316 F 316
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 15/108 (13%), Positives = 42/108 (38%), Gaps = 4/108 (3%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC-TELQGLSLQSN 130
+ L+++++ + L+ L+ L+ N+ EL + + L L+L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 131 YLSGSIPSE--LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176
+ + + L + + L + + P + +++ N++
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK-QGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 18/113 (15%), Positives = 33/113 (29%), Gaps = 9/113 (7%)
Query: 73 RVITLSLTNHKLSGPISA-DLGKLDQLKFLNLHSNN------FYGEIPSELGNCTELQGL 125
V L L + G + D L+ L L + + +I T +
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
SL S + +L++ + + L L+RL +
Sbjct: 288 SLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +GTV+K A + + ALKR+ D +EG RE+ +L +KH+ +V L
Sbjct: 10 IGEGTYGTVFK-AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+S L+++F L + + LD + + + KGL + H ++H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY-MQSGRATEKT 489
RD+K N+L++ N E ++++FGLA+ + V T Y P+ + +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 490 DVYSFGVLVLEVLSGKRP 507
D++S G + E+ + RP
Sbjct: 184 DMWSAGCIFAELANAGRP 201
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 54/236 (22%), Positives = 86/236 (36%), Gaps = 54/236 (22%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G+G FG V + D G FALK++ + R+ REL+I+ + H ++ L Y
Sbjct: 14 TLGTGSFGIVCE-VFDIESGKRFALKKVLQ----DPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---------LNIIMG---------- 412
+ + P + LN+IM
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 413 ---------------------AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSD 450
+ + ++H S I HRDIK N+L++ ++ D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 451 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGK 505
FG AK L E + I + Y APE M T D++S G + E++ GK
Sbjct: 186 FGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 50/237 (21%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK--------------------------LNEGF 346
IG G +G V KLA +D +A+K + K G
Sbjct: 21 IGKGSYGVV-KLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 347 DRFFERELEILGSIKHRYLVNLRGYCNSPT-SKL-LIYDFLPGGSL-DEALHER-SEQLD 402
+E+ IL + H +V L + P L ++++ + G + + + SE
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 403 WDARL---NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459
AR ++I G + YLH +IIHRDIK SN+L+ + +++DFG++ +
Sbjct: 138 -QARFYFQDLIKG----IEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 460 EESHITTIVAGTFGYLAPEYMQSGRAT---EKTDVYSFGVLVLEVLSGKRPTDASFI 513
++ ++ GT ++APE + R + DV++ GV + + G+ P I
Sbjct: 190 SDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------EL 354
+L D I +G+G FG V+ L +G +A+K + K + E
Sbjct: 4 SLQDFQILRTLGTGSFGRVH-LIRSRHNGRYYAMKVLKK-----EIVVRLKQVEHTNDER 57
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQL--DWDARL---NI 409
+L + H +++ + G +I D++ GG L R Q + A+ +
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAEV 115
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+ L YLH S II+RD+K NILLD N +++DFG AK + D +T +
Sbjct: 116 CLA----LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLC 164
Query: 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
GT Y+APE + + + D +SFG+L+ E+L+G P
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 68/211 (32%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 315 IGSGGFGTVY----KLAMDDGNVFALKRIDKLNEGFDRFFER-------ELEILGSIKHR 363
+G G FG V+ D ++A+K + K R E +IL + H
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKK-----ATLKVRDRVRTKMERDILVEVNHP 86
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAAKG 416
++V L Y KL LI DFL GG L L + +E+ D + + +
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELALA---- 138
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L +LH S II+RD+K NILLD +++DFGL+K D E + GT Y+A
Sbjct: 139 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMA 194
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
PE + T+ D +SFGVL+ E+L+G P
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 315 IGSGGFGTVYKLAMD-DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G +G VYK A D G + ALKRI D +EG RE+ +L + H +V+L
Sbjct: 29 VGEGTYGVVYK-AKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
+S L+++F+ L + L E L + +G+A+ H RI+HR
Sbjct: 88 IHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY-MQSGRATEKTD 490
D+K N+L++ + +++DFGLA+ T V T Y AP+ M S + + D
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 491 VYSFGVLVLEVLSGK 505
++S G + E+++GK
Sbjct: 203 IWSIGCIFAEMITGK 217
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------EL 354
T+++ +G G FG V L G +A+K + K + + E
Sbjct: 146 TMNEFEYLKLLGKGTFGKVI-LVKEKATGRYYAMKILKK-----EVIVAKDEVAHTLTEN 199
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NII 410
+L + +H +L L+ Y +L + ++ GG L L + AR I+
Sbjct: 200 RVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAG 470
L YLH + + +++RD+K N++LD + +++DFGL K + + + T G
Sbjct: 259 SA----LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-CG 311
Query: 471 TFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
T YLAPE ++ D + GV++ E++ G+ P
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 30/113 (26%), Positives = 49/113 (43%)
Query: 74 VITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
+ L+LT+++L +A+ + QL L++ N P L+ L+LQ N LS
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+NL L + SNS+ K + LIT ++S+N L
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 30/112 (26%), Positives = 44/112 (39%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+L + + +S KL LK LNL N CT L L L SN +
Sbjct: 53 SLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKI 112
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+ NL+ LD+S N LS + +L+ L +SNN + +
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-19
Identities = 25/114 (21%), Positives = 43/114 (37%), Gaps = 2/114 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L ++ + + K L L+L N LQ L L +N +
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160
Query: 136 IPSELGNLSN--LLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
EL +N L L++SSN + ++ P + RL ++N L ++
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 25/114 (21%), Positives = 42/114 (36%), Gaps = 3/114 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSG 134
L+LT +K+S S L L+ L+L N E+ E + + L N
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444
Query: 135 SIPSELGNLSNLLNLDISSNSLS--DYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ + +L L + +L D P L+ L ++SNN +
Sbjct: 445 LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 25/119 (21%), Positives = 44/119 (36%), Gaps = 8/119 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNN--------FYGEIPSELGNCTELQGLSL 127
L L+N+ ++ L L++L+ L+L NN G L + L L+L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+SN +L L +D+ N+L+ L + N+ N +
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-18
Identities = 26/114 (22%), Positives = 40/114 (35%), Gaps = 2/114 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L+L +++LS L L+L SN+ + L L L N LS +
Sbjct: 77 VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLG--KLQRLITFNVSNNFLVGAIPSD 187
L NL L +S+N + L L +S+N + P
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGC 190
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 9/137 (6%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
K + L L+ + L+ + L QL++ L NN L ++ L+L+
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 130 NYLSGSI---------PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ SI L L +L++ N + L L ++SN+F
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 181 VGAIPSDGVLTKFSESS 197
++ + S
Sbjct: 366 SLRTLTNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-17
Identities = 28/137 (20%), Positives = 44/137 (32%), Gaps = 4/137 (2%)
Query: 78 SLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIP 137
L H G L L L LNL SN F + EL+ + L N L+
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 138 SELGNLSNLLNLDISSNSLSDYIPPSLGK-LQRLITFNVSNNFLVGAIPSDGVLTKFSES 196
S N +L +L++ N ++ G + L ++ N S +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637
Query: 197 SFFGNRGLCGKQINVTC 213
+ L + C
Sbjct: 638 THTNIPELSS---HYLC 651
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-16
Identities = 23/120 (19%), Positives = 36/120 (30%), Gaps = 10/120 (8%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQSNYLSG 134
+ L+ +K + L+ L L PS L L L +N ++
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 135 SIPSELGNLSNLLNLDISSNSLSD--------YIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L L L LD+ N+L+ L L L N+ +N
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 26/122 (21%), Positives = 51/122 (41%), Gaps = 5/122 (4%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELG---NCTELQGLS 126
N + L L+++++ + +L L L++ + +L T ++ LS
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 127 LQSNYLSGSIPSELGNL--SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI 184
L ++ LS + + L +NL LD+S N+L+ S L +L F + N +
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 185 PS 186
Sbjct: 289 SH 290
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 28/128 (21%), Positives = 43/128 (33%), Gaps = 11/128 (8%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLD--QLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
N + LSL+N +LS + L L L+L NN +L+ L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279
Query: 128 QSNYLSGSIPSELGNLS---------NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ N + L L + IS SL S L+ L N+ +N
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339
Query: 179 FLVGAIPS 186
+ G +
Sbjct: 340 DIPGIKSN 347
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 30/118 (25%), Positives = 47/118 (39%), Gaps = 7/118 (5%)
Query: 76 TLSLTNHKLSGPISADLG--KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
L L+N+K+ S +L LK L L SN P L GL L + L
Sbjct: 149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208
Query: 134 GSIPSELG---NLSNLLNLDISSNSLSDYIPPSLGKLQ--RLITFNVSNNFLVGAIPS 186
S+ +L +++ NL +S++ LS + L+ L ++S N L
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-16
Identities = 28/122 (22%), Positives = 42/122 (34%), Gaps = 8/122 (6%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ + L K + L L L+L +NN L +L+ L LQ N L
Sbjct: 457 QRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
Query: 133 S--------GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI 184
+ G L LS+L L++ SN + L L ++ N L
Sbjct: 517 ARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLP 576
Query: 185 PS 186
S
Sbjct: 577 AS 578
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-15
Identities = 22/125 (17%), Positives = 35/125 (28%), Gaps = 3/125 (2%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQ--LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130
+ ++LS + L + L L LNL N L+ L L N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415
Query: 131 YLSGSIP-SELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGV 189
+ + E L N+ + +S N S + L + L S
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 190 LTKFS 194
Sbjct: 476 FQPLR 480
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 23/117 (19%), Positives = 45/117 (38%), Gaps = 7/117 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-----YGEIPSELGNCTELQGLSLQSN 130
L++ ++ + G S L LK+L+L ++ E L + + L L+L N
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKN 391
Query: 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFLVGAIPS 186
+S L +L LD+ N + + L+ + +S N + +
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRN 448
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 22/149 (14%), Positives = 42/149 (28%), Gaps = 37/149 (24%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI---------PSELGNCTELQGLS 126
L + + S L L +++LNL + I L+ L+
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISS----------------------------NSLSD 158
++ N + G + L NL L +S+ N +S
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 159 YIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+ L L ++ N + +
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 13/69 (18%), Positives = 28/69 (40%), Gaps = 4/69 (5%)
Query: 119 CT-ELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN 177
CT + L+ +P +L +N+ L+++ N L + + +L + +V
Sbjct: 2 CTVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 178 NFLVGAIPS 186
N + P
Sbjct: 59 NTISKLEPE 67
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 21/112 (18%), Positives = 39/112 (34%), Gaps = 8/112 (7%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELG-NCTELQGLSLQSN 130
+ + L + L+ ++ LK LNL N G L L ++ N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 131 YLSGSIPSELG-----NLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN 177
+ S N ++ ++SS+ L + PP + F+ S+
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNT-PPHY-HGFPVRLFDTSS 669
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 1e-20
Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 315 IGSGGFGTVYKLAMDD-GNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +G VYK A ++ G FALK+I +K +EG RE+ IL +KH +V L
Sbjct: 10 IGEGTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
++ +L+++ L L + L L+ + ++ G+AY H R++HR
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY-MQSGRATEKTD 490
D+K N+L++ E +++DFGLA+ T + T Y AP+ M S + + D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTID 183
Query: 491 VYSFGVLVLEVLSGK 505
++S G + E+++G
Sbjct: 184 IWSVGCIFAEMVNGT 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 42/168 (25%), Positives = 73/168 (43%), Gaps = 10/168 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G V+K + G + A+K+ + + + RE+ +L +KH LVNL
Sbjct: 11 IGEGSYGVVFK-CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
L++++ ++ L + +I + + + H IH
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIH 125
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
RD+K NIL+ + ++ DFG A+LL + VA T Y +PE
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G VYK A+D A+KRI + EG RE+ +L ++HR ++ L+
Sbjct: 42 LGEGTYGEVYK-AIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 371 YCNSPTSKLLIYDFLPGGSLD-EALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ LI+++ D + +++ + + + G+ + H S R +
Sbjct: 101 VIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCL 154
Query: 430 HRDIKSSNILLDGNLEAR-----VSDFGLAKLLEDEESHITTIVAGTFGYLAPEY-MQSG 483
HRD+K N+LL + + + DFGLA+ T + T Y PE + S
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSR 213
Query: 484 RATEKTDVYSFGVLVLEVLSGK 505
+ D++S + E+L
Sbjct: 214 HYSTSVDIWSIACIWAEMLMKT 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 10/168 (5%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G V K + G + A+K+ ++ + RE+++L ++H LVNL
Sbjct: 33 VGEGSYGMVMK-CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
C L+++F+ ++ + L LD+ + G+ + H S IIH
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHNIIH 147
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
RDIK NIL+ + ++ DFG A+ L VA T Y APE
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 315 IGSGGFGTVY----KLAMDDGNVFALKRIDKLNEGFDRFFERELE---------ILGSIK 361
+G GG+G V+ + G +FA+K + K + IL +K
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKK-----AMIVRNAKDTAHTKAERNILEEVK 79
Query: 362 HRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAA 414
H ++V+L Y KL LI ++L GG L L E A I M
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEISM--- 132
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
L +LH II+RD+K NI+L+ +++DFGL K + + T GT Y
Sbjct: 133 -ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEY 187
Query: 475 LAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
+APE + D +S G L+ ++L+G P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 21/128 (16%), Positives = 43/128 (33%), Gaps = 13/128 (10%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG- 134
+ K L L + L++ ++P L + ELQ L++ N
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530
Query: 135 --------SIPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFLVGAI 184
+ + + + N+L + P S L K+ +L + +N + +
Sbjct: 531 AQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HL 588
Query: 185 PSDGVLTK 192
+ G K
Sbjct: 589 EAFGTNVK 596
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 4e-18
Identities = 29/213 (13%), Positives = 62/213 (29%), Gaps = 42/213 (19%)
Query: 21 IIINKSRAINSDGEALLSFRTAVVSSD-GFLNQWRPEDPDPCNWK------------GVK 67
I + ++ D +AL + A+ + + + NW GV
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
D N RV LSL G + +G+L +LK L+ +++
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 128 QSNYLSGSIPSE-LGNLSNLLNLDISSNSLSD---------------------------- 158
+ + + L L D+ ++++
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT 438
Query: 159 YIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
+I ++ +L +L +N+ +
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTYDNIAVDWED 471
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-18
Identities = 20/126 (15%), Positives = 36/126 (28%), Gaps = 15/126 (11%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ N + A + N Y N +L + L +
Sbjct: 452 IIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506
Query: 136 IPSELGNLSNLLNLDISSNSLSDY---------IPPSLGKLQRLITFNVSNNFLVGAIPS 186
+P L +L L +L+I+ N + ++ F + N L P+
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPA 565
Query: 187 DGVLTK 192
L K
Sbjct: 566 SASLQK 571
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 9e-18
Identities = 23/132 (17%), Positives = 44/132 (33%), Gaps = 17/132 (12%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-------YGEIPSELGNCTEL 122
K T++L+ +++ + + + L +N N L
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 123 QGLSLQSNYLSGSIPSEL--GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFN------ 174
+ L+ N L+ S+ + L L N+D+S N S P +L F
Sbjct: 731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788
Query: 175 VSNNFLVGAIPS 186
N ++ P+
Sbjct: 789 AEGNRILRQWPT 800
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-17
Identities = 16/120 (13%), Positives = 47/120 (39%), Gaps = 6/120 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
+ ++++ IS + +L +L+ + ++ F + + + + +
Sbjct: 430 IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENE 483
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSES 196
NL +L ++++ + +P L L L + N++ N + A T+ ++
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 7e-17
Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 8/115 (6%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
+ + L P SA L K+ +L L+ N G +L L L N +
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE- 608
Query: 135 SIPSELG-NLSNLLNLDISSNSLSDYIPP--SLGKLQRLITFNVSNNFLVGAIPS 186
IP + + L S N L IP + + + + + S N + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 4e-16
Identities = 21/133 (15%), Positives = 42/133 (31%), Gaps = 18/133 (13%)
Query: 70 KNKRVITLSLTNHKLS-------GPISADLGKLDQLKFLNLHSNNFYGEIPSEL--GNCT 120
+ T+ L+N+ ++ P + L ++L N + +
Sbjct: 695 TGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLP 753
Query: 121 ELQGLSLQSNYLSGSIPSELGNLSNL------LNLDISSNSLSDYIPPSLGKLQRLITFN 174
L + + N S S P++ N S L D N + P + LI
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 175 VSNNFLVGAIPSD 187
+ +N + +
Sbjct: 813 IGSNDI-RKVDEK 824
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 5e-15
Identities = 17/132 (12%), Positives = 40/132 (30%), Gaps = 14/132 (10%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPS-----ELGNCTELQGLSLQS 129
L +++KL P + + + ++ N E + + ++L
Sbjct: 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSD-------YIPPSLGKLQRLITFNVSNNFLVG 182
N + S + + +S+N ++ + L T ++ N L
Sbjct: 683 NEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
Query: 183 AIPSDGVLTKFS 194
+ D T
Sbjct: 743 -LSDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 18/109 (16%), Positives = 35/109 (32%), Gaps = 10/109 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNL------HSNNFYGEIPSELGNCTELQGLSLQS 129
+ ++ + S QLK + N + P+ + C L L + S
Sbjct: 757 NMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
N + + +L L LDI+ N S+ + + +
Sbjct: 816 NDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 11/82 (13%), Positives = 26/82 (31%), Gaps = 5/82 (6%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL-SGS 135
+++ + L L + SN+ ++ +L +L L + N S
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISID 843
Query: 136 IPSELGNL-SNLLNLDISSNSL 156
+ S + + + L
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQD 865
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 37/215 (17%)
Query: 315 IGSGGFGTVY----KLAMDDGNVFALKRIDKLNEGFDRFFER---------ELEILGSIK 361
+G+G +G V+ D G ++A+K + K ++ E ++L I+
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-----ATIVQKAKTTEHTRTERQVLEHIR 116
Query: 362 HR-YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALH-ERSEQLDWD-ARL---NIIMGAA 414
+LV L Y +KL LI D++ GG L H + E+ ++ I++
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVL--- 170
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGY 474
L +LH II+RDIK NILLD N ++DFGL+K +E+ GT Y
Sbjct: 171 -ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 475 LAPEYMQSGRA--TEKTDVYSFGVLVLEVLSGKRP 507
+AP+ ++ G + + D +S GVL+ E+L+G P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G + TVYK + N+ ALK I +L EG RE+ +L +KH +V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
++ S L++++L L + L + ++ + +GLAY H +++HR
Sbjct: 69 IHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY-MQSGRATEKTD 490
D+K N+L++ E +++DFGLA+ V T Y P+ + S + + D
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQID 183
Query: 491 VYSFGVLVLEVLSGK 505
++ G + E+ +G+
Sbjct: 184 MWGVGCIFYEMATGR 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 54/172 (31%), Positives = 85/172 (49%), Gaps = 15/172 (8%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI-----DKLNEGFDRFFERELEILGSIKHRYLVN 367
+G G F TVYK A D + A+K+I + +G +R RE+++L + H ++
Sbjct: 18 LGEGQFATVYK-ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG-AAKGLAYLHHDCSP 426
L ++ L++DF+ L+ + + S L + + M +GL YLH
Sbjct: 77 LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLT-PSHIKAYMLMTLQGLEYLHQH--- 131
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
I+HRD+K +N+LLD N +++DFGLAK T V T Y APE
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPE 182
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G F V KLA + G A+K IDK LN + RE+ I+ + H +V L
Sbjct: 23 IGKGNFAKV-KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---LNIIMGAAKGLAYLHHDCSPR 427
+ + LI ++ GG + + L + +AR I+ + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQKR--- 134
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATE 487
I+HRD+K+ N+LLD ++ +++DFG + G Y APE + G+ +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPE-LFQGKKYD 191
Query: 488 --KTDVYSFGVLVLEVLSGKRPTDAS 511
+ DV+S GV++ ++SG P D
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQ 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRG 370
+G+G + TVYK ++ G ALK + KL+ EG RE+ ++ +KH +V L
Sbjct: 13 LGNGTYATVYK-GLNKTTGVYVALKEV-KLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 371 YCNSPTSKLLIYDFLPGGSLD-EALHERSEQLDWDARLNIIMGAA------KGLAYLHHD 423
++ L+++F+ D + + + L + + +GLA+ H +
Sbjct: 71 VIHTENKLTLVFEFM---DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY-MQS 482
+I+HRD+K N+L++ + ++ DFGLA+ + ++ V T Y AP+ M S
Sbjct: 128 ---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGS 183
Query: 483 GRATEKTDVYSFGVLVLEVLSGK 505
+ D++S G ++ E+++GK
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGK 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 31/186 (16%)
Query: 315 IGSGGFGTVYK---LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
+G G +G VYK D +ALK+I+ G RE+ +L +KH +++L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKV 86
Query: 372 CNSPTSKL--LIYDFLPGGSLD--EALHERSEQLDWDARLNIIMGAAK--------GLAY 419
S + L++D+ D + + + G K G+ Y
Sbjct: 87 FLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEAR----VSDFGLAKLLEDEE---SHITTIVAGTF 472
LH + ++HRD+K +NIL+ G R ++D G A+L + + +V TF
Sbjct: 144 LH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199
Query: 473 GYLAPE 478
Y APE
Sbjct: 200 WYRAPE 205
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSIKHRY 364
+G G FG V L G +A+K + K + + E +L + +H +
Sbjct: 13 LGKGTFGKVI-LVREKATGRYYAMKILRK-----EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 365 LVNLRGYCNSPTSKL-LIYDFLPGGSLDEALH-ERSEQLDWD-ARL---NIIMGAAKGLA 418
L L+ Y +L + ++ GG L H R + AR I+ L
Sbjct: 67 LTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVS----ALE 119
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
YLH S +++RDIK N++LD + +++DFGL K + + + T GT YLAPE
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPE 175
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
++ D + GV++ E++ G+ P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G V +LA++ A+K +D + + ++E+ I + H +V G
Sbjct: 15 LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENI-KKEICINKMLNHENVVKFYG 72
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---LNIIMGAAKGLAYLHHDCSPR 427
+ + L ++ GG L + + + DA+ ++ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLED--EESHITTIVAGTFGYLAPEYMQSGR- 484
I HRDIK N+LLD ++SDFGLA + E + + GT Y+APE + R
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 485 -ATEKTDVYSFGVLVLEVLSGKRPTD 509
E DV+S G+++ +L+G+ P D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 29/213 (13%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK----LNEGFDRFFERELEILGSIKHRYLVNL 368
+G G +G V K +D A+K + K + ++E+++L ++H+ ++ L
Sbjct: 13 LGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 369 RG--YCNSPTSKLLIYDFLPGGS---LDEALHER-SEQLDWDAR---LNIIMGAAKGLAY 419
Y ++ ++ G LD +R A +I GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV---CQAHGYFCQLI----DGLEY 124
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE-ESHITTIVAGTFGYLAPE 478
LH S I+H+DIK N+LL ++S G+A+ L G+ + PE
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 479 YMQSGRATE--KTDVYSFGVLVLEVLSGKRPTD 509
K D++S GV + + +G P +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 47/220 (21%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G FG V+K A G ALK++ + EGF RE++IL +KH +VNL
Sbjct: 25 IGQGTFGEVFK-ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 371 YCNSPTSKL--------LIYDFL----------PGGSLDEALHERS--EQLDWDARLNII 410
C + S L++DF + + + L
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIKRVMQML--------- 133
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL----LEDEESHITT 466
GL Y+H + +I+HRD+K++N+L+ + +++DFGLA+ + + T
Sbjct: 134 ---LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 467 IVAGTFGYLAPEY-MQSGRATEKTDVYSFGVLVLEVLSGK 505
V T Y PE + D++ G ++ E+ +
Sbjct: 188 RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 26/206 (12%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD--RFFERELEILGSIKHRYLVNLRG 370
IG G +G V A D + A+K+I R RE++IL +H ++ +
Sbjct: 35 IGEGAYGMVCS-AYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIND 92
Query: 371 YCNSPTSKL-----LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAYLHHD 423
+PT + ++ D + + L++ +++ L D + +GL Y+H
Sbjct: 93 IIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH-- 145
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH---ITTIVAGTFGYLAPEYM 480
S ++HRD+K SN+LL+ + ++ DFGLA++ + + H +T VA T Y APE M
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIM 203
Query: 481 -QSGRATEKTDVYSFGVLVLEVLSGK 505
S T+ D++S G ++ E+LS +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 9e-19
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 30/206 (14%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYLV 366
IGSG G V A D A+K KL+ F R + REL ++ + H+ ++
Sbjct: 70 IGSGAQGIVCA-AYDAVLDRNVAIK---KLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 124
Query: 367 NLRGYCNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIM-GAAKGLAY 419
+L + L+ + + D L + + R++ ++ G+ +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
LH S IIHRD+K SNI++ + ++ DFGLA+ +T V T Y APE
Sbjct: 180 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV-TRYYRAPEV 234
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGK 505
+ E D++S G ++ E++ K
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 313 HIIGSGGFGTVYKLAMD-DGNVFALKRIDK--LNEGFDRFFE---------RELEILGSI 360
I SG +G V +D +G A+KR+ + RE+ +L
Sbjct: 28 RFISSGSYGAVCA-GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 361 KHRYLVNLRGYCNSPTSKL-----LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
H ++ LR L+ + + L + +H++ + +
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
GL LH ++HRD+ NILL N + + DF LA+ + +++ T V Y
Sbjct: 146 GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVT-HRWYR 200
Query: 476 APEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
APE + Q T+ D++S G ++ E+ + K
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 29/213 (13%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFF---ERELEIL----GSIKH 362
+G GGFGTV + D A+K I + L E+ +L H
Sbjct: 39 LGKGGFGTV-FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 363 RYLVNLRGYCNSPTSKLLIYDF-LPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLA 418
++ L + + +L+ + LP L + + E+ E +R +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP---SR-CFFGQVVAAIQ 153
Query: 419 YLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
+ H S ++HRDIK NIL+D A++ DFG LL DE GT Y P
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-DF--DGTRVYSPP 207
Query: 478 EYMQSGR-ATEKTDVYSFGVLVLEVLSGKRPTD 509
E++ + V+S G+L+ +++ G P +
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 56/205 (27%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG V K+ G+ A+K +++ + +RE++ L +H +++ L
Sbjct: 19 LGVGTFGKV-KIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDCSP 426
++PT ++ +++ GG L + + + + +AR I+ + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCH---RH 130
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRAT 486
++HRD+K N+LLD ++ A+++DFGL+ ++ D E T+ G+ Y APE + SGR
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGRLY 187
Query: 487 E--KTDVYSFGVLVLEVLSGKRPTD 509
+ D++S GV++ +L G P D
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G V +LA++ A+K +D + + ++E+ I + H +V G
Sbjct: 15 LGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENI-KKEICINKMLNHENVVKFYG 72
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDAR---LNIIMGAAKGLAYLHHDCSPR 427
+ + L ++ GG L + + + DA+ ++ G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH---GIG 125
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLED--EESHITTIVAGTFGYLAPEYMQSGR- 484
I HRDIK N+LLD ++SDFGLA + E + + GT Y+APE + R
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE-LLKRRE 183
Query: 485 -ATEKTDVYSFGVLVLEVLSGKRPTD 509
E DV+S G+++ +L+G+ P D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IGSG FG +L D + A+K I++ D +RE+ S++H +V +
Sbjct: 28 IGSGNFGVA-RLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 373 NSPTSKLLIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAAKGLAYLHHDCSP 426
+PT +I ++ GG L E + SE +AR ++ G ++Y H S
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLSG----VSYCH---SM 135
Query: 427 RIIHRDIKSSNILLDGNLEAR--VSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
+I HRD+K N LLDG+ R + DFG +K +T+ GT Y+APE + +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPE-VLLRQ 192
Query: 485 --ATEKTDVYSFGVLVLEVLSGKRPTD 509
+ DV+S GV + +L G P +
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYLVN 367
+GSG +G V A+D G A+K KL F REL +L ++H ++
Sbjct: 33 VGSGAYGAVCS-AVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 368 LRGYCNSPTSKL------LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAY 419
L + L+ F+ L + + E+L D ++ KGL Y
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
+H + IIHRD+K N+ ++ + E ++ DFGLA+ + E +T V T Y APE
Sbjct: 144 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVV-TRWYRAPEV 196
Query: 480 M-QSGRATEKTDVYSFGVLVLEVLSGK 505
+ R T+ D++S G ++ E+++GK
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 30/207 (14%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYL 365
IGSG G V A D A+K KL+ F R + REL ++ + H+ +
Sbjct: 32 PIGSGAQGIVCA-AYDAILERNVAIK---KLSRPFQNQTHAKRAY-RELVLMKCVNHKNI 86
Query: 366 VNLRGYCNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIM-GAAKGLA 418
+ L S ++ + + D L + + R++ ++ G+
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
+LH S IIHRD+K SNI++ + ++ DFGLA+ +T V T Y APE
Sbjct: 142 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV-TRYYRAPE 196
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGK 505
+ E D++S G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFE---RELEILGSIKHR--Y 364
+GSGGFG+V + D A+K ++K + G E+ +L +
Sbjct: 51 LGSGGFGSV-YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 365 LVNLRGYCNSPTSKLLI----------YDFLPG-GSLDEALHERSEQLDWDARLNIIMGA 413
++ L + P S +LI +DF+ G+L E L AR +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----------AR-SFFWQV 158
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTF 472
+ + + H + ++HRDIK NIL+D N E ++ DFG LL+D + T GT
Sbjct: 159 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFD-GTR 212
Query: 473 GYLAPEYMQSGR-ATEKTDVYSFGVLVLEVLSGKRPTD 509
Y PE+++ R V+S G+L+ +++ G P +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 34/208 (16%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYLV 366
+GSG +G+V A D G A+K KL+ F R + REL +L +KH ++
Sbjct: 37 VGSGAYGSVCA-AFDTKTGLRVAVK---KLSRPFQSIIHAKRTY-RELRLLKHMKHENVI 91
Query: 367 NLRGYCNSPTSKL------LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLA 418
L S L+ + L+ + ++L D +I +GL
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
Y+H S IIHRD+K SN+ ++ + E ++ DFGLA+ DE +T VA T Y APE
Sbjct: 147 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVA-TRWYRAPE 199
Query: 479 YM-QSGRATEKTDVYSFGVLVLEVLSGK 505
M + D++S G ++ E+L+G+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 36/211 (17%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILG-SIKHR 363
IG G FG V LA + +A+K + K ++ E +L ++KH
Sbjct: 46 IGKGSFGKVL-LARHKAEEVFYAVKVLQK-----KAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAAKG 416
+LV L + KL + D++ GG L L E AR I
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA---- 151
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L YLH S I++RD+K NILLD ++DFGL K + S +T GT YLA
Sbjct: 152 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLA 207
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
PE + D + G ++ E+L G P
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 21/109 (19%), Positives = 42/109 (38%), Gaps = 1/109 (0%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ + +L + N LS + + L +L+ L+L P G L+ L L+
Sbjct: 206 QNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++P ++ L+ L LD+ +P + +L V +
Sbjct: 265 NLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 20/111 (18%), Positives = 44/111 (39%), Gaps = 2/111 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+L L + + A + L LK L + ++ + + + +L+ L L+ +
Sbjct: 187 SLRLEWTGIRS-LPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRN 244
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
P G + L L + S +P + +L +L ++ + +PS
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 22/127 (17%), Positives = 47/127 (37%), Gaps = 13/127 (10%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+ L L + L +L L+ + + + E+P + L+ L+L
Sbjct: 79 TQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLAR 136
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGK---------LQRLITFNVSNNFL 180
N L ++P+ + +L+ L L I + +P L L L + + +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 181 VGAIPSD 187
++P+
Sbjct: 196 R-SLPAS 201
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 29/121 (23%), Positives = 56/121 (46%), Gaps = 12/121 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC---------TELQGLS 126
TL+L + L + A + L++L+ L++ + E+P L + LQ L
Sbjct: 131 TLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLR 189
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+ + S+P+ + NL NL +L I ++ LS + P++ L +L ++ + P
Sbjct: 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPP 247
Query: 187 D 187
Sbjct: 248 I 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 5/111 (4%)
Query: 78 SLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTE--LQGLSLQSNYLSGS 135
N + SA + + L + T+ L L+S L
Sbjct: 37 RHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-Q 95
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
P + LS+L ++ I + L + +P ++ + L T ++ N L A+P+
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPA 144
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 16/95 (16%), Positives = 31/95 (32%), Gaps = 3/95 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L G LK L L + +P ++ T+L+ L L+
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 136 IPSELGNLSNLLNLDISSNSLS---DYIPPSLGKL 167
+PS + L + + + + + P +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 10/104 (9%), Positives = 22/104 (21%), Gaps = 22/104 (21%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG-------------------SIPS 138
+ L + L + + +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD 73
Query: 139 ELGNLS--NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L + + + L++ S L P +L L + L
Sbjct: 74 LLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 23/112 (20%), Positives = 37/112 (33%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L LT ++ +L L L +N + L L+ L +S
Sbjct: 61 FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSI 120
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
L N L +L + SN +S P ++L + NN + D
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 20/111 (18%), Positives = 35/111 (31%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L + + L + +L L FL+L Y + L L L +N L
Sbjct: 37 CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM 96
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ L L +L +S L + L + + +N +
Sbjct: 97 AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP 147
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 25/124 (20%), Positives = 48/124 (38%), Gaps = 2/124 (1%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
V +++L H S L+ L+L + + E+PS L + L+ L L +
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSA 310
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDG 188
N N +L +L I N+ + L L+ L ++S++ + + +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 189 VLTK 192
L
Sbjct: 371 QLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 30/129 (23%), Positives = 47/129 (36%), Gaps = 2/129 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL LT + L L LK L L N L+ L L SN++S
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL--ITFNVSNNFLVGAIPSDGVLTKF 193
+ L LD +N++ + LQ+ ++ N++ N + G P F
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVF 204
Query: 194 SESSFFGNR 202
+F G +
Sbjct: 205 QSLNFGGTQ 213
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 18/120 (15%), Positives = 33/120 (27%), Gaps = 3/120 (2%)
Query: 67 KCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLS 126
KC + + T + N L+ I L + + L N + L L
Sbjct: 7 KCIEKEVNKTYNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLD 63
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L + + L L +++N L +L + L +
Sbjct: 64 LTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI 123
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 4/114 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI---PSELGNCTELQGLSLQSNYL 132
L+L++ L L L+ LNL N+F + L L+ L L L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
S +L + ++D+S N L+ +L L+ + N+++N + +PS
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 24/115 (20%), Positives = 41/115 (35%), Gaps = 4/115 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSG 134
+L+L+ ++ + + QL+ L+L + S N L+ L+L + L
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYI---PPSLGKLQRLITFNVSNNFLVGAIPS 186
S L L +L++ N SL L RL +S L
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 24/119 (20%), Positives = 42/119 (35%), Gaps = 4/119 (3%)
Query: 72 KRVITLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFY--GEIPSELGNCTELQGLSLQ 128
+ LS+ + + L L+ L+ L+L ++ +L N + LQ L+L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFLVGAIPS 186
N L LD++ L S L L N+S++ L +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 23/106 (21%), Positives = 42/106 (39%), Gaps = 4/106 (3%)
Query: 76 TLSLTNHKLSGPI---SADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
L+L + + L L +L+ L L + + + + L N L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ S L +L + L+++SN +S +P L L + T N+ N
Sbjct: 513 TSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 1/82 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ LS L + ++L N L + + L+L SN++S
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISII 538
Query: 136 IPSELGNLSNLLNLDISSNSLS 157
+PS L LS +++ N L
Sbjct: 539 LPSLLPILSQQRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 23/142 (16%), Positives = 46/142 (32%), Gaps = 13/142 (9%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
K + +L L ++ +S ++LK L+ +N + ++ + + LSL N
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 132 LS-GSIPSELGNLSNLLNLDISSNSLSDYIPPSLG--KLQRLITFNVSNNFLVGAIPSDG 188
I + + +L+ I L +Q L +
Sbjct: 189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM---------- 238
Query: 189 VLTKFSESSFFGNRGLCGKQIN 210
S + F G + + IN
Sbjct: 239 DDEDISPAVFEGLCEMSVESIN 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 2e-17
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 308 TLDDDHI---IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------EL 354
L D + +G G FG V L+ ++A+K + K D + E
Sbjct: 339 KLTDFNFLMVLGKGSFGKVM-LSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEK 392
Query: 355 EILGSI-KHRYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NI 409
+L K +L L C +L + +++ GG L + + + A I
Sbjct: 393 RVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA 469
+G L +L S II+RD+K N++LD +++DFG+ K + T
Sbjct: 452 AIG----LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-C 503
Query: 470 GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
GT Y+APE + + D ++FGVL+ E+L+G+ P
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSI-KH 362
+IG G + V L ++A+K + K + + E + H
Sbjct: 16 VIGRGSYAKVL-LVRLKKTDRIYAMKVVKK-----ELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 363 RYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLA 418
+LV L C S+L + +++ GG L + + + + AR I + L
Sbjct: 70 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 124
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
YLH II+RD+K N+LLD +++D+G+ K +T GT Y+APE
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE 180
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
++ D ++ GVL+ E+++G+ P
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 37/217 (17%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYL 365
+G GG G V+ A+D A+K+I RE++I+ + H +
Sbjct: 18 PLGCGGNGLVFS-AVDNDCDKRVAIKKI-----VLTDPQSVKHAL-REIKIIRRLDHDNI 70
Query: 366 VNLRGYCNSPTSKLLIYDFLPGGSLDEA----------LHE--RSEQLDWDARLNIIMGA 413
V + P+ L D L+ L L + +
Sbjct: 71 VKVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESH---ITTIVA 469
+GL Y+H S ++HRD+K +N+ ++ +L ++ DFGLA++++ SH ++ +
Sbjct: 130 LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 470 GTFGYLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
T Y +P + T+ D+++ G + E+L+GK
Sbjct: 187 -TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 53/228 (23%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFER 352
L II + ++G G G V + FALK + + R
Sbjct: 8 LQIKKNAIIDDYKVTS--QVLGLGINGKVL-QIFNKRTQEKFALKMLQDCPK-----ARR 59
Query: 353 ELEILGSI-KHRYLVNLRG-YCNSPTSKLLIY---DFLPGGSLDEALHER-----SEQLD 402
E+E+ + ++V + Y N + + + L GG L + +R +E+
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-- 117
Query: 403 WDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLED 459
+A I+ + + YLH S I HRD+K N+L N +++DFG AK
Sbjct: 118 -EAS-EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172
Query: 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
E Y + D++S GV++ +L G P
Sbjct: 173 E------------KY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 33/207 (15%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRYLV 366
+GSG +G+V A+D G A+K KL+ F R + REL +L ++H ++
Sbjct: 32 VGSGAYGSVCS-AIDKRSGEKVAIK---KLSRPFQSEIFAKRAY-RELLLLKHMQHENVI 86
Query: 367 NLRGYCNSPTSKL------LIYDFLPGGSLDEALHERSEQLDWDARLNIIM-GAAKGLAY 419
L +S L+ F+ L + + ++ ++ KGL Y
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
+H S ++HRD+K N+ ++ + E ++ DFGLA+ + E +T V T Y APE
Sbjct: 142 IH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVV-TRWYRAPEV 194
Query: 480 M-QSGRATEKTDVYSFGVLVLEVLSGK 505
+ + D++S G ++ E+L+GK
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 36/211 (17%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSI-KHR 363
+G G FG V L+ ++A+K + K D + E +L K
Sbjct: 28 LGKGSFGKVM-LSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALH-ERSEQLDWD-ARL---NIIMGAAKGL 417
+L L C +L + +++ GG L H ++ + A I +G L
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIG----L 134
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED-EESHITTIVAGTFGYLA 476
+L S II+RD+K N++LD +++DFG+ K E+ + T GT Y+A
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 189
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
PE + + D ++FGVL+ E+L+G+ P
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD--RFFERELEILGSIKHRYLVNL 368
++G G +G V A G + A+K+I+ ++ R RE++IL KH ++ +
Sbjct: 17 SLLGEGAYGVVCS-ATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIITI 74
Query: 369 RGYCNSPTSKL-----LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAYLH 421
+ + +I + + LH ++ L D I + + LH
Sbjct: 75 FNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 422 HDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG-------- 473
+IHRD+K SN+L++ N + +V DFGLA+++++ + + G
Sbjct: 130 ---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 474 -YLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
Y APE M S + + DV+S G ++ E+ +
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 55/205 (26%), Positives = 107/205 (52%), Gaps = 21/205 (10%)
Query: 315 IGSGGFGTVYKLAMDD--GNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG V K+ + G+ A+K +++ + RE++ L +H +++ L
Sbjct: 24 LGVGTFGKV-KVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDCSP 426
++P+ ++ +++ GG L + + + + ++R I+ G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCH---RH 135
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRAT 486
++HRD+K N+LLD ++ A+++DFGL+ ++ D E T+ G+ Y APE + SGR
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGRLY 192
Query: 487 E--KTDVYSFGVLVLEVLSGKRPTD 509
+ D++S GV++ +L G P D
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFD 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 314 IIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSI-KH 362
+IG G + V L ++A++ + K + + E + H
Sbjct: 59 VIGRGSYAKVL-LVRLKKTDRIYAMRVVKK-----ELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 363 RYLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLA 418
+LV L C S+L + +++ GG L + + + + AR I + L
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 167
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPE 478
YLH II+RD+K N+LLD +++D+G+ K +T GT Y+APE
Sbjct: 168 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE 223
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
++ D ++ GVL+ E+++G+ P
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 27/211 (12%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDK--------LNEGFDRFFERELEILGSIKHRY 364
+GSG FG V A+D +K I K + + E+ IL ++H
Sbjct: 32 LGSGAFGFV-WTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 365 LVNLRGYCNSPTSKLLIYDF-LPGGSLDE--ALHER-SEQLDWDARLNIIMGAAKGLAYL 420
++ + + L+ + G L H R E L A I + YL
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL---AS-YIFRQLVSAVGYL 146
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM 480
IIHRDIK NI++ + ++ DFG A LE + T GT Y APE +
Sbjct: 147 R---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPE-V 200
Query: 481 QSGRATE--KTDVYSFGVLVLEVLSGKRPTD 509
G + +++S GV + ++ + P
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 38/212 (17%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILG-SIKHR 363
+G G FG V+ LA FA+K + K D E +L + +H
Sbjct: 25 LGKGSFGKVF-LAEFKKTNQFFAIKALKK-----DVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAAKG 416
+L ++ L + ++L GG L + A II+G
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILG---- 130
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL-LEDEESHITTIVAGTFGYL 475
L +LH S I++RD+K NILLD + +++DFG+ K + + T GT Y+
Sbjct: 131 LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYI 185
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
APE + + D +SFGVL+ E+L G+ P
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 36/211 (17%)
Query: 315 IGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFER--------ELEILGSI-KHR 363
+G G FG V LA + G+++A+K + K D + E IL H
Sbjct: 31 LGKGSFGKVM-LARVKETGDLYAVKVLKK-----DVILQDDDVECTMTEKRILSLARNHP 84
Query: 364 YLVNLRGYCNSPTSKL-LIYDFLPGGSLDEALHER---SEQLDWDARL---NIIMGAAKG 416
+L L C +L + +F+ GG L + + E AR II
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEIISA---- 136
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
L +LH II+RD+K N+LLD +++DFG+ K T GT Y+A
Sbjct: 137 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIA 192
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
PE +Q D ++ GVL+ E+L G P
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 35/212 (16%)
Query: 315 IGSGGFGTVYKLAMDD---GNVFALKRI--DKLNEGFDRFFERELEILGSIK---HRYLV 366
IG G +G V+K A D G ALKR+ EG RE+ +L ++ H +V
Sbjct: 19 IGEGAYGKVFK-ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 367 NLR----GYCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK------ 415
L +KL L+++ + + + LD + K
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 416 --GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
GL +LH R++HRD+K NIL+ + + +++DFGLA++ + + + +V T
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLW 184
Query: 474 YLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK 505
Y APE + D++S G + E+ K
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 23/112 (20%), Positives = 39/112 (34%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ L+ + L S +L++L+L L L L N +
Sbjct: 36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF 95
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
P L++L NL L+ +G+L L NV++NF+
Sbjct: 96 SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPA 147
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 24/106 (22%), Positives = 34/106 (32%), Gaps = 1/106 (0%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L ++ L L L + N+F S N T L L L L
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L L L++S N+L +L L T + S N +
Sbjct: 488 ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRI 533
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 25/104 (24%), Positives = 35/104 (33%), Gaps = 1/104 (0%)
Query: 76 TLSLT-NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
TL + N +S L FL+L LQ L++ N L
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
S L +L LD S N + + L FN++NN
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 26/113 (23%), Positives = 40/113 (35%), Gaps = 2/113 (1%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L + L L++L +L++ N + T L L + N
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ S N +NL LD+S L L RL N+S+N L+ S
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 6/117 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSG 134
L KL+ S +G+L LK LN+ N + ++P+ N T L + L NY+
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 135 SIPSELGNLSNL----LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
++L L L+LD+S N + +I + +L + NF I
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 19/113 (16%), Positives = 38/113 (33%), Gaps = 3/113 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSG 134
L L+ + +SA+ L++L+ L+ + S + +L L +
Sbjct: 380 HLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFLVGAIPS 186
L++L L ++ NS D + L ++S L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 26/120 (21%), Positives = 39/120 (32%), Gaps = 3/120 (2%)
Query: 67 KCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLS 126
C + IT + KLS + D+ K ++L N N +ELQ L
Sbjct: 6 PCIEVVPNITYQCMDQKLSK-VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLD 62
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L + L +L NL ++ N + + P S L L L
Sbjct: 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESF 122
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 17/82 (20%), Positives = 30/82 (36%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ +L L +L+ LN+ NN S L L N + S
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536
Query: 136 IPSELGNLSNLLNLDISSNSLS 157
+L ++++NS++
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 28/114 (24%), Positives = 44/114 (38%), Gaps = 8/114 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+LS+ +L + DL LK L L N G I + L L L N LS S
Sbjct: 311 SLSIIRCQLKQFPTLDLP---FLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFS 365
Query: 136 IPSELGNL--SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+L ++L +LD+S N + + L+ L + ++ L
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFS 418
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 20/108 (18%), Positives = 37/108 (34%), Gaps = 7/108 (6%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ LT L + ++L + + ++ + Q LS+ L
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
P+ +L L +L ++ N S I L L ++S N L
Sbjct: 320 K-QFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNAL 362
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 18/114 (15%), Positives = 37/114 (32%), Gaps = 11/114 (9%)
Query: 76 TLSLTNHKLSGPISADLGK-LDQLKFLNLHSNNFYGEIPSELGNCTELQGL--------S 126
L+L + S I + L L L F E E+ + ++GL
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L + L+N+ + ++ S+ + K + + ++ L
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 23/123 (18%), Positives = 41/123 (33%), Gaps = 12/123 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLH---SNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ L+ + + DL L + +NL S N I + +L L+L+ N+
Sbjct: 157 HVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFN 216
Query: 133 SGSIPSE-LGNLSNLLNLDISSNSLSDYI------PPSLGKLQRL--ITFNVSNNFLVGA 183
S +I L NL+ L + D P + L + F ++
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 184 IPS 186
Sbjct: 277 DIV 279
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 56/236 (23%), Positives = 92/236 (38%), Gaps = 43/236 (18%)
Query: 293 GDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDR 348
G L + + + IG G +GTVYK A D G+ ALK + G
Sbjct: 1 GPLGSMATSRYEPVA------EIGVGAYGTVYK-ARDPHSGHFVALKSVRVPNGGGGGGG 53
Query: 349 FFE---RELEILGSIK---HRYLVNLR----GYCNSPTSKL-LIYDFLPGGSLDEALHER 397
RE+ +L ++ H +V L K+ L+++ + +
Sbjct: 54 LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL 105
Query: 398 SEQLDWDARLNIIMGAAK--------GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449
LD + K GL +LH + I+HRD+K NIL+ +++
Sbjct: 106 RTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162
Query: 450 DFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK 505
DFGLA++ + + +V T Y APE + D++S G + E+ K
Sbjct: 163 DFGLARIYSYQMALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 315 IGSGGFGTVYKLA--MDDGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNLR 369
+G G FG V KLA ALK I + ERE+ L ++H +++ L
Sbjct: 17 LGEGSFGKV-KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARL---NIIMGAAKGLAYLHHDCSP 426
+PT +++ ++ GG L + + E+ + + R II + Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCH---RH 127
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRAT 486
+I+HRD+K N+LLD NL +++DFGL+ ++ D T+ G+ Y APE + +G+
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VINGKLY 184
Query: 487 E--KTDVYSFGVLVLEVLSGKRPTD 509
+ DV+S G+++ +L G+ P D
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 45/201 (22%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGY 371
+G G + V++ A++ + +K + + + + RE++IL +++ ++ L
Sbjct: 44 LGRGKYSEVFE-AINITNNEKVVVKILKPVKK--KKIK-REIKILENLRGGPNIITLADI 99
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQL-DWDARLNI--IMGAAKGLAYLHHDCSPRI 428
P S+ F + D + + L D+D R + I+ K L Y H S I
Sbjct: 100 VKDPVSRTPALVFEHVNNTD--FKQLYQTLTDYDIRFYMYEIL---KALDYCH---SMGI 151
Query: 429 IHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-T 486
+HRD+K N+++D + + R+ D+GLA+ + + VA + + PE + +
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPELLVDYQMYD 209
Query: 487 EKTDVYSFGVLVLEVLSGKRP 507
D++S G ++ ++ K P
Sbjct: 210 YSLDMWSLGCMLASMIFRKEP 230
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-15
Identities = 17/103 (16%), Positives = 37/103 (35%), Gaps = 3/103 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L + ++ +L L L L++ + I +++ ++ + L N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
I L L L +L+I + + DY + +L +
Sbjct: 152 I-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 21/103 (20%), Positives = 42/103 (40%), Gaps = 3/103 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L++ N + + + L L+ L + + + L T L L + + S
Sbjct: 70 DLTINNIHATN-YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
I +++ L + ++D+S N I P L L L + N+ +
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFD 169
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 17/95 (17%), Positives = 41/95 (43%), Gaps = 2/95 (2%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ +K L +++ + + + + L+ L + ++ L L++L LDI
Sbjct: 62 IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
S ++ D I + L ++ + ++S N + I
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 19/111 (17%), Positives = 51/111 (45%), Gaps = 6/111 (5%)
Query: 78 SLTNHKLSGPISADL--GKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ N L +A++ +++ L ++ L + N ++ + + ++ L++ + + +
Sbjct: 24 AYLNGLLGQSSTANITEAQMNSLTYITLANINV-TDL-TGIEYAHNIKDLTINNIHATNY 81
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
+ + LSNL L I ++ P+L L L ++S++ +I +
Sbjct: 82 --NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 14/83 (16%), Positives = 32/83 (38%), Gaps = 3/83 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L +++ I + L ++ ++L N +I L EL+ L++Q + +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY 174
Query: 136 IPSELGNLSNLLNLDISSNSLSD 158
+ + L L S ++
Sbjct: 175 RG--IEDFPKLNQLYAFSQTIGG 195
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 48/177 (27%), Positives = 69/177 (38%), Gaps = 39/177 (22%)
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
AKG+ +L S + IHRD+ + NILL ++ DFGLA+ + + + V
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDA 255
Query: 474 YL-----APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRP-----TDASFIEKGLNIVGW 522
L APE + T ++DV+SFGVL+ E+ S G P D F
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------- 305
Query: 523 LNFLISEDRQREIIDP-NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
L R R P + C P RPT +V+ L +
Sbjct: 306 CRRLKEGTRMRA---PDYT-------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L + +++S I+A + L +LK LN+ SN S L N ++L L L +N L
Sbjct: 247 WLEIGTNQISD-INA-VKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNE 302
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+G L+NL L +S N ++D P L L ++ + + +N +
Sbjct: 303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 6/110 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+L + N+K++ L L QL +L + +N + + + T+L+ L++ SN +S
Sbjct: 225 SLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD- 279
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
S L NLS L +L +++N L + +G L L T +S N + P
Sbjct: 280 -ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 25/105 (23%), Positives = 45/105 (42%), Gaps = 8/105 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L++T K+ + L L L+L+ N P L + T L + N ++
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI 214
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
P + N++ L +L I +N ++D P L L +L + N +
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI 255
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 23/141 (16%), Positives = 50/141 (35%), Gaps = 26/141 (18%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
I L ++ ++ +L+ + L + + T L+ L+L N
Sbjct: 22 AEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGNQ 77
Query: 132 LSG--------------------SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171
++ + S L NL+NL L ++ +++SD L L ++
Sbjct: 78 ITDISPLSNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISD--ISPLANLTKMY 135
Query: 172 TFNVSNNFLVGAIPSDGVLTK 192
+ N+ N + + +T
Sbjct: 136 SLNLGANHNLSDLSPLSNMTG 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 6e-12
Identities = 27/114 (23%), Positives = 55/114 (48%), Gaps = 7/114 (6%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
++ L + +K++ + L L L+ L L+ +N S L N T++ L+L +N+
Sbjct: 88 VKLTNLYIGTNKITDISA--LQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANH 143
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
S S L N++ L L ++ + + D + P + L L + +++ N + P
Sbjct: 144 NL-SDLSPLSNMTGLNYLTVTESKVKD-VTP-IANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.9 bits (154), Expect = 7e-11
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
++ L++ ++++S L L QL L L++N E +G T L L L
Sbjct: 263 DLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLS 157
N+++ P L +LS + + D ++ +
Sbjct: 321 NHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 8e-09
Identities = 16/89 (17%), Positives = 33/89 (37%), Gaps = 6/89 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
L + L + + + L + ++ SI + L+NL L++
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNL 73
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ N ++D P L L +L + N +
Sbjct: 74 NGNQITDISP--LSNLVKLTNLYIGTNKI 100
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 24/104 (23%), Positives = 46/104 (44%), Gaps = 5/104 (4%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L +++ + D L+ LNL N Y ++ ++ +L+ L L SN L+
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA- 204
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ E + + + + + +N L I +L Q L F++ N
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 24/106 (22%), Positives = 48/106 (45%), Gaps = 4/106 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSG 134
+ L N+K++ D G ++++L+L N + L+ L+LQ N++
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ ++ + L LD+SSN L+ + P + ++ NN L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 2/86 (2%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
++ K + ++ + S + ++ L L N LS ++L + L L++SSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L + L L L T +++NN++
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYV 92
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 26/109 (23%), Positives = 48/109 (44%), Gaps = 7/109 (6%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
R +T+ L +++ +K L+L N ++L T+L+ L+L SN
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L +L +LS L LD+++N + L + T + +NN +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 23/118 (19%), Positives = 43/118 (36%), Gaps = 10/118 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL L N+ + +L ++ L+ +NN + G + + L +N ++
Sbjct: 84 TLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRG--QGKKNIYLANNKITML 135
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+ G S + LD+ N + L L N+ NF+ + V K
Sbjct: 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK 192
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L+L + + + + +LK L+L SN + E + + +SL++N L
Sbjct: 173 HLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 136 IPSELGNLSNLLNLDISSNSLS-DYIPPSLGKLQRLITFNVSNN 178
I L NL + D+ N + K QR+ T
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 18/81 (22%), Positives = 30/81 (37%), Gaps = 1/81 (1%)
Query: 112 IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171
I N + + + L ++ S + N+ LD+S N LS L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 172 TFNVSNNFLVGAIPSDGVLTK 192
N+S+N L L+
Sbjct: 62 LLNLSSNVLYE-TLDLESLST 81
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 50/240 (20%), Positives = 92/240 (38%), Gaps = 49/240 (20%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFE-----RELEILGSIKHRYL 365
H+IG G +G VY A D A+K+++++ F+ + RE+ IL +K Y+
Sbjct: 32 HLIGRGSYGYVYL-AYDKNTEKNVAIKKVNRM---FEDLIDCKRILREITILNRLKSDYI 87
Query: 366 VNLRGYCNSPTSKL-----LIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMG-AAKGL 417
+ L ++ + D L + ++ + + I+ G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG---- 473
++H IIHRD+K +N LL+ + +V DFGLA+ + E+
Sbjct: 143 NFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 474 -----------------YLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK 515
Y APE + T+ D++S G + E+L+ + +
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 42/192 (21%), Positives = 80/192 (41%), Gaps = 29/192 (15%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIKHRY 364
H+IG+G +G V + A D + V A+K+I ++ F+ R RE+ IL + H +
Sbjct: 59 HLIGTGSYGHVCE-AYDKLEKRVVAIKKILRV---FEDLIDCKRIL-REIAILNRLNHDH 113
Query: 365 LVNLRGYCNSPTSKL-----LIYDFLPGGSLDEALHE--RSEQ-LDWDARLNIIMGAAKG 416
+V + + ++ + D + R+ L ++ G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
+ Y+H S I+HRD+K +N L++ + +V DFGLA+ ++ E+ + +
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 477 PEYMQSGRATEK 488
K
Sbjct: 226 NLVTFPHTKNLK 237
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFD------RFFERELEILGSIK-HR 363
+G G +G V+K ++D G V A+K K+ + F R F RE+ IL + H
Sbjct: 15 KKLGKGAYGIVWK-SIDRRTGEVVAVK---KIFDAFQNSTDAQRTF-REIMILTELSGHE 69
Query: 364 YLVNLRGYCNSPTSK--LLIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAY 419
+VNL + + L++D++ + LH R+ L+ + ++ K + Y
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG------ 473
LH S ++HRD+K SNILL+ +V+DFGL++ + I
Sbjct: 125 LH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 474 --------------YLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGK 505
Y APE + S + T+ D++S G ++ E+L GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 24/106 (22%), Positives = 46/106 (43%), Gaps = 5/106 (4%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L +++ + D L+ LNL N Y ++ ++ +L+ L L SN L+
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA- 204
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ E + + + + + +N L I +L Q L F++ N
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 25/105 (23%), Positives = 47/105 (44%), Gaps = 7/105 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+T+ L +++ +K L+L N ++L T+L+ L+L SN L
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE- 72
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+L +LS L LD+++N + L + T + +NN +
Sbjct: 73 -TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 2/86 (2%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
++ K + ++ + S + ++ L L N LS ++L + L L++SSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L + L L L T +++NN++
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYV 92
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 4/106 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSG 134
+ L N+K++ D G ++++L+L N + L+ L+LQ N++
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ ++ + L LD+SSN L+ ++ P + ++ NN L
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 23/118 (19%), Positives = 43/118 (36%), Gaps = 10/118 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
TL L N+ + +L ++ L+ +NN + G + + L +N ++
Sbjct: 84 TLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRG--QGKKNIYLANNKITML 135
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+ G S + LD+ N + L L N+ NF+ + V K
Sbjct: 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK 192
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L+L + + + + +LK L+L SN + E + + +SL++N L
Sbjct: 173 HLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 136 IPSELGNLSNLLNLDISSNSLS-DYIPPSLGKLQRLITFNVSNN 178
I L NL + D+ N + K QR+ T
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 17/69 (24%), Positives = 28/69 (40%)
Query: 112 IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171
I N + + + L ++ S + N+ LD+S N LS L +L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 172 TFNVSNNFL 180
N+S+N L
Sbjct: 62 LLNLSSNVL 70
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 12/106 (11%), Positives = 26/106 (24%), Gaps = 3/106 (2%)
Query: 67 KCDKNKRVITLSLTNHKLSGPISADLGKLD--QLKFLNLHSNNFYGEIPSELGNCTELQG 124
+C + L P + L L + L+ + + E N +
Sbjct: 282 ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET-ERLECERENQARQRE 340
Query: 125 LSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL 170
+ I + L+ +L + + L
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 9/127 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L ++++K+S L KL L+ L +N P LG T L LSL N L
Sbjct: 181 RLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD- 235
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSE 195
L +L+NL +LD+++N +S+ P L L +L + N + I LT +
Sbjct: 236 -IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTN 291
Query: 196 SSFFGNR 202
N+
Sbjct: 292 LELNENQ 298
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 37/127 (29%), Positives = 52/127 (40%), Gaps = 9/127 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L N+++S L L +L L L +N P L T L L L N L
Sbjct: 247 DLDLANNQISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI 302
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSE 195
P + NL NL L + N++SD P + L +L NN + + S LT +
Sbjct: 303 SP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINW 357
Query: 196 SSFFGNR 202
S N+
Sbjct: 358 LSAGHNQ 364
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 8/105 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
++ +N++L+ L L +L + +++N + L N T L GL+L +N ++
Sbjct: 72 QINFSNNQLTDITP--LKNLTKLVDILMNNNQI--ADITPLANLTNLTGLTLFNNQITDI 127
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
P L NL+NL L++SSN++SD +L L L + N
Sbjct: 128 DP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVT 168
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 25/121 (20%), Positives = 47/121 (38%), Gaps = 9/121 (7%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ L ++ +S LDQ+ L + + L ++ +N
Sbjct: 24 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQ 79
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
L+ P L NL+ L+++ +++N ++D P L L L + NN + I LT
Sbjct: 80 LTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD-IDPLKNLT 134
Query: 192 K 192
Sbjct: 135 N 135
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-12
Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 10/117 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+++ +S + L L L+ L+ N P L N T L+ L + SN +S
Sbjct: 138 RLELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD- 191
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
S L L+NL +L ++N +SD P LG L L +++ N L I + LT
Sbjct: 192 -ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTN 244
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 6/113 (5%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
K + L+L + +S + L +L+ L ++N S L N T + LS
Sbjct: 306 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAG 361
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLV 181
N +S P L NL+ + L ++ + ++ + T L+
Sbjct: 362 HNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI 412
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 18/94 (19%), Positives = 35/94 (37%), Gaps = 6/94 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
L + L N + + ++ L + + L+NL ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
S+N L+D P L L +L+ ++NN + P
Sbjct: 76 SNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 17/110 (15%), Positives = 37/110 (33%), Gaps = 5/110 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
LS ++++S L L ++ L L+ + + N + + + L
Sbjct: 357 WLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI-- 412
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
P+ + + + DI+ N S Y + +T G +
Sbjct: 413 APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 21/106 (19%), Positives = 37/106 (34%), Gaps = 1/106 (0%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ ++ L L L L N + LQ L L+
Sbjct: 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
Query: 136 IPSELGNLSNLLNLDISSNSLSD-YIPPSLGKLQRLITFNVSNNFL 180
+G+L L L+++ N + +P L L ++S+N +
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 22/105 (20%), Positives = 38/105 (36%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ + L S +L+ L+L + + L L L N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
LS+L L +L+ +G L+ L NV++N +
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 28/116 (24%), Positives = 41/116 (35%), Gaps = 6/116 (5%)
Query: 76 TLSLTNHKLS--GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
L L+ + LS G S LK+L+L S N + S +L+ L Q + L
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDL-SFNGVITMSSNFLGLEQLEHLDFQHSNLK 409
Query: 134 GSIPSE--LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+ +L NL+ LDIS L L ++ N D
Sbjct: 410 -QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 27/110 (24%), Positives = 48/110 (43%), Gaps = 5/110 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL-SG 134
TL LT + + L L+ L N +G+ L+ L++ N + S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL----ITFNVSNNFL 180
+P NL+NL +LD+SSN + L L ++ ++ ++S N +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 6/117 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-YGEIPSELGNCTELQGLSLQSNYLSG 134
L L+ + +G L LK LN+ N ++P N T L+ L L SN +
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 135 SIPSELGNLSNL----LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
++L L + L+LD+S N ++ +I P K RL + NNF +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 3/105 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L +++ + L L+ L + N+F + L L L L
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
P+ +LS+L L+++SN L +P +L L + N
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 4/108 (3%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L + L + L L +L++ + + L+ L + N
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFL 180
+ + L NL LD+S L + P+ L L N+++N L
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 21/108 (19%), Positives = 45/108 (41%), Gaps = 5/108 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE--LGNCTELQGLSLQSNYLS 133
L L+ + + +S++ L+QL+ L+ +N ++ + L L + +
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+ LS+L L ++ NS + P +L+ L ++S L
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 22/113 (19%), Positives = 33/113 (29%), Gaps = 3/113 (2%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
C + IT I +L K L+L N + ELQ L L
Sbjct: 3 CVEVVPNITYQCMELNFYK-IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ +LS+L L ++ N + + L L L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 1/90 (1%)
Query: 69 DKNKRVITLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
+ + L + + D +L L FL+L P+ + + LQ L++
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLS 157
SN L L++L + + +N
Sbjct: 502 ASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 26/119 (21%), Positives = 45/119 (37%), Gaps = 10/119 (8%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLH---SNNFYGEIPSELGNCTELQGLSLQ 128
+ L L+++K+ DL L Q+ LNL S N I L L+L+
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 129 SNYLSGSIPSE-LGNLSNL------LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+N+ S ++ + L+ L L + +L + +L L L +L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 30/137 (21%), Positives = 46/137 (33%), Gaps = 25/137 (18%)
Query: 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130
+++ L L N LS + L+ L N+ E+P + L +
Sbjct: 70 DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSL-TELPELPQSLKSLLVDNNNLK 124
Query: 131 YLSGSIPS---------------ELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNV 175
LS P EL N S L +D+ +NSL +P L+ +
Sbjct: 125 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFI---AA 180
Query: 176 SNNFLVGAIPSDGVLTK 192
NN L +P L
Sbjct: 181 GNNQLE-ELPELQNLPF 196
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 22/86 (25%), Positives = 33/86 (38%), Gaps = 8/86 (9%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L+F+ +N E EL N L + +N L +P +L ++ +N
Sbjct: 172 PPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNN 225
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L + P L L L T NN L
Sbjct: 226 ILEE--LPELQNLPFLTTIYADNNLL 249
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 10/90 (11%)
Query: 91 DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150
+L L L + +N+ ++P + L+ + +N L EL NL L +
Sbjct: 190 ELQNLPFLTAIYADNNSL-KKLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIY 243
Query: 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+N L +P L+ L NV +N+L
Sbjct: 244 ADNNLLKT-LPDLPPSLEAL---NVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 20/112 (17%), Positives = 36/112 (32%), Gaps = 18/112 (16%)
Query: 88 ISADLGKLDQLKFLNLHSNNFYGEIPSELGN-------------CTELQGLSLQSNYLSG 134
+ + + + + P G + L L + LS
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS- 84
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
S+P +L +L S NSL++ +P L+ L+ N + L P
Sbjct: 85 SLPELPPHLE---SLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPL 132
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 19/99 (19%), Positives = 30/99 (30%), Gaps = 18/99 (18%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS---------- 144
L+ HS+N E+P E N + + P G
Sbjct: 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 145 ---NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L++++ LS +P L+ L S N L
Sbjct: 69 LDRQAHELELNNLGLSS-LPELPPHLESL---VASCNSL 103
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 12/86 (13%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L +LN SN + + L+ L++ +N L +P+ L L S N
Sbjct: 296 PPNLYYLNASSNEI-RSLCDLPPS---LEELNVSNNKLI-ELPALPPRLERL---IASFN 347
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L++ +P L++L +V N L
Sbjct: 348 HLAE-VPELPQNLKQL---HVEYNPL 369
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 26/137 (18%), Positives = 46/137 (33%), Gaps = 38/137 (27%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSN-------------------NFYGEIPSEL 116
++ N+ L +L L L + +N N+ ++P
Sbjct: 219 SIVAGNNILEEL--PELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELP 276
Query: 117 GNCTELQGLSLQSNYLSGSIPS------------EL-GNLSNLLNLDISSNSLSDYIPPS 163
+ T L + LS P+ L +L L++S+N L + +P
Sbjct: 277 QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL 335
Query: 164 LGKLQRLITFNVSNNFL 180
+L+RL S N L
Sbjct: 336 PPRLERL---IASFNHL 349
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 14/77 (18%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 102 NLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIP 161
+L N+ E+P N L+ L +++N L P ++ +L ++S + D
Sbjct: 381 DLRMNSHLAEVPELPQN---LKQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYE 433
Query: 162 PSLGKLQRLITFNVSNN 178
+ +L ++
Sbjct: 434 FAHETTDKLEDDVFEHH 450
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 26/108 (24%), Positives = 43/108 (39%), Gaps = 3/108 (2%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L L+ + + ++ L+QL+ L L S I E N L+ L L S+ +
Sbjct: 28 RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF 87
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFL 180
P L +L L + LSD + L+ L ++S N +
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 18/112 (16%), Positives = 40/112 (35%), Gaps = 2/112 (1%)
Query: 71 NKRVITLSLTNHKLSGPISADLGKLDQ--LKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
++ H + P L + ++ L+L + +L+ L+L
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N ++ L NL L++S N L + + L ++ ++ N +
Sbjct: 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 30/134 (22%), Positives = 51/134 (38%), Gaps = 19/134 (14%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSE--LGNCTELQGLSLQSNYL 132
+ L+ ++L I L ++ L+ L L+ N F + L+ L L N L
Sbjct: 405 LIHLSENRLENLDILYFLLRVPHLQILILNQNRF-SSCSGDQTPSENPSLEQLFLGENML 463
Query: 133 SGSIPSEL-----GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+ +EL LS+L L ++ N L+ P L L ++++N
Sbjct: 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR-------- 515
Query: 188 GVLTKFSESSFFGN 201
LT S + N
Sbjct: 516 --LTVLSHNDLPAN 527
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 27/98 (27%), Positives = 38/98 (38%), Gaps = 3/98 (3%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISS 153
L+ + L L N S +LQ L L S Y +I E NL NL LD+ S
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 154 NSLSDYIPPS-LGKLQRLITFNVSNNFLVGAIPSDGVL 190
+ + ++ P L L + L A+ DG
Sbjct: 83 SKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 45/203 (22%), Positives = 72/203 (35%), Gaps = 17/203 (8%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADL-----GKLDQLKFLNLHSNNFYGEIPSELGNCTEL 122
+N + L L + L +L L L+ L L+ N P + T L
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506
Query: 123 QGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG 182
+GLSL SN L+ + +NL LDIS N L P+ L ++++N +
Sbjct: 507 RGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLA---PNPDVFVSLSVLDITHNKFIC 561
Query: 183 AIPSDGVLTKFSESSFFGNRGLCGKQINVTCKND---SGGSTTDSQSPNSAQNQGGKKNS 239
L+ F N + G ++ C SG S + + + K
Sbjct: 562 ECE----LSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLK 617
Query: 240 GRLLISASATVGALLLVALMCFW 262
L I + T+ L+ L
Sbjct: 618 FSLFIVCTVTLTLFLMTILTVTK 640
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 27/121 (22%), Positives = 43/121 (35%), Gaps = 5/121 (4%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI--PSELGNCTELQGLSLQS 129
+ L L + K+ L L L L+ + N L L L
Sbjct: 73 PNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 130 NYLSG-SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ--RLITFNVSNNFLVGAIPS 186
N + + G L++L ++D SSN + L LQ L F+++ N L +
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192
Query: 187 D 187
D
Sbjct: 193 D 193
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 26/111 (23%), Positives = 41/111 (36%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
V L L++ + S L LK LNL N LQ L+L
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N L S L + +D+ N ++ + L++L T ++ +N L
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 31/148 (20%), Positives = 46/148 (31%), Gaps = 13/148 (8%)
Query: 76 TLSLTNHKLSGPISAD--LGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYL 132
L L LS + D L L L+L N + G L+ + SN +
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 133 SGSIPSELGNLS--NLLNLDISSNSLSDYIPPSLGKLQ------RLITFNVSNNFLVGAI 184
EL L L +++NSL + GK L +VS N I
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 185 PSD--GVLTKFSESSFFGNRGLCGKQIN 210
+ ++K S + G
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFG 248
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 18/107 (16%), Positives = 32/107 (29%), Gaps = 15/107 (14%)
Query: 99 KFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSD 158
+ N ++P L + L L NY+ S L L L++ S
Sbjct: 7 RIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 159 YIPP-SLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204
I + L L ++ ++ + +F G L
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSK----------IYFLHPDAFQGLFHL 99
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 5/109 (4%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
K + L+L +K++ LD L+ LNL N S ++ + LQ N+
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ L L LD+ N+L+ + + + +S N L
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALTT-----IHFIPSIPDIFLSGNKL 393
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 16/110 (14%), Positives = 36/110 (32%), Gaps = 2/110 (1%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGN--CTELQGLSLQSN 130
V ++ +S + L + +N + + ++ L L
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHG 276
Query: 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ L +L L+++ N ++ + L L N+S N L
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 27/113 (23%), Positives = 38/113 (33%), Gaps = 8/113 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNC----TELQGLSLQSNY 131
LS+ + L L+L N GE C LQ L+L++
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 132 ---LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFL 180
SG + L LD+S NSL D +L + N+S L
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 28/112 (25%), Positives = 46/112 (41%), Gaps = 9/112 (8%)
Query: 76 TLSLTN---HKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNY 131
L+L N SG SA QL+ L+L N+ + ++L L+L
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGA 183
L +P L + L LD+S N L PS +L ++ ++ N + +
Sbjct: 265 LK-QVPKGL--PAKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 35/136 (25%), Positives = 52/136 (38%), Gaps = 14/136 (10%)
Query: 76 TLSLTNHKLSGPI----SADLGKLDQLKFLNLHSNNF---YGEIPSELGNCTELQGLSLQ 128
TL L+++ G + K L+ L L + G + +LQGL L
Sbjct: 177 TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS 236
Query: 129 SNYLSGSIPSEL-GNLSNLLNLDISSNSLSDYIPPSLG-KLQRLITFNVSNNFLVGAIPS 186
N L + + S L +L++S L +P L KL L ++S N L PS
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPAKLSVL---DLSYNRLDR-NPS 291
Query: 187 DGVLTKFSESSFFGNR 202
L + S GN
Sbjct: 292 PDELPQVGNLSLKGNP 307
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 23/126 (18%), Positives = 47/126 (37%), Gaps = 11/126 (8%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLD---QLKFLNLHSNNFYGEIPSELGNCT--ELQG 124
K+ + L++ ++ I ++ L+ L L + G P L T +L
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 125 LSLQSNYLSGSIPSELGNLSNLLN-----LDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
L+L++ + + L L L L I+ ++ + L T ++S+N
Sbjct: 126 LNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 180 LVGAIP 185
+G
Sbjct: 185 ELGERG 190
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 22/118 (18%), Positives = 40/118 (33%), Gaps = 10/118 (8%)
Query: 73 RVITLSLTNHKLSGPISADLGKLD--QLKFLNLHSNNFYGE--IPSELGNC--TELQGLS 126
+ L+L N +++G L + L LNL + ++ +EL L+ LS
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS----LGKLQRLITFNVSNNFL 180
+ + ++ L LD+S N K L + N +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 21/129 (16%), Positives = 41/129 (31%), Gaps = 11/129 (8%)
Query: 71 NKRVITLSLTNHKLSGPIS--ADLGKLDQ--LKFLNLHSNNFYGEIPSELGNCTELQGLS 126
+ L+L N + + A+L + + LK L++ + ++ L L
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179
Query: 127 LQSNYLSGSIPSE----LGNLSNLLNLDISSN---SLSDYIPPSLGKLQRLITFNVSNNF 179
L N G L L + + + S +L ++S+N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239
Query: 180 LVGAIPSDG 188
L A +
Sbjct: 240 LRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 23/147 (15%), Positives = 48/147 (32%), Gaps = 11/147 (7%)
Query: 56 EDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE 115
E+ CN+ K D + L + +L G G L ++
Sbjct: 10 EESCSCNFSDPKPDWSSAFNCLGAADVELYG------GGRSLEYLLKRVDTEADLGQFTD 63
Query: 116 LGNCTELQGLSLQSNYLSGSIPS---ELGNLSNLLNLDISSNSLSDYIPPSLGKLQ--RL 170
+ L+ L++++ + I + +S L L + + ++ PP L + L
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 171 ITFNVSNNFLVGAIPSDGVLTKFSESS 197
N+ N L ++ +
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPG 150
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 43/221 (19%), Positives = 92/221 (41%), Gaps = 43/221 (19%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK---------- 361
+G G F TV+ A D + A+K + + ++ + E E+++L +
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 362 -HRYLVNLRG---YCNSPTSKL-LIYDFLPGGSLDEALHERSEQLDWDARLNI--IMGAA 414
+++ L + + ++++ L G +L + + + + + + +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-----GIPLIYVKQIS 137
Query: 415 K----GLAYLHHDCSPRIIHRDIKSSNILLD------GNLEARVSDFGLAKLLEDEESHI 464
K GL Y+H C IIH DIK N+L++ ++ +++D G A + H
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHY 192
Query: 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK 505
T + Y +PE + D++S L+ E+++G
Sbjct: 193 TNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 26/105 (24%), Positives = 43/105 (40%), Gaps = 15/105 (14%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L LS + +L Q+ L + N +P + L+ L N LS +
Sbjct: 63 ELQLNRLNLSS-LPDNLPP--QITVLEITQNAL-ISLPELPAS---LEYLDACDNRLS-T 114
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+P +L +LD+ +N L+ +P L+ + N NN L
Sbjct: 115 LPELPASLK---HLDVDNNQLT-MLPELPALLEYI---NADNNQL 152
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 18/86 (20%), Positives = 34/86 (39%), Gaps = 12/86 (13%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L++L+ N +P + L + +N L+ +P L ++ +N
Sbjct: 99 PASLEYLDACDNRL-STLPELPASLKHLD---VDNNQLT-MLPELPALLE---YINADNN 150
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L+ +P L+ L +V NN L
Sbjct: 151 QLTM-LPELPTSLEVL---SVRNNQL 172
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 13/90 (14%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L+++N +N +P + L+ LS+++N L+ +P +L L D+S+N
Sbjct: 139 PALLEYINADNNQL-TMLPELPTS---LEVLSVRNNQLT-FLPELPESLEAL---DVSTN 190
Query: 155 SLSDYIPPSLGKLQRL----ITFNVSNNFL 180
L +P + I F N +
Sbjct: 191 LLES-LPAVPVRNHHSEETEIFFRCRENRI 219
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 16/116 (13%), Positives = 30/116 (25%), Gaps = 8/116 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLK----FLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
L ++ + L + A + + F N IP + + + L+ N
Sbjct: 184 ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNP 241
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
LS I L + + S + + SD
Sbjct: 242 LSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSD 295
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 14/93 (15%), Positives = 32/93 (34%), Gaps = 12/93 (12%)
Query: 95 LDQLKFLNLHSNNFYG---EIPSELGNC----TELQGLSLQSNYLSGSIPSELGNLSNLL 147
L +L N+FY ++ + + N + L ++
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 148 NLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L ++ +LS +P +L ++ ++ N L
Sbjct: 63 ELQLNRLNLSS-LPDNLP--PQITVLEITQNAL 92
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 5/114 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
++ N + +A L Q++ LNL+ EI + +Q L + N +
Sbjct: 49 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR- 106
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+P N+ L L + N LS +L T ++SNN L I D
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ L+ ++L + K+ +L+ L + +N + L+ L L N+L
Sbjct: 252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-H 309
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ L NL + NS+ + S L +S+N
Sbjct: 310 VERNQPQFDRLENLYLDHNSIVT-LKLST--HHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 23/106 (21%), Positives = 40/106 (37%), Gaps = 8/106 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L +++ ++ + + +L L L NN + L N L + L N L
Sbjct: 209 ELDASHNSINV-VRGPV--NVELTILKLQHNNL-TDTAW-LLNYPGLVEVDLSYNELE-K 262
Query: 136 IPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
I + L L IS+N L + + L ++S+N L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 307
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 22/120 (18%), Positives = 44/120 (36%), Gaps = 6/120 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L ++N++L ++ + LK L+L N+ + L+ L L N + +
Sbjct: 276 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 332
Query: 136 IPSELGNLSNLLNLDISSNSLS-DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFS 194
+ L L NL +S N + + + R + + + G+ K S
Sbjct: 333 LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 28/108 (25%), Positives = 46/108 (42%), Gaps = 9/108 (8%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLS 133
L + + + + + L L L N+ +P + N +L LS+ +N L
Sbjct: 97 KLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE 154
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
I + ++L NL +SSN L+ + SL + L NVS N L
Sbjct: 155 -RIEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 15/107 (14%), Positives = 39/107 (36%), Gaps = 6/107 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGS 135
+ + + L+ K + ++ ++P+ L + +++ L+L +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIE-E 83
Query: 136 IPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFL 180
I + + L + N++ Y+PP + L + N L
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 9/103 (8%), Positives = 35/103 (33%), Gaps = 6/103 (5%)
Query: 82 HKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS--ELGNCTELQGLSLQSNYLSGSIPSE 139
+ D F ++H + ++ E + ++ +++ + +P+
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA 63
Query: 140 -LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
L + + L+++ + + I + + + N +
Sbjct: 64 LLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAI 105
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 21/106 (19%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSN----------------YLSG 134
+L L++ +NN I + T LQ L L SN +S
Sbjct: 137 FHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSY 195
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ S L + LD S NS++ + + L + +N L
Sbjct: 196 NLLSTLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNL 238
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 6/104 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L + L+ L +L + L+L S+N +P L L+ L N L +
Sbjct: 445 VLHLAHKDLTVLCH--LEQLLLVTHLDL-SHNRLRALPPALAALRCLEVLQASDNALE-N 500
Query: 136 IPSELGNLSNLLNLDISSNSLSDY-IPPSLGKLQRLITFNVSNN 178
+ + NL L L + +N L L RL+ N+ N
Sbjct: 501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 21/84 (25%), Positives = 34/84 (40%), Gaps = 5/84 (5%)
Query: 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSL 156
++ L+L + + L + L L N L ++P L L L L S N+L
Sbjct: 442 DVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498
Query: 157 SDYIPPSLGKLQRLITFNVSNNFL 180
+ + + L RL + NN L
Sbjct: 499 EN-VDG-VANLPRLQELLLCNNRL 520
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 21/98 (21%), Positives = 36/98 (36%), Gaps = 8/98 (8%)
Query: 88 ISADLGKLDQLKFLNLH-----SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN 142
L + + + F E +++ L L L+ + L
Sbjct: 404 TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQ 461
Query: 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L + +LD+S N L +PP+L L+ L S+N L
Sbjct: 462 LLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 5/97 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG- 134
L L++++L + L L L+ L S+N + + N LQ L L +N L
Sbjct: 467 HLDLSHNRLRA-LPPALAALRCLEVLQA-SDNALENVD-GVANLPRLQELLLCNNRLQQS 523
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171
+ L + L+ L++ NSL +L ++
Sbjct: 524 AAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 559
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 19/92 (20%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
+ LN+ + +P L + L + N L+ S+P+ L L ++S N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+ +P L L F+ L
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPALPSG 122
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 12/86 (13%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L+ L++ N +P+ L L +N L+ S+P+ L L +S N
Sbjct: 180 PSGLQELSVSDNQL-ASLPTLPSE---LYKLWAYNNRLT-SLPALPSGLK---ELIVSGN 231
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
L+ +P +L+ L VS N L
Sbjct: 232 RLTS-LPVLPSELKEL---MVSGNRL 253
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 26/109 (23%), Positives = 41/109 (37%), Gaps = 16/109 (14%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ TL + ++ L+ + A +L+ L + N +P EL S +
Sbjct: 61 AHITTLVIPDNNLTS-LPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH 115
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L S L L I N L+ +P LQ L +VS+N L
Sbjct: 116 LPAL-------PSGLCKLWIFGNQLTS-LPVLPPGLQEL---SVSDNQL 153
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 20/92 (21%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L+ L++ N +P+ L L +N L+ S+P L L +S N
Sbjct: 140 PPGLQELSVSDNQL-ASLPALPSE---LCKLWAYNNQLT-SLPMLPSGLQ---ELSVSDN 191
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+ +P +L +L +N L
Sbjct: 192 QLAS-LPTLPSELYKLWAYNNRLTSLPALPSG 222
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 5/92 (5%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
+LK L + N +P L S+ N L+ +P L +LS+ +++ N
Sbjct: 240 PSELKELMVSGNRL-TSLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
LS+ +L ++ ++ A S
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 12/86 (13%), Positives = 27/86 (31%), Gaps = 2/86 (2%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L L+++ N +P L + + ++L+ N LS +
Sbjct: 260 PSGLLSLSVYRNQL-TRLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPI 317
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFL 180
D S + R + ++ +
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWLV 343
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 31/115 (26%), Positives = 47/115 (40%), Gaps = 5/115 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
+L L+ +K++ DL L+ L L S+ I + + L+ L L N+LS
Sbjct: 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNHLS- 87
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSD 187
S+ S G LS+L L++ N SL L L T + N I
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI---PSELGNCTELQGLSLQSNYL 132
+++ N K+ + L L+FL+L N E + G LQ L L N+L
Sbjct: 314 RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
Query: 133 S--GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L L NL +LDIS N+ +P S +++ N+S+ +
Sbjct: 374 RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 15/107 (14%), Positives = 39/107 (36%), Gaps = 2/107 (1%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L+L + +++ L L+ L + + + EI T L L +++ L
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L ++ ++ +L + + + + L + + + L
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 24/107 (22%), Positives = 38/107 (35%), Gaps = 2/107 (1%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG- 134
L L + +++ L L+ L+L N+ S G + L+ L+L N
Sbjct: 54 VLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTL 113
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+ S NL+NL L I + I L L + L
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 3/96 (3%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS 157
+K L+L N +L C LQ L L+S+ ++ +L +L +LD+S N LS
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 158 DYIPPS-LGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+ S G L L N+ N + +
Sbjct: 88 S-LSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 25/118 (21%), Positives = 41/118 (34%), Gaps = 9/118 (7%)
Query: 68 CDKNKRVITLSLTNHKLS---GPISADLGKLDQLKFLNLHSNNFY--GEIPSELGNCTEL 122
K + L L+ + + SA G L+ L L N+ + L L
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNL 389
Query: 123 QGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L + N +P + L++SS + + + Q L +VSNN L
Sbjct: 390 TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 14/90 (15%), Positives = 40/90 (44%), Gaps = 3/90 (3%)
Query: 94 KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153
+ ++ L++ + ++ + +++ ++++++ + S +L +L LD+S
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 154 NSLSDYIPPS---LGKLQRLITFNVSNNFL 180
N + + + G L T +S N L
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 20/85 (23%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155
D + S +F IPS L ++ L L N ++ +L +NL L + S+
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 156 LSDYIPPSLGKLQRLITFNVSNNFL 180
++ + L L ++S+N L
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHL 86
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 24/112 (21%), Positives = 42/112 (37%), Gaps = 11/112 (9%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
C +++ L+L++ + L+ L++ +NN L LQ L +
Sbjct: 406 CQWPEKMRFLNLSSTGIR---VVKTCIPQTLEVLDVSNNNL-DSFSLFLPR---LQELYI 458
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
N L ++P LL + IS N L +P +L L + N
Sbjct: 459 SRNKLK-TLPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 15/104 (14%), Positives = 34/104 (32%), Gaps = 1/104 (0%)
Query: 76 TLSLT-NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
TL + S D L L L + + + L + ++ L+L + +
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ LS++ L++ +L+ + L +
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 16/105 (15%), Positives = 35/105 (33%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L + L S L + + L LH + + + ++ L L+ L+
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
S L + + S S +L +L+ + + + +
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV 256
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 9/95 (9%), Positives = 36/95 (37%), Gaps = 8/95 (8%)
Query: 94 KLDQLKFLNLHSNN---FYGEIPSELGNCTELQGLSLQSNYLSG-----SIPSELGNLSN 145
+L +++F + N F + +++ ++++ ++ + + L
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 146 LLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ + + ++ + L+ L ++S N +
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 11/62 (17%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L +L+ L + N +P L + + N L L++L + + +N
Sbjct: 450 LPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 155 SL 156
Sbjct: 508 PW 509
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 25/107 (23%), Positives = 43/107 (40%), Gaps = 4/107 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
++ N + +A L Q++ LNL+ EI + +Q L + N +
Sbjct: 55 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR- 112
Query: 135 SIPSEL-GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+P + N+ L L + N LS +L T ++SNN L
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL 159
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 24/174 (13%), Positives = 55/174 (31%), Gaps = 6/174 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L ++N++L ++ + LK L+L N+ + L+ L L N + +
Sbjct: 282 RLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-T 338
Query: 136 IPSELGNLSNLLNLDISSNSLS-DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFS 194
+ L L NL +S N + + + R + + + G+ K S
Sbjct: 339 LK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKES 396
Query: 195 ESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLISASA 248
+ + +V K + ++ + + +
Sbjct: 397 DKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQG 450
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 5/105 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+ L+ ++L + K+ +L+ L + +N + L+ L L N+L
Sbjct: 258 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-H 315
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ L NL + NS+ + S L +S+N
Sbjct: 316 VERNQPQFDRLENLYLDHNSIVT-LKLST--HHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 24/113 (21%), Positives = 39/113 (34%), Gaps = 8/113 (7%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
V L +++ ++ +L L L NN + L N L + L
Sbjct: 208 AIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNL-TDTAW-LLNYPGLVEVDLS 262
Query: 129 SNYLSGSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N L I + L L IS+N L + + L ++S+N L
Sbjct: 263 YNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 313
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 7/91 (7%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNL 149
+ L L L N+ +P + N +L LS+ +N L I + ++L NL
Sbjct: 119 FQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNL 176
Query: 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+SSN L+ + SL + L NVS N L
Sbjct: 177 QLSSNRLTH-VDLSL--IPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 15/107 (14%), Positives = 39/107 (36%), Gaps = 6/107 (5%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGS 135
+ + + L+ K + ++ ++P+ L + +++ L+L +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-E 89
Query: 136 IPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFL 180
I + + L + N++ Y+PP + L + N L
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 8/88 (9%), Positives = 33/88 (37%), Gaps = 6/88 (6%)
Query: 97 QLKFLNLHSNNFYGEIPS--ELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISS 153
F ++H + ++ E + ++ +++ + +P+ L + + L+++
Sbjct: 26 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLND 84
Query: 154 NSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+ + I + + + N +
Sbjct: 85 LQIEE-IDTYAFAYAHTIQKLYMGFNAI 111
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 25/107 (23%), Positives = 38/107 (35%), Gaps = 23/107 (21%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIP------------- 137
+L L++ +NN I + T LQ L L SN L+ +
Sbjct: 143 FHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVS 200
Query: 138 ----SELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
S L + LD S NS++ P +L L + +N L
Sbjct: 201 YNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 10/79 (12%), Positives = 27/79 (34%), Gaps = 2/79 (2%)
Query: 103 LHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP 162
Y I S L + + E L+N + ++++ +P
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPA 68
Query: 163 S-LGKLQRLITFNVSNNFL 180
+ L +++ N+++ +
Sbjct: 69 ALLDSFRQVELLNLNDLQI 87
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 19/107 (17%), Positives = 45/107 (42%), Gaps = 8/107 (7%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
I ++ ++ ++ LD + L+ + L GL L+ N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQ 74
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
++ + + L NL+ + L++S N L + + + LQ + T ++++
Sbjct: 75 IT-DL-APLKNLTKITELELSGNPLKN-VSA-IAGLQSIKTLDLTST 117
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 8/105 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L+ + L +SA + L +K L+L S ++ + L + LQ L L N ++ +
Sbjct: 89 ELELSGNPLKN-VSA-IAGLQSIKTLDLTSTQI-TDV-TPLAGLSNLQVLYLDLNQIT-N 143
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
I S L L+NL L I + +SD + P L L +L T +N +
Sbjct: 144 I-SPLAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKI 185
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 23/106 (21%), Positives = 47/106 (44%), Gaps = 6/106 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
LS+ N ++S ++ L L +L L +N +I S L + L + L++N +S
Sbjct: 155 YLSIGNAQVSD-LTP-LANLSKLTTLKA-DDNKISDI-SPLASLPNLIEVHLKNNQIS-D 209
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLV 181
+ S L N SNL + +++ ++++ L + +
Sbjct: 210 V-SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 17/89 (19%), Positives = 35/89 (39%), Gaps = 6/89 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
L + +N + + LS ++ +I + L+NL+ L++
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLEL 70
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N ++D + P L L ++ +S N L
Sbjct: 71 KDNQITD-LAP-LKNLTKITELELSGNPL 97
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 11/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
N ++ L +K + D+ QL L+ N E+ + L L+ +
Sbjct: 146 HNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDT 200
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N ++ + L L LD SSN L++ + L +L F+ S N L
Sbjct: 201 NNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPL 245
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 18/111 (16%), Positives = 42/111 (37%), Gaps = 11/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
++ TL L DL QL + E+ ++ + T+L L Q+
Sbjct: 252 TLSKLTTLHCIQTDLL---EIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQA 306
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ + L L+ L +++ L++ + + +L + + N +
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 24/112 (21%), Positives = 44/112 (39%), Gaps = 10/112 (8%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
D N + + + I +L L L+ H+++ + + T L L
Sbjct: 17 DDNFASEVAAAFEMQATDTI--SEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICT 72
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
SN ++ ++ L +NL L SN L++ + + L +L N N L
Sbjct: 73 SNNIT-TLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKL 118
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 25/111 (22%), Positives = 46/111 (41%), Gaps = 11/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+ + +L N ++ ++ + KL L L SNN + L T L L+ S
Sbjct: 40 QLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDS 94
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N L+ ++ + L+ L L+ +N L+ + + L N + N L
Sbjct: 95 NKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTL 139
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 22/112 (19%), Positives = 43/112 (38%), Gaps = 11/112 (9%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
++ L+ +KL+ D+ + L +LN N EI + + T+L L
Sbjct: 103 TPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCH 156
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N + + + L LD S N +++ + + + L N N +
Sbjct: 157 LNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNI 203
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 17/111 (15%), Positives = 39/111 (35%), Gaps = 11/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+N ++ L +++KL+ D+ L QL + + N E+ + ++L L
Sbjct: 210 QNIQLTFLDCSSNKLT---EIDVTPLTQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQ 263
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L I L + + L+ + + +L + +
Sbjct: 264 TDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 21/111 (18%), Positives = 43/111 (38%), Gaps = 10/111 (9%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
N ++ L ++ DL + +L +L L++ E+ + + T+L+ LS +
Sbjct: 295 HNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVN 348
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++ +G + L N + +P L T VS + L
Sbjct: 349 AHIQ-DFS-SVGKIPALNNNFEAEGQTIT-MPKETLTNNSL-TIAVSPDLL 395
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 20/108 (18%), Positives = 37/108 (34%), Gaps = 5/108 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L +++ + L L+ L + N+F + L L L L
Sbjct: 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE- 188
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNNFL 180
+ +LS+L L++S N+ + L L + S N +
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI 235
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 29/117 (24%), Positives = 43/117 (36%), Gaps = 8/117 (6%)
Query: 76 TLSLTNHKLS--GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
LSL+++ LS G S LK+L+L S N + S +L+ L Q + L
Sbjct: 56 KLSLSSNGLSFKGCCSQSDFGTTSLKYLDL-SFNGVITMSSNFLGLEQLEHLDFQHSNLK 114
Query: 134 GSIPSE--LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
+ +L NL+ LDIS L L ++ N D
Sbjct: 115 -QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-09
Identities = 30/115 (26%), Positives = 46/115 (40%), Gaps = 5/115 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNN--FYGEIPSELGNCTELQGLSLQSNYLS 133
L L ++KL KL QL L+L SN F G T L+ L L N +
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 91
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSD 187
++ S L L +LD ++L S+ L+ LI ++S+ +
Sbjct: 92 -TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 21/109 (19%), Positives = 45/109 (41%), Gaps = 7/109 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE--LGNCTELQGLSLQSNYLS 133
L L+ + + +S++ L+QL+ L+ +N ++ + L L + +
Sbjct: 82 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTR 139
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+ LS+L L ++ NS + P +L+ L ++S L
Sbjct: 140 -VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 19/90 (21%), Positives = 34/90 (37%), Gaps = 5/90 (5%)
Query: 94 KLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDI 151
L L +L++ + + + L+ L + N + + L NL LD+
Sbjct: 124 SLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 152 SSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
S L + P + L L N+S+N
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNF 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 21/108 (19%), Positives = 38/108 (35%), Gaps = 8/108 (7%)
Query: 76 TLSLT-NHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L + N + +L L FL+L ++ + + LQ L++ N
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFF 212
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPPSL--GKLQRLITFNVSNN 178
S+ + L++L LD S N + L N++ N
Sbjct: 213 -SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 20/91 (21%), Positives = 35/91 (38%), Gaps = 6/91 (6%)
Query: 99 KFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS- 157
+ +S +P+ + + L L+SN L L+ L L +SSN LS
Sbjct: 10 TEIRCNSKGL-TSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 158 -DYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
S L ++S N ++ + S+
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN 96
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 1e-08
Identities = 35/229 (15%), Positives = 59/229 (25%), Gaps = 61/229 (26%)
Query: 287 SIVMFHGDLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRI------- 339
V F LP +K IG G FG V++ + D A+K I
Sbjct: 9 GPVPFSHCLPTEKLQRCEK---------IGEGVFGEVFQ-TIADHTPVAIKIIAIEGPDL 58
Query: 340 -DKLNEGFDRFFERELEIL---------GSIKHRYLVNLRGYC----------------- 372
+ ++ E+ I + + L
Sbjct: 59 VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 373 -------------NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
++ +F GG E R++ +I+ LA
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLE--QMRTKLSSLATAKSILHQLTASLAV 176
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIV 468
S R HRD+ N+LL ++ K + +
Sbjct: 177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 5/108 (4%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
+ T K+ L+ +N + G+ TEL+ L LQ N L +
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 137 PSELG---NLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFL 180
+ +L LDIS NS+S + L++ N+S+N L
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 26/107 (24%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L+++ + +S ++D+ L +L+ L + N S EL+ L L N L
Sbjct: 25 ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-K 83
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFL 180
I NL +LD+S N+ +P G + +L +S L
Sbjct: 84 ISC--HPTVNLKHLDLSFNAFDA-LPICKEFGNMSQLKFLGLSTTHL 127
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 20/95 (21%), Positives = 34/95 (35%), Gaps = 4/95 (4%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLS 157
LN+ N S++ + ++L+ L + N + S L LD+S N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 158 DYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
L+ L ++S N A+P
Sbjct: 83 KISCHPTVNLKHL---DLSFNAF-DALPICKEFGN 113
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 27/111 (24%), Positives = 41/111 (36%), Gaps = 4/111 (3%)
Query: 69 DKNKRVITLSL-TNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
+ K + L + N D L LN+ SN I L ++ L L
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDL 428
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
SN + SIP ++ L L L+++SN L +L L + N
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 24/128 (18%), Positives = 44/128 (34%), Gaps = 5/128 (3%)
Query: 58 PDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLG-----KLDQLKFLNLHSNNFYGEI 112
+ ++ + V S++N KL G + L L + S+ F
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 113 PSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLIT 172
+ + + + +S L+LD S+N L+D + + G L L T
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 173 FNVSNNFL 180
+ N L
Sbjct: 353 LILQMNQL 360
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 34/194 (17%), Positives = 67/194 (34%), Gaps = 13/194 (6%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP--SELGNCTELQGL 125
N+ + L L+++KL LK L+L N F +P E GN ++L+ L
Sbjct: 65 FKFNQELEYLDLSHNKLV---KISCHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFL 120
Query: 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
L + +L S + +L+ L + + + P LQ T ++ F P
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVF-----P 173
Query: 186 SDGVLTKFSESSFFGNRGLCGKQINVTCKNDSGGSTTDSQSPNSAQNQGGKKNSGRLLIS 245
++ + S L I +++ + + + +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 246 ASATVGALLLVALM 259
++ + L LV
Sbjct: 234 WNSFIRILQLVWHT 247
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 31/116 (26%), Positives = 53/116 (45%), Gaps = 6/116 (5%)
Query: 68 CDKNKRVITLSLTNHKLS--GPISADLGKLDQLKFLNLHSNNF-YGEIPSELGNCTELQG 124
C + TL L ++L I+ ++ L+ L++ N+ Y E + L
Sbjct: 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 125 LSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L++ SN L+ +I L + LD+ SN + IP + KL+ L NV++N L
Sbjct: 404 LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 4/89 (4%)
Query: 100 FLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDY 159
++ N +P +L + L++ NY+S S++ +LS L L IS N +
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 160 IPPSLGKLQRLITFNVSNNFLVGAIPSDG 188
Q L ++S+N L I
Sbjct: 61 DISVFKFNQELEYLDLSHNKL-VKISCHP 88
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 25/90 (27%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 68 CDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127
C K +++L+++++ L+ I L ++K L+LHSN IP ++ LQ L++
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNV 451
Query: 128 QSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
SN L S+P L++L + + +N
Sbjct: 452 ASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 53/240 (22%)
Query: 292 HGDLPYSSKDII-KKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDR 348
G D + + E L +IG G FG V K A D ALK + + + F R
Sbjct: 84 QGSYVQVPHDHVAYRYEVLK---VIGKGSFGQVVK-AYDHKVHQHVALKMV-RNEKRFHR 138
Query: 349 FFERELEILGSIKHR------YLVNLRGY-------CNSPTSKLL---IYDFL-----PG 387
E+ IL ++ + ++++ C T +LL +Y+ + G
Sbjct: 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC--MTFELLSMNLYELIKKNKFQG 196
Query: 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--DGNLE 445
SL + + + + + L LH RIIH D+K NILL G
Sbjct: 197 FSLP-LVRKFAHSI------------LQCLDALH---KNRIIHCDLKPENILLKQQGRSG 240
Query: 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK 505
+V DFG + E + T + F Y APE + R D++S G ++ E+L+G
Sbjct: 241 IKVIDFGSSC---YEHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 8/105 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L +KL+ I L L L +L L N ++ S L + +L+ LSL+ N +S
Sbjct: 69 KLFLNGNKLTD-IK-PLTNLKNLGWLFLDENKI-KDL-SSLKDLKKLKSLSLEHNGIS-D 123
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
I L +L L +L + +N ++D L +L +L T ++ +N +
Sbjct: 124 ING-LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 165
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 6/87 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ L + L L+ N +I L N L L L N + + S L +L L +L +
Sbjct: 61 IQYLPNVTKLFLNGNKL-TDI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSL 116
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNN 178
N +SD I L L +L + + NN
Sbjct: 117 EHNGISD-ING-LVHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 6/103 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
+L L N+K++ I+ L +L +L L+L N L T+LQ L L N++S
Sbjct: 135 SLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHIS-D 189
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ L L NL L++ S + L T ++
Sbjct: 190 L-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 15/87 (17%), Positives = 31/87 (35%), Gaps = 6/87 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ NL + + + + ++ + S+ + L N+ L +
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ N L+D I P L L+ L + N
Sbjct: 73 NGNKLTD-IKP-LTNLKNLGWLFLDEN 97
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 23/111 (20%), Positives = 47/111 (42%), Gaps = 8/111 (7%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSN 130
K++ + + + ++ I L L L+L N ++ + L L L L N
Sbjct: 171 KKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFN 226
Query: 131 YLSGSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+S ++ + L N +L L +++N L +P L + + + NN +
Sbjct: 227 SIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 28/143 (19%), Positives = 50/143 (34%), Gaps = 17/143 (11%)
Query: 61 CNWKGVKCDKNK----------RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
C+ + V+C L L N+K++ D L L L L +N
Sbjct: 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-S 89
Query: 111 EIPSE-LGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQ 168
+I +L+ L L N L +P ++ L L + N ++ + L
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLN 145
Query: 169 RLITFNVSNNFLVGAIPSDGVLT 191
++I + N L + +G
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQ 168
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 22/113 (19%), Positives = 46/113 (40%), Gaps = 13/113 (11%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L+ + +S + L L+ L+L++N ++P L + +Q + L +N +S
Sbjct: 220 KLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS- 276
Query: 135 SIPSE-------LGNLSNLLNLDISSNSLSDY-IPPSL-GKLQRLITFNVSNN 178
+I S ++ + + SN + + I PS + + N
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 19/110 (17%), Positives = 43/110 (39%), Gaps = 10/110 (9%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSN 130
++ L L+ ++L + + L+ L +H N ++ ++ + L +N
Sbjct: 100 VKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTN 155
Query: 131 YL-SGSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
L S I + + L + I+ +++ IP L L ++ N
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 8/110 (7%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNY 131
++ L ++ KL+G I DL + L L+L N I E L ++L L L N
Sbjct: 173 KLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQ 228
Query: 132 LSGSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
+ I + L L L L + +N LS +P L L+ L + N +
Sbjct: 229 IR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 32/143 (22%), Positives = 51/143 (35%), Gaps = 17/143 (11%)
Query: 61 CNWKGVKCDKNK----------RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
C+ + V+C L L N+ +S D L L L L +N
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-S 91
Query: 111 EIPSE-LGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQ 168
+I + +LQ L + N+L IP L S+L+ L I N + +P L+
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRK-VPKGVFSGLR 147
Query: 169 RLITFNVSNNFLVGAIPSDGVLT 191
+ + N L + G
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 9e-06
Identities = 18/113 (15%), Positives = 43/113 (38%), Gaps = 13/113 (11%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L ++++ I L L L+ L+L +N +P+ L + LQ + L +N ++
Sbjct: 221 RLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT- 277
Query: 135 SIPSE-------LGNLSNLLNLDISSNSLSDY-IPPSL-GKLQRLITFNVSNN 178
+ + + + +N + + + P+ + + N
Sbjct: 278 KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 29/115 (25%), Positives = 46/115 (40%), Gaps = 9/115 (7%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L N+K+S I L +L+ L + N+ EIP L + L L + N +
Sbjct: 82 ALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR- 136
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
+P L N+ +++ N L + P +L +S L IP D
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKD 190
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 26/115 (22%), Positives = 42/115 (36%), Gaps = 9/115 (7%)
Query: 76 TLSLTNHKL-SGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
+ + + L + +L +L + IP +L L L L N +
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDL--PETLNELHLDHNKIQ- 206
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
+I E L S L L + N + I SL L L ++ NN L +P+
Sbjct: 207 AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAG 259
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 29/108 (26%), Positives = 43/108 (39%), Gaps = 6/108 (5%)
Query: 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYL 132
+ L + + A L L K L L +NN +I S L L+ LSL N +
Sbjct: 26 EKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLI 82
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
I + L L IS N ++ + + KL L +SNN +
Sbjct: 83 K-KIENLDAVADTLEELWISYNQIAS-LSG-IEKLVNLRVLYMSNNKI 127
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 17/88 (19%), Positives = 32/88 (36%), Gaps = 4/88 (4%)
Query: 94 KLDQLKFLNLH-SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152
+ + + LH ++ + L + L+L +N + I S L + NL L +
Sbjct: 21 VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLG 78
Query: 153 SNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N + I L +S N +
Sbjct: 79 RNLIKK-IENLDAVADTLEELWISYNQI 105
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 33/112 (29%), Positives = 55/112 (49%), Gaps = 8/112 (7%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
V L L +KL+ I L L L +L L N ++ S L + +L+ LSL+
Sbjct: 65 QYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKV-KDL-SSLKDLKKLKSLSLE 120
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
N +S I L +L L +L + +N ++D I L +L +L T ++ +N +
Sbjct: 121 HNGIS-DING-LVHLPQLESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 29/113 (25%), Positives = 48/113 (42%), Gaps = 6/113 (5%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
++ +L L N+K++ I+ L +L +L L+L N L T+LQ L L
Sbjct: 131 VHLPQLESLYLGNNKITD-ITV-LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLS 186
Query: 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLV 181
N++S + L L NL L++ S + L T ++ LV
Sbjct: 187 KNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 15/87 (17%), Positives = 31/87 (35%), Gaps = 6/87 (6%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ NL + + + + ++ + S+ + L N+ L +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNN 178
+ N L+D I P L L+ L + N
Sbjct: 76 NGNKLTD-IKP-LANLKNLGWLFLDEN 100
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 29/118 (24%), Positives = 43/118 (36%), Gaps = 12/118 (10%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
+ L +++S +A L L LHSN I + L+ L L N
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS----LGKLQRLITFNVSNNFLVGAIPSD 187
S+ L L L + L + + P L LQ L + +N L A+P D
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYL---YLQDNALQ-ALPDD 147
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 30/116 (25%), Positives = 50/116 (43%), Gaps = 9/116 (7%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
TL L L + L L++L L N +P + + L L L N +S
Sbjct: 109 TLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
S+P L +L L + N ++ ++ P + L RL+T + N L A+P++
Sbjct: 167 -SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 26/107 (24%), Positives = 43/107 (40%), Gaps = 8/107 (7%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L L ++ L + D L L L LH N +P L L L N ++
Sbjct: 133 YLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
+ +L L+ L + +N+LS +P L L+ L +++N
Sbjct: 191 -HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 4/92 (4%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
+ + LH N + C L L L SN L+ I + L+ L LD+S N+
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 157 SDYIPPS-LGKLQRLITFNVSNNFLVGAIPSD 187
+ P+ L RL T ++ L +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPG 123
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 29/116 (25%), Positives = 50/116 (43%), Gaps = 7/116 (6%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
+L L+N++++ ++DL + L+ L L SN I + + L+ L L NYLS
Sbjct: 56 SLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS- 113
Query: 135 SIPSEL-GNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFLVGAIPSD 187
++ S LS+L L++ N + + L +L V N I
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 17/134 (12%), Positives = 39/134 (29%), Gaps = 12/134 (8%)
Query: 79 LTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIP 137
+ D L L+ L + +++ + L + + L L +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHI-LLL 214
Query: 138 SEL-GNLSNLLNLDISSNSLSD----YIPP----SLGKLQRLITFNVSNNFLVGAIPSDG 188
S++ L++ L + SL K +++ L +
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274
Query: 189 VLTKFSESSFFGNR 202
++ E F N+
Sbjct: 275 QISGLLELEFSRNQ 288
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 19/112 (16%), Positives = 36/112 (32%), Gaps = 11/112 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG----EIPS----ELGNCTELQGLSL 127
L L + + + ++ L L + E+ + L + + +
Sbjct: 202 HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
L + L +S LL L+ S N L +P +L L + N
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 17/97 (17%), Positives = 33/97 (34%), Gaps = 11/97 (11%)
Query: 69 DKNKRVITLSLTNHKLSGP--------ISADLGKLDQLKFLNLHSNNFYGEIPSELGNCT 120
D V L L + L + L K + + + + + ++ L +
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 121 ELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
L L N L S+P L++L + + +N
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 18/142 (12%), Positives = 51/142 (35%), Gaps = 11/142 (7%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L+L + ++ L +L+ L + + + + +I + T L+ L + ++ L
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVG----AIPSD 187
S + L ++ N+ +L + + + + + + L + +
Sbjct: 188 -SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELST- 244
Query: 188 GVLTKFSESSFFGNRGLCGKQI 209
G + F N + + +
Sbjct: 245 GETNSLIKKFTFRNVKITDESL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 24/94 (25%), Positives = 40/94 (42%), Gaps = 6/94 (6%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
D+ S + IPS L ++ L L +N ++ S+L NL L ++SN
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 155 SLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
++ I S L L ++S N+L + S
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSS 118
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 23/108 (21%), Positives = 43/108 (39%), Gaps = 6/108 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L +++ ++ + L L++ N +P + + L+ L+L N +S
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPIS- 261
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
+I L L L + + L+ + P + L L NVS N L
Sbjct: 262 TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL 308
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 6/109 (5%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
+LS+T+ L+ + L L+FLNL N I L LQ + L L+
Sbjct: 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLA- 285
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLV 181
+ L+ L L++S N L+ + S+ + L T + +N L
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 5/114 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L L+ + L L L L L N I L+ L +
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
++ NL +L I+ +L+ +P ++ L L N+S N + I
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGS 266
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 25/114 (21%), Positives = 49/114 (42%), Gaps = 4/114 (3%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L ++ +K+ + L LK L + N+ I L+ L+L+ L+
Sbjct: 108 KLDISENKIVILLDYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLT- 165
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
SIP+E L +L L+ L + +++ S +L RL +S+ + + +
Sbjct: 166 SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 23/92 (25%), Positives = 36/92 (39%), Gaps = 12/92 (13%)
Query: 95 LDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDIS 152
L L+ L L SN IP + L L + N + + + +L NL +L++
Sbjct: 79 LFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVG 136
Query: 153 SNSLSDYIPP----SLGKLQRLITFNVSNNFL 180
N L YI L L++L + L
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQL---TLEKCNL 164
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 25/95 (26%), Positives = 38/95 (40%), Gaps = 11/95 (11%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
+ L+L N E + L+ L L N +S ++ NL NL L + SN L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRL 92
Query: 157 SDYIPP----SLGKLQRLITFNVSNNFLVGAIPSD 187
IP L L +L ++S N +V +
Sbjct: 93 KL-IPLGVFTGLSNLTKL---DISENKIV-ILLDY 122
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 19/84 (22%), Positives = 34/84 (40%), Gaps = 5/84 (5%)
Query: 105 SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP-S 163
+ +P + TE + L L N + E + +L L+++ N +S + P +
Sbjct: 19 HRKRFVAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-VEPGA 75
Query: 164 LGKLQRLITFNVSNNFLVGAIPSD 187
L L T + +N L IP
Sbjct: 76 FNNLFNLRTLGLRSNRLK-LIPLG 98
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 27/105 (25%), Positives = 48/105 (45%), Gaps = 4/105 (3%)
Query: 76 TLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L N + + G + + ++L+FL+ N I + L +L+ L L N +SG
Sbjct: 21 ELVLDNSRSNEGKLEGLTDEFEELEFLST-INVGLTSI-ANLPKLNKLKKLELSDNRVSG 78
Query: 135 SIPSELGNLSNLLNLDISSNSLSDY-IPPSLGKLQRLITFNVSNN 178
+ NL +L++S N + D L KL+ L + ++ N
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 29/98 (29%), Positives = 45/98 (45%), Gaps = 7/98 (7%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLD 150
L L++LNL N EIP+ L +L L L N+LS +I L +L L
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 151 ISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
+ + + I + LQ L+ N+++N L +P D
Sbjct: 238 MIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHD 273
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 25/101 (24%), Positives = 39/101 (38%), Gaps = 9/101 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L +++ L L+ L L N+ I L L L N L+
Sbjct: 68 LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLT- 125
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS----LGKLQRL 170
+IP+ LS L L + +N + IP + L+RL
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 23/106 (21%), Positives = 43/106 (40%), Gaps = 8/106 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L L +L L +L L+L N+ I LQ L + + +
Sbjct: 189 YLNLAMCNLREI--PNLTPLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQ- 244
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
I NL +L+ ++++ N+L+ +P L L ++ +N
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 33/130 (25%), Positives = 50/130 (38%), Gaps = 6/130 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L L+ + + L L L L N IP+ ++L+ L L++N +
Sbjct: 92 ILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE- 149
Query: 135 SIPSEL-GNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
SIPS + +L LD+ YI + L L N++ L IP+ L K
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIK 208
Query: 193 FSESSFFGNR 202
E GN
Sbjct: 209 LDELDLSGNH 218
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 17/83 (20%), Positives = 30/83 (36%), Gaps = 4/83 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L L+ + LS L L+ L + + I N L ++L N L+
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLT- 268
Query: 135 SIPSE-LGNLSNLLNLDISSNSL 156
+P + L +L + + N
Sbjct: 269 LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155
+Q + N E+P + T + L+L N + + +L +L L +S N
Sbjct: 43 NQFSKVICVRKNL-REVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 156 LSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
+ I + L L T + +N L IP+
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIPNG 130
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 26/101 (25%), Positives = 39/101 (38%), Gaps = 9/101 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L + + + L L+ L L N+ +I L L L N+L+
Sbjct: 79 YLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLT- 136
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS----LGKLQRL 170
IPS LS L L + +N + IP + L RL
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRL 176
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 8/115 (6%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L K IS L LK+LNL N ++P+ L L+ L + N+
Sbjct: 175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP- 231
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
I LS+L L + ++ +S I + L L+ N+++N L ++P D
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHD 284
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 8/106 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L+L + +L L L+ L + N+F EI + L+ L + ++ +S
Sbjct: 200 YLNLGMCNIKDM--PNLTPLVGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVS- 255
Query: 135 SIPSE-LGNLSNLLNLDISSNSLSDYIPPS-LGKLQRLITFNVSNN 178
I L++L+ L+++ N+LS +P L+ L+ ++ +N
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 32/131 (24%), Positives = 50/131 (38%), Gaps = 8/131 (6%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLS 133
L L + + I L L L L N IPS ++L+ L L++N +
Sbjct: 103 VLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE 160
Query: 134 GSIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDGVLT 191
SIPS + +L+ LD+ +YI + L L N+ + +P+ L
Sbjct: 161 -SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLV 218
Query: 192 KFSESSFFGNR 202
E GN
Sbjct: 219 GLEELEMSGNH 229
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 18/83 (21%), Positives = 29/83 (34%), Gaps = 4/83 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L ++ + L LK L + ++ I L L+L N LS
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLS- 279
Query: 135 SIPSE-LGNLSNLLNLDISSNSL 156
S+P + L L+ L + N
Sbjct: 280 SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 20/93 (21%), Positives = 36/93 (38%), Gaps = 6/93 (6%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155
+Q + E+P + + + L+L N + +L +L L + NS
Sbjct: 54 NQFSKVVCTRRGL-SEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 156 LSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSD 187
+ I + L L T + +N+L IPS
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSG 141
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 52/266 (19%), Positives = 85/266 (31%), Gaps = 87/266 (32%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIK--------H 362
+G G F TV+ L+ D A+K + K E + E+ +L S++
Sbjct: 43 RKLGWGHFSTVW-LSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 363 RYLVNLRGY-----------CNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNII 410
+V L C ++++ L G L + + + + Q L II
Sbjct: 101 EMVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILL------------------------------ 440
+GL YLH C RIIH DIK NILL
Sbjct: 153 QQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 441 -------------------DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481
L+ +++D G A + + T Y + E +
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLI 266
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRP 507
D++S + E+ +G
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYL 292
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 25/108 (23%), Positives = 45/108 (41%), Gaps = 8/108 (7%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
LSL+ + +S D+ L +L+ L L N + + +L+ L + N L
Sbjct: 56 ALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ- 113
Query: 135 SIPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFL 180
+I +++L +LD+S N +P G L +L +S
Sbjct: 114 NISC--CPMASLRHLDLSFNDFDV-LPVCKEFGNLTKLTFLGLSAAKF 158
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 23/137 (16%), Positives = 52/137 (37%), Gaps = 7/137 (5%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP--SELGNCTELQGLS 126
N+ + L +++++L + + L+ L+L N+F +P E GN T+L L
Sbjct: 97 LFNQDLEYLDVSHNRLQ---NISCCPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLG 152
Query: 127 LQSNYLSGSIPSELGNLS-NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185
L + + +L + + LD+ S + SL + V + + ++
Sbjct: 153 LSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
Query: 186 SDGVLTKFSESSFFGNR 202
+ + +
Sbjct: 213 VNMSVNALGHLQLSNIK 229
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 25/99 (25%), Positives = 43/99 (43%), Gaps = 10/99 (10%)
Query: 85 SGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS 144
S + + LNL SN G + L +++ L L +N + SIP ++ +L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQ 473
Query: 145 NLLNLDISSNSLSDYIPP----SLGKLQRLITFNVSNNF 179
L L+++SN L +P L LQ + + N +
Sbjct: 474 ALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHD--NPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 21/127 (16%), Positives = 43/127 (33%), Gaps = 5/127 (3%)
Query: 59 DPCNWKGVKCDKNKRVITLSLTNHKLSGPI-----SADLGKLDQLKFLNLHSNNFYGEIP 113
C+ K + + V L++ N ++ I + L L ++ + F
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 114 SELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITF 173
+ E+ L + + S+ L+ + N +D + L+RL T
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 174 NVSNNFL 180
+ N L
Sbjct: 383 ILQRNGL 389
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 30/116 (25%), Positives = 50/116 (43%), Gaps = 6/116 (5%)
Query: 68 CDKNKRVITLSLTNHKLS--GPISADLGKLDQLKFLNLHSNNF-YGEIPSELGNCTELQG 124
C KR+ TL L + L ++ + L+ L++ N+ +
Sbjct: 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432
Query: 125 LSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
L+L SN L+GS+ L + LD+ +N + IP + LQ L NV++N L
Sbjct: 433 LNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 18/112 (16%), Positives = 34/112 (30%), Gaps = 4/112 (3%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
K ++ + N A ++ L ++ + + L+ N
Sbjct: 305 KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV 364
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPP---SLGKLQRLITFNVSNNFL 180
+ S+ L L L + N L + + L T +VS N L
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSL 415
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155
+ ++ + N +P +L + LSL N +S ++ LS L L +S N
Sbjct: 31 ELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR 87
Query: 156 LSDYIPPSL-GKLQRLITFNVSNNFLVGAIPSD 187
+ + + Q L +VS+N L I
Sbjct: 88 IR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC 118
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 54/240 (22%), Positives = 94/240 (39%), Gaps = 51/240 (21%)
Query: 292 HGDLPYSSKDIIK-KLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDR 348
+ D + + + E +IG G FG V K A D + A+K I K + F
Sbjct: 41 NYDYIVKNGEKWMDRYEIDS---LIGKGSFGQVVK-AYDRVEQEWVAIKII-KNKKAFLN 95
Query: 349 FFERELEILGSIKHR------YLVNLRGY-------CNSPTSKLL---IYDFL-----PG 387
+ E+ +L + Y+V+L+ + C ++L +YD L G
Sbjct: 96 QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC--LVFEMLSYNLYDLLRNTNFRG 153
Query: 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--DGNLE 445
SL+ + ++Q+ L +L IIH D+K NILL
Sbjct: 154 VSLN-LTRKFAQQM------------CTALLFLATP-ELSIIHCDLKPENILLCNPKRSA 199
Query: 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK 505
++ DFG + I + F Y +PE + D++S G +++E+ +G+
Sbjct: 200 IKIVDFGSSC---QLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 3e-07
Identities = 45/334 (13%), Positives = 90/334 (26%), Gaps = 124/334 (37%)
Query: 265 FLYKKLGKNESKGLARDVGGGASIV-MFHGDLPYSSKD----------IIKKLETLDDDH 313
FL + K E + + + D +K + + L L
Sbjct: 93 FLMSPI-KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAK 151
Query: 314 II---GSGGFG-TVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLR 369
+ G G G T +A+D + + ++ + +NL
Sbjct: 152 NVLIDGVLGSGKTW--VALD-----VCL-----SYKVQCKMDFKI---------FWLNL- 189
Query: 370 GYCNSPTSKL-----LIYDFLPGGS--LDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
CNSP + L L+Y P + D + + + A L ++ + +
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-----YE 244
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
+C ++ +++++ + K+L +TT
Sbjct: 245 NC--LLVLLNVQNAKAW-------NAFNLS-CKIL------LTT---------------- 272
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
R + TD FL + +D +
Sbjct: 273 -RFKQVTD----------------------------------FLSAATTTHISLDHHSMT 297
Query: 543 V-QSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575
+ E LL + + P D P V+
Sbjct: 298 LTPDEVKS-LLL---KYLDCRPQDLP--REVLTT 325
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 9/107 (8%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY 131
+ +L ++ +S +L ++ N ++N + + + T L+ L L N
Sbjct: 19 ANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQ 74
Query: 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+S + S L +L+ L L ++ N L + L RL + NN
Sbjct: 75 IS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNN 116
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 20/112 (17%), Positives = 43/112 (38%), Gaps = 6/112 (5%)
Query: 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129
+ + L L N++L L L L+ L++ +N + LG ++L+ L L
Sbjct: 104 PSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHG 159
Query: 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLV 181
N ++ + L L + +D++ + +L T + +
Sbjct: 160 NEIT-NT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWI 209
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 15/113 (13%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128
+ L L+++++S +S L L +L+ L+++ N L N + L
Sbjct: 60 QFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNR--------LKNLNGIPSACLS 109
Query: 129 SNYLSGSIPSELGNLSNLLNL---DISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+L + + +L +L NL I +N L I LG L +L ++ N
Sbjct: 110 RLFLDNNELRDTDSLIHLKNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLHGN 160
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 39/155 (25%), Positives = 64/155 (41%), Gaps = 13/155 (8%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-RELEILGSIKHRYLVNLRGYC 372
IGSG FG +Y + G A+K + E + +++ + +R
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVG--IPTIRWCG 74
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+++ + L G SL++ + S + L + + Y+H S IHRD
Sbjct: 75 AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 130
Query: 433 IKSSNILL----DGNLEARVSDFGLAKLLEDEESH 463
+K N L+ GNL + DFGLAK D +H
Sbjct: 131 VKPDNFLMGLGKKGNL-VYIIDFGLAKKYRDARTH 164
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 30/98 (30%), Positives = 41/98 (41%), Gaps = 8/98 (8%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI 136
L L+ + L A L +L LNL ++ + G L L L N L S+
Sbjct: 36 LHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ-SL 92
Query: 137 PSELGNLSNLLNLDISSNSLSDYIPP----SLGKLQRL 170
P L L LD+S N L+ +P LG+LQ L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQEL 129
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 7/106 (6%)
Query: 76 TLSLTNHKLSGPISADL-GKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLS 133
L ++ ++L+ + L +L+ L L N +P L +L+ LSL +N L+
Sbjct: 104 VLDVSFNRLTS-LPLGALRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT 161
Query: 134 GSIPSEL-GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178
+P+ L L NL L + NSL IP L + N
Sbjct: 162 -ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 18/109 (16%), Positives = 38/109 (34%), Gaps = 5/109 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
+ L+ + ++ +L L+FL + I + + L L L N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 135 SIPSE-LGNLSNLLNLDISSNSL-SDYIPP-SLGKLQRLITFNVSNNFL 180
+ + L+NL L ++ +L + L L + +N +
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 27/102 (26%), Positives = 46/102 (45%), Gaps = 11/102 (10%)
Query: 76 TLSLTNHKLSGPISAD-LGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLS 133
L+L ++++ I + L L LNL N G I S + N +L+ L L N++
Sbjct: 303 QLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR 360
Query: 134 GSIPSEL-GNLSNLLNLDISSNSLSDYIPP----SLGKLQRL 170
++ + L NL L + +N L +P L LQ++
Sbjct: 361 -ALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKI 400
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 3/97 (3%)
Query: 98 LKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSNS 155
+ +++L N+ E+ +LQ L ++ I + LS+L+ L + N
Sbjct: 32 VNYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 156 LSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK 192
+ L L ++ L GA+ S
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 30/161 (18%), Positives = 57/161 (35%), Gaps = 29/161 (18%)
Query: 50 LNQWRPEDPDPCNWKGVKC---DKNKRVITLSLTNHKLSG-PISADLGKLDQLKFLNLHS 105
L+ +D + KC KN + TL L+ + + K +L
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 106 NNFYGEIPSELGNC--------------TELQGLSLQSNYLSGSIPSEL-GNLSNLLNLD 150
+N Y S + ++ L + + ++ + + ++L L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLT 305
Query: 151 ISSNSLSDYIPP----SLGKLQRLITFNVSNNFLVGAIPSD 187
++ N ++ I L L +L N+S NFL G+I S
Sbjct: 306 LAQNEINK-IDDNAFWGLTHLLKL---NLSQNFL-GSIDSR 341
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 13/97 (13%)
Query: 97 QLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSN 154
+K +L + + + + T+L+ L+L N ++ I L++LL L++S N
Sbjct: 276 GVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQN 333
Query: 155 SLSDYIPP----SLGKLQRLITFNVSNNFLVGAIPSD 187
L I +L KL+ L ++S N + A+
Sbjct: 334 FLGS-IDSRMFENLDKLEVL---DLSYNHI-RALGDQ 365
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 20/90 (22%), Positives = 40/90 (44%), Gaps = 4/90 (4%)
Query: 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSL 127
++ L+L+ + L S LD+L+ L+L N+ + + L+ L+L
Sbjct: 320 WGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELAL 378
Query: 128 QSNYLSGSIPSE-LGNLSNLLNLDISSNSL 156
+N L S+P L++L + + +N
Sbjct: 379 DTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 31/106 (29%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 76 TLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
L L N K + G I + L+FL+L N + + L +L+ L L N + G
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSL-INVGLISVSN-LPKLPKLKKLELSENRIFG 85
Query: 135 SIPSELGNLSNLLNLDISSNSLSDY--IPPSLGKLQRLITFNVSNN 178
+ L NL +L++S N L D + P L KL+ L + ++ N
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 23/87 (26%), Positives = 36/87 (41%), Gaps = 3/87 (3%)
Query: 95 LDQLKFLNLH-SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153
++ L L + G+I L+ LSL + L S+ + L L L L++S
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80
Query: 154 NSLSDYIPPSLGKLQRLITFNVSNNFL 180
N + + KL L N+S N L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 20/126 (15%), Positives = 39/126 (30%), Gaps = 13/126 (10%)
Query: 58 PDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-L 116
PD C + + + L + L L + + + L
Sbjct: 2 PDAC-----CPHGSSGL----RCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDL 52
Query: 117 GNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNV 175
EL+ L++ + L + + L L++S N+L + + L +
Sbjct: 53 RGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVL 110
Query: 176 SNNFLV 181
S N L
Sbjct: 111 SGNPLH 116
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 27/118 (22%), Positives = 44/118 (37%), Gaps = 7/118 (5%)
Query: 76 TLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNFYGEIPSEL--GNCTELQGLSLQSNYL 132
L + N L P + D L + N + IP G C E L L +N
Sbjct: 109 FLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168
Query: 133 SGSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITF-NVSNNFLVGAIPSDG 188
+ S+ N + L + ++ N I + G + + +VS + A+PS G
Sbjct: 169 T-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 16/89 (17%), Positives = 32/89 (35%), Gaps = 6/89 (6%)
Query: 95 LDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSE--LGNLSNLLNLDI 151
L ++ + + + I + L L+ L + + L P + + L+I
Sbjct: 79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEI 137
Query: 152 SSNSLSDYIPPSL--GKLQRLITFNVSNN 178
+ N IP + G +T + NN
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNN 166
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 26/104 (25%), Positives = 43/104 (41%), Gaps = 7/104 (6%)
Query: 76 TLSLTNHKLSGPISADL--GKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS 133
L +T++ I + G ++ L L++N F + N T+L + L N
Sbjct: 134 ILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYL 192
Query: 134 GSIPSEL--GNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFN 174
I + G S LD+S S++ +P L L+ LI N
Sbjct: 193 TVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 20/96 (20%), Positives = 35/96 (36%), Gaps = 5/96 (5%)
Query: 98 LKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSNS 155
+ L L + IPS N + + + + + S NLS + +++I +
Sbjct: 33 TQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 156 LSDYIPPS-LGKLQRLITFNVSNNFLVGAIPSDGVL 190
YI P L +L L + N L P +
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV 126
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 36/159 (22%), Positives = 59/159 (37%), Gaps = 13/159 (8%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-RELEILGSIKHRYLVNLR 369
IG G FG + + A+K + E R + LGS + +
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG--IPQVY 71
Query: 370 GYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429
+ ++ + L G SL++ L I + + Y+H S +I
Sbjct: 72 YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLI 127
Query: 430 HRDIKSSNILL--DGNLEAR---VSDFGLAKLLEDEESH 463
+RD+K N L+ GN + + DF LAK D E+
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 41/154 (26%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFE-RELEILGSIKHRYLVNLRGYC 372
IGSG FG +Y + A+K + + +E + IL + N+R +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTG--IPNVRWFG 72
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+L+ D L G SL++ + S +L L + + ++H S +HRD
Sbjct: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128
Query: 433 IKSSNILLDGNLEAR---VSDFGLAKLLEDEESH 463
IK N L+ A + DFGLAK D +H
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 28/134 (20%), Positives = 46/134 (34%), Gaps = 14/134 (10%)
Query: 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGS 135
L L+ + L S +L+ L+L I + + L L L N + S
Sbjct: 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ-S 90
Query: 136 IPSEL-GNLSNLLNLDISSN---SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGV-- 189
+ LS+L L SL ++ L L+ L NV++N + +
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL---NVAHNLIQ-SFKLPEYFS 146
Query: 190 -LTKFSESSFFGNR 202
LT N+
Sbjct: 147 NLTNLEHLDLSSNK 160
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 25/102 (24%), Positives = 41/102 (40%), Gaps = 10/102 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG 134
TL LT + + L L+ L N + + G+ L+ L++ N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQ- 137
Query: 135 SIPSE--LGNLSNLLNLDISSNSLSDYIPP----SLGKLQRL 170
S NL+NL +LD+SSN + I L ++ L
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLL 178
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 28/156 (17%), Positives = 54/156 (34%), Gaps = 13/156 (8%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH-RYLVNLRGYC 372
IG G FG +++ + + A+K + E + + N+ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+L+ D L G SL++ L + + +H +++RD
Sbjct: 76 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131
Query: 433 IKSSNILL---DGNLEARVS--DFGLAKLLEDEESH 463
IK N L+ + + DFG+ K D +
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 33/174 (18%), Positives = 59/174 (33%), Gaps = 29/174 (16%)
Query: 315 IGSGGFGTVYK---------LAMDDGNVFALKRIDKLN---EGFDRFFERELEILGSIKH 362
G +Y+ + F+LK +D + FF+R + L K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 363 RYLVNLRG-------YCNSPTSK--LLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMG 412
+ L + K L+ L G SL AL + L + L +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHI 464
L +LH +H ++ + NI +D +++V + +G A H+
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 25/134 (18%), Positives = 51/134 (38%), Gaps = 17/134 (12%)
Query: 61 CNWKGVKCDKNKR-----------VITLSLTNHKLSG-PISADLGKLDQLKFLNLHSNNF 108
C V C N++ L L N++ + + KL QL+ +N +N
Sbjct: 11 CEGTTVDCS-NQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI 69
Query: 109 YGEIPSELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSNSLSDYIPP-SLGK 166
+ + + L SN L ++ ++ L +L L + SN ++ + S
Sbjct: 70 TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIG 127
Query: 167 LQRLITFNVSNNFL 180
L + ++ +N +
Sbjct: 128 LSSVRLLSLYDNQI 141
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 37/172 (21%), Positives = 60/172 (34%), Gaps = 28/172 (16%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEIL---------GSIKHR 363
IGSGGFG +Y LA A + K+ + EL+ R
Sbjct: 45 IGSGGFGLIY-LAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 364 YLVNLRG-----YCNSPTSKLLIYDF----LPGGSLDEALHERSEQLDWDARLNIIMGAA 414
++ G K Y F G L + + ++ L + +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL-QKISGQNGTFKKSTVLQLGIRML 161
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHI 464
L Y+H +H DIK++N+LL +V +D+GL+ +H
Sbjct: 162 DVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 22/116 (18%), Positives = 41/116 (35%), Gaps = 5/116 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL--GNCTELQGLSLQSNYLS 133
L ++N + Q L++ N I G E L L N +
Sbjct: 108 YLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFLVGAIPSDG 188
I + N + L L++S N+ + +P + ++S + ++PS G
Sbjct: 168 -EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 26/141 (18%), Positives = 51/141 (36%), Gaps = 16/141 (11%)
Query: 61 CNWKGVKCDKNK----------RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
C+ + C ++K I L KL L+ + + N+
Sbjct: 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 111 EIPSE-LGNCTELQGLSLQ-SNYLSGSIPSE-LGNLSNLLNLDISSNSLSDYIPP-SLGK 166
I ++ N +L + ++ +N L I E NL NL L IS+ + +P
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIH 126
Query: 167 LQRLITFNVSNNFLVGAIPSD 187
+ + ++ +N + I +
Sbjct: 127 SLQKVLLDIQDNINIHTIERN 147
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSL-QSNYLSGSIPSE-LGNLSNLLNLDISSN 154
+ L L+ N EI + N T+L L+L +N L +P++ S + LDIS
Sbjct: 155 ESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRT 212
Query: 155 SLSDYIPPSLGKLQRLITFNVSNN 178
+ L L++L + N
Sbjct: 213 RIHSLPSYGLENLKKLRARSTYNL 236
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 26/102 (25%), Positives = 42/102 (41%), Gaps = 11/102 (10%)
Query: 76 TLSLTNHKLSGPISADL-GKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLS 133
L L ++KL + A + +L L+ L + N +P + L L L N L
Sbjct: 65 LLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK 122
Query: 134 GSIPSEL-GNLSNLLNLDISSNSLSDYIPP----SLGKLQRL 170
S+P + +L+ L L + N L +P L L+ L
Sbjct: 123 -SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKEL 162
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 13/89 (14%), Positives = 27/89 (30%), Gaps = 3/89 (3%)
Query: 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151
+ + L+L I + + + N + + L L L +
Sbjct: 15 YTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLV 71
Query: 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFL 180
++N + L L ++NN L
Sbjct: 72 NNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 10/107 (9%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS--ELGNCTELQGLSLQSNYLS 133
L L +K+ I LDQ ++ N EI L+ L + +N +
Sbjct: 23 ELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLKTLLVNNNRIC 77
Query: 134 GSIPSELGNLSNLLNLDISSNSLSDY--IPPSLGKLQRLITFNVSNN 178
L +L L +++NSL + + P L L+ L + N
Sbjct: 78 RIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 36/173 (20%), Positives = 57/173 (32%), Gaps = 27/173 (15%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKR-----IDKLNEGFDRF---FERELEILGSIKHRYLV 366
IG GGFG +Y M+ ++ + G F + I+
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 367 NLRGYCNSPTSK-------------LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGA 413
Y P +I D G L + +++ L + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHI 464
L Y+H +H DIK+SN+LL+ +V D+GLA E H
Sbjct: 162 LDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 36/140 (25%), Positives = 52/140 (37%), Gaps = 32/140 (22%)
Query: 58 PDPCNWKGVKCDKNKRVITLSLTNHKLS---GPISADLGKLDQLKFLNLHSNNFYGEIPS 114
P C C N LS + +L + + LD L NN + +
Sbjct: 13 PANC-----LCASN----ILSCSKQQLPNVPQSLPSYTALLD------LSHNNL-SRLRA 56
Query: 115 E--LGNCTELQGLSLQSNYLSGSIPSE-LGNLSNLLNLDISSNSLSDYIPP----SLGKL 167
E T L L L N+L+ I SE + NL LD+SSN L + L L
Sbjct: 57 EWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQAL 114
Query: 168 QRLITFNVSNNFLVGAIPSD 187
+ L + NN +V + +
Sbjct: 115 EVL---LLYNNHIV-VVDRN 130
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 29/110 (26%), Positives = 44/110 (40%), Gaps = 9/110 (8%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSG 134
L L+++ L L L+ L L++N+ + + +LQ L L N +S
Sbjct: 92 YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS- 149
Query: 135 SIPSE----LGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS--NN 178
P E L L+ LD+SSN L L KL + + NN
Sbjct: 150 RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 26/102 (25%), Positives = 44/102 (43%), Gaps = 11/102 (10%)
Query: 76 TLSLTNHKLSGPISADL-GKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLS 133
+ L+N+++S ++ D L L L L+ N E+P L LQ L L +N ++
Sbjct: 60 RIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN 117
Query: 134 GSIPSEL-GNLSNLLNLDISSNSLSDYIPP----SLGKLQRL 170
+ + +L NL L + N L I L +Q +
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 22/111 (19%), Positives = 44/111 (39%), Gaps = 12/111 (10%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS----ELGNCTELQGLSLQSNY 131
+ L + + +L+ ++L SNN E+ L L L L N
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDL-SNNQISELAPDAFQGL---RSLNSLVLYGNK 91
Query: 132 LSGSIPSEL-GNLSNLLNLDISSNSLSDYIPP-SLGKLQRLITFNVSNNFL 180
++ +P L L +L L +++N ++ + + L L ++ +N L
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 19/125 (15%), Positives = 37/125 (29%), Gaps = 22/125 (17%)
Query: 76 TLSLTNHKLSG----PISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSL 127
SL ++ + A L + D +K + L N E + + + +L+
Sbjct: 8 GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 67
Query: 128 QSNYLS----------GSIPSELGNLSNLLNLDISSNSLSD----YIPPSLGKLQRLITF 173
+ + L L + +S N+ + L K L
Sbjct: 68 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 127
Query: 174 NVSNN 178
+ NN
Sbjct: 128 YLHNN 132
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 594 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.89 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.89 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.88 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.87 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.87 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.82 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.81 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.81 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.81 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.81 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.81 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.81 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.8 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.8 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.8 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.79 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.77 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.75 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.75 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.74 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.74 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.74 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.72 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.72 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.72 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.72 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.72 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.71 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.71 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.7 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.7 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.7 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.69 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.69 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.69 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.69 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.69 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.68 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.68 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.68 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.68 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.68 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.68 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.68 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.67 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.67 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.67 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.67 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.67 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.66 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.66 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.66 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.66 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.66 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.66 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.66 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.65 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.65 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.64 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.64 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.64 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.63 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.63 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.63 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.62 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.62 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.61 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.61 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.6 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.59 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.59 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.59 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.59 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.59 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.59 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.59 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.58 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.58 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.58 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.58 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.58 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.58 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.57 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.57 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.56 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.56 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.55 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.55 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.55 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.55 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.54 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.54 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.54 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.53 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.53 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.52 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.52 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.51 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.5 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.46 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.45 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.44 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.43 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.42 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.42 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.41 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.39 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.37 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.34 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.34 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.33 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.29 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.29 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.28 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.27 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.11 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.99 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.9 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.86 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.83 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.67 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.67 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.65 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.57 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.42 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.3 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.3 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.27 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.18 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.01 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.99 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.94 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.51 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.49 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.42 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.4 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.38 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.33 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.3 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.16 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.15 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.02 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.0 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.79 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.73 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.56 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.87 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.46 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 87.26 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.65 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.61 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 84.12 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=436.17 Aligned_cols=257 Identities=21% Similarity=0.384 Sum_probs=213.9
Q ss_pred cCCCccceeeeecceEEEEEEec------CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|...+.||+|+||+||+|.+. ++..||||+++..+....+.|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777899999999999999864 478899999988777777889999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcC------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEE
Q 007668 381 IYDFLPGGSLDEALHERS------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l 448 (594)
||||+++|+|.++++.+. ..++|..++.|+.|||+||+|||+ .+|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 469999999999999999999995 49999999999999999999999
Q ss_pred eecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHH
Q 007668 449 SDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
+|||+++......... .....||++|||||++.++.++.++|||||||++|||+| |+.||...... +.....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence 9999998765444332 234569999999999999999999999999999999999 89999764322 111222
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
..... ...+...+.++.+|+.+||+.||++|||++||.+.|++...
T Consensus 244 ~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 244 TQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111 11223345679999999999999999999999999988644
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=437.94 Aligned_cols=258 Identities=22% Similarity=0.402 Sum_probs=208.2
Q ss_pred cCCCccceeeeecceEEEEEEec------CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|...+.||+|+||+||+|.++ +++.||||+++..+....+.|.+|+++|++++|||||+++|+|.+....++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999865 478899999988777777889999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcE
Q 007668 381 IYDFLPGGSLDEALHERS--------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEA 446 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 446 (594)
||||+++|+|.++++.+. ..++|.+++.|+.|||+||+|||+ .+|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 999999999999997532 359999999999999999999995 499999999999999999999
Q ss_pred EEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHH
Q 007668 447 RVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 447 ~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 524 (594)
||+|||+++....... .......||++|||||++.+..++.++|||||||++|||+| |+.||...... +.+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAID 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence 9999999987654332 23345679999999999999999999999999999999999 89999764321 1112
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
....... + ..+...+.++.+|+.+||+.||++|||++||++.|+.+...
T Consensus 272 ~i~~g~~------~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CITQGRE------L---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHTCC------C---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCC------C---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2211111 1 11223456799999999999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=427.52 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=206.3
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.+++...+.||+|+||+||+|.+++ .||||+++.. +....+.|.+|++++++++|||||+++|+|.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4577888999999999999998764 5899998743 33445789999999999999999999999865 56899999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC-c
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-S 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~-~ 462 (594)
|+++|+|.++++.....++|..+..|+.|||+||+|||+ .+||||||||+|||+++++.+||+|||+|+...... .
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999999998777789999999999999999999995 499999999999999999999999999998765432 2
Q ss_pred eeeeeeecccCccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQS---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.......||+.|||||++.+ +.++.++|||||||++|||+||+.||...... ..+...+... ...+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~----~~~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRG----YASPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTT----CCCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcC----CCCCC
Confidence 23345689999999999864 46899999999999999999999999753211 1111111111 12222
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
....+...+..+.+|+.+||+.||++||||+||++.|+..
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3333445567899999999999999999999999988754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=431.05 Aligned_cols=255 Identities=21% Similarity=0.353 Sum_probs=209.9
Q ss_pred cCCCccceeeeecceEEEEEEec------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
..++..+.||+|+||+||+|.+. +++.||||+++.. .....+.|.+|+.++++++|||||+++|+|.++...+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556789999999999999863 4678999999753 3334678999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC
Q 007668 380 LIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 444 (594)
+||||+++|+|.++|+.+ ...++|..+++|+.|||+||+|||+ .+||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 999999999999999643 2358999999999999999999995 4999999999999999999
Q ss_pred cEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHH
Q 007668 445 EARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGW 522 (594)
Q Consensus 445 ~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 522 (594)
.+||+|||+++.....+. .......||++|||||++.++.++.++|||||||++|||+| |+.||...... +.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~------~~ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH------HH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH------HH
Confidence 999999999987654332 22345679999999999999999999999999999999999 89999764322 11
Q ss_pred HHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 523 LNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
........ . .+.+...+..+.+|+.+||+.||++||||+||++.|+..
T Consensus 257 ~~~i~~~~-~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNRQ-V--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTC-C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCC-C--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 12211111 1 112334457799999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=422.58 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=203.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|+..+.||+|+||+||+|... +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 468999999999999999999764 6899999999753 3344577999999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
||+++|+|.+++..+ ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999754 3457999999999999999999995 499999999999999999999999999998765432
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. .....+||+.|||||++.+..++.++||||+||++|||++|+.||...... ..+....... .+
T Consensus 180 ~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~---------~~ 243 (350)
T 4b9d_A 180 E-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIISGS---------FP 243 (350)
T ss_dssp H-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTC---------CC
T ss_pred c-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcCC---------CC
Confidence 1 223467999999999999999999999999999999999999999764321 1122222111 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122334567999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=414.88 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=209.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+.|+..+.||+|+||+||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888899999999999999765 68999999997655555667899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.+..... ..
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 99999999975 469999999999999999999995 4999999999999999999999999999987764433 23
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||......+ ........ ..+... ...
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~------~~~~~~-~~~ 294 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDN------LPPRLK-NLH 294 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS------SCCCCS-CGG
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcC------CCCCCC-ccc
Confidence 45689999999999999999999999999999999999999997643221 11111111 111111 123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+.++.+|+.+||+.||++|||++|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 34577899999999999999999999876
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=424.05 Aligned_cols=272 Identities=26% Similarity=0.385 Sum_probs=220.1
Q ss_pred CCCCHHHHHHHhcCCCccceeeeecceEEEEEEecC------CcEEEEEeecccc-hhhHHHHHHHHHHHhhCCC-Ceee
Q 007668 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSIKH-RYLV 366 (594)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv 366 (594)
.++...+++...++|+..+.||+|+||+||+|.+.. ++.||||+++... ....+.|.+|+++|.+++| ||||
T Consensus 52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 356666676677899999999999999999997653 3579999997643 3345679999999999965 8999
Q ss_pred eeeeEEeCC-CceEEEEEccCCCchhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 007668 367 NLRGYCNSP-TSKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430 (594)
Q Consensus 367 ~l~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 430 (594)
+++|+|.+. ...++|||||++|+|.++|+.. ...+++..+..++.|||+||+|||+ .+|||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiH 208 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIH 208 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeec
Confidence 999999764 5689999999999999999753 2348999999999999999999995 49999
Q ss_pred CCCCCCCeEecCCCcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCC
Q 007668 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPT 508 (594)
Q Consensus 431 ~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~ 508 (594)
|||||+|||+++++.+||+|||+|+....+.. .......||++|||||++.++.++.++|||||||++|||+| |+.||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999997655443 33445679999999999999999999999999999999998 99999
Q ss_pred CcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 509 DASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
....... .+...+..... + ..+...+.++.+++.+||+.||++|||++||++.|++.+...
T Consensus 289 ~~~~~~~------~~~~~i~~g~~-----~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 289 PGVKIDE------EFCRRLKEGTR-----M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp TTCCCSH------HHHHHHHHTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCHHH------HHHHHHHcCCC-----C---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 7643211 11111111110 1 112234467899999999999999999999999998876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=400.26 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=196.3
Q ss_pred CccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC----CCceEEEE
Q 007668 310 DDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLLIY 382 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 382 (594)
...+.||+|+||+||+|... ++..||+|++... .....+.|.+|++++++++|||||++++++.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45578999999999999765 5889999999643 33445679999999999999999999999854 34578999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~~~~~ 461 (594)
||+++|+|.+++++. ..+++..+..++.||+.||+|||++ .++|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999999764 5799999999999999999999965 33499999999999998 4789999999999864432
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....+||+.|||||++.+ .++.++|||||||++|||+||+.||..... ............ ....
T Consensus 186 --~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~~~~-~~~~------ 250 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGV-KPAS------ 250 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTC-CCGG------
T ss_pred --ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHHcCC-CCCC------
Confidence 2345689999999998865 699999999999999999999999964321 111111111111 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+...++++.+|+.+||+.||++|||++|+++
T Consensus 251 -~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 -FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223356899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=410.69 Aligned_cols=265 Identities=24% Similarity=0.349 Sum_probs=202.5
Q ss_pred CCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC----ceEEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----SKLLIYD 383 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e 383 (594)
+|...+.||+|+||+||+|.+ +|+.||||++...... ...+..|+..+.+++|||||+++|+|.++. ..++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466778999999999999988 5899999999754322 233445666677899999999999997654 4689999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
|+++|+|.++++. ..++|+.+.+++.|+++||+|||+++ +++|+||||||+|||++.++++||+|||+++...
T Consensus 82 y~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999999976 45899999999999999999999642 4599999999999999999999999999998765
Q ss_pred cCCcee---eeeeecccCccCccccccC------CCCccchhhhHHHHHHHHHhCCCCCCcchhccc---------chHH
Q 007668 459 DEESHI---TTIVAGTFGYLAPEYMQSG------RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG---------LNIV 520 (594)
Q Consensus 459 ~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~---------~~~~ 520 (594)
...... .....||+.|||||++.+. .++.++|||||||++|||+||..|+........ ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 443322 2345799999999998764 367899999999999999999888754322111 0111
Q ss_pred HHHHHHhcccccccccCCCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 521 GWLNFLISEDRQREIIDPNCEG--VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
. ....+.. ...+|.++. ...+....+.+|+.+||+.||++||||+||++.|+++..
T Consensus 240 ~-~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 240 E-MRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp H-HHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-HHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1 1111111 122333332 223556789999999999999999999999999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=409.29 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=204.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.+.|...+.||+|+||+||+|... +|+.||||+++.... ..+|++++++++|||||++++++.++...++||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456777889999999999999865 689999999975322 24699999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++|+|.++++.. +.+++..+..++.||+.||+||| +.+|+||||||+|||++.++ ++||+|||+++....+...
T Consensus 132 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999864 56999999999999999999999 45999999999999999887 6999999999977543321
Q ss_pred ----eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 464 ----ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 464 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.....+||+.|||||++.+..++.++||||+||++|||++|+.||........ . .........
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~---~~i~~~~~~------- 274 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---C---LKIASEPPP------- 274 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---H---HHHHHSCCG-------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---H---HHHHcCCCC-------
Confidence 12335799999999999999999999999999999999999999976433221 1 111111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
....+...+..+.+++.+||+.||++|||++|+++.|...
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 0112233457789999999999999999999999887664
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=408.50 Aligned_cols=247 Identities=21% Similarity=0.336 Sum_probs=208.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||+||+|... +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56889999999999999999764 6899999999753 2334567999999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++++. +.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999764 569999999999999999999995 4999999999999999999999999999998764432
Q ss_pred -eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 -HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
......+||+.|||||++.+..++.++||||+||++|||++|+.||...... .......... ..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~~-------~~-- 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIKLE-------YD-- 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-------CC--
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC-------CC--
Confidence 3345678999999999999999999999999999999999999999764322 1111111111 01
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 573 (594)
.+...+.++.+|+.+||+.||++|||++|++
T Consensus 253 -~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 -FPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1223446789999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=415.25 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=209.2
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+.|+..+.||+|+||+||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888999999999999999765 68999999997655555667899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++|+|.++++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 231 ~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 304 (423)
T 4fie_A 231 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 304 (423)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CB
T ss_pred CCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cc
Confidence 99999999975 459999999999999999999995 4999999999999999999999999999987765433 23
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||......+ .+...... ..+... ...
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~------~~~~~~-~~~ 371 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDN------LPPRLK-NLH 371 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS------CCCCCS-CTT
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcC------CCCCCc-ccc
Confidence 45689999999999999999999999999999999999999997643221 11111111 011111 112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+.+|+.+||+.||++|||++|+++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 34467899999999999999999999886
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=395.64 Aligned_cols=246 Identities=23% Similarity=0.387 Sum_probs=191.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
..+|+..+.||+|+||+||+|... +|+.||||++.+. .....+.+.+|++++++++|||||++++++.+++..++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999764 6899999999753 233456799999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+ +|+|.+++.++ +.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 9999 68999999764 579999999999999999999995 499999999999999999999999999998765432
Q ss_pred ceeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
.....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... .......... .
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i~~~~-------~-- 229 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNISNGV-------Y-- 229 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-------C--
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCC-------C--
Confidence 2345679999999999998776 58999999999999999999999764221 1112111111 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 230 -~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112233467899999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=402.76 Aligned_cols=242 Identities=26% Similarity=0.367 Sum_probs=193.9
Q ss_pred cCCCccceeeeecceEEEEEEec----CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|+..+.||+|+||+||+|... .++.||||++++.. ......+.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57889999999999999999753 47889999997532 2223468889999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.+++.+. +.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999764 579999999999999999999995 49999999999999999999999999999865443
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
.. .....+||+.|||||++.+..++.++||||+||++|||++|+.||.+.... .......... .
T Consensus 180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~-~-------- 243 (304)
T 3ubd_A 180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILKAK-L-------- 243 (304)
T ss_dssp -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C--------
T ss_pred Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHcCC-C--------
Confidence 32 234567999999999999999999999999999999999999999764322 1111111111 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
..+...+.++.+|+.+||+.||++|||+
T Consensus 244 -~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 -GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122344678999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=392.31 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=188.2
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc-------
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS------- 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------- 377 (594)
++|+..+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45788899999999999999765 68999999997543 3345679999999999999999999999865442
Q ss_pred -----eEEEEEccCCCchhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEee
Q 007668 378 -----KLLIYDFLPGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (594)
Q Consensus 378 -----~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~D 450 (594)
.++||||+++|+|.+++..+. ...++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence 689999999999999998643 236677889999999999999995 4999999999999999999999999
Q ss_pred cccccccccCCce-----------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchH
Q 007668 451 FGLAKLLEDEESH-----------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI 519 (594)
Q Consensus 451 fgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 519 (594)
||+|+........ .....+||+.|||||++.+..++.++|||||||++|||++ ||......
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~----- 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER----- 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-----
Confidence 9999877543221 1234579999999999999999999999999999999996 77542111
Q ss_pred HHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 520 VGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...... +.....+.......+...+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~---------~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTD---------VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHH---------HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHH---------HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000 0111111122334456788999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=377.96 Aligned_cols=289 Identities=40% Similarity=0.798 Sum_probs=246.5
Q ss_pred CCCCHHHHHHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccch-hhHHHHHHHHHHHhhCCCCeeeeeeeEEe
Q 007668 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCN 373 (594)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 373 (594)
..++..++....++|...+.||+|+||.||+|...+++.||||++..... .....+.+|+++++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45788999999999999999999999999999988899999999975432 22346899999999999999999999999
Q ss_pred CCCceEEEEEccCCCchhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEee
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~D 450 (594)
.....++||||+++|+|.++++... ..+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998643 3499999999999999999999976555999999999999999999999999
Q ss_pred cccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhc--ccchHHHHHHHHhc
Q 007668 451 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIE--KGLNIVGWLNFLIS 528 (594)
Q Consensus 451 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~ 528 (594)
||++...............||+.|+|||++.+..++.++||||||+++|||++|+.||+..... .......|......
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 9999887665555555667999999999999889999999999999999999999999754322 33455666666666
Q ss_pred ccccccccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 529 EDRQREIIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 529 ~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
........+..... ........+.+++.+||+.||++|||++||++.|++.....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 66666666655543 56778889999999999999999999999999999865543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=387.80 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=199.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC------CCc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS------PTS 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~ 377 (594)
++|...+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. ...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46888999999999999999764 6999999999753 23345678899999999999999999998753 367
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.|+||||++ |+|.+++.. .+.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999995 789999975 4679999999999999999999995 49999999999999999999999999999876
Q ss_pred ccCC---ceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc--
Q 007668 458 EDEE---SHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR-- 531 (594)
Q Consensus 458 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 531 (594)
.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+....+...........
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 4332 2223456899999999998775 569999999999999999999999976433221111100000000000
Q ss_pred ------cc---cccCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 ------QR---EIIDPNCE----GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ------~~---~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. ..+.+..+ ......+..+.+|+.+||+.||++|||++|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00000000 011123467889999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=376.28 Aligned_cols=282 Identities=38% Similarity=0.647 Sum_probs=240.4
Q ss_pred HHHHHHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 299 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
..++...+++|+..+.||+|+||.||+|...+++.||||++........+.+.+|++++++++||||+++++++.+....
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34445567899999999999999999999988999999998876666677899999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 379 LLIYDFLPGGSLDEALHERS---EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999997542 358999999999999999999995 499999999999999999999999999998
Q ss_pred ccccCC-ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 456 LLEDEE-SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 456 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.............|............
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 654322 2223345689999999999989999999999999999999999999987665555566666655555555556
Q ss_pred ccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 535 IIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 535 ~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
.+++.... ........+.+++.+||+.||++|||++|+++.|+..+...
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 66665543 56788889999999999999999999999999999876543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=377.25 Aligned_cols=196 Identities=26% Similarity=0.364 Sum_probs=168.5
Q ss_pred hcCCCccceeeeecceEEEEEEec----CCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 380 (594)
.++|+..+.||+|+||+||+|..+ .++.||+|++..... ...+.+|++++..+ +||||+++++++.+.+..++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 467999999999999999999753 467899999876433 45688999999998 69999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC-CcEEEeeccccccccc
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLED 459 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~~l~Dfgl~~~~~~ 459 (594)
||||+++|+|.+++. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 98 vmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 98 AMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 999999999999984 48999999999999999999995 499999999999999876 7999999999986543
Q ss_pred CCc---------------------------eeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCc
Q 007668 460 EES---------------------------HITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDA 510 (594)
Q Consensus 460 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~ 510 (594)
... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 211 112345799999999999775 589999999999999999999999854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=393.01 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=211.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|++.+.||+|+||+||+|..+ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+....++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468899999999999999999765 6899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC--CcEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN--LEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~~l~Dfgl~~~~~~~~~ 462 (594)
+++|+|.+++..+...+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 99999999998766789999999999999999999995 499999999999999854 899999999999876543
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .......... .++. .
T Consensus 312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~~~~~---~~~~---~ 378 (573)
T 3uto_A 312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDW---NMDD---S 378 (573)
T ss_dssp -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCC---CCCS---G
T ss_pred -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHhCCC---CCCc---c
Confidence 2345679999999999999999999999999999999999999997643221 1111111100 0000 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+|+.+||+.||++|||++|+++
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223467889999999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=391.84 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=200.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHH---HHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFE---RELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|+..++||+|+||+||+|... +|+.||+|++.+.. ......+. .++.+++.++|||||++++++.+....
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467889999999999999999765 68999999997521 11222333 346667788999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
|+||||++||+|.+++... +.+++..+..++.||+.||+||| +.+||||||||+|||++.+|++||+|||+|+.+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999999864 56999999999999999999999 5599999999999999999999999999998765
Q ss_pred cCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
... ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||......+. ...........
T Consensus 344 ~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~~~------- 410 (689)
T 3v5w_A 344 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMA------- 410 (689)
T ss_dssp SCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHHCC-------
T ss_pred CCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCCC-------
Confidence 433 345689999999999964 5799999999999999999999999976432211 11111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
. ..+...+.++.+|+.+||+.||++|++ ++||++
T Consensus 411 ~---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 V---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0 112234567899999999999999998 677763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=357.22 Aligned_cols=258 Identities=25% Similarity=0.464 Sum_probs=212.3
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|...+.||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 356788899999999999999875 5899999999877777778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++|+|.+++......+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999998877789999999999999999999995 499999999999999999999999999998765433211
Q ss_pred -------------eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 465 -------------TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 465 -------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
.....||+.|+|||++.+..++.++||||||+++|||++|..|+.............. ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~~---- 240 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFL---- 240 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHHH----
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hccc----
Confidence 1145799999999999999999999999999999999999999865432211100000 0000
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
..... ...+..+.+++.+||+.||++|||++|+++.|++.
T Consensus 241 -~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 241 -DRYCP-------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -HHTCC-------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cccCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00011 12224688999999999999999999999998874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=359.26 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=212.0
Q ss_pred cCCCccceeeeecceEEEEEEec----CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
++|...+.||+|+||.||+|... .+..||||+++.. .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56778899999999999999874 4556999999764 444567799999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.++++.....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 99999999999998776789999999999999999999995 499999999999999999999999999998765433
Q ss_pred ce--eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 462 SH--ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 462 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.. ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....... ......... .
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~--~----- 272 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEGY--R----- 272 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTC--C-----
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHcCC--C-----
Confidence 22 2223456788999999998999999999999999999999 999986543221 111111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP 585 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 585 (594)
...+...+..+.+++.+||+.||++|||++||++.|+.....+..
T Consensus 273 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 273 --LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred --CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 111223446799999999999999999999999999988765543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=355.49 Aligned_cols=264 Identities=28% Similarity=0.448 Sum_probs=204.6
Q ss_pred HHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.....+|+..+.||+|+||+||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 33466888999999999999999977 58889999987533 3345678999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 381 IYDFLPGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPR--IIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
||||+++|+|.+++..... .+++..+..++.||+.||+|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999976432 389999999999999999999954 7 99999999999999999999999999975
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......... ..
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~-~~--- 257 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKC-KR--- 257 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSC-CC---
T ss_pred ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-CC---
Confidence 44322 22334578999999999999999999999999999999999999997643221 111110000 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP 585 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 585 (594)
...+...+..+.+++.+||+.||++|||++++++.|+..+....|
T Consensus 258 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 258 ----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred ----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 112233446789999999999999999999999999988765444
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=347.63 Aligned_cols=257 Identities=24% Similarity=0.368 Sum_probs=214.7
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|+..+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 457888899999999999999999888999999976443 3467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++...........
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 162 (268)
T 3sxs_A 86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162 (268)
T ss_dssp TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence 9999999998776679999999999999999999995 4999999999999999999999999999987765544434
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||....... ......... ... .+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~---~~~------~~ 227 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGH---RLY------RP 227 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTC---CCC------CC
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCC---CCC------CC
Confidence 44556788999999998889999999999999999999 999987543221 111111110 111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
...+..+.+++.+||+.||++|||++|+++.|+....
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 2234678999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.45 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=213.6
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|+..+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 3578888999999999999999988999999999864432 467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++...........
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 9999999998777779999999999999999999995 4999999999999999999999999999986654332223
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||....... ......... . . ..+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~~~~--~-~------~~~ 229 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGF--R-L------YKP 229 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTC--C-C------CCC
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhcCc--c-C------CCC
Confidence 33456788999999999999999999999999999999 999987643221 111111110 0 0 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
...+..+.+++.+||+.||++|||++|+++.|++...
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 2234678999999999999999999999999987643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=345.32 Aligned_cols=279 Identities=33% Similarity=0.592 Sum_probs=229.6
Q ss_pred CCCCHHHHHHHhcCCCcc------ceeeeecceEEEEEEecCCcEEEEEeeccc----chhhHHHHHHHHHHHhhCCCCe
Q 007668 295 LPYSSKDIIKKLETLDDD------HIIGSGGFGTVYKLAMDDGNVFALKRIDKL----NEGFDRFFERELEILGSIKHRY 364 (594)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~n 364 (594)
..|+..++.+++.+|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468899999999999887 8999999999999987 5889999998652 2334577999999999999999
Q ss_pred eeeeeeEEeCCCceEEEEEccCCCchhhhhhhc--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC
Q 007668 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER--SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442 (594)
Q Consensus 365 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 442 (594)
|+++++++.+....++||||+++++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998743 3469999999999999999999995 49999999999999999
Q ss_pred CCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHH
Q 007668 443 NLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVG 521 (594)
Q Consensus 443 ~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~ 521 (594)
++.++|+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||........ ...
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHH
Confidence 999999999999876543322 2234568999999998864 588999999999999999999999976433221 111
Q ss_pred HHHHHh-cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 522 WLNFLI-SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 522 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
+..... ........+++............+.+++.+||+.||++|||+++|++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111111 12223344555556667788889999999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=347.12 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=208.5
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|+..+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.++++++||||+++++++......++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45789999999999999999975 56899999999765555567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 9999999999763 58999999999999999999995 49999999999999999999999999999876544332
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
.....||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ......... .. . ..+
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~-~~-----~-~~~ 239 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT-PE-----L-QNP 239 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS-CC-----C-SCG
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCC-CC-----C-CCc
Confidence 3445799999999999999999999999999999999999999965432211 111111110 00 0 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+..+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 334567899999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=361.97 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=210.6
Q ss_pred hcCCCccceeeeecceEEEEEEec--------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 375 (594)
.++|...+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888899999999999999753 3567999999754 333456799999999999 899999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
...++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999998643 348999999999999999999995 499999999999999
Q ss_pred cCCCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 99999999999999866543321 1223456889999999999999999999999999999999 999987643221
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
......... ....+...+..+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 314 ---~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 ---LFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ---HHHHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111111 011222344679999999999999999999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=363.55 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=201.3
Q ss_pred hcCCCccceeeeecceEEEEEEec----CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
..+|+..+.||+|+||.||+|... ++..||||+++.. .....+.+.+|++++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999865 5778999999753 34445679999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.++++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999998777789999999999999999999995 49999999999999999999999999999876543
Q ss_pred Ccee--eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 461 ESHI--TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 461 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
.... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .......... .
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~------~~~~i~~~~~--~--- 269 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD------VIKAVDEGYR--L--- 269 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH------HHHHHHTTEE--C---
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC--C---
Confidence 3221 122345778999999999999999999999999999998 999986542211 1111111110 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
+ .+...+..+.+++.+||+.||++||++.+|++.|++....
T Consensus 270 ~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 P----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp C----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0 1123446799999999999999999999999999886543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=347.61 Aligned_cols=261 Identities=23% Similarity=0.344 Sum_probs=215.0
Q ss_pred CCCCHHHHHHHhcC----------CCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCC
Q 007668 295 LPYSSKDIIKKLET----------LDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHR 363 (594)
Q Consensus 295 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 363 (594)
.+++.+++..+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 46788888888764 566779999999999999876 7999999999866655667899999999999999
Q ss_pred eeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC
Q 007668 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN 443 (594)
Q Consensus 364 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~ 443 (594)
||+++++++......++||||+++++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999999864 469999999999999999999995 499999999999999999
Q ss_pred CcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHH
Q 007668 444 LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWL 523 (594)
Q Consensus 444 ~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~ 523 (594)
+.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------~~ 250 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AM 250 (321)
T ss_dssp CCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH
T ss_pred CcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH
Confidence 99999999999876543322 234579999999999999999999999999999999999999997532211 11
Q ss_pred HHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 524 NFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...... ..+... .....+..+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~------~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 KRLRDS------PPPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHS------SCCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhcC------CCCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 111111 11233467899999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=354.20 Aligned_cols=265 Identities=28% Similarity=0.437 Sum_probs=209.0
Q ss_pred hcCCCccceeeeecceEEEEEEe-----cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--CCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 378 (594)
.++|+..+.||+|+||.||++.+ .+++.||||++........+.+.+|++++.+++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788889999999999999974 3688999999987776667789999999999999999999999854 3558
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999998766679999999999999999999995 499999999999999999999999999998765
Q ss_pred cCCce--eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhccc---------chHHHHHHHHh
Q 007668 459 DEESH--ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG---------LNIVGWLNFLI 527 (594)
Q Consensus 459 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~ 527 (594)
..... ......++..|+|||.+.+..++.++||||||+++|||++|..|+........ ...........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 43321 12234577889999999999999999999999999999999999875432200 00000001111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
... .....+...+..+.+++.+||+.||++|||++|+++.|++...
T Consensus 246 ~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 246 KNN--------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HTT--------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcc--------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111 1111223445779999999999999999999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=355.40 Aligned_cols=265 Identities=28% Similarity=0.372 Sum_probs=206.4
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc----eEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS----KLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~lv 381 (594)
.++|+..+.||+|+||+||+|... ++.||||++..... ....+.+|+.++.+++||||+++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467888999999999999999876 78999999975433 24456678999999999999999999977543 6899
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-------CCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-------SPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
|||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ +++|+||||||+|||++.++.+||+|||++
T Consensus 101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 999999999999976 34999999999999999999999420 129999999999999999999999999999
Q ss_pred cccccCCce-eeeeeecccCccCccccccC-----CCCccchhhhHHHHHHHHHhCCCCCCcchhcccch----------
Q 007668 455 KLLEDEESH-ITTIVAGTFGYLAPEYMQSG-----RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN---------- 518 (594)
Q Consensus 455 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~---------- 518 (594)
+........ ......||+.|+|||++.+. .++.++||||||+++|||++|+.||..........
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 876543322 22335789999999998863 45678899999999999999999997643322111
Q ss_pred HHHHHHHHhcccccccccCCCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEG--VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
...+...... . ...+.... ........+.+++.+||+.||++|||++||++.|++.
T Consensus 259 ~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 259 LEDMQEVVVH-K----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HHHHHHHHTT-S----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhhhhhhhc-c----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111 1 11111111 1234566799999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=364.52 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=210.1
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|...+.||+|+||.||+|... +++.||||.++... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999886 78999999987542 3334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++|+|.++++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 999999999998776779999999999999999999995 49999999999999999999999999999865432211
Q ss_pred ee-eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 464 IT-TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 464 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.. ....+++.|+|||.+.++.++.++||||||+++|||++ |..||....... .......... .
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~---------~ 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGGR---------L 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH------HHHHHHTTCC---------C
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC---------C
Confidence 11 12235778999999998899999999999999999998 999987643221 1111111110 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
..+...+..+.+++.+||+.||++|||++++++.|++..
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 112233467899999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=348.28 Aligned_cols=257 Identities=22% Similarity=0.347 Sum_probs=210.5
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|...+.||+|+||.||++...++..||+|++...... .+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 4578888999999999999999998999999999864433 467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++...........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 9999999998766779999999999999999999995 4999999999999999999999999999987654332223
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||....... ........ ... ..+
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~--~~~-------~~~ 243 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQG--LRL-------YRP 243 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTT--CCC-------CCC
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHhcc--cCC-------CCC
Confidence 33456788999999999999999999999999999998 999987643221 11111111 000 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
...+..+.+++.+||+.||++|||++|+++.|++.+.
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 2223678999999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=346.77 Aligned_cols=263 Identities=26% Similarity=0.365 Sum_probs=208.1
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||.||++... ++..||+|.+... .....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 46888899999999999999754 6899999998542 3334567899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 91 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp ECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999764 569999999999999999999995 4999999999999999999999999999987665443
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.......||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... .......... ... ...
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~-~~~----~~~ 235 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSV-PNV----TTD 235 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCC-CCH----HHH
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccC-CCc----chh
Confidence 33445679999999999999999999999999999999999999997643211 1111111100 000 000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhcccCCCC
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRP-TMHRVVQILESEVMTPC 584 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~~~~~~~ 584 (594)
.....+..+.+++.+|++.||++|| +++++.+.|++.+....
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 1223346799999999999999999 99999999998776543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=353.71 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=206.1
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
..+|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++......++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788999999999999999987 57999999999753 3344567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++..+ ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 94 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp CCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred ECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 999999999999764 569999999999999999999995 4999999999999999999999999999986654322
Q ss_pred eeeeeeecccCccCccccccCCCC-ccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRAT-EKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....||+.|+|||++.+..+. .++||||+|+++|||++|+.||+..... ...........
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~~---------- 231 (328)
T 3fe3_A 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLRGKY---------- 231 (328)
T ss_dssp --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC----------
T ss_pred --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC----------
Confidence 2345799999999999887764 8999999999999999999999764322 11111111110
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011223467889999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=347.41 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=198.3
Q ss_pred hcCCCccceeeeecceEEEEEEecC----CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.++|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++. ....++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678889999999999999997653 457999998753 3344567899999999999999999999985 456889
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 999999999999998766679999999999999999999995 49999999999999999999999999999876654
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .. .......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~---~~i~~~~--------- 234 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRIENGE--------- 234 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HHHHTTC---------
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH---HHHHcCC---------
Confidence 4333344557889999999998999999999999999999997 999987643221 11 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
....+...+..+.+++.+||+.||++|||+.|+++.|++.+
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01122334467899999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=359.74 Aligned_cols=270 Identities=26% Similarity=0.400 Sum_probs=216.5
Q ss_pred CCCCHHHHHHHhcCCCccceeeeecceEEEEEEe------cCCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeee
Q 007668 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLV 366 (594)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv 366 (594)
.++...++....++|...+.||+|+||.||+|.+ .+++.||||+++.. .....+.+.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 4566677777788999999999999999999963 34678999999763 333456799999999999 799999
Q ss_pred eeeeEEeCCCc-eEEEEEccCCCchhhhhhhcCC----------------------------------------------
Q 007668 367 NLRGYCNSPTS-KLLIYDFLPGGSLDEALHERSE---------------------------------------------- 399 (594)
Q Consensus 367 ~l~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------- 399 (594)
++++++.+... .++||||+++|+|.++++....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999987655 8999999999999999975432
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 400 -------------------QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 400 -------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 189999999999999999999954 9999999999999999999999999999876443
Q ss_pred Cc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.. .......||+.|+|||++.+..++.++||||||+++|||++ |..||........ ..........
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~------ 314 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTR------ 314 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCC------
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCC------
Confidence 32 23344678999999999999999999999999999999998 9999976432210 1111111100
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
...+...+..+.+++.+||+.||++|||++|+++.|++.+.
T Consensus 315 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 315 --MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 01122234678999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=369.63 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=212.5
Q ss_pred HhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
..++|...+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++. ....++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 3567888899999999999999999899999999986443 3678999999999999999999999986 5678999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++|+|.++++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999853 2468999999999999999999995 49999999999999999999999999999876543222
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......+++.|+|||++..+.++.++||||||+++|||++ |+.||......+ ........... .
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~---------~ 405 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRM---------P 405 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHHTCCC---------C
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCC---------C
Confidence 2233446789999999999999999999999999999999 999997542211 11111111100 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
.+...+..+.+++.+||+.||++|||+++|++.|++.....
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 12234467999999999999999999999999999876654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=352.96 Aligned_cols=262 Identities=24% Similarity=0.414 Sum_probs=212.6
Q ss_pred HhcCCCccceeeeecceEEEEEEec------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
..++|...+.||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++.+...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3578899999999999999999875 3478999999754 33445779999999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCC
Q 007668 378 KLLIYDFLPGGSLDEALHERS-----------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIK 434 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 434 (594)
.++||||+++|+|.+++.... ..+++..++.++.||++||+|||+ .+|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 999999999999999997632 569999999999999999999995 499999999
Q ss_pred CCCeEecCCCcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcch
Q 007668 435 SSNILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASF 512 (594)
Q Consensus 435 ~~NIll~~~~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~ 512 (594)
|+||+++.++.+||+|||++........ .......||+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986643322 22334567899999999999999999999999999999999 999987542
Q ss_pred hcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 007668 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPC 584 (594)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~ 584 (594)
..+ ....... . .....+...+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 282 ~~~------~~~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 282 HEE------VIYYVRD-G--------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHH------HHHHHHT-T--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred hHH------HHHHHhC-C--------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 211 1111111 1 1111222344679999999999999999999999999998776543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=346.22 Aligned_cols=261 Identities=22% Similarity=0.363 Sum_probs=203.8
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|+..+.||+|+||+||+|...+|+.||+|++... .......+.+|++++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 4678889999999999999999988999999998743 23335678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|++ |+|.+.+......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 997 58888888766779999999999999999999995 4999999999999999999999999999987653322
Q ss_pred eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccc----------
Q 007668 464 ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQ---------- 532 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 532 (594)
......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+. ...... .......
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~-~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPKIFS-ILGTPNPREWPQVQELP 251 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHHHHH-HHCCCCTTTSGGGTTSH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HHCCCChHHhhhhhccc
Confidence 2333568999999999876 5689999999999999999999999976433221 111111 1100000
Q ss_pred ------ccccCCC-CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 ------REIIDPN-CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ------~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....... .....+....++.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 00011223467889999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=341.24 Aligned_cols=257 Identities=27% Similarity=0.394 Sum_probs=212.6
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|...+.||+|+||.||++...+++.||+|++...... .+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 3567888999999999999999988999999999864432 467899999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++++|.+++......+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...........
T Consensus 86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 9999999998776779999999999999999999995 4999999999999999999999999999986644322222
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....++..|+|||.+.+..++.++||||+|+++|||++ |+.||....... ......... .. ..+
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i~~~~--~~-------~~~ 227 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGF--RL-------YKP 227 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTC--CC-------CCC
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHHhcCC--cC-------CCC
Confidence 23456788999999998899999999999999999999 899987532211 111111110 00 011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
...+..+.+++.+||+.||++|||++++++.|++...
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2234678999999999999999999999999987643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=366.31 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=208.1
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|...+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++.+ ...++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 456788899999999999999999888999999986443 35679999999999999999999999876 6789999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++|+|.++++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999853 3569999999999999999999995 499999999999999999999999999998765443333
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||.+.++.++.++||||||+++|||++ |+.||......+ .......... ...
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~---------~~~ 402 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYR---------MPC 402 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC---------CCC
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC---------CCC
Confidence 334557889999999999999999999999999999999 999987542211 1111111110 011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP 585 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 585 (594)
+...+..+.+++.+||+.||++|||++++++.|+.......|
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 223446789999999999999999999999999988766554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=348.35 Aligned_cols=262 Identities=23% Similarity=0.421 Sum_probs=208.3
Q ss_pred cCCCccceeeeecceEEEEEEe-----cCCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--Cce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 378 (594)
+.|+..+.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|++++.+++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577889999999999999983 46899999999753 333457789999999999999999999999776 668
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 99999999999999998777789999999999999999999995 499999999999999999999999999998776
Q ss_pred cCCce--eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcc---------cchHHHHHHHHh
Q 007668 459 DEESH--ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK---------GLNIVGWLNFLI 527 (594)
Q Consensus 459 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~ 527 (594)
..... ......||..|+|||.+.+..++.++||||+|+++|||++|..|+....... .......... .
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT-L 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH-H
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH-H
Confidence 54432 2233567888999999999899999999999999999999999865432110 0000111111 1
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
... .....+...+..+.+++.+||+.||++|||++++++.|++.+
T Consensus 257 ~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEG--------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTT--------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcc--------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 110 111122344577999999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=342.61 Aligned_cols=272 Identities=16% Similarity=0.196 Sum_probs=215.5
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|...+.||+|+||.||+|.. .+++.||||++..... .+.+.+|++++..+ +|+|++++++++.+....++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 4688889999999999999975 5789999998865332 34578899999999 799999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc-----EEEeeccccccccc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-----ARVSDFGLAKLLED 459 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~~l~Dfgl~~~~~~ 459 (594)
+ +++|.+++......+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||++.....
T Consensus 88 ~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 88 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9 99999999876677999999999999999999999 459999999999999987766 99999999987654
Q ss_pred CCce------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccc
Q 007668 460 EESH------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533 (594)
Q Consensus 460 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (594)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 3321 2244579999999999999999999999999999999999999997643221111111111100000000
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC--CCccccccC
Q 007668 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP--CPSDFYDSN 592 (594)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~--~~~~~~~~~ 592 (594)
. .....+..+.+++.+||+.||++|||+++|++.|++..... ...+-|+|+
T Consensus 244 ~--------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 244 E--------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp H--------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred H--------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 0 01123367999999999999999999999999999876543 333455554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=351.73 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=213.0
Q ss_pred cCCCccceeeeecceEEEEEEe-----cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEe--CCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN--SPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~ 379 (594)
++|+..+.||+|+||.||++.+ .++..||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999984 468899999998776666778999999999999999999999886 455688
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 9999999999999998766679999999999999999999995 4999999999999999999999999999987654
Q ss_pred CCcee--eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhccc--------chHHHHHHHHhcc
Q 007668 460 EESHI--TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG--------LNIVGWLNFLISE 529 (594)
Q Consensus 460 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~ 529 (594)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||........ .............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 43322 2334578889999999988899999999999999999999999865432100 0000000001111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
. .....+...+..+.+++.+||+.||++|||++|+++.|+.....
T Consensus 260 ~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 260 G--------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp T--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred c--------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 0 11112334457799999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=347.59 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=205.6
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||.||++... +|+.||+|++++. .......+.+|++++..++||||+++++++.+....++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467888999999999999999775 6899999999753 223456788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999999753 568999999999999999999995 499999999999999999999999999998643322
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .......... . .
T Consensus 160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-~------~-- 223 (337)
T 1o6l_A 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEE-I------R-- 223 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C------C--
T ss_pred C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-C------C--
Confidence 2 234567999999999999999999999999999999999999999754221 1111111111 0 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
.+...+..+.+++.+||+.||++|| +++|+++
T Consensus 224 -~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 -FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1223446789999999999999999 8998875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=348.71 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=201.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCc----EEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|+..+.||+|+||+||+|.+. +++ +||+|.+... .....+.+.+|++++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888899999999999999864 344 3588887643 3344678999999999999999999999998754 789
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||+++|+|.+++......+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999988777899999999999999999999964 9999999999999999999999999999876544
Q ss_pred Cce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||........ .. .+....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~----~~~~~~------- 236 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SS----ILEKGE------- 236 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTC-------
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HH----HHHcCC-------
Confidence 322 2233457889999999999999999999999999999999 9999976432211 11 111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
....+......+.+++.+||+.||++|||+.|+++.|+...
T Consensus 237 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00112234467899999999999999999999999997754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=370.02 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=214.1
Q ss_pred hcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|...+.||+|+||.||+|.+.. +..||||.++.... ..+.|.+|++++++++||||++++++|.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4567888999999999999998875 88999999976443 356799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++|+|.++++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999864 3559999999999999999999995 49999999999999999999999999999876544333
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......++..|+|||++.+..++.++||||||+++|||++ |..||....... .. ....... +. .
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~---~~~~~~~--~~-------~ 439 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY---ELLEKDY--RM-------E 439 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH---HHHHTTC--CC-------C
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHHcCC--CC-------C
Confidence 3333456789999999998999999999999999999999 999987643221 11 1111110 00 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
.+...+..+.+|+.+||+.||++|||+.+|++.|+......
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 12234467899999999999999999999999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=355.00 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=211.0
Q ss_pred hcCCCccceeeeecceEEEEEEec--------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 375 (594)
.++|...+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457888899999999999999753 3457999999764 334457789999999999 899999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
...++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 99999999999999999998643 359999999999999999999995 499999999999999
Q ss_pred cCCCcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---- 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999987654332 22233457889999999999999999999999999999999 99998754322
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
........... ...+...+..+.+++.+||+.||++|||++||++.|++...
T Consensus 301 --~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 --ELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp --HHHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111110 01122334679999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=351.22 Aligned_cols=264 Identities=23% Similarity=0.397 Sum_probs=210.1
Q ss_pred HHhcCCCccceeeeecceEEEEEEe------cCCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 375 (594)
...++|...+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|++++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457888999999999999999986 24568999999753 233456789999999999 899999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcCC----------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSE----------------------QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl 433 (594)
...++||||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 999999999999999999986432 37999999999999999999995 49999999
Q ss_pred CCCCeEecCCCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcc
Q 007668 434 KSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDAS 511 (594)
Q Consensus 434 k~~NIll~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~ 511 (594)
||+||+++.++.++|+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999876544332 2334567889999999999999999999999999999998 99998764
Q ss_pred hhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 007668 512 FIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPC 584 (594)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~ 584 (594)
.... ... ...... .. . ..+...+..+.+++.+||+.||++|||+.|+++.|+..+....
T Consensus 279 ~~~~--~~~----~~~~~~-~~----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDA--NFY----KLIQNG-FK----M---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSH--HHH----HHHHTT-CC----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHH--HHH----HHHhcC-CC----C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 3211 111 111111 00 0 1122234679999999999999999999999999998765543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.14 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=201.4
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|...+.||+|+||.||+|...+++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5688889999999999999998889999999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++ +|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 975 9999998766779999999999999999999995 4999999999999999999999999999986653222 2
Q ss_pred eeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc-------cccccc
Q 007668 465 TTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED-------RQREII 536 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 536 (594)
.....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+. ............ ......
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhccccc
Confidence 233468999999999876 4589999999999999999999999976432211 111111000000 000001
Q ss_pred CCCC--------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNC--------EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~--------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
++.. .......+..+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111 0111234567889999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=346.15 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=195.0
Q ss_pred hcCCCccceeeeecceEEEEEEecCCc----EEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce-
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGN----VFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK- 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~- 378 (594)
.++|...+.||+|+||.||+|...... .||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 467889999999999999999876433 7999998753 334467799999999999999999999999877665
Q ss_pred -----EEEEEccCCCchhhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEE
Q 007668 379 -----LLIYDFLPGGSLDEALHERS-----EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (594)
Q Consensus 379 -----~lv~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l 448 (594)
++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 89999999999999986432 258999999999999999999995 49999999999999999999999
Q ss_pred eecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHH
Q 007668 449 SDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYL 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------HHHHH
Confidence 999999876543322 2233456889999999999999999999999999999999 999987643221 11111
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
.... ....+...+..+.+++.+||+.||++|||+.++++.|++.+..
T Consensus 253 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 IGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 1112223446799999999999999999999999999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=338.65 Aligned_cols=268 Identities=24% Similarity=0.317 Sum_probs=210.6
Q ss_pred cCCCccceeeeecceEEEEEEecC-CcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC--ceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT--SKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~ 382 (594)
++|...+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 467888999999999999998764 8999999997533 233567889999999999999999999987655 678999
Q ss_pred EccCCCchhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe----cCCCcEEEeecccccc
Q 007668 383 DFLPGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKL 456 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~~l~Dfgl~~~ 456 (594)
||+++++|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999986432 39999999999999999999995 499999999999999 7788899999999987
Q ss_pred cccCCceeeeeeecccCccCccccc--------cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQ--------SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 528 (594)
...... .....||+.|+|||++. +..++.++||||||+++|||++|+.||......... .........
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~ 241 (319)
T 4euu_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIIT 241 (319)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHH
T ss_pred cCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhc
Confidence 654432 23356899999999986 567899999999999999999999998653222111 111111111
Q ss_pred ccc---cccc---------cC---CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 529 EDR---QREI---------ID---PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 529 ~~~---~~~~---------~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
... .... .. +............+.+++.+||+.||++|||++|+++...+...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 110 0000 00 11113556778889999999999999999999999998876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=339.11 Aligned_cols=260 Identities=26% Similarity=0.465 Sum_probs=197.9
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
-.+|+..+.||+|+||.||+|...+ .||+|+++.. .....+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 3578889999999999999998653 5999998753 334456799999999999999999999976 4556899999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC-c
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE-S 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~-~ 462 (594)
|+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++....... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 999999999998777789999999999999999999995 499999999999999999999999999998654322 2
Q ss_pred eeeeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.......||+.|+|||.+. +..++.++||||||+++|||++|+.||....... .... ..... ...+.
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~-~~~~~----~~~~~ 246 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-----QIIE-MVGRG----SLSPD 246 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-----HHHH-HHHHT----SCCCC
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-----HHHH-Hhccc----ccCcc
Confidence 2233456899999999986 5678899999999999999999999997532211 1111 11111 11222
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
........+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 222333455789999999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=354.92 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=207.7
Q ss_pred hcCCCccceeeeecceEEEEEEec------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|...+.||+|+||.||+|.+. ++..||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888899999999999999853 4678999999753 344456788999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC---cEEEe
Q 007668 379 LLIYDFLPGGSLDEALHERS------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVS 449 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~~l~ 449 (594)
++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999998643 359999999999999999999995 4999999999999999554 59999
Q ss_pred ecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHh
Q 007668 450 DFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLI 527 (594)
Q Consensus 450 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 527 (594)
|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||...... .......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH
Confidence 9999986533221 22233567899999999999999999999999999999998 99998764322 1111111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.... ...+...+..+.+++.+||+.||++|||+++|++.|+...
T Consensus 301 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111 1112233467899999999999999999999999997753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.84 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=211.2
Q ss_pred hcCCCccceeeeecceEEEEEEe------cCCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|...+.||+|+||.||+|.. .++..||||++... .....+.+.+|++++++++||||+++++++.+....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788889999999999999975 34578999999753 334457789999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 007668 379 LLIYDFLPGGSLDEALHERS-----------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKS 435 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~ 435 (594)
++||||+++|+|.+++.... ..+++..+..++.||++||+|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 99999999999999998642 2389999999999999999999964 999999999
Q ss_pred CCeEecCCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchh
Q 007668 436 SNILLDGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFI 513 (594)
Q Consensus 436 ~NIll~~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 513 (594)
+||+++.++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765443322 233457889999999998889999999999999999999 9999876432
Q ss_pred cccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 514 EKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
.. .. ... .... ....+...+..+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 259 ~~---~~---~~~-~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 ER---LF---NLL-KTGH--------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp GG---HH---HHH-HTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---HH---HHh-hcCC--------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 21 11 111 1110 011122344679999999999999999999999999988654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=359.31 Aligned_cols=251 Identities=26% Similarity=0.391 Sum_probs=206.0
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC-ceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT-SKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~ 384 (594)
.++|...+.||+|+||.||+|... ++.||||+++... ..+.|.+|++++++++||||+++++++.+.. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 457888899999999999999886 7899999998643 3567999999999999999999999987665 68999999
Q ss_pred cCCCchhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++|+|.++++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 999999999987544 37999999999999999999995 499999999999999999999999999998543221
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ........ ..
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~---~~i~~~~~---------~~ 406 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---PRVEKGYK---------MD 406 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH---HHHHTTCC---------CC
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHHcCCC---------CC
Confidence 22357889999999999999999999999999999998 999997643221 11 11111110 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
.+...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 123345779999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=346.23 Aligned_cols=260 Identities=16% Similarity=0.188 Sum_probs=208.4
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|...+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+++++++ +||||+++++++......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 4678889999999999999975 5789999999875432 34588999999999 999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc-----EEEeeccccccccc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-----ARVSDFGLAKLLED 459 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~~l~Dfgl~~~~~~ 459 (594)
+ +++|.+++......+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 9 9999999987667899999999999999999999954 9999999999999998887 99999999987654
Q ss_pred CCce------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccc
Q 007668 460 EESH------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533 (594)
Q Consensus 460 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (594)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..............
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL---KERYQKIGDTKRAT 239 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH---HHHHHHHHHHHHHS
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH---HHHHHHHHhhhccC
Confidence 3321 12346799999999999999999999999999999999999999976432211 11111111000000
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
. . .......+ .+.+++.+||+.||.+||++++|.+.|++...
T Consensus 240 ~-~----~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 240 P-I----EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp C-H----HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred C-H----HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 0 0 00001122 79999999999999999999999999987644
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=346.23 Aligned_cols=252 Identities=26% Similarity=0.343 Sum_probs=208.6
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.+.|...+.||+|+||.||+|... +++.||+|.+..........+.+|++++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467889999999999999999765 6889999999876555566799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec--CCCcEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999998766679999999999999999999995 4999999999999997 457899999999987765432
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.....||+.|+|||++.+..++.++||||||+++|||++|..||....... ......... ..+++ .
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~i~~~~---~~~~~---~ 272 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCD---WEFDE---D 272 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCC---CCCCS---S
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC---CCCCc---c
Confidence 234569999999999999999999999999999999999999997643211 111111110 00111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11233467899999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=353.05 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=202.6
Q ss_pred CCCccceeeeecceEEEEEEecC--C--cEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-CCceEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD--G--NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSKLLI 381 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv 381 (594)
.|...+.||+|+||.||+|...+ + ..||+|.++.. .....+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 35566899999999999997642 2 36899988753 33446789999999999999999999998754 4577899
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.++++.....+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999998777779999999999999999999995 499999999999999999999999999998664432
Q ss_pred ce---eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 462 SH---ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 462 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+ ... ....... .
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~---~~~~~~~---~-- 315 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV---YLLQGRR---L-- 315 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH---HHHTTCC---C--
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH---HHHcCCC---C--
Confidence 21 1233457889999999999999999999999999999999 677776532211 111 1111110 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCcccccc
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDS 591 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~~~~ 591 (594)
..+...+..+.+++.+||+.||++|||++|+++.|++.........|..-
T Consensus 316 ----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~~ 365 (373)
T 3c1x_A 316 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV 365 (373)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCC
T ss_pred ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceeec
Confidence 11122346789999999999999999999999999998887776665543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.95 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=210.6
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccch---hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC
Q 007668 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNE---GFDRFFERELEILGSIKHRYLVNLRGYCNSP 375 (594)
Q Consensus 300 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 375 (594)
.++....++|+..++||+|+||+||+|.... ++.||+|++.+... .....+.+|+.++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3344446789999999999999999998765 78899999975321 2233488999999999999999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
...++||||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~ 223 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence 99999999999999999998766789999999999999999999995 499999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||......+ .........
T Consensus 224 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~ 297 (437)
T 4aw2_A 224 KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHK 297 (437)
T ss_dssp ECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHH
T ss_pred hcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHhhhhcc
Confidence 77655544445568999999999987 4578999999999999999999999997643221 111111111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDD--RPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~ 574 (594)
. ...+ +......+..+.+|+.+|+..+|++ ||+++|+++
T Consensus 298 ~-~~~~----p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 E-RFQF----PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp H-HCCC----CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred c-cccC----CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0 0011 1111123467899999999888888 999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=337.90 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=205.2
Q ss_pred hcCCCccceeeeecceEEEEEEecC-C-------cEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-G-------NVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
.++|...+.||+|+||.||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3577888999999999999997653 3 4799999987666667889999999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc--------EEEe
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--------ARVS 449 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~~l~ 449 (594)
.++||||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeec
Confidence 999999999999999998766669999999999999999999995 49999999999999998877 9999
Q ss_pred ecccccccccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCC-CCcchhcccchHHHHHHHHh
Q 007668 450 DFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRP-TDASFIEKGLNIVGWLNFLI 527 (594)
Q Consensus 450 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~ 527 (594)
|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|..| +...... .......
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~~~~~~ 232 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RKLQFYE 232 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHH
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HHHHHhh
Confidence 99998765432 22457999999999987 6799999999999999999996554 4332111 1111111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 007668 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPC 584 (594)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~ 584 (594)
... .+.. ..+..+.+++.+||+.||++|||++|+++.|++...+..
T Consensus 233 ~~~----~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 233 DRH----QLPA-------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp TTC----CCCC-------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ccC----CCCC-------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 111 1111 112458899999999999999999999999998876543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=344.09 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=204.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchh------hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEG------FDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.+.|...+.||+|+||.||++... +|+.||+|.+...... ..+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356888999999999999999765 5899999999753321 346789999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC----cEEEeecccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLA 454 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~~l~Dfgl~ 454 (594)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999975 3579999999999999999999995 4999999999999998776 7999999999
Q ss_pred cccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
........ .....||+.|+|||++.+..++.++||||+|+++|+|++|..||....... ......... .
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~~~~---~ 235 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITAVS---Y 235 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC---C
T ss_pred eEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC---C
Confidence 87654322 234579999999999999999999999999999999999999997643221 111111100 0
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+++ ......+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 DFDE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 000123466899999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=346.13 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=203.2
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
..+|...+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45788899999999999999986 578999999986521 22345789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 78999988764 5699999999999999999999965 99999999999999999999999999998765433
Q ss_pred ceeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
. .....||+.|+|||++.+..+ ++++||||+|+++|+|++|+.||+....... ...+....
T Consensus 163 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~~ 224 (336)
T 3h4j_B 163 F--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSCV 224 (336)
T ss_dssp T--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSSC
T ss_pred c--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcCC
Confidence 2 234569999999999988775 7899999999999999999999976432211 00111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+...+..+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122334567899999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=339.75 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=208.1
Q ss_pred cCCCccceeeeecceEEEEEEecC----CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEE-eCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYC-NSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~l 380 (594)
.+|...+.||+|+||.||+|...+ ...+|+|.+... .....+.+.+|++++++++||||+++++++ ......++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 357778999999999999997643 235899998753 334456789999999999999999999986 45567889
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 999999999999998767779999999999999999999995 49999999999999999999999999999876543
Q ss_pred Cc---eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 461 ES---HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 461 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
.. .......||+.|+|||.+.+..++.++||||+|+++|||++ |.+||....... .. ....... ..
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~---~~~~~~~--~~-- 251 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---IT---VYLLQGR--RL-- 251 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HH---HHHHTTC--CC--
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HH---HHHhcCC--CC--
Confidence 32 12234567889999999999999999999999999999999 555554432211 11 1111111 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCccc
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDF 588 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~ 588 (594)
..+...+..+.+++.+||+.||++|||++|+++.|++.........|
T Consensus 252 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~~y 298 (298)
T 3f66_A 252 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 298 (298)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCSCC
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccCCC
Confidence 11122346799999999999999999999999999998876665544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=340.23 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=210.4
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|...+.||+|+||.||+|...++..||+|.+..... ..+.+.+|++++++++||||+++++++.+ ...++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 467888999999999999999998888999999876433 35678999999999999999999999864 4689999999
Q ss_pred CCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999997532 369999999999999999999995 499999999999999999999999999998776544333
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ......... .. ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~--~~-------~~ 231 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGY--RM-------VR 231 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTC--CC-------CC
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHhccc--CC-------CC
Confidence 334457889999999998889999999999999999999 899986532211 111111110 00 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
+...+..+.+++.+|++.||++|||++++++.|++....
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 223346799999999999999999999999999886543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=339.72 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=201.6
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhh--CCCCeeeeeeeEEeC----CCceE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS--IKHRYLVNLRGYCNS----PTSKL 379 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~----~~~~~ 379 (594)
.++|+..+.||+|+||+||+|.. +++.||||++.... ...+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35788999999999999999987 68999999986532 3455667776666 799999999998643 34578
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----SPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
+||||+++|+|.++++. ..+++..+..++.||+.||+|||... +.+|+||||||+|||++.++.+||+|||++
T Consensus 83 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999999999964 46999999999999999999999311 349999999999999999999999999999
Q ss_pred cccccCCcee---eeeeecccCccCccccccC------CCCccchhhhHHHHHHHHHhC----------CCCCCcchhcc
Q 007668 455 KLLEDEESHI---TTIVAGTFGYLAPEYMQSG------RATEKTDVYSFGVLVLEVLSG----------KRPTDASFIEK 515 (594)
Q Consensus 455 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~vl~elltg----------~~p~~~~~~~~ 515 (594)
+......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8765443332 1234799999999999876 445799999999999999999 77775432221
Q ss_pred cchHHHHHHHHhcccccccccCCCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 516 GLNIVGWLNFLISEDRQREIIDPNCEG--VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
. ........... .. ..+..+. .....+..+.+++.+||+.||++|||++||++.|++.
T Consensus 241 ~-~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 P-SFEDMRKVVCV-DQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp C-CHHHHHHHHTT-SC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred c-chhhhhHHHhc-cC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 11111111111 11 1111111 2345678899999999999999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.32 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=201.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999766 78999999986432 2234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~- 462 (594)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++..+.....
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999753 459999999999999999999995 4999999999999999999999999999986643322
Q ss_pred eeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||........ ....+. .... . .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~---~~~~-----~----~ 228 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK---EKKT-----Y----L 228 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH---TTCT-----T----S
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh---cccc-----c----C
Confidence 22234679999999999987765 7899999999999999999999976432211 111110 0000 0 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.........+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 011233467889999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=334.63 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=195.5
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccch----hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||.||+|... ++.||||+++.... ...+.+.+|+++++.++||||+++++++.+....++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 457888899999999999999875 88999999875322 2346789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC--------CCcEEEeeccc
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--------NLEARVSDFGL 453 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------~~~~~l~Dfgl 453 (594)
|||+++++|.+++.. ..+++..+..++.|++.||+|||+....+|+||||||+||+++. ++.++|+|||+
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999999863 56999999999999999999999751123999999999999985 67899999999
Q ss_pred ccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccc
Q 007668 454 AKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533 (594)
Q Consensus 454 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (594)
+........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ...... ....
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~ 232 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAM-NKLA 232 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHT-SCCC
T ss_pred ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhc-CCCC
Confidence 986554322 234689999999999999999999999999999999999999976422110 011111 1111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
. ..+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 233 ~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 233 L-------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp C-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C-------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1 1122344679999999999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=347.31 Aligned_cols=264 Identities=20% Similarity=0.357 Sum_probs=213.9
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEe
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCN 373 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 373 (594)
++....++|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999764 36789999997543 334557899999999999999999999999
Q ss_pred CCCceEEEEEccCCCchhhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHERS---------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~ 444 (594)
+....++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 9999999999999999999997532 4579999999999999999999954 999999999999999999
Q ss_pred cEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHH
Q 007668 445 EARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGW 522 (594)
Q Consensus 445 ~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~ 522 (594)
.+||+|||++.......... .....||+.|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~ 249 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV 249 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HH
Confidence 99999999998665433221 223457889999999999999999999999999999999 88998653221 11
Q ss_pred HHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 523 LNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
........ ....+...+..+.+++.+||+.||++|||+.|+++.|++.+..
T Consensus 250 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 250 LRFVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11111111 1112223446789999999999999999999999999987664
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.39 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=205.2
Q ss_pred hcCCCccceeeeecceEEEEEEecC----CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.++|...+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|++++++++||||+++++++.+ ...++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999997643 235999998764 33446779999999999999999999999865 45689
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++++|.+++......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 999999999999998777779999999999999999999995 49999999999999999999999999999876654
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... .......
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~---~~~~~~~-------- 232 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG---VLEKGDR-------- 232 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH---HHHHTCC--------
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH---HHhcCCC--------
Confidence 4333344567889999999998999999999999999999998 999986532221 111 1111100
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
...+...+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 233 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 233 -LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 0011223467899999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=333.72 Aligned_cols=252 Identities=30% Similarity=0.540 Sum_probs=203.0
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhh-------HHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGF-------DRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
++|+..+.||+|+||.||+|... +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888899999999999999774 78999999986432211 167899999999999999999999986654
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCCeEecCCCc-----EEEeec
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR--IIHRDIKSSNILLDGNLE-----ARVSDF 451 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~-----~~l~Df 451 (594)
++||||+++|+|.+.+......+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 799999999999999987777899999999999999999999954 7 999999999999987776 999999
Q ss_pred ccccccccCCceeeeeeecccCccCccccc--cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 452 GLAKLLEDEESHITTIVAGTFGYLAPEYMQ--SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 452 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
|+++.... ......||+.|+|||.+. ...++.++||||+|+++|||++|+.||....... ..........
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~ 245 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREE 245 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHHS
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhcc
Confidence 99975433 233456899999999983 4567899999999999999999999997543221 1111111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.... ..+...+..+.+++.+||+.||++|||++|+++.|++.
T Consensus 246 -~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 246 -GLRP-------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -CCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -CCCC-------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 12223446799999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.72 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=215.1
Q ss_pred HhcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
..++|+..+.||+|+||.||+|.... +..||+|.+..... ..+.+.+|++++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35678888999999999999998765 78899999876433 35678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 384 FLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
|+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999863 35599999999999999999999965 999999999999999999999999999988776555
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.......+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||........ . ...... .. .
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~---~~~~~~--~~-------~ 231 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y---ELLEKD--YR-------M 231 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H---HHHHTT--CC-------C
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---HHHhcc--CC-------C
Confidence 55555667889999999999999999999999999999999 9999876432211 1 111110 00 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
..+...+..+.+++.+|++.||++|||++|+++.|++...
T Consensus 232 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 232 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 1122334679999999999999999999999999987644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=340.14 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=198.2
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|+..+.||+|+||.||++... ++.||+|++.... ..+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 356788899999999999999875 7889999987533 35678999999999999999999998874 479999999
Q ss_pred CCCchhhhhhhcCC--CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc-EEEeecccccccccCCc
Q 007668 386 PGGSLDEALHERSE--QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE-ARVSDFGLAKLLEDEES 462 (594)
Q Consensus 386 ~~gsL~~~l~~~~~--~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~~l~Dfgl~~~~~~~~~ 462 (594)
++|+|.+++..... .+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999985432 4789999999999999999999642369999999999999998876 799999999765432
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......... .. ...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~--------~~~ 224 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GT--------RPP 224 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TC--------CCC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CC--------CCC
Confidence 123458999999999999999999999999999999999999997532110 111111111 10 011
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
.....+..+.+++.+||+.||++|||++|+++.|+....
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 112334678999999999999999999999999987543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.67 Aligned_cols=251 Identities=21% Similarity=0.312 Sum_probs=206.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+++++.++||||+++++++.+....++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 357888999999999999999765 57889999887543 3356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC--CCcEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--NLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~~l~Dfgl~~~~~~~~~ 462 (594)
+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 99999999998766679999999999999999999995 49999999999999986 7899999999998775443
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......||+.|+|||++.+..++.++||||+|+++|+|++|..||....... ........... ++. .
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~---~~~---~ 225 (321)
T 1tki_A 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYT---FDE---E 225 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCC---CCH---H
T ss_pred -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCCCC---CCh---h
Confidence 2344678999999999998889999999999999999999999997643221 11111111100 000 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00123467899999999999999999999987
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=341.59 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=212.4
Q ss_pred hcCCCccceeeeecceEEEEEEe------cCCcEEEEEeecccch-hhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLNE-GFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 377 (594)
.++|...+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++.++ +||||+++++++.+...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999975 3467899999975432 3457799999999999 99999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 378 KLLIYDFLPGGSLDEALHERSE-----------------QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
.++||||+++|+|.+++..... .+++..+..++.||+.||+|||+ .+|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999986432 48999999999999999999995 499999999999999
Q ss_pred cCCCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
+.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 99999999999999877654432 2234557889999999999999999999999999999999 9999876432210
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
.. ...... .... .+...+..+.+++.+||+.||++|||++|+++.|++.+..
T Consensus 257 ~~----~~~~~~-~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 FY----KMIKEG-FRML-------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HH----HHHHHT-CCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHhccC-CCCC-------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 11 111111 1111 1122346789999999999999999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=332.59 Aligned_cols=253 Identities=23% Similarity=0.342 Sum_probs=204.4
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC--CceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP--TSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 381 (594)
.++|...+.||+|+||.||+|... ++.||||++... .....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467888999999999999999886 889999999753 334456799999999999999999999999877 778999
Q ss_pred EEccCCCchhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 382 YDFLPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|||+++|+|.+++..... .+++..+..++.||+.||+|||+. ..+++||||||+||+++.++.++++|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 999999999999986543 589999999999999999999954 222999999999999999999999999887653332
Q ss_pred CceeeeeeecccCccCccccccCCCCc---cchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATE---KTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
...||+.|+|||.+.+...+. ++||||||+++|||++|+.||....... ......... ..
T Consensus 167 ------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~~---- 229 (271)
T 3kmu_A 167 ------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEG-LR---- 229 (271)
T ss_dssp ------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSC-CC----
T ss_pred ------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcC-CC----
Confidence 235799999999998765444 8999999999999999999997542211 111111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
+ ..+...+..+.+++.+||+.||++|||++|+++.|++..
T Consensus 230 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 P---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1 112234467999999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.35 Aligned_cols=267 Identities=26% Similarity=0.433 Sum_probs=212.2
Q ss_pred hcCCCccceeeeecceEEEEEEec--------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD--------DGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 375 (594)
.++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888999999999999999763 5678999999754 333456789999999999 899999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
...++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 99999999999999999998643 248999999999999999999995 499999999999999
Q ss_pred cCCCcEEEeecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
+.++.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 999999999999998765443222 233457889999999998889999999999999999999 999987542221
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCccccc
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYD 590 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~~~ 590 (594)
.......... ...+...+..+.+++.+||+.||++|||++|+++.|++.+......+|.+
T Consensus 268 ---~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~~~~~ 327 (334)
T 2pvf_A 268 ---LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLD 327 (334)
T ss_dssp ---HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC------
T ss_pred ---HHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccCcccC
Confidence 1111111110 01122334678999999999999999999999999999876555555543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.32 Aligned_cols=259 Identities=22% Similarity=0.340 Sum_probs=207.9
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 376 (594)
+.....++|+..+.||+|+||+||++... +|+.||+|++.+.. ....+.+.+|.+++..++||||+++++++.+..
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 33444678999999999999999999875 68999999997532 222345888999999999999999999999999
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
..++||||+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 9999999999999999998766689999999999999999999995 4999999999999999999999999999987
Q ss_pred cccCCceeeeeeecccCccCccccc-------cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQ-------SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
............+||+.|+|||++. +..++.++|||||||++|||++|+.||......+ ........
T Consensus 212 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~ 285 (412)
T 2vd5_A 212 LRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------TYGKIVHY 285 (412)
T ss_dssp CCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTH
T ss_pred ccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------HHHHHHhc
Confidence 7655444444568999999999987 3568999999999999999999999997643221 11111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDR---PTMHRVVQ 574 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~ev~~ 574 (594)
... . ..+......+..+.+++.+||. +|++| |+++|+++
T Consensus 286 ~~~--~---~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 286 KEH--L---SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHH--C---CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccC--c---CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 0 0111112234678999999999 99998 58888875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=347.73 Aligned_cols=250 Identities=22% Similarity=0.363 Sum_probs=199.3
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 380 (594)
.++|+..+.||+|+||+||+|... +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 567889999999999999999876 57889999997532 22234578899999887 89999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999764 569999999999999999999995 49999999999999999999999999999863322
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhccc--chHHHHHHHHhcccccccccCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG--LNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..........+.....
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 2 223456799999999999999999999999999999999999999965322111 1111111111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
..+...+..+.+|+.+||+.||++||++
T Consensus 280 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ---RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1122344678999999999999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.95 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=197.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc------
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS------ 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 377 (594)
.++|+..+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888999999999999999876 7899999999753 33456789999999999999999999999855432
Q ss_pred ---------------------------------------------------eEEEEEccCCCchhhhhhhcC--CCCCHH
Q 007668 378 ---------------------------------------------------KLLIYDFLPGGSLDEALHERS--EQLDWD 404 (594)
Q Consensus 378 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~--~~l~~~ 404 (594)
.++||||+++|+|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 789999999999999998643 336777
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-----------eeeeeeecccC
Q 007668 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-----------HITTIVAGTFG 473 (594)
Q Consensus 405 ~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~-----------~~~~~~~gt~~ 473 (594)
.++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 899999999999999995 4999999999999999999999999999987765422 11233569999
Q ss_pred ccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHH
Q 007668 474 YLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLA 553 (594)
Q Consensus 474 y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 553 (594)
|+|||++.+..++.++||||||+++|||++|..|+..... .... ......+.........+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~--------~~~~---------~~~~~~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--------IITD---------VRNLKFPLLFTQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH--------HHHH---------HHTTCCCHHHHHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH--------HHHH---------hhccCCCcccccCChhHHH
Confidence 9999999999999999999999999999998877432110 0000 0011111122344567889
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 007668 554 VATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 554 l~~~cl~~dP~~RPs~~ev~~ 574 (594)
++.+||+.||++|||++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.95 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=200.3
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 379 (594)
..++|+..+.||+|+||.||+|... +++.||+|++++. .....+.+.+|.+++..+ +||||+++++++.+....+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999765 5899999999753 233456688899999988 6999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999764 569999999999999999999995 4999999999999999999999999999985433
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.. ......+||+.|+|||++.+..++.++||||+|+++|||++|+.||......+ ..........
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~-------- 241 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDEV-------- 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC--------
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC--------
Confidence 22 22345679999999999998899999999999999999999999997643221 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTM------HRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ev~~ 574 (594)
..+......+.+++.+||+.||++||++ +|+++
T Consensus 242 --~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0112234678999999999999999998 66654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=342.83 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=203.2
Q ss_pred cCCCccceeeeecceEEEEEEecC-----CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|...+.||+|+||.||+|.... +..||+|.++.. .......+.+|++++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 356667899999999999997653 235999999753 33345678999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.+++......+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 9999999999999987777899999999999999999999964 9999999999999999999999999999876543
Q ss_pred Cce--eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 461 ESH--ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 461 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...........
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~~~~~~------ 268 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFR------ 268 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC------
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHCCCc------
Confidence 221 1222346789999999999999999999999999999999 99998653221 11111111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
...+...+..+.+++.+||+.||++||++.++++.|++....
T Consensus 269 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 269 ---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011223446789999999999999999999999999886544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.88 Aligned_cols=261 Identities=27% Similarity=0.427 Sum_probs=213.9
Q ss_pred HhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
..++|...+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|+++|++++||||+++++++.+ ...++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3567888899999999999999999888999999986443 35679999999999999999999999876 678999999
Q ss_pred cCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++|+|.++++.. ...+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999853 3569999999999999999999995 49999999999999999999999999999876543222
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......... . .
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~--~-------~ 484 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYR--M-------P 484 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH------HHHHHHTTCC--C-------C
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC--C-------C
Confidence 2223446789999999999999999999999999999999 999987542211 1111111110 0 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP 585 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 585 (594)
.+...+..+.+|+.+||+.||++|||+++|++.|+.......|
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 1223446789999999999999999999999999998776554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.79 Aligned_cols=249 Identities=27% Similarity=0.353 Sum_probs=203.4
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch------hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
+.|...+.||+|+||.||++... +|+.||+|.+..... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46788899999999999999775 589999999875322 13567999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC----cEEEeeccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLAK 455 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~~l~Dfgl~~ 455 (594)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||++.
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999975 3569999999999999999999995 4999999999999999877 89999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........ ........
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~----- 233 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVN----- 233 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHTC-----
T ss_pred ECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHhcC-----
Confidence 7654322 2345699999999999989999999999999999999999999975432211 11111000
Q ss_pred cCCCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 IDPNCE-GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 ~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ......+..+.+++.+||+.||++|||++|+++
T Consensus 234 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 000122356889999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=345.05 Aligned_cols=274 Identities=18% Similarity=0.201 Sum_probs=205.6
Q ss_pred cCCCccceeeeecceEEEEEEec----CCcEEEEEeecccchh-----------hHHHHHHHHHHHhhCCCCeeeeeeeE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKLNEG-----------FDRFFERELEILGSIKHRYLVNLRGY 371 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~ 371 (594)
++|...+.||+|+||.||+|... ++..+|+|++...... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 46888899999999999999876 5788999998754321 12346678889999999999999999
Q ss_pred EeC----CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC--c
Q 007668 372 CNS----PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL--E 445 (594)
Q Consensus 372 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~--~ 445 (594)
+.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+||+++.++ .
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCc
Confidence 877 67789999999 999999997643 79999999999999999999995 4999999999999999777 9
Q ss_pred EEEeecccccccccCCce------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchH
Q 007668 446 ARVSDFGLAKLLEDEESH------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI 519 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 519 (594)
+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~ 269 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--A 269 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--H
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--H
Confidence 999999999876533211 11345789999999999999999999999999999999999999965322111 0
Q ss_pred HHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCccccc
Q 007668 520 VGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYD 590 (594)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~~~ 590 (594)
................ ..... ....+..+.+++.+||+.||++|||+++|++.|++......+.|+-.
T Consensus 270 ~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~~~ 337 (345)
T 2v62_A 270 VQTAKTNLLDELPQSV-LKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFST 337 (345)
T ss_dssp HHHHHHHHHHTTTHHH-HHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCCCC
T ss_pred HHHHHHhhcccccHHH-Hhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCccc
Confidence 1111111100000000 00000 01234679999999999999999999999999999887776666543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=336.84 Aligned_cols=264 Identities=26% Similarity=0.395 Sum_probs=208.7
Q ss_pred CCCccceeeeecceEEEEEEecC-C---cEEEEEeecccch-hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce-EEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD-G---NVFALKRIDKLNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK-LLI 381 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lv 381 (594)
.|...+.||+|+||.||+|...+ + ..+|+|.+..... ...+.+.+|++++++++||||+++++++.+.... ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34556899999999999997543 2 3799999876433 3456789999999999999999999999776665 899
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+||+.+|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999987677899999999999999999999964 99999999999999999999999999998654432
Q ss_pred c---eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 462 S---HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 462 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+...... .... .......
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~---~~~~~~~-------- 245 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLT---HFLAQGR-------- 245 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHH---HHHHTTC--------
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHH---HHhhcCC--------
Confidence 1 1223346789999999999999999999999999999999966654322111 1111 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCccc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDF 588 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~ 588 (594)
....+...+..+.+++.+||+.||++|||++++++.|++.........|
T Consensus 246 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 246 -RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred -CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 0111223346789999999999999999999999999998776655544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=334.66 Aligned_cols=262 Identities=21% Similarity=0.322 Sum_probs=201.7
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
++|+..+.||+|+||+||+|... +++.||+|++... .......+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57888899999999999999875 5899999999743 33345678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++ ++.+.+......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9965 67776666567799999999999999999999954 999999999999999999999999999987653322
Q ss_pred eeeeeecccCccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc--cccc---c---
Q 007668 464 ITTIVAGTFGYLAPEYMQSGR-ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE--DRQR---E--- 534 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~---~--- 534 (594)
......||+.|+|||++.+.. ++.++||||+|+++|||++|..|+........ ............ .... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhccccc
Confidence 223456899999999997765 79999999999999999999888543211100 011111100000 0000 0
Q ss_pred -------ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 -------IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 -------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.............+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000111122345577899999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=344.99 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=199.5
Q ss_pred CccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCC
Q 007668 310 DDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 388 (594)
...+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++.+++||||+++++++.+....++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 34578999999999999764 68999999998766556678999999999999999999999999999999999999999
Q ss_pred chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe--cCCCcEEEeecccccccccCCceeee
Q 007668 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL--DGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 9999998766679999999999999999999995 499999999999999 5678999999999987654332 23
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (594)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......... ..... ....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~--~~~~~----~~~~ 314 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACRW--DLEDE----EFQD 314 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCC--CSCSG----GGTT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccC--CCChh----hhcc
Confidence 3468999999999998899999999999999999999999997643221 1111111110 00000 1112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 547 SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 547 ~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+..+.+++.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3467899999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=346.09 Aligned_cols=262 Identities=23% Similarity=0.378 Sum_probs=210.6
Q ss_pred HHHHhcCCCccceeeeecceEEEEEEecC------CcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEe
Q 007668 302 IIKKLETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCN 373 (594)
Q Consensus 302 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 373 (594)
.....++|...+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|++++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 33445788889999999999999998643 2479999997643 33456789999999999 8999999999999
Q ss_pred CCCceEEEEEccCCCchhhhhhhc-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHER-------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
+....++||||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEE
Confidence 999999999999999999999753 2458999999999999999999995 499999999999999
Q ss_pred cCCCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
+.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++ |..||....... .
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~ 275 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--K 275 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--H
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--H
Confidence 99999999999999876543332 2234567889999999999999999999999999999999 999987542211 0
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
. ....... ... . .+...+..+.+++.+||+.||++|||++|+++.|++..
T Consensus 276 ~----~~~~~~~-~~~----~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 F----YKLVKDG-YQM----A---QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp H----HHHHHHT-CCC----C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHHhcC-CCC----C---CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1 1111111 000 0 11122467899999999999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=335.42 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=207.9
Q ss_pred cCCCccc-eeeeecceEEEEEEec---CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDH-IIGSGGFGTVYKLAMD---DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
++|...+ .||+|+||.||+|... ++..||+|+++.. .....+.+.+|++++.+++||||+++++++. ....++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence 3444555 8999999999999754 5788999999864 3344677999999999999999999999994 5568999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++++|.+++......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 99999999999998766779999999999999999999995 499999999999999999999999999998775443
Q ss_pred ceee--eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 462 SHIT--TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 462 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... ....||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. .......
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---~~i~~~~-------- 230 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM---AFIEQGK-------- 230 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH---HHHHTTC--------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HH---HHHhcCC--------
Confidence 3222 22346889999999998889999999999999999998 999987643211 11 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
....+...+..+.+++.+||+.||++||++.++++.|++...
T Consensus 231 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 231 -RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011223345779999999999999999999999999988643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=347.97 Aligned_cols=268 Identities=17% Similarity=0.227 Sum_probs=205.5
Q ss_pred hcCCCccceeeeecceEEEEEEecC------CcEEEEEeecccchhh-----------HHHHHHHHHHHhhCCCCeeeee
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD------GNVFALKRIDKLNEGF-----------DRFFERELEILGSIKHRYLVNL 368 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l 368 (594)
.++|...+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3478889999999999999998765 4789999987543211 1224456667778899999999
Q ss_pred eeEEeCC----CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec--C
Q 007668 369 RGYCNSP----TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--G 442 (594)
Q Consensus 369 ~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~ 442 (594)
++++... ...++||||+ +++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCC
Confidence 9998664 4478999999 999999998876789999999999999999999995 4999999999999999 8
Q ss_pred CCcEEEeecccccccccCCcee------eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhccc
Q 007668 443 NLEARVSDFGLAKLLEDEESHI------TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG 516 (594)
Q Consensus 443 ~~~~~l~Dfgl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~ 516 (594)
++.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~- 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP- 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH-
Confidence 8999999999998765432211 133459999999999999999999999999999999999999997533221
Q ss_pred chHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 517 LNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
........... .....++++.+. ....+..+.+++..||+.||++||+++++++.|++.+..
T Consensus 269 -~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 269 -KYVRDSKIRYR-ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp -HHHHHHHHHHH-HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHHhh-hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 11111111111 111111111110 012236789999999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=351.23 Aligned_cols=256 Identities=21% Similarity=0.324 Sum_probs=207.1
Q ss_pred HHHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 302 IIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 302 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
+....++|...+.||+|+||+||+|... +++.||+|++.+.. ....+.+.+|+.++..++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3344678999999999999999999876 58899999987522 1223458889999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++||||+++|+|.++++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++..
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999999999999975 358999999999999999999995 49999999999999999999999999999877
Q ss_pred ccCCceeeeeeecccCccCccccccCC----CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccc
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSGR----ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (594)
...........+||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .............
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSL 292 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHHHHC
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhccccc
Confidence 655444445678999999999998655 788999999999999999999999764322 1111111111000
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007668 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDD--RPTMHRVVQ 574 (594)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ev~~ 574 (594)
. -+.. ...+..+.+|+.+||+.+|++ ||+++||++
T Consensus 293 ~--~p~~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 293 T--FPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp C--CCTT----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred c--CCCc----ccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0 0111 123467899999999999988 999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=335.05 Aligned_cols=273 Identities=19% Similarity=0.237 Sum_probs=213.0
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEE-eCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC-NSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e 383 (594)
.++|...+.||+|+||.||+|.. .+++.||||++..... .+.+.+|++++..++|+++++.++++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 35788899999999999999986 6789999998865433 24688999999999998877776665 56667799999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccccC
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+ +++|.+++......+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 9999999986667899999999999999999999954 99999999999999 48889999999999876554
Q ss_pred Cce------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 461 ESH------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 461 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................ .
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-H
Confidence 321 123457999999999999999999999999999999999999999764332222111111110000000 0
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC--ccccccC
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP--SDFYDSN 592 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~--~~~~~~~ 592 (594)
.. ....+..+.+++.+||+.||++|||++++++.|++....... .+-|+|+
T Consensus 241 ~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 241 VL-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HH-------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred HH-------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 00 112236799999999999999999999999999987654332 3346664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=331.94 Aligned_cols=249 Identities=25% Similarity=0.441 Sum_probs=185.8
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 56788899999999999999976 578999999986532 22346789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+||+++++|.+++......+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 999999999999987767899999999999999999999954 99999999999999999999999999998765332
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.....
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~- 229 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLADY- 229 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC-
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhccc-
Confidence 2 123356899999999999888999999999999999999999999764322110 00000000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+...+..+.+++.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 112234467899999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=338.58 Aligned_cols=245 Identities=25% Similarity=0.383 Sum_probs=204.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||.||++... +|+.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467888999999999999999775 68999999997532 23356788899999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 999999999999976 356899999999999999999999 459999999999999999999999999999865432
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .......... . .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~-~------~-- 221 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAE-L------R-- 221 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCC-C------C--
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-C------C--
Confidence 23457999999999999999999999999999999999999999764221 1111111111 0 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
.+...+..+.+++.+|++.||++|| +++|+++
T Consensus 222 -~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 222 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1123346789999999999999999 8888874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=341.64 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=201.4
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcE----EEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNV----FALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|...+.||+|+||.||+|... +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 56888899999999999999764 3443 577777542 3345678999999999999999999999998754 789
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||+++|+|.+++......+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999988777899999999999999999999954 9999999999999999999999999999876543
Q ss_pred Cce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... .. .. +....
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~---~~-~~~~~------- 236 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS---SI-LEKGE------- 236 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HH-HHTTC-------
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH---HH-HHcCC-------
Confidence 322 2233456889999999999999999999999999999999 999997643321 11 11 11110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
....+...+..+.+++.+||+.||++|||++|+++.|+.....
T Consensus 237 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 -RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111223446789999999999999999999999999886543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.87 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=202.4
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcE----EEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNV----FALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
++|...+.||+|+||.||+|... +++. ||+|.+.... ......+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46778899999999999999764 3443 7888775432 223356778999999999999999999986 456889
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||+++|+|.+++......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 9999999999999987666799999999999999999999954 9999999999999999999999999999877544
Q ss_pred Cce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
... ......|+..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ....... .
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~~~~---~--- 236 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD---LLEKGER---L--- 236 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH---HHHTTCB---C---
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH---HHHcCCC---C---
Confidence 332 2344567889999999999999999999999999999999 999997643221 111 1111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
..+...+..+.+++.+||+.||++|||++|+++.|++...
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 237 ---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111223457899999999999999999999999987643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=333.72 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=201.5
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
..++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.+++||||+++++++......++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999865 68899999987532 2334678999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999764 5689999999999999999999954 9999999999999999999999999999876554
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............ .
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~------~ 254 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR------P 254 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC------G
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC------c
Confidence 433334557899999999999999999999999999999999999999764322 111111111000 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhcccCCCC
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRP-TMHRVVQILESEVMTPC 584 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~~~~~~~ 584 (594)
.......+..+.+++.+||+.||++|| +++++++.|++.+....
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 011223345789999999999999999 99999999998766543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=338.93 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=200.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 380 (594)
.++|...+.||+|+||.||+|... +++.||+|++.+. .....+.+.+|..++.++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467888999999999999999876 5889999999753 233355688899999988 89999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999764 569999999999999999999995 49999999999999999999999999999864332
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc--hHHHHHHHHhcccccccccCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL--NIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 538 (594)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .........+.....
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 2234467999999999999999999999999999999999999999653211110 001111111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTM 569 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 569 (594)
..+...+..+.+++.+||+.||++||++
T Consensus 237 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ---RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1122344678999999999999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.29 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=196.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch--------------------------hhHHHHHHHHHHHh
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--------------------------GFDRFFERELEILG 358 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 358 (594)
.++|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467888999999999999999764 688999999865321 11246889999999
Q ss_pred hCCCCeeeeeeeEEeC--CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 007668 359 SIKHRYLVNLRGYCNS--PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSS 436 (594)
Q Consensus 359 ~l~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~ 436 (594)
+++||||+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 9999999999999976 5678999999999999987643 5699999999999999999999964 9999999999
Q ss_pred CeEecCCCcEEEeecccccccccCCceeeeeeecccCccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCcchh
Q 007668 437 NILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR---ATEKTDVYSFGVLVLEVLSGKRPTDASFI 513 (594)
Q Consensus 437 NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~ 513 (594)
||+++.++.+||+|||++........ ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999987654432 233457999999999998665 37889999999999999999999975322
Q ss_pred cccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 514 EKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ....... ...... +. ....+..+.+++.+||+.||++|||++|+++
T Consensus 246 ~------~~~~~~~-~~~~~~---~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 M------CLHSKIK-SQALEF---PD----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H------HHHHHHH-HCCCCC---CS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H------HHHHHHh-cccCCC---CC----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1111111 111100 11 1123467899999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=338.15 Aligned_cols=244 Identities=22% Similarity=0.290 Sum_probs=193.6
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||+||+|... +++.||||++.... ......+..|+..+.++ +||||+++++++.+....++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888999999999999999876 78999999986532 22333455566555554 8999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+ +++|.+++......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 7799999987777899999999999999999999964 99999999999999999999999999998765432
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... +.. . ........
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~~~-~-~~~~~~~~------- 272 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------WQQ-L-RQGYLPPE------- 272 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------HHH-H-TTTCCCHH-------
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHH-H-hccCCCcc-------
Confidence 2334568999999999875 799999999999999999999776544211 000 0 00100000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 273 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11123467999999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.15 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=202.2
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-----hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
+.|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+....++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888999999999999999765 68999999986421 1235679999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc---EEEeecccc
Q 007668 381 IYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFGLA 454 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~~l~Dfgl~ 454 (594)
||||+++|+|.+.+... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888643 3458999999999999999999995 49999999999999986554 999999999
Q ss_pred cccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
........ ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ...........
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~i~~~~~~-- 250 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-------LFEGIIKGKYK-- 250 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-------HHHHHHHTCCC--
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-------HHHHHHcCCCC--
Confidence 87654332 233457999999999999999999999999999999999999999764221 11111111000
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 251 -~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 -MNPR---QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -CCHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCcc---ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 00123467899999999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=342.62 Aligned_cols=270 Identities=26% Similarity=0.410 Sum_probs=216.1
Q ss_pred CCCCHHHHHHHhcCCCccceeeeecceEEEEEEe------cCCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeee
Q 007668 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLV 366 (594)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv 366 (594)
.++...+.....++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +||||+
T Consensus 15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence 3555666666678899999999999999999974 356889999997643 33456789999999999 799999
Q ss_pred eeeeEEeCCCc-eEEEEEccCCCchhhhhhhcCCC---------------CCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 007668 367 NLRGYCNSPTS-KLLIYDFLPGGSLDEALHERSEQ---------------LDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430 (594)
Q Consensus 367 ~l~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 430 (594)
++++++..... .++|+||+++|+|.+++...... +++..+..++.||+.||+|||+ .+|+|
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H 171 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIH 171 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence 99999876554 89999999999999999864332 8899999999999999999995 49999
Q ss_pred CCCCCCCeEecCCCcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCC
Q 007668 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPT 508 (594)
Q Consensus 431 ~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~ 508 (594)
|||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654433 22334568899999999999999999999999999999998 99998
Q ss_pred CcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 509 DASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
....... . .... ...... . ..+...+..+.+++.+||+.||++|||+.|+++.|++.+.
T Consensus 252 ~~~~~~~--~---~~~~-~~~~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 252 PGVKIDE--E---FCRR-LKEGTR-----M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp TTCCCSH--H---HHHH-HHHTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchhH--H---HHHH-hccCcc-----C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 6543211 0 1111 111100 0 1112234678999999999999999999999999988654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=340.83 Aligned_cols=259 Identities=24% Similarity=0.391 Sum_probs=205.7
Q ss_pred CCccceeeeecceEEEEEEec-----CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--CCceEE
Q 007668 309 LDDDHIIGSGGFGTVYKLAMD-----DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKLL 380 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 380 (594)
|+..+.||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999988643 68899999998643 3445679999999999999999999999976 456789
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999999763 489999999999999999999964 9999999999999999999999999999877654
Q ss_pred Cce--eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhccc------chHH--HHHHHHhccc
Q 007668 461 ESH--ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG------LNIV--GWLNFLISED 530 (594)
Q Consensus 461 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~------~~~~--~~~~~~~~~~ 530 (594)
... ......||..|+|||.+.+..++.++||||||+++|||++|+.||........ .... ..........
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 332 22345678899999999998999999999999999999999999865432100 0000 0000111110
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.....+...+..+.+++.+||+.||++|||++|+++.|++..
T Consensus 268 --------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 268 --------ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 011122334577999999999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.18 Aligned_cols=273 Identities=19% Similarity=0.240 Sum_probs=209.6
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEE-eCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC-NSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e 383 (594)
.++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+|++++..++|++++..++++ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46789999999999999999976 5788999998654322 23578899999999988877777666 66677799999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccccC
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+ +++|.+++......+++..+..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99 9999999987667899999999999999999999954 99999999999999 78899999999999876544
Q ss_pred Cce------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 461 ESH------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 461 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................ .
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-h
Confidence 321 123457899999999999999999999999999999999999999764332222111111110000000 0
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC--CCccccccC
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP--CPSDFYDSN 592 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~--~~~~~~~~~ 592 (594)
.. ....+..+.+++.+||+.||++|||++++++.|++..... ...+.++|+
T Consensus 241 ~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 241 VL-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp HH-------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred hh-------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 00 0112367999999999999999999999999999876632 223345554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=348.46 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=203.9
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|...+.||+|+||.||++.. .+|+.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 46788899999999999999965 468999999987533 334567899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec---CCCcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~~l~Dfgl~~~~~~ 459 (594)
||+++|+|.+.+..+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||++.....
T Consensus 90 E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 90 DLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp CCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999764 569999999999999999999995 4999999999999998 567899999999987654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
... ......||+.|+|||++.+..++.++||||+|+++|+|++|..||....... ......... .....+.
T Consensus 166 ~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~--~~~~~~~ 236 (444)
T 3soa_A 166 EQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR------LYQQIKAGA--YDFPSPE 236 (444)
T ss_dssp TCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTC--CCCCTTT
T ss_pred CCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhCC--CCCCccc
Confidence 332 2334679999999999999899999999999999999999999996542211 111111111 0111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 237 W----DTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c----ccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 233467899999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=346.45 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=203.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++..++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467889999999999999999765 5789999998653 223356788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 999999999999976 4569999999999999999999995 499999999999999999999999999998765432
Q ss_pred ceeeeeeecccCccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQS---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ..... .
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~~~~~-~-------- 235 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV---HTFET-T-------- 235 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH---HHHHH-C--------
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH---HHHhh-c--------
Confidence 2344679999999999864 45899999999999999999999999754322111111 11110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPT-MHRVVQ 574 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~ 574 (594)
....+...+..+.+++.+||+.||++||+ ++++.+
T Consensus 236 -~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 -VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01122234467999999999999999998 677654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=342.66 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=204.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||.||++... +|+.||+|++.... ....+.+.+|++++..++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467888999999999999999875 68999999997532 23356788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999764 469999999999999999999995 49999999999999999999999999999876543
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-~--------- 255 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGK-V--------- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C---------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHHcCC-C---------
Confidence 23457899999999999999999999999999999999999999764221 1111111111 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
..+...+..+.+++.+||+.||++||+ ++|+++
T Consensus 256 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112234467899999999999999998 888874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=345.85 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=203.5
Q ss_pred HHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCce
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 378 (594)
...++|...+.||+|+||.||+|... +++.||+|++++.. ....+.+..|.+++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45678999999999999999999875 58899999997532 23345678899998876 999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++...
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999999999763 569999999999999999999995 499999999999999999999999999998643
Q ss_pred cCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ......... +
T Consensus 170 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~-------~ 235 (345)
T 1xjd_A 170 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDN-------P 235 (345)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-------C
T ss_pred cCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC-------C
Confidence 3222 2345679999999999999999999999999999999999999997643221 111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMH-RVV 573 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~ 573 (594)
. .+...+..+.+++.+||+.||++||++. +++
T Consensus 236 ~---~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 F---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp C---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C---CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 1122346789999999999999999997 554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=340.66 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=204.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999765 5899999999753 3334567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC---CcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN---LEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~~l~Dfgl~~~~~~ 459 (594)
||+++|+|.+.+..+ ..+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||++.....
T Consensus 108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999998753 5689999999999999999999954 99999999999999865 4599999999987654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... .......... . ....+
T Consensus 184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~-~-~~~~~- 252 (362)
T 2bdw_A 184 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGA-Y-DYPSP- 252 (362)
T ss_dssp CCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-C-CCCTT-
T ss_pred Ccc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC-C-CCCcc-
Confidence 322 23457999999999999989999999999999999999999999753221 1111111110 0 00000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 253 ---~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 ---EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ---GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11233467899999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=339.92 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=194.4
Q ss_pred hcCCCccceeeeecceEEEEEEe----cCCcEEEEEeecccc----hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
.++|+..+.||+|+||.||++.. .+++.||+|++++.. ......+.+|++++++++||||+++++++.....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999987 478999999997532 2234567889999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999764 5689999999999999999999954 9999999999999999999999999999754
Q ss_pred ccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......... .
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~---~--- 238 (327)
T 3a62_A 172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKILKCK---L--- 238 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTC---C---
T ss_pred ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCC---C---
Confidence 43221 2334568999999999999899999999999999999999999997643221 111111110 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+...+..+.+++.+||+.||++|| ++.|+++
T Consensus 239 ----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11122346789999999999999999 6777764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=366.98 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=200.8
Q ss_pred eeeeecceEEEEEEec---CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCCCc
Q 007668 314 IIGSGGFGTVYKLAMD---DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 314 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999764 46679999998643 3356789999999999999999999999976 56899999999999
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee--ee
Q 007668 390 LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT--TI 467 (594)
Q Consensus 390 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~--~~ 467 (594)
|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......... ..
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 999998777779999999999999999999995 4999999999999999999999999999987654332222 22
Q ss_pred eecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHH
Q 007668 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546 (594)
Q Consensus 468 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (594)
..+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ .. ........ ...+..
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~---~~i~~~~~---------~~~p~~ 563 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM---AFIEQGKR---------MECPPE 563 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH---HHHHTTCC---------CCCCTT
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH---HHHHcCCC---------CCCCCc
Confidence 345689999999999999999999999999999998 999997643221 11 11111111 111223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 547 SLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 547 ~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
.+..+.+++.+||+.||++||++.+|++.|+....
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 45779999999999999999999999999988643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=341.63 Aligned_cols=274 Identities=24% Similarity=0.375 Sum_probs=201.0
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHH--HhhCCCCeeeeeeeEEe-----CCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEI--LGSIKHRYLVNLRGYCN-----SPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~-----~~~~~ 378 (594)
.++|...+.||+|+||.||+|.. +++.||||++..... ..+..|.++ +..++||||+++++.+. .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 56888899999999999999976 589999999875332 334444444 55689999999998542 23356
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC------SPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
++||||+++|+|.+++... ..++..+..++.||+.||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 8999999999999999754 3589999999999999999999431 1299999999999999999999999999
Q ss_pred cccccccCCc-------eeeeeeecccCccCcccccc-------CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-
Q 007668 453 LAKLLEDEES-------HITTIVAGTFGYLAPEYMQS-------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL- 517 (594)
Q Consensus 453 l~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~- 517 (594)
++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|..|+.........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987654321 11223469999999999876 35667899999999999999998775432211110
Q ss_pred -h---------HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCc
Q 007668 518 -N---------IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPS 586 (594)
Q Consensus 518 -~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 586 (594)
. ..............+..+...+. .....+..+.+++.+||+.||++|||++|+++.|++.+......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK-ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC-CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccc-cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 0 00111111112222222222221 23456678999999999999999999999999999877655443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.59 Aligned_cols=245 Identities=26% Similarity=0.405 Sum_probs=200.4
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
+.|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4577889999999999999976 578999999987432 223457889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||++ |+|.+.+......+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9996 789888876667899999999999999999999964 9999999999999999999999999999866532
Q ss_pred eeeeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
....||+.|+|||++. .+.++.++||||||+++|||++|+.||...... .......... ....
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~-~~~~---- 273 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-SPAL---- 273 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCC----
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-CCCC----
Confidence 2346899999999984 567899999999999999999999998653221 1111111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+||+.||++|||++++++
T Consensus 274 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 274 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11223466889999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.28 Aligned_cols=262 Identities=22% Similarity=0.359 Sum_probs=189.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|+..+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999765 58999999987533 2334678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 384 FLPGGSLDEALHERS-----EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
|++ |+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999887532 458999999999999999999995 499999999999999999999999999998765
Q ss_pred cCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc--cccc---
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS--EDRQ--- 532 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~--- 532 (594)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ ....-. ....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI--FDIMGTPNESLWPSV 236 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCSCCTTTCGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCChhHhhhh
Confidence 3322 1233468999999999876 46899999999999999999999999764332111100 000000 0000
Q ss_pred --ccccCCCCC----C---------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 --REIIDPNCE----G---------VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 --~~~~~~~~~----~---------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+... . ........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000 0 01123457899999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=337.90 Aligned_cols=261 Identities=24% Similarity=0.334 Sum_probs=206.4
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEe----CCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN----SPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~l 380 (594)
.++|...+.||+|+||.||++.. .+++.||||++........+.+.+|+++++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788899999999999999986 578999999997766666778999999999999999999999986 3456789
Q ss_pred EEEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 381 IYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
|+||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999875 356799999999999999999999964 9999999999999999999999999998765
Q ss_pred ccCCce--------eeeeeecccCccCccccccCC---CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHH
Q 007668 458 EDEESH--------ITTIVAGTFGYLAPEYMQSGR---ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 458 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||......... ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHH----
Confidence 421110 011235799999999987554 688999999999999999999998653322111 1110
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
... ... .+ .....+..+.+++.+||+.||++|||++++++.|+.....
T Consensus 260 ~~~-~~~---~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 VQN-QLS---IP----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHC-C-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred hhc-cCC---CC----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 000 000 00 1123346799999999999999999999999999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=342.98 Aligned_cols=263 Identities=28% Similarity=0.443 Sum_probs=210.2
Q ss_pred cCCCccceeeeecceEEEEEEe-----cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC--ceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-----DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT--SKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~ 379 (594)
++|...+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.... ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4678889999999999999973 468999999998766666778999999999999999999999986544 678
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+|+||+++++|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 9999999999999998776779999999999999999999995 4999999999999999999999999999987765
Q ss_pred CCceee--eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcc------c---chHHHHHHHHhc
Q 007668 460 EESHIT--TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK------G---LNIVGWLNFLIS 528 (594)
Q Consensus 460 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~------~---~~~~~~~~~~~~ 528 (594)
...... ....++..|+|||.+.+..++.++||||||+++|||++|..|+......- . ..........+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 433221 23456778999999998889999999999999999999999976432110 0 000000011111
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
... ....+...+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 278 ~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 278 NNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp TTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 01112334567999999999999999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.06 Aligned_cols=264 Identities=20% Similarity=0.294 Sum_probs=203.0
Q ss_pred hcCCCccceeeee--cceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSG--GFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
..+|+..+.||+| +||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4578899999999 99999999876 68999999997532 3445678899999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 381 IYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999764 3569999999999999999999995 4999999999999999999999999999875432
Q ss_pred CCce------eeeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc---
Q 007668 460 EESH------ITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS--- 528 (594)
Q Consensus 460 ~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 528 (594)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 258 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLL 258 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC---------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCccc
Confidence 2211 1122468999999999987 5789999999999999999999999976332211 0000000000
Q ss_pred ------cc-------------ccccc----------cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 ------ED-------------RQREI----------IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ------~~-------------~~~~~----------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. ..... .+..........+..+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 00000 000000122334567999999999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=335.03 Aligned_cols=268 Identities=25% Similarity=0.380 Sum_probs=202.1
Q ss_pred HHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhh--CCCCeeeeeeeEEeCC----Cc
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS--IKHRYLVNLRGYCNSP----TS 377 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~ 377 (594)
...++|...+.||+|+||.||+|... ++.||||++.... ...+.+|.+++.. ++||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34578999999999999999999876 8999999986533 2344555555554 4899999999998776 67
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----SPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
.++||||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+|||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 8999999999999999975 35899999999999999999999431 2299999999999999999999999999
Q ss_pred cccccccCCceee---eeeecccCccCccccccCCCCcc------chhhhHHHHHHHHHhC----------CCCCCcchh
Q 007668 453 LAKLLEDEESHIT---TIVAGTFGYLAPEYMQSGRATEK------TDVYSFGVLVLEVLSG----------KRPTDASFI 513 (594)
Q Consensus 453 l~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~G~vl~elltg----------~~p~~~~~~ 513 (594)
++........... ....||+.|+|||++.+...+.+ +||||||+++|||++| +.||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 9986654332211 24579999999999987766655 9999999999999999 555543221
Q ss_pred cccchHHHHHHHHhcccccccccCCCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 514 EKGLNIVGWLNFLISEDRQREIIDPNCEG--VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
... .... ......... ..+..+. .....+..+.+++.+||+.||++|||++||++.|++.....
T Consensus 268 ~~~-~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 268 SDP-SYED-MREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp SSC-CHHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCC-chhh-hHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 111 1111 111111111 1111111 12366788999999999999999999999999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=336.41 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=195.7
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce---
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK--- 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--- 378 (594)
.++|+..+.||+|+||.||++.. .+++.||||++... .......+.+|++++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35788899999999999999976 57899999999753 233346788999999999999999999998665544
Q ss_pred -EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 379 -LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 379 -~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
++||||+++++|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 8999999999999999764 5699999999999999999999954 9999999999999999999999999999876
Q ss_pred ccCCc--eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 458 EDEES--HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 458 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPPS 240 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCCcc
Confidence 54322 12234568999999999999999999999999999999999999997643221 11111111100000
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHhcc
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV-QILESE 579 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~-~~L~~~ 579 (594)
......+..+.+++.+||+.||++||++.+++ ..+.+.
T Consensus 241 ------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 241 ------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00112346789999999999999999765544 455443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.22 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=203.4
Q ss_pred HhcCCCccceeeeecceEEEEEEecC-CcEEEEEeeccc---chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 379 (594)
..++|...+.||+|+||.||+|.... ++.||+|++++. .....+.+..|.+++..+ +||||+++++++.+....+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35688899999999999999998764 788999999753 223356688899999988 7999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999999764 469999999999999999999995 4999999999999999999999999999986433
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.. ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~-~------- 238 (353)
T 2i0e_A 174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN-V------- 238 (353)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C-------
T ss_pred CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCC-C-------
Confidence 22 2234567999999999999999999999999999999999999999764321 1111111111 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
..+...+..+.+++.+||+.||++||+ ++++++
T Consensus 239 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112234467899999999999999996 466653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.05 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=180.2
Q ss_pred ccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEEccCCC
Q 007668 311 DDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFLPGG 388 (594)
Q Consensus 311 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g 388 (594)
..+.||+|+||.||++... +++.||||++... ....+.+|++++..++ ||||+++++++.+....++||||+++|
T Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp TSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 4588999999999999775 5899999998653 3456788999999997 999999999999999999999999999
Q ss_pred chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC---cEEEeecccccccccCCceee
Q 007668 389 SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 389 sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||+++....... ..
T Consensus 92 ~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~ 166 (325)
T 3kn6_A 92 ELFERIKKK-KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL 166 (325)
T ss_dssp BHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence 999999764 679999999999999999999995 4999999999999998665 899999999986654332 23
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhccc-chHHHHHHHHhcccccccccCCCCCC-C
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG-LNIVGWLNFLISEDRQREIIDPNCEG-V 543 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 543 (594)
....||+.|+|||++.+..++.++||||+|+++|||++|+.||........ ............ ... .... .
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~-~~~------~~~~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-GDF------SFEGEA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT-TCC------CCCSHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc-CCC------CCCccc
Confidence 345689999999999999999999999999999999999999976433211 111111111111 100 0000 0
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+..+.+|+.+||+.||++|||++|+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1224567999999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=329.69 Aligned_cols=259 Identities=19% Similarity=0.349 Sum_probs=198.2
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
..+|...+.||+|+||.||+|.. .+|+.||+|++... .......+.+|++++++++||||+++++++.+....++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 46788899999999999999976 57899999998752 334456789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 382 YDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
|||+++++|.+++.. ....+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999874 34569999999999999999999995 499999999999999999999999999998665
Q ss_pred cCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... .......
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~~--- 258 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-QCDYPPL--- 258 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHH-TTCSCCC---
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhh-cccCCCC---
Confidence 4322 223356899999999999999999999999999999999999998653211 111111111 1111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.....+..+.+++.+||+.||++|||+++|++.|++..
T Consensus 259 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 259 ----PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11223467999999999999999999999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=330.27 Aligned_cols=246 Identities=29% Similarity=0.485 Sum_probs=200.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||+|... ++..||+|++... .......+.+|++++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 567889999999999999999765 5678999998653 223356789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 9999999999999764 56899999999999999999999 4599999999999999999999999999986544322
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||....... ........ ...
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-------~~~-- 225 (279)
T 3fdn_A 164 ---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRV-------EFT-- 225 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT-------CCC--
T ss_pred ---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HHHHHHhC-------CCC--
Confidence 234568999999999999999999999999999999999999997543221 11111100 001
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+...+..+.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11223467889999999999999999999996
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=336.71 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=188.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.+.|...+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 456888899999999999999876 47899999987643 245688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---CCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~~l~Dfgl~~~~~~~~ 461 (594)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 130 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 130 VTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp CCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999999763 5689999999999999999999954 9999999999999975 8899999999998654332
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......... .....+
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~--~~~~~~--- 273 (349)
T 2w4o_A 206 --LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCE--YYFISP--- 273 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTC--CCCCTT---
T ss_pred --ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCC--CccCCc---
Confidence 2234568999999999999999999999999999999999999986532211 0111111111 011111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+||+.||++|||+.|+++
T Consensus 274 -~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 -WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11234467899999999999999999999886
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=331.21 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=205.0
Q ss_pred hcCCCccc-eeeeecceEEEEEEec---CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 306 LETLDDDH-IIGSGGFGTVYKLAMD---DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 306 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
.++|...+ .||+|+||.||+|... +++.||||+++... ....+.+.+|+++++.++||||+++++++ +....+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35667777 9999999999999543 46789999997532 33356799999999999999999999999 556789
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999763 5699999999999999999999954 999999999999999999999999999987765
Q ss_pred CCceee--eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 460 EESHIT--TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 460 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
...... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ... ....
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~~-~~~~----- 237 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT---AML-EKGE----- 237 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH---HHH-HTTC-----
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH---HHH-HcCC-----
Confidence 443322 22346789999999998889999999999999999999 999987643221 11 111 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
....+...+..+.+++.+||+.||++|||+.++++.|++.+.
T Consensus 238 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 238 ---RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011223345679999999999999999999999999987643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=334.92 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=197.2
Q ss_pred HhcCCCccceeeeecceEEEEEEec----CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc-
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS- 377 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~- 377 (594)
..++|...+.||+|+||.||+|... .+..||+|.+... .....+.+.+|++++++++||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3567888899999999999999764 3457999998753 33345678999999999999999999999977553
Q ss_pred ----eEEEEEccCCCchhhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEE
Q 007668 378 ----KLLIYDFLPGGSLDEALHE-----RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (594)
Q Consensus 378 ----~~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l 448 (594)
.++|+||+++|+|.+++.. ....+++..++.++.||++||.||| +.+|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEE
Confidence 4899999999999999853 2356999999999999999999999 459999999999999999999999
Q ss_pred eecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHH
Q 007668 449 SDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MYDYL 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHH
Confidence 999999876543322 2233457889999999999999999999999999999999 888986543221 11111
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
.... ....+...+..+.+++.+||+.||++|||+.++++.|++...
T Consensus 263 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 263 LHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 011122344679999999999999999999999999988654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.59 Aligned_cols=252 Identities=21% Similarity=0.393 Sum_probs=207.3
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
..+|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++......++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888899999999999999876 78999999997532 22346789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++.. ...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999975 356999999999999999999999 4599999999999999999999999999998765433
Q ss_pred ceeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
. .....||+.|+|||++.+..+ +.++||||+|+++|||++|+.||+..... .......... .
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~-----~---- 233 (476)
T 2y94_A 171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKKICDGI-----F---- 233 (476)
T ss_dssp C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHHHHTTC-----C----
T ss_pred c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhcCC-----c----
Confidence 2 234579999999999988765 78999999999999999999999764221 1111111110 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhcc
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILESE 579 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~~ 579 (594)
..+...+..+.+++.+||+.||++|||++|+++ .++..
T Consensus 234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 111223467899999999999999999999997 55543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=338.19 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=193.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|...+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467889999999999999999876 789999999975433 346688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc--EEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--ARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~~l~Dfgl~~~~~~~~~ 462 (594)
+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 98 ASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999999763 469999999999999999999995 49999999999999987665 9999999997533222
Q ss_pred eeeeeeecccCccCccccccCCCCcc-chhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEK-TDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
......||+.|+|||++.+..+..+ +||||+|+++|+|++|+.||........ ............. ..+
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~-------~~~ 242 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKY-------SIP 242 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCC-------CCC
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCC-------CCC
Confidence 2234569999999999988877655 8999999999999999999976433211 1111111111110 000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 243 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 243 -DDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 01123467899999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=341.45 Aligned_cols=272 Identities=17% Similarity=0.227 Sum_probs=209.0
Q ss_pred cCCCccceeeeecceEEEEEEecC---------CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeee----------
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD---------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVN---------- 367 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 367 (594)
++|...+.||+|+||.||+|.... ++.||+|.+... +.+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999998764 789999998754 35788999999999999987
Q ss_pred -----eeeEEeC-CCceEEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 368 -----LRGYCNS-PTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 368 -----l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
+++++.. ....++||||+ +++|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 5667655 67789999999 99999999864 46799999999999999999999954 99999999999999
Q ss_pred cCCC--cEEEeecccccccccCCcee------eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcch
Q 007668 441 DGNL--EARVSDFGLAKLLEDEESHI------TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASF 512 (594)
Q Consensus 441 ~~~~--~~~l~Dfgl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 512 (594)
+.++ .+||+|||+++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9988 89999999998765432211 123478999999999999999999999999999999999999997643
Q ss_pred hcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC--CCCccccc
Q 007668 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT--PCPSDFYD 590 (594)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~--~~~~~~~~ 590 (594)
.... ......... .. ......+... .....+..+.+++.+||+.||++|||++++++.|++.+.. ..+.+-++
T Consensus 273 ~~~~-~~~~~~~~~-~~-~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~d 347 (352)
T 2jii_A 273 PNTE-DIMKQKQKF-VD-KPGPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIG 347 (352)
T ss_dssp TCHH-HHHHHHHHH-HH-SCCCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCC
T ss_pred cCHH-HHHHHHHhc-cC-Chhhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcccc
Confidence 2111 111111111 11 1111111110 0112246799999999999999999999999999987653 23334444
Q ss_pred cC
Q 007668 591 SN 592 (594)
Q Consensus 591 ~~ 592 (594)
|+
T Consensus 348 w~ 349 (352)
T 2jii_A 348 LP 349 (352)
T ss_dssp CC
T ss_pred Cc
Confidence 43
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=344.02 Aligned_cols=269 Identities=23% Similarity=0.305 Sum_probs=211.1
Q ss_pred cCCCccceeeeecceEEEEEEecC-CcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC--ceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT--SKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~ 382 (594)
++|...+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 467888999999999999998764 8999999997533 233567889999999999999999999987655 679999
Q ss_pred EccCCCchhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe----cCCCcEEEeecccccc
Q 007668 383 DFLPGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSDFGLAKL 456 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~~l~Dfgl~~~ 456 (594)
||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999998543 239999999999999999999995 499999999999999 7778899999999987
Q ss_pred cccCCceeeeeeecccCccCcccccc--------CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQS--------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 528 (594)
...... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .........
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~ 241 (396)
T 4eut_A 166 LEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIIT 241 (396)
T ss_dssp CCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHH
T ss_pred ccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhc
Confidence 654332 233568999999999865 46788999999999999999999998653322111 111111111
Q ss_pred ccccc---cc------------cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 529 EDRQR---EI------------IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 529 ~~~~~---~~------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
..... .. ..+............+.+++.+||+.||++|||++|+++.++..+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11000 00 00111234567788899999999999999999999999999886654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=326.34 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=203.4
Q ss_pred hcCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|+..+.||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4568888999999999999997664 678999999876555577899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999998764 568999999999999999999995 499999999999999 788899999999998765433
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. .....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||....... ......... .. ....
T Consensus 164 ~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~-~~~~--- 229 (277)
T 3f3z_A 164 M--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIREGT-FT-FPEK--- 229 (277)
T ss_dssp C--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CC-CCHH---
T ss_pred c--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCC-CC-CCch---
Confidence 2 233568999999999865 48999999999999999999999997643221 111111100 00 0000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+|++.||++|||+.++++
T Consensus 230 -~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 -DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00023467899999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.40 Aligned_cols=249 Identities=19% Similarity=0.345 Sum_probs=195.3
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCC--CeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKH--RYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~ 382 (594)
++|...+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++| |||+++++++.+....++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 467888999999999999999999999999998743 33445778999999999986 99999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
| +.+++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++.......
T Consensus 89 e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 89 E-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp C-CCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred e-CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 9 568899999986 35799999999999999999999964 999999999999997 57899999999987654432
Q ss_pred e-eeeeeecccCccCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 463 H-ITTIVAGTFGYLAPEYMQS-----------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 463 ~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ...........
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~ 237 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPN 237 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCTT
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHhcCC
Confidence 2 2334679999999999865 67899999999999999999999999653211 11111111111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. . . ..+......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~-~----~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 238 H-E----I---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp S-C----C---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c-c----c---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 1 0 0 111122356889999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=329.41 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=198.4
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-CceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-TSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~ 384 (594)
.++|+..+.||+|+||.||++... |+.||||.++... ..+.+.+|++++++++||||+++++++.+. ...++|+||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467889999999999999999875 8899999987543 356789999999999999999999997554 468999999
Q ss_pred cCCCchhhhhhhcCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHERSE-QLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++++|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999999976432 38999999999999999999995 499999999999999999999999999987654322
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ......... . ..
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~------~---~~ 234 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGY------K---MD 234 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHHHTTTC------C---CC
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcCC------C---CC
Confidence 22357889999999999999999999999999999998 999987643221 111111110 0 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.+...+..+.+++.+||+.||++|||+.|+++.|++..
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 22334567999999999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.76 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=196.2
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchh-hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEG-FDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|...+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888899999999999999876 6899999998753321 122456799999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++ |+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 96 69999998777789999999999999999999995 4999999999999999999999999999986543322 2
Q ss_pred eeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc---cccc------
Q 007668 465 TTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED---RQRE------ 534 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~------ 534 (594)
.....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+.. ..+....... ....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcchh
Confidence 234568999999999876 56899999999999999999999999765332211 1111110000 0000
Q ss_pred ---ccCCCCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 ---IIDPNCE-----GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ---~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+... .........+.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 011123467889999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=332.87 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=199.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 357888999999999999999876 48999999986533 233567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 82 EYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp ECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 99999999998764 4569999999999999999999995 4999999999999999999999999999987653322
Q ss_pred eeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHH---------HHHHhccccc
Q 007668 463 HITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGW---------LNFLISEDRQ 532 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~ 532 (594)
......||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+....... ..........
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 2234568999999999876 6789999999999999999999999976433221111100 0000000000
Q ss_pred ccccCCCCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 REIIDPNCEG------VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.... .....+..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 01234466899999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.81 Aligned_cols=259 Identities=23% Similarity=0.266 Sum_probs=201.1
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-----chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-----NEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 374 (594)
++....++|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34555678899999999999999999764 6789999998643 23445789999999999999999999999999
Q ss_pred CCceEEEEEccCCCchhhhhhhc---------------------------------------CCCCCHHHHHHHHHHHHH
Q 007668 375 PTSKLLIYDFLPGGSLDEALHER---------------------------------------SEQLDWDARLNIIMGAAK 415 (594)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~ 415 (594)
....++||||+++|+|.+++... ...+++..+..++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 112357778899999999
Q ss_pred HHHHhhhcCCCCeeeCCCCCCCeEecCCC--cEEEeecccccccccCCc---eeeeeeecccCccCcccccc--CCCCcc
Q 007668 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNL--EARVSDFGLAKLLEDEES---HITTIVAGTFGYLAPEYMQS--GRATEK 488 (594)
Q Consensus 416 ~L~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~~l~Dfgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~ 488 (594)
||+|||+. +|+||||||+||+++.++ .+||+|||++..+..... .......||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999954 999999999999998766 899999999986643221 22344679999999999875 678999
Q ss_pred chhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 007668 489 TDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT 568 (594)
Q Consensus 489 ~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 568 (594)
+||||||+++|||++|+.||......+ .......... ....+ .....+..+.+++.+||+.||++|||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~--~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKL--CFENP----NYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC--CTTSG----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhccc--ccCCc----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999997643221 1111111110 00000 11123467899999999999999999
Q ss_pred HHHHHH
Q 007668 569 MHRVVQ 574 (594)
Q Consensus 569 ~~ev~~ 574 (594)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=328.26 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=196.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|...+.||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56788899999999999999764 58899999987543 33457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccc
Q 007668 385 LPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 385 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~~l~Dfgl~~~~~ 458 (594)
+++|+|.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999864 24679999999999999999999995 499999999999999 456789999999998665
Q ss_pred cCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||........ .........
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~------~~~~~~~~~------- 242 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQKATYKEP------- 242 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC-------
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH------HhhhccCCc-------
Confidence 4322 23456899999999876 5789999999999999999999999976432211 111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
............+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000001113367889999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=343.52 Aligned_cols=249 Identities=18% Similarity=0.348 Sum_probs=196.4
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCC--CCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIK--HRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~ 382 (594)
..|...+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ ||||+++++++......++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999888999999998643 3444577999999999996 599999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
| +.+++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 136 E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp E-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred e-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 9 5688999999864 478999999999999999999994 5999999999999996 57999999999987654332
Q ss_pred e-eeeeeecccCccCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 463 H-ITTIVAGTFGYLAPEYMQS-----------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 463 ~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...........
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~~~~ 284 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPN 284 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHCTT
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHhCcc
Confidence 2 2344579999999999865 46899999999999999999999999653211 11111111111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ... .+......+.+++.+||+.||++|||+.|+++
T Consensus 285 ~-----~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 285 H-----EIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp S-----CCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c-----cCC---CCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1 001 11112357889999999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.43 Aligned_cols=251 Identities=26% Similarity=0.345 Sum_probs=204.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchh------hHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEG------FDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|...+.||+|+||.||+|... +|+.||+|.+...... ..+.+.+|++++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999865 6899999998753221 356799999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC----cEEEeecccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLA 454 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~~l~Dfgl~ 454 (594)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .++|+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999975 3568999999999999999999995 4999999999999999887 7999999999
Q ss_pred cccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ......... .
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~---~ 235 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITSVS---Y 235 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTC---C
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcc---c
Confidence 87654322 234568999999999999999999999999999999999999997643221 111111100 0
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..++ ......+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccCh---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 000123356899999999999999999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=354.86 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=195.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||.||+|... +|+.||||++... .......+.+|++++..++||||+++++++.+....++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999764 6899999999753 223345678899999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++... ..+++..+..++.||+.||+|||++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 227 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999999764 5799999999999999999999951 499999999999999999999999999998644332
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .......... .
T Consensus 304 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-~--------- 366 (446)
T 4ejn_A 304 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE-I--------- 366 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C---------
T ss_pred c-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhCC-C---------
Confidence 2 234467999999999999999999999999999999999999999764322 1111111111 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+...+..+.+++.+||+.||++|| +++|+++
T Consensus 367 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 01222346789999999999999999 9999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=337.42 Aligned_cols=251 Identities=17% Similarity=0.193 Sum_probs=203.9
Q ss_pred hcCCCccceeeeecceEEEEE------EecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC---CCeeeeeeeEEeCCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKL------AMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK---HRYLVNLRGYCNSPT 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~ 376 (594)
.++|...+.||+|+||.||+| ...+++.||+|++.... ...+.+|++++..++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 457888899999999999999 35568899999987643 346778888888886 999999999999999
Q ss_pred ceEEEEEccCCCchhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC----------
Q 007668 377 SKLLIYDFLPGGSLDEALHE----RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---------- 442 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---------- 442 (594)
..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999974 34569999999999999999999994 59999999999999998
Q ss_pred -CCcEEEeeccccccccc-CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH
Q 007668 443 -NLEARVSDFGLAKLLED-EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV 520 (594)
Q Consensus 443 -~~~~~l~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 520 (594)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 89999999999976542 22333455679999999999999999999999999999999999999985432210
Q ss_pred HHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHhcccCC
Q 007668 521 GWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDR-PTMHRVVQILESEVMT 582 (594)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~ev~~~L~~~~~~ 582 (594)
...... .... .....+.+++..|++.+|.+| |+++++.+.|++.+..
T Consensus 293 ---------~~~~~~----~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 ---------CKPEGL----FRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ---------EEECSC----CTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---------eeechh----cccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 001111 1111 124567789999999999998 5788888888876543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=328.22 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=200.0
Q ss_pred hcCCCccceeeeecceEEEEEEec--CCc--EEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD--DGN--VFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|+..+.||+|+||.||+|.+. +++ .||+|.++.. .....+.+.+|++++.+++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888899999999999999753 233 6899998753 2344577899999999999999999999997765 8
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||+++++|.+++......+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 899999999999999987667799999999999999999999954 99999999999999999999999999998765
Q ss_pred cCCcee--eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 459 DEESHI--TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 459 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
...... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... ........... .
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~-~-- 243 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE-R-- 243 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCC-C--
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCC-C--
Confidence 443322 223457889999999998889999999999999999999 99998764322 11111111110 0
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPC 584 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~ 584 (594)
...+...+..+.+++.+||+.||++|||+.++++.|++......
T Consensus 244 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 244 -----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred -----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 01122344679999999999999999999999999998765443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=334.10 Aligned_cols=257 Identities=21% Similarity=0.296 Sum_probs=196.4
Q ss_pred cCCCc-cceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDD-DHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 383 (594)
+.|.. .+.||+|+||.||+|... +++.||||++..........+.+|++++.++ +||||+++++++.+....++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45665 478999999999999754 6899999999876555567899999999885 79999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc---EEEeecccccccccC
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFGLAKLLEDE 460 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~~l~Dfgl~~~~~~~ 460 (594)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||++......
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999764 5689999999999999999999964 9999999999999997766 999999998765422
Q ss_pred Cc------eeeeeeecccCccCcccccc-----CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-h--------HH
Q 007668 461 ES------HITTIVAGTFGYLAPEYMQS-----GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-N--------IV 520 (594)
Q Consensus 461 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~--------~~ 520 (594)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... . ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11223468999999999875 45789999999999999999999999764322100 0 00
Q ss_pred HHHHHHhcccccccccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 521 GWLNFLISEDRQREIIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....... .... ..+. .....+..+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~i~-~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQ-EGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHH-HCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHh-ccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0011111 0000 0000 00123467899999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=329.13 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=197.7
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc-----hhhHHHHHHHHHHHhhC---CCCeeeeeeeEEeCCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN-----EGFDRFFERELEILGSI---KHRYLVNLRGYCNSPT 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~ 376 (594)
.++|+..+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+++++++ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 56899999999999999999986 568999999987422 12234567788777766 4999999999997655
Q ss_pred -----ceEEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEee
Q 007668 377 -----SKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450 (594)
Q Consensus 377 -----~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~D 450 (594)
..++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 4789999996 69999998643 3499999999999999999999964 999999999999999999999999
Q ss_pred cccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc--
Q 007668 451 FGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS-- 528 (594)
Q Consensus 451 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 528 (594)
||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .........
T Consensus 164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~i~~~~~~~~ 239 (308)
T 3g33_A 164 FGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GKIFDLIGLPP 239 (308)
T ss_dssp CSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH--HHHHHHHCCCC
T ss_pred CccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCC
Confidence 999986653322 23457899999999999999999999999999999999999999764332111 111110000
Q ss_pred cccc-------ccccCCCCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 EDRQ-------REIIDPNCE----GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ~~~~-------~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ...+.+... .........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0000 000000000 011233467899999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=336.25 Aligned_cols=257 Identities=27% Similarity=0.422 Sum_probs=204.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcE--EEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNV--FALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 380 (594)
.++|...+.||+|+||.||+|... ++.. +|+|.+... .....+.+.+|++++.++ +||||+++++++.+....++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 467889999999999999999765 4554 499988753 233456789999999999 89999999999999999999
Q ss_pred EEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 381 IYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 999999999999997543 469999999999999999999995 49999999999999999999
Q ss_pred EEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHH
Q 007668 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 524 (594)
+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 181 ~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE 252 (327)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH
T ss_pred EEEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHHH
Confidence 99999999874332211 223456889999999998889999999999999999998 99999764321 1111
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
...... . ...+...+..+.+++.+||+.||++|||++|+++.|++.+..
T Consensus 253 ~~~~~~------~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 KLPQGY------R---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HGGGTC------C---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhhcCC------C---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111110 0 011223446799999999999999999999999999886554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=326.03 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=211.1
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467888999999999999999776 57789999986532 22356789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999999764 46899999999999999999999 4599999999999999999999999999987654322
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ........ +..
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~-------~~~-- 230 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVNV-------DLK-- 230 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTT-------CCC--
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhcc-------ccC--
Confidence 233568999999999999899999999999999999999999997642211 11111111 001
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhcccCCCCCcccc
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILESEVMTPCPSDFY 589 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~~~~~~~~~~~~ 589 (594)
.+...+..+.+++.+|++.||++|||++|+++ .++.......|..+.
T Consensus 231 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~~~ 279 (284)
T 2vgo_A 231 -FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ 279 (284)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCCC-
T ss_pred -CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCccc
Confidence 11233467899999999999999999999986 565554444444433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=321.02 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=204.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|+..+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 357888999999999999999765 5889999998653 3334567889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc---EEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~~l~Dfgl~~~~~~ 459 (594)
||+++++|.+.+... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999988764 568999999999999999999995 49999999999999986655 99999999987654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
... .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||....... ......... . ....+.
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~-~-~~~~~~ 230 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQIKAGA-Y-DYPSPE 230 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-C-CCCTTT
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------HHHHHHhcc-c-cCCchh
Confidence 332 234568999999999999999999999999999999999999996543221 111111110 0 011111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+..+.+++.+||+.||++|||++|+++
T Consensus 231 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 ----WDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1233467899999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=326.81 Aligned_cols=243 Identities=21% Similarity=0.367 Sum_probs=198.1
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457888999999999999999876 7899999998753 233456788899999999 999999999999999999999
Q ss_pred EEccCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC----------------
Q 007668 382 YDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---------------- 442 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---------------- 442 (594)
|||+++++|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999753 2568999999999999999999995 49999999999999984
Q ss_pred ---CCcEEEeecccccccccCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccch
Q 007668 443 ---NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN 518 (594)
Q Consensus 443 ---~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 518 (594)
...++|+|||.+........ ..||+.|+|||.+.+. .++.++||||||+++|||++|.+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 44799999999987654322 3489999999999765 567899999999999999999987643211
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+.. .... ..+..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ---~~~--~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ---WHE--IRQG--------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---HHH--HHTT--------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHH--HHcC--------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 100 0111 111122234467899999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.19 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=205.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||+|... +|+.||+|++... .......+.+|++++.+++||||+++++++.+....++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999875 6899999999753 223356688999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 382 YDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||++......
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999997643 3499999999999999999999964 9999999999999999999999999999876543
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... .. .
T Consensus 340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~-~~------~-- 406 (576)
T 2acx_A 340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKE-VP------E-- 406 (576)
T ss_dssp CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHH-CC------C--
T ss_pred cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhc-cc------c--
Confidence 32 3345799999999999998999999999999999999999999976432211 1111111111 00 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+...+..+.+|+.+||+.||++|| +++|+++
T Consensus 407 -~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 -EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11223446789999999999999999 6788874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=324.06 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=204.1
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+++++.++||||+++++++.+....++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467888999999999999999876 6899999998743 23345778999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~- 462 (594)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999999975 3568999999999999999999995 4999999999999999999999999999986643322
Q ss_pred eeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+.. ... . .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~---~~~----~-----~ 228 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE---KKT----Y-----L 228 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT---TCT----T-----S
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh---ccc----c-----c
Confidence 12234568999999999987665 7899999999999999999999976432110 1111110 000 0 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+..+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011233467889999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=361.36 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=198.5
Q ss_pred ceeeeecceEEEEEEec---CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMD---DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||.||+|.+. .++.||||+++... ....+.+.+|++++.+++||||+++++++.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 46789999997532 3346789999999999999999999999965 458899999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce--ee
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH--IT 465 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~--~~ 465 (594)
|+|.++++. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 454 g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 999999975 45799999999999999999999964 9999999999999999999999999999876544322 22
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .......... ...+
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~---------~~~p 594 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGER---------MGCP 594 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC---------CCCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC---------CCCC
Confidence 33456889999999999999999999999999999998 999997643221 1111111110 1112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
...+..+.+++.+||+.||++|||+++|++.|++..
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 234477999999999999999999999999998643
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=342.61 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=194.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHH-HhhCCCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEI-LGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.++|...+.||+|+||.||++... +++.||+|++.+.. ......+.+|..+ ++.++||||+++++++.+....++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457888999999999999999876 57889999997533 2233456667766 577899999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999763 568999999999999999999995 49999999999999999999999999999864332
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
. ......+||+.|+|||++.+..++.++||||||+++|||++|..||...... .......... . .
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~~-~--~----- 257 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNKP-L--Q----- 257 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHSC-C--C-----
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhcc-c--C-----
Confidence 2 2234567999999999999999999999999999999999999999764322 1111111111 0 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQI 575 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~ 575 (594)
.+...+..+.+++.+||+.||++||++.+.++.
T Consensus 258 --~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 258 --LKPNITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred --CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 112234678999999999999999998644433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=335.46 Aligned_cols=264 Identities=24% Similarity=0.336 Sum_probs=198.6
Q ss_pred HHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch-----hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
...++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++.+++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44678999999999999999999875 589999999874321 123467899999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++||||+++ +|.+++......+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999975 89999887667799999999999999999999954 9999999999999999999999999999876
Q ss_pred ccCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc--ccccc
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE--DRQRE 534 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 534 (594)
..... ......||+.|+|||++.+. .++.++||||||+++|||++|..||........ +.......... .....
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSS
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChhhhhh
Confidence 54332 23345689999999998754 589999999999999999999999876432211 11111100000 00000
Q ss_pred -------ccCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 -------IIDPNCEGVQ-----SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 -------~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+..+ ...+..+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000001111 233467999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=330.07 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=202.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEe--CCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCN--SPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~l 380 (594)
.++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999999999999775 6899999999753 3344567899999999999999999999874 4667899
Q ss_pred EEEccCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 381 IYDFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDC--SPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
||||+++++|.+++... ...+++..+..++.|++.||+|||+.. ..+|+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 344999999999999999999999751 0129999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..... .....
T Consensus 165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~i-~~~~~--- 233 (279)
T 2w5a_A 165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKI-REGKF--- 233 (279)
T ss_dssp HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHTCC---
T ss_pred eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------HHHHH-hhccc---
Confidence 76543221 223468999999999999899999999999999999999999987643211 11111 11111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
...+...+..+.+++.+||+.||++|||++|+++.+..
T Consensus 234 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11122344679999999999999999999999986643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=334.82 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=203.6
Q ss_pred hcCCCccceeeeecceEEEEEEe------cCCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM------DDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|...+.||+|+||.||+|.. .++..||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788999999999999999974 35778999999753 344456789999999999999999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---CCcEEEe
Q 007668 379 LLIYDFLPGGSLDEALHERS------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVS 449 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~~l~ 449 (594)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++. +..++|+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999998643 348999999999999999999995 49999999999999984 4569999
Q ss_pred ecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHh
Q 007668 450 DFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLI 527 (594)
Q Consensus 450 Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 527 (594)
|||++........ .......|++.|+|||.+.+..++.++||||||+++|||++ |..||...... .......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVT 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHHHHHh
Confidence 9999976543322 12233467899999999999999999999999999999998 99998653221 1111111
Q ss_pred cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.... ...+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus 260 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1110 1112233467899999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=338.79 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=201.3
Q ss_pred HhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-----CCeeeeeeeEEeCCCce
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIK-----HRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~ 378 (594)
..++|...+.||+|+||.||+|.. .+++.||||++... ....+.+..|++++..++ ||||+++++++......
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 356888999999999999999977 46889999998753 234566788999999986 99999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---------------
Q 007668 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--------------- 442 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------------- 442 (594)
++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccc
Confidence 9999999 999999998643 459999999999999999999995 49999999999999975
Q ss_pred ----------CCcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcch
Q 007668 443 ----------NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASF 512 (594)
Q Consensus 443 ----------~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 512 (594)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 7899999999998654322 34568999999999999999999999999999999999999997643
Q ss_pred hcccchHHHH---------HHHHhcccccccc----cCCCCCC--CC---------------HHHHHHHHHHHHHcccCC
Q 007668 513 IEKGLNIVGW---------LNFLISEDRQREI----IDPNCEG--VQ---------------SESLDALLAVATQCVSSS 562 (594)
Q Consensus 513 ~~~~~~~~~~---------~~~~~~~~~~~~~----~~~~~~~--~~---------------~~~~~~l~~l~~~cl~~d 562 (594)
..+....... ............. ....++. .. ......+.+|+.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 2211111100 0000000000000 0000000 00 011256789999999999
Q ss_pred CCCCCCHHHHHH
Q 007668 563 PDDRPTMHRVVQ 574 (594)
Q Consensus 563 P~~RPs~~ev~~ 574 (594)
|++|||++|+++
T Consensus 344 P~~Rpta~elL~ 355 (360)
T 3llt_A 344 PTLRPSPAELLK 355 (360)
T ss_dssp GGGSCCHHHHTT
T ss_pred hhhCCCHHHHhc
Confidence 999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=336.56 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=201.1
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccch--------hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNE--------GFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 376 (594)
.++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46788999999999999999975 4688999999875321 12345778999999999999999999999999
Q ss_pred ceEEEEEccCCC-chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 377 SKLLIYDFLPGG-SLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 377 ~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
..++||||+.+| +|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 999999999777 99999875 35699999999999999999999954 99999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ...
T Consensus 179 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~~~ 239 (335)
T 3dls_A 179 YLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------VEA 239 (335)
T ss_dssp ECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------TTT
T ss_pred ECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------Hhh
Confidence 7654432 234569999999999988776 88999999999999999999999653211 000
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... .+...+..+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 240 AIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp CCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccC-----CCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 11123467899999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=347.96 Aligned_cols=260 Identities=20% Similarity=0.276 Sum_probs=193.6
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC------C
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------T 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~ 376 (594)
.++|...+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888999999999999999755 6889999999753 344456788999999999999999999999654 3
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 56999999965 5666664 348999999999999999999995 4999999999999999999999999999987
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH-H--------H-----
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV-G--------W----- 522 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-~--------~----- 522 (594)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+ . +
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 65432 234467999999999999999999999999999999999999999764322111000 0 0
Q ss_pred --HHHHhcccc------cccccCCCC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 523 --LNFLISEDR------QREIIDPNC----EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 523 --~~~~~~~~~------~~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......... ....+.... ..........+.+|+.+||+.||++|||++|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000000000 0011122567899999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=328.34 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=200.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|+..+.||+|+||.||+|... ++..||+|.+........+.+.+|++++.+++||||+++++++......++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467888999999999999999876 5889999999876655667899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++++|.+++......+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++....... ..
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 173 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK 173 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence 99999999998767779999999999999999999995 499999999999999999999999999876432211 11
Q ss_pred eeeeecccCccCcccc-----ccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 465 TTIVAGTFGYLAPEYM-----QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.....||+.|+|||++ .+..++.++||||||+++|+|++|..||....... ........... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-~----- 241 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDPP-T----- 241 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCC-C-----
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCCc-c-----
Confidence 2334689999999998 36678999999999999999999999987643211 11111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+...+..+.+++.+||+.||++|||++++++
T Consensus 242 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0112334467899999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.48 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=198.5
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+.+....+||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455566999999999999976 468899999998766666678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-CCcEEEeecccccccccCCc
Q 007668 386 PGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 386 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~~l~Dfgl~~~~~~~~~ 462 (594)
++++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.++|+|||++........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999998643 346789999999999999999995 49999999999999987 89999999999987654322
Q ss_pred eeeeeeecccCccCccccccCC--CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGR--ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
......|++.|+|||++.+.. ++.++||||||+++|||++|+.||....... ........ .. ..+
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~--~~----~~~-- 245 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGM--FK----VHP-- 245 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHH--HC----CCC--
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhcc--cc----ccc--
Confidence 123456899999999987643 8899999999999999999999986532111 00000000 00 111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 246 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 246 -EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122234467899999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=340.27 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=190.2
Q ss_pred HhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCC--ce
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPT--SK 378 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~ 378 (594)
..++|...+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357889999999999999999975 46899999998643 3344567889999999997 999999999996544 67
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999997 689999875 468999999999999999999995 499999999999999999999999999998653
Q ss_pred cC--------------------CceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc
Q 007668 459 DE--------------------ESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517 (594)
Q Consensus 459 ~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 517 (594)
.. .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 1112234579999999999876 67899999999999999999999999764322111
Q ss_pred hHHHHHHHHhccccc---------------------ccccCCCCCCC-------------CHHHHHHHHHHHHHcccCCC
Q 007668 518 NIVGWLNFLISEDRQ---------------------REIIDPNCEGV-------------QSESLDALLAVATQCVSSSP 563 (594)
Q Consensus 518 ~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~-------------~~~~~~~l~~l~~~cl~~dP 563 (594)
... . ........ ........... ....+..+.+|+.+||+.||
T Consensus 241 ~~i--~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 241 ERI--I-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHH--H-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHH--H-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 100 0 00000000 00000000000 00224578999999999999
Q ss_pred CCCCCHHHHHH
Q 007668 564 DDRPTMHRVVQ 574 (594)
Q Consensus 564 ~~RPs~~ev~~ 574 (594)
++|||++|+++
T Consensus 318 ~~R~t~~e~l~ 328 (388)
T 3oz6_A 318 NKRISANDALK 328 (388)
T ss_dssp GGSCCHHHHTT
T ss_pred ccCCCHHHHhC
Confidence 99999999876
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.36 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=203.6
Q ss_pred hcCCCccceeeeecceEEEEEEe----cCCcEEEEEeecccc----hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM----DDGNVFALKRIDKLN----EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPT 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 376 (594)
.++|...+.||+|+||.||++.. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46788999999999999999987 478999999987532 22345677899999999 6999999999999999
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999764 469999999999999999999995 4999999999999999999999999999987
Q ss_pred cccCCceeeeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
.............||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ............
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~---- 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE---- 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC----
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC----
Confidence 65444333445679999999999985 3478999999999999999999999975432211 111111111110
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
...+...+..+.+++.+||+.||++|| +++|+++
T Consensus 283 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 283 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 112223446788999999999999999 8999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=337.17 Aligned_cols=270 Identities=20% Similarity=0.272 Sum_probs=199.8
Q ss_pred HHHHHHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccch-----------hhHHHHHHHHHHHhhCCCCeeee
Q 007668 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE-----------GFDRFFERELEILGSIKHRYLVN 367 (594)
Q Consensus 299 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~ 367 (594)
..++....++|...+.||+|+||.||+|...+|..||||++..... ...+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 3566667789999999999999999999988899999999864221 12367899999999999999999
Q ss_pred eeeEEeC-----CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC
Q 007668 368 LRGYCNS-----PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442 (594)
Q Consensus 368 l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 442 (594)
+++++.. ....++||||++ |+|.+.+......+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence 9999833 345799999997 789998887667899999999999999999999964 9999999999999999
Q ss_pred CCcEEEeecccccccccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchH-H
Q 007668 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI-V 520 (594)
Q Consensus 443 ~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~-~ 520 (594)
++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||........... .
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999997544332 2234568999999999876 6789999999999999999999999976432211000 0
Q ss_pred HHHH-------HHhcccccccccCCCC--------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 521 GWLN-------FLISEDRQREIIDPNC--------EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 521 ~~~~-------~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ...........+.... ..........+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0000 0000000000000000 0111223467899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.23 Aligned_cols=240 Identities=17% Similarity=0.207 Sum_probs=188.7
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecc---cchhhHHHHHHHH---HHHhhCCCCeeeeee-------eE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDK---LNEGFDRFFEREL---EILGSIKHRYLVNLR-------GY 371 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~ 371 (594)
.++|...+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35678889999999999999986 5689999999974 2334467889999 455566899999998 66
Q ss_pred EeCCC-----------------ceEEEEEccCCCchhhhhhhcCC------CCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 007668 372 CNSPT-----------------SKLLIYDFLPGGSLDEALHERSE------QLDWDARLNIIMGAAKGLAYLHHDCSPRI 428 (594)
Q Consensus 372 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~------~l~~~~~~~i~~~ia~~L~~LH~~~~~~i 428 (594)
+.+++ ..++||||+ +|+|.+++..... .+++..+..|+.||+.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55543 278999999 6899999985321 234688889999999999999964 99
Q ss_pred eeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecccCccCccccccC-----------CCCccchhhhHHHH
Q 007668 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG-----------RATEKTDVYSFGVL 497 (594)
Q Consensus 429 vH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~v 497 (594)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 2344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 498 VLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 498 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+|||++|+.||......... ..+.. ... ..+..+.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~---------------~~~~~-~~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS---------------EWIFR-SCK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCS---------------GGGGS-SCC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccch---------------hhhhh-hcc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999764322111 11111 111 22367899999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=320.61 Aligned_cols=250 Identities=27% Similarity=0.375 Sum_probs=200.4
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch------hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE------GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
++|...+.||+|+||.||++... +++.||+|.++.... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46788899999999999999876 689999999875321 13577999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC----cEEEeeccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLAK 455 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~~l~Dfgl~~ 455 (594)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++ .++|+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999753 568999999999999999999995 4999999999999998777 89999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ......... ..
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~---~~ 229 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNISAVN---YD 229 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC---CC
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHhHhcc---cC
Confidence 7654322 233468999999999999999999999999999999999999997643221 111110000 00
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+ .......+..+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 FD---EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC---HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Cc---chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 0000122356899999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.69 Aligned_cols=248 Identities=24% Similarity=0.412 Sum_probs=204.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
..+|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888899999999999999876 4788999998653 233456788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999988753 568999999999999999999995 499999999999999999999999999998765332
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.. .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......+ ......... .
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~----------~ 232 (294)
T 2rku_A 170 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE----------Y 232 (294)
T ss_dssp CC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC----------C
T ss_pred cc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhhcc----------C
Confidence 22 234568999999999998889999999999999999999999997643221 111111100 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+......+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111223467889999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=329.83 Aligned_cols=267 Identities=25% Similarity=0.371 Sum_probs=208.6
Q ss_pred HHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhh--CCCCeeeeeeeEEeCCC----
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGS--IKHRYLVNLRGYCNSPT---- 376 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~---- 376 (594)
....++|...+.||+|+||.||+|.. +++.||||++.... ...+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34457899999999999999999987 48999999986532 4567788888887 78999999999998776
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----SPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||... +.+|+||||||+||+++.++.+||+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred eeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 78999999999999999975 35899999999999999999999310 248999999999999999999999999
Q ss_pred ccccccccCCcee---eeeeecccCccCccccccCC------CCccchhhhHHHHHHHHHhC----------CCCCCcch
Q 007668 452 GLAKLLEDEESHI---TTIVAGTFGYLAPEYMQSGR------ATEKTDVYSFGVLVLEVLSG----------KRPTDASF 512 (594)
Q Consensus 452 gl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg----------~~p~~~~~ 512 (594)
|++.......... .....||+.|+|||.+.+.. ++.++||||||+++|||++| ..||....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 9998765544321 23456899999999987652 33789999999999999999 67775432
Q ss_pred hcccchHHHHHHHHhcccccccccCCCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEG--VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 513 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
... .....+..... .. ...+..+. ........+.+++.+||+.||++|||++||++.|++...
T Consensus 272 ~~~-~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 272 PSD-PSVEEMRKVVC-EQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CSS-CCHHHHHHHHT-TS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCc-ccHHHHHHHHH-HH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 211 11122222111 11 11122221 223566789999999999999999999999999988654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=324.93 Aligned_cols=250 Identities=28% Similarity=0.483 Sum_probs=203.5
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-----------
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS----------- 374 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----------- 374 (594)
.+|+..+.||+|+||.||+|... +++.||+|++..... .+.+|++++.+++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 56888899999999999999876 789999999976443 46789999999999999999998754
Q ss_pred -----CCceEEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEE
Q 007668 375 -----PTSKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (594)
Q Consensus 375 -----~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l 448 (594)
....++||||+++++|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.++|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEE
Confidence 44578999999999999999754 4579999999999999999999995 49999999999999999999999
Q ss_pred eecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc
Q 007668 449 SDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 528 (594)
+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+..... ..... .
T Consensus 164 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--------~~~~~-~ 232 (284)
T 2a19_B 164 GDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--------FFTDL-R 232 (284)
T ss_dssp CCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--------HHHHH-H
T ss_pred Ccchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--------HHHHh-h
Confidence 99999987654332 2334689999999999999999999999999999999999998643210 11111 1
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 007668 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP 585 (594)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 585 (594)
. ..+. ...+..+.+++.+||+.||++|||+.|+++.|+........
T Consensus 233 ~----~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 233 D----GIIS-------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp T----TCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred c----cccc-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1 1111 12235688999999999999999999999999887655443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=324.84 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=201.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|...+.||+|+||.||++... +|+.||+|.+........+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356888899999999999999875 6899999999865554556789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 9999999998764 568999999999999999999995 499999999999999 788899999999987644321
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... ......... . .. ..
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~-~-~~-~~--- 228 (304)
T 2jam_A 164 ---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEKIKEGY-Y-EF-ES--- 228 (304)
T ss_dssp ---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHCC-C-CC-CT---
T ss_pred ---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCC-C-CC-Cc---
Confidence 223468999999999999999999999999999999999999987542211 111111110 0 00 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+..+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234467899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.61 Aligned_cols=193 Identities=25% Similarity=0.365 Sum_probs=153.4
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-----CCce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS-----PTSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~ 378 (594)
++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57888999999999999999765 6899999998753 33345678999999999999999999999843 3568
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 133 ~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999998 5799999865 4569999999999999999999995 499999999999999999999999999998764
Q ss_pred cCCc--------------------------eeeeeeecccCccCcccc-ccCCCCccchhhhHHHHHHHHHhC
Q 007668 459 DEES--------------------------HITTIVAGTFGYLAPEYM-QSGRATEKTDVYSFGVLVLEVLSG 504 (594)
Q Consensus 459 ~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg 504 (594)
.... ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 3221 122345789999999986 556799999999999999999994
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.06 Aligned_cols=262 Identities=23% Similarity=0.382 Sum_probs=203.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|...+.||+|+||.||++... ++..||+|++... .....+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56888899999999999999776 6899999998754 344467799999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++++|.+++... ..+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.++|+|||++.......
T Consensus 113 ~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 9999999999764 4689999999999999999999952 289999999999999999999999999997654322
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHH----------HHH--------
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWL----------NFL-------- 526 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~----------~~~-------- 526 (594)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||............... ...
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence 23356899999999999999999999999999999999999999764322110000000 000
Q ss_pred --hcc-------cccccccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 527 --ISE-------DRQREIIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 527 --~~~-------~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... .....+....... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 0000000000000 11223467999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.75 Aligned_cols=262 Identities=25% Similarity=0.374 Sum_probs=196.8
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC------c
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------S 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 377 (594)
++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 5688889999999999999976 46899999998643 3334567889999999999999999999987653 4
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 59999999 8899999875 468999999999999999999995 49999999999999999999999999999875
Q ss_pred ccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHH---------HHHHHh
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVG---------WLNFLI 527 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~---------~~~~~~ 527 (594)
... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+...... +.....
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 432 233568999999999877 679999999999999999999999997643221110000 000000
Q ss_pred cc------cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhc
Q 007668 528 SE------DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILES 578 (594)
Q Consensus 528 ~~------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~ 578 (594)
.. ..........+.......+..+.+|+.+||+.||++|||++|+++ .+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 00 000001111111122334567899999999999999999999987 4443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=333.64 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=187.7
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEe--------CCC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCN--------SPT 376 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--------~~~ 376 (594)
.+|+..+.||+|+||.||+|... +++.||+|++........+.+.+|+.++.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47888899999999999999864 68999999997766666778999999999996 999999999983 344
Q ss_pred ceEEEEEccCCCchhhhhhh--cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 377 SKLLIYDFLPGGSLDEALHE--RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
..++|+||++ |+|.+++.. ....+++..++.++.||+.||+|||+. .++|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 4789999995 799998864 345699999999999999999999954 122999999999999999999999999999
Q ss_pred cccccCCcee-----------eeeeecccCccCcccc---ccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH
Q 007668 455 KLLEDEESHI-----------TTIVAGTFGYLAPEYM---QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV 520 (594)
Q Consensus 455 ~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~ 520 (594)
.......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---- 261 (337)
T 3ll6_A 186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI---- 261 (337)
T ss_dssp BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh----
Confidence 8765432211 1134589999999998 566789999999999999999999999865322110
Q ss_pred HHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 521 GWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
. ...... + ........+.+++.+||+.||++|||++|+++.|+....
T Consensus 262 --~-----~~~~~~---~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 --V-----NGKYSI---P----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -----------CCC---C----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --h-----cCcccC---C----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 000000 0 011122447899999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.22 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=199.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|...+.||+|+||.||++... +++.||+|.+...... ..+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467888999999999999999765 5889999999764332 35688888887 79999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC----CcEEEeeccccccccc
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN----LEARVSDFGLAKLLED 459 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~~l~Dfgl~~~~~~ 459 (594)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||++.....
T Consensus 97 ~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999753 569999999999999999999995 499999999999998533 3599999999987654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
... ......||+.|+|||++.+..++.++||||+|+++|||++|..||....... ............ . . +.
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~i~~~~-~-~-~~-- 243 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEEILARIGSGK-F-S-LS-- 243 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHHHHHHHHHCC-C-C-CC--
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHHHHHHHccCC-c-c-cC--
Confidence 332 2334578999999999988888999999999999999999999997532211 111111111111 0 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......+..+.+++.+||+.||++|||+.|+++
T Consensus 244 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 244 -GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0112234467899999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=361.57 Aligned_cols=257 Identities=24% Similarity=0.363 Sum_probs=206.0
Q ss_pred HhcCCCccceeeeecceEEEEEEecC----CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
..++|...+.||+|+||.||+|.... +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 34678888999999999999998643 457999998753 33445779999999999999999999999854 5689
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||+++|+|.++++.+...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 9999999999999998766679999999999999999999995 4999999999999999999999999999987765
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
..........+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ ..........
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~i~~~~~------- 610 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGER------- 610 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHHTCC-------
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHcCCC-------
Confidence 44333344567889999999999999999999999999999997 999987643221 1111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
...+...+..+.+++.+||+.||++|||+.|+++.|++.+
T Consensus 611 --~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 611 --LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0112234467899999999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=335.58 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=200.6
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--------
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNS-------- 374 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 374 (594)
..+|...+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46888999999999999999987 578999999986432 2334578899999999999999999999876
Q ss_pred CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
....++||||++ |+|.+.+......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 346789999996 58888887766779999999999999999999995 49999999999999999999999999999
Q ss_pred cccccCC---ceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 455 KLLEDEE---SHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 455 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
+...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......................
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 8765322 122234568999999999876 458999999999999999999999998643322111111000000000
Q ss_pred cccc-----------ccCCCCCCCCHH-----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQRE-----------IIDPNCEGVQSE-----SLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~-----------~~~~~~~~~~~~-----~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ............ ....+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 000000000000 1345889999999999999999999886
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=350.33 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=204.7
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|...+.||+|+||.||++... +|+.||+|++.+.. ......+.+|++++.+++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56788899999999999999875 68999999997532 223467889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhc---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHER---SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
||+++|+|.+++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999998753 3469999999999999999999995 4999999999999999999999999999987654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............
T Consensus 342 ~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~--------- 409 (543)
T 3c4z_A 342 GQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQA--------- 409 (543)
T ss_dssp TCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCC---------
T ss_pred CCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcc---------
Confidence 3322 334579999999999999999999999999999999999999997643211 1111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTM-----HRVV 573 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~ 573 (594)
...+...+..+.+++.+||+.||++||++ ++++
T Consensus 410 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 410 -VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred -cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 01122345678999999999999999975 5665
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.23 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=189.7
Q ss_pred cCCCcc-ceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHh-hCCCCeeeeeeeEEeC----CCceE
Q 007668 307 ETLDDD-HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILG-SIKHRYLVNLRGYCNS----PTSKL 379 (594)
Q Consensus 307 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~----~~~~~ 379 (594)
++|... +.||+|+||+||++... +++.||||++... ..+.+|++++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455554 68999999999999765 6889999998642 35677888864 4589999999998864 56689
Q ss_pred EEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---CCcEEEeeccccc
Q 007668 380 LIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAK 455 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~~l~Dfgl~~ 455 (594)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998643 469999999999999999999995 49999999999999997 7899999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc-hHHHHHHHHhccccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL-NIVGWLNFLISEDRQRE 534 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 534 (594)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+ ..... .
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~~-~ 285 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQY-E 285 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTCC-C
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCcc-c
Confidence 655332 223457899999999999999999999999999999999999999764332110 011110 00100 0
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+. ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 286 ~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 286 FPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCTTT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCcc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111 1233467899999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=322.59 Aligned_cols=247 Identities=21% Similarity=0.372 Sum_probs=195.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999876 78999999986532 23356789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++++|.+++... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999764 4689999999999999999999965 99999999999999999999999999998765432
Q ss_pred ceeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
. .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... ........ .. .
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~--~------ 228 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIRG-GV--F------ 228 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CC--C------
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhc-Cc--c------
Confidence 2 233468999999999987765 68999999999999999999999763221 11111111 10 0
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+......+.+++.+||+.||++|||++|+++
T Consensus 229 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 -YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011223467899999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.71 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=206.6
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
..+|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888899999999999999776 4788999998653 334456789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999988753 5689999999999999999999954 99999999999999999999999999998765332
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... . .
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~---~----~-- 259 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIKKNE---Y----S-- 259 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC---C----C--
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHhcCC---C----C--
Confidence 2 2234568999999999998899999999999999999999999997643221 111111110 0 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhc
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILES 578 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~ 578 (594)
.+......+.+++.+||+.||++|||++|+++ .+.+
T Consensus 260 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 260 -IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 11223356889999999999999999999986 4443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.15 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=201.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|+..+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 467888999999999999999776 58999999987543 245788999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+++++|.+++......+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++........ .
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 181 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K 181 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence 99999999998666789999999999999999999995 4999999999999999999999999999987654322 2
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||........ ... ..... .+.. ..+
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~-----~~~~-~~~ 248 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFM-IPTNP-----PPTF-RKP 248 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-HHHSC-----CCCC-SSG
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHH-HhcCC-----Cccc-CCc
Confidence 2345689999999999998999999999999999999999999975322110 000 00010 0000 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+..+.+++.+||+.||++|||+.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 233467899999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=326.53 Aligned_cols=248 Identities=29% Similarity=0.444 Sum_probs=204.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.+.|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999754 68899999987532 3345789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 9999999999864 569999999999999999999995 4999999999999999999999999999987654332
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (594)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .... ..... . + ..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~-~----~---~~ 239 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFL-IPKNN-P----P---TL 239 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHSC-C----C---CC
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHH-hhcCC-C----C---CC
Confidence 2234568999999999999999999999999999999999999987532211 1111 11110 0 1 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 544 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 2233467899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=340.98 Aligned_cols=253 Identities=10% Similarity=0.021 Sum_probs=182.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch---hhHHHHHHHHHHHhhC--CCCeeeeee-------eEEe
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE---GFDRFFERELEILGSI--KHRYLVNLR-------GYCN 373 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~ 373 (594)
..|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45788899999999999999865 789999999986432 3345677885554444 699988754 4443
Q ss_pred CC-----------------CceEEEEEccCCCchhhhhhhcCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCCeee
Q 007668 374 SP-----------------TSKLLIYDFLPGGSLDEALHERSEQLDWDAR------LNIIMGAAKGLAYLHHDCSPRIIH 430 (594)
Q Consensus 374 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~ivH 430 (594)
.. ...++||||++ |+|.+++......+++..+ ..++.||+.||+|||+ .+|+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 22 33799999998 8999999875555666666 7888999999999995 49999
Q ss_pred CCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCC
Q 007668 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPT 508 (594)
Q Consensus 431 ~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~ 508 (594)
|||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999865432 223457799999999987 67999999999999999999999999
Q ss_pred CcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 509 DASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......... +...............+ .....+..+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGS---WKRPSLRVPGTDSLAFG----SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTC---CCBCCTTSCCCCSCCCT----TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccc---hhhhhhhhccccccchh----hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 7753221100 00000000000001111 11234567999999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=332.29 Aligned_cols=264 Identities=20% Similarity=0.292 Sum_probs=193.3
Q ss_pred HHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch--hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
....++|...+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344678999999999999999999754 688999999975332 23456789999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-----CCCcEEEeecccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-----GNLEARVSDFGLA 454 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-----~~~~~~l~Dfgl~ 454 (594)
+||||++ |+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||++
T Consensus 110 lv~e~~~-~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEEECCS-EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEEecCC-CCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9999997 5999999764 4699999999999999999999964 999999999999994 4556999999999
Q ss_pred cccccCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc--c
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED--R 531 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 531 (594)
........ ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+. ............ .
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTT
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCchhh
Confidence 87653322 22345689999999999874 489999999999999999999999976432211 111111000000 0
Q ss_pred ccc-----ccC---CCCCCC------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 QRE-----IID---PNCEGV------QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ~~~-----~~~---~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... ... +..... .......+.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 000 000000 0113467889999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.07 Aligned_cols=262 Identities=20% Similarity=0.256 Sum_probs=206.6
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCC-CeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKH-RYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+|++++..++| +++..+..++.+....++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 5788899999999999999986 5689999998765332 2357889999999987 5555666666778888999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+ +++|.+++......+++..++.|+.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9 999999998766789999999999999999999995 499999999999999 688999999999998766543
Q ss_pred ce------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 462 SH------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 462 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..........................+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 22 122467999999999999999999999999999999999999999764332211111111111000000000
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
....+.++.+++.+||+.+|++||++++|++.|+..+..
T Consensus 241 --------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 241 --------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp --------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 011236789999999999999999999999999987553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=329.45 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=185.6
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468889999999999999999754 68899999986532 3335678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 384 FLPGGSLDEALHE-------RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 384 ~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
|+++++|.+++.. ....+++..+..++.||+.||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999874 24558999999999999999999995 4999999999999999999999999999976
Q ss_pred cccCCc----eeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc
Q 007668 457 LEDEES----HITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR 531 (594)
Q Consensus 457 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 531 (594)
...... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~ 244 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTLQNDP 244 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHTSSC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHhccCC
Confidence 653321 11234568999999999875 5689999999999999999999999976432211 011111110
Q ss_pred c---ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 Q---REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 ~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ....++ ......+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDK---EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccccccccc---hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 000011 111233467899999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=317.94 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=196.4
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC----CCceEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLL 380 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~l 380 (594)
.|...+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667788999999999999764 5788999998753 34446778999999999999999999998754 455789
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeeccccccccc
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLED 459 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~~~ 459 (594)
||||+++++|.+++... ..+++..+..++.||+.||.|||+. ..+|+||||||+||+++ .++.++|+|||++.....
T Consensus 107 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999999764 5689999999999999999999954 12399999999999998 789999999999976543
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.. .....||+.|+|||.+. +.++.++||||+|+++|+|++|+.||...... ........... ....
T Consensus 185 ~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~-~~~~---- 250 (290)
T 1t4h_A 185 SF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGV-KPAS---- 250 (290)
T ss_dssp TS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTC-CCGG----
T ss_pred cc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhccC-Cccc----
Confidence 32 23456899999999887 46899999999999999999999999653211 11111111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 251 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 ---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11122356899999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.34 Aligned_cols=264 Identities=23% Similarity=0.391 Sum_probs=199.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 568889999999999999999876 48999999986532 333566889999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 104 EFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp ECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999998887654 3569999999999999999999995 4999999999999999999999999999986654322
Q ss_pred eeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHH---------HHHHHhccccc
Q 007668 463 HITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVG---------WLNFLISEDRQ 532 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~ 532 (594)
......||+.|+|||++.+. .++.++||||+|+++|||++|+.||............. +..........
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 22345689999999998875 78999999999999999999999997643221110000 00000000000
Q ss_pred ccccCCCCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 533 REIIDPNCEG------VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 533 ~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.... .....+..+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111110 11133567999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.45 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=186.5
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|+..+.||+|+||.||++.. .+++.||+|++.... ....+.+.++...++.++||||+++++++.+....++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788899999999999999976 478999999997532 222334555555688899999999999999999999999
Q ss_pred EccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
||++ |+|.+++.. ....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9996 588887753 456799999999999999999999952 2999999999999999999999999999987654
Q ss_pred CCceeeeeeecccCccCcccc----ccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 460 EESHITTIVAGTFGYLAPEYM----QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
... .....||+.|+|||.+ .+..++.++||||+|+++|||++|+.||...... .. .......... ..
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~-~~~~~~~~~~-~~- 233 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQ-QLKQVVEEPS-PQ- 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HH-HHHHHHHSCC-CC-
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HH-HHHHHhccCC-CC-
Confidence 322 2334689999999996 5567899999999999999999999999752111 11 1111111110 00
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+..+.+++.+||+.||++|||++|+++
T Consensus 234 ------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 ------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 011233467899999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.61 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=190.3
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--------hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--------EGFDRFFERELEILGSIKHRYLVNLRGYCNSP 375 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 375 (594)
..++|...+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3568899999999999999999765 57999999986532 1112347899999999999999999999865
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC---CcEEEeecc
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN---LEARVSDFG 452 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~~l~Dfg 452 (594)
...++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.+ ..+||+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 457999999999999999875 35699999999999999999999954 99999999999999754 459999999
Q ss_pred cccccccCCceeeeeeecccCccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQS---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..... ...
T Consensus 288 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~----i~~ 359 (419)
T 3i6u_A 288 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----ITS 359 (419)
T ss_dssp TTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----HHT
T ss_pred cceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----Hhc
Confidence 998765432 2344679999999999853 578889999999999999999999997532211 11110 000
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ..+......+..+.+++.+||+.||++|||++|+++
T Consensus 360 ~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYN-----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCC-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-----CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 000001123467899999999999999999999886
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=337.41 Aligned_cols=199 Identities=25% Similarity=0.365 Sum_probs=166.3
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-----Cc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TS 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 377 (594)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357888999999999999999765 5788999999753 333456789999999999999999999998665 56
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++||||++ |+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999985 699999975 4569999999999999999999995 49999999999999999999999999999876
Q ss_pred ccCCce---------------------eeeeeecccCccCcccc-ccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 007668 458 EDEESH---------------------ITTIVAGTFGYLAPEYM-QSGRATEKTDVYSFGVLVLEVLSGKRPTD 509 (594)
Q Consensus 458 ~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 509 (594)
...... ......||+.|+|||++ .+..++.++||||+||++|||++|..|+.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 543211 12456799999999986 56679999999999999999998666554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.94 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=203.3
Q ss_pred HHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--------hhhHHHHHHHHHHHhhC-CCCeeeeeeeEE
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--------EGFDRFFERELEILGSI-KHRYLVNLRGYC 372 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 372 (594)
....++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 334567899999999999999999875 69999999986432 12245688999999999 799999999999
Q ss_pred eCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 373 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
......++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG 245 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFG 245 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecC
Confidence 9999999999999999999999753 5699999999999999999999964 99999999999999999999999999
Q ss_pred cccccccCCceeeeeeecccCccCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHH
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQS------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 526 (594)
++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ......
T Consensus 246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~~~~~i 317 (365)
T 2y7j_A 246 FSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------LMLRMI 317 (365)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred cccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------HHHHHH
Confidence 9987654332 234578999999999863 35788999999999999999999999753221 111111
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... .. ...+.+ ...+..+.+++.+||+.||++|||++|+++
T Consensus 318 ~~~~-~~-~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQ-YQ-FSSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTC-CC-CCHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCC-CC-CCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1110 00 000000 112356899999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.90 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=198.9
Q ss_pred hcCCCcc-ceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDD-HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~l 380 (594)
.+.|... +.||+|+||.||+|... +++.||+|++.... ......+.+|+.++..++ ||||+++++++.+....++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3455555 88999999999999766 58999999987532 233577899999999995 6999999999999999999
Q ss_pred EEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---CCcEEEeecccccc
Q 007668 381 IYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAKL 456 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~~l~Dfgl~~~ 456 (594)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999998643 4569999999999999999999995 49999999999999987 78999999999987
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...... .. ....
T Consensus 184 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~-~~-~~~~ 253 (327)
T 3lm5_A 184 IGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------YLNISQ-VN-VDYS 253 (327)
T ss_dssp C-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-TC-CCCC
T ss_pred cCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HHHHHh-cc-cccC
Confidence 654322 2345689999999999999999999999999999999999999976432211 000000 00 0000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......+..+.+++.+||+.||++|||++|+++
T Consensus 254 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 254 ----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1112234467899999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.65 Aligned_cols=258 Identities=21% Similarity=0.340 Sum_probs=203.5
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhh-----------------HHHHHHHHHHHhhCCCCeeeee
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF-----------------DRFFERELEILGSIKHRYLVNL 368 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 368 (594)
.++|...+.||+|+||.||+|.. +++.||+|++....... .+.+.+|++++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35788899999999999999988 89999999987532211 1789999999999999999999
Q ss_pred eeEEeCCCceEEEEEccCCCchhhh------hhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec
Q 007668 369 RGYCNSPTSKLLIYDFLPGGSLDEA------LHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD 441 (594)
Q Consensus 369 ~g~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~ 441 (594)
++++.+....++||||+++|+|.++ +... ...+++..+..++.||+.||+|||+ ..+|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 9999999999999999999999998 5542 4669999999999999999999996 15999999999999999
Q ss_pred CCCcEEEeecccccccccCCceeeeeeecccCccCccccccC-CCCc-cchhhhHHHHHHHHHhCCCCCCcchhcccchH
Q 007668 442 GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG-RATE-KTDVYSFGVLVLEVLSGKRPTDASFIEKGLNI 519 (594)
Q Consensus 442 ~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~ 519 (594)
.++.++|+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----- 258 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----- 258 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----
Confidence 9999999999999876443 23445689999999999877 5666 999999999999999999999764321
Q ss_pred HHHHHHHhccccccc-----ccCCC----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 520 VGWLNFLISEDRQRE-----IIDPN----CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 520 ~~~~~~~~~~~~~~~-----~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
............... ...+. ........+..+.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111100000 00000 00011334567899999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=343.90 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=201.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|...+.||+|+||+||++... +++.||||++... .......+.+|++++++++||||+++++++.+....++|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457888999999999999999775 6899999998642 2234567899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec---CCCcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~~l~Dfgl~~~~~~ 459 (594)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||++.....
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999998764 569999999999999999999995 4999999999999995 456799999999987654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.. ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||....... .......... . ..
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~-~----~~ 242 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKY-A----FD 242 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC-C----SC
T ss_pred CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-C----CC
Confidence 32 2334569999999999875 59999999999999999999999997643221 1111111110 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 243 L-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp S-GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 011233467899999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=329.68 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=200.1
Q ss_pred HhcCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
..++|...+.||+|+||.||+|...+ .+|+|+++.. .....+.+.+|+.++++++||||+++++++.+....++|+
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35678889999999999999998764 4899988643 2223356788999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++++|.+++......+++..+..++.||+.||+|||+. +++||||||+||+++ ++.++|+|||++........
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 99999999999987666799999999999999999999964 999999999999998 67999999999876532211
Q ss_pred ----eeeeeeecccCccCcccccc---------CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 463 ----HITTIVAGTFGYLAPEYMQS---------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 463 ----~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
.......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..... ..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~-~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQM-GT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HHHHH-HT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHh-cc
Confidence 11233458999999999864 457899999999999999999999997643221 11111 11
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
... +... ....+..+.+++.+||+.||++|||+.++++.|++....
T Consensus 258 ~~~-----~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 258 GMK-----PNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp TCC-----CCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCC-----CCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1110 111234688999999999999999999999999987654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=320.85 Aligned_cols=254 Identities=18% Similarity=0.294 Sum_probs=199.6
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc----hhhHHHHHHHHHHHhhCCCCeeeeeeeEE--eCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN----EGFDRFFERELEILGSIKHRYLVNLRGYC--NSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~~ 378 (594)
..+|...+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++ .+....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999874 68899999997532 23457799999999999999999999998 445678
Q ss_pred EEEEEccCCCchhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 379 LLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
++||||++++ |.+++.. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 7676654 345699999999999999999999954 9999999999999999999999999999876
Q ss_pred ccCC-ceeeeeeecccCccCccccccCCC--CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 458 EDEE-SHITTIVAGTFGYLAPEYMQSGRA--TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 458 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~--~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
.... ........||+.|+|||++.+... +.++||||||+++|||++|+.||...... ......... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~~-~~-- 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFENIGKG-SY-- 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHC-CC--
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHHHhcC-CC--
Confidence 5322 222344568999999999876543 78999999999999999999999764221 111111111 00
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhcc
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILESE 579 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~~ 579 (594)
..+......+.+++.+||+.||++|||++|+++ .+++.
T Consensus 231 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 -------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp -------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred -------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 011223467889999999999999999999996 45543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=343.77 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=197.9
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|...+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888899999999999999875 68899999987532 333567899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---CCcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~~l~Dfgl~~~~~~ 459 (594)
||+++|+|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++.....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988764 568999999999999999999995 49999999999999975 44599999999987654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
... .....||+.|+|||++. +.++.++||||+||++|+|++|..||....... .......... ....+.
T Consensus 192 ~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~--~~~~~~ 260 (494)
T 3lij_A 192 QKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVEKGKY--TFDSPE 260 (494)
T ss_dssp TBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC--CCCSGG
T ss_pred Ccc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC--CCCchh
Confidence 332 33456999999999886 569999999999999999999999997643221 1111111110 000111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+ ...+..+.+++.+||+.||++|||+.|+++
T Consensus 261 ~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 261 W----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp G----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1 123467899999999999999999999884
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.08 Aligned_cols=253 Identities=15% Similarity=0.277 Sum_probs=197.3
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeC--CCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNS--PTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~ 382 (594)
++|+..+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|++++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5788889999999999999975 578999999987533 467899999999997 9999999999987 66789999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~~~~~~~ 461 (594)
||+++++|.+++.. +++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999853 8899999999999999999995 4999999999999999766 89999999998765433
Q ss_pred ceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhccc--c---------hHHHHHHHHh--
Q 007668 462 SHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKG--L---------NIVGWLNFLI-- 527 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~--~---------~~~~~~~~~~-- 527 (594)
. .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ . ....+.....
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2 233468999999999877 6789999999999999999999999854221100 0 0000000000
Q ss_pred ---------cc---cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 528 ---------SE---DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 528 ---------~~---~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. ......... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHS---ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCT---TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccchhhhhhhccccchhhhccc---cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000000000 011224577999999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=327.40 Aligned_cols=260 Identities=22% Similarity=0.366 Sum_probs=199.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-----Cce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 378 (594)
..+|+..+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357888999999999999999765 68889999997533 33456789999999999999999999998654 467
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||++ |+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 99999996 699999875 459999999999999999999995 499999999999999999999999999998765
Q ss_pred cCCcee--eeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc----
Q 007668 459 DEESHI--TTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR---- 531 (594)
Q Consensus 459 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 531 (594)
...... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+..... . .......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~-~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI--L-GILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH--H-HHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH--H-HHhCCCCHHHH
Confidence 433221 234579999999998654 55899999999999999999999999764332211110 0 0000000
Q ss_pred -----------cccccCCCC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 532 -----------QREIIDPNC---EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 532 -----------~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+.. ..........+.+|+.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 0011223467899999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=356.47 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=204.5
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceE
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 379 (594)
..++|+..+.||+|+||.||+|... +++.||||++++. .....+.+..|.+++..+ +||+|+++++++.+....+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568889999999999999999765 5788999999753 223346678899999887 7999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||+++|+|.++++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999999999864 569999999999999999999995 4999999999999999999999999999986443
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~--------- 558 (674)
T 3pfq_A 495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHN--------- 558 (674)
T ss_dssp TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHSSC---------
T ss_pred CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCC---------
Confidence 322 244567999999999999999999999999999999999999999764322 1111111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTM-----HRVV 573 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ev~ 573 (594)
...+...+.++.+|+.+||+.||++||++ +||+
T Consensus 559 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~ 596 (674)
T 3pfq_A 559 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 596 (674)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence 01223345779999999999999999997 6665
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.49 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=181.6
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC------Cc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TS 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 377 (594)
++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 5788889999999999999975 46899999998653 333456788999999999999999999998654 56
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 79999999 7899999865 569999999999999999999995 49999999999999999999999999999865
Q ss_pred ccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc-------
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE------- 529 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 529 (594)
... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||............ ......
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~~~~~ 255 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAELLK 255 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHHHT
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHHHH
Confidence 432 234578999999999876 67899999999999999999999999764322111100 000000
Q ss_pred ----cccccccC--CCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 ----DRQREIID--PNCEG-----VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ----~~~~~~~~--~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+. +..+. ........+.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000 00000 11123466899999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=345.27 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=203.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888899999999999999876 7899999998643 233467799999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccc
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~~l~Dfgl~~~~~ 458 (594)
+||+++|+|.+.+..+ ..+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++....
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999999763 5699999999999999999999954 99999999999999 567899999999998765
Q ss_pred cCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... .....||+.|+|||++.+ .++.++||||+|+++|+|++|+.||....... ......... . ..
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~-~----~~ 246 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVEKGK-Y----TF 246 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-C----CC
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCC-C----CC
Confidence 4332 233569999999999875 79999999999999999999999997643221 111111111 0 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. ......+..+.+++.+||+.||++|||++|+++
T Consensus 247 ~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 EL-PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CS-GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00 011234467899999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=321.52 Aligned_cols=251 Identities=23% Similarity=0.392 Sum_probs=194.9
Q ss_pred HhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeC------CC
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNS------PT 376 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~ 376 (594)
..++|...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++.++ +||||+++++++.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 4567888999999999999999874 689999999875432 356788999999998 79999999999866 46
Q ss_pred ceEEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 789999999999999999864 3569999999999999999999995 499999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
....... ......|++.|+|||++. +..++.++||||||+++|+|++|+.||........ .. .....
T Consensus 178 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~-~~~~~ 249 (326)
T 2x7f_A 178 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LF-LIPRN 249 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH-HHHHS
T ss_pred ecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HH-HhhcC
Confidence 6643221 223456899999999986 56789999999999999999999999865432111 00 11111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...... ....+..+.+++.+||+.||++|||++++++
T Consensus 250 ~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 250 PAPRLK-------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCCCS-------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccCC-------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111 1223467899999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=318.60 Aligned_cols=251 Identities=25% Similarity=0.417 Sum_probs=193.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC----------
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS---------- 374 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------- 374 (594)
.++|+..+.||+|+||.||+|... +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 456888899999999999999864 7899999998653 3345678999999999999999999998754
Q ss_pred ---CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 375 ---PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 375 ---~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
....++||||+++|+|.+++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence 3567899999999999999987666789999999999999999999964 9999999999999999999999999
Q ss_pred ccccccccCC-------------ceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccc
Q 007668 452 GLAKLLEDEE-------------SHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL 517 (594)
Q Consensus 452 gl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~ 517 (594)
|++....... ........||+.|+|||.+.+. .++.++||||||+++|||++ ||......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--- 234 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--- 234 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH---
Confidence 9998664321 1122345689999999998764 78999999999999999998 54432111
Q ss_pred hHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 518 NIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......... ...+.+ ......+..+.+++.+||+.||++|||++++++
T Consensus 235 --~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 --VNILKKLRSV---SIEFPP---DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHHHHHST---TCCCCT---TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHhcccc---ccccCc---cccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1111111110 011111 123344567899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=334.49 Aligned_cols=260 Identities=21% Similarity=0.249 Sum_probs=199.1
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCC--------CCeeeeeeeEEe----
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIK--------HRYLVNLRGYCN---- 373 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~---- 373 (594)
++|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 5788899999999999999975 46889999998754 334567889999999885 788999999987
Q ss_pred CCCceEEEEEccCCCchhhhhhh-cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC--------
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHE-RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-------- 444 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-------- 444 (594)
.....++||||+ ++++.+.+.. ....+++..+..++.||+.||+|||++ .+|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhhhhhh
Confidence 566789999999 5566665554 346699999999999999999999952 1899999999999999775
Q ss_pred -----------------------------------------cEEEeecccccccccCCceeeeeeecccCccCccccccC
Q 007668 445 -----------------------------------------EARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483 (594)
Q Consensus 445 -----------------------------------------~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 483 (594)
.+||+|||++...... .....||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876543 2234689999999999999
Q ss_pred CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHH---HHhcc---------cccccccC----------CC--
Q 007668 484 RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLN---FLISE---------DRQREIID----------PN-- 539 (594)
Q Consensus 484 ~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~---------~~~~~~~~----------~~-- 539 (594)
.++.++|||||||++|||++|+.||................ ..... ......+. ..
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 99999999999999999999999997643222111111000 00000 00000000 00
Q ss_pred --------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 --------CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 --------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...........+.+|+.+||+.||++|||++|+++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01134566788999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=326.86 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=191.1
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC------
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------ 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 376 (594)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357888999999999999999765 6889999998753 3344567889999999999999999999997654
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
..++||||++ |+|.+.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCC-CCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 6799999996 57888875 348999999999999999999995 4999999999999999999999999999986
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH---------HH-----
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV---------GW----- 522 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~---------~~----- 522 (594)
..... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||............ .+
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 54322 233457899999999999999999999999999999999999999764322110000 00
Q ss_pred --HHHHhcccc------c----ccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 523 --LNFLISEDR------Q----REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 523 --~~~~~~~~~------~----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......... . ....-+............+.+|+.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000 0 000000000011233567999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=328.51 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=194.5
Q ss_pred HHhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--------
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS-------- 374 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 374 (594)
...++|...+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3456888999999999999999976 5789999999875433 23479999999999999999999843
Q ss_pred ------------------------------CCceEEEEEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhh
Q 007668 375 ------------------------------PTSKLLIYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLH 421 (594)
Q Consensus 375 ------------------------------~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH 421 (594)
....++||||++ |+|.+.+.. ....+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 233789999997 588877763 3567999999999999999999999
Q ss_pred hcCCCCeeeCCCCCCCeEec-CCCcEEEeecccccccccCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHH
Q 007668 422 HDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVL 499 (594)
Q Consensus 422 ~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~ 499 (594)
+.+|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+|+++|
T Consensus 159 ---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 159 ---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp ---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred ---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 45999999999999998 688999999999987654432 2334689999999998765 4899999999999999
Q ss_pred HHHhCCCCCCcchhcccchHHHHHHHHhcc---------cccccccCCCCCC------CCHHHHHHHHHHHHHcccCCCC
Q 007668 500 EVLSGKRPTDASFIEKGLNIVGWLNFLISE---------DRQREIIDPNCEG------VQSESLDALLAVATQCVSSSPD 564 (594)
Q Consensus 500 elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~ 564 (594)
||++|+.||......+.. .......-.. .......-+.... .+...+..+.+|+.+||+.||+
T Consensus 234 ell~g~~pf~~~~~~~~~--~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQL--VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHSSCSSCCSSHHHHH--HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHhCCCCCCCCChHHHH--HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999764322111 1111000000 0000000000000 1223456789999999999999
Q ss_pred CCCCHHHHHH
Q 007668 565 DRPTMHRVVQ 574 (594)
Q Consensus 565 ~RPs~~ev~~ 574 (594)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.59 Aligned_cols=197 Identities=23% Similarity=0.295 Sum_probs=170.5
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhC------CCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSI------KHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~ 379 (594)
.+|+..+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++..+ +|+||+++++++......+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46888999999999999999665 58899999997532 3356677888888776 5779999999999999999
Q ss_pred EEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc--EEEeecccccc
Q 007668 380 LIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE--ARVSDFGLAKL 456 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~~l~Dfgl~~~ 456 (594)
+||||++ ++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999995 69999987643 4599999999999999999999965 9999999999999998887 99999999976
Q ss_pred cccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcch
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASF 512 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 512 (594)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 4432 233568999999999999999999999999999999999999997643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.14 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=199.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch-------------hhHHHHHHHHHHHhhCCCCeeeeeeeE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-------------GFDRFFERELEILGSIKHRYLVNLRGY 371 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~g~ 371 (594)
.++|...+.||+|+||+||+|... +++.||+|++..... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888999999999999999875 578999999875321 235678999999999999999999999
Q ss_pred EeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC---cEEE
Q 007668 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL---EARV 448 (594)
Q Consensus 372 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~~l 448 (594)
+.+....++||||+++|+|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999764 569999999999999999999995 4999999999999998765 6999
Q ss_pred eecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc
Q 007668 449 SDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 528 (594)
+|||++........ .....||+.|+|||++. +.++.++||||+|+++|+|++|..||....... .......
T Consensus 191 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~ 261 (504)
T 3q5i_A 191 VDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKKVEK 261 (504)
T ss_dssp CCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH
T ss_pred EECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence 99999987654332 23456999999999987 468999999999999999999999997643221 1111111
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... . ++. ......+..+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~-~--~~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 GKY-Y--FDF---NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCC-C--CCH---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC-C--CCc---cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 110 0 000 000123467899999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=317.96 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=203.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---------hhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---------EGFDRFFERELEILGSIK-HRYLVNLRGYCNS 374 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 374 (594)
.++|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++.+++ ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 568889999999999999999875 58899999986432 123456889999999996 9999999999999
Q ss_pred CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
....++||||+++++|.+++..+ ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999764 568999999999999999999995 49999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccCccCccccc------cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQ------SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 528 (594)
........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||....... .......
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~ 243 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMS 243 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHHHHhc
Confidence 87654332 23356899999999885 4568899999999999999999999986532211 1111111
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. . .... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~-~-~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GN-Y-QFGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TC-C-CCCT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CC-c-ccCc----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 0 0000 111234567999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=323.80 Aligned_cols=259 Identities=20% Similarity=0.323 Sum_probs=200.6
Q ss_pred cCCCccceeeeecceEEEEEEe--cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCC------eeeeeeeEEeCCCce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM--DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR------YLVNLRGYCNSPTSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~g~~~~~~~~ 378 (594)
++|+..+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++..++|+ +++++++++......
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4788899999999999999976 368899999987543 3456788899999888665 499999999999999
Q ss_pred EEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---------------
Q 007668 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--------------- 442 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--------------- 442 (594)
++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 889999997643 368999999999999999999995 49999999999999987
Q ss_pred ----CCcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccch
Q 007668 443 ----NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN 518 (594)
Q Consensus 443 ----~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 518 (594)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+...
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999865432 223568999999999999999999999999999999999999997643322111
Q ss_pred HHHHHHH-----Hhccccccccc---------------------CC--CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007668 519 IVGWLNF-----LISEDRQREII---------------------DP--NCEGVQSESLDALLAVATQCVSSSPDDRPTMH 570 (594)
Q Consensus 519 ~~~~~~~-----~~~~~~~~~~~---------------------~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 570 (594)
....... ..........+ .+ ............+.+++.+||+.||++|||++
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 1100000 00000000000 00 00012335567899999999999999999999
Q ss_pred HHHH
Q 007668 571 RVVQ 574 (594)
Q Consensus 571 ev~~ 574 (594)
|+++
T Consensus 325 ell~ 328 (339)
T 1z57_A 325 EALK 328 (339)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.43 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=199.5
Q ss_pred HhcCCCccceeeeecceEEEEEEe--cCCcEEEEEeecccc--hhhHHHHHHHHHHHhhC---CCCeeeeeeeEEe----
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAM--DDGNVFALKRIDKLN--EGFDRFFERELEILGSI---KHRYLVNLRGYCN---- 373 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~---- 373 (594)
..++|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346789999999999999999987 468899999987432 22233566777777666 8999999999986
Q ss_pred -CCCceEEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 007668 374 -SPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDF 451 (594)
Q Consensus 374 -~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Df 451 (594)
.....++|+||++ |+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 5667889999997 69999997643 449999999999999999999995 49999999999999999999999999
Q ss_pred ccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc--
Q 007668 452 GLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE-- 529 (594)
Q Consensus 452 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 529 (594)
|++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..........
T Consensus 165 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~i~~~~~~~~~ 240 (326)
T 1blx_A 165 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIGLPGE 240 (326)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCG
T ss_pred cccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHcCCCCc
Confidence 9998665332 123356899999999999999999999999999999999999999764322110 0000000000
Q ss_pred ccc-------cccc----CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 DRQ-------REII----DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~~-------~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... ...+ ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000 00011122334567899999999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=326.24 Aligned_cols=262 Identities=22% Similarity=0.325 Sum_probs=192.8
Q ss_pred cCCCccceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEe------------
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN------------ 373 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------ 373 (594)
.+|...+.||+|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 467888999999999999998764 8999999998766666778999999999999999999999873
Q ss_pred --CCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEee
Q 007668 374 --SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSD 450 (594)
Q Consensus 374 --~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~D 450 (594)
+....++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+++ +++.+||+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467789999997 699999864 568999999999999999999995 4999999999999997 567999999
Q ss_pred cccccccccCCce--eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHH-----
Q 007668 451 FGLAKLLEDEESH--ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGW----- 522 (594)
Q Consensus 451 fgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~----- 522 (594)
||+++........ ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999876532211 1233457899999998865 6789999999999999999999999976432211000000
Q ss_pred ----HHHHhcc--ccccc-ccCCCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 523 ----LNFLISE--DRQRE-IIDPNC--EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 523 ----~~~~~~~--~~~~~-~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....... ..... ...+.. .......+..+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000 00000 000000 0011223567999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=326.46 Aligned_cols=200 Identities=23% Similarity=0.322 Sum_probs=171.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CC-----eeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HR-----YLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~ 378 (594)
.++|...+.||+|+||+||+|... +++.||||+++... .....+.+|++++..++ |+ +++++.+++......
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 568889999999999999999765 67889999997532 33566788888888875 44 499999999999999
Q ss_pred EEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec--CCCcEEEeeccccc
Q 007668 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAK 455 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~~l~Dfgl~~ 455 (594)
++||||++ |+|.+++.... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 99999995 59999998643 5699999999999999999999954 46999999999999995 57789999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcch
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASF 512 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~ 512 (594)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 76532 233568999999999999999999999999999999999999998643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.78 Aligned_cols=260 Identities=21% Similarity=0.338 Sum_probs=197.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC-----Cce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSP-----TSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~ 378 (594)
.++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357888899999999999999875 68899999997533 33456788999999999999999999987654 678
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++|+||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999996 699999875 469999999999999999999995 499999999999999999999999999998765
Q ss_pred cCCce---------eeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc
Q 007668 459 DEESH---------ITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528 (594)
Q Consensus 459 ~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 528 (594)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhC
Confidence 32211 1123468999999998764 678999999999999999999999997643221100 0000000
Q ss_pred ccc------------cc----cc---cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 EDR------------QR----EI---IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ~~~------------~~----~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... .. .. ............+..+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 00 00 000000011233467899999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=324.09 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=194.6
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch--------hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--------GFDRFFERELEILGSIKHRYLVNLRGYCNSPT 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 376 (594)
.++|...+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 357888999999999999999765 578999999864321 12345889999999999999999999987655
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc---EEEeeccc
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFGL 453 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~~l~Dfgl 453 (594)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 8999999999999999875 3569999999999999999999995 49999999999999986654 99999999
Q ss_pred ccccccCCceeeeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 454 AKLLEDEESHITTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 454 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
+....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||....... .+..... ..
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~----~~ 235 (322)
T 2ycf_A 164 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT----SG 235 (322)
T ss_dssp CEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHH----HT
T ss_pred ceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHH----hC
Confidence 98765322 122346899999999974 4678999999999999999999999997543221 1111110 00
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... ..+......+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYN-----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCC-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc-----cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000 000001123467899999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=323.86 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=195.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc------
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS------ 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 377 (594)
++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 46778899999999999999765 6899999999753 33345678899999999999999999999977654
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 104 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999996 68988874 3489999999999999999999964 9999999999999999999999999999865
Q ss_pred ccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHh---------
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLI--------- 527 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 527 (594)
... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ......-
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILKVTGVPGTEFVQK 250 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH--HHHHHHCBCCHHHHTT
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHHH
Confidence 432 233568999999999876 678999999999999999999999997643221100 0000000
Q ss_pred -cc-------cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 528 -SE-------DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 528 -~~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. ........+.+.......+..+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000001111222223345678999999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=332.84 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=193.3
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc------eEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS------KLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~l 380 (594)
.+|...+.||+|+||.||+|....+..+|+|++...... ..+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468888999999999999999988888999988653322 3469999999999999999999854333 679
Q ss_pred EEEccCCCchhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeeccccccc
Q 007668 381 IYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLL 457 (594)
Q Consensus 381 v~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~ 457 (594)
||||++++.+....+ .....+++..+..++.||++||+|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999997754443332 235679999999999999999999995 4999999999999999 7999999999999876
Q ss_pred ccCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHH----------H
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNF----------L 526 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~----------~ 526 (594)
..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. +...... .
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHH
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHh
Confidence 54332 2345689999999998764 589999999999999999999999976432211 1111100 0
Q ss_pred hcccccccccCCCCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 527 ISEDRQREIIDPNCEG------VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.........+ +.... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKF-PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCC-CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhcc-ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000000 00000 11224467999999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=335.16 Aligned_cols=197 Identities=25% Similarity=0.412 Sum_probs=153.0
Q ss_pred CCc-cceeeeecceEEEEEEec---CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEE--eCCCceEEEE
Q 007668 309 LDD-DHIIGSGGFGTVYKLAMD---DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC--NSPTSKLLIY 382 (594)
Q Consensus 309 ~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lv~ 382 (594)
|.. .++||+|+||.||+|... ++..||+|++..... ...+.+|++++++++||||+++++++ ......++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 443 568999999999999865 578899999975432 34688999999999999999999999 4467789999
Q ss_pred EccCCCchhhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe----cCCCcEEEee
Q 007668 383 DFLPGGSLDEALHER--------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----DGNLEARVSD 450 (594)
Q Consensus 383 e~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~~l~D 450 (594)
||++ |+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 5888877531 1249999999999999999999995 499999999999999 6778999999
Q ss_pred cccccccccCCc--eeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcc
Q 007668 451 FGLAKLLEDEES--HITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDAS 511 (594)
Q Consensus 451 fgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~ 511 (594)
||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 999987654322 223446789999999998874 5899999999999999999999999754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=329.71 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=192.0
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC----C--ceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP----T--SKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----~--~~~ 379 (594)
.+|...+.||+|+||.||+|... +|+.||||++..... ...+|++++++++||||+++++++... . ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46788899999999999999875 589999999875432 234799999999999999999988432 2 256
Q ss_pred EEEEccCCCchhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC-CcEEEeeccccc
Q 007668 380 LIYDFLPGGSLDEALH---ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAK 455 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~~l~Dfgl~~ 455 (594)
+||||+++ ++.+.+. .....+++..+..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 6666554 23567999999999999999999999 4599999999999999955 678999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc------
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS------ 528 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 528 (594)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.......-.
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHH
Confidence 7654332 2335689999999998764 789999999999999999999999976432211 1111110000
Q ss_pred ---ccccccccCCCCCC------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 ---EDRQREIIDPNCEG------VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ---~~~~~~~~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.........+.... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00001111111111 11233467999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.08 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=194.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCce-----
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSK----- 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----- 378 (594)
++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 46788899999999999999765 6899999999753 333457788999999999999999999999877655
Q ss_pred -EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 379 -LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 379 -~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
++||||++ ++|.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 122 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999996 68888874 3499999999999999999999954 9999999999999999999999999999865
Q ss_pred ccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc--------
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS-------- 528 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 528 (594)
... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.. .......-.
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--TQILKVTGVPGTEFVQK 268 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCHHHHTT
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCcHHHHHH
Confidence 432 233568999999999887 68899999999999999999999999764322110 000000000
Q ss_pred --c----cccccccCCC---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 --E----DRQREIIDPN---CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 --~----~~~~~~~~~~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. .......... ........+..+.+|+.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 0000000000 00011223567999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=324.24 Aligned_cols=269 Identities=19% Similarity=0.259 Sum_probs=191.8
Q ss_pred HHHHHHHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 299 SKDIIKKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 299 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
........++|...+.||+|+||.||+|... +++.||||++..... ....+.+|++.+..++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 4566777899999999999999999999875 689999998865332 23456678888899999999999999865433
Q ss_pred -------eEEEEEccCCCchhhhhh---hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-CCcE
Q 007668 378 -------KLLIYDFLPGGSLDEALH---ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEA 446 (594)
Q Consensus 378 -------~~lv~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ 446 (594)
.++||||+++ +|.+.+. .....+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcE
Confidence 6899999976 5544443 2456689999999999999999999943 459999999999999996 8999
Q ss_pred EEeecccccccccCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHH
Q 007668 447 RVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNF 525 (594)
Q Consensus 447 ~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 525 (594)
||+|||++........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......... ......
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHH
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHHHH
Confidence 9999999987654332 2334689999999998665 4899999999999999999999999764332111 111110
Q ss_pred -----------HhcccccccccCCC-------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 526 -----------LISEDRQREIIDPN-------CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 526 -----------~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...........+.. ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000000 01112234678999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=318.29 Aligned_cols=250 Identities=19% Similarity=0.339 Sum_probs=195.1
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCC--CCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIK--HRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv 381 (594)
.++|...+.||+|+||.||++...+++.||||++... .....+.+.+|++++.+++ ||||+++++++.+....++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4678889999999999999999988999999998643 3344577899999999997 59999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|| +.+++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||++++ +.+||+|||++.......
T Consensus 107 ~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred Ee-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 99 5688999999764 5789999999999999999999954 9999999999999974 899999999998765433
Q ss_pred ce-eeeeeecccCccCcccccc-----------CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 462 SH-ITTIVAGTFGYLAPEYMQS-----------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 462 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
.. ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~ 255 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDP 255 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCT
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHHHhc
Confidence 22 2234568999999999875 46888999999999999999999998653211 1111111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. . .. .+......+.+++.+||+.||++|||++|+++
T Consensus 256 ~~-~----~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 256 NH-E----IE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp TS-C----CC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cc-c----cC---CcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11 0 01 11122357899999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=331.88 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=189.1
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+|...++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 35777899999999997766677899999999865332 2356799999999 7999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-----CCcEEEeecccccccccC
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-----NLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~~l~Dfgl~~~~~~~ 460 (594)
+ |+|.+++........+..+..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 5 69999998766556666778999999999999995 49999999999999953 336889999999876543
Q ss_pred Cc--eeeeeeecccCccCccccc---cCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 461 ES--HITTIVAGTFGYLAPEYMQ---SGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 461 ~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
.. .......||+.|+|||++. ...++.++|||||||++|||++ |..||....... .........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~--- 246 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS--- 246 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC---
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC---
Confidence 22 2234467999999999987 4567889999999999999999 899985432211 111111111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.............+.+|+.+||+.||++|||++||++
T Consensus 247 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 ---LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111122344566889999999999999999999983
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=319.57 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=177.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHH-HHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELE-ILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|...+.||+|+||.||+|... +|+.||||++.... ......+..|+. +++.++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 357788899999999999999875 68999999997542 333445556665 677789999999999999999999999
Q ss_pred EccCCCchhhhhhh----cCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 383 DFLPGGSLDEALHE----RSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 383 e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++....
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99974 88877753 246699999999999999999999952 289999999999999999999999999998765
Q ss_pred cCCceeeeeeecccCccCcccc----ccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 459 DEESHITTIVAGTFGYLAPEYM----QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
.... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||........ ...... .
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~------~ 244 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV------K 244 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC------C
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh------c
Confidence 4322 2234689999999998 456789999999999999999999999975321100 000000 0
Q ss_pred ccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+.+.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00011110 11234567999999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=309.03 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=201.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+....++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467889999999999999999876 6899999998653 2334567899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC---CcEEEeeccccccccc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN---LEARVSDFGLAKLLED 459 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~~l~Dfgl~~~~~~ 459 (594)
||+++++|.+.+... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.+ +.+||+|||++.....
T Consensus 101 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999999999998754 468999999999999999999995 499999999999999754 4799999999986654
Q ss_pred CCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 460 EESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 460 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||....... ......... .. ..
T Consensus 177 ~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~----~~ 242 (287)
T 2wei_A 177 NTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGK-YA----FD 242 (287)
T ss_dssp CSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-CC----CC
T ss_pred CCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-CC----CC
Confidence 322 223458999999998875 58999999999999999999999997643221 111111111 00 00
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+ .....+..+.+++.+||+.||++|||++|+++
T Consensus 243 ~~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 LP-QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp SG-GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ch-hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 01123467899999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.28 Aligned_cols=252 Identities=23% Similarity=0.381 Sum_probs=181.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch--hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE--GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.++..+++.++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 567888899999999999999875 689999999975432 22334455556788889999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+ ++.+..+.......+++..+..++.||+.||.|||+. .+|+||||||+||+++.++.+||+|||++........
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 999 5566666555567799999999999999999999951 2899999999999999999999999999976654322
Q ss_pred eeeeeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 463 HITTIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
.....||+.|+|||++. ...++.++||||||+++|||++|+.||...... .............
T Consensus 181 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~----- 248 (318)
T 2dyl_A 181 --KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEPP----- 248 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCCC-----
T ss_pred --ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCCC-----
Confidence 23346899999999984 456889999999999999999999999753211 1111111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+ .....+..+.+++.+||+.||++|||++|+++
T Consensus 249 -~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 249 -LLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -CCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 010 01123467899999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=319.11 Aligned_cols=256 Identities=20% Similarity=0.261 Sum_probs=174.1
Q ss_pred hcCCCcc-ceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC----CCceE
Q 007668 306 LETLDDD-HIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKL 379 (594)
Q Consensus 306 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 379 (594)
.++|... ++||+|+||.||+|... +++.||||++..... ...+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 57999999999999876 689999999865321 22222334567799999999999865 44578
Q ss_pred EEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---CCcEEEeeccccc
Q 007668 380 LIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLAK 455 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~~l~Dfgl~~ 455 (594)
+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998653 4699999999999999999999964 9999999999999986 4559999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... .......... ...
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~-~~~ 252 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQ-YGF 252 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CC
T ss_pred eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhccc-ccc
Confidence 654322 234568999999999988889999999999999999999999997643221100 0000000000 000
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhcc
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILESE 579 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~~ 579 (594)
..+ .....+..+.+++.+||+.||++|||++|+++ .+++.
T Consensus 253 ~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 253 PNP----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CTT----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred Cch----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 011 11234567899999999999999999999997 55543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.06 Aligned_cols=248 Identities=24% Similarity=0.320 Sum_probs=186.2
Q ss_pred CCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
|...+.||+|+||+||.+...+|+.||||++.... .+.+.+|++++.++ +||||+++++++.+....++||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 34467899999999988777789999999986532 34678899999876 89999999999999999999999995
Q ss_pred CchhhhhhhcCCC------CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCC-------------CcEEE
Q 007668 388 GSLDEALHERSEQ------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGN-------------LEARV 448 (594)
Q Consensus 388 gsL~~~l~~~~~~------l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-------------~~~~l 448 (594)
|+|.+++...... .++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999754221 1233457899999999999995 499999999999999754 48999
Q ss_pred eecccccccccCCce---eeeeeecccCccCcccccc-------CCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccc
Q 007668 449 SDFGLAKLLEDEESH---ITTIVAGTFGYLAPEYMQS-------GRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGL 517 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~ 517 (594)
+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 999999877654322 1234579999999999875 578999999999999999999 999986542211
Q ss_pred hHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 518 NIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...... ... .+..........+..+.+++.+||+.||++|||+.||++
T Consensus 248 --~~i~~~---~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SNIIRG---IFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HHHHHT---CCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHhcC---CCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111100 000 000001123566788999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.27 Aligned_cols=259 Identities=22% Similarity=0.288 Sum_probs=197.6
Q ss_pred cCCCccceeeeecceEEEEEEec-CC-cEEEEEeecccchhhHHHHHHHHHHHhhCCCCe------eeeeeeEEeCCCce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DG-NVFALKRIDKLNEGFDRFFERELEILGSIKHRY------LVNLRGYCNSPTSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~ 378 (594)
++|...+.||+|+||.||+|... ++ ..||+|+++... ...+.+.+|++++++++|++ ++.+.+++......
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 57888999999999999999764 34 689999987532 34567888999999987665 89999999999999
Q ss_pred EEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe-----------------
Q 007668 379 LLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL----------------- 440 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll----------------- 440 (594)
++||||+ ++++.+.+... ...+++..+..++.||+.||+||| +.+|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 66777776654 356999999999999999999999 4599999999999999
Q ss_pred --cCCCcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccch
Q 007668 441 --DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN 518 (594)
Q Consensus 441 --~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~ 518 (594)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 567899999999998654322 33568999999999999999999999999999999999999997643221111
Q ss_pred HHHHHHH-----Hhcccccccc-------cCC----------------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007668 519 IVGWLNF-----LISEDRQREI-------IDP----------------NCEGVQSESLDALLAVATQCVSSSPDDRPTMH 570 (594)
Q Consensus 519 ~~~~~~~-----~~~~~~~~~~-------~~~----------------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 570 (594)
....... .......... .+. ............+.+|+.+||+.||++|||++
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 1000000 0000000000 000 00011234456899999999999999999999
Q ss_pred HHHH
Q 007668 571 RVVQ 574 (594)
Q Consensus 571 ev~~ 574 (594)
|+++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=324.02 Aligned_cols=264 Identities=19% Similarity=0.244 Sum_probs=199.0
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-----------CCeeeeeeeEEeC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIK-----------HRYLVNLRGYCNS 374 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~ 374 (594)
.+|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++.+++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788899999999999999976 56889999998753 234567888999988886 8999999999875
Q ss_pred CC----ceEEEEEccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec------CC
Q 007668 375 PT----SKLLIYDFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD------GN 443 (594)
Q Consensus 375 ~~----~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~------~~ 443 (594)
.. ..++||||+ +++|.+++... ...+++..+..++.||+.||+|||++ .+|+||||||+|||++ ..
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCc
Confidence 43 678999999 89999999763 34599999999999999999999952 2899999999999994 44
Q ss_pred CcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccc----hH
Q 007668 444 LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL----NI 519 (594)
Q Consensus 444 ~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~----~~ 519 (594)
+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .+
T Consensus 175 ~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 489999999998765332 2346899999999999999999999999999999999999999764321110 01
Q ss_pred HHHHHHH-----------------hccc-ccccccCC----------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007668 520 VGWLNFL-----------------ISED-RQREIIDP----------NCEGVQSESLDALLAVATQCVSSSPDDRPTMHR 571 (594)
Q Consensus 520 ~~~~~~~-----------------~~~~-~~~~~~~~----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 571 (594)
....... .... ....+... .....+......+.+|+.+||+.||++|||++|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 1100000 0000 00000000 001234567788999999999999999999999
Q ss_pred HHH--HHhc
Q 007668 572 VVQ--ILES 578 (594)
Q Consensus 572 v~~--~L~~ 578 (594)
+++ .+.+
T Consensus 331 ll~hp~f~~ 339 (373)
T 1q8y_A 331 LVNHPWLKD 339 (373)
T ss_dssp HHTCGGGTT
T ss_pred HhhChhhhc
Confidence 987 4544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=316.72 Aligned_cols=243 Identities=23% Similarity=0.335 Sum_probs=191.2
Q ss_pred HHHhcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchh------hHHHHHHHHHHHhhC----CCCeeeeeeeE
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEG------FDRFFERELEILGSI----KHRYLVNLRGY 371 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~g~ 371 (594)
..-.++|...+.||+|+||.||+|.. .+++.||||++...... ....+.+|++++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 33456799999999999999999976 46889999999753321 123456789999888 89999999999
Q ss_pred EeCCCceEEEEEc-cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEe
Q 007668 372 CNSPTSKLLIYDF-LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVS 449 (594)
Q Consensus 372 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~ 449 (594)
+......++|+|| +++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++ .++.++|+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 9999999999999 7899999999764 4699999999999999999999965 999999999999999 88999999
Q ss_pred ecccccccccCCceeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc
Q 007668 450 DFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS 528 (594)
Q Consensus 450 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 528 (594)
|||++....... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||...... ..
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------~~ 247 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------------LE 247 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------HH
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------------hh
Confidence 999998765432 234568999999999887666 45899999999999999999999753210 00
Q ss_pred ccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 EDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. . ..+......+.+++.+||+.||++|||++|+++
T Consensus 248 -~~--~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 -AE--L-------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -TC--C-------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hc--c-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0 011223467899999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=316.48 Aligned_cols=240 Identities=25% Similarity=0.371 Sum_probs=197.5
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchh------hHHHHHHHHHHHhhCC--CCeeeeeeeEEeCCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEG------FDRFFERELEILGSIK--HRYLVNLRGYCNSPT 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~ 376 (594)
.++|...+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.++++++ ||||+++++++....
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 45788899999999999999975 46889999998753221 2245678999999996 599999999999999
Q ss_pred ceEEEEEccCC-CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeecccc
Q 007668 377 SKLLIYDFLPG-GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLA 454 (594)
Q Consensus 377 ~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~ 454 (594)
..++|+|++.+ ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++ +++.+||+|||++
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred cEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 99999999976 8999999763 568999999999999999999995 4999999999999999 7899999999999
Q ss_pred cccccCCceeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (594)
....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ... .
T Consensus 198 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------------~~~---~ 259 (320)
T 3a99_A 198 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------IRG---Q 259 (320)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------HHC---C
T ss_pred ccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh------------hcc---c
Confidence 8765432 233568999999999887665 68899999999999999999999753210 000 0
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ...+..+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 VFFR-------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccc-------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 123367899999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.26 Aligned_cols=264 Identities=26% Similarity=0.372 Sum_probs=201.1
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC------CCc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNS------PTS 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~ 377 (594)
..+|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999764 6899999998753 44446679999999999999999999998755 677
Q ss_pred eEEEEEccCCCchhhhhhhcC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc---EEEeecc
Q 007668 378 KLLIYDFLPGGSLDEALHERS--EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE---ARVSDFG 452 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~~l~Dfg 452 (594)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. ++|+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 799999999999999998643 358999999999999999999995 49999999999999997665 9999999
Q ss_pred cccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc-
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR- 531 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 531 (594)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..||...... ..|.........
T Consensus 170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence 9987654332 23457899999999999999999999999999999999999999753211 111110000000
Q ss_pred -------ccc--ccC---CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHhcc
Q 007668 532 -------QRE--IID---PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHR-----VVQILESE 579 (594)
Q Consensus 532 -------~~~--~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-----v~~~L~~~ 579 (594)
... .+. +.........+..+.+++.+||+.||++|||++| +.+.++..
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 000 000 1111244567788999999999999999999977 44455443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=337.64 Aligned_cols=237 Identities=19% Similarity=0.340 Sum_probs=191.4
Q ss_pred cCCCccceeeeecceEEEEEEec--CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc-----e
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS-----K 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~ 378 (594)
++|...+.||+|+||.||+|... +++.||||++... .......+.+|++++.+++||||+++++++..... .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57888999999999999999875 5899999998653 33445678999999999999999999999977665 6
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999998754 699999999999999999999954 99999999999999976 99999999998765
Q ss_pred cCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.. ....||+.|+|||++.++. +.++||||||+++|+|++|..|+....... + ..
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~-~~ 286 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------L-PE 286 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------C-CT
T ss_pred cC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------c-cc
Confidence 43 3356899999999987654 899999999999999999998875422110 0 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHhc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPT-MHRVVQILES 578 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ev~~~L~~ 578 (594)
..........+.+++.+||+.||++||+ ++++...|..
T Consensus 287 --~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 --DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp --TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0011123367889999999999999995 5666665554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=299.40 Aligned_cols=231 Identities=12% Similarity=0.080 Sum_probs=182.8
Q ss_pred cCCCccceeeeecceEEEEEEecC-CcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.+|...+.||+|+||.||+|.... ++.||||++.... ....+.+.+|++.+.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 468888999999999999998764 8999999997532 333477899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++++|.+++... ....++.+++.|++.||+|||++ +|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 999999999999542 35667889999999999999964 99999999999999999999997443
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC-
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE- 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 541 (594)
|++ .++.++||||||+++|||++|+.||........... ..........
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~~~ 224 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQPIE 224 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSCBCC
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccCCCC
Confidence 333 368899999999999999999999976433211000 0000000000
Q ss_pred --CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCC
Q 007668 542 --GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPC 584 (594)
Q Consensus 542 --~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~ 584 (594)
......+..+.+++.+||+.||++| |+.|+++.|++......
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0112234678999999999999999 99999999998765443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=314.91 Aligned_cols=238 Identities=16% Similarity=0.186 Sum_probs=178.4
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccch---hhHHHHHHHHHHHhhCCC-Cee---------------e
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNE---GFDRFFERELEILGSIKH-RYL---------------V 366 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------------v 366 (594)
..|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++..++| +|. +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4567778999999999999984 5789999999874222 235679999999999987 211 1
Q ss_pred ee------eeEEeC-----CCceEEEEEccCCCchhhhhh------hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 007668 367 NL------RGYCNS-----PTSKLLIYDFLPGGSLDEALH------ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRII 429 (594)
Q Consensus 367 ~l------~g~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv 429 (594)
.+ +.++.. ....+++|+++ +++|.+++. .....+++..++.++.||++||+|||+ .+|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 11 111111 22356777755 789999984 223458888999999999999999995 4999
Q ss_pred eCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecccCccCcccc----------ccCCCCccchhhhHHHHHH
Q 007668 430 HRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM----------QSGRATEKTDVYSFGVLVL 499 (594)
Q Consensus 430 H~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~G~vl~ 499 (594)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865432 344567 999999998 5556888999999999999
Q ss_pred HHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007668 500 EVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 500 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 573 (594)
||++|+.||........ ...++. .... .+..+.+|+.+||+.||++|||+.+++
T Consensus 309 elltg~~Pf~~~~~~~~---------------~~~~~~-~~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG---------------SEWIFR-SCKN----IPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSC---------------SGGGGS-SCCC----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhh---------------HHHHHh-hccc----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999976432211 111111 1111 236699999999999999999976664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=293.68 Aligned_cols=232 Identities=21% Similarity=0.321 Sum_probs=179.8
Q ss_pred hcCCCcc-ceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHH-hhCCCCeeeeeeeEEeC----CCce
Q 007668 306 LETLDDD-HIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEIL-GSIKHRYLVNLRGYCNS----PTSK 378 (594)
Q Consensus 306 ~~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~ 378 (594)
.++|... +.||+|+||.||++.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3456555 7899999999999976 46899999998642 3567788887 56699999999999876 6678
Q ss_pred EEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---CCcEEEeecccc
Q 007668 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLA 454 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~~l~Dfgl~ 454 (594)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.++|+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998653 469999999999999999999995 49999999999999997 788999999998
Q ss_pred cccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
..... ..++.++||||+|+++|||++|+.||........ .......
T Consensus 168 ~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~ 213 (299)
T 3m2w_A 168 KETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTR 213 (299)
T ss_dssp EECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCS
T ss_pred ccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHH
Confidence 64331 3467899999999999999999999965432110 0000001
Q ss_pred ccCCCCCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhccc
Q 007668 535 IIDPNCEGVQ----SESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILESEV 580 (594)
Q Consensus 535 ~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~~~ 580 (594)
+.... ...+ ...+..+.+++.+||+.||++|||++|+++ .+.+..
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 214 IRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred Hhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 11111 1111 123567999999999999999999999997 454443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=305.84 Aligned_cols=241 Identities=18% Similarity=0.197 Sum_probs=184.1
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccc--------hhhHHHHHHHHHHHhhCC---------CCeeeee
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--------EGFDRFFERELEILGSIK---------HRYLVNL 368 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 368 (594)
.++|...+.||+|+||+||+|.. +|+.||||++.... ....+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45678889999999999999987 68999999997542 223367889999988885 7777766
Q ss_pred eeEE-----------------e-------------CCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 007668 369 RGYC-----------------N-------------SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418 (594)
Q Consensus 369 ~g~~-----------------~-------------~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~ 418 (594)
.+.+ . +....++||||+++|++.+.+.+ ..+++..+..++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 6653 2 26788999999999987777754 56899999999999999999
Q ss_pred Hhh-hcCCCCeeeCCCCCCCeEecCCC--------------------cEEEeecccccccccCCceeeeeeecccCccCc
Q 007668 419 YLH-HDCSPRIIHRDIKSSNILLDGNL--------------------EARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477 (594)
Q Consensus 419 ~LH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP 477 (594)
||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+||
T Consensus 176 ~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 65 999999999999999887 8999999999876532 34699999999
Q ss_pred cccccCCCCccchhhhHHHH-HHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC-CCCCCCHHHHHHHHHHH
Q 007668 478 EYMQSGRATEKTDVYSFGVL-VLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP-NCEGVQSESLDALLAVA 555 (594)
Q Consensus 478 E~~~~~~~~~~~Dv~s~G~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~ 555 (594)
|++.+.. +.++||||+|++ .+++++|..||... .|.......-........ .........+.++.+|+
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 316 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFH 316 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHH
Confidence 9998766 899999998776 78888999997431 111111100000000111 11112345778899999
Q ss_pred HHcccCCCCCCCCHHHHH
Q 007668 556 TQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 556 ~~cl~~dP~~RPs~~ev~ 573 (594)
.+||+.| |++|++
T Consensus 317 ~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 317 RTMLNFS-----SATDLL 329 (336)
T ss_dssp HHGGGSS-----SHHHHH
T ss_pred HHHhccC-----CHHHHH
Confidence 9999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-29 Score=268.60 Aligned_cols=184 Identities=18% Similarity=0.125 Sum_probs=129.3
Q ss_pred eeeecceEEEEE-EecCCcEEEEEeeccc----------chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEEEE
Q 007668 315 IGSGGFGTVYKL-AMDDGNVFALKRIDKL----------NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 315 lG~G~~g~Vy~~-~~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.+.|+.|.+..+ ...-|+.+|+|.+... .+...++|.+|+++|+++ .|+||+++++++.++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 455666655543 2335888999998642 122346799999999999 6999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||++|++|.+.+... +.++.. +|+.||+.||+|+|+ .|||||||||+|||++.++++||+|||+++.......
T Consensus 322 Eyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp ECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C
T ss_pred ecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc
Confidence 999999999999764 556654 589999999999995 4999999999999999999999999999987654332
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p 507 (594)
.....+||++|+|||++.+ .+..++|+|++|++++++.++..+
T Consensus 395 -~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 -WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2344679999999999875 567789999999998888765544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=235.30 Aligned_cols=175 Identities=35% Similarity=0.600 Sum_probs=161.1
Q ss_pred CCCcchHHHHHHHHHhccCCCCCCcCCCCCCCCCCc--cceeEeCCC---CcEEEEEcccCCCCC--CCCccccCcccCC
Q 007668 27 RAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCN--WKGVKCDKN---KRVITLSLTNHKLSG--PISADLGKLDQLK 99 (594)
Q Consensus 27 ~~~~~~~~~L~~~k~~~~~~~~~l~~w~~~~~~~c~--w~gv~c~~~---~~l~~L~L~~n~l~~--~~~~~~~~l~~L~ 99 (594)
.|.+.|++||++||+++.++. .+++|.. +.+||. |.||+|+.. .+|+.|+|++|++++ .+|..|.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 477889999999999997665 7899974 578998 999999854 799999999999998 8999999999999
Q ss_pred eeeccc-CccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecc
Q 007668 100 FLNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178 (594)
Q Consensus 100 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 178 (594)
+|+|++ |.+.+.+|..|.++++|++|+|++|.+++.+|..|..+++|++|+|++|+|++.+|..+..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 9999999999999999999999999999999999999999999999999999989999999999999999999
Q ss_pred cccccCCCC-cccc-cCCcccccCCCC
Q 007668 179 FLVGAIPSD-GVLT-KFSESSFFGNRG 203 (594)
Q Consensus 179 ~l~~~~~~~-~~l~-~l~~l~l~~N~~ 203 (594)
++++.+|.. ..++ +|+.|++++|+.
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCee
Confidence 999777654 6777 999999999974
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=249.23 Aligned_cols=184 Identities=17% Similarity=0.196 Sum_probs=145.3
Q ss_pred CccceeeeecceEEEEEEecCCcEEEEEeecccc--------hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLN--------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
...+.||+|+||.||++.. .+..+++|+..... ....+.+.+|++++++++||||+++..++......++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999944 47788888764311 11234589999999999999999777777777888999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++++|.+++.. +..++.|+++||+|||+ .+|+||||||+|||++. ++||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999975 56899999999999995 49999999999999998 99999999999876533
Q ss_pred cee------eeeeecccCccCcccccc--CCCCccchhhhHHHHHHHHHhCCCCC
Q 007668 462 SHI------TTIVAGTFGYLAPEYMQS--GRATEKTDVYSFGVLVLEVLSGKRPT 508 (594)
Q Consensus 462 ~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~vl~elltg~~p~ 508 (594)
... .....||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 221 234679999999999986 56788899999999888888877776
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-24 Score=240.35 Aligned_cols=175 Identities=23% Similarity=0.377 Sum_probs=116.0
Q ss_pred hccCCCcchHHHHHHHHHhccCCCCCCcCCCCCCCCCCccceeEeCCCCcEEEEEcccCCCCCC---CC-----------
Q 007668 24 NKSRAINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGP---IS----------- 89 (594)
Q Consensus 24 ~~~~~~~~~~~~L~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~l~~L~L~~n~l~~~---~~----------- 89 (594)
+++.+.+.|++||++||+++.++. .+++|. .+.+||.|+||+|+ .++|+.|+|+++.++|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~-~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWS-SNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SSTTCC-TTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cccCCC-CCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 344456789999999999998877 899997 46799999999998 78999999999999876 44
Q ss_pred ------------ccccCcccCCeeecccCccCCCCCC--CcCCCCccceeecccccccCCCChhh-hCCCCCceEeccCC
Q 007668 90 ------------ADLGKLDQLKFLNLHSNNFYGEIPS--ELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSN 154 (594)
Q Consensus 90 ------------~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N 154 (594)
..|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 4566666777777777777666666 66667777777777776666666544 55666666666666
Q ss_pred cCCCCCCcc---ccccCCCcEEEeecccccccCCCCcccccCCcccccCCC
Q 007668 155 SLSDYIPPS---LGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 155 ~l~~~~~~~---~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
++++..|.. +.++++|++|++++|.+++..+. ..+++|+.|++++|.
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-~~l~~L~~L~Ls~n~ 211 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDV-SRCVNLEFLDVSSNN 211 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC-TTCTTCCEEECCSSC
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCc-ccCCcCCEEECcCCc
Confidence 665544433 34444444444444444433322 334444444444443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.6e-23 Score=198.47 Aligned_cols=152 Identities=22% Similarity=0.272 Sum_probs=139.0
Q ss_pred CCCCCCccceeEeCC----------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCcccee
Q 007668 56 EDPDPCNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGL 125 (594)
Q Consensus 56 ~~~~~c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 125 (594)
.+...|+|++|.|+. .++|+.|+|++|+|++..|..|.++++|++|+|++|+|+...+..|.++++|++|
T Consensus 14 ~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 93 (229)
T 3e6j_A 14 PSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL 93 (229)
T ss_dssp CTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE
Confidence 357889999999964 3589999999999999889999999999999999999996666778999999999
Q ss_pred ecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 126 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
+|++|+|++..+..|..+++|++|+|++|+|+. +|..+..+++|+.|+|++|+|++.++.. ..+++|+.|++.+|++.
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCS-CCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCcccc-cCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 999999997777778999999999999999995 8999999999999999999999888754 78999999999999999
Q ss_pred CCCc
Q 007668 205 CGKQ 208 (594)
Q Consensus 205 c~~~ 208 (594)
|+|+
T Consensus 173 c~c~ 176 (229)
T 3e6j_A 173 CECR 176 (229)
T ss_dssp TTBG
T ss_pred CCcc
Confidence 9986
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.4e-23 Score=194.98 Aligned_cols=151 Identities=16% Similarity=0.210 Sum_probs=137.9
Q ss_pred CCccceeEeCC----------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccc
Q 007668 60 PCNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (594)
Q Consensus 60 ~c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (594)
.|.|..|.|.. ..+|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 10 ~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp EEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred EECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 36788899963 24799999999999977777999999999999999999988899999999999999999
Q ss_pred ccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCc
Q 007668 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 130 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~ 208 (594)
|+|+...+..|..+++|++|+|++|+|+++.|..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|+|.|+|.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 9999665666899999999999999999988999999999999999999999998864 789999999999999999988
Q ss_pred cc
Q 007668 209 IN 210 (594)
Q Consensus 209 ~~ 210 (594)
+.
T Consensus 170 l~ 171 (220)
T 2v9t_B 170 LK 171 (220)
T ss_dssp GH
T ss_pred cH
Confidence 64
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-23 Score=203.35 Aligned_cols=151 Identities=12% Similarity=0.089 Sum_probs=120.8
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccch------------------hhHHHHHHHHHHHhhCCC
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE------------------GFDRFFERELEILGSIKH 362 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 362 (594)
.+......|...+.||+|+||.||+|...+|+.||+|.++.... .....+.+|++++++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444556667799999999999999887899999999864221 12456899999999999
Q ss_pred CeeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC
Q 007668 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG 442 (594)
Q Consensus 363 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~ 442 (594)
| +++.+++.. ...++||||+++|+|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||++
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-
Confidence 4 666665543 55699999999999999 532 1245799999999999995 4999999999999999
Q ss_pred CCcEEEeecccccccccCCceeeeeeecccCccCccccc
Q 007668 443 NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQ 481 (594)
Q Consensus 443 ~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 481 (594)
++.++|+|||+++. +..+.|||++.
T Consensus 228 ~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999863 45578999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-23 Score=209.46 Aligned_cols=176 Identities=17% Similarity=0.269 Sum_probs=153.8
Q ss_pred cCCCcchHHHHHHHHHhc-cCCCCCCcCCC---CCCCCCCccceeEeC---------CCCcEEEEEcccCCCCCCCCccc
Q 007668 26 SRAINSDGEALLSFRTAV-VSSDGFLNQWR---PEDPDPCNWKGVKCD---------KNKRVITLSLTNHKLSGPISADL 92 (594)
Q Consensus 26 ~~~~~~~~~~L~~~k~~~-~~~~~~l~~w~---~~~~~~c~w~gv~c~---------~~~~l~~L~L~~n~l~~~~~~~~ 92 (594)
+.+...|.+||++||..+ .++.+++.+|. ....++|.|.|+.|+ ...+|+.|+|++|+|+ .+|..+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 345678999999999998 45667888994 456789999999995 2478999999999999 788889
Q ss_pred cCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccc------
Q 007668 93 GKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGK------ 166 (594)
Q Consensus 93 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~------ 166 (594)
.++++|++|+|++|.|+ .+|..|.++++|++|+|++|.++ .+|..+.++++|++|+|++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 89999999999999999999999 88999999999999999999888888887664
Q ss_pred ---cCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 167 ---LQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 167 ---l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
+++|+.|+|++|+|+..+.....+++|+.|++++|+..
T Consensus 179 ~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~ 219 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS 219 (328)
T ss_dssp EEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCC
T ss_pred hccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCC
Confidence 99999999999999966656688899999999998754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-23 Score=234.74 Aligned_cols=171 Identities=24% Similarity=0.277 Sum_probs=149.0
Q ss_pred CcchHHHHHHHHHhccCCCCCCcCCCCCC----CCC--Ccc------------ceeEeCCCCcEEEEEcccCCCCCCCCc
Q 007668 29 INSDGEALLSFRTAVVSSDGFLNQWRPED----PDP--CNW------------KGVKCDKNKRVITLSLTNHKLSGPISA 90 (594)
Q Consensus 29 ~~~~~~~L~~~k~~~~~~~~~l~~w~~~~----~~~--c~w------------~gv~c~~~~~l~~L~L~~n~l~~~~~~ 90 (594)
...|..||++||.++.++ +|+.++ .+| |+| .||+|+...+|+.|+|++|+|+|.+|+
T Consensus 267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 457999999999999665 786554 466 999 999998888999999999999999999
Q ss_pred cccCcccCCeeec-ccCccCCC----------------------------------------------------------
Q 007668 91 DLGKLDQLKFLNL-HSNNFYGE---------------------------------------------------------- 111 (594)
Q Consensus 91 ~~~~l~~L~~L~L-~~N~l~~~---------------------------------------------------------- 111 (594)
.|++|++|+.|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 77765444
Q ss_pred ------------------CCCCcCCCCccceeecccccccC-----------------CCChhhh--CCCCCceEeccCC
Q 007668 112 ------------------IPSELGNCTELQGLSLQSNYLSG-----------------SIPSELG--NLSNLLNLDISSN 154 (594)
Q Consensus 112 ------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~l~~N 154 (594)
+|..|++|++|++|+|++|+|++ .+|..++ ++++|++|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 78889999999999999999997 3898877 9999999999999
Q ss_pred cCCCCCCccccccCCCcEEEeeccc-ccc-cCCC-Cccc-------ccCCcccccCCCCC
Q 007668 155 SLSDYIPPSLGKLQRLITFNVSNNF-LVG-AIPS-DGVL-------TKFSESSFFGNRGL 204 (594)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~l~l~~N~-l~~-~~~~-~~~l-------~~l~~l~l~~N~~~ 204 (594)
++.+.+|..|.++++|+.|+|++|+ +++ .+|. ...+ ++|+.|++++|...
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 9999999999999999999999998 887 4443 2444 48999999999865
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-22 Score=191.06 Aligned_cols=151 Identities=19% Similarity=0.234 Sum_probs=136.2
Q ss_pred CCccceeEeCC----------CCcEEEEEcccCCCCCCCC-ccccCcccCCeeecccCccCCCCCCCcCCCCccceeecc
Q 007668 60 PCNWKGVKCDK----------NKRVITLSLTNHKLSGPIS-ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128 (594)
Q Consensus 60 ~c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 128 (594)
-|.|..+.|+. ...++.|+|++|+|++..+ ..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 10 ~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 10 RCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred EECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 36788888853 2468899999999997655 468999999999999999998777899999999999999
Q ss_pred cccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCC
Q 007668 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGK 207 (594)
Q Consensus 129 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~ 207 (594)
+|+|++..+..|..+++|++|+|++|+|+++.|..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|++.|+|
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 99999888888999999999999999999988999999999999999999999997754 88999999999999999998
Q ss_pred ccc
Q 007668 208 QIN 210 (594)
Q Consensus 208 ~~~ 210 (594)
++.
T Consensus 170 ~l~ 172 (220)
T 2v70_A 170 YLA 172 (220)
T ss_dssp GGH
T ss_pred chH
Confidence 864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.7e-23 Score=225.24 Aligned_cols=173 Identities=22% Similarity=0.240 Sum_probs=152.2
Q ss_pred cchHHHHHHHHHhccCCCC--------CCcCCCCCCCCCCcc---ceeEeCCCCcEEEEEcccCCCCCCCCccccCcccC
Q 007668 30 NSDGEALLSFRTAVVSSDG--------FLNQWRPEDPDPCNW---KGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQL 98 (594)
Q Consensus 30 ~~~~~~L~~~k~~~~~~~~--------~l~~w~~~~~~~c~w---~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L 98 (594)
..|..||.+++.++.+++. ...+|+. +.+||.| .||+|+..++|+.|+|++|+++|.+|+.|++|++|
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L 107 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTC
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccc
Confidence 4689999999999866542 2347984 5899999 99999877899999999999999999999999999
Q ss_pred CeeecccCc-----------------------------------------------------------------------
Q 007668 99 KFLNLHSNN----------------------------------------------------------------------- 107 (594)
Q Consensus 99 ~~L~L~~N~----------------------------------------------------------------------- 107 (594)
++|+|++|.
T Consensus 108 ~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~ 187 (636)
T 4eco_A 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187 (636)
T ss_dssp CEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTT
T ss_pred eEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhh
Confidence 999999984
Q ss_pred -------cCCCCCCCcCCCCccceeecccccccCC-----------------CChhhh--CCCCCceEeccCCcCCCCCC
Q 007668 108 -------FYGEIPSELGNCTELQGLSLQSNYLSGS-----------------IPSELG--NLSNLLNLDISSNSLSDYIP 161 (594)
Q Consensus 108 -------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~~ 161 (594)
|++ +|..|+++++|++|+|++|.|++. +|..+. ++++|++|+|++|++.+.+|
T Consensus 188 l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p 266 (636)
T 4eco_A 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP 266 (636)
T ss_dssp TTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC
T ss_pred hccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh
Confidence 445 888899999999999999999975 999988 99999999999999999999
Q ss_pred ccccccCCCcEEEeeccc-ccc-cCCC-Cccc------ccCCcccccCCCCC
Q 007668 162 PSLGKLQRLITFNVSNNF-LVG-AIPS-DGVL------TKFSESSFFGNRGL 204 (594)
Q Consensus 162 ~~~~~l~~L~~l~l~~N~-l~~-~~~~-~~~l------~~l~~l~l~~N~~~ 204 (594)
..+.++++|++|+|++|+ +++ .+|. ...+ ++|+.|++++|...
T Consensus 267 ~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 267 TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp TTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred HHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 999999999999999998 987 4553 3555 89999999999865
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=184.68 Aligned_cols=150 Identities=21% Similarity=0.205 Sum_probs=135.5
Q ss_pred CCCccceeEeCC----------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecc
Q 007668 59 DPCNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128 (594)
Q Consensus 59 ~~c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 128 (594)
..|.|.+|.|+. .++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 5 C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 84 (208)
T 2o6s_A 5 CSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS 84 (208)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence 347899999964 3579999999999997777789999999999999999997766778999999999999
Q ss_pred cccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCC
Q 007668 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGK 207 (594)
Q Consensus 129 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~ 207 (594)
+|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|++.|.+
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence 99999766677899999999999999999977778999999999999999999888864 78999999999999999987
Q ss_pred c
Q 007668 208 Q 208 (594)
Q Consensus 208 ~ 208 (594)
|
T Consensus 165 ~ 165 (208)
T 2o6s_A 165 P 165 (208)
T ss_dssp T
T ss_pred C
Confidence 7
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.82 E-value=6.3e-20 Score=178.52 Aligned_cols=136 Identities=24% Similarity=0.276 Sum_probs=114.3
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 46788888888888877777788888888888888888877777788888888888888888866666678888899999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCG 206 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~ 206 (594)
|++|+|+++.+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|++.|.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999988866667888889999999999998887744 7788899999999998887
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2e-20 Score=211.38 Aligned_cols=124 Identities=38% Similarity=0.625 Sum_probs=117.6
Q ss_pred ccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCc
Q 007668 92 LGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171 (594)
Q Consensus 92 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 171 (594)
+.++++|++|||++|+++|.+|..|+++++|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|+
T Consensus 628 ~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 707 (768)
T 3rgz_A 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707 (768)
T ss_dssp CSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCS
T ss_pred hhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC
Confidence 33467899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCcccccCCcccccCCCCCCCCcccccccCC
Q 007668 172 TFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTCKND 216 (594)
Q Consensus 172 ~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~~~~c~~~ 216 (594)
+|+|++|+|+|.+|..+.+..+..+++.||+.+||.|++ .|...
T Consensus 708 ~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp EEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred EEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 999999999999999989999999999999999999988 88643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.7e-22 Score=211.76 Aligned_cols=146 Identities=23% Similarity=0.267 Sum_probs=119.5
Q ss_pred CCccceeEeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcC-CCCccceeecccccccCCCCh
Q 007668 60 PCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELG-NCTELQGLSLQSNYLSGSIPS 138 (594)
Q Consensus 60 ~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~ 138 (594)
.|.+.++.|...++|+.|+|++|.|++..|..|+++++|++|+|++|.|++.+|..+. .+++|+.|+|++|.|++. |.
T Consensus 108 ~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~ 186 (487)
T 3oja_A 108 NNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG 186 (487)
T ss_dssp SSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC
T ss_pred CCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc
Confidence 3566777777778888889999988887788888888999999999998887777775 788899999999988854 33
Q ss_pred hhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCc
Q 007668 139 ELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~ 208 (594)
+..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|+|+++++....+++|+.|++++|++.|++.
T Consensus 187 -~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~~~ 254 (487)
T 3oja_A 187 -QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTL 254 (487)
T ss_dssp -CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHHHH
T ss_pred -cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCcch
Confidence 3458889999999999987 5556888889999999999998877777788888999999998887644
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8.3e-20 Score=177.65 Aligned_cols=133 Identities=23% Similarity=0.222 Sum_probs=121.7
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 57899999999999888889999999999999999999888888999999999999999999777788899999999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCC-CcccccCCcccccCCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-DGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~l~~N~~~ 204 (594)
++|+|+++.+..|..+++|+.|+|++|+|++.++. ...+++|+.|++++|+..
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 99999987777789999999999999999988885 478999999999999754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-19 Score=180.81 Aligned_cols=139 Identities=24% Similarity=0.186 Sum_probs=126.4
Q ss_pred CCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
..++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 3578999999999999 788889999999999999999997777889999999999999999997777778999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCcc
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
+|++|+|+++.+..|..+++|+.|+|++|+|+.+++....+.+|+.+++++|||.|+|.+
T Consensus 154 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (290)
T ss_dssp ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred ECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCcc
Confidence 999999998767778899999999999999998888778888999999999999999865
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.5e-20 Score=169.53 Aligned_cols=132 Identities=22% Similarity=0.274 Sum_probs=120.5
Q ss_pred EEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCC
Q 007668 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (594)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 154 (594)
+.+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 36788899999 6776653 69999999999999 88899999999999999999999887888999999999999999
Q ss_pred cCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCccc
Q 007668 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~~ 210 (594)
+|+++.|..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|+|.|+|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~ 145 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQ 145 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGH
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCH
Confidence 999988889999999999999999999888864 78999999999999999998864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.81 E-value=8e-20 Score=170.02 Aligned_cols=133 Identities=21% Similarity=0.275 Sum_probs=116.1
Q ss_pred EEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCC-CcCCCCccceeecccccccCCCChhhhCCCCCceEeccC
Q 007668 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPS-ELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153 (594)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 153 (594)
+.|++++|+|+ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 46788889997 67776644 899999999999966554 489999999999999999988899999999999999999
Q ss_pred CcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCccc
Q 007668 154 NSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 154 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~~ 210 (594)
|+|++..+..|..+++|++|+|++|+|++.++.. ..+++|+.|++++|++.|++++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~ 145 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch
Confidence 9999988888999999999999999999987765 78999999999999999998863
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2e-19 Score=177.17 Aligned_cols=139 Identities=24% Similarity=0.203 Sum_probs=125.9
Q ss_pred CCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
..++|++|+|++|.|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|
T Consensus 83 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 162 (272)
T 3rfs_A 83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTEL 162 (272)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEE
Confidence 45789999999999998777888999999999999999997777778999999999999999997777778999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCc
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~ 208 (594)
+|++|+|++..+..+..+++|+.|+|++|++++.++.. ..+++|+.|++++|++.|.+|
T Consensus 163 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 163 DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 99999999877778899999999999999999988865 789999999999999999877
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.80 E-value=2.8e-20 Score=187.22 Aligned_cols=138 Identities=30% Similarity=0.528 Sum_probs=112.8
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEecc
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 152 (594)
+|+.|+|++|.+++.+|..+..++ |++|+|++|++++.+|..|..+++|+.|+|++|.+++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 556666666666655666666655 66666666666666777777788888888888888865555 7788999999999
Q ss_pred CCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCcccccc
Q 007668 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTC 213 (594)
Q Consensus 153 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~~~~c 213 (594)
+|+|++.+|..+..+++|+.|+|++|++++.+|....+++|+.+++.+|+++||.|++ .|
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 9999988999999999999999999999999998889999999999999999999887 45
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=3.1e-20 Score=172.86 Aligned_cols=151 Identities=23% Similarity=0.301 Sum_probs=128.9
Q ss_pred CCccceeEeCC----------CCcEEEEEcccCCCCCCCCc-cccCcccCCeeecccCccCCCCCCCcCCCCccceeecc
Q 007668 60 PCNWKGVKCDK----------NKRVITLSLTNHKLSGPISA-DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQ 128 (594)
Q Consensus 60 ~c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 128 (594)
.|.|+.+.|+. ..+++.|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 7 ~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 36788888863 24899999999999966664 59999999999999999998889999999999999999
Q ss_pred cccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCc
Q 007668 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 129 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~ 208 (594)
+|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+.......++...+.++...|+.|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 99999888888999999999999999999988999999999999999999999876533222234445667777788776
Q ss_pred cc
Q 007668 209 IN 210 (594)
Q Consensus 209 ~~ 210 (594)
..
T Consensus 167 ~~ 168 (192)
T 1w8a_A 167 SK 168 (192)
T ss_dssp TT
T ss_pred hH
Confidence 54
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.6e-19 Score=175.13 Aligned_cols=138 Identities=25% Similarity=0.216 Sum_probs=108.5
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|.|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|.|++..+..|..+++|+.|+
T Consensus 84 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 163 (270)
T 2o6q_A 84 LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELR 163 (270)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeE
Confidence 45677777777777766666677778888888888888766666778888888888888888855555678888888888
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCc
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~ 208 (594)
|++|+|+++.+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|+|.|+|+
T Consensus 164 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 164 LYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred ecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 8888888766667888888888888888888777654 678888888888888888775
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.78 E-value=7e-19 Score=173.05 Aligned_cols=132 Identities=23% Similarity=0.258 Sum_probs=100.9
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|+...+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 35777888888888666667888888888888888887555555677888888888888888655666777888888888
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRG 203 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~ 203 (594)
++|+|++..+..|..+++|++|+|++|+|++.++.. ..+++|+.|++++|..
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l 169 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence 888888766777778888888888888888776653 6778888888887764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=176.63 Aligned_cols=137 Identities=20% Similarity=0.197 Sum_probs=105.2
Q ss_pred CCccceeeeecceEEEEEEe-cCCcE--EEEEeecccchh------------------------hHHHHHHHHHHHhhCC
Q 007668 309 LDDDHIIGSGGFGTVYKLAM-DDGNV--FALKRIDKLNEG------------------------FDRFFERELEILGSIK 361 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 361 (594)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|++.+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999987 68888 999987542111 1236888999999998
Q ss_pred CCee--eeeeeEEeCCCceEEEEEccCC-C----chhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeeCCC
Q 007668 362 HRYL--VNLRGYCNSPTSKLLIYDFLPG-G----SLDEALHERSEQLDWDARLNIIMGAAKGLAYLH-HDCSPRIIHRDI 433 (594)
Q Consensus 362 h~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dl 433 (594)
|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 8754 333332 356899999942 4 56655432 234457789999999999999 54 9999999
Q ss_pred CCCCeEecCCCcEEEeecccccccc
Q 007668 434 KSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 434 k~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
||.|||++. .++|+|||++....
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETT
T ss_pred CHHHEEEcC--cEEEEECcccccCC
Confidence 999999998 99999999997543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.1e-18 Score=160.05 Aligned_cols=129 Identities=19% Similarity=0.191 Sum_probs=109.2
Q ss_pred EEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcC
Q 007668 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSL 156 (594)
Q Consensus 77 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 156 (594)
+++++|+++ .+|..+ .++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus 12 l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 88 (177)
T 2o6r_A 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL 88 (177)
T ss_dssp EECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCc
Confidence 344567777 555444 37899999999999977777789999999999999999966667789999999999999999
Q ss_pred CCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCc
Q 007668 157 SDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 157 ~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~ 208 (594)
++..+..+..+++|+.|+|++|+|++.++.. ..+++|+.|++++|++.|.++
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 89 QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9877777899999999999999999888765 678999999999999999876
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.5e-19 Score=175.95 Aligned_cols=140 Identities=21% Similarity=0.193 Sum_probs=105.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 35677777777777766666777777777777777777755555677777777777777777755555677777888888
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCC-CcccccCCcccccCCCCCCCCccc
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-DGVLTKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~l~~N~~~c~~~~~ 210 (594)
|++|+|++..|..|..+++|+.|+|++|++++.++. ...+++|+.|++++|++.|+|++.
T Consensus 184 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~ 244 (285)
T 1ozn_A 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred CCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH
Confidence 888888776777788888888888888888876654 367788888888888888887753
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-19 Score=183.52 Aligned_cols=138 Identities=20% Similarity=0.215 Sum_probs=73.9
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 143 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence 44555555555555444444555555555555555555444444555555555555555555444555555555555555
Q ss_pred cCCcCCCCCCccc---cccCCCcEEEeecccccccCCCC-ccccc--CCcccccCCCCCCCCcc
Q 007668 152 SSNSLSDYIPPSL---GKLQRLITFNVSNNFLVGAIPSD-GVLTK--FSESSFFGNRGLCGKQI 209 (594)
Q Consensus 152 ~~N~l~~~~~~~~---~~l~~L~~l~l~~N~l~~~~~~~-~~l~~--l~~l~l~~N~~~c~~~~ 209 (594)
++|+|+++.+..| ..+++|+.|+|++|+|++.++.. ..+++ ++.|++.+|+|.|+|.+
T Consensus 144 ~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred CCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 5555554222223 34555555555555555444321 33333 36788888888888865
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-18 Score=184.56 Aligned_cols=137 Identities=22% Similarity=0.187 Sum_probs=130.7
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|..+++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 58999999999999989999999999999999999999888999999999999999999999888899999999999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCc
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~ 208 (594)
++|+|++..|..|..+++|++|+|++|+|++.++.. ..+++|+.|++++|++.|+||
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999988999999999999999999999988765 789999999999999999998
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.3e-18 Score=190.40 Aligned_cols=134 Identities=19% Similarity=0.175 Sum_probs=121.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
+.++++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..+..|.++++|++|+
T Consensus 51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 35899999999999977778999999999999999999977788899999999999999999976777899999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccC-CCC-cccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI-PSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~-~~~-~~l~~l~~l~l~~N~~~ 204 (594)
|++|+|+++.+..|.++++|++|+|++|.+++.. |.. ..+++|+.|++++|+..
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 186 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 186 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccc
Confidence 9999999977788999999999999999998753 333 77999999999999864
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.3e-18 Score=172.58 Aligned_cols=139 Identities=18% Similarity=0.211 Sum_probs=101.6
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCC-CCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
.++|+.|+|++|.+++..+..|.++++|++|+|++|.+++ .+|..|..+++|++|+|++|.+++..|..|..+++|++|
T Consensus 125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 3567777777777776666677777777777777777765 467777777777777777777776667777777777777
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-ccc-ccCCcccccCCCCCCCCcc
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVL-TKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l-~~l~~l~l~~N~~~c~~~~ 209 (594)
+|++|+|++..+..+..+++|+.|+|++|++++.++.. ..+ ++|+.|++++|++.|+|++
T Consensus 205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp ECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred ECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence 77777777766667777777888888888877766644 555 3778888888887777664
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.9e-18 Score=155.86 Aligned_cols=131 Identities=24% Similarity=0.273 Sum_probs=119.4
Q ss_pred CCcEEEEEcccCCCC-CCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
.++|+.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 468999999999998 78899999999999999999999955 789999999999999999997789988889999999
Q ss_pred eccCCcCCCCCC-ccccccCCCcEEEeecccccccCC----CCcccccCCcccccCCCC
Q 007668 150 DISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIP----SDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 150 ~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~----~~~~l~~l~~l~l~~N~~ 203 (594)
+|++|+|++..+ ..+..+++|+.|+|++|++++.++ ....+++|+.|++++|+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 999999998432 789999999999999999998887 457899999999999974
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-18 Score=160.65 Aligned_cols=124 Identities=22% Similarity=0.296 Sum_probs=111.5
Q ss_pred CCccceeEeCC----------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccc
Q 007668 60 PCNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (594)
Q Consensus 60 ~c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (594)
.|.|..+.|+. .++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 9 ~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 9 TCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 35666777753 358999999999999 7889999999999999999999988888899999999999999
Q ss_pred ccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccC
Q 007668 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI 184 (594)
Q Consensus 130 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~ 184 (594)
|+|++..|..|..+++|+.|+|++|+|+.+.+..|..+++|+.|+|++|++....
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 9999888888999999999999999999877778999999999999999998643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.72 E-value=4.2e-18 Score=151.43 Aligned_cols=128 Identities=21% Similarity=0.273 Sum_probs=115.9
Q ss_pred CCcEEEEEcccCCCC-CCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
.++|+.|++++|.++ +.+|..+..+++|++|+|++|++++. ..+..+++|++|+|++|.+++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 368999999999999 88999999999999999999999965 689999999999999999997799988899999999
Q ss_pred eccCCcCCCC-CCccccccCCCcEEEeecccccccCC----CCcccccCCcccccC
Q 007668 150 DISSNSLSDY-IPPSLGKLQRLITFNVSNNFLVGAIP----SDGVLTKFSESSFFG 200 (594)
Q Consensus 150 ~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~----~~~~l~~l~~l~l~~ 200 (594)
+|++|+|++. .+..+..+++|+.|++++|++++.++ ....+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999983 34889999999999999999998877 347889999998864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=8.3e-18 Score=165.92 Aligned_cols=138 Identities=23% Similarity=0.241 Sum_probs=94.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCC-CChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS-IPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L 149 (594)
.++|++|+|++|.|++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|.+++. +|..|..+++|++|
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L 154 (276)
T 2z62_A 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred CcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEE
Confidence 35666777777777655556666677777777777776655555666777777777777777642 46667777777777
Q ss_pred eccCCcCCCCCCcccccc---------------------------CCCcEEEeecccccccCCCC-cccccCCcccccCC
Q 007668 150 DISSNSLSDYIPPSLGKL---------------------------QRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGN 201 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l---------------------------~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N 201 (594)
+|++|+|++..+..+..+ .+|+.|+|++|+|++.++.. ..+++|+.|++++|
T Consensus 155 ~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N 234 (276)
T 2z62_A 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234 (276)
T ss_dssp ECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSS
T ss_pred ECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCC
Confidence 777777665443333222 25777777778887776654 67888888889999
Q ss_pred CCCCCCc
Q 007668 202 RGLCGKQ 208 (594)
Q Consensus 202 ~~~c~~~ 208 (594)
++.|+|+
T Consensus 235 ~~~c~c~ 241 (276)
T 2z62_A 235 PWDCSCP 241 (276)
T ss_dssp CBCCCTT
T ss_pred cccccCC
Confidence 8888876
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=7.7e-18 Score=186.14 Aligned_cols=140 Identities=18% Similarity=0.212 Sum_probs=128.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCcc-CCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNF-YGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
..+++.++++.|.+++..+..+..+++|+.|+|++|++ .+.+|..|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 46788999999999988899999999999999999985 44688899999999999999999998889999999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-ccc-ccCCcccccCCCCCCCCccc
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVL-TKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l-~~l~~l~l~~N~~~c~~~~~ 210 (594)
+|++|+|+++.|..|..+++|++|+|++|+|++.++.. ..+ ++|+.|++++|||.|+|.+.
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~ 586 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 586 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGH
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcH
Confidence 99999999988899999999999999999999998875 555 68999999999999999863
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=5.1e-18 Score=186.80 Aligned_cols=140 Identities=18% Similarity=0.126 Sum_probs=126.5
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCC-CCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG-EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
.++|+.|+|++|.+++..|..+.++++|++|+|++|++++ .+|..|..+++|++|+|++|++++..|..|..+++|++|
T Consensus 423 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 502 (606)
T 3vq2_A 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502 (606)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence 4688899999999988888889999999999999999987 478889999999999999999998888999999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccc-cCCcccccCCCCCCCCccc
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLT-KFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~-~l~~l~l~~N~~~c~~~~~ 210 (594)
+|++|++++..|..+..+++|+.|+|++|+|+.+++....++ +|+.|++++|++.|+|++.
T Consensus 503 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp ECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred ECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 999999999889999999999999999999998777767776 5999999999999999864
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=176.81 Aligned_cols=138 Identities=25% Similarity=0.266 Sum_probs=113.5
Q ss_pred CCcEEEEEcccCCCCCCCCc-------------------------cccCcccCCeeecccCccCCCCCCCcCCCCcccee
Q 007668 71 NKRVITLSLTNHKLSGPISA-------------------------DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGL 125 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~-------------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 125 (594)
.++|++|+|++|.|+...+. .|.++++|++|+|++|+|+ .+| .+..+++|++|
T Consensus 135 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L 212 (440)
T 3zyj_A 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDEL 212 (440)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEE
T ss_pred cccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEE
Confidence 45777888888777644332 3555667777777777776 555 47778888888
Q ss_pred ecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 126 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
+|++|.|++..|..|.++++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|||.
T Consensus 213 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 88888888777888999999999999999999888889999999999999999999888765 78999999999999999
Q ss_pred CCCccc
Q 007668 205 CGKQIN 210 (594)
Q Consensus 205 c~~~~~ 210 (594)
|+|.+.
T Consensus 293 CdC~l~ 298 (440)
T 3zyj_A 293 CNCDIL 298 (440)
T ss_dssp CSSTTH
T ss_pred CCCCch
Confidence 999753
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=163.41 Aligned_cols=132 Identities=20% Similarity=0.174 Sum_probs=116.7
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 57999999999999777778999999999999999999777778999999999999999999777788999999999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccC-C-CCcccccCCcccccCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI-P-SDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~-~-~~~~l~~l~~l~l~~N~~ 203 (594)
++|++++..+..+..+++|++|+|++|++++.. | ....+++|+.|++++|+.
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCC
Confidence 999999877778999999999999999998742 4 447889999999999964
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.6e-18 Score=161.67 Aligned_cols=116 Identities=18% Similarity=0.174 Sum_probs=108.9
Q ss_pred CCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
..++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|
T Consensus 55 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 134 (220)
T 2v70_A 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134 (220)
T ss_dssp GCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred cCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence 35789999999999998888899999999999999999998888889999999999999999998889999999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 185 (594)
+|++|+|+++.|..|..+++|+.|+|++|++++..+
T Consensus 135 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp ECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999999999889999999999999999999987654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=3.1e-17 Score=162.65 Aligned_cols=133 Identities=21% Similarity=0.203 Sum_probs=109.3
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccccc-ccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY-LSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L 149 (594)
.++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|. ++...|..|..+++|++|
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 4578888888888887666778888888888888888887778888888888888888886 775557788888888888
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRG 203 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~ 203 (594)
+|++|++++..|..+..+++|++|+|++|++++.++.. ..+++|+.|++++|..
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 165 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcc
Confidence 88888888877788888888888888888888777653 6788888888888864
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.1e-17 Score=175.09 Aligned_cols=138 Identities=23% Similarity=0.234 Sum_probs=116.3
Q ss_pred CCcEEEEEcccCCCCCCCCc-------------------------cccCcccCCeeecccCccCCCCCCCcCCCCcccee
Q 007668 71 NKRVITLSLTNHKLSGPISA-------------------------DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGL 125 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~-------------------------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 125 (594)
.++|++|+|++|.|+...+. .|.++++|++|+|++|+|+ .+| .+..+++|++|
T Consensus 146 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L 223 (452)
T 3zyi_A 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEEL 223 (452)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEE
T ss_pred cCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-ccc-cccccccccEE
Confidence 46788888888888744433 3556667777777777777 344 47788888899
Q ss_pred ecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 126 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
+|++|.|++..|..|.++++|+.|+|++|+|+++.|..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|+|.
T Consensus 224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 99999999888889999999999999999999988999999999999999999999888765 77999999999999999
Q ss_pred CCCccc
Q 007668 205 CGKQIN 210 (594)
Q Consensus 205 c~~~~~ 210 (594)
|+|.+.
T Consensus 304 CdC~~~ 309 (452)
T 3zyi_A 304 CDCDIL 309 (452)
T ss_dssp CSTTTH
T ss_pred CCCCch
Confidence 999853
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.8e-17 Score=158.97 Aligned_cols=132 Identities=25% Similarity=0.280 Sum_probs=120.7
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|.+++ + ..+.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 5789999999999996 3 4789999999999999999987777899999999999999999977777899999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
|++|+|++..+..+..+++|+.|+|++|++++.++.. ..+++|+.|++++|+..
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 194 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK 194 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence 9999999977788899999999999999999888875 78999999999999754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.4e-17 Score=166.74 Aligned_cols=132 Identities=21% Similarity=0.322 Sum_probs=117.7
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhC--------
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGN-------- 142 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------- 142 (594)
.++|++|+|++|.|+ .+|..++++++|++|+|++|+|+ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 468999999999999 88999999999999999999999 88989999999999999999888889887764
Q ss_pred -CCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCC
Q 007668 143 -LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 143 -l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c 205 (594)
+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++.++....+++|+.|++++|+...
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~ 243 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALR 243 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCC
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchh
Confidence 899999999999999 58888999999999999999999887777888999999999987654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.5e-17 Score=168.63 Aligned_cols=145 Identities=24% Similarity=0.272 Sum_probs=124.7
Q ss_pred CCCCccceeEeCC------------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCcccee
Q 007668 58 PDPCNWKGVKCDK------------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGL 125 (594)
Q Consensus 58 ~~~c~w~gv~c~~------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 125 (594)
..+|.|.|+ |+. .++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 456788776 531 3589999999999997666799999999999999999998888889999999999
Q ss_pred ecccccccCCCChhhhCCCCCceEeccCCcCCCCCC-ccccccCCCcEEEeecc-cccccCCCC-cccccCCcccccCCC
Q 007668 126 SLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIP-PSLGKLQRLITFNVSNN-FLVGAIPSD-GVLTKFSESSFFGNR 202 (594)
Q Consensus 126 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N-~l~~~~~~~-~~l~~l~~l~l~~N~ 202 (594)
+|++|+|++..+..|.++++|++|+|++|+++++.+ ..+..+++|+.|++++| .++..++.. ..+++|+.|++++|.
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 999999995555559999999999999999997444 48999999999999999 577776644 789999999999997
Q ss_pred C
Q 007668 203 G 203 (594)
Q Consensus 203 ~ 203 (594)
.
T Consensus 186 l 186 (353)
T 2z80_A 186 L 186 (353)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7.3e-17 Score=160.19 Aligned_cols=130 Identities=23% Similarity=0.220 Sum_probs=76.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|.|++. +.. +.+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|++|+
T Consensus 54 l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~ 130 (290)
T 1p9a_G 54 YTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (290)
T ss_dssp CTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence 34555555555555532 222 45556666666666665 5555566666666666666666644445566666666666
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~ 203 (594)
|++|+|+++.+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|+.
T Consensus 131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184 (290)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcC
Confidence 6666666555555566666666666666666555544 4566666666666653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-16 Score=152.42 Aligned_cols=133 Identities=17% Similarity=0.218 Sum_probs=118.6
Q ss_pred eeEeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCC
Q 007668 65 GVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS 144 (594)
Q Consensus 65 gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 144 (594)
+-.|.. +.+++++|+++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.+++
T Consensus 8 ~C~C~~----~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~ 80 (220)
T 2v9t_B 8 ACTCSN----NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLR 80 (220)
T ss_dssp TSEEET----TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCS
T ss_pred CCEECC----CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCc
Confidence 456642 46899999999 6777664 7999999999999977777999999999999999999988899999999
Q ss_pred CCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 145 NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 145 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
+|++|+|++|+|+++.+..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|+..
T Consensus 81 ~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp SCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 9999999999999877777899999999999999999997765 78999999999999753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.6e-17 Score=174.55 Aligned_cols=146 Identities=17% Similarity=0.183 Sum_probs=128.6
Q ss_pred CCCccce--eEeCC---------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCC-CCCcCCCCccceee
Q 007668 59 DPCNWKG--VKCDK---------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI-PSELGNCTELQGLS 126 (594)
Q Consensus 59 ~~c~w~g--v~c~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 126 (594)
+.|.|.+ |.|+. .++|++|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4566665 77753 267999999999999888999999999999999999998655 56799999999999
Q ss_pred cccccccCCCChhhhCCCCCceEeccCCcCCCCCCcc--ccccCCCcEEEeecccccccCCC--CcccccCCcccccCCC
Q 007668 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFLVGAIPS--DGVLTKFSESSFFGNR 202 (594)
Q Consensus 127 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~l~~L~~l~l~~N~l~~~~~~--~~~l~~l~~l~l~~N~ 202 (594)
|++|.+++..|..|.++++|++|+|++|++++..|.. +..+++|++|+|++|++++..|. ...+++|+.|++++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999855544 99999999999999999998776 4789999999999998
Q ss_pred CC
Q 007668 203 GL 204 (594)
Q Consensus 203 ~~ 204 (594)
..
T Consensus 166 l~ 167 (455)
T 3v47_A 166 VK 167 (455)
T ss_dssp BS
T ss_pred cc
Confidence 54
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=152.94 Aligned_cols=136 Identities=20% Similarity=0.195 Sum_probs=120.2
Q ss_pred ccceeEeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhh
Q 007668 62 NWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELG 141 (594)
Q Consensus 62 ~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 141 (594)
.|..-.|+ .+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|.
T Consensus 13 ~~~~~~Cs----~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 85 (229)
T 3e6j_A 13 CPSQCSCS----GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85 (229)
T ss_dssp CCTTCEEE----TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CCCCCEEe----CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcc
Confidence 34556775 346999999999 6776664 8999999999999988899999999999999999999966667789
Q ss_pred CCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 142 NLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 142 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
.+++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|+.++.....+++|+.|++++|+..
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~ 148 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLK 148 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCC
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCC
Confidence 999999999999999997778889999999999999999977777789999999999999754
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.8e-17 Score=165.57 Aligned_cols=144 Identities=24% Similarity=0.277 Sum_probs=117.8
Q ss_pred ccceeEeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCc-CCCCccceeecccccccCCCChhh
Q 007668 62 NWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSGSIPSEL 140 (594)
Q Consensus 62 ~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~ 140 (594)
...++.+...++|+.|+|++|++++..+..+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.|++. |. .
T Consensus 110 ~l~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~ 187 (317)
T 3o53_A 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-Q 187 (317)
T ss_dssp CCSEEEECCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-C
T ss_pred ccCCcCccccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-c
Confidence 3455555556778889999999987777788889999999999999987767666 4788999999999999844 43 3
Q ss_pred hCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCc
Q 007668 141 GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 141 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~ 208 (594)
..+++|++|+|++|+|++ +|..+..+++|+.|+|++|+|++.++....+++|+.|++++|++.|++.
T Consensus 188 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~~~ 254 (317)
T 3o53_A 188 VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTL 254 (317)
T ss_dssp CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHHHH
T ss_pred cccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCcCH
Confidence 358899999999999997 5666889999999999999999877777888999999999999888644
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.68 E-value=5.5e-17 Score=151.47 Aligned_cols=128 Identities=18% Similarity=0.228 Sum_probs=101.3
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|.++ .+ ..+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..|..+..+++|++|+
T Consensus 65 l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 467888888888776 23 4678888888888888888876777888888888888888888877788888888888888
Q ss_pred ccCCc-CCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNS-LSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~-l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
|++|. ++. +| .+..+++|+.|++++|++++.. ....+++|+.|++++|+.
T Consensus 143 L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 143 LSYNGAITD-IM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC--
T ss_pred ccCCCCccc-cH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCccc
Confidence 88887 665 44 6888888888888888888754 557788888888888873
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=6.3e-17 Score=178.09 Aligned_cols=134 Identities=20% Similarity=0.214 Sum_probs=120.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 46899999999999988888999999999999999999988888999999999999999999988899999999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccc-cCC-CCcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG-AIP-SDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~-~~~-~~~~l~~l~~l~l~~N~~~ 204 (594)
|++|++++..+..+.++++|++|+|++|.+++ .+| ....+++|+.|++++|...
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~ 166 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCC
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcce
Confidence 99999998777889999999999999999986 334 4588999999999999754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.68 E-value=5.2e-17 Score=156.55 Aligned_cols=132 Identities=16% Similarity=0.153 Sum_probs=117.5
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCc-cCCCCCCCcCCCCccceeeccc-ccccCCCChhhhCCCCCce
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNN-FYGEIPSELGNCTELQGLSLQS-NYLSGSIPSELGNLSNLLN 148 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~ 148 (594)
..+++.|+|++|+|++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|++
T Consensus 30 ~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~ 109 (239)
T 2xwt_C 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109 (239)
T ss_dssp CTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred CCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence 3589999999999997777799999999999999997 8866666899999999999999 9999766678999999999
Q ss_pred EeccCCcCCCCCCccccccCCCc---EEEeecc-cccccCCCC-cccccCC-cccccCCCCC
Q 007668 149 LDISSNSLSDYIPPSLGKLQRLI---TFNVSNN-FLVGAIPSD-GVLTKFS-ESSFFGNRGL 204 (594)
Q Consensus 149 L~l~~N~l~~~~~~~~~~l~~L~---~l~l~~N-~l~~~~~~~-~~l~~l~-~l~l~~N~~~ 204 (594)
|+|++|++++ +|. +..+++|+ .|++++| ++++.++.. ..+++|+ .|++++|...
T Consensus 110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 9999999998 666 88888888 9999999 999888764 7899999 9999999753
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.68 E-value=9.9e-17 Score=169.90 Aligned_cols=134 Identities=15% Similarity=0.105 Sum_probs=118.8
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+
T Consensus 74 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 153 (452)
T 3zyi_A 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELW 153 (452)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEE
T ss_pred CCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEE
Confidence 35899999999999988899999999999999999999988889999999999999999999977677799999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeec-ccccccCCC-CcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSN-NFLVGAIPS-DGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~-N~l~~~~~~-~~~l~~l~~l~l~~N~~~ 204 (594)
|++|+|+++.+..|.++++|+.|+|++ |.+...++. ...+++|+.|++++|...
T Consensus 154 L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 209 (452)
T 3zyi_A 154 LRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209 (452)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc
Confidence 999999987777899999999999998 555555554 377899999999998754
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=8e-17 Score=171.90 Aligned_cols=134 Identities=22% Similarity=0.200 Sum_probs=117.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
..+++.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 31 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 110 (477)
T 2id5_A 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLD 110 (477)
T ss_dssp CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEE
T ss_pred CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEE
Confidence 35788999999999987788999999999999999999988888999999999999999999965556688999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
|++|++++..|..|..+++|+.|+|++|++++..+.. ..+++|+.|++++|...
T Consensus 111 Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 165 (477)
T 2id5_A 111 ISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT 165 (477)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS
T ss_pred CCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc
Confidence 9999999888888999999999999999998887754 77889999999998653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.5e-17 Score=177.02 Aligned_cols=144 Identities=24% Similarity=0.229 Sum_probs=126.6
Q ss_pred CCccceeEeCC------------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeec
Q 007668 60 PCNWKGVKCDK------------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSL 127 (594)
Q Consensus 60 ~c~w~gv~c~~------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 127 (594)
.|.|.|+ |+. .++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4888887 752 258999999999999888899999999999999999999888889999999999999
Q ss_pred ccccccCCCChhhhCCCCCceEeccCCcCCCC-CCccccccCCCcEEEeeccc-ccccCC-CCcccccCCcccccCCCCC
Q 007668 128 QSNYLSGSIPSELGNLSNLLNLDISSNSLSDY-IPPSLGKLQRLITFNVSNNF-LVGAIP-SDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 128 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~-l~~~~~-~~~~l~~l~~l~l~~N~~~ 204 (594)
++|++++..|..|.++++|++|+|++|++++. .|..+.++++|++|++++|+ +...++ ....+++|+.|++++|...
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 99999987777799999999999999999963 57789999999999999999 444443 3478999999999999753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-16 Score=169.23 Aligned_cols=134 Identities=15% Similarity=0.090 Sum_probs=111.7
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+...+..|..+++|++|+
T Consensus 63 ~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 142 (440)
T 3zyj_A 63 STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142 (440)
T ss_dssp CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEE
T ss_pred CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceee
Confidence 35788999999999977778999999999999999999977778899999999999999999966666789999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecc-cccccCCC-CcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNN-FLVGAIPS-DGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N-~l~~~~~~-~~~l~~l~~l~l~~N~~~ 204 (594)
|++|+|+++.+..|..+++|+.|+|++| .+....+. ...+++|+.|++++|...
T Consensus 143 L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 143 LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp CCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred CCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 9999999877778888888888888884 45544443 367888888888888643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.4e-16 Score=181.83 Aligned_cols=136 Identities=22% Similarity=0.238 Sum_probs=117.9
Q ss_pred CCcEEEEEcccCCCCCCCCc-cccCcccCCeeecccCccC-----CCCCCCcCCCCccceeecccccccCCCChhhhCCC
Q 007668 71 NKRVITLSLTNHKLSGPISA-DLGKLDQLKFLNLHSNNFY-----GEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS 144 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 144 (594)
.++|+.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|..++
T Consensus 425 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 504 (844)
T 3j0a_A 425 VPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLT 504 (844)
T ss_dssp CTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCC
T ss_pred CCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchh
Confidence 46888899999998865443 4667889999999999987 34456789999999999999999988888899999
Q ss_pred CCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCccc
Q 007668 145 NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 145 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~~ 210 (594)
+|+.|+|++|+|+++.|..+. ++|+.|+|++|+|++.+|.. +.+|+.+++++|||.|+|++.
T Consensus 505 ~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 505 ALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECELS 566 (844)
T ss_dssp SCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSCC
T ss_pred hhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccccH
Confidence 999999999999987776665 89999999999999998864 678999999999999998863
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=7.7e-17 Score=175.93 Aligned_cols=139 Identities=19% Similarity=0.218 Sum_probs=122.4
Q ss_pred CCcEEEEEcccCCCCCCCC-ccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccccccc-CCCChhhhCCCCCce
Q 007668 71 NKRVITLSLTNHKLSGPIS-ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS-GSIPSELGNLSNLLN 148 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~ 148 (594)
.++|+.|+|++|.+++..+ ..+.++++|++|+|++|.+++..|..|.++++|++|+|++|.++ +.+|..+..+++|++
T Consensus 395 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~ 474 (570)
T 2z63_A 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474 (570)
T ss_dssp CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCE
Confidence 4567777788887776555 46888899999999999998888888999999999999999997 578889999999999
Q ss_pred EeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCcc
Q 007668 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 149 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
|+|++|++++..|..+..+++|+.|+|++|++++.++.. ..+++|+.|++++|++.|+||.
T Consensus 475 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred EECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 999999999988999999999999999999999988764 7899999999999999999875
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=5.1e-17 Score=178.83 Aligned_cols=139 Identities=22% Similarity=0.191 Sum_probs=115.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCC---CCCCcCCCCccceeecccccccCCCChhhhCCCCCc
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGE---IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLL 147 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 147 (594)
.++|+.|+|++|.+++..|..+.++++|++|+|++|++++. .+..+..+++|++|+|++|++++..|..|..+++|+
T Consensus 424 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 503 (606)
T 3t6q_A 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503 (606)
T ss_dssp CTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred cccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCC
Confidence 46778888888888877777788888888888888888752 235678888888888888888877788888889999
Q ss_pred eEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCccc
Q 007668 148 NLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 148 ~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~~ 210 (594)
+|+|++|++++..|..+..+++| .|+|++|++++.++.. ..+++|+.+++++|++.|+|+..
T Consensus 504 ~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 566 (606)
T 3t6q_A 504 HVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566 (606)
T ss_dssp EEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred EEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH
Confidence 99999999988888888899999 9999999999887765 77899999999999999998853
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=1e-16 Score=174.64 Aligned_cols=139 Identities=21% Similarity=0.194 Sum_probs=94.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCC--CCCCcCCCCccceeecccccccCCCChh-hhC-----
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGE--IPSELGNCTELQGLSLQSNYLSGSIPSE-LGN----- 142 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~----- 142 (594)
.++|+.|+|++|.+++.+|..+.++++|++|+|++|++++. +|..|.++++|++|+|++|++++.+|.. +..
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 45566666666666655555555566666666666655531 1234555555555555555555423321 222
Q ss_pred ----------------C-CCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCC-CcccccCCcccccCCCCC
Q 007668 143 ----------------L-SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-DGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 143 ----------------l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~l~~N~~~ 204 (594)
+ ++|+.|+|++|+|+. +|..+..+++|+.|+|++|+|+++++. ...+++|+.|++++|+|.
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 510 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBC
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcC
Confidence 2 578888888888885 777777999999999999999987776 588999999999999999
Q ss_pred CCCccc
Q 007668 205 CGKQIN 210 (594)
Q Consensus 205 c~~~~~ 210 (594)
|+|++.
T Consensus 511 c~c~~~ 516 (562)
T 3a79_B 511 CTCPGI 516 (562)
T ss_dssp CCHHHH
T ss_pred CCcchH
Confidence 998863
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=8.7e-17 Score=179.46 Aligned_cols=139 Identities=20% Similarity=0.218 Sum_probs=116.5
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCC--------CCcCCCCccceeecccccccCCCChhhhC
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP--------SELGNCTELQGLSLQSNYLSGSIPSELGN 142 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 142 (594)
.++|+.|+|++|+|++..+..|.++++|++|+|++|++++..+ ..|.++++|++|+|++|+|+...+..|.+
T Consensus 479 l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 558 (680)
T 1ziw_A 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred CCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccc
Confidence 4678888899998887777788888999999999998875321 23788899999999999998444456899
Q ss_pred CCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-c-ccccCCcccccCCCCCCCCcc
Q 007668 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-G-VLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 143 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~-~l~~l~~l~l~~N~~~c~~~~ 209 (594)
+++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|++.++.. . .+++|+.+++++|||.|+|++
T Consensus 559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 999999999999999877777889999999999999999887764 3 689999999999999999885
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=7.5e-17 Score=167.43 Aligned_cols=133 Identities=20% Similarity=0.146 Sum_probs=118.5
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+++.|++++|.++...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 67899999999999554456789999999999999999777779999999999999999999888888999999999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
++|+|+.+.+..|..+++|++|+|++|++++.++.. ..+++|+.|++++|+..
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence 999999855566799999999999999999887764 78999999999999753
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-16 Score=143.45 Aligned_cols=109 Identities=20% Similarity=0.230 Sum_probs=96.0
Q ss_pred EEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCC
Q 007668 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (594)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 154 (594)
+.|++++|+|+ .+|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 46888999999 577666 389999999999999888889999999999999999999777777899999999999999
Q ss_pred cCCCCCCccccccCCCcEEEeecccccccCCC
Q 007668 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186 (594)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 186 (594)
+|+++.+..|..+++|+.|+|++|+++...+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 99987777899999999999999999877653
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.66 E-value=9.6e-17 Score=146.92 Aligned_cols=127 Identities=18% Similarity=0.144 Sum_probs=110.8
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcc-cCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLD-QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
..+|+.|+|++|+|+ .++. +..+. +|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..|..+++|++|
T Consensus 18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence 468999999999999 4554 55555 999999999999954 589999999999999999996555666999999999
Q ss_pred eccCCcCCCCCCc--cccccCCCcEEEeecccccccCCC----CcccccCCcccccCCC
Q 007668 150 DISSNSLSDYIPP--SLGKLQRLITFNVSNNFLVGAIPS----DGVLTKFSESSFFGNR 202 (594)
Q Consensus 150 ~l~~N~l~~~~~~--~~~~l~~L~~l~l~~N~l~~~~~~----~~~l~~l~~l~l~~N~ 202 (594)
+|++|+|+. +|. .+..+++|+.|++++|+++..+.. ...+++|+.|++++|+
T Consensus 94 ~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~ 151 (176)
T 1a9n_A 94 ILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVK 151 (176)
T ss_dssp ECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECC
T ss_pred ECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCC
Confidence 999999986 665 899999999999999999977664 5789999999999986
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.66 E-value=7.1e-17 Score=180.26 Aligned_cols=174 Identities=20% Similarity=0.183 Sum_probs=114.2
Q ss_pred CCcchHHHHHHHHHhccCC-CCCCcCCCCCCCCCCccceeEeCCCCcE------------------EEEEcccCCCCC--
Q 007668 28 AINSDGEALLSFRTAVVSS-DGFLNQWRPEDPDPCNWKGVKCDKNKRV------------------ITLSLTNHKLSG-- 86 (594)
Q Consensus 28 ~~~~~~~~L~~~k~~~~~~-~~~l~~w~~~~~~~c~w~gv~c~~~~~l------------------~~L~L~~n~l~~-- 86 (594)
....+.++|+++....... ......|.......+.|.+++++. +++ ..++|++|.|.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 3467788999998776332 223345654455567788776653 223 334444444442
Q ss_pred -------CCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCC
Q 007668 87 -------PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDY 159 (594)
Q Consensus 87 -------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 159 (594)
..+..|..+++|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..|.+|++|++|+|++|+|+ .
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~ 284 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S 284 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence 34667888999999999999999 78888889999999999999999 89999999999999999999999 5
Q ss_pred CCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCC
Q 007668 160 IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 160 ~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c 205 (594)
+|..|..|++|++|+|++|.|+.++.....+++|+.|+|++|++..
T Consensus 285 lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~ 330 (727)
T 4b8c_D 285 LPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEK 330 (727)
T ss_dssp CCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCS
T ss_pred cChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCC
Confidence 7999999999999999999999777777899999999999998753
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=8.3e-17 Score=176.59 Aligned_cols=133 Identities=20% Similarity=0.135 Sum_probs=115.8
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+++.|++++|.++...+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|.|++..|..|.++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 56788999999998665666888999999999999999877788999999999999999999888888899999999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCC-CcccccCCcccccCCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-DGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~l~~N~~~ 204 (594)
++|.|+++.+..|.++++|++|+|++|.|++.++. ...+++|+.|++++|...
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 99999986666678999999999999999988875 478899999999999753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=8.8e-17 Score=173.53 Aligned_cols=139 Identities=23% Similarity=0.238 Sum_probs=95.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCC--CCCCCcCCCCccceeecccccccCCCChh-hhCC----
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQSNYLSGSIPSE-LGNL---- 143 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l---- 143 (594)
.++|++|+|++|++++.+|..+.++++|++|+|++|++++ .+|..+..+++|++|+|++|.+++.+|.. +..+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 4556666666666665566666666666666666666653 33344555555555555555555433322 2222
Q ss_pred ------------------CCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCC-CcccccCCcccccCCCCC
Q 007668 144 ------------------SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-DGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 144 ------------------~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~l~~N~~~ 204 (594)
++|+.|+|++|+|+. +|..+..+++|+.|+|++|+|+.+++. ...+++|+.|++++|++.
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 481 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCcccc-cchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCc
Confidence 577778888888874 777777999999999999999987776 578999999999999999
Q ss_pred CCCccc
Q 007668 205 CGKQIN 210 (594)
Q Consensus 205 c~~~~~ 210 (594)
|+|++.
T Consensus 482 c~c~~~ 487 (520)
T 2z7x_B 482 CSCPRI 487 (520)
T ss_dssp CCHHHH
T ss_pred ccCCch
Confidence 998863
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-16 Score=145.13 Aligned_cols=127 Identities=22% Similarity=0.263 Sum_probs=113.6
Q ss_pred CCccceeEeCC----------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccc
Q 007668 60 PCNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (594)
Q Consensus 60 ~c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (594)
.|.|.++.|+. .++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 6 ~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 46899999963 35899999999999987777889999999999999999977777789999999999999
Q ss_pred ccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCC
Q 007668 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186 (594)
Q Consensus 130 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~ 186 (594)
|+|++..+..|..+++|++|+|++|+|+++.+..+..+++|+.|+|++|++++..+.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 999977777789999999999999999987666788999999999999999987653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.7e-16 Score=149.39 Aligned_cols=129 Identities=21% Similarity=0.200 Sum_probs=114.4
Q ss_pred CCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
..++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|
T Consensus 50 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 50 ELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL 129 (208)
T ss_dssp TCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence 35789999999999997777788999999999999999997777778999999999999999997777778999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
+|++|+|+++.+..+..+++|+.|+|++|++.+. +++|+.|++.+|...
T Consensus 130 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------~~~l~~L~~~~n~~~ 178 (208)
T 2o6s_A 130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKHS 178 (208)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC------TTTTHHHHHHHHHCT
T ss_pred ECCCCccceeCHHHhccCCCccEEEecCCCeecC------CCCHHHHHHHHHhCC
Confidence 9999999987777799999999999999998764 456778888888644
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.2e-16 Score=173.74 Aligned_cols=134 Identities=18% Similarity=0.126 Sum_probs=124.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
+.+++.|+|++|.|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 32 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 111 (606)
T 3t6q_A 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111 (606)
T ss_dssp CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEE
T ss_pred CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEee
Confidence 36899999999999988899999999999999999999988899999999999999999999988899999999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccC-CCCcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAI-PSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~-~~~~~l~~l~~l~l~~N~~~ 204 (594)
|++|+|++..|..+.++++|++|+|++|++++.. +....+++|+.|++++|+..
T Consensus 112 L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 166 (606)
T 3t6q_A 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166 (606)
T ss_dssp CTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCC
T ss_pred ccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCccc
Confidence 9999999977889999999999999999999854 55556999999999999754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.3e-16 Score=180.04 Aligned_cols=144 Identities=22% Similarity=0.209 Sum_probs=123.7
Q ss_pred CCccceeEeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCC-CCCcCCCCccceeecccccccCCCCh
Q 007668 60 PCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI-PSELGNCTELQGLSLQSNYLSGSIPS 138 (594)
Q Consensus 60 ~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~ 138 (594)
.|+|+.|++ .+++|++|+|++|.|++..+..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.|++..|.
T Consensus 13 ~~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 13 FCNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 356888887 6789999999999999888889999999999999999666555 77899999999999999999988899
Q ss_pred hhhCCCCCceEeccCCcCCCCCCcc--ccccCCCcEEEeecccccccCCC--CcccccCCcccccCCCCC
Q 007668 139 ELGNLSNLLNLDISSNSLSDYIPPS--LGKLQRLITFNVSNNFLVGAIPS--DGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~~~~~--~~~l~~L~~l~l~~N~l~~~~~~--~~~l~~l~~l~l~~N~~~ 204 (594)
.|.++++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..+. ...+++|+.|++++|...
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~ 161 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence 9999999999999999998866654 88999999999999999887653 478899999999998754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=2.2e-16 Score=158.20 Aligned_cols=132 Identities=19% Similarity=0.231 Sum_probs=84.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCC-CCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
.++|++|+|++|.++ .+|..+.++++|++|+|++|++++..+ ..+..+++|++|+|++|.+++..|..|..+++|++|
T Consensus 77 ~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 77 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp CSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 356677777777766 455556666677777777776664433 456666666666666666666666666666666666
Q ss_pred eccCCcCCC-CCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCC
Q 007668 150 DISSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRG 203 (594)
Q Consensus 150 ~l~~N~l~~-~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~ 203 (594)
+|++|.+++ .+|..+..+++|+.|+|++|++++.++.. ..+++|+.|++++|+.
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 211 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCcc
Confidence 666666664 45666666666666666666666665433 5566666666666654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.64 E-value=5.6e-16 Score=141.33 Aligned_cols=110 Identities=21% Similarity=0.223 Sum_probs=95.9
Q ss_pred EEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCC
Q 007668 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (594)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 154 (594)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57899999998 6777664 89999999999999888889999999999999999999666666789999999999999
Q ss_pred cCCCCCCccccccCCCcEEEeecccccccCCCC
Q 007668 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187 (594)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 187 (594)
+|+++.+..|..+++|+.|+|++|+|...++..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~ 124 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDI 124 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccccH
Confidence 999866667999999999999999998765543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.64 E-value=5.8e-16 Score=140.75 Aligned_cols=109 Identities=19% Similarity=0.234 Sum_probs=99.0
Q ss_pred cCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEee
Q 007668 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176 (594)
Q Consensus 97 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 176 (594)
..+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578999999999 6887664 899999999999998888999999999999999999999777788999999999999
Q ss_pred cccccccCCC-CcccccCCcccccCCCCCCCCc
Q 007668 177 NNFLVGAIPS-DGVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 177 ~N~l~~~~~~-~~~l~~l~~l~l~~N~~~c~~~ 208 (594)
+|+|++.++. ...+++|+.|++++|++.|.|+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999998886 4789999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.6e-16 Score=169.57 Aligned_cols=140 Identities=20% Similarity=0.136 Sum_probs=112.0
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcc------------------------cCCeeecccCccCCCCCCCcCCCCccceee
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLD------------------------QLKFLNLHSNNFYGEIPSELGNCTELQGLS 126 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~------------------------~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 126 (594)
.++|+.|+|++|.+++..+..|.+++ +|+.|+|++|+|+...+..|..+++|+.|+
T Consensus 175 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 254 (477)
T 2id5_A 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLN 254 (477)
T ss_dssp CTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEE
T ss_pred cCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeE
Confidence 35666666666666655444555544 555556666667633335678889999999
Q ss_pred cccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCC
Q 007668 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 127 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c 205 (594)
|++|.|++..+..|..+++|+.|+|++|+|+++.|..|..+++|+.|+|++|+|++.++.. ..+++|+.|++++|++.|
T Consensus 255 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred CCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 9999999777778899999999999999999988999999999999999999999887765 778999999999999999
Q ss_pred CCccc
Q 007668 206 GKQIN 210 (594)
Q Consensus 206 ~~~~~ 210 (594)
+|++.
T Consensus 335 ~c~~~ 339 (477)
T 2id5_A 335 DCRLL 339 (477)
T ss_dssp SGGGH
T ss_pred ccchH
Confidence 98753
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.1e-16 Score=142.26 Aligned_cols=107 Identities=21% Similarity=0.291 Sum_probs=98.2
Q ss_pred CeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecc
Q 007668 99 KFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178 (594)
Q Consensus 99 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 178 (594)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999998 7887775 89999999999999888999999999999999999999966677899999999999999
Q ss_pred cccccCCC-CcccccCCcccccCCCCCCCCc
Q 007668 179 FLVGAIPS-DGVLTKFSESSFFGNRGLCGKQ 208 (594)
Q Consensus 179 ~l~~~~~~-~~~l~~l~~l~l~~N~~~c~~~ 208 (594)
+|+++++. ...+++|+.|++++|++.|.++
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 99998886 5889999999999999999986
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.2e-16 Score=147.42 Aligned_cols=128 Identities=16% Similarity=0.206 Sum_probs=115.3
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|+|+ .+| .+..+++|++|+|++|.++ .+ ..+..+++|++|+|++|.+++..|..|..+++|++|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 467999999999999 666 6999999999999999876 33 4799999999999999999987899999999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeeccc-ccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNF-LVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~-l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
|++|++++..|..+..+++|+.|+|++|+ ++. ++....+++|+.|++++|+.
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~~l~~l~~L~~L~l~~n~i 171 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IMPLKTLPELKSLNIQFDGV 171 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CGGGGGCSSCCEEECTTBCC
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cHhhcCCCCCCEEECCCCCC
Confidence 99999998788999999999999999998 655 45678899999999999974
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=5.8e-16 Score=172.78 Aligned_cols=134 Identities=25% Similarity=0.218 Sum_probs=115.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
+++|++|+|++|.|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..|.++++|++|+
T Consensus 24 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 103 (680)
T 1ziw_A 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103 (680)
T ss_dssp CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence 36789999999999987777899999999999999999988888899999999999999999955455789999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
|++|+++++.|..|.++++|++|+|++|.+++.++.. ..+++|+.|++++|...
T Consensus 104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 158 (680)
T 1ziw_A 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158 (680)
T ss_dssp CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC
T ss_pred CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc
Confidence 9999999877788999999999999999998887764 77889999999988753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-15 Score=154.03 Aligned_cols=143 Identities=11% Similarity=0.079 Sum_probs=101.5
Q ss_pred HHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccch--------------hhH--------HHHHHHHHHHhhC
Q 007668 303 IKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE--------------GFD--------RFFERELEILGSI 360 (594)
Q Consensus 303 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~E~~~l~~l 360 (594)
...-.-|.+.+.||+|+||.||+|...+|+.||||+++.... ... ....+|...|.++
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 333334888899999999999999999999999998753100 000 1123566667776
Q ss_pred CCCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 361 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
.+.++....-+.. ...++||||++++.|.+.... .....++.|++.+|.|||+. +||||||||.|||+
T Consensus 171 ~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl 238 (397)
T 4gyi_A 171 YEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILI 238 (397)
T ss_dssp HHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred HhcCCCCCeeeec--cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence 5444322111111 234799999999988776432 12356889999999999954 99999999999999
Q ss_pred cCCC----------cEEEeeccccccc
Q 007668 441 DGNL----------EARVSDFGLAKLL 457 (594)
Q Consensus 441 ~~~~----------~~~l~Dfgl~~~~ 457 (594)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8776 3899999976543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=8.3e-16 Score=155.69 Aligned_cols=141 Identities=21% Similarity=0.286 Sum_probs=123.1
Q ss_pred CCccceeEeCC----------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccc
Q 007668 60 PCNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (594)
Q Consensus 60 ~c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (594)
.|.|+.+.|.. .++++.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 46889999863 35799999999999987777999999999999999999988899999999999999999
Q ss_pred ccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccc--cCCC-CcccccCCcccccCCCC
Q 007668 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG--AIPS-DGVLTKFSESSFFGNRG 203 (594)
Q Consensus 130 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~--~~~~-~~~l~~l~~l~l~~N~~ 203 (594)
|.|+ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|+++. ..+. ...+++|+.|++++|..
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 9999 6776654 799999999999998777789999999999999999964 4443 37789999999999874
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.62 E-value=1e-15 Score=155.10 Aligned_cols=140 Identities=23% Similarity=0.273 Sum_probs=120.4
Q ss_pred CccceeEeCC----------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccc
Q 007668 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130 (594)
Q Consensus 61 c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 130 (594)
|.|..+.|.. .++++.|+|++|.|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 6899999863 257999999999999777889999999999999999999888889999999999999999
Q ss_pred cccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccc--cCCCC-cccccCCcccccCCCCC
Q 007668 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVG--AIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 131 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~--~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
.++ .+|..+. ++|++|+|++|+|++..+..|..+++|+.|++++|.++. ..+.. ..+ +|+.|++++|...
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 999 6776655 899999999999998777779999999999999999964 44443 445 8999999998743
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=9.7e-16 Score=165.91 Aligned_cols=121 Identities=24% Similarity=0.273 Sum_probs=109.6
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEecc
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 152 (594)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58899999999995 676 999999999999999999 889999999999999999999995 77 89999999999999
Q ss_pred CCcCCCCC-CccccccCCCcEEEeecccccccCCCCc----ccccCCcccc
Q 007668 153 SNSLSDYI-PPSLGKLQRLITFNVSNNFLVGAIPSDG----VLTKFSESSF 198 (594)
Q Consensus 153 ~N~l~~~~-~~~~~~l~~L~~l~l~~N~l~~~~~~~~----~l~~l~~l~l 198 (594)
+|+|++.. |..+..+++|+.|+|++|+|++.++... .+++|+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999976 9999999999999999999999988653 3677877753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.2e-16 Score=173.02 Aligned_cols=144 Identities=21% Similarity=0.234 Sum_probs=128.3
Q ss_pred CCccceeEe--CCCCcEEEEEcccCCCCCC-----------------CCcccc--CcccCCeeecccCccCCCCCCCcCC
Q 007668 60 PCNWKGVKC--DKNKRVITLSLTNHKLSGP-----------------ISADLG--KLDQLKFLNLHSNNFYGEIPSELGN 118 (594)
Q Consensus 60 ~c~w~gv~c--~~~~~l~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~ 118 (594)
.+...|+.- ...++|++|+|++|.|++. +|..++ ++++|++|+|++|++.+.+|..|.+
T Consensus 192 ~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~ 271 (636)
T 4eco_A 192 SNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271 (636)
T ss_dssp SCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT
T ss_pred cCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc
Confidence 345566432 2467999999999999985 999999 9999999999999999999999999
Q ss_pred CCccceeeccccc-ccC-CCChhhhCC------CCCceEeccCCcCCCCCCc--cccccCCCcEEEeecccccccCCCCc
Q 007668 119 CTELQGLSLQSNY-LSG-SIPSELGNL------SNLLNLDISSNSLSDYIPP--SLGKLQRLITFNVSNNFLVGAIPSDG 188 (594)
Q Consensus 119 l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~~~--~~~~l~~L~~l~l~~N~l~~~~~~~~ 188 (594)
+++|++|+|++|+ +++ .+|..+..+ ++|++|+|++|+++ .+|. .+.++++|+.|+|++|+++|.+|...
T Consensus 272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~ 350 (636)
T 4eco_A 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFG 350 (636)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCE
T ss_pred CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhC
Confidence 9999999999998 998 899988887 99999999999999 5888 89999999999999999997777668
Q ss_pred ccccCCcccccCCCCC
Q 007668 189 VLTKFSESSFFGNRGL 204 (594)
Q Consensus 189 ~l~~l~~l~l~~N~~~ 204 (594)
.+++|+.|++++|...
T Consensus 351 ~l~~L~~L~L~~N~l~ 366 (636)
T 4eco_A 351 SEIKLASLNLAYNQIT 366 (636)
T ss_dssp EEEEESEEECCSSEEE
T ss_pred CCCCCCEEECCCCccc
Confidence 8999999999999754
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=9.5e-16 Score=166.54 Aligned_cols=134 Identities=22% Similarity=0.218 Sum_probs=100.7
Q ss_pred CcEEEEEcccCCCCCCCC--ccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhh---------
Q 007668 72 KRVITLSLTNHKLSGPIS--ADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL--------- 140 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--------- 140 (594)
++|+.|+|++|+|++..+ ..+..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|..+
T Consensus 361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~L 438 (549)
T 2z81_A 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDV 438 (549)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEEC
T ss_pred ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEEC
Confidence 456666666666664322 34666777777777777777 56666777777777777777766 333221
Q ss_pred ---------hCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCcc
Q 007668 141 ---------GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 141 ---------~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
..+++|++|+|++|+|+. +|. ...+++|+.|+|++|+|++.++.. ..+++|+.|++++|++.|+||.
T Consensus 439 s~N~l~~~~~~l~~L~~L~Ls~N~l~~-ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 439 SNNNLDSFSLFLPRLQELYISRNKLKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CSSCCSCCCCCCTTCCEEECCSSCCSS-CCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred CCCChhhhcccCChhcEEECCCCccCc-CCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 267889999999999985 665 568999999999999999988874 8899999999999999999883
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.4e-15 Score=165.83 Aligned_cols=134 Identities=19% Similarity=0.178 Sum_probs=114.3
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
+++++.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 45788999999999977777899999999999999999877778899999999999999999877778899999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeeccccccc-CC-CCcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGA-IP-SDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~-~~-~~~~l~~l~~l~l~~N~~~ 204 (594)
|++|++++..+..+.++++|++|+|++|.+++. .| ....+++|+.|++++|+..
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~ 162 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc
Confidence 999999886666788999999999999999873 24 4477889999999988753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.6e-16 Score=156.30 Aligned_cols=130 Identities=18% Similarity=0.118 Sum_probs=63.1
Q ss_pred CcEEEEEcccCCCCCCCCccccCc-----ccCCeeecccCccCCCCCCCcCCCCccceeecccccccCC--CChhh--hC
Q 007668 72 KRVITLSLTNHKLSGPISADLGKL-----DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS--IPSEL--GN 142 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~--~~ 142 (594)
++|++|+|++|+|++. |..+..+ ++|++|+|++|+|++..|..|.++++|++|+|++|++.+. +|..+ ..
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 4455555555555543 4444444 5555555555555544445555555555555555554433 12222 45
Q ss_pred CCCCceEeccCCcCCCC--CC-ccccccCCCcEEEeecccccccCC--CCcccccCCcccccCCC
Q 007668 143 LSNLLNLDISSNSLSDY--IP-PSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNR 202 (594)
Q Consensus 143 l~~L~~L~l~~N~l~~~--~~-~~~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~l~~N~ 202 (594)
+++|++|+|++|+|++. ++ ..+..+++|+.|+|++|+|++.++ ....+++|+.|++++|.
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~ 264 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSC
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCc
Confidence 55555555555555521 11 122344555555555555555442 12334555555555554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-15 Score=155.95 Aligned_cols=131 Identities=18% Similarity=0.112 Sum_probs=118.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|.|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.++...+..|..+++|++|+
T Consensus 68 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 68 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence 46899999999999977778999999999999999999988888899999999999999999954445579999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
|++|++++..|..+..+++|+.|+|++|++++.. ...+++|+.|++++|..
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLL 198 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSSCC
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccccc
Confidence 9999999988888999999999999999999763 46788999999998864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.59 E-value=7e-16 Score=148.60 Aligned_cols=130 Identities=16% Similarity=0.098 Sum_probs=113.8
Q ss_pred CCcEEEEEcccCC-CCCCCCccccCcccCCeeeccc-CccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCc-
Q 007668 71 NKRVITLSLTNHK-LSGPISADLGKLDQLKFLNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLL- 147 (594)
Q Consensus 71 ~~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~- 147 (594)
.++|++|+|++|+ +++..+..|.++++|++|+|++ |+|++..+..|.++++|++|+|++|.+++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 5789999999997 8866667899999999999998 99997667789999999999999999994 776 88888888
Q ss_pred --eEeccCC-cCCCCCCccccccCCCc-EEEeecccccccCCCCcccccCCcccccCCC
Q 007668 148 --NLDISSN-SLSDYIPPSLGKLQRLI-TFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 148 --~L~l~~N-~l~~~~~~~~~~l~~L~-~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
+|++++| +++++.+..|..+++|+ .|++++|+++.+++.....++|+.|++++|+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCT
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCC
Confidence 9999999 99987777899999999 9999999999777665444889999999995
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.3e-15 Score=152.89 Aligned_cols=130 Identities=20% Similarity=0.146 Sum_probs=91.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCC--C--CCCcCCCCccceeecccccccCCCCh----hhhC
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGE--I--PSELGNCTELQGLSLQSNYLSGSIPS----ELGN 142 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~ 142 (594)
.++|++|+|++|+|++..+..|.++++|++|+|++|++.+. + +..+..+++|++|+|++|+|+ .++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 45777788888888777777777778888888888876531 2 223467777888888888776 4443 2466
Q ss_pred CCCCceEeccCCcCCCCCCcccccc---CCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 143 LSNLLNLDISSNSLSDYIPPSLGKL---QRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 143 l~~L~~L~l~~N~l~~~~~~~~~~l---~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
+++|++|+|++|+|++..|..+..+ ++|++|+|++|+|+.++... .++|+.|++++|+.
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~--~~~L~~L~Ls~N~l 284 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGL--PAKLRVLDLSSNRL 284 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCC--CSCCSCEECCSCCC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhh--cCCCCEEECCCCcC
Confidence 7788888888888877667666665 57888888888887554433 26777888887764
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.59 E-value=2e-15 Score=147.48 Aligned_cols=126 Identities=23% Similarity=0.260 Sum_probs=104.8
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|+|++..+ +.++++|++|+|++|+|++ +|. +.. ++|+.|+|++|+|++ ++ .+..+++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 4689999999999996544 8899999999999999984 553 333 899999999999984 44 588999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCG 206 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~ 206 (594)
|++|+|++. + .+..+++|+.|+|++|+|++. +....+++|+.|++++|++.|.
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 999999874 4 688999999999999999887 5567889999999999987654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-15 Score=164.84 Aligned_cols=131 Identities=18% Similarity=0.112 Sum_probs=119.3
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|.|++..+..|+++++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|.++++|++|+
T Consensus 74 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 74 FRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 36899999999999988888999999999999999999988888899999999999999999965556679999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
|++|.|++..|..|..+++|+.|+|++|.|++.. ...+++|+.|++++|..
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLL 204 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCC
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCcc
Confidence 9999999988889999999999999999999864 45688899999988864
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.8e-15 Score=150.93 Aligned_cols=131 Identities=18% Similarity=0.186 Sum_probs=76.7
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccC--CCCCCCcCCC--------------------Cccceeecccc
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFY--GEIPSELGNC--------------------TELQGLSLQSN 130 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l--------------------~~L~~L~Ls~N 130 (594)
+|++|+|++|.|++..+..|.++++|+.|+|++|.++ +..|..|..+ ++|++|+|++|
T Consensus 124 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n 203 (332)
T 2ft3_A 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHN 203 (332)
T ss_dssp TCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSS
T ss_pred cCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCC
Confidence 4555555555555444445666666666666666664 2444444443 34555555555
Q ss_pred cccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 131 YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 131 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
.+++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+.++.....+++|+.|++++|+.
T Consensus 204 ~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l 276 (332)
T 2ft3_A 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNI 276 (332)
T ss_dssp CCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCC
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCC
Confidence 5554444556666666666666666666555566666666666666666665544455666666666666654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.2e-15 Score=164.15 Aligned_cols=134 Identities=21% Similarity=0.151 Sum_probs=117.3
Q ss_pred eeEeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCC
Q 007668 65 GVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS 144 (594)
Q Consensus 65 gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 144 (594)
++..+-.+++++|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .++
T Consensus 45 ~ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~ 121 (562)
T 3a79_B 45 HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMA 121 (562)
T ss_dssp SCCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCT
T ss_pred cCCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccc
Confidence 333333478999999999999888889999999999999999999888999999999999999999999 67776 899
Q ss_pred CCceEeccCCcCCCC-CCccccccCCCcEEEeecccccccCCCCcccccC--CcccccCCCC
Q 007668 145 NLLNLDISSNSLSDY-IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKF--SESSFFGNRG 203 (594)
Q Consensus 145 ~L~~L~l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l--~~l~l~~N~~ 203 (594)
+|++|+|++|+|++. +|..|.++++|++|+|++|++++. ....+++| +.|++++|+.
T Consensus 122 ~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 122 SLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL--DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp TCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT--TTGGGTTSCEEEEEEEESSC
T ss_pred cCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC--chhhhhhceeeEEEeecccc
Confidence 999999999999973 468999999999999999999863 34566677 9999999975
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.58 E-value=2.1e-15 Score=153.84 Aligned_cols=135 Identities=19% Similarity=0.160 Sum_probs=108.4
Q ss_pred CccceeEeCCCCcEEEEEcccC-CCCCCCCccccCcccCCeeeccc-CccCCCCCCCcCCCCccceeecccccccCCCCh
Q 007668 61 CNWKGVKCDKNKRVITLSLTNH-KLSGPISADLGKLDQLKFLNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPS 138 (594)
Q Consensus 61 c~w~gv~c~~~~~l~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 138 (594)
|.|..|.| +++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|.
T Consensus 8 C~~~~v~~-----------~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRC-----------TRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEEC-----------CSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEc-----------CCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 77766655 455 788 5777 99999999999996 999977778899999999999999999998889
Q ss_pred hhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC--cccccCCcccccCCCCCCCCcc
Q 007668 139 ELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD--GVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~--~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
.|.+|++|+.|+|++|+|+++.+..|..++ |+.|+|++|+|....... ..+.+.....+..+...|..|.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 999999999999999999986666676666 999999999998654311 2222334445566777787664
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=8e-16 Score=154.53 Aligned_cols=131 Identities=24% Similarity=0.153 Sum_probs=110.3
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCC--CCCCc--CCCCccceeecccccccC--CCC-hhhhCCC
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGE--IPSEL--GNCTELQGLSLQSNYLSG--SIP-SELGNLS 144 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~~--~~p-~~~~~l~ 144 (594)
++|++|+|++|+|++..+..|+++++|++|+|++|++.+. +|..+ ..+++|++|+|++|+|++ .++ ..+..++
T Consensus 149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~ 228 (312)
T 1wwl_A 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228 (312)
T ss_dssp TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC
T ss_pred CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC
Confidence 7899999999999988889999999999999999998765 23334 899999999999999983 122 3456889
Q ss_pred CCceEeccCCcCCCCCC-ccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 145 NLLNLDISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 145 ~L~~L~l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
+|++|+|++|+|++..| ..+..+++|+.|+|++|+|+.++.... ++|+.|++++|+..
T Consensus 229 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~ 287 (312)
T 1wwl_A 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLD 287 (312)
T ss_dssp CCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCSSCCC
T ss_pred CCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCCCCCC
Confidence 99999999999998775 567778999999999999996655444 89999999999753
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=8.4e-16 Score=157.23 Aligned_cols=133 Identities=16% Similarity=0.156 Sum_probs=118.5
Q ss_pred CCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCCh--hhhCCCCCc
Q 007668 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPS--ELGNLSNLL 147 (594)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~ 147 (594)
..++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+|. .|..+++|+
T Consensus 74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 74 RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred cCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 3578999999999999888889999999999999999999555555999999999999999999 5555 789999999
Q ss_pred eEeccCC-cCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCC
Q 007668 148 NLDISSN-SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRG 203 (594)
Q Consensus 148 ~L~l~~N-~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~ 203 (594)
+|++++| .+++..+..+..+++|+.|++++|++++..+.. ..+++|+.|++++|..
T Consensus 153 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred EEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 9999999 578767889999999999999999999986654 8899999999999873
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=4.9e-15 Score=150.02 Aligned_cols=131 Identities=19% Similarity=0.184 Sum_probs=71.8
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCC--CCCCCcCCCCccceeecc---------------------
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQ--------------------- 128 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls--------------------- 128 (594)
++|++|+|++|.+++..+..|.++++|++|+|++|.++. ..+..|.++++|++|+|+
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~ 200 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLD 200 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECT
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECC
Confidence 456666666666665444455555566666666555532 344445555555555554
Q ss_pred cccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCC
Q 007668 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 129 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
+|.+++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+++..+.....+++|+.|++++|+
T Consensus 201 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~ 274 (330)
T 1xku_A 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274 (330)
T ss_dssp TSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCc
Confidence 45554444455555555555555555555544445555555555555555555444444555555555555554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.57 E-value=4.4e-15 Score=147.40 Aligned_cols=124 Identities=28% Similarity=0.361 Sum_probs=97.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|++++..+ +.++++|++|+|++|++++ +| .+..+++|++|+|++|++++ + ..+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 4678888888888885444 8888888888888888874 44 48888888888888888884 3 4577888888888
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
|++|+|++. ..+..+++|+.|+|++|++++.++ ...+++|+.|++++|+.
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcC
Confidence 888888874 567888888888888888887766 66778888888888864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-15 Score=172.02 Aligned_cols=142 Identities=18% Similarity=0.195 Sum_probs=124.5
Q ss_pred CccceeEe--CCCCcEEEEEcccCCCCC-----------------CCCcccc--CcccCCeeecccCccCCCCCCCcCCC
Q 007668 61 CNWKGVKC--DKNKRVITLSLTNHKLSG-----------------PISADLG--KLDQLKFLNLHSNNFYGEIPSELGNC 119 (594)
Q Consensus 61 c~w~gv~c--~~~~~l~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l 119 (594)
+...|++- ...++|+.|+|++|.|++ .+|..++ ++++|++|+|++|++.+.+|..|.++
T Consensus 435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L 514 (876)
T 4ecn_A 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDL 514 (876)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGC
T ss_pred CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCC
Confidence 44555542 246789999999999997 3888887 99999999999999999999999999
Q ss_pred Cccceeeccccc-ccC-CCChhhhCCC-------CCceEeccCCcCCCCCCc--cccccCCCcEEEeecccccccCCCCc
Q 007668 120 TELQGLSLQSNY-LSG-SIPSELGNLS-------NLLNLDISSNSLSDYIPP--SLGKLQRLITFNVSNNFLVGAIPSDG 188 (594)
Q Consensus 120 ~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~~~--~~~~l~~L~~l~l~~N~l~~~~~~~~ 188 (594)
++|+.|+|++|+ +++ .+|..+..++ +|+.|+|++|+|+ .+|. .+.++++|+.|+|++|+++ .+|...
T Consensus 515 ~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~ 592 (876)
T 4ecn_A 515 PELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFG 592 (876)
T ss_dssp SSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCC
T ss_pred CCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhc
Confidence 999999999998 998 7898877766 9999999999999 5888 8999999999999999999 555778
Q ss_pred ccccCCcccccCCCCC
Q 007668 189 VLTKFSESSFFGNRGL 204 (594)
Q Consensus 189 ~l~~l~~l~l~~N~~~ 204 (594)
.+++|+.|++++|...
T Consensus 593 ~L~~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 593 TNVKLTDLKLDYNQIE 608 (876)
T ss_dssp TTSEESEEECCSSCCS
T ss_pred CCCcceEEECcCCccc
Confidence 8999999999999865
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.8e-15 Score=151.36 Aligned_cols=144 Identities=19% Similarity=0.118 Sum_probs=126.8
Q ss_pred CccceeEeCC----------CCcEEEEEcccCCCCCCCCcccc-CcccCCeeecccCccCCCCCCCcCCCCccceeeccc
Q 007668 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLG-KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (594)
Q Consensus 61 c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (594)
|.+..+.|.. ...++.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 5677778853 35688999999999987777787 999999999999999977778899999999999999
Q ss_pred ccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC----cccccCCcccccCCCCC
Q 007668 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD----GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 130 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~----~~l~~l~~l~l~~N~~~ 204 (594)
|+|++..+..|..+++|+.|+|++|+|+++.|..|..+++|+.|+|++|+|++.++.. ..+++|+.|+|++|+..
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 9999777778999999999999999999988999999999999999999999877654 46899999999999753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-15 Score=152.34 Aligned_cols=130 Identities=20% Similarity=0.215 Sum_probs=109.9
Q ss_pred CCCcEEEEEcccCCCCCC--C--CccccCcccCCeeecccCccCCCCCC----CcCCCCccceeecccccccCCCChhhh
Q 007668 70 KNKRVITLSLTNHKLSGP--I--SADLGKLDQLKFLNLHSNNFYGEIPS----ELGNCTELQGLSLQSNYLSGSIPSELG 141 (594)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 141 (594)
..++|++|+|++|++.+. + +..+.++++|++|+|++|+|+ .+|. .+.++++|++|+|++|+|++..|..+.
T Consensus 167 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~ 245 (310)
T 4glp_A 167 AFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAP 245 (310)
T ss_dssp CCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCS
T ss_pred cCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHH
Confidence 357899999999998742 2 234578999999999999998 4444 257889999999999999988788887
Q ss_pred CC---CCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 142 NL---SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 142 ~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
.+ ++|++|+|++|+|+. +|..+. ++|+.|+|++|+|++.+ ....+++|+.|++++|++.
T Consensus 246 ~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~~-~~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 246 RCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRAP-QPDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp SCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSCC-CTTSCCCCSCEECSSTTTS
T ss_pred hccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCCc-hhhhCCCccEEECcCCCCC
Confidence 77 699999999999995 777764 89999999999999863 3578899999999999864
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.55 E-value=4.2e-15 Score=148.89 Aligned_cols=129 Identities=26% Similarity=0.367 Sum_probs=102.3
Q ss_pred CCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCce
Q 007668 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLN 148 (594)
Q Consensus 69 ~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 148 (594)
...++|+.|+|++|.|++ ++ .+.++++|++|+|++|++++ +| .+..+++|++|+|++|.+++ ++. +..+++|+.
T Consensus 82 ~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~ 155 (308)
T 1h6u_A 82 KNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQY 155 (308)
T ss_dssp TTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCE
T ss_pred ccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCc-Ccc-ccCCCCccE
Confidence 345789999999999985 33 68888999999999999884 44 38888999999999998884 443 788888888
Q ss_pred EeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCC
Q 007668 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCG 206 (594)
Q Consensus 149 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~ 206 (594)
|+|++|++++.. . +..+++|+.|+|++|++++.++ ...+++|+.|++++|+...-
T Consensus 156 L~l~~n~l~~~~-~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~ 210 (308)
T 1h6u_A 156 LSIGNAQVSDLT-P-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDV 210 (308)
T ss_dssp EECCSSCCCCCG-G-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBC
T ss_pred EEccCCcCCCCh-h-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcc
Confidence 888888888743 3 7888888888888888887655 56788888888888875543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.2e-15 Score=162.54 Aligned_cols=128 Identities=22% Similarity=0.231 Sum_probs=115.6
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+
T Consensus 20 ~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 20 SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp CTTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred cccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 368999999999999888889999999999999999999888999999999999999999999 67776 899999999
Q ss_pred ccCCcCCCC-CCccccccCCCcEEEeecccccccCCCCcccccC--CcccccCCCC
Q 007668 151 ISSNSLSDY-IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKF--SESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~-~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l--~~l~l~~N~~ 203 (594)
|++|+|++. +|..|.++++|++|+|++|+|++. ....+++| +.|++++|..
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~--~~~~l~~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS--SVLPIAHLNISKVLLVLGET 150 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG--GGGGGTTSCEEEEEEEECTT
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccchh--hccccccceeeEEEeecccc
Confidence 999999973 688999999999999999999873 34667788 9999999976
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=7.7e-15 Score=143.36 Aligned_cols=125 Identities=26% Similarity=0.291 Sum_probs=109.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|+|+ .++ .+..+++|++|+|++|+|++..| +.++++|++|+|++|+|++ +|.. .. ++|+.|+
T Consensus 40 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~ 112 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLF 112 (263)
T ss_dssp HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEE
T ss_pred cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEE
Confidence 468999999999999 555 78999999999999999995444 9999999999999999994 5553 33 9999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c 205 (594)
|++|+|++ + ..+..+++|+.|+|++|+|++.+ ....+++|+.|++++|+...
T Consensus 113 L~~N~l~~-~-~~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 113 LDNNELRD-T-DSLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSB-S-GGGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCCB
T ss_pred ccCCccCC-C-hhhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCcc
Confidence 99999997 4 36999999999999999999874 56789999999999998654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.55 E-value=9.9e-15 Score=146.17 Aligned_cols=125 Identities=22% Similarity=0.315 Sum_probs=106.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|.+++..+ +.++++|++|+|++|++++ +| .+..+++|++|+|++|++++ ++. +..+++|++|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 5789999999999995444 8999999999999999984 44 68899999999999999984 554 88999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
|++|++++..+ +..+++|+.|+|++|++++.++ ...+++|+.|++++|...
T Consensus 136 l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 136 LDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred CCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccC
Confidence 99999997443 8899999999999999987665 678899999999999754
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.54 E-value=6.2e-15 Score=146.32 Aligned_cols=128 Identities=27% Similarity=0.348 Sum_probs=113.0
Q ss_pred CCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCce
Q 007668 69 DKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLN 148 (594)
Q Consensus 69 ~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 148 (594)
...++|+.|+|++|.+++ ++ .+.++++|++|+|++|++++ + ..+..+++|+.|+|++|++++. ..+..+++|+.
T Consensus 87 ~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~ 160 (291)
T 1h6t_A 87 ANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDT 160 (291)
T ss_dssp TTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred ccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCE
Confidence 356899999999999995 44 49999999999999999995 4 4789999999999999999954 57999999999
Q ss_pred EeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCC
Q 007668 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 149 L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c 205 (594)
|+|++|+|++..| +..+++|+.|+|++|+|++.+ ....+++|+.|++++|+..+
T Consensus 161 L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 161 LSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp EECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEEEEEEC
T ss_pred EEccCCccccchh--hcCCCccCEEECCCCcCCCCh-hhccCCCCCEEECcCCcccC
Confidence 9999999998554 999999999999999999764 46789999999999998654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.54 E-value=4.5e-15 Score=134.57 Aligned_cols=113 Identities=26% Similarity=0.240 Sum_probs=101.5
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCC--hhhhCCCCCce
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIP--SELGNLSNLLN 148 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~ 148 (594)
.++|+.|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|++|+|++|.|++ +| ..+..+++|+.
T Consensus 48 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~ 124 (168)
T 2ell_A 48 FVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECLKS 124 (168)
T ss_dssp GGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCCCE
T ss_pred CCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCCCE
Confidence 47899999999999965 889999999999999999997788888889999999999999995 44 78999999999
Q ss_pred EeccCCcCCCCCC---ccccccCCCcEEEeecccccccCCC
Q 007668 149 LDISSNSLSDYIP---PSLGKLQRLITFNVSNNFLVGAIPS 186 (594)
Q Consensus 149 L~l~~N~l~~~~~---~~~~~l~~L~~l~l~~N~l~~~~~~ 186 (594)
|+|++|.+++..+ ..+..+++|+.|++++|.+...+..
T Consensus 125 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 165 (168)
T 2ell_A 125 LDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDS 165 (168)
T ss_dssp EECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCSS
T ss_pred EEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcccc
Confidence 9999999998544 4899999999999999999876654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=2.4e-17 Score=154.00 Aligned_cols=129 Identities=26% Similarity=0.263 Sum_probs=94.3
Q ss_pred cEEEEEcccCCCCCCCCc------cccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCC
Q 007668 73 RVITLSLTNHKLSGPISA------DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNL 146 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 146 (594)
+++.++|+.+.++|..|. .+.++++|++|+|++|+|++ +| .+.++++|++|+|++|.|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 455556666666655555 77778888888888888874 66 7777888888888888887 677777777788
Q ss_pred ceEeccCCcCCCCCCccccccCCCcEEEeecccccccCC--CCcccccCCcccccCCCCCCC
Q 007668 147 LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRGLCG 206 (594)
Q Consensus 147 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~l~~N~~~c~ 206 (594)
+.|+|++|+|++ +| .+..+++|+.|+|++|++++.++ ....+++|+.|++++|++.|.
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 888888888876 44 57777888888888888876543 346677788888888876554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.54 E-value=9.9e-15 Score=148.85 Aligned_cols=109 Identities=21% Similarity=0.159 Sum_probs=98.8
Q ss_pred CeeecccC-ccCCCCCCCcCCCCccceeeccc-ccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEee
Q 007668 99 KFLNLHSN-NFYGEIPSELGNCTELQGLSLQS-NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176 (594)
Q Consensus 99 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 176 (594)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..+..|.+|++|+.|+|++|+|+++.|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35799998 899 6888 99999999999996 99998777899999999999999999999888999999999999999
Q ss_pred cccccccCCCCcccccCCcccccCCCCCCCCcc
Q 007668 177 NNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 177 ~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
+|+|+++++......+|+.|+|.+|++.|+|.+
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~l 121 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCcc
Confidence 999999888764444499999999999999874
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.54 E-value=5e-15 Score=157.97 Aligned_cols=128 Identities=20% Similarity=0.114 Sum_probs=101.3
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhh-CCCCCceEe
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELG-NLSNLLNLD 150 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 150 (594)
++|+.|+|++|.|++..+. .+++|+.|+|++|.|++..|..|.++++|+.|+|++|.|++.+|..+. .+++|+.|+
T Consensus 99 ~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 4556666666666644433 357888889999998888788888889999999999999887887775 788999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
|++|.|++. |. +..+++|+.|+|++|.|++.++....+++|+.|++++|...
T Consensus 176 Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 227 (487)
T 3oja_A 176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (487)
T ss_dssp CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred cCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCc
Confidence 999998875 32 34588899999999999988887788888999999988743
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-15 Score=168.99 Aligned_cols=132 Identities=28% Similarity=0.275 Sum_probs=115.9
Q ss_pred CCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
...+|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..|.+|++|++|+|++|.|+ .+|..|..|++|++|
T Consensus 222 ~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred cCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 3578999999999999 78888889999999999999999 89999999999999999999999 889999999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCCc-cc-ccCCcccccCCCCCC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDG-VL-TKFSESSFFGNRGLC 205 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~-~l-~~l~~l~l~~N~~~c 205 (594)
+|++|.|+. +|..|..|++|+.|+|++|+|++.+|... .+ ..+..+++.+|....
T Consensus 299 ~L~~N~l~~-lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~ 355 (727)
T 4b8c_D 299 YFFDNMVTT-LPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI 355 (727)
T ss_dssp ECCSSCCCC-CCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred ECCCCCCCc-cChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence 999999985 78889999999999999999998877542 21 122346788887654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.53 E-value=7e-15 Score=130.44 Aligned_cols=108 Identities=21% Similarity=0.186 Sum_probs=98.6
Q ss_pred CcccCCeeecccCccC-CCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcE
Q 007668 94 KLDQLKFLNLHSNNFY-GEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLIT 172 (594)
Q Consensus 94 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 172 (594)
..++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|+|++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 4589999999999998 78999999999999999999999965 77999999999999999999888888888999999
Q ss_pred EEeecccccccC--CCCcccccCCcccccCCCC
Q 007668 173 FNVSNNFLVGAI--PSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 173 l~l~~N~l~~~~--~~~~~l~~l~~l~l~~N~~ 203 (594)
|++++|++++.+ .....+++|+.|++++|+.
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGG
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcc
Confidence 999999999864 5568899999999999974
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.52 E-value=6e-15 Score=159.03 Aligned_cols=134 Identities=25% Similarity=0.301 Sum_probs=102.9
Q ss_pred CcCCCCCCCCCC-----cccee-EeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccc
Q 007668 50 LNQWRPEDPDPC-----NWKGV-KCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQ 123 (594)
Q Consensus 50 l~~w~~~~~~~c-----~w~gv-~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 123 (594)
+.+|.. +.++| .|.|+ .|. .++|+.|+|++|+|++ +|..+ +++|++|+|++|+|+ .+| ..+++|+
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~-~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECL-INQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHH-HTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhc-cCCccccccchhhhccccc-cCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCC
Confidence 455643 45678 69998 675 3578999999999986 66655 378999999999988 677 4578888
Q ss_pred eeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 124 GLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 124 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
+|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++++. .+++|+.|++++|+.
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCC
Confidence 89999988885 776 654 88888888888887 555 57888888888888887544 567788888888864
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.4e-14 Score=156.00 Aligned_cols=124 Identities=28% Similarity=0.354 Sum_probs=93.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|+|++..+ +..+++|+.|+|++|.|++ +| .+..+++|+.|+|++|.|++ ++ .+..+++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEE
Confidence 4678888888888885544 7788888888888888873 44 67778888888888888874 33 477778888888
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
|++|+|+++ ..+..+++|+.|+|++|+|++.++ ...+++|+.|+|++|+.
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCC
Confidence 888888764 567777888888888888877666 66677777888877764
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.4e-14 Score=147.60 Aligned_cols=128 Identities=21% Similarity=0.233 Sum_probs=73.0
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|++++|.+++..+ +..+++|++|+|++|++++. +. +..+++|++|+|++|.+++ + ..+..+++|++|+
T Consensus 198 l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~ 271 (347)
T 4fmz_A 198 LTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLN 271 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEE
T ss_pred CCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEE
Confidence 3456666666666664333 55666666666666666632 22 5566666666666666653 2 2455666666666
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCG 206 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~ 206 (594)
+++|++++. ..+..+++|+.|+|++|++++..+.. ..+++|+.|++++|+...-
T Consensus 272 l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred ccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 666666652 34556666666666666665554432 4556666666666654433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-14 Score=146.54 Aligned_cols=128 Identities=20% Similarity=0.114 Sum_probs=98.4
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhh-hCCCCCceEe
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLD 150 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ 150 (594)
++|+.|+|++|+|++..+. .+++|++|+|++|++++..|..+..+++|++|+|++|.+++..+..+ ..+++|++|+
T Consensus 99 ~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 4556666666666643332 35778888888888887777788888899999999998887666666 4788899999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
|++|+|++. +. ...+++|+.|+|++|+|++.++....+++|+.|++++|+..
T Consensus 176 L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC
T ss_pred CCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc
Confidence 999998874 32 33588899999999999888777778888999999988754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.49 E-value=3.2e-14 Score=154.96 Aligned_cols=126 Identities=27% Similarity=0.361 Sum_probs=112.8
Q ss_pred CCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
..++|+.|+|++|.|++ ++ .+..+++|+.|+|++|+|++ ++ .+..|++|+.|+|++|.|++. ..+..+++|+.|
T Consensus 85 ~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 158 (605)
T 1m9s_A 85 NLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 158 (605)
T ss_dssp GCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred cCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence 46789999999999995 44 79999999999999999995 44 699999999999999999954 679999999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
+|++|+|++..| +..+++|+.|+|++|+|++. +....+++|+.|+|++|+..
T Consensus 159 ~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEE
T ss_pred ECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCc
Confidence 999999998666 99999999999999999986 55688999999999999854
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=5.2e-16 Score=144.94 Aligned_cols=125 Identities=22% Similarity=0.274 Sum_probs=109.4
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|.|++ +| .+.++++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +| .+..+++|++|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 5789999999999996 67 8999999999999999999 788888888999999999999995 66 689999999999
Q ss_pred ccCCcCCCCCC-ccccccCCCcEEEeecccccccCCC-----------CcccccCCcccccCCC
Q 007668 151 ISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIPS-----------DGVLTKFSESSFFGNR 202 (594)
Q Consensus 151 l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~-----------~~~l~~l~~l~l~~N~ 202 (594)
|++|+|++..+ ..+..+++|+.|++++|++++.+|. ...+++|+.|+ +|+
T Consensus 122 l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~ 183 (198)
T 1ds9_A 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMP 183 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGG
T ss_pred CCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--Ccc
Confidence 99999997332 4789999999999999999888665 46778888775 554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.46 E-value=5.7e-14 Score=143.35 Aligned_cols=143 Identities=16% Similarity=0.115 Sum_probs=107.6
Q ss_pred CccceeEeCC----------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCC-CCcCCCCccce-eecc
Q 007668 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP-SELGNCTELQG-LSLQ 128 (594)
Q Consensus 61 c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~Ls 128 (594)
|+|..|.|+. ++++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.++++|++ +.++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 6788888853 2578889999999985555678889999999999998866565 46788888765 6667
Q ss_pred cccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeec-ccccccCCCC-ccc-ccCCcccccCCCC
Q 007668 129 SNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN-NFLVGAIPSD-GVL-TKFSESSFFGNRG 203 (594)
Q Consensus 129 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~-N~l~~~~~~~-~~l-~~l~~l~l~~N~~ 203 (594)
+|+|+...|..|..+++|++|++++|+|+...+..+....++..|++.+ |++..+++.. ..+ ..++.|++++|..
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i 166 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence 7888877778888899999999999999876666677777777888765 5666655543 333 3567778887763
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.45 E-value=8e-14 Score=148.08 Aligned_cols=125 Identities=30% Similarity=0.306 Sum_probs=83.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|.+++..+ +..+++|+.|+|++|.+++..+ +..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 242 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 4567777777777775444 6777777777777777774333 6677777777777777774333 66677777777
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
|++|++++..| +..+++|+.|++++|++++. +....+++|+.|++++|+..
T Consensus 316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQIS 366 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC
T ss_pred CcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccC
Confidence 77777776444 56667777777777777655 34456666777777766654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.44 E-value=6e-14 Score=128.18 Aligned_cols=111 Identities=17% Similarity=0.121 Sum_probs=95.5
Q ss_pred ccccCcccCCeeecccCccCCCCCCCcCCCC-ccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccC
Q 007668 90 ADLGKLDQLKFLNLHSNNFYGEIPSELGNCT-ELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ 168 (594)
Q Consensus 90 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 168 (594)
..+.++++|+.|+|++|+++ .+|. +..+. +|++|+|++|.|++. ..|..+++|++|+|++|+|+++.+..+..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 35678899999999999999 5664 55555 999999999999954 6799999999999999999985556669999
Q ss_pred CCcEEEeecccccccCC--CCcccccCCcccccCCCCC
Q 007668 169 RLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 169 ~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~l~~N~~~ 204 (594)
+|+.|+|++|+|+..++ ....+++|+.|++++|+..
T Consensus 89 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence 99999999999987665 4578999999999999854
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.6e-13 Score=142.31 Aligned_cols=119 Identities=24% Similarity=0.258 Sum_probs=80.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|.|++. | .+..+++|++|+|++|+|++ +| ++.+++|++|+|++|.|++ +| +..+++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEE
Confidence 35677777777777743 4 56777777777777777774 33 6677777777777777774 33 66777777777
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
|++|+|++ +| +..+++|+.|++++|+|++. ....+++|+.|++++|+
T Consensus 113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~ 159 (457)
T 3bz5_A 113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNK 159 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCS
T ss_pred CCCCcCCe-ec--CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCC
Confidence 77777776 33 66777777777777777764 24556666677776664
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.2e-13 Score=146.88 Aligned_cols=121 Identities=22% Similarity=0.232 Sum_probs=76.2
Q ss_pred ceeEeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCC
Q 007668 64 KGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNL 143 (594)
Q Consensus 64 ~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 143 (594)
..+. ...++|+.|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|.|++ +|. .+
T Consensus 93 ~~ip-~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l 159 (571)
T 3cvr_A 93 ISLP-ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LP 159 (571)
T ss_dssp SCCC-CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CC
T ss_pred cccc-cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cC
Confidence 3444 345778888888888885 665 554 77788888877774 554 56777777777777773 554 45
Q ss_pred CCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccC-------CcccccCCCCC
Q 007668 144 SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKF-------SESSFFGNRGL 204 (594)
Q Consensus 144 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l-------~~l~l~~N~~~ 204 (594)
++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+.++. ... +| +.|++++|+..
T Consensus 160 ~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~ 220 (571)
T 3cvr_A 160 TSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT 220 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC
T ss_pred CCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce
Confidence 667777777777766 454 44 666666666666664444 221 44 56666666543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.42 E-value=2.6e-13 Score=144.20 Aligned_cols=126 Identities=29% Similarity=0.374 Sum_probs=106.5
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++..| +..+++|++|+|++|.+++. +. +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEE
Confidence 46899999999999853 468889999999999999986554 88899999999999999954 44 88899999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c 205 (594)
|++|++++..+ +..+++|+.|+|++|++++.++ ...+++|+.|++++|+...
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCC
Confidence 99999998544 7889999999999999998776 5788999999999997554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.9e-13 Score=137.83 Aligned_cols=124 Identities=24% Similarity=0.340 Sum_probs=86.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|+|++|.+++ ++. +..+++|++|+
T Consensus 176 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~ 249 (347)
T 4fmz_A 176 LTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLE 249 (347)
T ss_dssp CTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEE
T ss_pred CCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEE
Confidence 4567777777777774332 6777777777777777774433 6777777777777777773 333 67777777777
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
|++|.+++. ..+..+++|+.|++++|++++. +....+++|+.|++++|+.
T Consensus 250 l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l 299 (347)
T 4fmz_A 250 IGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQL 299 (347)
T ss_dssp CCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCC
T ss_pred CCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcC
Confidence 777777763 4567777777777777777765 3446677777777777764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=4.2e-13 Score=145.22 Aligned_cols=103 Identities=22% Similarity=0.256 Sum_probs=94.6
Q ss_pred cCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEee
Q 007668 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVS 176 (594)
Q Consensus 97 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~ 176 (594)
.|+.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47789999999994 776 999999999999999999 899999999999999999999998 67 89999999999999
Q ss_pred cccccccC--CCCcccccCCcccccCCCCC
Q 007668 177 NNFLVGAI--PSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 177 ~N~l~~~~--~~~~~l~~l~~l~l~~N~~~ 204 (594)
+|+|++.+ .....+++|+.|++++|+..
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 99999994 45589999999999999853
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-13 Score=151.08 Aligned_cols=136 Identities=24% Similarity=0.274 Sum_probs=91.8
Q ss_pred CCcCCCCCCCCCCccceeEeC-------CCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCc
Q 007668 49 FLNQWRPEDPDPCNWKGVKCD-------KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTE 121 (594)
Q Consensus 49 ~l~~w~~~~~~~c~w~gv~c~-------~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 121 (594)
..+.|. ...+||.|+|..|. ...+++.|++++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++
T Consensus 11 ~w~~W~-~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 11 VWSAWR-RAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHHH-HTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHHHH-hcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 345564 34578888664321 1235788888888888 6676664 68888888888887 5664 4677
Q ss_pred cceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCC
Q 007668 122 LQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGN 201 (594)
Q Consensus 122 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N 201 (594)
|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|++++.. +++|+.|++++|
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N 151 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDN 151 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSS
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCC
Confidence 888888888887 5665 56777888888887776 444 456677777777777665442 366667777666
Q ss_pred CC
Q 007668 202 RG 203 (594)
Q Consensus 202 ~~ 203 (594)
+.
T Consensus 152 ~l 153 (622)
T 3g06_A 152 QL 153 (622)
T ss_dssp CC
T ss_pred cC
Confidence 53
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=137.27 Aligned_cols=130 Identities=16% Similarity=0.186 Sum_probs=90.0
Q ss_pred CccceeEeCCCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhh
Q 007668 61 CNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL 140 (594)
Q Consensus 61 c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 140 (594)
|...++.....++|++|+|++|+|++ ++ ++++++|++|+|++|+|++ ++ ++.+++|++|++++|...+.+ .+
T Consensus 95 N~l~~~~~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~ 166 (457)
T 3bz5_A 95 NKLTNLDVTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DV 166 (457)
T ss_dssp SCCSCCCCTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CC
T ss_pred CCCceeecCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--cc
Confidence 34455545556789999999999986 44 8888999999999999885 33 677777777777777544454 36
Q ss_pred hCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 141 GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 141 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
..+++|+.|+|++|+|++ +| +..+++|+.|++++|++++. ....+++|+.|++++|+.
T Consensus 167 ~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l 224 (457)
T 3bz5_A 167 TPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKL 224 (457)
T ss_dssp TTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCC
T ss_pred ccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcc
Confidence 666777777777777776 34 56666666666666666655 245566666666666653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.34 E-value=3.8e-14 Score=146.76 Aligned_cols=133 Identities=19% Similarity=0.206 Sum_probs=88.4
Q ss_pred CcEEEEEcccCCCC-CCCC---ccccCcccCCeeecccCccC--C---CCCCCcCCCCccceeeccccccc----CCCCh
Q 007668 72 KRVITLSLTNHKLS-GPIS---ADLGKLDQLKFLNLHSNNFY--G---EIPSELGNCTELQGLSLQSNYLS----GSIPS 138 (594)
Q Consensus 72 ~~l~~L~L~~n~l~-~~~~---~~~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~ 138 (594)
++|++|+|++|+|+ +.++ ..+..+++|++|+|++|+|+ | ..|..+..+++|+.|+|++|.|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 56777777777776 3333 35556677777777777776 2 34446677777777777777774 45677
Q ss_pred hhhCCCCCceEeccCCcCCCC----CCcccc--ccCCCcEEEeecccccc-----cCCCC-cccccCCcccccCCCCC
Q 007668 139 ELGNLSNLLNLDISSNSLSDY----IPPSLG--KLQRLITFNVSNNFLVG-----AIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~----~~~~~~--~l~~L~~l~l~~N~l~~-----~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
.+..+++|++|+|++|.|++. ++..+. .+++|+.|+|++|+|++ .+... ..+++|+.|++++|+..
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 777777777777777777654 344553 37777777777777776 33333 34677777777777644
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.34 E-value=3e-14 Score=144.51 Aligned_cols=130 Identities=22% Similarity=0.287 Sum_probs=84.9
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCC-CCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGE-IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.+++.|++++|.+++..+. +.++++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..+..+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5667777777777755444 44677777777777776644 566666777777777777777666666677777777777
Q ss_pred ccCC-cCCCC-CCccccccCCCcEEEeecc-ccccc--CCCCcccc-cCCcccccCCC
Q 007668 151 ISSN-SLSDY-IPPSLGKLQRLITFNVSNN-FLVGA--IPSDGVLT-KFSESSFFGNR 202 (594)
Q Consensus 151 l~~N-~l~~~-~~~~~~~l~~L~~l~l~~N-~l~~~--~~~~~~l~-~l~~l~l~~N~ 202 (594)
|++| .+++. ++..+..+++|+.|+|++| .+++. +.....++ +|+.|++++|.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~ 206 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR 206 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence 7777 56542 4555666777777777777 66642 22235566 77777777664
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.5e-12 Score=140.31 Aligned_cols=56 Identities=27% Similarity=0.215 Sum_probs=26.5
Q ss_pred CCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 144 SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 144 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+.+++....+++|+.|++++|++
T Consensus 241 ~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l 296 (622)
T 3g06_A 241 SELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPL 296 (622)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCC
T ss_pred CcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCC
Confidence 444444444444443 332 33445555555555554433334455555555555554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.33 E-value=3.7e-12 Score=134.43 Aligned_cols=117 Identities=22% Similarity=0.251 Sum_probs=70.7
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
++|+.|+|++|++++ ++.. .++|++|+|++|++++ +| .|+++++|++|++++|++++ +|..+ ++|++|+|
T Consensus 111 ~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L 180 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA 180 (454)
T ss_dssp TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred CCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence 455556666665553 2211 1567777777777774 55 47777777777777777763 55432 46677777
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
++|++++ +| .+.++++|+.|++++|++++.+.. .++|+.|++++|..
T Consensus 181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~n~l 227 (454)
T 1jl5_A 181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDL---PLSLESIVAGNNIL 227 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCC
T ss_pred cCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCC---cCcccEEECcCCcC
Confidence 7777766 44 466667777777777766654322 24566666666643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.29 E-value=8.1e-13 Score=139.47 Aligned_cols=125 Identities=20% Similarity=0.131 Sum_probs=54.8
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCcc-------------ceeecccccccCCCCh
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTEL-------------QGLSLQSNYLSGSIPS 138 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------------~~L~Ls~N~l~~~~p~ 138 (594)
++|++|++++|++ |.+|..++++++|++|+|++|.++|.+|..++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 5677777777777 4677777777777777777777776777766666543 555555555552 332
Q ss_pred hhhCCCCCceEeccCCcCCCCCCcccc----------------cc-CCCcEEEeecccccccCCCCcccccCCcccccCC
Q 007668 139 ELGNLSNLLNLDISSNSLSDYIPPSLG----------------KL-QRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGN 201 (594)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~~~~~~~----------------~l-~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N 201 (594)
. .++|++|+|++|++++ +|..+. .+ ++|++|++++|++++. |....+++|+.|++++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~l-p~~~~l~~L~~L~l~~N 163 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKL-PELQNSSFLKIIDVDNN 163 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSS
T ss_pred C---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCCC-cccCCCCCCCEEECCCC
Confidence 1 1334444444444443 222110 11 4566666666666653 34556666666666666
Q ss_pred CC
Q 007668 202 RG 203 (594)
Q Consensus 202 ~~ 203 (594)
+.
T Consensus 164 ~l 165 (454)
T 1jl5_A 164 SL 165 (454)
T ss_dssp CC
T ss_pred cC
Confidence 53
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.4e-13 Score=141.04 Aligned_cols=132 Identities=20% Similarity=0.216 Sum_probs=82.9
Q ss_pred CcEEEEEcccCCCCCCCC----ccccCcc-cCCeeecccCccCCCCCCCcCCC-----CccceeecccccccCCCChhhh
Q 007668 72 KRVITLSLTNHKLSGPIS----ADLGKLD-QLKFLNLHSNNFYGEIPSELGNC-----TELQGLSLQSNYLSGSIPSELG 141 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~ 141 (594)
++|++|+|++|.|++..+ ..|.+++ +|++|+|++|+|++..+..|..+ ++|++|+|++|.|++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 457777777777775544 5666666 77777777777776555555554 7777777777777755555433
Q ss_pred ----CC-CCCceEeccCCcCCCCCCccccc-----cCCCcEEEeecccccccCCCC-----cccc-cCCcccccCCCC
Q 007668 142 ----NL-SNLLNLDISSNSLSDYIPPSLGK-----LQRLITFNVSNNFLVGAIPSD-----GVLT-KFSESSFFGNRG 203 (594)
Q Consensus 142 ----~l-~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~l~l~~N~l~~~~~~~-----~~l~-~l~~l~l~~N~~ 203 (594)
.+ ++|++|+|++|+|++..+..+.. .++|++|+|++|+|+...... ..++ +|+.|++++|+.
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l 179 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence 33 67777777777777644444332 247777777777776432211 1222 677777777753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.29 E-value=4.1e-12 Score=129.48 Aligned_cols=125 Identities=15% Similarity=0.059 Sum_probs=104.6
Q ss_pred EEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCC-hhhhCCCCCce-Eecc
Q 007668 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIP-SELGNLSNLLN-LDIS 152 (594)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~l~ 152 (594)
++++.++++|+ .+|..+ .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|++ ++++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 35789999999 788766 4689999999999995555679999999999999999976666 46889999875 6778
Q ss_pred CCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCC
Q 007668 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNR 202 (594)
Q Consensus 153 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~ 202 (594)
+|+|+.+.|..|..+++|++|++++|+|+..++.. ....++..+++.+|.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~ 139 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI 139 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCT
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccc
Confidence 89999988899999999999999999999887654 455667777776654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=8.2e-12 Score=121.76 Aligned_cols=148 Identities=18% Similarity=0.122 Sum_probs=114.7
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceE
Q 007668 301 DIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 301 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 379 (594)
.+......|.....++.|+.+.||++... +..+++|............+.+|+++++.+. +..+.++++++......+
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34455677887888899999999998755 6889999887532222346889999999884 677888999988888899
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD------------------------------------ 423 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------ 423 (594)
+||||++|.+|.+.+.. ......++.++++++..||..
T Consensus 87 lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999999876421 122347888999999999971
Q ss_pred --------------------CCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 424 --------------------CSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 424 --------------------~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
....++|+|+++.||+++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876556799998764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-13 Score=139.89 Aligned_cols=139 Identities=19% Similarity=0.162 Sum_probs=119.4
Q ss_pred CCCccceeEeCCCCcEEEEEcccCCCCCCCCccccCc--ccCCeeecccCccCCCCCCCcCCCCccceeecccccccCC-
Q 007668 59 DPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKL--DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS- 135 (594)
Q Consensus 59 ~~c~w~gv~c~~~~~l~~L~L~~n~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~- 135 (594)
-|..|.++.|+ ...++.|++++|.+. +..+..+ ++|+.|+|++|.+.+..+. +..+++|++|+|++|.+++.
T Consensus 35 vc~~W~~~~~~-~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~ 109 (336)
T 2ast_B 35 VCKRWYRLASD-ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 109 (336)
T ss_dssp SCHHHHHHHTC-STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred HHHHHHHHhcC-chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence 34579998876 556889999999887 5667777 9999999999999977665 66899999999999999866
Q ss_pred CChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecc-ccccc-CCC-CcccccCCcccccCCC
Q 007668 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN-FLVGA-IPS-DGVLTKFSESSFFGNR 202 (594)
Q Consensus 136 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N-~l~~~-~~~-~~~l~~l~~l~l~~N~ 202 (594)
+|..+..+++|++|+|++|.+++..+..+..+++|++|+|++| .+++. .+. ...+++|+.|++++|+
T Consensus 110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 179 (336)
T ss_dssp HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT
T ss_pred HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC
Confidence 8888999999999999999999878888999999999999999 67752 333 4778999999999984
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.27 E-value=1.2e-13 Score=142.97 Aligned_cols=131 Identities=18% Similarity=0.238 Sum_probs=68.9
Q ss_pred CcEEEEEcccCCCCC----CCCccccCcccCCeeecccCccCCCCCCC----cCCC---------Cccceeeccccccc-
Q 007668 72 KRVITLSLTNHKLSG----PISADLGKLDQLKFLNLHSNNFYGEIPSE----LGNC---------TELQGLSLQSNYLS- 133 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l---------~~L~~L~Ls~N~l~- 133 (594)
++|++|+|++|.|++ .++..+.++++|++|+|++|.|+...+.. +..+ ++|++|+|++|+|+
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 456666666666654 24455555666666666666654322222 2222 56666666666655
Q ss_pred CCCC---hhhhCCCCCceEeccCCcCCC-----CCCccccccCCCcEEEeeccccc----ccC-CCCcccccCCcccccC
Q 007668 134 GSIP---SELGNLSNLLNLDISSNSLSD-----YIPPSLGKLQRLITFNVSNNFLV----GAI-PSDGVLTKFSESSFFG 200 (594)
Q Consensus 134 ~~~p---~~~~~l~~L~~L~l~~N~l~~-----~~~~~~~~l~~L~~l~l~~N~l~----~~~-~~~~~l~~l~~l~l~~ 200 (594)
+.+| ..+..+++|++|+|++|+|+. ..|..+..+++|+.|+|++|.|+ +.+ .....+++|+.|++++
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 2333 344555566666666666551 23335555666666666666653 222 2224455566666666
Q ss_pred CC
Q 007668 201 NR 202 (594)
Q Consensus 201 N~ 202 (594)
|+
T Consensus 254 n~ 255 (386)
T 2ca6_A 254 CL 255 (386)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.24 E-value=7.7e-13 Score=135.59 Aligned_cols=129 Identities=22% Similarity=0.216 Sum_probs=108.7
Q ss_pred EEEcccCCCCCCCCccccCcccCCeeecccCccCCCCC----CCcCCCC-ccceeecccccccCCCChhhhCC-----CC
Q 007668 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP----SELGNCT-ELQGLSLQSNYLSGSIPSELGNL-----SN 145 (594)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 145 (594)
.+.|+.|++++.+|..+...++|++|+|++|.|++..+ ..|..++ +|++|+|++|.|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999888888777889999999999996665 6788898 99999999999998878888776 99
Q ss_pred CceEeccCCcCCCCCCccccc----c-CCCcEEEeecccccccCCCC-----cc-cccCCcccccCCCCC
Q 007668 146 LLNLDISSNSLSDYIPPSLGK----L-QRLITFNVSNNFLVGAIPSD-----GV-LTKFSESSFFGNRGL 204 (594)
Q Consensus 146 L~~L~l~~N~l~~~~~~~~~~----l-~~L~~l~l~~N~l~~~~~~~-----~~-l~~l~~l~l~~N~~~ 204 (594)
|++|+|++|+|++..+..+.. + ++|+.|+|++|+|++..+.. .. .++|+.|++++|...
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 999999999999866665544 4 89999999999998776532 12 358999999999744
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=7.1e-11 Score=114.79 Aligned_cols=136 Identities=15% Similarity=0.062 Sum_probs=99.6
Q ss_pred CCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCe--eeeeeeEEeCCCceEEEEEcc
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY--LVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~ 385 (594)
.+....+.+.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34433333456669999998877888999987653 1245788999998886544 456888888777889999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC----------------------------------------- 424 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------------- 424 (594)
++.++. ... .+ ...++.++++.|..||...
T Consensus 98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 998884 211 12 2357788888888888531
Q ss_pred --------------CCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 425 --------------SPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 425 --------------~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877666799999875
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.11 E-value=9.2e-13 Score=139.59 Aligned_cols=131 Identities=20% Similarity=0.111 Sum_probs=71.2
Q ss_pred CcEEEEEcccCCCCCCC-----CccccCcccCCeeecccCccCCC----CCCCcCCCCccceeecccccccCCCChhhhC
Q 007668 72 KRVITLSLTNHKLSGPI-----SADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGSIPSELGN 142 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 142 (594)
++|+.|+|++|.++... +..+..+++|++|+|++|+++.. ++..+..+++|++|+|++|.+++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 56667777777665321 12223456666777776666632 4555555666666666666665433333322
Q ss_pred C-----CCCceEeccCCcCCCC----CCccccccCCCcEEEeecccccccCCCC-c-----ccccCCcccccCCC
Q 007668 143 L-----SNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAIPSD-G-----VLTKFSESSFFGNR 202 (594)
Q Consensus 143 l-----~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~-----~l~~l~~l~l~~N~ 202 (594)
. ++|++|+|++|.+++. ++..+..+++|+.|+|++|++++..+.. . ..++|+.|++++|+
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 2 4666666666666543 2344455566666666666665432211 0 13456666666664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.01 E-value=5.5e-12 Score=133.62 Aligned_cols=130 Identities=22% Similarity=0.189 Sum_probs=71.2
Q ss_pred cEEEEEcccCCCCC----CCCccccCcccCCeeecccCccCCCCCCCc-----CCCCccceeecccccccCC----CChh
Q 007668 73 RVITLSLTNHKLSG----PISADLGKLDQLKFLNLHSNNFYGEIPSEL-----GNCTELQGLSLQSNYLSGS----IPSE 139 (594)
Q Consensus 73 ~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~ 139 (594)
+|++|+|++|+|+. .++..+.++++|++|+|++|.+++..+..+ ..+++|++|+|++|.+++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 46666666666662 345566666666666666666653222221 2244566666666666642 2444
Q ss_pred hhCCCCCceEeccCCcCCCCCCcccc-----ccCCCcEEEeeccccccc-----CCCCcccccCCcccccCCC
Q 007668 140 LGNLSNLLNLDISSNSLSDYIPPSLG-----KLQRLITFNVSNNFLVGA-----IPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 140 ~~~l~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~l~l~~N~l~~~-----~~~~~~l~~l~~l~l~~N~ 202 (594)
+..+++|++|+|++|.+++..+..+. .+++|+.|+|++|.++.. +.....+++|+.|++++|+
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 238 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSB
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCc
Confidence 55556666666666666543232232 144666666666666542 1112345666666666664
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.1e-09 Score=111.96 Aligned_cols=142 Identities=17% Similarity=0.249 Sum_probs=106.9
Q ss_pred ccceeeeecceEEEEEEecCCcEEEEEeec--ccc-hhhHHHHHHHHHHHhhCC--CCeeeeeeeEEeCC---CceEEEE
Q 007668 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRID--KLN-EGFDRFFERELEILGSIK--HRYLVNLRGYCNSP---TSKLLIY 382 (594)
Q Consensus 311 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lv~ 382 (594)
..+.|+.|.++.||++...+ ..+++|+.. ... ......+.+|+++++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 34678999999999988764 578888776 322 122456888999999987 45678888888766 3478999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-------------------------------------- 424 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 424 (594)
||+++..+.+.. ...++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999998886532 233678888999999999999999720
Q ss_pred -----------------CCCeeeCCCCCCCeEecCCCc--EEEeecccccc
Q 007668 425 -----------------SPRIIHRDIKSSNILLDGNLE--ARVSDFGLAKL 456 (594)
Q Consensus 425 -----------------~~~ivH~Dlk~~NIll~~~~~--~~l~Dfgl~~~ 456 (594)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997653 68999998864
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=1e-11 Score=127.17 Aligned_cols=132 Identities=17% Similarity=0.144 Sum_probs=100.0
Q ss_pred CcEEEEEcccCCCCCCCCc-cccCcccCCeeecccCccCCCCCCCc-----CCCCccceeecccccccC----CCChhhh
Q 007668 72 KRVITLSLTNHKLSGPISA-DLGKLDQLKFLNLHSNNFYGEIPSEL-----GNCTELQGLSLQSNYLSG----SIPSELG 141 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~ 141 (594)
.+|++|+|++|.|+..-.. ....+++|+.|+|++|+|+......+ ...++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 6899999999999743222 33457899999999999974333333 346889999999999974 2455567
Q ss_pred CCCCCceEeccCCcCCCC----CCccccccCCCcEEEeecccccccCC-----CCcccccCCcccccCCCC
Q 007668 142 NLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAIP-----SDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 142 ~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~~~-----~~~~l~~l~~l~l~~N~~ 203 (594)
.+++|++|+|++|.|++. ++..+...++|+.|+|++|.|+.... .....++|+.|++++|+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 889999999999999752 24566778899999999999975322 113458899999999974
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.97 E-value=2.5e-11 Score=117.17 Aligned_cols=65 Identities=29% Similarity=0.355 Sum_probs=33.5
Q ss_pred CCCccceeecccccccC--CCChhhhCCCCCceEeccCCcCCCCCCccccccC--CCcEEEeecccccccC
Q 007668 118 NCTELQGLSLQSNYLSG--SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQ--RLITFNVSNNFLVGAI 184 (594)
Q Consensus 118 ~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~l~l~~N~l~~~~ 184 (594)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|++++..
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~ 236 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTF 236 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGC
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcccc
Confidence 34555555555555554 2334445555555555555555542 2233333 5555555555555433
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1e-09 Score=109.38 Aligned_cols=187 Identities=20% Similarity=0.201 Sum_probs=122.3
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCe--eeeeeeEEeCCC---ceEEEEEcc
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRY--LVNLRGYCNSPT---SKLLIYDFL 385 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lv~e~~ 385 (594)
.+.++.|....||++. ..+++|..... .....+.+|+++++.+. +.. +.+++....... ..++||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 46888875432 33567889999998873 322 334444433332 347899999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD------------------------------------------ 423 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 423 (594)
+|.++.+... ..++..++..++.++++.++.||..
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9998876433 2367778888888999988888851
Q ss_pred -------------CCCCeeeCCCCCCCeEecC--CCcEEEeecccccccccCCceeeee-------------eecccCcc
Q 007668 424 -------------CSPRIIHRDIKSSNILLDG--NLEARVSDFGLAKLLEDEESHITTI-------------VAGTFGYL 475 (594)
Q Consensus 424 -------------~~~~ivH~Dlk~~NIll~~--~~~~~l~Dfgl~~~~~~~~~~~~~~-------------~~gt~~y~ 475 (594)
..+.++|+|+++.||++++ +..+.++||+.+............. +....+..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 0145899999999999997 4567899999886533211000000 00000111
Q ss_pred C-ccccccCCCCccchhhhHHHHHHHHHhCCCCCC
Q 007668 476 A-PEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTD 509 (594)
Q Consensus 476 a-PE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~ 509 (594)
. |+.... .....+.|+++.++|++.+|..++.
T Consensus 256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1 222111 1223689999999999999988753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.90 E-value=1.2e-09 Score=110.01 Aligned_cols=129 Identities=14% Similarity=0.149 Sum_probs=78.7
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCC--------------------------------
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGN-------------------------------- 118 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-------------------------------- 118 (594)
..+|+.|+|.+ +++.+-+.+|.++++|+.|+|++|.+....+..|.+
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 36788999998 888666678999999999999999875343444443
Q ss_pred ----------------------------------------------CCccceeecccccccCCCChhhhCCCCCceEecc
Q 007668 119 ----------------------------------------------CTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (594)
Q Consensus 119 ----------------------------------------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 152 (594)
+++|+.|+|++|+++...+..|.++++|+.|+|.
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 3455555555555553333445555566666665
Q ss_pred CCcCCCCCCccccccCCCc-EEEeecccccccCCCC-cccccCCcccccCCC
Q 007668 153 SNSLSDYIPPSLGKLQRLI-TFNVSNNFLVGAIPSD-GVLTKFSESSFFGNR 202 (594)
Q Consensus 153 ~N~l~~~~~~~~~~l~~L~-~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~ 202 (594)
+| ++.+.+..|.++++|+ .|++.+ .++.+.+.. ..+++|+.+++.+|.
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~ 308 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDK 308 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSC
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCc
Confidence 55 5544445555666665 565555 454444433 455555555555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.86 E-value=3.1e-09 Score=107.14 Aligned_cols=102 Identities=13% Similarity=-0.012 Sum_probs=90.0
Q ss_pred cccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCc-eEeccCCcCCCCCCccccccCCCcEE
Q 007668 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLL-NLDISSNSLSDYIPPSLGKLQRLITF 173 (594)
Q Consensus 95 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~l 173 (594)
+++|+.|+|++|+++...+..|.++++|+.|+|++| ++..-+..|.++++|+ .|+|.+ .++.+.+..|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 678999999999999666678999999999999998 7756667899999999 999999 8887778999999999999
Q ss_pred EeecccccccCCCC-cccccCCcccc
Q 007668 174 NVSNNFLVGAIPSD-GVLTKFSESSF 198 (594)
Q Consensus 174 ~l~~N~l~~~~~~~-~~l~~l~~l~l 198 (594)
++++|+++.+.+.. ..+++|+.++.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EeCCCccCccchhhhcCCcchhhhcc
Confidence 99999999888765 77888887754
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.83 E-value=3.5e-11 Score=123.27 Aligned_cols=132 Identities=16% Similarity=0.093 Sum_probs=99.2
Q ss_pred CcEEEEEcccCCCCCCCCccccCc-----ccCCeeecccCccCCCCCCC-cCCCCccceeecccccccCCCChhh-----
Q 007668 72 KRVITLSLTNHKLSGPISADLGKL-----DQLKFLNLHSNNFYGEIPSE-LGNCTELQGLSLQSNYLSGSIPSEL----- 140 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~----- 140 (594)
++|+.|+|++|.|+......+... ++|++|+|++|.|+...... ...+++|+.|+|++|.|+..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 579999999999985444444433 79999999999997432222 3457789999999999985444444
Q ss_pred hCCCCCceEeccCCcCCCC----CCccccccCCCcEEEeecccccccC-----CCCcccccCCcccccCCCC
Q 007668 141 GNLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAI-----PSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 141 ~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~~-----~~~~~l~~l~~l~l~~N~~ 203 (594)
...++|++|+|++|.|++. ++..+..+++|++|+|++|.|+... ......++|+.|++++|..
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i 223 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCC
Confidence 2468899999999999752 3445577899999999999997532 1224567899999999963
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.67 E-value=1.9e-09 Score=103.96 Aligned_cols=80 Identities=26% Similarity=0.397 Sum_probs=65.5
Q ss_pred cCcccCCeeecccCccCC--CCCCCcCCCCccceeecccccccCCCChhhhCCC--CCceEeccCCcCCCCCCc------
Q 007668 93 GKLDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLS--NLLNLDISSNSLSDYIPP------ 162 (594)
Q Consensus 93 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~~~------ 162 (594)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 468899999999999997 4556777899999999999999954 3345555 999999999999976663
Q ss_pred -cccccCCCcEEE
Q 007668 163 -SLGKLQRLITFN 174 (594)
Q Consensus 163 -~~~~l~~L~~l~ 174 (594)
.+..+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 367888998875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.67 E-value=4.7e-10 Score=122.70 Aligned_cols=131 Identities=15% Similarity=0.092 Sum_probs=83.4
Q ss_pred CcEEEEEcccCCCCCCCCccccC-cccCCeeecc----cCccCCC-----CCCCcCCCCccceeecccc--cccCCCChh
Q 007668 72 KRVITLSLTNHKLSGPISADLGK-LDQLKFLNLH----SNNFYGE-----IPSELGNCTELQGLSLQSN--YLSGSIPSE 139 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~ 139 (594)
++|++|+|+.|++++..+..+.. +++|+.|+|+ .|.+++. ++..+.++++|+.|+|++| .+++..+..
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 45666666666666544444544 6677777775 5666642 2223556777777777643 355444444
Q ss_pred hh-CCCCCceEeccCCcCCC-CCCccccccCCCcEEEeeccccccc-CCCC-cccccCCcccccCCC
Q 007668 140 LG-NLSNLLNLDISSNSLSD-YIPPSLGKLQRLITFNVSNNFLVGA-IPSD-GVLTKFSESSFFGNR 202 (594)
Q Consensus 140 ~~-~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~l~l~~N~l~~~-~~~~-~~l~~l~~l~l~~N~ 202 (594)
+. .+++|+.|+|++|++++ .++..+..+++|+.|+|++|+++.. ++.. ..+++|+.|++++|+
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 43 37788888888888765 2344556778888888888887543 2222 467788888888887
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.65 E-value=3.6e-09 Score=115.57 Aligned_cols=104 Identities=13% Similarity=0.152 Sum_probs=64.9
Q ss_pred cEEEEEcccCC-CC-CCCCccccCcccCCeeecccCccCCC----CCCCcCCCCccceeeccccccc----CCCChhhhC
Q 007668 73 RVITLSLTNHK-LS-GPISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLS----GSIPSELGN 142 (594)
Q Consensus 73 ~l~~L~L~~n~-l~-~~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~ 142 (594)
+|++|+|++|. ++ ..++....++++|++|+|++|.+++. ++..+.++++|++|+|++|.++ +.++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 47777777765 21 01222233667777777777777644 2233456677777777777776 233444566
Q ss_pred CCCCceEeccCCcCCCCCCccccccCCCcEEEeec
Q 007668 143 LSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSN 177 (594)
Q Consensus 143 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~ 177 (594)
+++|+.|+|++|.+.+ +|..+..+++|+.|+++.
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 7777777777777765 556666666666666664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.57 E-value=2.5e-09 Score=98.00 Aligned_cols=111 Identities=21% Similarity=0.262 Sum_probs=70.5
Q ss_pred CCcEEEEEcccC-CCCC----CCCccccCcccCCeeecccCccCCC----CCCCcCCCCccceeecccccccCC----CC
Q 007668 71 NKRVITLSLTNH-KLSG----PISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGS----IP 137 (594)
Q Consensus 71 ~~~l~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p 137 (594)
.++|++|+|++| .|.. .+...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 456777888887 7762 1334455567778888888877531 233344556777777877777732 34
Q ss_pred hhhhCCCCCceEec--cCCcCCCC----CCccccccCCCcEEEeeccccc
Q 007668 138 SELGNLSNLLNLDI--SSNSLSDY----IPPSLGKLQRLITFNVSNNFLV 181 (594)
Q Consensus 138 ~~~~~l~~L~~L~l--~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~ 181 (594)
..+...++|++|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 45666677777777 67777642 2234445577777777777764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.48 E-value=5.3e-09 Score=114.31 Aligned_cols=129 Identities=11% Similarity=0.128 Sum_probs=72.0
Q ss_pred CcEEEEEcccCCCCCCCCcccc-CcccCCeeecc--c----CccCCCCC------CCcCCCCccceeecccccccCCCCh
Q 007668 72 KRVITLSLTNHKLSGPISADLG-KLDQLKFLNLH--S----NNFYGEIP------SELGNCTELQGLSLQSNYLSGSIPS 138 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~p------~~~~~l~~L~~L~Ls~N~l~~~~p~ 138 (594)
++|+.|.+..|++++.....+. .+++|+.|+|+ + |.++ ..| ..+.++++|+.|+|++ .+++..+.
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 3455555555555533333333 35666666666 3 4444 111 1144566677777755 45444444
Q ss_pred hhhC-CCCCceEeccCCcCCCCCCccc-cccCCCcEEEeecccccccCC--CCcccccCCcccccCCC
Q 007668 139 ELGN-LSNLLNLDISSNSLSDYIPPSL-GKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNR 202 (594)
Q Consensus 139 ~~~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~l~~N~ 202 (594)
.+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++... ....+++|+.|++++|+
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 4443 6677777777777654333333 456777777777777743322 12456777777777765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=2.4e-06 Score=84.78 Aligned_cols=136 Identities=18% Similarity=0.170 Sum_probs=93.8
Q ss_pred cceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCC---eeeeeeeEEe-CCCceEEEEEccCC
Q 007668 312 DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR---YLVNLRGYCN-SPTSKLLIYDFLPG 387 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~e~~~~ 387 (594)
.+.++.|....||+. |..+++|.-.. ......+.+|++++..+.+. .+.+.+.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356889999999987 56678887432 23356789999999999652 3556666663 44557899999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------------
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD-------------------------------------------- 423 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------------- 423 (594)
..+.+... ..++...+..++.++++.|+.||..
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876321 1234444555555555555555532
Q ss_pred -------------CCCCeeeCCCCCCCeEecC---CCc-EEEeecccccc
Q 007668 424 -------------CSPRIIHRDIKSSNILLDG---NLE-ARVSDFGLAKL 456 (594)
Q Consensus 424 -------------~~~~ivH~Dlk~~NIll~~---~~~-~~l~Dfgl~~~ 456 (594)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1336799999999999987 455 48999997764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.42 E-value=1.3e-08 Score=93.14 Aligned_cols=115 Identities=16% Similarity=0.110 Sum_probs=88.3
Q ss_pred CCccccCcccCCeeecccC-ccCC----CCCCCcCCCCccceeecccccccCC----CChhhhCCCCCceEeccCCcCCC
Q 007668 88 ISADLGKLDQLKFLNLHSN-NFYG----EIPSELGNCTELQGLSLQSNYLSGS----IPSELGNLSNLLNLDISSNSLSD 158 (594)
Q Consensus 88 ~~~~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 158 (594)
+...+...++|++|+|++| .|.. .+...+...++|++|+|++|.|... +...+...++|++|+|++|.|.+
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3345667899999999999 8863 2344567789999999999999742 34556677899999999999985
Q ss_pred C----CCccccccCCCcEEEe--ecccccccCC-----CCcccccCCcccccCCC
Q 007668 159 Y----IPPSLGKLQRLITFNV--SNNFLVGAIP-----SDGVLTKFSESSFFGNR 202 (594)
Q Consensus 159 ~----~~~~~~~l~~L~~l~l--~~N~l~~~~~-----~~~~l~~l~~l~l~~N~ 202 (594)
. +...+...++|++|+| ++|.|+..-. .....++|+.|++++|.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~ 162 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 162 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence 3 3456778889999999 8899975321 12445789999999885
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.3e-08 Score=111.27 Aligned_cols=129 Identities=16% Similarity=0.172 Sum_probs=77.2
Q ss_pred CcEEEEEcccCCCCCCCCcccc-CcccCCeeecccC-ccCCC-CCCCcCCCCccceeecccccccCCCChhhh----CCC
Q 007668 72 KRVITLSLTNHKLSGPISADLG-KLDQLKFLNLHSN-NFYGE-IPSELGNCTELQGLSLQSNYLSGSIPSELG----NLS 144 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~ 144 (594)
++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 5677777777777755555554 5777777777777 44421 333344677777777777777654444333 556
Q ss_pred CCceEeccCCcCCCCCCcc----ccccCCCcEEEeecc-cccccCCCCcccccCCcccccCC
Q 007668 145 NLLNLDISSNSLSDYIPPS----LGKLQRLITFNVSNN-FLVGAIPSDGVLTKFSESSFFGN 201 (594)
Q Consensus 145 ~L~~L~l~~N~l~~~~~~~----~~~l~~L~~l~l~~N-~l~~~~~~~~~l~~l~~l~l~~N 201 (594)
+|+.|+|++|. ..+.... +..+++|+.|+|++| .+++.+.....+++|+.|++.++
T Consensus 185 ~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 185 SLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp CCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBC
T ss_pred cCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccc
Confidence 77777777776 2111122 234577777777777 44432222245666666665544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.7e-06 Score=81.79 Aligned_cols=135 Identities=21% Similarity=0.213 Sum_probs=96.4
Q ss_pred ceeeeecce-EEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEEccCCCc
Q 007668 313 HIIGSGGFG-TVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 313 ~~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
+.+..|..| .||+.... ++..+++|+-... ....+.+|...++.+. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345566665 68987665 4567888875432 3456888999988874 3336678888888888999999999988
Q ss_pred hhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------------
Q 007668 390 LDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD---------------------------------------------- 423 (594)
Q Consensus 390 L~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------------------------- 423 (594)
+.+..... ......++.++++.|..||..
T Consensus 107 ~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 107 AFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 87765321 122334666666777777632
Q ss_pred ---------CCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 424 ---------CSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 424 ---------~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
....++|+|+.+.||++++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01248899999999999987777899999775
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=6.3e-08 Score=98.27 Aligned_cols=127 Identities=17% Similarity=0.137 Sum_probs=59.0
Q ss_pred CcEEEEEcccCC-CCCCCCccccCcccCCeeecccCccCCCCCCCcC--CCCccceeeccc--ccccCC-----CChhh-
Q 007668 72 KRVITLSLTNHK-LSGPISADLGKLDQLKFLNLHSNNFYGEIPSELG--NCTELQGLSLQS--NYLSGS-----IPSEL- 140 (594)
Q Consensus 72 ~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~- 140 (594)
++|+.|+|++|. ++ ++. + .+++|+.|+|..|.+.......+. .+++|+.|+|+. |...+. +...+
T Consensus 172 P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 172 PLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp TTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 456666665552 22 222 2 255666666666555422111222 456666666542 111111 11111
Q ss_pred -hCCCCCceEeccCCcCCCCCCcccc---ccCCCcEEEeeccccccc-----CCCCcccccCCcccccCCC
Q 007668 141 -GNLSNLLNLDISSNSLSDYIPPSLG---KLQRLITFNVSNNFLVGA-----IPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 141 -~~l~~L~~L~l~~N~l~~~~~~~~~---~l~~L~~l~l~~N~l~~~-----~~~~~~l~~l~~l~l~~N~ 202 (594)
..+++|+.|+|++|.+.+..+..+. .+++|++|+|+.|.|+.. ......+++|+.|++++|.
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence 2355666666666665532222222 355666666666666542 1111345566666665553
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.3e-06 Score=88.82 Aligned_cols=80 Identities=8% Similarity=0.049 Sum_probs=55.3
Q ss_pred cee-eeecceEEEEEEec-------CCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCC---CeeeeeeeEEeCC---
Q 007668 313 HII-GSGGFGTVYKLAMD-------DGNVFALKRIDKLN---EGFDRFFERELEILGSIKH---RYLVNLRGYCNSP--- 375 (594)
Q Consensus 313 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~--- 375 (594)
+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998765 26678888765432 1012457788888887742 3466777777654
Q ss_pred CceEEEEEccCCCchhh
Q 007668 376 TSKLLIYDFLPGGSLDE 392 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~ 392 (594)
...++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.30 E-value=9.3e-07 Score=91.20 Aligned_cols=126 Identities=14% Similarity=0.150 Sum_probs=98.4
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccccccc-----CCCChhhhCCCCC
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLS-----GSIPSELGNLSNL 146 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L 146 (594)
.+|+.|+|.+| ++.+-..+|.+ .+|+.+.| .|.++...+..|.++++|+.++|.+|.+. ..-+..|.++++|
T Consensus 226 ~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 226 SQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 57888888875 66455667777 78999999 45566566778999999999999888775 3456678999999
Q ss_pred ceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCC
Q 007668 147 LNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRG 203 (594)
Q Consensus 147 ~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~ 203 (594)
+.++|. |.++.+-...|.++++|+.|+|.+| ++.+.... ..+ +|+.+.+.+|..
T Consensus 303 ~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~ 357 (401)
T 4fdw_A 303 ARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTP 357 (401)
T ss_dssp CEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSC
T ss_pred CeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCC
Confidence 999998 4587767788999999999999655 76665554 556 899999988853
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.27 E-value=1.1e-06 Score=90.78 Aligned_cols=125 Identities=14% Similarity=0.084 Sum_probs=103.0
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+|+.+.|.++ ++.+-...|.++++|+.|+|.+| ++..-...|.+ .+|+.+.| .|.++..-+..|.++++|+.+++
T Consensus 203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE
T ss_pred cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEe
Confidence 57889999854 77667779999999999999986 56456667877 89999999 55677566778999999999999
Q ss_pred cCCcCC-----CCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCC
Q 007668 152 SSNSLS-----DYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGN 201 (594)
Q Consensus 152 ~~N~l~-----~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N 201 (594)
.+|.+. .+.+..|.++++|+.++|. |.++.+.... ..+.+|+.+.+..|
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 999876 4567889999999999999 5587776655 67899999999766
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=2.2e-07 Score=94.30 Aligned_cols=130 Identities=18% Similarity=0.220 Sum_probs=89.2
Q ss_pred CCcEEEEEcccCCCCCCCCcccc--CcccCCeeeccc--CccCCC-----CCCCc--CCCCccceeecccccccCCCChh
Q 007668 71 NKRVITLSLTNHKLSGPISADLG--KLDQLKFLNLHS--NNFYGE-----IPSEL--GNCTELQGLSLQSNYLSGSIPSE 139 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~ 139 (594)
..+|+.|+|..+.++......+. .+|+|+.|+|+. |...+. +...+ ..+++|++|+|++|.+++..+..
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHH
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHH
Confidence 46899999999988743333343 789999999963 222111 11122 35799999999999998554444
Q ss_pred hh---CCCCCceEeccCCcCCCC----CCccccccCCCcEEEeecccccccCCCCccccc-C-CcccccCCC
Q 007668 140 LG---NLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTK-F-SESSFFGNR 202 (594)
Q Consensus 140 ~~---~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~-l-~~l~l~~N~ 202 (594)
+. .+++|++|+|+.|.|++. ++..+..+++|+.|+|++|.|+... ...+.+ + ..+++++|+
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~--~~~l~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM--KKELQKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH--HHHHHHHCCSEEECCSBC
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH--HHHHHHHcCCEEEecCCc
Confidence 43 578999999999999863 3445567899999999999886431 122332 2 346666665
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=3.7e-05 Score=77.31 Aligned_cols=138 Identities=21% Similarity=0.320 Sum_probs=79.1
Q ss_pred ceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-----CCeeeeee-e--EEeCCCceEEEEEc
Q 007668 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-----HRYLVNLR-G--YCNSPTSKLLIYDF 384 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-g--~~~~~~~~~lv~e~ 384 (594)
+.|+.|..+.||++...+| .+++|+.... ...+..|.+++..+. .|.++... | +....+..+++++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566678899999887655 4889988752 123344555555442 34443311 1 11235567899999
Q ss_pred cCCCchh--------------hhhhhcCC-------------CCCHHHH-------------------------------
Q 007668 385 LPGGSLD--------------EALHERSE-------------QLDWDAR------------------------------- 406 (594)
Q Consensus 385 ~~~gsL~--------------~~l~~~~~-------------~l~~~~~------------------------------- 406 (594)
++|..+. ..+|.... ...|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986543 11221100 0123211
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 407 LNIIMGAAKGLAYLHH----------DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 407 ~~i~~~ia~~L~~LH~----------~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
..+...+..++.+|++ .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666653 025689999999999999878899999999764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=7.4e-06 Score=69.80 Aligned_cols=60 Identities=15% Similarity=0.209 Sum_probs=34.8
Q ss_pred eEeccCCcCC-CCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCcc
Q 007668 148 NLDISSNSLS-DYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 148 ~L~l~~N~l~-~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
.++-+++.|+ ..+|..+. ++|+.|+|++|+|+.+++.. ..+++|+.|+|.+|||.|+|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l 73 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL 73 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence 4555555554 11443221 24566666666666555544 4566667777788888888775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=3.2e-05 Score=79.70 Aligned_cols=75 Identities=11% Similarity=-0.016 Sum_probs=48.6
Q ss_pred cceeeeecceEEEEEEec-CCcEEEEEeecccch-------hhHHHHHHHHHHHhhCCC--Ce-eeeeeeEEeCCCceEE
Q 007668 312 DHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-------GFDRFFERELEILGSIKH--RY-LVNLRGYCNSPTSKLL 380 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~g~~~~~~~~~l 380 (594)
.+.||.|.++.||++... ++..++||....... .....+..|.+++..+.. +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999754 467899997653211 123456778888887742 33 3345543 3445689
Q ss_pred EEEccCCC
Q 007668 381 IYDFLPGG 388 (594)
Q Consensus 381 v~e~~~~g 388 (594)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.90 E-value=2.5e-06 Score=76.25 Aligned_cols=83 Identities=12% Similarity=0.115 Sum_probs=42.9
Q ss_pred cCCeeecccCccCCCCCCCcCCCCccceeeccccc-ccCCCChhhhCC----CCCceEeccCCc-CCCCCCccccccCCC
Q 007668 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNY-LSGSIPSELGNL----SNLLNLDISSNS-LSDYIPPSLGKLQRL 170 (594)
Q Consensus 97 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~~~~~~~l~~L 170 (594)
+|+.|||+++.|+..--..+.++++|+.|+|++|. |+..--..+..+ ++|++|+|+++. |++.--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555543322334556666666666653 443222233332 356666666653 554222345566666
Q ss_pred cEEEeeccc
Q 007668 171 ITFNVSNNF 179 (594)
Q Consensus 171 ~~l~l~~N~ 179 (594)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.86 E-value=9e-05 Score=72.62 Aligned_cols=77 Identities=14% Similarity=0.196 Sum_probs=56.3
Q ss_pred CccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCC---CeeeeeeeEEeCCCceEEEEEccC
Q 007668 310 DDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH---RYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
...+.+|.|..+.||+....+|+.+++|+-..........|.+|++.|+.+.- -.+.+++++. ..++||||++
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~ 93 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence 34567899999999999999999999998765444444568899999888842 1234444432 3478999998
Q ss_pred CCch
Q 007668 387 GGSL 390 (594)
Q Consensus 387 ~gsL 390 (594)
.+..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00015 Score=71.66 Aligned_cols=137 Identities=16% Similarity=0.195 Sum_probs=92.0
Q ss_pred ccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC---CCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK---HRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 311 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
..+.|+.|....+|+... ++..+++|+.... ....+.+|++.|+.+. ...+.+++.++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 446789999999999876 4677888876542 2567888999888873 36677888888777889999999998
Q ss_pred Cchhh-----------hhhhcCC---------------------CCCHHHHH---HHHH----------------HHHHH
Q 007668 388 GSLDE-----------ALHERSE---------------------QLDWDARL---NIIM----------------GAAKG 416 (594)
Q Consensus 388 gsL~~-----------~l~~~~~---------------------~l~~~~~~---~i~~----------------~ia~~ 416 (594)
..+.. .+|.... .-+|.... ++.. .+.+-
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76532 2232111 12454332 1111 11111
Q ss_pred -HHHhhh-cCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 417 -LAYLHH-DCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 417 -L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223321 1256899999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.65 E-value=8.3e-06 Score=72.83 Aligned_cols=87 Identities=11% Similarity=0.072 Sum_probs=66.5
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCc-cCCCCCCCcCCC----Cccceeeccccc-ccCCCChhhhCCCC
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNN-FYGEIPSELGNC----TELQGLSLQSNY-LSGSIPSELGNLSN 145 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 145 (594)
-+|+.|||+++.|+..--..+.++++|+.|+|+++. |+..--..+..+ ++|++|+|++|. |+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999885444567899999999999985 663222335554 479999999984 87544455788999
Q ss_pred CceEeccCCc-CCC
Q 007668 146 LLNLDISSNS-LSD 158 (594)
Q Consensus 146 L~~L~l~~N~-l~~ 158 (594)
|++|+|++.. +++
T Consensus 141 L~~L~L~~c~~Itd 154 (176)
T 3e4g_A 141 LKYLFLSDLPGVKE 154 (176)
T ss_dssp CCEEEEESCTTCCC
T ss_pred CCEEECCCCCCCCc
Confidence 9999999975 553
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00064 Score=62.13 Aligned_cols=148 Identities=13% Similarity=0.100 Sum_probs=96.5
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
.-+|.+.|...+.++++++++.++.|.+.+|.-+-.. ... ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3489999998899999999999999999998776211 001 1233457999999999998774 1110
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCHH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (594)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-+... +
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~---------------------------------e 141 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEER---------------------------------E 141 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEE---------------------------------C
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccch---------------------------------h
Confidence 0123466888763 456788899999999999997555422110 1
Q ss_pred HHHHHHHHHHHcccC-------------------------CCCCCCCHHHHHHHHhcccCCCC
Q 007668 547 SLDALLAVATQCVSS-------------------------SPDDRPTMHRVVQILESEVMTPC 584 (594)
Q Consensus 547 ~~~~l~~l~~~cl~~-------------------------dP~~RPs~~ev~~~L~~~~~~~~ 584 (594)
.+..|-+|+..|... .+..|++.++|++..+..+..+.
T Consensus 142 LS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~ps 204 (229)
T 2yle_A 142 LSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTES 204 (229)
T ss_dssp CCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSSSGG
T ss_pred hCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhccCcc
Confidence 113344444444433 45789999999999998887653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00013 Score=75.10 Aligned_cols=112 Identities=13% Similarity=0.182 Sum_probs=75.1
Q ss_pred CCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccc
Q 007668 87 PISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGK 166 (594)
Q Consensus 87 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 166 (594)
+-...|.+.++|+.+.+.++..+ .....|.++++|+.+.+. +.++..-...|.++++|+.++|..| ++.+-..+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 33456777778888887766554 555667778888888875 4455344456777788888888654 55555667778
Q ss_pred cCCCcEEEeecccccccCCCC-cccccCCcccccCCC
Q 007668 167 LQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNR 202 (594)
Q Consensus 167 l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~ 202 (594)
+.+|+.+.|..+ ++.+.... ..+.+|+.+.+.+|.
T Consensus 333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 888888887544 55444433 566777777777765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00056 Score=70.84 Aligned_cols=79 Identities=10% Similarity=0.057 Sum_probs=47.5
Q ss_pred CCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeeeeeecccCccCccccccC---CCCccchhhhHHHHHHHH
Q 007668 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG---RATEKTDVYSFGVLVLEV 501 (594)
Q Consensus 425 ~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~vl~el 501 (594)
...++|+|+++.|||++.++ ++++||+.+..-.....-......-...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 56899999999999998776 99999998875332110000000001345666654311 112234556777777777
Q ss_pred HhC
Q 007668 502 LSG 504 (594)
Q Consensus 502 ltg 504 (594)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00017 Score=61.28 Aligned_cols=37 Identities=24% Similarity=0.241 Sum_probs=21.2
Q ss_pred CCceEeccCCcCCCCCCccccccCCCcEEEeeccccc
Q 007668 145 NLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLV 181 (594)
Q Consensus 145 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~ 181 (594)
+|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555555544455555666666666666554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00046 Score=68.62 Aligned_cols=157 Identities=18% Similarity=0.178 Sum_probs=87.7
Q ss_pred CCCHHHHHHHhcCCCcc-----ceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCe--eeee
Q 007668 296 PYSSKDIIKKLETLDDD-----HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRY--LVNL 368 (594)
Q Consensus 296 ~~~~~~~~~~~~~~~~~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l 368 (594)
.++.+++......|... +.|+.|....+|+....+| .+++|...... ....+..|+.++..+.... +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 35566776666666542 3466788899999887766 57888776521 1234556777776663211 2233
Q ss_pred eeE------EeCCCceEEEEEccCCCchhh--------------hhhhcCC----C----C---CHHHHHH---------
Q 007668 369 RGY------CNSPTSKLLIYDFLPGGSLDE--------------ALHERSE----Q----L---DWDARLN--------- 408 (594)
Q Consensus 369 ~g~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~----l---~~~~~~~--------- 408 (594)
+.. ....+..+++++|++|..+.. .+|.... . . .|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 112345689999998865421 1221100 0 1 1322111
Q ss_pred ---HHHHHHHHHHHhhhc----CCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 409 ---IIMGAAKGLAYLHHD----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 409 ---i~~~ia~~L~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
+...+.+.+.++++. ...+++|+|+.+.||+++++..+.++||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001134445555432 13479999999999999987556899998765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.38 E-value=1.4e-05 Score=72.73 Aligned_cols=62 Identities=13% Similarity=0.248 Sum_probs=27.2
Q ss_pred CcEEEEEcccC-CCCC----CCCccccCcccCCeeecccCccCC----CCCCCcCCCCccceeeccccccc
Q 007668 72 KRVITLSLTNH-KLSG----PISADLGKLDQLKFLNLHSNNFYG----EIPSELGNCTELQGLSLQSNYLS 133 (594)
Q Consensus 72 ~~l~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 133 (594)
..|++|+|++| +|.. .+.+.+..-+.|+.|+|++|+|.. .+...+..-+.|+.|+|++|.|.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 34555555553 4431 122233334455555555555541 11122223344555555555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00043 Score=70.62 Aligned_cols=125 Identities=14% Similarity=0.109 Sum_probs=83.6
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEecc
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDIS 152 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 152 (594)
+++.+.+..+ ++.+....|.+..+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++++|+.+.+.
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~ 294 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMD 294 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEEC
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccc
Confidence 3444544433 33244456677778888888765 55355566778888888888654 443444567888888888888
Q ss_pred CCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCC
Q 007668 153 SNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGN 201 (594)
Q Consensus 153 ~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N 201 (594)
+|.++.+-...|.++.+|+.+.|..+ ++.+.... ..+.+|+.+.+..|
T Consensus 295 ~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 295 NSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred ccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 88887766778888888888888654 65554443 56677777777544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00079 Score=66.23 Aligned_cols=74 Identities=9% Similarity=0.046 Sum_probs=44.4
Q ss_pred CCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCee-eeeeeEEeCCCceEEEEEcc-C
Q 007668 309 LDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL-VNLRGYCNSPTSKLLIYDFL-P 386 (594)
Q Consensus 309 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~-~ 386 (594)
+...+.|+.|....+|+. ..+++|+........ ....+|+.+++.+....+ .+++++. ...-++|+||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 333678999999999998 457888765432211 123457777766642222 3455443 33457899999 5
Q ss_pred CCch
Q 007668 387 GGSL 390 (594)
Q Consensus 387 ~gsL 390 (594)
+.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 5544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00043 Score=71.02 Aligned_cols=124 Identities=8% Similarity=0.095 Sum_probs=86.8
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+|+.+.+.++..+ +-...|.++++|+.+.+. +.++......|.++++|+.++|..| ++..-...|.++++|+.+.|
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 45667777665444 556688899999999996 4566455678999999999999865 66455677999999999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGN 201 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N 201 (594)
..| ++.+-..+|.++++|+.+++.+|.... .......+|+.+.+..|
T Consensus 342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp CTT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC--------
T ss_pred Ccc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCC
Confidence 755 776667889999999999999886542 12234455666655444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0011 Score=68.83 Aligned_cols=72 Identities=17% Similarity=0.192 Sum_probs=48.6
Q ss_pred ceeeeecceEEEEEEecC--------CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCee-eeeeeEEeCCCceEEEEE
Q 007668 313 HIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL-VNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 383 (594)
+.|+.|....+|++...+ +..+++|+.... .....+.+|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 568889999999998753 478888877432 111445578888888743333 556666542 38999
Q ss_pred ccCCCch
Q 007668 384 FLPGGSL 390 (594)
Q Consensus 384 ~~~~gsL 390 (594)
|+++.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00055 Score=70.22 Aligned_cols=84 Identities=11% Similarity=0.086 Sum_probs=52.5
Q ss_pred CcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccC
Q 007668 115 ELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKF 193 (594)
Q Consensus 115 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l 193 (594)
.|..+.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++.+-..+|.++.+|+.+++..| ++.+.... ..+.+|
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence 4566666777776554 44333455777777777777643 55555567777777777777665 55554443 556677
Q ss_pred CcccccCC
Q 007668 194 SESSFFGN 201 (594)
Q Consensus 194 ~~l~l~~N 201 (594)
+.+.+..|
T Consensus 369 ~~i~lp~~ 376 (394)
T 4fs7_A 369 KKVELPKR 376 (394)
T ss_dssp CEEEEEGG
T ss_pred CEEEECCC
Confidence 77766544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.005 Score=61.13 Aligned_cols=156 Identities=12% Similarity=0.114 Sum_probs=88.5
Q ss_pred CCHHHHHHHhcCCCc-----cceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCC--eeeeee
Q 007668 297 YSSKDIIKKLETLDD-----DHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR--YLVNLR 369 (594)
Q Consensus 297 ~~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~ 369 (594)
.+.+.+....+.|.. ...++ |....||++...+|+.+++|....... ....+..|..++..+... .+.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence 445566655555532 23466 888899998877787899998763211 234567788887776421 234444
Q ss_pred eE-----EeCCCceEEEEEccCCCchhh--------------hhhhc--------CCCCCHHHH----HHH---------
Q 007668 370 GY-----CNSPTSKLLIYDFLPGGSLDE--------------ALHER--------SEQLDWDAR----LNI--------- 409 (594)
Q Consensus 370 g~-----~~~~~~~~lv~e~~~~gsL~~--------------~l~~~--------~~~l~~~~~----~~i--------- 409 (594)
.. ....+..+++++|+++..+.. .+|.. ....++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 33 112344578999998765421 01210 011222211 001
Q ss_pred ------HHHHHHHHHHhhhc----CCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 410 ------IMGAAKGLAYLHHD----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 410 ------~~~ia~~L~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
...+...+..+... ....++|+|+++.||+++ + .+.++||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01111222222211 145689999999999999 4 899999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0031 Score=62.84 Aligned_cols=139 Identities=15% Similarity=0.120 Sum_probs=71.1
Q ss_pred ceeeeecceE-EEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCC--CeeeeeeeEEeCCCceEEEEEccCCCc
Q 007668 313 HIIGSGGFGT-VYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH--RYLVNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 313 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
+.|+.|.... +|+....++..+++|....... ..+..|+.++..+.. -.+.+++.+..+. . +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~-g-~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR-G-LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT-T-EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC-C-EEEEeeCCCcc
Confidence 4566665554 6677654467777775543221 234456666666532 2344566554333 2 78999997766
Q ss_pred hhhhhhhc---------------------C----CCCCHHHHH-------HH-------------HHHHHHHHHHhhh--
Q 007668 390 LDEALHER---------------------S----EQLDWDARL-------NI-------------IMGAAKGLAYLHH-- 422 (594)
Q Consensus 390 L~~~l~~~---------------------~----~~l~~~~~~-------~i-------------~~~ia~~L~~LH~-- 422 (594)
+.+.+... . ..++..... .+ ...+...+..+.+
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65433210 0 112211110 00 0011122222211
Q ss_pred -cCCCCeeeCCCCCCCeEecCC----CcEEEeecccccc
Q 007668 423 -DCSPRIIHRDIKSSNILLDGN----LEARVSDFGLAKL 456 (594)
Q Consensus 423 -~~~~~ivH~Dlk~~NIll~~~----~~~~l~Dfgl~~~ 456 (594)
.....++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 114579999999999999874 6899999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0021 Score=65.24 Aligned_cols=139 Identities=14% Similarity=0.158 Sum_probs=82.4
Q ss_pred ceeeeecceEEEEEEecC--------CcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEE
Q 007668 313 HIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 383 (594)
+.+..|-...+|+....+ +..+++|+..... .....+.+|.++++.+. +.-..++++++.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567778889999987652 4788888753322 22455668999888774 3223566666654 39999
Q ss_pred ccCCCchhhh-----------------hhhc----CCCCC--HHHHHHHHHHHHH-------------------HHHHhh
Q 007668 384 FLPGGSLDEA-----------------LHER----SEQLD--WDARLNIIMGAAK-------------------GLAYLH 421 (594)
Q Consensus 384 ~~~~gsL~~~-----------------l~~~----~~~l~--~~~~~~i~~~ia~-------------------~L~~LH 421 (594)
|++|..+... +|.- ..... |.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9987665421 1111 11122 4555555544422 123332
Q ss_pred h----c-CCCCeeeCCCCCCCeEecCC----CcEEEeecccccc
Q 007668 422 H----D-CSPRIIHRDIKSSNILLDGN----LEARVSDFGLAKL 456 (594)
Q Consensus 422 ~----~-~~~~ivH~Dlk~~NIll~~~----~~~~l~Dfgl~~~ 456 (594)
+ . ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 1 13478999999999999876 7899999987753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0012 Score=67.68 Aligned_cols=124 Identities=8% Similarity=-0.004 Sum_probs=71.2
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.+|+++.|.+ .++.+-..+|.++++|+.++|.+| ++..-...|.++++|+.+.+..+--. .-...|.++..+.....
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~-i~~~aF~~~~~~~~~~~ 147 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKS-IGVEAFKGCDFKEITIP 147 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCE-ECTTTTTTCCCSEEECC
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceee-ecceeeecccccccccC
Confidence 5788888864 466455567888888888888755 55344566788888888777655222 33344444433322222
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGN 201 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N 201 (594)
.. +..+....|.++++|+.+.+.++. ..+.... ..+.+|+.+.+..|
T Consensus 148 ~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~ 195 (394)
T 4fs7_A 148 EG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN 195 (394)
T ss_dssp TT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT
T ss_pred cc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC
Confidence 22 122233556667777777765543 2233322 45566666666555
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00087 Score=68.28 Aligned_cols=108 Identities=13% Similarity=0.118 Sum_probs=86.9
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
..|+.+.+..+ ++.+-...|.+..+|+.+.+..+ +.......|.++++|+.+.+.+|.++..-...|.++++|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 56788888765 66455678899999999999765 55355568999999999999999998555678999999999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeeccccccc
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGA 183 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~ 183 (594)
..| ++.+-..+|.++++|+.+.+..| ++.+
T Consensus 318 p~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I 347 (379)
T 4h09_A 318 PTA-LKTIQVYAFKNCKALSTISYPKS-ITLI 347 (379)
T ss_dssp CTT-CCEECTTTTTTCTTCCCCCCCTT-CCEE
T ss_pred Ccc-ccEEHHHHhhCCCCCCEEEECCc-cCEE
Confidence 765 77666788999999999988654 4433
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0028 Score=64.23 Aligned_cols=73 Identities=16% Similarity=0.154 Sum_probs=42.8
Q ss_pred ceeeeecceEEEEEEecC---------CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCe-eeeeeeEEeCCCceEEEE
Q 007668 313 HIIGSGGFGTVYKLAMDD---------GNVFALKRIDKLNEGFDRFFERELEILGSIKHRY-LVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~ 382 (594)
+.|+.|....+|+....+ +..+++|+........ .....|.+++..+...+ +.++++... -++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 467788889999987654 2678888765432211 12356777777774223 345555441 36899
Q ss_pred EccCCCch
Q 007668 383 DFLPGGSL 390 (594)
Q Consensus 383 e~~~~gsL 390 (594)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0086 Score=62.37 Aligned_cols=74 Identities=16% Similarity=0.148 Sum_probs=47.2
Q ss_pred cceeeeecceEEEEEEecC-CcEEEEEeecccchhhHHHHHHHHHHHhhCCCCee-eeeeeEEeCCCceEEEEEccCCCc
Q 007668 312 DHIIGSGGFGTVYKLAMDD-GNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL-VNLRGYCNSPTSKLLIYDFLPGGS 389 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gs 389 (594)
.+.|+.|-...+|++...+ +..+++|+........ -...+|..++..+...++ .++++.+. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578889999999998765 4778888764322111 112578888888864444 45666663 2 35999998755
Q ss_pred h
Q 007668 390 L 390 (594)
Q Consensus 390 L 390 (594)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.00029 Score=64.02 Aligned_cols=87 Identities=18% Similarity=0.191 Sum_probs=62.5
Q ss_pred ccCcccCCeeecccC-ccCC----CCCCCcCCCCccceeecccccccC----CCChhhhCCCCCceEeccCCcCCCC---
Q 007668 92 LGKLDQLKFLNLHSN-NFYG----EIPSELGNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISSNSLSDY--- 159 (594)
Q Consensus 92 ~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~--- 159 (594)
+.+-+.|+.|+|++| +|.. .+-+.+..-+.|+.|+|++|+|.. .+...+..-+.|+.|+|++|.|.+.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344578999999986 7752 233456677899999999999983 2344555668899999999999742
Q ss_pred -CCccccccCCCcEEEeecc
Q 007668 160 -IPPSLGKLQRLITFNVSNN 178 (594)
Q Consensus 160 -~~~~~~~l~~L~~l~l~~N 178 (594)
+-..+..-+.|+.|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 1234455567999999865
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0072 Score=60.41 Aligned_cols=32 Identities=22% Similarity=0.335 Sum_probs=27.8
Q ss_pred CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 425 ~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
...++|+|+.+.||++++++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35799999999999999888899999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.086 Score=54.08 Aligned_cols=138 Identities=17% Similarity=0.185 Sum_probs=81.8
Q ss_pred ceeeeecceEEEEEEecC--------CcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEE
Q 007668 313 HIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 383 (594)
+.+..|-...+|+....+ +..+++++........ -...+|.++++.+. +.-..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 567788889999987763 5778888764432211 12356787777774 222345555432 378999
Q ss_pred ccCCCchhhh-----------------hhh--c---------CCC-CCHHHHHHHHHHHH-------------------H
Q 007668 384 FLPGGSLDEA-----------------LHE--R---------SEQ-LDWDARLNIIMGAA-------------------K 415 (594)
Q Consensus 384 ~~~~gsL~~~-----------------l~~--~---------~~~-l~~~~~~~i~~~ia-------------------~ 415 (594)
|+++..|... +|. . ... .-|.++.++..++- .
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9988764310 111 0 001 12444444433221 2
Q ss_pred HHHHhhh---------------------cCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 416 GLAYLHH---------------------DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 416 ~L~~LH~---------------------~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
.+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233321 11346899999999999 7888999999998763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.46 E-value=0.26 Score=50.25 Aligned_cols=30 Identities=27% Similarity=0.390 Sum_probs=25.0
Q ss_pred CeeeCCCCCCCeEe------cCCCcEEEeecccccc
Q 007668 427 RIIHRDIKSSNILL------DGNLEARVSDFGLAKL 456 (594)
Q Consensus 427 ~ivH~Dlk~~NIll------~~~~~~~l~Dfgl~~~ 456 (594)
.++|+|+.+.||++ +++..+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4566799999988763
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.26 E-value=0.3 Score=31.82 Aligned_cols=28 Identities=21% Similarity=0.240 Sum_probs=12.2
Q ss_pred eeehhhhhHHHHHHHHhhhhceeecccc
Q 007668 244 ISASATVGALLLVALMCFWGCFLYKKLG 271 (594)
Q Consensus 244 i~~~~~~~~~ll~~~~~~~~~~~~~~~~ 271 (594)
+++.++++++++++++..++++.++++.
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 3344444455544444444334444333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.65 E-value=2.3 Score=38.79 Aligned_cols=116 Identities=13% Similarity=0.088 Sum_probs=79.3
Q ss_pred CCCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeeeCCCCCCCeE
Q 007668 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA-YLHHDCSPRIIHRDIKSSNIL 439 (594)
Q Consensus 361 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivH~Dlk~~NIl 439 (594)
.||++ -..+-.+++...+.|+.-+++.=...++ ..+...+++++.+|+.... +++ .-+|--+.|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 67887 3444466777777777654544344443 3788899999999988777 666 4578889999999
Q ss_pred ecCCCcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCc
Q 007668 440 LDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA 510 (594)
Q Consensus 440 l~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 510 (594)
++.++.+++.-.|+-..+ +|.- .++.-=.-.+=+++..++.++..|+.
T Consensus 117 f~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp ECTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EeCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999877754432 2221 11111233566788888888887654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.61 E-value=1.7 Score=39.51 Aligned_cols=117 Identities=11% Similarity=0.135 Sum_probs=80.0
Q ss_pred CCCeeeeeeeEEeCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 361 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
.||++++. .+-.+.+...+.|+.-+.+.=...+ ...+...+++++.+|+..-.+++ .=+|--+.|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEEE
Confidence 68888866 4555666655666644433222223 33788999999999999887777 34788899999999
Q ss_pred cCCCcEEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCc
Q 007668 441 DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDA 510 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~ 510 (594)
+.++.+++.-.|+...+.+ . ..++..=.-.+=+++..+++++..|+.
T Consensus 113 ~~~~~p~i~~RGik~~l~P------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVDP------------------L-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp CTTSCEEESCCEETTTBSC------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred cCCCCEEEEEccCccCCCC------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999987775433222 1 112222234567888999999988765
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.12 E-value=0.35 Score=31.45 Aligned_cols=28 Identities=21% Similarity=0.287 Sum_probs=12.1
Q ss_pred eeehhhhhHHHHHHHHhhhhceeecccc
Q 007668 244 ISASATVGALLLVALMCFWGCFLYKKLG 271 (594)
Q Consensus 244 i~~~~~~~~~ll~~~~~~~~~~~~~~~~ 271 (594)
+++.++++++++++++..++++.++|+.
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 3344444455544444443333433333
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 594 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-17 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 8e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-71
Identities = 74/272 (27%), Positives = 135/272 (49%), Gaps = 22/272 (8%)
Query: 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
IGSG FGTVYK G+V A+K ++ + F+ E+ +L +H ++ G
Sbjct: 14 QRIGSGSFGTVYK-GKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
Y +P ++ + G SL LH + + ++I A+G+ YLH IIH
Sbjct: 72 YSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAPEYMQ---SGRAT 486
RD+KS+NI L +L ++ DFGLA + SH ++G+ ++APE ++ +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 487 EKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSE 546
++DVY+FG+++ E+++G+ P +N + F++ R + P+ V+S
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMV----GRGYLSPDLSKVRSN 237
Query: 547 SLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
A+ + +C+ D+RP +++ +E
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-65
Identities = 72/285 (25%), Positives = 132/285 (46%), Gaps = 29/285 (10%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERE 353
++P + ++++ +G+G FG V+ + A+K + + + D F E
Sbjct: 9 EVPRETLKLVER---------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-LAE 58
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMG 412
++ ++H+ LV L +I +++ GSL + L S +L + L++
Sbjct: 59 ANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
A+G+A++ IHRD++++NIL+ L +++DFGLA+L+ED E
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQ 532
+ APE + G T K+DV+SFG+L+ E+++ R G+ + L E
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-----PGMTNPEVIQNL--ERGY 227
Query: 533 REIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
R + NC + L + C P+DRPT + +LE
Sbjct: 228 RMVRPDNCP-------EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 3e-64
Identities = 63/288 (21%), Positives = 111/288 (38%), Gaps = 28/288 (9%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
IG G FG V++ G A+K E F E E+ ++H ++ N
Sbjct: 11 IGKGRFGEVWR-GKWRGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 375 PTSKL----LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC-----S 425
L+ D+ GSL + L+ + + + + + + A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI---TTIVAGTFGYLAPEYMQS 482
P I HRD+KS NIL+ N ++D GLA + I GT Y+APE +
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 483 ------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEK----GLNIVGWLNFLISEDRQ 532
+ ++ D+Y+ G++ E+ + L + +
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 533 REIIDPNCEG--VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ + PN E+L + + +C ++ R T R+ + L
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-63
Identities = 69/287 (24%), Positives = 127/287 (44%), Gaps = 27/287 (9%)
Query: 300 KDIIKKLETLD-DDHIIGSGGFGTVYK---LAMDDGNVFALKRIDK-LNEGFDRFFEREL 354
K + K + L D +G G FG+V + A+K + + + RE
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 355 EILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAA 414
+I+ + + Y+V L G C + + +L+ + GG L + L + E++ ++ +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 415 KGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT--TIVAGTF 472
G+ YL +HRD+ + N+LL A++SDFGL+K L ++S+ T +
Sbjct: 120 MGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 473 GYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDR 531
+ APE + + + ++DV+S+GV + E LS G++P + + + E
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI--------EQG 228
Query: 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
+R P C L A+ + C +DRP V Q + +
Sbjct: 229 KRMECPPEC-------PPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-62
Identities = 63/263 (23%), Positives = 114/263 (43%), Gaps = 18/263 (6%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
IGSG FG V+ + + A+K I + + F E E++ + H LV L G C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDF-IEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIK 434
L+++F+ G L + L + + L + + +G+ + +IHRD+
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHRDLA 128
Query: 435 SSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSF 494
+ N L+ N +VSDFG+ + + D++ +T + +PE R + K+DV+SF
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188
Query: 495 GVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAV 554
GVL+ EV S + + + + + + R + P + +
Sbjct: 189 GVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFR---LYKPRLAS------THVYQI 234
Query: 555 ATQCVSSSPDDRPTMHRVVQILE 577
C P+DRP R+++ L
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 6e-62
Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 20/281 (7%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLV 366
E+L + +G G FG V+ + A+K + + F +E +++ ++H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAF-LQEAQVMKKLRHEKLV 75
Query: 367 NLRGYCNSPTSKLLIYDFLPGGSLDEALH-ERSEQLDWDARLNIIMGAAKGLAYLHHDCS 425
L S ++ +++ GSL + L E + L +++ A G+AY+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131
Query: 426 PRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA 485
+HRD++++NIL+ NL +V+DFGLA+L+ED E + APE GR
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 486 TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545
T K+DV+SFG+L+ E+ + R + + + E R P C
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYRMPCPPEC----- 239
Query: 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPS 586
++L + QC P++RPT + LE + P
Sbjct: 240 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (516), Expect = 3e-61
Identities = 81/307 (26%), Positives = 135/307 (43%), Gaps = 37/307 (12%)
Query: 296 PYSSKDIIK---------KLETLDDDHIIGSGGFGTVYK----LAMDDGNVFALKRIDK- 341
P++ +D + + + + +IG+G FG V L A+K +
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 342 LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQL 401
E R F E I+G H +++L G T ++I +F+ GSLD L + Q
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 402 DWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461
+ ++ G A G+ YL +HRD+ + NIL++ NL +VSDFGL++ LED+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 462 SHITTIVA----GTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKG 516
S T A + APE +Q + T +DV+S+G+++ EV+S G+RP +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 517 LNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQIL 576
+N + E R +C AL + C + RP ++V L
Sbjct: 243 INAI--------EQDYRLPPPMDCP-------SALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 577 ESEVMTP 583
+ + P
Sbjct: 288 DKMIRNP 294
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-61
Identities = 71/306 (23%), Positives = 134/306 (43%), Gaps = 35/306 (11%)
Query: 291 FHGDLPYSSKDIIKKLE---------TLDDDHIIGSGGFGTVYKLAMDDGN----VFALK 337
H DL + ++++ ++ + + +IG G FG VY + D + A+K
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 61
Query: 338 RIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYC-NSPTSKLLIYDFLPGGSLDEALH 395
++++ + G F E I+ H +++L G C S S L++ ++ G L +
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR 121
Query: 396 ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455
+ + + AKG+ S + +HRD+ + N +LD +V+DFGLA+
Sbjct: 122 NETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 456 LLEDEE---SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASF 512
+ D+E H T ++A E +Q+ + T K+DV+SFGVL+ E+++ P
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----- 233
Query: 513 IEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRV 572
+N +L+ R ++ P D L V +C + RP+ +
Sbjct: 234 PYPDVNTFDITVYLLQGRR---LLQP------EYCPDPLYEVMLKCWHPKAEMRPSFSEL 284
Query: 573 VQILES 578
V + +
Sbjct: 285 VSRISA 290
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-61
Identities = 57/264 (21%), Positives = 107/264 (40%), Gaps = 20/264 (7%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374
+G+G FG V A+K I + + D F E +++ ++ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEF-IEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIK 434
+I +++ G L L E + L + + + YL + +HRD+
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLA 127
Query: 435 SSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSF 494
+ N L++ +VSDFGL++ + D+E + + PE + + + K+D+++F
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187
Query: 495 GVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLA 553
GVL+ E+ S GK P + + + R + +
Sbjct: 188 GVLMWEIYSLGKMPYERFTNSETAEHI--------AQGLRLYRPHLAS-------EKVYT 232
Query: 554 VATQCVSSSPDDRPTMHRVVQILE 577
+ C D+RPT ++ +
Sbjct: 233 IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-60
Identities = 73/295 (24%), Positives = 120/295 (40%), Gaps = 29/295 (9%)
Query: 306 LETLDDD----HIIGSGGFGTVYK-LAMDDGNVFALKRIDK-LNEGFDRFFERELEILGS 359
+E DDD +G+G G V+K G V A K I + REL++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
Y+V G S + + + GGSLD+ L + ++ + + KGL Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTY 119
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEY 479
L +I+HRD+K SNIL++ E ++ DFG++ L D + GT Y++PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPER 174
Query: 480 MQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539
+Q + ++D++S G+ ++E+ G+ P +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP----------------DAKELELMFGCQ 218
Query: 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDFYDSNSD 594
EG +E+ S D RP M + ++L+ V P P S
Sbjct: 219 VEGDAAETPPRPRTPGRPLSSYGMDSRPPM-AIFELLDYIVNEPPPKLPSGVFSL 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-60
Identities = 62/271 (22%), Positives = 117/271 (43%), Gaps = 26/271 (9%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG+G +G K DG + K +D + E + E+ +L +KH +V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 371 YCNSPTSKLL--IYDFLPGGSLDEALHERSEQ---LDWDARLNIIMGAAKGLAYLH--HD 423
T+ L + ++ GG L + + +++ LD + L ++ L H D
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
++HRD+K +N+ LDG ++ DFGLA++L + S GT Y++PE M
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNRM 189
Query: 484 RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543
EK+D++S G L+ E+ + P + + +R I
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGKFRR--IPYRY--- 238
Query: 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
S+ L+ ++ T+ ++ RP++ +++
Sbjct: 239 -SDELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-59
Identities = 64/267 (23%), Positives = 108/267 (40%), Gaps = 26/267 (9%)
Query: 313 HIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG V GN A+K I + + F E ++ ++H LV L G
Sbjct: 13 QTIGKGEFGDVML-GDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 373 NSPTSKL-LIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
L ++ +++ GSL + L R L D L + + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RD+ + N+L+ + A+VSDFGL K + + APE ++ + + K+D
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTKSD 182
Query: 491 VYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDA 550
V+SFG+L+ E+ S R + + + + E + C A
Sbjct: 183 VWSFGILLWEIYSFGRVPYP-----RIPLKDVVPRV--EKGYKMDAPDGCP-------PA 228
Query: 551 LLAVATQCVSSSPDDRPTMHRVVQILE 577
+ V C RP+ ++ + LE
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-59
Identities = 63/266 (23%), Positives = 111/266 (41%), Gaps = 23/266 (8%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCN 373
+G G FG VYK + + A K ID +E + E++IL S H +V L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDI 433
+ ++ +F GG++D + E L + L YLH +IIHRD+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 136
Query: 434 KSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRA-----TEK 488
K+ NIL + + +++DFG++ + + GT ++APE + + K
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYK 195
Query: 489 TDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESL 548
DV+S G+ ++E+ + P LN + L + + S +
Sbjct: 196 ADVWSLGITLIEMAEIEPPHH------ELNPMRVLLKIAKSEPPTLAQPSRW----SSNF 245
Query: 549 DALLAVATQCVSSSPDDRPTMHRVVQ 574
L +C+ + D R T +++Q
Sbjct: 246 KDFL---KKCLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 5e-59
Identities = 66/283 (23%), Positives = 120/283 (42%), Gaps = 29/283 (10%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK---LAMDDGNVFALKRIDK--LNEGFDRFFERELEILG 358
+KL TL+D +GSG FGTV K A+K + + E ++
Sbjct: 5 RKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+ + Y+V + G C + S +L+ + G L++ L + + + ++ + G+
Sbjct: 64 QLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMK 121
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT--IVAGTFGYLA 476
YL +HRD+ + N+LL A++SDFGL+K L +E++ + A
Sbjct: 122 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535
PE + + + K+DV+SFGVL+ E S G++P + ++ E +R
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--------EKGERMG 230
Query: 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
C + + C + ++RP V L +
Sbjct: 231 CPAGC-------PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 8e-59
Identities = 68/285 (23%), Positives = 123/285 (43%), Gaps = 25/285 (8%)
Query: 307 ETLDDDHIIGSGGFGTVYKLAMDDGN-----VFALKRIDK-LNEGFDRFFERELEILGSI 360
+ +IG+G FG VYK + + A+K + E F E I+G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
H ++ L G + ++I +++ G+LD+ L E+ + + ++ G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM--- 123
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVA--GTFGYLAPE 478
+ + +HRD+ + NIL++ NL +VSDFGL+++LED+ T + APE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538
+ + T +DV+SFG+++ EV++ L + + + I D
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAINDG 229
Query: 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
+ A+ + QC RP +V IL+ + P
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 9e-59
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 27/271 (9%)
Query: 312 DHIIGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNL 368
D IG G F TVYK L + A + L + + F+ E E+L ++H +V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 369 RGYCNSPTSK----LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
S +L+ + + G+L L R + + + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 425 SPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
P IIHRD+K NI + G ++ D GLA L V GT ++APE +
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYE-E 187
Query: 484 RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543
+ E DVY+FG+ +LE+ + + P + ++ + D
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA--- 238
Query: 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ + + C+ + D+R ++ ++
Sbjct: 239 ----IPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 71/312 (22%), Positives = 129/312 (41%), Gaps = 43/312 (13%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDK-LNEGFD 347
LPY K + L +G+G FG V + + D A+K + +
Sbjct: 12 LPYDHKWEFPR-NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 348 RFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ------ 400
EL++L + H +VNL G C L+I ++ G L L + +
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 401 -----------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVS 449
LD + L+ AKG+A+L S IHRD+ + NILL ++
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKIC 187
Query: 450 DFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPT 508
DFGLA+ ++++ ++ + ++APE + + T ++DV+S+G+ + E+ S
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 509 DASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT 568
G+ + +I E R + + + + C + P RPT
Sbjct: 248 Y-----PGMPVDSKFYKMIKEGF-RMLSPEHAP-------AEMYDIMKTCWDADPLKRPT 294
Query: 569 MHRVVQILESEV 580
++VQ++E ++
Sbjct: 295 FKQIVQLIEKQI 306
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-58
Identities = 75/274 (27%), Positives = 119/274 (43%), Gaps = 30/274 (10%)
Query: 308 TLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSI 360
L+D I +G G FG VY + ALK + K G + RE+EI +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+H ++ L GY + T LI ++ P G++ L + S + D I A L+Y
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYC 122
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM 480
H S R+IHRDIK N+LL E +++DFG + + GT YL PE +
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMI 176
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540
+ EK D++S GVL E L GK P +A+ ++ + + F + D
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--- 233
Query: 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ ++ + +P RP + V++
Sbjct: 234 -------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (496), Expect = 2e-58
Identities = 62/277 (22%), Positives = 117/277 (42%), Gaps = 22/277 (7%)
Query: 305 KLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHR 363
+ + H +G G +G VY+ + A+K + + + F +E ++ IKH
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-LKEAAVMKEIKHP 73
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-LDWDARLNIIMGAAKGLAYLHH 422
LV L G C +I +F+ G+L + L E + Q + L + + + YL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 132
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
IHRD+ + N L+ N +V+DFGL++L+ + + APE +
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
+ + K+DV++FGVL+ E+ + I + E+++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPG---------------IDLSQVYELLEKDYRM 235
Query: 543 VQSESL-DALLAVATQCVSSSPDDRPTMHRVVQILES 578
+ E + + + C +P DRP+ + Q E+
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (493), Expect = 7e-58
Identities = 63/294 (21%), Positives = 116/294 (39%), Gaps = 48/294 (16%)
Query: 315 IGSGGFGTVYK------LAMDDGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVN 367
IG G FG V++ L + + A+K + + + F+RE ++ + +V
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ-----------------------LDWD 404
L G C L+++++ G L+E L S L
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 405 ARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESH 463
+L I A G+AYL + +HRD+ + N L+ N+ +++DFGL++ + +
Sbjct: 141 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197
Query: 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWL 523
A ++ PE + R T ++DV+++GV++ E+ S
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--------------PY 243
Query: 524 NFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ E+ + D N L + C S P DRP+ + +IL+
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 5e-57
Identities = 68/285 (23%), Positives = 117/285 (41%), Gaps = 33/285 (11%)
Query: 297 YSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFER 352
+ D K L IG G FG VY + + V A+K++ + + +
Sbjct: 8 FFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 353 ELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMG 412
E+ L ++H + RG + L+ ++ G + D + + L + G
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHG 123
Query: 413 AAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTF 472
A +GLAYLH S +IHRD+K+ NILL ++ DFG A ++ GT
Sbjct: 124 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTP 175
Query: 473 GYLAPEYMQS---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529
++APE + + G+ K DV+S G+ +E+ K P L + I++
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHIAQ 228
Query: 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ + + SE + C+ P DRPT +++
Sbjct: 229 NESPALQSGHW----SEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 7e-57
Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 25/279 (8%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELE 355
S D KK + IG G GTVY AMD G A+++++ + E+
Sbjct: 14 SVGDPKKKYTRFE---KIGQGASGTVYT-AMDVATGQEVAIRQMNLQQQPKKELIINEIL 69
Query: 356 ILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
++ K+ +VN ++ ++L GGSL + + E D + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQ 127
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYL 475
L +LH S ++IHRDIKS NILL + +++DFG + E+S +T+V GT ++
Sbjct: 128 ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 183
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535
APE + K D++S G++ +E++ G+ P N + L + +
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGTPELQ 237
Query: 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
S L +C+ + R + ++Q
Sbjct: 238 NPEKL----SAIFRDFL---NRCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 190 bits (484), Expect = 5e-56
Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 26/287 (9%)
Query: 303 IKKLETLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
IK LD I +G+G FG V++ GN FA K + +E +E++ +
Sbjct: 19 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 78
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
++H LVNL ++IY+F+ GG L E + + ++ D + + KGL
Sbjct: 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 419 YLHHDCSPRIIHRDIKSSNILL--DGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
++H +H D+K NI+ + E ++ DFGL L+ ++S T GT + A
Sbjct: 139 HMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAA 193
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536
PE + TD++S GVL +LSG P ++ L V ++ + + I
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI- 252
Query: 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
SE + + + + P+ R T+H Q LE +TP
Sbjct: 253 --------SEDGKDFI---RKLLLADPNTRMTIH---QALEHPWLTP 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-55
Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 25/271 (9%)
Query: 314 IIGSGGFGTVYK----LAMDDGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNL 368
IG G FG V++ + A+K ++ F +E + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRI 428
G + +I + G L L R LD + + + LAYL S R
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 429 IHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEK 488
+HRDI + N+L+ N ++ DFGL++ +ED + + ++APE + R T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 489 TDVYSFGVLVLEVL-SGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSES 547
+DV+ FGV + E+L G +P + + E+ +R + PNC
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLPMPPNCP------ 235
Query: 548 LDALLAVATQCVSSSPDDRPTMHRVVQILES 578
L ++ T+C + P RP + L +
Sbjct: 236 -PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 3e-55
Identities = 61/316 (19%), Positives = 116/316 (36%), Gaps = 48/316 (15%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDK-LNEGFD 347
Y K + E L+ ++GSG FG V A+K + + +
Sbjct: 26 YEYDLKWEFPR-ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 84
Query: 348 RFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQ------ 400
EL+++ + H +VNL G C LI+++ G L L + E+
Sbjct: 85 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 401 ----------------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL 444
L ++ L AKG+ +L +HRD+ + N+L+
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGK 201
Query: 445 EARVSDFGLAKLL-EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS 503
++ DFGLA+ + D + ++APE + G T K+DV+S+G+L+ E+ S
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 504 GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSP 563
G+ + + + ++ + + + + C +
Sbjct: 262 LGVNPY-----PGIPVDANF-YKLIQNGFKMDQPFYAT-------EEIYIIMQSCWAFDS 308
Query: 564 DDRPTMHRVVQILESE 579
RP+ + L +
Sbjct: 309 RKRPSFPNLTSFLGCQ 324
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 8e-55
Identities = 59/266 (22%), Positives = 104/266 (39%), Gaps = 23/266 (8%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G +G V A++ A+K +D ++E+ I + H +V G
Sbjct: 12 TLGEGAYGEVQL-AVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
+ + L ++ GG L + + + G+ YLH I H
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH---GIGITH 126
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAPEYMQSGR-ATEK 488
RDIK N+LLD ++SDFGLA + + + + GT Y+APE ++ E
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 489 TDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESL 548
DV+S G+++ +L+G+ P D + E + +
Sbjct: 187 VDVWSCGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPWKKI----DSAP 236
Query: 549 DALLAVATQCVSSSPDDRPTMHRVVQ 574
ALL + + +P R T+ + +
Sbjct: 237 LALL---HKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-54
Identities = 68/272 (25%), Positives = 112/272 (41%), Gaps = 26/272 (9%)
Query: 315 IGSGGFGTVYKLAMD----DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVN 367
+G G FG V + D A+K + F RE+ + S+ HR L+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 368 LRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPR 427
L G +P K+ + + P GSL + L + + A+G+ YL S R
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 428 IIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH--ITTIVAGTFGYLAPEYMQSGRA 485
IHRD+ + N+LL ++ DFGL + L + H + F + APE +++
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 486 TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545
+ +D + FGV + E+ + + GLN L I ++ +R +C
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQIL-HKIDKEGERLPRPEDCP---- 241
Query: 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ V QC + P+DRPT + L
Sbjct: 242 ---QDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-54
Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 27/289 (9%)
Query: 303 IKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK-----LNEGFDRFFERELEI 356
I K ++GSG FGTVYK L + +G + K + ++ E +
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 357 LGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKG 416
+ S+ + ++ L G C + T LI +P G L + + E + + LN + AKG
Sbjct: 65 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 417 LAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYL 475
+ YL R++HRD+ + N+L+ +++DFGLAKLL EE + ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 476 APEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534
A E + T ++DV+S+GV V E+++ G +P D + +I+ E +R
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--------EKGERL 232
Query: 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583
P C + + +C D RP ++ P
Sbjct: 233 PQPPICT-------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 183 bits (466), Expect = 2e-53
Identities = 74/300 (24%), Positives = 120/300 (40%), Gaps = 28/300 (9%)
Query: 303 IKKLETLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
+K+ D I +GSG FG V++ + G VF K I+ + E+ I+
Sbjct: 22 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN 81
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+ H L+NL +LI +FL GG L + + ++ +N + A +GL
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 419 YLHHDCSPRIIHRDIKSSNILLDGNLEARV--SDFGLAKLLEDEESHITTIVAGTFGYLA 476
++H I+H DIK NI+ + + V DFGLA L +E T T + A
Sbjct: 142 HMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAA 196
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536
PE + TD+++ GVL +LSG P + L V ++ ED +
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV- 255
Query: 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTM-----HRVVQILESEVMTPCPSDFYDS 591
S + + P R T+ H ++ S + + PS Y+
Sbjct: 256 --------SPEAKDFI---KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNK 304
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-52
Identities = 74/308 (24%), Positives = 124/308 (40%), Gaps = 46/308 (14%)
Query: 314 IIGSGGFGTVYKLAMDDGN---VFALKRIDK-LNEGFDRFFERELEILGSI-KHRYLVNL 368
+IG G FG V K + A+KR+ + ++ R F ELE+L + H ++NL
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 369 RGYCNSPTSKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGA 413
G C L ++ P G+L + L + + L L+
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 414 AKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
A+G+ YL + IHRD+ + NIL+ N A+++DFGL++ E T+
Sbjct: 137 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVR 191
Query: 474 YLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533
++A E + T +DV+S+GVL+ E++S G+ L R
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKLPQGYRLE 246
Query: 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE-------SEVMTPCPS 586
NC+ D + + QC P +RP+ +++ L + V T
Sbjct: 247 --KPLNCD-------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297
Query: 587 DFYDSNSD 594
F + D
Sbjct: 298 KFTYAGID 305
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-51
Identities = 72/311 (23%), Positives = 130/311 (41%), Gaps = 46/311 (14%)
Query: 294 DLPYSSKDIIKKLETLDDDHIIGSGGFGTVYK--------LAMDDGNVFALKRIDK-LNE 344
+LP + + + + L +G G FG V + A+K + E
Sbjct: 1 ELPEDPRWELPR-DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 345 GFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHER------ 397
E+E++ I KH+ ++NL G C +I ++ G+L E L R
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119
Query: 398 ---------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448
EQL ++ A+G+ YL S + IHRD+ + N+L+ + ++
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKI 176
Query: 449 SDFGLAKLLEDEESHITTIV-AGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKR 506
+DFGLA+ + + + T ++APE + T ++DV+SFGVL+ E+ + G
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
Query: 507 PTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDR 566
P +E+ ++ ++ R NC + L + C + P R
Sbjct: 237 PYPGVPVEELFKLL--------KEGHRMDKPSNC-------TNELYMMMRDCWHAVPSQR 281
Query: 567 PTMHRVVQILE 577
PT ++V+ L+
Sbjct: 282 PTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 1e-50
Identities = 72/309 (23%), Positives = 117/309 (37%), Gaps = 41/309 (13%)
Query: 295 LPYSSKDIIKKLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDK-LNEGFD 347
LPY + + L +G G FG V + A+K + +
Sbjct: 1 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 60
Query: 348 RFFERELEILGSIKHRY-LVNLRGYCNSPTSKLLI-YDFLPGGSLDEALHERSEQ----- 400
R EL+IL I H +VNL G C P L++ +F G+L L + +
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 401 ----------LDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSD 450
L + + AKG+ +L S + IHRD+ + NILL ++ D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICD 177
Query: 451 FGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTD 509
FGLA+ + + ++ ++APE + T ++DV+SFGVL+ E+ S
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 510 ASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTM 569
G+ I + E + D + + C P RPT
Sbjct: 238 -----PGVKIDEEFCRRLKEGTRMRAPD--------YTTPEMYQTMLDCWHGEPSQRPTF 284
Query: 570 HRVVQILES 578
+V+ L +
Sbjct: 285 SELVEHLGN 293
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-50
Identities = 60/323 (18%), Positives = 122/323 (37%), Gaps = 43/323 (13%)
Query: 297 YSSKDIIK------KLETLDDDHIIGSGGFGTVYK------LAMDDGNVFALKRIDK-LN 343
+S+ D+ E + +G G FG VY+ + + A+K +++ +
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 344 EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALH-------- 395
F E ++ ++V L G + L+I + + G L L
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 396 -ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454
+ + A G+AYL + + +HRD+ + N ++ + ++ DFG+
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 455 KLL-EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFI 513
+ + E + +++PE ++ G T +DV+SFGV++ E+ +
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------ 234
Query: 514 EKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573
L +E R +++ D L + C +P RP+ ++
Sbjct: 235 --------PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
Query: 574 QILESEVMTPCPSD--FYDSNSD 594
++ E M P + FY S +
Sbjct: 287 SSIKEE-MEPGFREVSFYYSEEN 308
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-50
Identities = 58/278 (20%), Positives = 117/278 (42%), Gaps = 24/278 (8%)
Query: 300 KDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILG 358
K++ +K + +G G FG V++ + + K + K+ ++E+ IL
Sbjct: 1 KELYEKYMIAE---DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILN 56
Query: 359 SIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLA 418
+HR +++L S ++I++F+ G + E ++ + +L+ ++ + + L
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 419 YLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLA 476
+LH S I H DI+ NI+ + ++ +FG A+ L+ ++ Y A
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYA 171
Query: 477 PEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536
PE Q + TD++S G LV +LSG P A ++ + + + E+ +EI
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI- 230
Query: 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
S + + + R T +Q
Sbjct: 231 --------SIEAMDFV---DRLLVKERKSRMTASEALQ 257
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-49
Identities = 53/279 (18%), Positives = 106/279 (37%), Gaps = 25/279 (8%)
Query: 304 KKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGS 359
K+ E I+G G F TV + +A+K ++K + E + RE +++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 360 IKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAY 419
+ H + V L + G L + + + D A+ ++
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYT---AEIVSA 120
Query: 420 LHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL-EDEESHITTIVAGTFGYLAPE 478
L + IIHRD+K NILL+ ++ +++DFG AK+L + + GT Y++PE
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538
+ A + +D+++ G ++ ++++G P A + L + E + D
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD- 239
Query: 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE 577
+ + + R +
Sbjct: 240 ---------------LVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 1e-47
Identities = 70/281 (24%), Positives = 114/281 (40%), Gaps = 29/281 (10%)
Query: 304 KKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK-LNEGFDRFFERELEI 356
K+ E + D ++G+G F V A D + A+K I K EG + E E+ +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVIL-AEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 357 LGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKG 416
L IKH +V L S LI + GG L + + E+ +I
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDA 119
Query: 417 LAYLHHDCSPRIIHRDIKSSNILL---DGNLEARVSDFGLAKLLEDEESHITTIVAGTFG 473
+ YLH I+HRD+K N+L D + + +SDFGL+K+ + + + GT G
Sbjct: 120 VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPG 174
Query: 474 YLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533
Y+APE + ++ D +S GV+ +L G P K + +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+I S+S + + P+ R T + +Q
Sbjct: 235 DI---------SDSAKDFI---RHLMEKDPEKRFTCEQALQ 263
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 4e-46
Identities = 60/275 (21%), Positives = 96/275 (34%), Gaps = 25/275 (9%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IGSG FG +Y D G A+K + E +I ++ + +C
Sbjct: 15 IGSGSFGDIYL-GTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
+ ++ L G SL++ + S + L + + Y+H S IHRD
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 433 IKSSNIL---LDGNLEARVSDFGLAKLLEDEESHI------TTIVAGTFGYLAPEYMQSG 483
+K N L + DFGLAK D +H + GT Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 484 RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGV 543
+ + D+ S G +++ G P ISE + I+ C+G
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----ERISEKKMSTPIEVLCKGY 244
Query: 544 QSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
SE C S DD+P + Q+ +
Sbjct: 245 PSE----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (409), Expect = 4e-46
Identities = 61/278 (21%), Positives = 114/278 (41%), Gaps = 35/278 (12%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDK---------LNEGFDRFFERELEILGSIK-H 362
I+G G V + + +A+K ID + +E++IL + H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 363 RYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
++ L+ + T L++D + G L + L E+ L I+ + + LH
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH- 127
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
I+HRD+K NILLD ++ +++DFG + L+ E V GT YLAPE ++
Sbjct: 128 --KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIEC 183
Query: 483 GRA------TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536
++ D++S GV++ +L+G P L ++ N+ +
Sbjct: 184 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY- 242
Query: 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
S+++ L++ + + P R T +
Sbjct: 243 --------SDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (407), Expect = 7e-46
Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDK---LNEGFDRFFERELEILGSIKHRYLVNL 368
I+G GG V+ A D A+K + + F F RE + ++ H +V +
Sbjct: 14 ILGFGGMSEVHL-ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 369 RGYCNSPTSKL----LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
+ T ++ +++ G +L + +H + + +I A + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFS---H 128
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI--TTIVAGTFGYLAPEYMQS 482
IIHRD+K +NI++ +V DFG+A+ + D + + T V GT YL+PE +
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
++DVYS G ++ EVL+G+ P G + V + ED EG
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVREDPIPPSARH--EG 240
Query: 543 VQSESLDALLAVATQCVSSSPDDRPT 568
+ S LDA++ + ++ +P++R
Sbjct: 241 L-SADLDAVVL---KALAKNPENRYQ 262
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (409), Expect = 4e-45
Identities = 68/273 (24%), Positives = 110/273 (40%), Gaps = 31/273 (11%)
Query: 308 TLDD---DHIIGSGGFGTVYK-LAMDDGNVFALKRIDK------LNEGFDRFFERELEIL 357
T++D IIG GGFG VY D G ++A+K +DK E L ++
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 358 GSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGL 417
+ ++V + ++P I D + GG L L + + D R GL
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAAEIILGL 120
Query: 418 AYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP 477
++H + +++RD+K +NILLD + R+SD GLA ++ H + GT GY+AP
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 174
Query: 478 EYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536
E +Q G A D +S G ++ ++L G P +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR------QHKTKDKHEIDRMTLTMAVEL 228
Query: 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTM 569
+ S L +LL + + R
Sbjct: 229 PDSF----SPELRSLL---EGLLQRDVNRRLGC 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 1e-44
Identities = 64/275 (23%), Positives = 124/275 (45%), Gaps = 19/275 (6%)
Query: 315 IGSGGFGTVYKLAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G +G VYK + G FALK+I +K +EG RE+ IL +KH +V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ +L+++ L L L+ + ++ G+AY H R++HRD
Sbjct: 70 HTKKRLVLVFEHLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 433 IKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVY 492
+K N+L++ E +++DFGLA+ T + + M S + + D++
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 493 SFGVLVLEVLSGKRP----TDASFIEKGLNIVGWLNFL----ISEDRQREIIDPNCEGVQ 544
S G + E+++G ++A + + I+G N ++E + + E +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 545 SESL-----DALLAVATQCVSSSPDDRPTMHRVVQ 574
ES ++ + + ++ + P+ R T + ++
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-44
Identities = 65/286 (22%), Positives = 125/286 (43%), Gaps = 31/286 (10%)
Query: 314 IIGSGGFGTVYKLAMD--DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G V A D + A+K+I ++ + + RE++IL +H ++ +
Sbjct: 15 YIGEGAYGMVCS-AYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 371 YCNSPTSK----LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSP 426
+PT + + + L G L + L + L D + +GL Y+H S
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SA 128
Query: 427 RIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI--VAGTFGYLAPEYMQSGR 484
++HRD+K SN+LL+ + ++ DFGLA++ + + H + T Y APE M + +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 485 A-TEKTDVYSFGVLVLEVLSGKRP-TDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
T+ D++S G ++ E+LS + ++++ +I+G L ED I
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248
Query: 543 VQSESL--------------DALLAVATQCVSSSPDDRPTMHRVVQ 574
+ S L + + ++ +P R + + +
Sbjct: 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-43
Identities = 57/270 (21%), Positives = 109/270 (40%), Gaps = 29/270 (10%)
Query: 309 LDD---DHIIGSGGFGTVYK-LAMDDGNVFALKRIDK----LNEGFDRFFERELEILGSI 360
++D ++G G FG V+ FA+K + K +++ + + + +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+H +L ++ + + + ++L GG L + + D GL +L
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFL 119
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM 480
S I++RD+K NILLD + +++DFG+ K ++ T GT Y+APE +
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEIL 175
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540
+ D +SFGVL+ E+L G+ P E+ + + N ++E D
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD--- 232
Query: 541 EGVQSESLDALLAVATQCVSSSPDDRPTMH 570
+ + P+ R +
Sbjct: 233 -------------LLVKLFVREPEKRLGVR 249
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 2e-43
Identities = 43/277 (15%), Positives = 83/277 (29%), Gaps = 27/277 (9%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYC 372
IG G FG +++ + + A+K + ++ E + + Y
Sbjct: 13 IGEGSFGVIFE-GTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRD 432
++ L G SL++ L + + +H +++RD
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 433 IKSSNILLDGNLE-----ARVSDFGLAKLLEDEESHI------TTIVAGTFGYLAPEYMQ 481
IK N L+ V DFG+ K D + ++GT Y++
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 482 SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541
+ + D+ + G + + L G P I E +Q + C
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----ERIGEKKQSTPLRELCA 242
Query: 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578
G E + + D P + +
Sbjct: 243 GFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (393), Expect = 2e-43
Identities = 64/271 (23%), Positives = 117/271 (43%), Gaps = 31/271 (11%)
Query: 308 TLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSI 360
+L D I +G+G FG V+ + +G +A+K + K + E +L +
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
H +++ + G +I D++ GG L L + + A+ A+ L
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA----AEVCLAL 117
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM 480
+ S II+RD+K NILLD N +++DFG AK + D + GT Y+APE +
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVV 173
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540
+ + D +SFG+L+ E+L+G P N + +++ + + P
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFY------DSNTMKTYEKILNAELR---FPPFF 224
Query: 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHR 571
+E + LL+ + ++ R +
Sbjct: 225 ----NEDVKDLLS---RLITRDLSQRLGNLQ 248
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-43
Identities = 57/293 (19%), Positives = 112/293 (38%), Gaps = 28/293 (9%)
Query: 315 IGSGGFGTVYKLAMD--DGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
IG G +G VYK A + G V ALK+I D EG RE+ +L + H +V L
Sbjct: 10 IGEGTYGVVYK-ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 371 YCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIH 430
++ L+++FL + + + +GLA+ S R++H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLH 125
Query: 431 RDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTD 490
RD+K N+L++ +++DFGLA+ T V + + + D
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 491 VYSFGVLVLEVLSGKRP----TDASFIEKGLNIVGWLNFLISEDRQR---------EIID 537
++S G + E+++ + ++ + + +G + ++ +
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWAR 245
Query: 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILE----SEVMTPCPS 586
+ V + ++ +Q + P+ R + L +V P P
Sbjct: 246 QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK---AALAHPFFQDVTKPVPH 295
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-43
Identities = 57/283 (20%), Positives = 116/283 (40%), Gaps = 28/283 (9%)
Query: 315 IGSGGFGTVYK--LAMDDGNVFALKRIDK--LNEGFDRFFERELEI---LGSIKHRYLVN 367
IG G +G V+K + G ALKR+ EG RE+ + L + +H +V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 368 LRGYCNSPTSK-----LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
L C + L+++ + + + +++ +GL +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 133
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQS 482
S R++HRD+K NIL+ + + +++DFGLA++ + + + + T Y APE +
Sbjct: 134 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVLLQ 189
Query: 483 GRATEKTDVYSFGVLVLEVLSGKRP----TDASFIEKGLNIVGWL-------NFLISEDR 531
D++S G + E+ K +D + K L+++G + +
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
E ++ + + +C++ +P R + + +
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 9e-43
Identities = 70/287 (24%), Positives = 117/287 (40%), Gaps = 34/287 (11%)
Query: 303 IKKLETLDD----DHIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEI 356
IKK +DD ++G G G V + + FALK + + RE+E+
Sbjct: 4 IKKNAIIDDYKVTSQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDCPK-----ARREVEL 57
Query: 357 LGSI-KHRYLVNLRGYCNSPTSK----LLIYDFLPGGSLDEALHERSEQ-LDWDARLNII 410
+ ++V + + + L++ + L GG L + +R +Q I+
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 411 MGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLEDEESHITTI 467
+ + YLH S I HRD+K N+L N +++DFG AK S T
Sbjct: 118 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLI 527
T Y+APE + + + D++S GV++ +L G P + GL I + I
Sbjct: 175 Y--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS---NHGLAISPGMKTRI 229
Query: 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
Q E +P V SE + L+ + + P R T+ +
Sbjct: 230 RMG-QYEFPNPEWSEV-SEEVKMLI---RNLLKTEPTQRMTITEFMN 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 9e-43
Identities = 69/300 (23%), Positives = 118/300 (39%), Gaps = 36/300 (12%)
Query: 303 IKKLETLDDD----HIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRF------FE 351
+ + E +DD +GSG F V K G +A K I K R E
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 352 RELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIM 411
RE+ IL I+H ++ L + T +LI + + GG L + L E+ E L + +
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLK 120
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLD----GNLEARVSDFGLAKLLEDEESHITTI 467
G +++ S +I H D+K NI+L ++ DFGLA ++
Sbjct: 121 QILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKN 175
Query: 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLI 527
+ GT ++APE + + D++S GV+ +LSG P ++ L V +N+
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 528 SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSD 587
++ S + + + P R T+ L+ + P +
Sbjct: 236 EDEYFSNT---------SALAKDFI---RRLLVKDPKKRMTIQ---DSLQHPWIKPKDTQ 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 9e-43
Identities = 72/303 (23%), Positives = 121/303 (39%), Gaps = 34/303 (11%)
Query: 307 ETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK-----LNEGFDRFFERELEILGSI 360
E LD +G G F TVYK + + A+K+I +G +R RE+++L +
Sbjct: 1 EKLD---FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
H ++ L ++ L++DF+ + + S L ++ +GL YL
Sbjct: 58 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM 480
H I+HRD+K +N+LLD N +++DFGLAK T V T Y APE +
Sbjct: 117 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELL 172
Query: 481 QSGRA-TEKTDVYSFGVLVLEVLSGKRP----TDASFIEKGLNIVGWLNFLISED----- 530
R D+++ G ++ E+L +D + + +G D
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 531 ---RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT----P 583
+ + S + D LL + +P R T Q L+ + + P
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT---QALKMKYFSNRPGP 289
Query: 584 CPS 586
P
Sbjct: 290 TPG 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 72/294 (24%), Positives = 122/294 (41%), Gaps = 36/294 (12%)
Query: 310 DDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNL 368
D +IG+G FG VY+ D G + A+K++ + RF REL+I+ + H +V L
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL 78
Query: 369 RGYCNSPTSK------LLIYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKGLAYL 420
R + S K L+ D++P A H + L + + LAY+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 421 HHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAP-E 478
H S I HRDIK N+LLD + ++ DFG AK L E +++ I + Y AP
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPEL 193
Query: 479 YMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII-- 536
+ T DV+S G ++ E+L G+ L + + + ++ RE+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 537 -----------DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579
P + + + +A+ ++ + +P R T +
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL---EACAHS 304
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 8e-40
Identities = 65/309 (21%), Positives = 119/309 (38%), Gaps = 46/309 (14%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRIDK--LNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G FG V+K G ALK++ EGF RE++IL +KH +VNL
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 372 CNSPTSK--------LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD 423
C + S L++DF + + + + + M L L++
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML----LNGLYYI 133
Query: 424 CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES---HITTIVAGTFGYLAPEYM 480
+I+HRD+K++N+L+ + +++DFGLA+ ++ + T T Y PE +
Sbjct: 134 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 481 QSGRA-TEKTDVYSFGVLVLEVLSGKRP----TDASFIEKGLNIVG-------------- 521
R D++ G ++ E+ + T+ + + G
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253
Query: 522 -WLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580
+ + + ++R++ D V+ L+ + + P R L +
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLI---DKLLVLDPAQRIDSD---DALNHDF 307
Query: 581 MT--PCPSD 587
P PSD
Sbjct: 308 FWSDPMPSD 316
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-39
Identities = 60/272 (22%), Positives = 105/272 (38%), Gaps = 39/272 (14%)
Query: 314 IIGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRF------FERELEILGSIK--HRY 364
++GSGGFG+VY + + D A+K ++K E+ +L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
++ L + P S +LI + L + + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 425 SPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSG 483
+ ++HRDIK NIL+D N E ++ DFG LL+D + T GT Y PE+++
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYH 184
Query: 484 RA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
R V+S G+L+ +++ G P + I+ R +
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEII----------RGQVFFRQRV-- 227
Query: 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
S L+ C++ P DRPT +
Sbjct: 228 --SSECQHLI---RWCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 9e-39
Identities = 54/277 (19%), Positives = 107/277 (38%), Gaps = 21/277 (7%)
Query: 315 IGSGGFGTVYK-LAMDDGNVFALKRI--DKLNEGFDRFFERELEILGSIKHRYLVNLRGY 371
IG G +GTV+K + + ALKR+ D +EG RE+ +L +KH+ +V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 372 CNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431
+S L+++F + + + L L S ++HR
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS----FLFQLLKGLGFCHSRNVLHR 125
Query: 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDV 491
D+K N+L++ N E ++++FGLA+ + V + + + D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 492 YSFGVLVLEVLSGKRP-----TDASFIEKGLNIVG------WLNFLISEDRQREIIDP-- 538
+S G + E+ + RP +++ ++G W + D + + P
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 539 -NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574
+ V + + + +P R + +Q
Sbjct: 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 59/279 (21%), Positives = 110/279 (39%), Gaps = 30/279 (10%)
Query: 308 TLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFERELEILGSI 360
T++D +G G FG V G +A+K + K + + E +L +
Sbjct: 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 361 KHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYL 420
+H +L L+ + + ++ GG L L + AR A+ ++ L
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSAL 118
Query: 421 HHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYM 480
+ S +++RDIK N++LD + +++DFGL K + + + T GT YLAPE +
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 481 QSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540
+ D + GV++ E++ G+ P E+ ++ +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---------LMEEIRFPRTL 228
Query: 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHR--VVQILE 577
S +LLA + P R +++E
Sbjct: 229 ----SPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 60/304 (19%), Positives = 119/304 (39%), Gaps = 33/304 (10%)
Query: 297 YSSKDIIKKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDR 348
+ +++ K + +GSG +G V A+D G A+K++ + +E F +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAK 62
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHE---RSEQLDWDA 405
REL +L ++H ++ L + DF + E+L D
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122
Query: 406 RLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465
++ KGL Y+H + IIHRD+K N+ ++ + E ++ DFGLA+ + S +T
Sbjct: 123 IQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMT 176
Query: 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP----TDASFIEKGLNIVG 521
V + + R T+ D++S G ++ E+++GK +++ + + G
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 522 ------WLNFLISEDRQREIIDPNCEGVQSESL-----DALLAVATQCVSSSPDDRPTMH 570
E + P E S+ + + + + + R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 571 RVVQ 574
+
Sbjct: 297 EALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 7e-36
Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 29/277 (10%)
Query: 314 IIGSGGFGTVYK----LAMDDGNVFALKRIDKLN----EGFDRFFERELEILGSIKHR-Y 364
++G+G +G V+ D G ++A+K + K E ++L I+ +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 365 LVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC 424
LV L + T LI D++ GG L L +R + + ++ + + + L H
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV----GEIVLALEHLH 146
Query: 425 SPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGR 484
II+RDIK NILLD N ++DFGL+K +E+ GT Y+AP+ ++ G
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 485 A--TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542
+ + D +S GVL+ E+L+G P + + +
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-----SRRILKSEPPYPQEM-- 259
Query: 543 VQSESLDALLAVATQCVSSSPDDRPTMHR--VVQILE 577
S L+ + + P R +I E
Sbjct: 260 --SALAKDLI---QRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 2e-35
Identities = 59/280 (21%), Positives = 102/280 (36%), Gaps = 31/280 (11%)
Query: 296 PYSSKDIIKKLETLDDDHIIGSGGFGTVYK-LAMDDGNVFALKRIDK---LNEGFDRFFE 351
P + + + + + +G+G FG V + GN +A+K +DK +
Sbjct: 33 PSQNTAQLDQFDRIK---TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 352 RELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIM 411
E IL ++ +LV L ++ ++ +++ GG + L +
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAA 148
Query: 412 GAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTIVAGT 471
YLH S +I+RD+K N+L+D +V+DFG AK T + GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGT 201
Query: 472 FGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR 531
LAPE + S + D ++ GVL+ E+ +G P A +
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----------------QPIQ 245
Query: 532 QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHR 571
E I S L + + R +
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLK 285
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 8e-32
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 23/220 (10%)
Query: 298 SSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDRFFERE 353
S+ ++K+ + L IGSG G V A D A+K++ + N+ + RE
Sbjct: 11 STFTVLKRYQNLK---PIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 354 LEILGSIKHRYLVNLRGYCNSPTSK------LLIYDFLPGGSLDEALHERSEQLDWDARL 407
L ++ + H+ +++L + L+ + + E D +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMS 122
Query: 408 NIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI 467
++ G+ +LH IIHRD+K SNI++ + ++ DFGLA+ S + T
Sbjct: 123 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 177
Query: 468 VAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP 507
T Y APE + E D++S G ++ E++ K
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (306), Expect = 2e-31
Identities = 45/309 (14%), Positives = 113/309 (36%), Gaps = 43/309 (13%)
Query: 297 YSSKDIIKKLETLDDDHI---IGSGGFGTVYK-LAMDDGNVFALKRIDKLNEGFDRFFER 352
+ + + + DD + +G G + V++ + + + +K + + + + +R
Sbjct: 22 WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKR 78
Query: 353 ELEILGSIK-HRYLVNLRGYCNSPTSKL--LIYDFLPGGSLDEALHERSEQLDWDARLNI 409
E++IL +++ ++ L P S+ L+++ + + L
Sbjct: 79 EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFY 134
Query: 410 IMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAKLLEDEESHITTIV 468
+ K L Y H I+HRD+K N+++D + + R+ D+GLA+ + + +
Sbjct: 135 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVR 189
Query: 469 AGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRP-----TDASFIEKGLNIVGW 522
+ + PE + + D++S G ++ ++ K P + + + ++G
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249
Query: 523 LNFLISEDRQREIIDPNCEGVQSESL-----------------DALLAVATQCVSSSPDD 565
+ D+ +DP + L + +
Sbjct: 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309
Query: 566 RPTMHRVVQ 574
R T ++
Sbjct: 310 RLTAREAME 318
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 5e-31
Identities = 67/321 (20%), Positives = 127/321 (39%), Gaps = 42/321 (13%)
Query: 297 YSSKDIIKKLETLDDD----HIIGSGGFGTVYKLAMD--DGNVFALKRIDK--LNEGFDR 348
+ +++ K + + + +GSG +G+V A D G A+K++ + + +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 349 FFERELEILGSIKHRYLVNLRGYCNSPTS-----KLLIYDFLPGGSLDEALHERSEQLDW 403
REL +L +KH ++ L S + + L G L+ + ++L
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTD 120
Query: 404 DARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463
D +I +GL Y+H S IIHRD+K SN+ ++ + E ++ DFGLA+ +D
Sbjct: 121 DHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---E 174
Query: 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRP----TDASFIEKGLNI 519
+T VA + + + D++S G ++ E+L+G+ ++ L +
Sbjct: 175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234
Query: 520 VGWLNFLISEDRQRE-----------IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT 568
VG + + E + N V + + + + + D R T
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
Query: 569 MHRVVQILESEVMT--PCPSD 587
Q L P D
Sbjct: 295 AA---QALAHAYFAQYHDPDD 312
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 2e-26
Identities = 43/234 (18%), Positives = 76/234 (32%), Gaps = 23/234 (9%)
Query: 313 HIIGSGGFGTVYKLAMD--DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRG 370
+G G F TV+ A D + A+K + ++ + E E+++L +
Sbjct: 19 RKLGWGHFSTVWL-AKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 371 YCNSPTSKLLIY---------------DFLPGGSLDEALHERSEQLDWDARLNIIMGAAK 415
+ KLL + + L L + I
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 416 GLAYLHHDCSPRIIHRDIKSSNILLDGN-LEARVSDFGLAKLLEDEESHITTI-VAGTFG 473
GL Y+H C IIH DIK N+L++ + +A L T
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 474 YLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLI 527
Y +PE + D++S L+ E+++G + + +I
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 4e-17
Identities = 24/160 (15%), Positives = 51/160 (31%), Gaps = 20/160 (12%)
Query: 314 IIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGF----------DRFFERELEILGSIKHR 363
++G G V+ + +K + F D F + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 364 YLVNLRGYCNSPTSKLLIYDFLPGGSLDE-ALHERSEQLDWDARLNIIMGAAKGLAYLHH 422
L L+G +Y + L E + ++ + ++ + +A +H
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 423 DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462
I+H D+ N+L+ + DF + + +E
Sbjct: 122 RG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW 157
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.8 bits (182), Expect = 2e-15
Identities = 54/163 (33%), Positives = 75/163 (46%), Gaps = 8/163 (4%)
Query: 31 SDGEALLSFRTAVVSSDGFLNQWRPE-DPDPCNWKGVKCDKN---KRVITLSLTNHKLSG 86
D +ALL + + + L+ W P D W GV CD + RV L L+ L
Sbjct: 6 QDKQALLQIKKDL-GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 87 --PISADLGKLDQLKFLNLHSN-NFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNL 143
PI + L L L FL + N G IP + T+L L + +SG+IP L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 144 SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L+ LD S N+LS +PPS+ L L+ N + GAIP
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 69.4 bits (168), Expect = 2e-13
Identities = 25/66 (37%), Positives = 37/66 (56%)
Query: 144 SNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203
NL LD+ +N + +P L +L+ L + NVS N L G IP G L +F S++ N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 204 LCGKQI 209
LCG +
Sbjct: 304 LCGSPL 309
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.1 bits (149), Expect = 4e-11
Identities = 17/55 (30%), Positives = 25/55 (45%), Gaps = 1/55 (1%)
Query: 102 NLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSL 156
+L +N YG +P L L L++ N L G IP + GNL ++N
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 3e-09
Identities = 22/87 (25%), Positives = 35/87 (40%), Gaps = 1/87 (1%)
Query: 51 NQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
Q + + K +K + L L N+++ G + L +L L LN+ NN G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIP 137
EIP + GN + +N P
Sbjct: 283 EIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 71.6 bits (174), Expect = 5e-14
Identities = 26/84 (30%), Positives = 40/84 (47%), Gaps = 6/84 (7%)
Query: 95 LDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154
L L +L L+ NN P + + T+LQ L +N +S S L NL+N+ L N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 155 SLSDYIPPSLGKLQRLITFNVSNN 178
+SD P L L R+ +++
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.1 bits (152), Expect = 3e-11
Identities = 30/134 (22%), Positives = 49/134 (36%), Gaps = 26/134 (19%)
Query: 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP------------------ 113
+ L L N+++S L L +L L L +N P
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 298
Query: 114 --SELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171
S + N L L+L N +S P + +L+ L L ++N +SD SL L +
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 172 TFNVSNNFLVGAIP 185
+ +N + P
Sbjct: 355 WLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 25/111 (22%), Positives = 42/111 (37%), Gaps = 6/111 (5%)
Query: 51 NQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
R + K + +L TN+++S + L L+L+ N
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD 233
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIP 161
L + T L L L +N +S P L L+ L L + +N +S+ P
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 8/86 (9%)
Query: 95 LDQLKFLNLHSNNFYGEIP-SELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153
L + L N + ++L T LQ L + G + L+NL ++ S+
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75
Query: 154 NSLSDYIPPSLGKLQRLITFNVSNNF 179
N L+D P L L +L+ ++NN
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQ 99
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 59.3 bits (142), Expect = 3e-10
Identities = 24/152 (15%), Positives = 41/152 (26%), Gaps = 10/152 (6%)
Query: 61 CNWKGVKCDKN----------KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
C+ + V+C L L N+K++ D L L L L +N
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL 170
P +L+ L L N L L L + + + L ++ +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 171 ITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202
+ + K S
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 18/112 (16%), Positives = 32/112 (28%), Gaps = 3/112 (2%)
Query: 94 KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153
+ L + G +L + + ++ +IP G +L L +
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDG 180
Query: 154 NSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLC 205
N ++ SL L L +S N + T N L
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 26/135 (19%), Positives = 45/135 (33%), Gaps = 3/135 (2%)
Query: 48 GFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADL--GKLDQLKFLNLHS 105
LNQ + K + L+ +++ + G L L+L
Sbjct: 121 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDG 180
Query: 106 NNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLG 165
N + L L L L N +S L N +L L +++N L +P L
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLA 239
Query: 166 KLQRLITFNVSNNFL 180
+ + + NN +
Sbjct: 240 DHKYIQVVYLHNNNI 254
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 21/120 (17%), Positives = 39/120 (32%), Gaps = 9/120 (7%)
Query: 51 NQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
P+ + + + S I + L+ LN+ +N
Sbjct: 239 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-I 297
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL 170
E+P+ L+ L N+L+ +P NL L + N L + P ++ L
Sbjct: 298 ELPALPPR---LERLIASFNHLA-EVPELPQNLKQL---HVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.5 bits (85), Expect = 0.004
Identities = 17/60 (28%), Positives = 26/60 (43%), Gaps = 5/60 (8%)
Query: 127 LQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
N S I S +L L++S+N L + +P +L+RL S N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHL-AEVPE 321
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 25/106 (23%), Positives = 43/106 (40%), Gaps = 5/106 (4%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLH-SNNFYGEIPSELGNCTELQGLSLQSNYLSG 134
TL LT L + G+L + +F + +E + +Q + L ++ +
Sbjct: 4 TLDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 135 -SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
++ L S L NL + LSD I +L K L+ N+S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 2e-07
Identities = 15/82 (18%), Positives = 28/82 (34%), Gaps = 9/82 (10%)
Query: 97 QLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGSIPSELG-----NLSNLL 147
L+ L L + + + L L+ L L +N L + +L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 148 NLDISSNSLSDYIPPSLGKLQR 169
L + S+ + L L++
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 2e-06
Identities = 15/75 (20%), Positives = 27/75 (36%), Gaps = 5/75 (6%)
Query: 98 LKFLNLHSNNFYGEIPSEL-GNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDIS 152
++ L++ +EL + Q + L L+ I S L L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 153 SNSLSDYIPPSLGKL 167
SN L D + +
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 6e-06
Identities = 19/89 (21%), Positives = 30/89 (33%), Gaps = 5/89 (5%)
Query: 76 TLSLTNHKLS-GPISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSN 130
+L + +LS + L L Q + + L I S L L L+L+SN
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 131 YLSGSIPSELGNLSNLLNLDISSNSLSDY 159
L + + I SL +
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 22/116 (18%), Positives = 38/116 (32%), Gaps = 10/116 (8%)
Query: 48 GFLNQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSG----PISADLGKLDQLKFLNL 103
++ R ED + L L + +S ++A L L+ L+L
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404
Query: 104 HSNNFYGEIPSELG-----NCTELQGLSLQSNYLSGSIPSELGNLS-NLLNLDISS 153
+N +L L+ L L Y S + L L + +L + S
Sbjct: 405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 2e-05
Identities = 15/65 (23%), Positives = 27/65 (41%), Gaps = 5/65 (7%)
Query: 121 ELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSNSLSD----YIPPSLGKLQRLITFNV 175
++Q L +Q LS + +EL L + + L++ I +L L N+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 176 SNNFL 180
+N L
Sbjct: 63 RSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 9/78 (11%)
Query: 118 NCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQR---- 169
+ L+ L L +S S+ + L +L LD+S+N L D L + R
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 170 -LITFNVSNNFLVGAIPS 186
L + + + +
Sbjct: 427 LLEQLVLYDIYWSEEMED 444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 1e-06
Identities = 23/126 (18%), Positives = 40/126 (31%), Gaps = 32/126 (25%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQG----------- 124
L L + L+ L +L + L+L N P+ L L+
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 125 -----------LSLQSNYL-SGSIPSELGNLSNLLNLDISSNSLSD------YIPPSLGK 166
L L +N L + L + L+ L++ NSL + L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 167 LQRLIT 172
+ ++T
Sbjct: 119 VSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.003
Identities = 17/55 (30%), Positives = 25/55 (45%), Gaps = 3/55 (5%)
Query: 125 LSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNF 179
L L L+ + L L + +LD+S N L PP+L L+ L S+N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNA 54
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 4e-06
Identities = 19/74 (25%), Positives = 31/74 (41%), Gaps = 4/74 (5%)
Query: 104 HSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS 163
N + L N ++L L N +S P L +L NL+ + + +N +SD P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212
Query: 164 LGKLQRLITFNVSN 177
L L ++N
Sbjct: 213 LANTSNLFIVTLTN 226
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 2e-05
Identities = 22/99 (22%), Positives = 34/99 (34%), Gaps = 3/99 (3%)
Query: 91 DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG--SIPSELGNLSNLLN 148
DL + LN ++ + N EL L+L +N L + S + NL
Sbjct: 37 DLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 95
Query: 149 LDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187
L++S N L K +L + N L
Sbjct: 96 LNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 25/111 (22%), Positives = 38/111 (34%), Gaps = 1/111 (0%)
Query: 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS 135
L L +++S L L L LH N P + L L L +N LS
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 136 IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS 186
L L L L ++ N + L F S++ + ++P
Sbjct: 217 PTEALAPLRALQYLRLNDNPW-VCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.003
Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 4/61 (6%)
Query: 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSL 156
L++L L+ N + + + LQ S+ + S+P L +++N L
Sbjct: 226 ALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRD---LKRLAANDL 281
Query: 157 S 157
Sbjct: 282 Q 282
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 9e-05
Identities = 14/79 (17%), Positives = 22/79 (27%)
Query: 100 FLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDY 159
L L+ N + +N L S + LDIS +
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216
Query: 160 IPPSLGKLQRLITFNVSNN 178
L L++L + N
Sbjct: 217 PSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 5e-04
Identities = 10/112 (8%), Positives = 24/112 (21%), Gaps = 3/112 (2%)
Query: 51 NQWRPEDPDPCNWKGVKCDKNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYG 110
+ + + + L L + + + + +NN
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 111 EIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPP 162
+ L + + L NL L + +P
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 10/87 (11%), Positives = 26/87 (29%), Gaps = 5/87 (5%)
Query: 98 LKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISS 153
LK + + + + L ++ + L N + + + + +L + S
Sbjct: 10 LKLDAI-TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 154 NSLSDYIPPSLGKLQRLITFNVSNNFL 180
L+ L+ + L
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 12/65 (18%), Positives = 24/65 (36%), Gaps = 3/65 (4%)
Query: 115 ELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFN 174
E+ ++ L+ ++P +L + L +S N L + +L RL N
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 175 VSNNF 179
+
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 12/65 (18%), Positives = 23/65 (35%), Gaps = 3/65 (4%)
Query: 91 DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150
++ K+ +N N +P +L + L L N L + L + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 151 ISSNS 155
+
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 7e-04
Identities = 21/75 (28%), Positives = 27/75 (36%), Gaps = 1/75 (1%)
Query: 104 HSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPS 163
N P L +L+ LSL +N L+ L L NL L + NSL IP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKG 190
Query: 164 LGKLQRLITFNVSNN 178
L + N
Sbjct: 191 FFGSHLLPFAFLHGN 205
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 3e-04
Identities = 15/81 (18%), Positives = 26/81 (32%), Gaps = 4/81 (4%)
Query: 105 SNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSL 164
+ + N + L L+ + I + L +D S N +
Sbjct: 4 TAELIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGF 59
Query: 165 GKLQRLITFNVSNNFLVGAIP 185
L+RL T V+NN +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGE 80
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 8e-04
Identities = 21/115 (18%), Positives = 31/115 (26%), Gaps = 2/115 (1%)
Query: 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSEL-GNLSNLLNLDISSN 154
L + + L L L +++ + L L NL I +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209
L P + RL N+S N L E GN C +
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 14/50 (28%), Positives = 20/50 (40%), Gaps = 2/50 (4%)
Query: 104 HSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153
+ L T+LQ L L N++S L L NL L++ S
Sbjct: 162 SLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 594 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.77 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.72 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.68 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.63 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.62 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.6 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.59 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.53 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.52 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.49 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.45 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.38 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.37 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.36 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.35 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.26 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.22 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.15 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.03 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.94 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.78 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.68 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.66 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.57 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.5 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.27 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.13 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.44 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.4 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.86 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.5 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.34 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=408.49 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=201.4
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
++|+..+.||+|+||+||+|.+.+++.||||+++.... ..+.|.+|++++++++|||||+++|+|.++...++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 35777899999999999999999999999999976433 35679999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+|+|.+++......+++..+..++.|||+||+|||+ .+|+||||||+|||+++++.+||+|||+++...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 999999998777789999999999999999999995 49999999999999999999999999999877655444445
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSG-KRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...||+.|+|||++.+..++.++|||||||++|||+|+ .+|+..... ............ .. .+.
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~i~~~~~---~~------~p~ 225 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTGFR---LY------KPR 225 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHHHHHTCC---CC------CCT
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHHHHHhcCC---CC------Ccc
Confidence 56789999999999999999999999999999999995 555443211 111111111111 11 112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
..+.++.+++.+||+.||++|||++||++.|+++.
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 23467899999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-52 Score=413.21 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=200.9
Q ss_pred CCCccceeeeecceEEEEEEecC-C---cEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMDD-G---NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
.|+..+.||+|+||+||+|.++. + ..||||++... .....+.|.+|++++++++|||||+++|+|.++...++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 44556899999999999998753 2 35899988653 4445678999999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++......+++.++..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 9999999999998777789999999999999999999995 4999999999999999999999999999987654432
Q ss_pred ee----eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 463 HI----TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 463 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
.. .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... ...........
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~i~~~~~------ 251 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINAIEQDYR------ 251 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC------
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC------
Confidence 21 122457999999999999999999999999999999998 89998754322 11111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
...+...+..+.+|+.+||+.||++|||++||++.|++.+..
T Consensus 252 ---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 ---LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 112233456799999999999999999999999999987654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=406.67 Aligned_cols=259 Identities=26% Similarity=0.464 Sum_probs=205.7
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|...+.||+|+||+||+|.+++ .||||+++.. +....+.|.+|++++++++|||||+++|++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4578889999999999999998653 5999998743 34456789999999999999999999999865 56899999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES- 462 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~- 462 (594)
|+++|+|.++++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999999999998777789999999999999999999995 4999999999999999999999999999987654332
Q ss_pred eeeeeeecccCccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQS---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+....... ...+.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~----~~~p~ 230 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRG----YLSPD 230 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHT----SCCCC
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcC----CCCCc
Confidence 23345679999999999864 358999999999999999999999997532211 111111111 11122
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
........+..+.+|+.+||+.||++|||++||++.|+.+.
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22233344578999999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=407.86 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=208.5
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|+..+.||+|+||+||+|.+++++.||||+++.... ..+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 467888899999999999999999889999999976433 35679999999999999999999998865 5679999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++|+|.+++... ...+++..++.|+.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999988643 3469999999999999999999995 499999999999999999999999999999876555444
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
.....||+.|+|||++.++.++.++|||||||++|||+||..|+...... ........... .+ ..+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~~~~~i~~~~------~~---~~p 232 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNLERGY------RM---VRP 232 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTC------CC---CCC
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcC------CC---CCc
Confidence 45567899999999999999999999999999999999976654332111 11111111111 11 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
...+..+.+|+.+||+.||++|||++||++.|+.
T Consensus 233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2344678999999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=397.41 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=215.5
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLP 386 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 386 (594)
++|+..+.||+|+||+||+|.++++..||||+++.... ..+.|.+|++++++++||||++++|+|.+....++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999999899999999986443 35689999999999999999999999999999999999999
Q ss_pred CCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceeee
Q 007668 387 GGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITT 466 (594)
Q Consensus 387 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~~ 466 (594)
+|+|.+++......+++..+.+++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999999988777789999999999999999999995 49999999999999999999999999999877655544444
Q ss_pred eeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 467 IVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 467 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
...||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ ......... + . ..+.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~i~~~~--~-~------~~p~ 224 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGL--R-L------YRPH 224 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTC--C-C------CCCT
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HHHHHHhCC--C-C------CCcc
Confidence 5678999999999999999999999999999999998 899987643221 111111111 1 1 1122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
..+..+.+|+.+||+.||++|||++|+++.|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 334679999999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-51 Score=407.32 Aligned_cols=261 Identities=23% Similarity=0.354 Sum_probs=216.1
Q ss_pred HHhcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 304 KKLETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 304 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
...++|+..+.||+|+||+||+|.+. +++.||||+++.... ..+.|.+|++++++++|||||+++|+|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567888899999999999999876 588999999876433 3567999999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
||+++|+|.+++... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999753 45699999999999999999999964 99999999999999999999999999999877665
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
........|++.|+|||++.++.++.++|||||||++|||++|..|+..... ......... .. . .+
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~~~~~i~-~~-~----~~--- 235 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE-KD-Y----RM--- 235 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHH-TT-C----CC---
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHHHHHHHh-cC-C----CC---
Confidence 5555556789999999999999999999999999999999997776543211 111111111 11 0 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT 582 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~ 582 (594)
..+...+..+.+|+.+||+.||++|||++||++.|+.....
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12223446799999999999999999999999999887554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=394.32 Aligned_cols=246 Identities=29% Similarity=0.486 Sum_probs=206.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||+||+|..+ +++.||+|++.+. .....+.+.+|++++++++||||+++++++.++...++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 357888999999999999999875 6889999998742 233467789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 9999999999999764 569999999999999999999995 499999999999999999999999999998665432
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......... ..
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-------~~-- 222 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVE-------FT-- 222 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-------CC--
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHHHHcCC-------CC--
Confidence 234579999999999999999999999999999999999999997643221 111111111 01
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+...+.++.+|+.+||+.||++|||++|+++
T Consensus 223 -~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 12234467899999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=398.56 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=208.1
Q ss_pred cCCCccce-eeeecceEEEEEEec---CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHI-IGSGGFGTVYKLAMD---DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
++|...+. ||+|+||+||+|.++ ++..||||+++.. .....+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 44555664 999999999999764 3557999999754 33446789999999999999999999999875 468999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++......+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 99999999999988767789999999999999999999995 499999999999999999999999999999776544
Q ss_pred ceee--eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 462 SHIT--TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 462 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... ....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... .+ .........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~---~~~i~~~~~------- 230 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EV---MAFIEQGKR------- 230 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HH---HHHHHTTCC-------
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HH---HHHHHcCCC-------
Confidence 3222 23568999999999999999999999999999999998 89999764221 11 111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
...+...+.++.+|+.+||+.||++|||+.+|.+.|+...
T Consensus 231 --~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 231 --MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1122334567899999999999999999999999998653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-50 Score=394.61 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=208.6
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
++|+..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4689999999999999999976 469999999998655555678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.+...... .
T Consensus 100 ~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (293)
T ss_dssp TTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-B
T ss_pred CCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-c
Confidence 99999998865 459999999999999999999995 49999999999999999999999999999877544332 3
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCCH
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQS 545 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (594)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........... .. ..+.
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~------~~-~~~~ 240 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP------EL-QNPE 240 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC------CC-SSGG
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC------CC-CCcc
Confidence 44579999999999999999999999999999999999999996533211 11111111110 00 1123
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 546 ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 546 ~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+..+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34577899999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=396.50 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=202.6
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|+..+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57888999999999999999875 68999999987532 23345689999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc-e
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES-H 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~-~ 463 (594)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 85 ~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 85 CSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999999975 3569999999999999999999995 4999999999999999999999999999987654432 2
Q ss_pred eeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... ..+... ..... ...
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~~~-~~~~~--------~~~ 227 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QEYSDW-KEKKT--------YLN 227 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS----HHHHHH-HTTCT--------TST
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH----HHHHHH-hcCCC--------CCC
Confidence 2345679999999999988775 678999999999999999999997543211 101011 10000 001
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.++.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11233467889999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=399.04 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=204.4
Q ss_pred cCCCccceeeeecceEEEEEEecCC-----cEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDG-----NVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
+.|+..++||+|+||+||+|.+++. ..||||++... .......|.+|++++++++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3567789999999999999987643 36999999753 33445679999999999999999999999999999999
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
|+||+.+|++.+.+......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 999999999999998877889999999999999999999995 49999999999999999999999999999876543
Q ss_pred Cce--eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESH--ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
... ......||+.|+|||++.++.++.++|||||||++|||++|..|+...... .+.........
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~~~-------- 230 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDGF-------- 230 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTC--------
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHHHHhccC--------
Confidence 322 223456899999999999999999999999999999999976665432111 11111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
....+...+..+.+|+.+||+.||++||||.||++.|+.....+
T Consensus 231 -~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 231 -RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp -CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 11122334567999999999999999999999999998876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=395.87 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=194.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--CCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS--PTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 380 (594)
.++|+..+.||+|+||+||+|... +|+.||||.+... ++...+.+.+|++++++++|||||++++++.+ ....++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367889999999999999999764 6899999998753 33445678999999999999999999999864 455789
Q ss_pred EEEccCCCchhhhhhh---cCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 381 IYDFLPGGSLDEALHE---RSEQLDWDARLNIIMGAAKGLAYLHHDC--SPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999874 3467999999999999999999999751 1359999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREI 535 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 535 (594)
....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ ...... ...
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~i~-~~~---- 230 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGKIR-EGK---- 230 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHH-HTC----
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHHHHH-cCC----
Confidence 7764332 2345679999999999999999999999999999999999999997643221 111111 111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
....+...+.++.+|+.+||+.||++|||++|+++
T Consensus 231 ----~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 ----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11122334567999999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=395.94 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=206.8
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++|+..+.||+|+||+||+|.+++++.||||+++.... ..+.|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 467889999999999999999999988999999975433 35679999999999999999999999855 5689999999
Q ss_pred CCCchhhhhhhc-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 386 PGGSLDEALHER-SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 386 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
++|+|.+++... ...++|..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999998753 45699999999999999999999964 99999999999999999999999999998776554444
Q ss_pred eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 465 TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
.....||+.|+|||++.++.++.++||||||+++|||++|..|+...... ........... +. ..+
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~~~i~~~~--~~-------~~~ 236 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVERGY--RM-------PCP 236 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTC--CC-------CCC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcC--CC-------CCC
Confidence 45567899999999999999999999999999999999976665432111 11111111111 11 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCC
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCP 585 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 585 (594)
...+.++.+++.+||+.||++|||+++|+++|+.......|
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 23346789999999999999999999999999987765544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=395.68 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=207.5
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
+.|+..+.||+|+||+||+|... +++.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45788899999999999999865 68999999998766666678999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
++|+|.+++.+....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 99999999887677899999999999999999999964 999999999999999999999999999976543221 12
Q ss_pred eeeecccCccCccccc-----cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCC
Q 007668 466 TIVAGTFGYLAPEYMQ-----SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNC 540 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (594)
....||+.|+|||++. ...++.++|||||||++|||++|+.||......+ .......... +.
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~~------~~- 234 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEP------PT- 234 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSCC------CC-
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCC------CC-
Confidence 3457999999999984 4568999999999999999999999997643221 1111111110 01
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 541 EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 541 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122344577999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=391.05 Aligned_cols=247 Identities=25% Similarity=0.411 Sum_probs=199.9
Q ss_pred ceeeeecceEEEEEEecC---CcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEccCC
Q 007668 313 HIIGSGGFGTVYKLAMDD---GNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFLPG 387 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 387 (594)
+.||+|+||+||+|.+++ ++.||||+++.. +....+.|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999997653 467999999642 33345679999999999999999999999965 467899999999
Q ss_pred CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee--
Q 007668 388 GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT-- 465 (594)
Q Consensus 388 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~-- 465 (594)
|+|.++++. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..........
T Consensus 92 g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 999999976 4569999999999999999999995 4999999999999999999999999999987665443322
Q ss_pred eeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCCCC
Q 007668 466 TIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQ 544 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (594)
....||++|+|||.+.+..++.++|||||||++|||+| |+.||......+ .......... ...+
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~------~~~~i~~~~~---------~~~p 232 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGER---------MGCP 232 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC---------CCCC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH------HHHHHHcCCC---------CCCC
Confidence 34568999999999999999999999999999999998 899997642211 1111111111 1122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 545 SESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 545 ~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
...+.++.+|+.+||+.||++|||+++|.+.|+..
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 33446789999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=397.74 Aligned_cols=256 Identities=23% Similarity=0.397 Sum_probs=206.5
Q ss_pred hcCCCccceeeeecceEEEEEEecCC------cEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDG------NVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 377 (594)
.++|+..+.||+|+||+||+|..... ..||||++... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 46788899999999999999986532 36899998653 334456789999999998 89999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 007668 378 KLLIYDFLPGGSLDEALHERS----------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKS 435 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~ 435 (594)
.++||||+++|+|.++++.+. ..+++..++.++.||++||+|||+ .+|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 999999999999999997542 248999999999999999999995 4999999999
Q ss_pred CCeEecCCCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchh
Q 007668 436 SNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFI 513 (594)
Q Consensus 436 ~NIll~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~ 513 (594)
+|||++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876554433 3345678999999999999999999999999999999998 8999875432
Q ss_pred cccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhc
Q 007668 514 EKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILES 578 (594)
Q Consensus 514 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~ 578 (594)
... +. ..+.... .+ ..+...+..+.+|+.+||+.||++|||++||++.|..
T Consensus 273 ~~~--~~----~~~~~~~-----~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DAN--FY----KLIQNGF-----KM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHH--HH----HHHHTTC-----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH--HH----HHHhcCC-----CC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 211 11 1111110 11 1122344679999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=380.68 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=195.7
Q ss_pred CccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC----CCceEEEE
Q 007668 310 DDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS----PTSKLLIY 382 (594)
Q Consensus 310 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 382 (594)
...+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999765 5889999998753 34445679999999999999999999999854 34578999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec-CCCcEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD-GNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~~l~Dfgl~~~~~~~~ 461 (594)
||+++|+|.+++.+. ..+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++......
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~ 169 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 169 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence 999999999999764 5699999999999999999999965 33499999999999997 57899999999998644332
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ........... ....
T Consensus 170 ---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~i~~~~-~~~~------ 233 (270)
T d1t4ha_ 170 ---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGV-KPAS------ 233 (270)
T ss_dssp ---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTC-CCGG------
T ss_pred ---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHHHHcCC-CCcc------
Confidence 345679999999999875 6999999999999999999999999643211 11111111111 1111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+...++++.+|+.+||+.||++|||++|+++
T Consensus 234 -~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 -FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11223356889999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=387.42 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=199.1
Q ss_pred hcCCCccceeeeecceEEEEEEecC----CcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD----GNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.++|...+.||+|+||.||+|.+.. +..||||+++.. .....+.|.+|++++++++||||++++|++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 3578888999999999999997653 356899988753 33445679999999999999999999999964 67899
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
||||+++|+|.+++......+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 999999999999988777789999999999999999999995 49999999999999999999999999999877655
Q ss_pred CceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 461 ESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 461 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||......+ +. ........
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~---~~i~~~~~-------- 227 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRIENGER-------- 227 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HHHHTTCC--------
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HH---HHHHcCCC--------
Confidence 5444555678999999999999999999999999999999998 899987643321 11 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
...+...+..+.+|+.+||+.||++|||++||++.|++++
T Consensus 228 -~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1122334467999999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=390.98 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=203.8
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
++|+..+.||+|+||+||+|... +|+.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999874 6899999998742 2334567999999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|.+++... +.+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999998764 579999999999999999999995 4999999999999999999999999999987754332
Q ss_pred -eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 463 -HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 463 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......... .
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-------~--- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLE-------Y--- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTC-------C---
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHcCC-------C---
Confidence 23345679999999999999999999999999999999999999997643221 111111111 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112234467899999999999999999998753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-48 Score=392.47 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=211.0
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.++|++.+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 568999999999999999999764 6899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec--CCCcEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
+++|+|.+++......+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 99999999997666779999999999999999999995 4999999999999996 467899999999987765432
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .......... .++. .
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~---~~~~---~ 247 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDW---NMDD---S 247 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCC---CSCC---G
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC---CCCc---c
Confidence 345679999999999999999999999999999999999999997643221 1111111110 0000 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11233467899999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=396.06 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=205.5
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
.++|+..+.||+|+||+||+|... +|+.||+|+++.. .......+.+|++++++++|||||+++++|.++...++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467888999999999999999864 6899999999753 34445789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+++|+|.+++.++ +.+++..+..++.||+.||+|||+. .+|+||||||+|||++.++++||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 159 (322)
T ss_dssp CCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence 99999999999764 5699999999999999999999952 389999999999999999999999999998765432
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH---------------HHHHHHhc
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV---------------GWLNFLIS 528 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~---------------~~~~~~~~ 528 (594)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||............ .+......
T Consensus 160 -~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp -C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred -cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 23467999999999999999999999999999999999999999764322110000 00000000
Q ss_pred cc------------ccccccCCCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 529 ED------------RQREIIDPNCEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 529 ~~------------~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.. ....+.....+. .....+.++.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 000000000000 11123467899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-49 Score=391.92 Aligned_cols=261 Identities=23% Similarity=0.403 Sum_probs=211.6
Q ss_pred HHHHhcCCCccceeeeecceEEEEEEec------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC
Q 007668 302 IIKKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNS 374 (594)
Q Consensus 302 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 374 (594)
++...++|+..+.||+|+||+||+|..+ +++.||||+++.. .....+.|.+|++++++++||||++++++|.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3344678999999999999999999864 3578999999753 33346779999999999999999999999999
Q ss_pred CCceEEEEEccCCCchhhhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 007668 375 PTSKLLIYDFLPGGSLDEALHERS-----------------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431 (594)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 431 (594)
....++|+||+++|+|.++++... ..+++..++.++.||+.||+|||+ .+|+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEee
Confidence 999999999999999999997421 248899999999999999999995 499999
Q ss_pred CCCCCCeEecCCCcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCC-CCCC
Q 007668 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK-RPTD 509 (594)
Q Consensus 432 Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~ 509 (594)
||||+|||++.++.+||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999986654332 2334567899999999999999999999999999999999986 5665
Q ss_pred cchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 510 ASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.....+ ....... .. ....+...+.++.+|+.+||+.||++||||.||+++|+++.
T Consensus 245 ~~~~~e------~~~~v~~-~~--------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEE------VIYYVRD-GN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHH------HHHHHHT-TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHH------HHHHHHc-CC--------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 532221 1111111 11 11122334467899999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-47 Score=388.98 Aligned_cols=252 Identities=27% Similarity=0.359 Sum_probs=211.0
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
.+.|+..+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.++...++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45788999999999999999976 46999999999876655567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec--CCCcEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD--GNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
+++|+|.+.+......+++..+..|+.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||++........
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 99999999988766779999999999999999999995 4999999999999997 678999999999998765433
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... .......... . +. ..
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~--~-~~---~~ 250 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCDW--E-FD---ED 250 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCCC--C-CC---SS
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC--C-CC---cc
Confidence 344578999999999999999999999999999999999999997643221 1111111110 0 01 01
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12234467899999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=380.64 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=197.2
Q ss_pred hcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-CCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~ 384 (594)
.++|+..+.||+|+||.||+|.++ |+.||||+++... ..+.|.+|++++++++||||++++|+|.+ ....++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356777899999999999999985 7889999997643 34679999999999999999999999865 4568999999
Q ss_pred cCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 385 LPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 385 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
+++|+|.++++.+. ..++|..+++|+.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++......
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 99999999997543 358999999999999999999995 599999999999999999999999999998654322
Q ss_pred eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
....+|+.|+|||++.++.+++++||||||+++|||+| |+.|+...... .+..+ ..... . +.
T Consensus 158 --~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~---i~~~~------~---~~ 220 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR---VEKGY------K---MD 220 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH---HTTTC------C---CC
T ss_pred --ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH---HHcCC------C---CC
Confidence 23457999999999999999999999999999999998 67777653222 11211 11111 1 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
.+...+.++.+|+.+||+.||++|||+.|+++.|+++
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 2223446789999999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-48 Score=384.59 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=190.0
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+.|+..+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56888999999999999999875 68999999997532 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec---CCCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+. +++.+||+|||+++......
T Consensus 89 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999999976 4579999999999999999999995 4999999999999995 57899999999998665432
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .......... . ++.
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~--~-~~~--- 230 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEY--E-FDS--- 230 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTCC--C-CCT---
T ss_pred --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccCC--C-CCC---
Confidence 2334679999999999999999999999999999999999999997643221 1111111110 0 010
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
......+..+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 112234467899999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-48 Score=384.47 Aligned_cols=245 Identities=25% Similarity=0.390 Sum_probs=200.0
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc---hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN---EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 382 (594)
+.|+..+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|++++++++|||||++++++.++...++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3578889999999999999976 468899999987533 233456899999999999999999999999999999999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~ 462 (594)
||+++|+|..++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 99999999766654 4679999999999999999999995 49999999999999999999999999999865432
Q ss_pred eeeeeeecccCccCcccccc---CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQS---GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPN 539 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (594)
....||+.|+|||++.+ +.++.++|||||||++|||++|+.||...... .......... ....
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~-~~~~---- 234 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-SPAL---- 234 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-CCCC----
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC-CCCC----
Confidence 23569999999999864 46899999999999999999999998653221 1111111111 1111
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 540 CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 540 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+..+.+|+.+||+.||++|||++|+++
T Consensus 235 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11223467999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=384.38 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=208.9
Q ss_pred cceeeeecceEEEEEEecCC----cEEEEEeecc-cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-CCceEEEEEcc
Q 007668 312 DHIIGSGGFGTVYKLAMDDG----NVFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNLRGYCNS-PTSKLLIYDFL 385 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~~ 385 (594)
.++||+|+||+||+|.+.++ ..||||+++. .+....+.|.+|++++++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987543 3589999975 344456789999999999999999999999865 56789999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce--
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH-- 463 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~-- 463 (594)
++|+|.++++......++..+++++.|+++||.|+|+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999999998877789999999999999999999995 59999999999999999999999999999876543322
Q ss_pred -eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCCC
Q 007668 464 -ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCEG 542 (594)
Q Consensus 464 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (594)
......||+.|+|||.+.++.++.++||||||+++|||+||+.||...... .++........+. .
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~i~~g~~~---------~ 254 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQGRRL---------L 254 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCCC---------C
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCC---------C
Confidence 122356899999999999999999999999999999999988887543211 1122222221111 1
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCCCCccc
Q 007668 543 VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTPCPSDF 588 (594)
Q Consensus 543 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~ 588 (594)
.+...+..+.+|+.+||+.||++||||.||++.|+++.......+|
T Consensus 255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~ 300 (311)
T d1r0pa_ 255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 300 (311)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhc
Confidence 1122346789999999999999999999999999998766554443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=377.78 Aligned_cols=255 Identities=25% Similarity=0.392 Sum_probs=198.8
Q ss_pred cCCCccceeeeecceEEEEEEecC--C--cEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDD--G--NVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
++|+..+.||+|+||+||+|.... + ..||||++... .....+.|.+|++++++++||||++++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 467888999999999999997643 2 36899998753 33445679999999999999999999999976 4678
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLED 459 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~ 459 (594)
+||||+++|++.+.+..+...+++..++.++.|||+||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999999998777789999999999999999999995 4999999999999999999999999999998755
Q ss_pred CCcee--eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 460 EESHI--TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 460 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
..... .....|+..|+|||++.+..++.++||||||+++|||+| |+.||......+ ......... .+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~-~~~-- 234 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEG-ERL-- 234 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSC-CCC--
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCC-CCC--
Confidence 43322 234567889999999999999999999999999999998 899987543221 111111111 110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
..+...+..+.+|+.+||+.||++|||++||.+.|+++
T Consensus 235 -----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 -----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11223346799999999999999999999999999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-48 Score=387.40 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=203.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCc----EEEEEeecc-cchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGN----VFALKRIDK-LNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 380 (594)
.+|+..++||+|+||+||+|.+. +|+ +||+|+++. ......+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35788899999999999999765 343 589998865 3344567899999999999999999999999875 5678
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
++||+.+|+|.+.+..+...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 899999999999998878889999999999999999999995 49999999999999999999999999999977654
Q ss_pred Ccee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccchHHHHHHHHhcccccccccCC
Q 007668 461 ESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDP 538 (594)
Q Consensus 461 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 538 (594)
.... .....||+.|+|||++.++.++.++|||||||++|||+| |..||+.....+ +. ........
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~---~~i~~~~~------- 231 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS---SILEKGER------- 231 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH---HHHHHTCC-------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH---HHHHcCCC-------
Confidence 4332 334568999999999999999999999999999999998 788887643221 11 11111111
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcc
Q 007668 539 NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESE 579 (594)
Q Consensus 539 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~ 579 (594)
...+...+..+.+|+.+||+.||++|||++|+++.|+..
T Consensus 232 --~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 232 --LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 011233446789999999999999999999999988764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=377.54 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=204.5
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc------hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN------EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 379 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 379 (594)
++|+..+.||+|+||+||+|.. .+|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+....+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688999999999999999987 468999999986421 123577999999999999999999999999999999
Q ss_pred EEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC----cEEEeeccccc
Q 007668 380 LIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL----EARVSDFGLAK 455 (594)
Q Consensus 380 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~~l~Dfgl~~ 455 (594)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+|++|||++.
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999999764 569999999999999999999995 4999999999999998766 59999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc-cccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED-RQRE 534 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 534 (594)
....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ........ ....
T Consensus 166 ~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~~~~~~ 237 (293)
T d1jksa_ 166 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAVNYEFED 237 (293)
T ss_dssp ECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHTTCCCCCH
T ss_pred hcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------HHHHHhcCCCCCc
Confidence 7654332 3345689999999999999999999999999999999999999976432211 11111110 0000
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. .....+..+.+|+.+||+.||++|||++|+++
T Consensus 238 ~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 238 E-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp H-------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h-------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 11123467889999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=384.38 Aligned_cols=261 Identities=20% Similarity=0.344 Sum_probs=213.1
Q ss_pred HhcCCCccceeeeecceEEEEEEec------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc
Q 007668 305 KLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKL-NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 305 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 377 (594)
..++|...+.||+|+||+||+|.+. +++.||||+++.. .......|.+|++++++++||||++++|+|.....
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3567888899999999999999764 3578999999753 33445578999999999999999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhc---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEE
Q 007668 378 KLLIYDFLPGGSLDEALHER---------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARV 448 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l 448 (594)
.++||||+++|+|.+++... ...+++..+.+++.|+|+||.|||+ .+|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence 99999999999999998742 1347999999999999999999996 49999999999999999999999
Q ss_pred eecccccccccCCcee-eeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCC-CCCCcchhcccchHHHHHHHH
Q 007668 449 SDFGLAKLLEDEESHI-TTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK-RPTDASFIEKGLNIVGWLNFL 526 (594)
Q Consensus 449 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~ 526 (594)
+|||+++......... .....||+.|+|||.+.++.++.++||||||+++|||+||. .||..... .......
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~i 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFV 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHHH
Confidence 9999998765443322 23346899999999999999999999999999999999985 66644322 2222222
Q ss_pred hcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCCC
Q 007668 527 ISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMTP 583 (594)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~~ 583 (594)
.... ....+...+..+.+++.+||+.+|++|||+++|++.|++.+...
T Consensus 249 ~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 249 MEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred HhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 2211 11122334467999999999999999999999999999876644
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=383.51 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=207.0
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||+||+|.. .+|+.||+|++++. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46788999999999999999976 47899999999753 233456788999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999998764 568999999999999999999995 599999999999999999999999999998765433
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ......... .
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~~~-------~--- 222 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE-------I--- 222 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-------C---
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhcCC-------C---
Confidence 2 2345679999999999999999999999999999999999999997643221 111111111 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
..+...+.++.+|+.+||+.||++||+ ++|+++
T Consensus 223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112234567899999999999999995 777765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=381.39 Aligned_cols=269 Identities=26% Similarity=0.373 Sum_probs=202.8
Q ss_pred CCCHHHHHHHhcCCCccceeeeecceEEEEEEec------CCcEEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeee
Q 007668 296 PYSSKDIIKKLETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVN 367 (594)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~ 367 (594)
|+...+++...++|...+.||+|+||.||+|... +++.||||+++.. .....+.+.+|...+.++ +|+||+.
T Consensus 2 p~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 3444555445578999999999999999999764 2468999999753 334456678888887776 6899999
Q ss_pred eeeEEeCC-CceEEEEEccCCCchhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 007668 368 LRGYCNSP-TSKLLIYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHR 431 (594)
Q Consensus 368 l~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~ 431 (594)
+++++.+. ...++||||+++|+|.++++.. ...+++..+..++.||++||+|||+ .+|+||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCC
Confidence 99998664 4578999999999999999753 2348999999999999999999995 499999
Q ss_pred CCCCCCeEecCCCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCC-CCCC
Q 007668 432 DIKSSNILLDGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGK-RPTD 509 (594)
Q Consensus 432 Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~-~p~~ 509 (594)
||||+|||+++++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+||. .||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876543332 234467999999999999999999999999999999999975 5665
Q ss_pred cchhcccchHHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 510 ASFIEKGLNIVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
...... .+...+..... + ..+...+.++.+++.+||+.||++|||++||++.|++.+.
T Consensus 239 ~~~~~~------~~~~~~~~~~~-----~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 239 GVKIDE------EFCRRLKEGTR-----M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp TCCCSH------HHHHHHHHTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHH------HHHHHHhcCCC-----C---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 432111 11111111111 1 1122334678999999999999999999999999987653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.3e-47 Score=378.55 Aligned_cols=245 Identities=25% Similarity=0.379 Sum_probs=204.8
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||+||+|.. .+|+.||||++++. .....+.+.+|+.++++++||||+++++++.++...++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 35788899999999999999986 46899999999742 233456789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|..++.. ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence 999999999998875 456889999999999999999999 5599999999999999999999999999998765432
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... ..
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~---~~------ 219 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAE---LR------ 219 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCC---CC------
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHcCC---CC------
Confidence 3467999999999999999999999999999999999999999764322 1111111111 01
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
.+...+.++.+++.+||+.||.+|| |++|+++
T Consensus 220 -~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1122346789999999999999996 8999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-46 Score=368.85 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=200.5
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCc----e
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTS----K 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~ 378 (594)
++|+..+.||+|+||+||+|.. .+|+.||||+++.. +....+.+.+|++++++++||||+++++++..... .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 5688899999999999999976 57899999999753 23345679999999999999999999999865443 7
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||+++|+|.+++... +.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++..+++|||.+....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence 8999999999999988764 569999999999999999999995 499999999999999999999999999987654
Q ss_pred cCCc--eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccccc
Q 007668 459 DEES--HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREII 536 (594)
Q Consensus 459 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (594)
.... .......||+.|+|||++.+..+++++||||+||++|||+||+.||...... ...............
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~~- 235 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPPS- 235 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCGG-
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCCc-
Confidence 3322 2334567999999999999999999999999999999999999999764322 111112221111100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhcc
Q 007668 537 DPNCEGVQSESLDALLAVATQCVSSSPDDRP-TMHRVVQILESE 579 (594)
Q Consensus 537 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ev~~~L~~~ 579 (594)
......+..+.+++.+||+.||++|| |++++++.|.+.
T Consensus 236 -----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 236 -----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 01122346789999999999999999 899999988764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=378.05 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=201.0
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC----ceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----SKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~ 382 (594)
++|...+.||+|+||.||+|.+ +|+.||||+++.... .......|+..+.+++||||++++|+|.+.. ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4566778999999999999986 588999999865332 1222344555567789999999999996544 468999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHD-----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
||+++|+|.+++++. .++|..+..++.|+|.||+|+|+. .+++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999999863 599999999999999999999963 1369999999999999999999999999999877
Q ss_pred ccCCce---eeeeeecccCccCccccccCC------CCccchhhhHHHHHHHHHhCCCCCCcchhcccc--------hHH
Q 007668 458 EDEESH---ITTIVAGTFGYLAPEYMQSGR------ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL--------NIV 520 (594)
Q Consensus 458 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~--------~~~ 520 (594)
...... ......||++|+|||++.+.. ++.++|||||||++|||+||..|+......... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 544332 223467999999999987542 577899999999999999999887543221110 011
Q ss_pred HHHHHHhcccccccccCCCCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 521 GWLNFLISEDRQREIIDPNCEG--VQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
......... ...+|.++. ........+.+|+.+||+.||++|||+.||++.|++..
T Consensus 239 ~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 239 EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111111111 122233322 12345567999999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=379.56 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=204.2
Q ss_pred hcCCCccceeeeecceEEEEEEecC-Cc--EEEEEeeccc-chhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCceEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD-GN--VFALKRIDKL-NEGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 380 (594)
.++|+..++||+|+||+||+|.+++ |. .||||+++.. .....+.|.+|++++.++ +|||||+++|+|.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 4688889999999999999998764 33 5788887643 333456799999999998 79999999999999999999
Q ss_pred EEEccCCCchhhhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCc
Q 007668 381 IYDFLPGGSLDEALHER---------------SEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLE 445 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 445 (594)
||||+++|+|.++++.+ ...+++..+..++.||++||.|+|+ .+|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 99999999999999743 3569999999999999999999995 49999999999999999999
Q ss_pred EEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCC-CCCcchhcccchHHHHHH
Q 007668 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKR-PTDASFIEKGLNIVGWLN 524 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~-p~~~~~~~~~~~~~~~~~ 524 (594)
+||+|||+++....... .....||..|+|||.+.++.++.++||||||+++|||++|.. ||...... ....
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~------~~~~ 237 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYE 237 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH------HHHH
Confidence 99999999986543322 233468999999999999999999999999999999999765 56543221 1112
Q ss_pred HHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 525 FLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
....... ...+...+..+.+|+.+||+.||++||||+||++.|++...
T Consensus 238 ~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 238 KLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2111111 11223345679999999999999999999999999988654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=376.97 Aligned_cols=257 Identities=28% Similarity=0.415 Sum_probs=204.5
Q ss_pred hcCCCccceeeeecceEEEEEEecC--------CcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMDD--------GNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSP 375 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 375 (594)
.++|...+.||+|+||.||+|.... +..||||+++... ......+.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3678888999999999999997542 3479999997633 34457788899998888 899999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 376 TSKLLIYDFLPGGSLDEALHERS---------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
...++||||+++|+|.+++..+. ..+++..++.++.||+.||+|||+ .+|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999997543 358999999999999999999995 499999999999999
Q ss_pred cCCCcEEEeecccccccccCCce-eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHh-CCCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEESH-ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLS-GKRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~ellt-g~~p~~~~~~~~~~~ 518 (594)
+.++.+||+|||+++........ ......||+.|+|||.+.++.++.++||||||+++|||++ |..||.......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 99999999999999876544332 2344568999999999999999999999999999999998 688876543221
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhccc
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEV 580 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~ 580 (594)
.......... + ..+...+..+.+|+.+||+.||++|||+.||++.|++++
T Consensus 246 ---~~~~i~~~~~------~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 ---LFKLLKEGHR------M---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ---HHHHHHTTCC------C---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHcCCC------C---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 1111111111 1 112234467999999999999999999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=373.50 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=206.8
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
+++|...+.||+|+||+||+|... +++.||||.++.... ....+.+|++++++++|||||++++++.+....++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467889999999999999999775 688999999976443 345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC--CCcEEEeecccccccccCCc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG--NLEARVSDFGLAKLLEDEES 462 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~~l~Dfgl~~~~~~~~~ 462 (594)
+++|+|.+++..+...+++..+..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 99999999998766679999999999999999999995 49999999999999984 4589999999998765433
Q ss_pred eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccc-cccccCCCCC
Q 007668 463 HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDR-QREIIDPNCE 541 (594)
Q Consensus 463 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 541 (594)
......||+.|+|||...+..++.++||||+||++|+|++|+.||......+ .......... ....
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~~~~~~~------ 225 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTFDEE------ 225 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCCCCHH------
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCChh------
Confidence 2344678999999999999999999999999999999999999997643221 1111111110 0000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.....+.++.+|+.+||+.||++|||++|+++
T Consensus 226 -~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 -AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00123466899999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=375.91 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=209.7
Q ss_pred hcCCCccceeeeecceEEEEEEec------CCcEEEEEeecccc-hhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeCCCc
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD------DGNVFALKRIDKLN-EGFDRFFERELEILGSI-KHRYLVNLRGYCNSPTS 377 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 377 (594)
.++|+..+.||+|+||.||+|.+. +++.||||+++... ......|.+|+.++.++ +|||||+++|+|.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467888999999999999999753 45689999997533 34456789999999999 69999999999999999
Q ss_pred eEEEEEccCCCchhhhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEe
Q 007668 378 KLLIYDFLPGGSLDEALHERS-----------------EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILL 440 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll 440 (594)
.++||||+++|+|.++++... ..+++..+..++.||++||+|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999997532 2589999999999999999999954 99999999999999
Q ss_pred cCCCcEEEeecccccccccCCc-eeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhC-CCCCCcchhcccch
Q 007668 441 DGNLEARVSDFGLAKLLEDEES-HITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSG-KRPTDASFIEKGLN 518 (594)
Q Consensus 441 ~~~~~~~l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg-~~p~~~~~~~~~~~ 518 (594)
+.++.++++|||+++....... .......||+.|+|||++.++.++.++||||||+++|||+|+ .+|+....... .
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~ 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999997765443 333456799999999999999999999999999999999995 55554322111 1
Q ss_pred HHHHHHHHhcccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC
Q 007668 519 IVGWLNFLISEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM 581 (594)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~ 581 (594)
+...+... .+.. .+...+..+.+|+.+||+.||++|||++||+++|++.+.
T Consensus 257 ----~~~~i~~~-~~~~-------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 ----FYKMIKEG-FRML-------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ----HHHHHHHT-CCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHhcC-CCCC-------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 11111111 1111 112334679999999999999999999999999987653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.2e-46 Score=363.70 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=204.0
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccch---------hhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCC
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNE---------GFDRFFERELEILGSIK-HRYLVNLRGYCNSP 375 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 375 (594)
++|+..+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999976 4689999999865321 12346889999999997 99999999999999
Q ss_pred CceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 376 TSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 376 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
+..++||||+++|+|.++++.+ ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999764 5699999999999999999999964 99999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccCccCcccccc------CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQS------GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE 529 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 529 (594)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... ........
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~~~i~~~ 230 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMSG 230 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHT
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------HHHHHHhC
Confidence 7765332 234579999999999853 356889999999999999999999998653221 11111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 DRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. .. ... ......+.++.+|+.+||+.||++|||++||++
T Consensus 231 ~-~~-~~~----~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 N-YQ-FGS----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C-CC-CCT----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C-CC-CCC----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 10 001 112244577999999999999999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-46 Score=379.54 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=198.7
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeecccc---hhhHHHHHH---HHHHHhhCCCCeeeeeeeEEeCCCce
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLN---EGFDRFFER---ELEILGSIKHRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~ 378 (594)
.++|+..+.||+|+||.||+|... +|+.||||++.+.. ......+.+ |+++++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 357888999999999999999865 68999999986421 122233444 46677788899999999999999999
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
++||||+++|+|.+++..+ ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999999764 568999999999999999999995 499999999999999999999999999998765
Q ss_pred cCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccC
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIID 537 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 537 (594)
... .....||+.|+|||++.. ..++.++||||+||++|||+||+.||........ ........ .
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~-~-------- 223 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTL-T-------- 223 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSS-S--------
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcc-c--------
Confidence 433 234579999999999865 5689999999999999999999999976432211 11101000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 538 PNCEGVQSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 538 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
.....+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 224 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 -MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 001112234467899999999999999999 677764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-46 Score=378.66 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=205.4
Q ss_pred hcCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEE
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 381 (594)
.++|+..+.||+|+||.||+|..+ +|+.||||++.+. .....+.+.+|+++++.++|||||++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 367889999999999999999764 6999999998642 223356789999999999999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+||+.+|+|.+++... +.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999999764 569999999999999999999995 49999999999999999999999999999876543
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||...... .......... .
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~-~--------- 255 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGK-V--------- 255 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-C---------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHhcCC-C---------
Confidence 23457999999999999999999999999999999999999999764221 1111111111 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRP-----TMHRVVQ 574 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ev~~ 574 (594)
..+...+.++.+++.+||+.||++|+ |++|+++
T Consensus 256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223446789999999999999994 8999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=374.59 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=201.3
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc---chhhHHHHHHHHHHHh-hCCCCeeeeeeeEEeCCCceEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL---NEGFDRFFERELEILG-SIKHRYLVNLRGYCNSPTSKLLI 381 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv 381 (594)
++|...+.||+|+||+||+|... +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999775 6899999999752 2223445666777655 68999999999999999999999
Q ss_pred EEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 007668 382 YDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 382 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~ 461 (594)
|||+++|+|.++++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999764 568999999999999999999995 499999999999999999999999999998665433
Q ss_pred ceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccccccCCCCC
Q 007668 462 SHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQREIIDPNCE 541 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (594)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ......... +.
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~-------~~-- 221 (320)
T d1xjda_ 158 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDN-------PF-- 221 (320)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-------CC--
T ss_pred c-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCC-------CC--
Confidence 2 2344579999999999999999999999999999999999999997643221 111111110 11
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007668 542 GVQSESLDALLAVATQCVSSSPDDRPTMH-RVV 573 (594)
Q Consensus 542 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ev~ 573 (594)
.+...+.++.+|+.+||+.||++|||+. |++
T Consensus 222 -~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 222 -YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -CCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 1223346789999999999999999995 674
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=371.40 Aligned_cols=248 Identities=22% Similarity=0.311 Sum_probs=197.1
Q ss_pred hcCCCcc-ceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhC-CCCeeeeeeeEEeC----CCce
Q 007668 306 LETLDDD-HIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSI-KHRYLVNLRGYCNS----PTSK 378 (594)
Q Consensus 306 ~~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~ 378 (594)
.++|.+. ++||+|+||+||+|.. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4567765 5699999999999976 56899999998652 4577899987654 89999999999854 4567
Q ss_pred EEEEEccCCCchhhhhhhcC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC---CCcEEEeecccc
Q 007668 379 LLIYDFLPGGSLDEALHERS-EQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG---NLEARVSDFGLA 454 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~~l~Dfgl~ 454 (594)
++||||+++|+|.+++..+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccccccee
Confidence 99999999999999998653 469999999999999999999995 49999999999999985 567999999999
Q ss_pred cccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 455 KLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 455 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
+....... .....||+.|+|||++.+..++.++||||+||++|+|+||+.||.+....... .... ..
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~--------~~ 228 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMK--------TR 228 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------C
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHH--------HH
Confidence 87665432 23457999999999999999999999999999999999999999764322110 0000 00
Q ss_pred ccCCC--CCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPN--CEG-VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~--~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
+.... .+. .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 111 11345578999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=366.50 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=199.5
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc--hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN--EGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
++|+..+.||+|+||+||+|.. .+|+.||||+++... +...+.+.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788899999999999999976 568999999996532 2335678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
|+.++.+..........+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 9976544444444566799999999999999999999954 999999999999999999999999999987654332
Q ss_pred eeeeeecccCccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhc--ccccccc-----
Q 007668 464 ITTIVAGTFGYLAPEYMQSGR-ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLIS--EDRQREI----- 535 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----- 535 (594)
......||+.|+|||.+.... ++.++||||+||++|+|++|+.||......+.. ......... +......
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH--HHHHHhcCCCchhhccccccccc
Confidence 233457999999999877655 588999999999999999999999764322110 000000000 0000000
Q ss_pred cCCC---CCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 536 IDPN---CEG-----VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 536 ~~~~---~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... ... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 000 11123467899999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=365.54 Aligned_cols=258 Identities=24% Similarity=0.298 Sum_probs=195.9
Q ss_pred cceeeeecceEEEEEEec-CCcEEEEEeecccch-----hhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEcc
Q 007668 312 DHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE-----GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDFL 385 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 385 (594)
.++||+|+||+||+|... +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999865 689999999864322 12346889999999999999999999999999999999999
Q ss_pred CCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCceee
Q 007668 386 PGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHIT 465 (594)
Q Consensus 386 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~~ 465 (594)
+++++..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 8877776654 45678999999999999999999995 49999999999999999999999999999876544322 2
Q ss_pred eeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc---cccc-------c
Q 007668 466 TIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE---DRQR-------E 534 (594)
Q Consensus 466 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~-------~ 534 (594)
....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+... .+...... .... .
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~---~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH---HHHHhcCCCChhhccchhccchh
Confidence 345799999999998654 57999999999999999999999997643221110 00000000 0000 0
Q ss_pred ccCCCCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHh
Q 007668 535 IIDPNCEGVQ-----SESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILE 577 (594)
Q Consensus 535 ~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~ 577 (594)
......+..+ ...+..+.+|+.+||+.||++|||++|+++ .++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 284 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence 0000011111 123467899999999999999999999986 454
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.4e-45 Score=360.99 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=200.0
Q ss_pred cCCCccceeeeecceEEEEEEecCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|+..+.||+|+||+||+|..++|+.||||+++.. .....+.+.+|+.++++++||||+++++++..+...++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 578889999999999999999999999999999653 233457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCcee
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHI 464 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~~ 464 (594)
+.++.+....+ ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||.+........ .
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 97766665554 45779999999999999999999995 4999999999999999999999999999987654332 2
Q ss_pred eeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcc--ccc-----cccc
Q 007668 465 TTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISE--DRQ-----REII 536 (594)
Q Consensus 465 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~-----~~~~ 536 (594)
.....|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+..... ....... ... ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI--FRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCTTTSTTGGGSTTC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHH--HHhhCCCChhhccchhhhhhc
Confidence 3344689999999998754 5699999999999999999999999764332111100 0000000 000 0000
Q ss_pred CCCC--------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 537 DPNC--------EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 537 ~~~~--------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.... .......+..+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0112233467899999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-45 Score=364.43 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=198.2
Q ss_pred hcCCCccceeeeecceEEEEEEec-C-CcEEEEEeeccc--chhhHHHHHHHHHHHhhC---CCCeeeeeeeEEe-----
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD-D-GNVFALKRIDKL--NEGFDRFFERELEILGSI---KHRYLVNLRGYCN----- 373 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~----- 373 (594)
.++|+..+.||+|+||+||+|... + ++.||||+++.. .......+.+|+++++.+ +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 367889999999999999999863 4 567999998642 222233466777776665 8999999999984
Q ss_pred CCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 007668 374 SPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGL 453 (594)
Q Consensus 374 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl 453 (594)
.....++++||++++++..........+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 2346789999999888776666666779999999999999999999995 4999999999999999999999999999
Q ss_pred ccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc---
Q 007668 454 AKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED--- 530 (594)
Q Consensus 454 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 530 (594)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+...............
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 88654332 2344679999999999999999999999999999999999999997643322111110000000000
Q ss_pred --------ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 --------RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 --------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.................+..+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000011122234467889999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-45 Score=358.04 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=195.0
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccch------hhHHHHHHHHHHHhhCC--CCeeeeeeeEEeCCCc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNE------GFDRFFERELEILGSIK--HRYLVNLRGYCNSPTS 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~ 377 (594)
.+|++.+.||+|+||+||+|... +|+.||||++.+... .....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46888999999999999999764 689999999864221 11234678999999986 8999999999999999
Q ss_pred eEEEEEccCC-CchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-CCcEEEeeccccc
Q 007668 378 KLLIYDFLPG-GSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-NLEARVSDFGLAK 455 (594)
Q Consensus 378 ~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~~l~Dfgl~~ 455 (594)
.++||||+.+ +++.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 577777765 3569999999999999999999995 59999999999999985 5799999999998
Q ss_pred ccccCCceeeeeeecccCccCccccccCCC-CccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 456 LLEDEESHITTIVAGTFGYLAPEYMQSGRA-TEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 456 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ... ..
T Consensus 160 ~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------~~~---~~ 221 (273)
T d1xwsa_ 160 LLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------IRG---QV 221 (273)
T ss_dssp ECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------HHC---CC
T ss_pred eccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------------hhc---cc
Confidence 654332 334679999999999987665 67799999999999999999999763210 000 11
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.+.+ ..+.++.+|+.+||+.||++|||++|+++
T Consensus 222 ~~~~-------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 FFRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC-------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111 23467899999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-43 Score=348.86 Aligned_cols=272 Identities=16% Similarity=0.197 Sum_probs=211.9
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCC-CeeeeeeeEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKH-RYLVNLRGYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~ 384 (594)
++|.+.+.||+|+||+||+|... +|+.||||.+..... ...+.+|++.+..++| +|++.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 46888999999999999999865 688999998865332 2357789999999975 8999999999999999999999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecC-----CCcEEEeeccccccccc
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDG-----NLEARVSDFGLAKLLED 459 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~~l~Dfgl~~~~~~ 459 (594)
+ +++|.++++.....+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9 78999999877778999999999999999999999 559999999999999974 57899999999987654
Q ss_pred CCce------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhcccccc
Q 007668 460 EESH------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQR 533 (594)
Q Consensus 460 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 533 (594)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 3221 2234679999999999999999999999999999999999999997543322211111111110001111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccCC--CCCccccccC
Q 007668 534 EIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVMT--PCPSDFYDSN 592 (594)
Q Consensus 534 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~~--~~~~~~~~~~ 592 (594)
+ +.+ ..+.++.+++..|++.+|++||+++.+.+.|++.+.. ....+-|||.
T Consensus 239 ~-l~~-------~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 239 E-LCA-------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp H-HTT-------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred H-hcC-------CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence 1 111 1235688999999999999999999999988876532 2233456764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-43 Score=351.96 Aligned_cols=270 Identities=19% Similarity=0.214 Sum_probs=203.6
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeee-eEEeCCCceEEEEEc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLR-GYCNSPTSKLLIYDF 384 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-g~~~~~~~~~lv~e~ 384 (594)
++|+..+.||+|+||+||+|.. .+|+.||||++..... ...+.+|+++++.++|+|++..+ ++..+....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 3688899999999999999976 4689999998765332 24578899999999877766554 455777788899999
Q ss_pred cCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEec---CCCcEEEeecccccccccCC
Q 007668 385 LPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLD---GNLEARVSDFGLAKLLEDEE 461 (594)
Q Consensus 385 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~~l~Dfgl~~~~~~~~ 461 (594)
+ ++++.+.+......+++..+..++.|++.||+|||+ .+|+||||||+|||++ .+..++++|||+++.+....
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 667777777667789999999999999999999995 4999999999999986 45579999999999775433
Q ss_pred ce------eeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH-HHHHHHhccccccc
Q 007668 462 SH------ITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV-GWLNFLISEDRQRE 534 (594)
Q Consensus 462 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 534 (594)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .+....... .. .
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~-~ 238 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI-E 238 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CH-H
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Ch-h
Confidence 21 223467999999999999999999999999999999999999999764333221111 111111100 00 0
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhcccC--CCCCcccccc
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQILESEVM--TPCPSDFYDS 591 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~~L~~~~~--~~~~~~~~~~ 591 (594)
.. ....+.++.+++.+||+.+|++||+++++.+.|+..+. .....+.|||
T Consensus 239 ~~-------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw 290 (299)
T d1ckia_ 239 VL-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 290 (299)
T ss_dssp HH-------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHH
T ss_pred Hh-------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCc
Confidence 01 11233678999999999999999999999998887643 2333334554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-43 Score=350.84 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=195.3
Q ss_pred hcCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC--------
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS-------- 374 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------- 374 (594)
.++|+..+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46888999999999999999986 47999999998643 33445678899999999999999999998855
Q ss_pred CCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 007668 375 PTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLA 454 (594)
Q Consensus 375 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~ 454 (594)
....++||||++++.+.... .....++...+..++.||+.||.|||+ .+|+||||||+|||++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 34578999999877666554 345678999999999999999999995 49999999999999999999999999999
Q ss_pred cccccCCce---eeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc
Q 007668 455 KLLEDEESH---ITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED 530 (594)
Q Consensus 455 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 530 (594)
+........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||......................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 876543321 22335699999999998754 68999999999999999999999997643222111111100000000
Q ss_pred cccccc--------C-CCCCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 RQREII--------D-PNCEGVQS-------ESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ~~~~~~--------~-~~~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
...... . ........ .....+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000000 0 00000000 11345778999999999999999999885
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=355.07 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=195.5
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccc-hhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC----ceEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLN-EGFDRFFERELEILGSIKHRYLVNLRGYCNSPT----SKLL 380 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~l 380 (594)
++|+..+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688889999999999999975 579999999997543 344567899999999999999999999986543 2355
Q ss_pred EEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 007668 381 IYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDE 460 (594)
Q Consensus 381 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~ 460 (594)
+++|+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 88 l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 5666779999999975 3699999999999999999999964 9999999999999999999999999999876543
Q ss_pred Cce--eeeeeecccCccCccccc-cCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc-------
Q 007668 461 ESH--ITTIVAGTFGYLAPEYMQ-SGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED------- 530 (594)
Q Consensus 461 ~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 530 (594)
... ......||+.|+|||++. +..++.++||||+||++|||++|+.||......+...............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 322 224467999999999985 4567899999999999999999999997643321111110000000000
Q ss_pred ---ccccccCCCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 ---RQREIIDPNCEG-----VQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 ---~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
.......+.... .....+..+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 11122356889999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=352.97 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=195.0
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCC------c
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPT------S 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 377 (594)
++|+..+.||+|+||+||+|... +|+.||||+++.. +....+.+.+|+++|++++|||||+++++|.... .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 57888899999999999999764 6999999999753 3344567899999999999999999999997654 4
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++||||+ +.+|....+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++..
T Consensus 98 ~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceecc
Confidence 69999999 6678777654 469999999999999999999995 49999999999999999999999999999876
Q ss_pred ccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHH--------h-
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL--------I- 527 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--------~- 527 (594)
.... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.................. .
T Consensus 172 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 172 DSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred CCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 5432 34568999999999876 45789999999999999999999999764322111000000000 0
Q ss_pred ------cccccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhc
Q 007668 528 ------SEDRQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILES 578 (594)
Q Consensus 528 ------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~ 578 (594)
............+..........+.+|+.+||+.||++|||++|+++ .+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 00000011111111122334467889999999999999999999987 3554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=351.62 Aligned_cols=258 Identities=26% Similarity=0.323 Sum_probs=192.0
Q ss_pred CCCccceeeeecceEEEEEEec-CCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCC------CceEE
Q 007668 308 TLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSP------TSKLL 380 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 380 (594)
+|+..++||+|+||+||+|... +|+.||||++...... +.+|++++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999875 6899999999764332 34799999999999999999998432 33689
Q ss_pred EEEccCCCchhhhhh--hcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeeccccccc
Q 007668 381 IYDFLPGGSLDEALH--ERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLL 457 (594)
Q Consensus 381 v~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~~~ 457 (594)
||||++++.+....+ .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444433 33556999999999999999999999 55999999999999999765 8999999999876
Q ss_pred ccCCceeeeeeecccCccCcccccc-CCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH---------HHHHHHh
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQS-GRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV---------GWLNFLI 527 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~---------~~~~~~~ 527 (594)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+..... .+.....
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 54432 234578999999998765 56899999999999999999999999764322111000 0000000
Q ss_pred ccc---ccccccCCCC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 528 SED---RQREIIDPNC-EGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 528 ~~~---~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
... .........+ .......+..+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000000 0011234467899999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=350.63 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=203.3
Q ss_pred hcCCCccceeeeecceEEEEEEec----CCcEEEEEeeccc----chhhHHHHHHHHHHHhhCCC-CeeeeeeeEEeCCC
Q 007668 306 LETLDDDHIIGSGGFGTVYKLAMD----DGNVFALKRIDKL----NEGFDRFFERELEILGSIKH-RYLVNLRGYCNSPT 376 (594)
Q Consensus 306 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~ 376 (594)
.++|+..+.||+|+||+||+|... +|+.||||.++.. +....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 467999999999999999999752 4789999998642 22234568899999999976 89999999999999
Q ss_pred ceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 377 SKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 377 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
..++|+||+.+|+|.+++... ..+++.....++.||+.||+|+|+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999999764 457888999999999999999995 4999999999999999999999999999987
Q ss_pred cccCCceeeeeeecccCccCccccccC--CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccccccc
Q 007668 457 LEDEESHITTIVAGTFGYLAPEYMQSG--RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISEDRQRE 534 (594)
Q Consensus 457 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 534 (594)
+............|++.|+|||.+.+. .++.++||||+||++|||++|+.||............ ........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~~~---- 252 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSE---- 252 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCC----
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcccCC----
Confidence 765554444556799999999998754 4688999999999999999999999765433221111 11111100
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007668 535 IIDPNCEGVQSESLDALLAVATQCVSSSPDDRPT-----MHRVVQ 574 (594)
Q Consensus 535 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ev~~ 574 (594)
+ ..+...+.++.+++.+||+.||++||| ++|+++
T Consensus 253 ---~---~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ---P---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---C---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---C---CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 122334578999999999999999995 788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-42 Score=340.63 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=202.5
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeCCCceEEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 383 (594)
++|+..+.||+|+||+||+|.. .+++.||||+++.. .......+.+|+.++++++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5788899999999999999986 46889999998643 33446789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCce
Q 007668 384 FLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESH 463 (594)
Q Consensus 384 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~~~~~~ 463 (594)
++.++++..+++. .+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++........
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9999988887764 46789999999999999999999964 9999999999999999999999999999876543322
Q ss_pred eeeeeecccCccCccccccCC-CCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHHhccc------------
Q 007668 464 ITTIVAGTFGYLAPEYMQSGR-ATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFLISED------------ 530 (594)
Q Consensus 464 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 530 (594)
.....+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....... .....+.......
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhhcc
Confidence 23345788999999987655 6899999999999999999999964321110 0011010000000
Q ss_pred --ccccc--cCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 531 --RQREI--IDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 531 --~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
..... ...............+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 001111122334567889999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=342.99 Aligned_cols=256 Identities=16% Similarity=0.267 Sum_probs=195.2
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeC--CCceEEEE
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNS--PTSKLLIY 382 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~ 382 (594)
++|+..+.||+|+||+||+|.. .+|+.||||+++... .+.+.+|+++|.+++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5788999999999999999976 568999999987543 457889999999995 9999999999864 45688999
Q ss_pred EccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccccCC
Q 007668 383 DFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL-EARVSDFGLAKLLEDEE 461 (594)
Q Consensus 383 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~~l~Dfgl~~~~~~~~ 461 (594)
||+++++|.... +.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999998764 358999999999999999999995 4999999999999998654 69999999998765443
Q ss_pred ceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccc--hHH---------HHHHHHhcc
Q 007668 462 SHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGL--NIV---------GWLNFLISE 529 (594)
Q Consensus 462 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~--~~~---------~~~~~~~~~ 529 (594)
. .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... .+. .+.......
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2 3445689999999998765 4799999999999999999999998653321110 000 000000000
Q ss_pred c--ccccccCCC---------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 530 D--RQREIIDPN---------CEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 530 ~--~~~~~~~~~---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
. ......... ........+.++.+|+.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000000 00011234467899999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-41 Score=342.07 Aligned_cols=259 Identities=20% Similarity=0.263 Sum_probs=188.4
Q ss_pred cCCCccceeeeecceEEEEEEec-CCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC------CCc
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAMD-DGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS------PTS 377 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~ 377 (594)
++|+..++||+|+||+||+|... +|+.||||++... +......+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57888999999999999999865 6999999999753 33345678899999999999999999999853 367
Q ss_pred eEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 007668 378 KLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLL 457 (594)
Q Consensus 378 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~ 457 (594)
.++||||+.++.+ +.+. ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.++++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 7999999966544 4443 458999999999999999999995 49999999999999999999999999998865
Q ss_pred ccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHH---------HHH-----
Q 007668 458 EDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIV---------GWL----- 523 (594)
Q Consensus 458 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~---------~~~----- 523 (594)
.... ......||+.|+|||++.+..+++++||||+||++|||++|+.||.+.......... .+.
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 5432 234456899999999999999999999999999999999999999653221110000 000
Q ss_pred --HHHhcccc----------cccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007668 524 --NFLISEDR----------QREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ 574 (594)
Q Consensus 524 --~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~ 574 (594)
........ ......+.........+..+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 0000111111122345677899999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=344.27 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=195.3
Q ss_pred cCCCccceeeeecceEEEEEEe-cCCcEEEEEeeccc--chhhHHHHHHHHHHHhhCCCCeeeeeeeEEeC-----CCce
Q 007668 307 ETLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKL--NEGFDRFFERELEILGSIKHRYLVNLRGYCNS-----PTSK 378 (594)
Q Consensus 307 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~ 378 (594)
++|+..+.||+|+||+||+|.. .+|+.||||++... +....+.+.+|++++++++|||+|++++++.. ....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 5788899999999999999975 57999999999753 23345678899999999999999999999853 3345
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 458 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~~~ 458 (594)
+++++|+.+|+|.++++. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++....
T Consensus 98 ~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC
Confidence 677888889999999964 469999999999999999999995 499999999999999999999999999997654
Q ss_pred cCCceeeeeeecccCccCccccccC-CCCccchhhhHHHHHHHHHhCCCCCCcchhcccchHHHHHHHH--------hcc
Q 007668 459 DEESHITTIVAGTFGYLAPEYMQSG-RATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNIVGWLNFL--------ISE 529 (594)
Q Consensus 459 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~ 529 (594)
.. .....|++.|+|||...+. .++.++||||+||++|+|++|+.||.+................ ...
T Consensus 173 ~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp GG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 32 2335689999999987665 4689999999999999999999999764322111110000000 000
Q ss_pred c-------ccccccCCCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhc
Q 007668 530 D-------RQREIIDPNCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVVQ--ILES 578 (594)
Q Consensus 530 ~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~~--~L~~ 578 (594)
. .........+.......+..+.+|+.+||+.||++|||++|+++ .+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 0 00000000000011123466889999999999999999999987 4544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-36 Score=309.81 Aligned_cols=260 Identities=19% Similarity=0.209 Sum_probs=187.5
Q ss_pred CCCccceeeeecceEEEEEEe-cCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-----------CCeeeeeeeEEeC-
Q 007668 308 TLDDDHIIGSGGFGTVYKLAM-DDGNVFALKRIDKLNEGFDRFFERELEILGSIK-----------HRYLVNLRGYCNS- 374 (594)
Q Consensus 308 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~- 374 (594)
+|+..+.||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 478899999999999999986 5799999999976432 3456788998888775 5789999988754
Q ss_pred -CCceEEEEEccCCCchhhhh--hhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCC------c
Q 007668 375 -PTSKLLIYDFLPGGSLDEAL--HERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNL------E 445 (594)
Q Consensus 375 -~~~~~lv~e~~~~gsL~~~l--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~------~ 445 (594)
....++++++...+...... ......+++..+..++.||+.||+|||+. .+|+||||||+|||++.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 34556666666555433332 23456689999999999999999999962 4999999999999998554 3
Q ss_pred EEEeecccccccccCCceeeeeeecccCccCccccccCCCCccchhhhHHHHHHHHHhCCCCCCcchhcccch----HHH
Q 007668 446 ARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLN----IVG 521 (594)
Q Consensus 446 ~~l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~vl~elltg~~p~~~~~~~~~~~----~~~ 521 (594)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||.......... +..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999999865432 234568999999999999999999999999999999999999997643221111 111
Q ss_pred HHHHH-----------------hccccc-ccccCC----------CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007668 522 WLNFL-----------------ISEDRQ-REIIDP----------NCEGVQSESLDALLAVATQCVSSSPDDRPTMHRVV 573 (594)
Q Consensus 522 ~~~~~-----------------~~~~~~-~~~~~~----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev~ 573 (594)
..... ...... ..+... .........+..+.+|+.+||+.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 10000 000000 000000 01123456778899999999999999999999998
Q ss_pred H
Q 007668 574 Q 574 (594)
Q Consensus 574 ~ 574 (594)
+
T Consensus 327 ~ 327 (362)
T d1q8ya_ 327 N 327 (362)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=6.4e-30 Score=255.64 Aligned_cols=183 Identities=34% Similarity=0.583 Sum_probs=159.5
Q ss_pred CCcchHHHHHHHHHhccCCCCCCcCCCCCCCCCC--ccceeEeCCC---CcEEEEEcccCCCCC--CCCccccCcccCCe
Q 007668 28 AINSDGEALLSFRTAVVSSDGFLNQWRPEDPDPC--NWKGVKCDKN---KRVITLSLTNHKLSG--PISADLGKLDQLKF 100 (594)
Q Consensus 28 ~~~~~~~~L~~~k~~~~~~~~~l~~w~~~~~~~c--~w~gv~c~~~---~~l~~L~L~~n~l~~--~~~~~~~~l~~L~~ 100 (594)
|.+.|++||++||+++.++ ..+++|. .+.||| .|.||+|+.. .+|+.|+|++|+++| .+|..+++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~-~~l~sW~-~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNP-TTLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCC-GGGTTCC-TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCC-CcCCCCC-CCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 7789999999999999766 4789997 467999 4999999853 379999999999997 47899999999999
Q ss_pred eeccc-CccCCCCCCCcCCCCccceeecccccccCC--------------------------------------------
Q 007668 101 LNLHS-NNFYGEIPSELGNCTELQGLSLQSNYLSGS-------------------------------------------- 135 (594)
Q Consensus 101 L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-------------------------------------------- 135 (594)
|+|++ |+++|.+|..|++|++|++|+|++|+|++.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99996 899999999999999999999998886611
Q ss_pred ---------------------------------------------------------------------------CChhh
Q 007668 136 ---------------------------------------------------------------------------IPSEL 140 (594)
Q Consensus 136 ---------------------------------------------------------------------------~p~~~ 140 (594)
.+..+
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~ 240 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 11122
Q ss_pred hCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCcccccc
Q 007668 141 GNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQINVTC 213 (594)
Q Consensus 141 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~~~~c 213 (594)
..+++|+.|+|++|+|+|.+|..|.++++|++|+|++|+|+|.+|....+++|+.+++.+|+++||.|++ .|
T Consensus 241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 3346788999999999988999999999999999999999999998888999999999999999999987 55
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=7.2e-23 Score=188.29 Aligned_cols=161 Identities=14% Similarity=0.129 Sum_probs=119.1
Q ss_pred ccceeeeecceEEEEEEecCCcEEEEEeecccch------------------hhHHHHHHHHHHHhhCCCCeeeeeeeEE
Q 007668 311 DDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNE------------------GFDRFFERELEILGSIKHRYLVNLRGYC 372 (594)
Q Consensus 311 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g~~ 372 (594)
..+.||+|+||+||+|...+|+.||||+++.... .....+..|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 5689999999999999989999999998753100 1123456688899999999999887663
Q ss_pred eCCCceEEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 007668 373 NSPTSKLLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFG 452 (594)
Q Consensus 373 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfg 452 (594)
..+++|||+++..+.+ ++......++.|++++++|||++ +|+||||||+|||++++ .++|+|||
T Consensus 84 ----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp ----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred ----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECC
Confidence 2379999998866544 23334567999999999999964 99999999999999965 59999999
Q ss_pred cccccccCCceeeeeeecccCccCc------cccccCCCCccchhhhHHHH
Q 007668 453 LAKLLEDEESHITTIVAGTFGYLAP------EYMQSGRATEKTDVYSFGVL 497 (594)
Q Consensus 453 l~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~s~G~v 497 (594)
.+......... .|... |. ..+.++.++|+||..--
T Consensus 148 ~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence 99765433211 11111 11 23567888999996543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.80 E-value=9.5e-20 Score=167.24 Aligned_cols=132 Identities=21% Similarity=0.271 Sum_probs=113.0
Q ss_pred EEEcccCCCCCCCCccccCcccCCeeecccCccCCCC-CCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCC
Q 007668 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI-PSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (594)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 154 (594)
+++.++++|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|.++...+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4667788888 6777663 68999999999997644 566788999999999999999888888999999999999999
Q ss_pred cCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCccc
Q 007668 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~~ 210 (594)
+|+.+.|..|.++++|++|+|++|+|+++++.. ..+++|+++++++|++.|++++.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~ 145 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA 145 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH
Confidence 999877888999999999999999999888875 78899999999999999987653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=3.2e-20 Score=170.50 Aligned_cols=150 Identities=22% Similarity=0.303 Sum_probs=129.0
Q ss_pred CccceeEeCC----------CCcEEEEEcccCCCCCCC-CccccCcccCCeeecccCccCCCCCCCcCCCCccceeeccc
Q 007668 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPI-SADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQS 129 (594)
Q Consensus 61 c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 129 (594)
|.|..|.|+. +.++++|+|++|.|++.+ +..|.++++|+.|+|++|++....+..|..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 5688888863 358999999999998644 56889999999999999999988999999999999999999
Q ss_pred ccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCcc
Q 007668 130 NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 130 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
|+|+...|..|.++++|++|+|++|+|+++.|..|..+++|++|+|++|++............++.+.+..|...|+.|.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh
Confidence 99998888889999999999999999999888999999999999999999987654333334466677778877787664
Q ss_pred c
Q 007668 210 N 210 (594)
Q Consensus 210 ~ 210 (594)
.
T Consensus 168 ~ 168 (192)
T d1w8aa_ 168 K 168 (192)
T ss_dssp T
T ss_pred h
Confidence 3
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=8.5e-19 Score=169.67 Aligned_cols=138 Identities=24% Similarity=0.187 Sum_probs=106.6
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|+|+ ..+..+.++++|++|+|++|.+....+..+..+.+|++|++++|.++...+..+..+++|+.|+
T Consensus 76 l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~ 154 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (266)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcc
Confidence 345555555555555 3444555566666666666666555555566666667777777777755566678899999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCcc
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
+++|+|+++.+..|..+++|++|+|++|+|+.+++....+++|+.|+|+||||.|+|.+
T Consensus 155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 155 LANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred cccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 99999999888889999999999999999998777778899999999999999999875
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=3.1e-18 Score=167.35 Aligned_cols=140 Identities=21% Similarity=0.202 Sum_probs=130.0
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 46899999999999977788899999999999999999977778899999999999999999988888999999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCCCCCCCccc
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c~~~~~ 210 (594)
+++|+++++.|..|..+++|++|++++|++++.++.. ..+++|+.|++++|++.|+|++.
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~ 244 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccch
Confidence 9999999988999999999999999999999988755 78999999999999999998863
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.68 E-value=4.8e-17 Score=137.08 Aligned_cols=117 Identities=24% Similarity=0.303 Sum_probs=97.5
Q ss_pred EEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCC
Q 007668 75 ITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (594)
Q Consensus 75 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 154 (594)
+.|+|++|+|+ .++ .+.++++|++|+|++|+|+ .+|..|..+++|+.|++++|.|+ .+| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 36899999999 555 4899999999999999999 77888999999999999999999 566 4899999999999999
Q ss_pred cCCCCCC-ccccccCCCcEEEeecccccccCCCC----cccccCCcc
Q 007668 155 SLSDYIP-PSLGKLQRLITFNVSNNFLVGAIPSD----GVLTKFSES 196 (594)
Q Consensus 155 ~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~~----~~l~~l~~l 196 (594)
+|++... ..+..+++|+.|++++|+++...... ..+|+|+.+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 9997432 57889999999999999998664322 335555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=1.4e-16 Score=140.94 Aligned_cols=125 Identities=18% Similarity=0.145 Sum_probs=105.2
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
..++++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+.|+
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 93 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence 457899999999999 56777788999999999999999 554 589999999999999999965556678899999999
Q ss_pred ccCCcCCCCCC-ccccccCCCcEEEeecccccccCCC----CcccccCCcccc
Q 007668 151 ISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIPS----DGVLTKFSESSF 198 (594)
Q Consensus 151 l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~~----~~~l~~l~~l~l 198 (594)
|++|+|+.... ..+..+++|++|++++|+++..+.. ...+++|+.|+.
T Consensus 94 L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 94 LTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred eccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 99999987422 4688999999999999999876531 356788887763
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.62 E-value=7.5e-16 Score=151.78 Aligned_cols=73 Identities=26% Similarity=0.385 Sum_probs=63.7
Q ss_pred CccceeEeCC----------CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccc
Q 007668 61 CNWKGVKCDK----------NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN 130 (594)
Q Consensus 61 c~w~gv~c~~----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 130 (594)
|.|++|.|+. ++++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 6799999963 367999999999999655668999999999999999999777888999999999999998
Q ss_pred ccc
Q 007668 131 YLS 133 (594)
Q Consensus 131 ~l~ 133 (594)
+|+
T Consensus 90 ~l~ 92 (305)
T d1xkua_ 90 QLK 92 (305)
T ss_dssp CCS
T ss_pred ccC
Confidence 876
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=6.9e-16 Score=148.85 Aligned_cols=128 Identities=27% Similarity=0.215 Sum_probs=84.3
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
+++++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .+..+++|++|+|++|+++ .++..+..+++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 46777777777777555567777777777777777777 444 3566777777777777777 45556667777777777
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCC-cccccCCcccccCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD-GVLTKFSESSFFGNR 202 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~ 202 (594)
++|.+.+..+..+..+.+|+.|++++|.++..++.. ..+++++.+++++|.
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 777666655555555566666666666655555443 445555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=1.8e-15 Score=132.77 Aligned_cols=103 Identities=19% Similarity=0.126 Sum_probs=62.5
Q ss_pred EEcccCCCCCCCCccccCcccCCeeecccC-ccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCc
Q 007668 77 LSLTNHKLSGPISADLGKLDQLKFLNLHSN-NFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNS 155 (594)
Q Consensus 77 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 155 (594)
++++++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 344555655 45666666777777777654 3664444556777777777777777775556666677777777777777
Q ss_pred CCCCCCccccccCCCcEEEeeccccc
Q 007668 156 LSDYIPPSLGKLQRLITFNVSNNFLV 181 (594)
Q Consensus 156 l~~~~~~~~~~l~~L~~l~l~~N~l~ 181 (594)
|+.+.+..|.. .+|+.|+|++|++.
T Consensus 92 l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 92 LESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp CSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CcccChhhhcc-ccccccccCCCccc
Confidence 76533333332 24555555555553
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=1.7e-15 Score=127.46 Aligned_cols=101 Identities=23% Similarity=0.260 Sum_probs=90.5
Q ss_pred CeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecc
Q 007668 99 KFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNN 178 (594)
Q Consensus 99 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N 178 (594)
|+|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|..|..+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 68999999999 666 5999999999999999999 788889999999999999999997 44 5899999999999999
Q ss_pred cccccCC--CCcccccCCcccccCCCCC
Q 007668 179 FLVGAIP--SDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 179 ~l~~~~~--~~~~l~~l~~l~l~~N~~~ 204 (594)
+|+..+. ....+++|+.|++++|+..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 9997764 3478899999999999854
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=9.4e-16 Score=149.46 Aligned_cols=140 Identities=19% Similarity=0.184 Sum_probs=122.5
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
..+|+.+++++|+|+++.+..|..+++|+.|+|++|+|++..+..|.++++|+.|++++|++++..|..|..+++|++|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 56899999999999977788999999999999999999988888999999999999999999988899999999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCCCCCccc
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQIN 210 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~~ 210 (594)
+++|++++..+..|..+++|+.|+|++|++.+..+...-...++.+....+...|..|..
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~ 267 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR 267 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGG
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCchH
Confidence 999999998888999999999999999999876543333344666666777777765543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=2.7e-15 Score=132.60 Aligned_cols=110 Identities=15% Similarity=0.085 Sum_probs=96.5
Q ss_pred cccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCC
Q 007668 91 DLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRL 170 (594)
Q Consensus 91 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 170 (594)
.|.+..+|++|+|++|+|+ .+|..+..+++|+.|+|++|.|+ .++ .|..+++|++|+|++|+|+.+.+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4678889999999999999 67877788999999999999999 565 48999999999999999998666667889999
Q ss_pred cEEEeecccccccCC--CCcccccCCcccccCCCC
Q 007668 171 ITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 171 ~~l~l~~N~l~~~~~--~~~~l~~l~~l~l~~N~~ 203 (594)
+.|+|++|+|+.... ....+++|+.|++++|+.
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCcc
Confidence 999999999987643 347889999999999985
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.4e-14 Score=126.97 Aligned_cols=113 Identities=20% Similarity=0.135 Sum_probs=100.7
Q ss_pred ccCCeeecccCccCCCCCCCcCCCCccceeecccc-cccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEE
Q 007668 96 DQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSN-YLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFN 174 (594)
Q Consensus 96 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~ 174 (594)
...+.++.+++.+. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+.+.|..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34567999999998 77888999999999999866 59866667899999999999999999998889999999999999
Q ss_pred eecccccccCCCCcccccCCcccccCCCCCCCCcc
Q 007668 175 VSNNFLVGAIPSDGVLTKFSESSFFGNRGLCGKQI 209 (594)
Q Consensus 175 l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~c~~~~ 209 (594)
|++|+|+.+++......+|+.|++++|+|.|+|.+
T Consensus 87 Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 87 LSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp CCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred ccCCCCcccChhhhccccccccccCCCcccCCchH
Confidence 99999998888776566899999999999999875
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.49 E-value=3.1e-14 Score=139.95 Aligned_cols=132 Identities=20% Similarity=0.243 Sum_probs=115.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.+++++|+++ .+|..+ +++|+.|++++|.+++..+..|.+++.+++|++++|.+++..+..+.++++|++|+
T Consensus 149 l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~ 225 (305)
T d1xkua_ 149 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225 (305)
T ss_dssp CTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred ccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeee
Confidence 467899999999998 566544 68999999999999988899999999999999999999988888999999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCC-------CcccccCCcccccCCCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPS-------DGVLTKFSESSFFGNRGLCG 206 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~-------~~~l~~l~~l~l~~N~~~c~ 206 (594)
|++|+|+. +|.+|..+++|++|+|++|+|+.+... ...+.+|+.|++.+|++.+.
T Consensus 226 L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 226 LNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred cccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 99999996 788999999999999999999976442 24567899999999998763
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.45 E-value=8.6e-14 Score=127.60 Aligned_cols=124 Identities=30% Similarity=0.401 Sum_probs=100.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|+|++..+ ++++++|++|++++|.+. .++ .+.++++|+.|++++|.+.. ++ .+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccccc-cc-ccchhhhhHHhh
Confidence 4788999999999885433 888899999999999887 454 48888999999999888873 33 477889999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
+++|++.. + ..+..+++|+.|++++|++++.. ....+++|+.|++++|+.
T Consensus 135 l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 135 LSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKV 184 (199)
T ss_dssp CCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCC
T ss_pred hhhhhhcc-c-ccccccccccccccccccccCCc-cccCCCCCCEEECCCCCC
Confidence 99999875 3 35788899999999999988754 356788999999999863
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.42 E-value=2.3e-13 Score=125.77 Aligned_cols=124 Identities=28% Similarity=0.362 Sum_probs=101.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|+|++. + .++++++|++|+|++|+|+ .+| .+.++++|+.|++++|.+. .++ .+..+++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCc-c-ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccc-cccccccccccc
Confidence 57899999999999854 3 3678999999999999998 455 5888999999999999887 444 578889999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
+++|.+++ +..+..+++|+.+++++|++++..+ ...+++|+.|++++|+.
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 190 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred cccccccc--ccccccccccccccccccccccccc-ccCCCCCCEEECCCCCC
Confidence 99999885 3457788999999999999987543 56789999999999864
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=2e-15 Score=138.21 Aligned_cols=110 Identities=24% Similarity=0.305 Sum_probs=70.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|+.|+|++|+|+ .++ .+.++++|++|+|++|.|+ .+|..+..+++|+.|++++|+|+ .++ .+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccc
Confidence 456777777777777 343 4667777777777777776 55544455566777777777776 333 366667777777
Q ss_pred ccCCcCCCCCC-ccccccCCCcEEEeecccccccCC
Q 007668 151 ISSNSLSDYIP-PSLGKLQRLITFNVSNNFLVGAIP 185 (594)
Q Consensus 151 l~~N~l~~~~~-~~~~~l~~L~~l~l~~N~l~~~~~ 185 (594)
|++|+|+.... ..+..+++|+.|+|++|+++...+
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcc
Confidence 77777765221 346667777777777777665544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=1.9e-15 Score=138.48 Aligned_cols=122 Identities=26% Similarity=0.274 Sum_probs=102.5
Q ss_pred EEcccC--CCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCC
Q 007668 77 LSLTNH--KLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSN 154 (594)
Q Consensus 77 L~L~~n--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 154 (594)
+++.++ .++ .++..+..|++|++|+|++|+|+ .++ .|.++++|+.|+|++|.|+ .+|..+..+++|+.|++++|
T Consensus 28 ~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N 103 (198)
T d1m9la_ 28 VELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN 103 (198)
T ss_dssp EECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEE
T ss_pred eeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccc
Confidence 444443 344 56778999999999999999999 565 5999999999999999999 77877777789999999999
Q ss_pred cCCCCCCccccccCCCcEEEeecccccccCC--CCcccccCCcccccCCCCC
Q 007668 155 SLSDYIPPSLGKLQRLITFNVSNNFLVGAIP--SDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 155 ~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~l~~N~~~ 204 (594)
+|+. + ..+..+++|+.|+|++|+|+.... ....+++|+.|++++|+..
T Consensus 104 ~i~~-l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 104 QIAS-L-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp ECCC-H-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccc-c-ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 9997 3 458899999999999999987643 3478999999999999843
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.38 E-value=5.3e-13 Score=122.20 Aligned_cols=124 Identities=26% Similarity=0.360 Sum_probs=106.9
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
..+++.|++++|+|+ .++ .+..+++|++|+|++|+|++..| +.++++|++|++++|.+. .++. +.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-cccc-ccccccccccc
Confidence 357899999999999 443 58899999999999999995443 999999999999999998 5554 88999999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
+++|.+... ..+..+++|+.|++++|++... +....+++|+.|++.+|..
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhccc-ccccccccccccccccccc
Confidence 999999863 4588999999999999999854 4567889999999999864
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.37 E-value=4.3e-13 Score=123.92 Aligned_cols=122 Identities=26% Similarity=0.334 Sum_probs=105.5
Q ss_pred CCCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceE
Q 007668 70 KNKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNL 149 (594)
Q Consensus 70 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 149 (594)
..++|+.|++++|+|++ ++ .+.++++|+.|++++|.+. .++ .+..+++|+.+++++|.+++ +..+..+++|+.+
T Consensus 88 ~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l 161 (210)
T d1h6ta2 88 NLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTL 161 (210)
T ss_dssp TCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEE
T ss_pred cCccccccccccccccc-cc-ccccccccccccccccccc-ccc-cccccccccccccccccccc--ccccccccccccc
Confidence 46799999999999994 55 5889999999999999997 444 68899999999999999983 3457889999999
Q ss_pred eccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccC
Q 007668 150 DISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFG 200 (594)
Q Consensus 150 ~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~ 200 (594)
++++|+++++ + .+.++++|+.|+|++|+|+.+ +....+++|+.|++++
T Consensus 162 ~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 162 SLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFS 209 (210)
T ss_dssp ECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEE
T ss_pred cccccccccc-c-cccCCCCCCEEECCCCCCCCC-hhhcCCCCCCEEEccC
Confidence 9999999974 3 388999999999999999865 4567899999999864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.36 E-value=3.7e-13 Score=136.39 Aligned_cols=126 Identities=29% Similarity=0.287 Sum_probs=80.7
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCC---------------
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI--------------- 136 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--------------- 136 (594)
.+++.|++++|.++. + +.+..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..
T Consensus 219 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccc
Confidence 456667777776663 2 245566666666666666664332 555666666666666555321
Q ss_pred -----ChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 137 -----PSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 137 -----p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
...+..+++|+.|++++|+|+++. .+..+++|+.|+|++|+|+++ +....+++|+.|++++|+..
T Consensus 295 n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 295 NQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-SSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp SCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCC
T ss_pred cccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-hhHcCCCCCCEEECCCCcCC
Confidence 123556677788888888887643 367778888888888877754 34566777888888777643
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.35 E-value=2.1e-13 Score=134.45 Aligned_cols=110 Identities=32% Similarity=0.436 Sum_probs=101.7
Q ss_pred cccCCeeecccCccCC--CCCCCcCCCCccceeeccc-ccccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCc
Q 007668 95 LDQLKFLNLHSNNFYG--EIPSELGNCTELQGLSLQS-NYLSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171 (594)
Q Consensus 95 l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 171 (594)
-.+++.|+|++|.++| .+|..+++|++|++|+|++ |+++|.+|..|++|++|++|+|++|+|.+..+..+..+.+|+
T Consensus 49 ~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 49 TYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred cEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 3479999999999998 4889999999999999997 899999999999999999999999999998899999999999
Q ss_pred EEEeecccccccCCCC-cccccCCcccccCCCCC
Q 007668 172 TFNVSNNFLVGAIPSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 172 ~l~l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~ 204 (594)
.+++++|.+.+.+|.. ..+++++.+++++|...
T Consensus 129 ~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~ 162 (313)
T d1ogqa_ 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred ccccccccccccCchhhccCcccceeeccccccc
Confidence 9999999999888754 88999999999999754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.26 E-value=7.3e-12 Score=117.03 Aligned_cols=126 Identities=23% Similarity=0.352 Sum_probs=92.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCC-------------
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIP------------- 137 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------------- 137 (594)
.++|+.|+|++|.|++..| +.++++|++|++++|.++ .++ .+.++++|+.|++++|.+.+..+
T Consensus 62 l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 5788888888888885443 788888888888888887 444 57778888888888777663211
Q ss_pred -------hhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCC
Q 007668 138 -------SELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 138 -------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~ 203 (594)
..+..+++|+.|++++|.+++. ..+.++++|+.|+|++|++++. +....+++|+.|++++|+.
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~l 207 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQI 207 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCC
T ss_pred hhhhchhhhhccccccccccccccccccc--hhhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcC
Confidence 1245567788888888887753 3377888888888888888764 3356778888888888863
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.22 E-value=1e-11 Score=125.56 Aligned_cols=123 Identities=25% Similarity=0.331 Sum_probs=70.2
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCC--------------------CCcCCCCccceeeccccc
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIP--------------------SELGNCTELQGLSLQSNY 131 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--------------------~~~~~l~~L~~L~Ls~N~ 131 (594)
++++.|++++|.+++..+ +..+++|++|++++|++++..+ ..+..+++|+.|+|++|+
T Consensus 241 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~ 318 (384)
T d2omza2 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred cccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCC
Confidence 456666666666664332 5556666666666666553211 123444566666666666
Q ss_pred ccCCCChhhhCCCCCceEeccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCC
Q 007668 132 LSGSIPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGN 201 (594)
Q Consensus 132 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N 201 (594)
+++. + .+..+++|++|+|++|+|++ ++ .+.++++|++|+|++|+|++.+| ...+++|+.|++++|
T Consensus 319 l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 319 ISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 6633 2 25566666666666666664 32 46666666666666666665544 445666666666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=5e-11 Score=111.18 Aligned_cols=125 Identities=25% Similarity=0.342 Sum_probs=98.5
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
..+|+.|++.+|+|+ .++ .+.++++|++|+|++|++++..| +..+++|+.|++++|.++ .++ .+..+++|+.|+
T Consensus 40 l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~ 113 (227)
T d1h6ua2 40 LDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLD 113 (227)
T ss_dssp HHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEE
T ss_pred cCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccc
Confidence 368999999999999 454 68999999999999999995544 899999999999999998 555 488999999999
Q ss_pred ccCCcCCCCCC--------------------ccccccCCCcEEEeecccccccCCCCcccccCCcccccCCC
Q 007668 151 ISSNSLSDYIP--------------------PSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 151 l~~N~l~~~~~--------------------~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~ 202 (594)
+++|.+.+..+ ..+..+++|+.|++++|.++...+ ...+++|+.|++++|+
T Consensus 114 l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~ 184 (227)
T d1h6ua2 114 LTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNK 184 (227)
T ss_dssp CTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred cccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchh-hcccccceecccCCCc
Confidence 99998775422 124455667777777777764433 4567777777777775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=2.1e-11 Score=114.94 Aligned_cols=85 Identities=22% Similarity=0.281 Sum_probs=39.1
Q ss_pred cEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCC-CCCcCCCCccceeeccc-ccccCCCChhhhCCCCCceEe
Q 007668 73 RVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEI-PSELGNCTELQGLSLQS-NYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 73 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 150 (594)
++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++.. |.+....+..|.++++|+.|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 4445555555554333334445555555555555444322 22344455555554432 344434444444555555555
Q ss_pred ccCCcCC
Q 007668 151 ISSNSLS 157 (594)
Q Consensus 151 l~~N~l~ 157 (594)
+++|.++
T Consensus 110 l~~~~l~ 116 (242)
T d1xwdc1 110 ISNTGIK 116 (242)
T ss_dssp EESCCCC
T ss_pred cchhhhc
Confidence 5555544
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.03 E-value=2.4e-10 Score=107.41 Aligned_cols=107 Identities=18% Similarity=0.183 Sum_probs=89.6
Q ss_pred EEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCC-ChhhhCCCCCceEecc-C
Q 007668 76 TLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSI-PSELGNLSNLLNLDIS-S 153 (594)
Q Consensus 76 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~-~ 153 (594)
.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|..++++++|++. .
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 4566677888 7776653 58999999999999555567999999999999999998655 4568899999999986 4
Q ss_pred CcCCCCCCccccccCCCcEEEeecccccccCC
Q 007668 154 NSLSDYIPPSLGKLQRLITFNVSNNFLVGAIP 185 (594)
Q Consensus 154 N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~ 185 (594)
|.+....+..|.++++|+.|++++|.++...+
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~ 120 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCCSCCC
T ss_pred ccccccccccccccccccccccchhhhccccc
Confidence 78888788889999999999999999986544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.94 E-value=1.3e-09 Score=107.93 Aligned_cols=102 Identities=25% Similarity=0.270 Sum_probs=82.4
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEec
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDI 151 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 151 (594)
.++++|+|++|+|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++... +.|++|+|
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---cccccccc
Confidence 35789999999999 67753 578999999999999 788654 57899999999998 555421 46999999
Q ss_pred cCCcCCCCCCccccccCCCcEEEeecccccccCCCC
Q 007668 152 SSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSD 187 (594)
Q Consensus 152 ~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~ 187 (594)
++|.|+. +|. +..+++|+.|++++|.++..+...
T Consensus 106 ~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~~~ 139 (353)
T d1jl5a_ 106 SNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPDLP 139 (353)
T ss_dssp CSSCCSS-CCC-CTTCTTCCEEECCSSCCSCCCCCC
T ss_pred ccccccc-ccc-hhhhccceeecccccccccccccc
Confidence 9999996 564 678999999999999998766543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=7.2e-11 Score=103.63 Aligned_cols=90 Identities=23% Similarity=0.111 Sum_probs=44.1
Q ss_pred CcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCC--CChhhhCCCCCceEeccCCcCCCCCCccccccCCCc
Q 007668 94 KLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGS--IPSELGNLSNLLNLDISSNSLSDYIPPSLGKLQRLI 171 (594)
Q Consensus 94 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 171 (594)
.+..+..|++.+|... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+.+.+-.+....+|+
T Consensus 40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~ 118 (162)
T d1koha1 40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118 (162)
T ss_dssp TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccc
Confidence 3344444444444333 3333334455666666666666532 123345556666666666666553222233334556
Q ss_pred EEEeecccccccC
Q 007668 172 TFNVSNNFLVGAI 184 (594)
Q Consensus 172 ~l~l~~N~l~~~~ 184 (594)
.|++++|+++...
T Consensus 119 ~L~L~~Npl~~~~ 131 (162)
T d1koha1 119 ELWLDGNSLSDTF 131 (162)
T ss_dssp SCCCTTSTTSSSS
T ss_pred eeecCCCCcCcCc
Confidence 6666666665443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.68 E-value=3.8e-08 Score=97.14 Aligned_cols=119 Identities=24% Similarity=0.229 Sum_probs=87.1
Q ss_pred CCcEEEEEcccCCCCCCCCccccCcccCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEe
Q 007668 71 NKRVITLSLTNHKLSGPISADLGKLDQLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLD 150 (594)
Q Consensus 71 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 150 (594)
.++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++. + .+.|++|+|++|.++ .+|. +..+++|+.|+
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeec
Confidence 468999999999999 77765 458999999999998 5553 2 146999999999999 6775 68899999999
Q ss_pred ccCCcCCCCCCccccccCCCcEEEeecccccccCCCCcccccCCcccccCCCCC
Q 007668 151 ISSNSLSDYIPPSLGKLQRLITFNVSNNFLVGAIPSDGVLTKFSESSFFGNRGL 204 (594)
Q Consensus 151 l~~N~l~~~~~~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~l~~N~~~ 204 (594)
+++|.++. .+.. ...+..+.+..+.... ......++.++.+.+.+|...
T Consensus 127 l~~~~~~~-~~~~---~~~l~~l~~~~~~~~~-~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 127 VDNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCS
T ss_pred cccccccc-cccc---cccccchhhccccccc-cccccccccceeccccccccc
Confidence 99999986 3332 3455566666555542 223345666666666666543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66 E-value=1.3e-09 Score=105.04 Aligned_cols=34 Identities=38% Similarity=0.472 Sum_probs=17.2
Q ss_pred CcEEEEEcccCCCCCCCCccccCcccCCeeeccc
Q 007668 72 KRVITLSLTNHKLSGPISADLGKLDQLKFLNLHS 105 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 105 (594)
++|++|+|+++.++...+..++++++|++|+|++
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 3455555555555444444444555555555555
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.57 E-value=3.2e-09 Score=92.80 Aligned_cols=104 Identities=23% Similarity=0.118 Sum_probs=79.9
Q ss_pred cCCeeecccCccCCCCCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccCCcCCCCC--CccccccCCCcEEE
Q 007668 97 QLKFLNLHSNNFYGEIPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISSNSLSDYI--PPSLGKLQRLITFN 174 (594)
Q Consensus 97 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~l~ 174 (594)
..+.|+++++... + .+..+..+..|++.+|.+. .++..+..+++|++|+|++|+|+.+. +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4566777765532 2 4666777788888888776 66777788999999999999999743 35578899999999
Q ss_pred eecccccccCCCC-cccccCCcccccCCCCCC
Q 007668 175 VSNNFLVGAIPSD-GVLTKFSESSFFGNRGLC 205 (594)
Q Consensus 175 l~~N~l~~~~~~~-~~l~~l~~l~l~~N~~~c 205 (594)
|++|.|+...+.. ....+|+.+++.|||..+
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCc
Confidence 9999999765522 334578999999999654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=3e-09 Score=109.22 Aligned_cols=111 Identities=23% Similarity=0.283 Sum_probs=86.1
Q ss_pred CcEEEEEcccCCCCCC-CCccccCcccCCeeecccCccCC----CCCCCcCCCCccceeecccccccCC----CChhhh-
Q 007668 72 KRVITLSLTNHKLSGP-ISADLGKLDQLKFLNLHSNNFYG----EIPSELGNCTELQGLSLQSNYLSGS----IPSELG- 141 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~- 141 (594)
.+|++|||++|+|++. +...+..+++|++|+|++|.|+. .+...+..+++|++|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 4799999999999942 24456788999999999999872 3345577899999999999998732 222222
Q ss_pred CCCCCceEeccCCcCCCC----CCccccccCCCcEEEeecccccc
Q 007668 142 NLSNLLNLDISSNSLSDY----IPPSLGKLQRLITFNVSNNFLVG 182 (594)
Q Consensus 142 ~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~l~l~~N~l~~ 182 (594)
..++|++|+|++|+|++. ++..+..+++|++|+|++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 235799999999999753 34567788999999999999864
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=3.9e-07 Score=85.95 Aligned_cols=149 Identities=18% Similarity=0.123 Sum_probs=102.7
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCce
Q 007668 300 KDIIKKLETLDDDHIIGSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSK 378 (594)
Q Consensus 300 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 378 (594)
.++.+..+.|+..+..+.++.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 56667777777666555555678999865 45667888876544444445778888887764 33356677777778888
Q ss_pred EEEEEccCCCchhhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 007668 379 LLIYDFLPGGSLDEALHERSEQLDWDARLNIIMGAAKGLAYLHHDC---------------------------------- 424 (594)
Q Consensus 379 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------- 424 (594)
++||+++++.++.+..... .. ...++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 9999999998886654321 11 2334555666666666320
Q ss_pred ----------------------CCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 425 ----------------------SPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 425 ----------------------~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
...++|+|+.+.||++++++...|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1247899999999999987667799998775
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.46 E-value=3.6e-09 Score=104.91 Aligned_cols=133 Identities=18% Similarity=0.155 Sum_probs=89.4
Q ss_pred CcEEEEEcccCCCCCC----CCccccCcccCCeeecccCccCCC-----CCCCcCCCCccceeecccccccCC----CCh
Q 007668 72 KRVITLSLTNHKLSGP----ISADLGKLDQLKFLNLHSNNFYGE-----IPSELGNCTELQGLSLQSNYLSGS----IPS 138 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 138 (594)
..++.|++++|.++.. +...+...++|+.|+|++|+|... +...+..+++|+.|+|++|.++.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 4566677777666521 223345567899999999988631 344577788899999999988632 345
Q ss_pred hhhCCCCCceEeccCCcCCCCCCc----ccc--ccCCCcEEEeecccccccC-----CCC-cccccCCcccccCCCCC
Q 007668 139 ELGNLSNLLNLDISSNSLSDYIPP----SLG--KLQRLITFNVSNNFLVGAI-----PSD-GVLTKFSESSFFGNRGL 204 (594)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~~~~----~~~--~l~~L~~l~l~~N~l~~~~-----~~~-~~l~~l~~l~l~~N~~~ 204 (594)
.+..+++|++|+|++|.|++.-.. .+. ..+.|+.|++++|+|+..- ... ..+++|+.|++++|++.
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 567888899999999988753222 222 2357889999999886421 111 24667888999888764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.27 E-value=2.1e-08 Score=99.22 Aligned_cols=131 Identities=15% Similarity=0.160 Sum_probs=70.2
Q ss_pred CcEEEEEcccCCCCCC----CCccccCcccCCeeecccCccCCCCCC-------------CcCCCCccceeecccccccC
Q 007668 72 KRVITLSLTNHKLSGP----ISADLGKLDQLKFLNLHSNNFYGEIPS-------------ELGNCTELQGLSLQSNYLSG 134 (594)
Q Consensus 72 ~~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~-------------~~~~l~~L~~L~Ls~N~l~~ 134 (594)
++|+.|+|++|.++.. +...+...++|+.|+|++|.+...-.. .....+.|+.|++++|.++.
T Consensus 93 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~ 172 (344)
T d2ca6a1 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 172 (344)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccc
Confidence 4566667776666532 222334456666777766665311000 01234556666666666552
Q ss_pred C----CChhhhCCCCCceEeccCCcCCCC-----CCccccccCCCcEEEeeccccccc-----CCCCcccccCCcccccC
Q 007668 135 S----IPSELGNLSNLLNLDISSNSLSDY-----IPPSLGKLQRLITFNVSNNFLVGA-----IPSDGVLTKFSESSFFG 200 (594)
Q Consensus 135 ~----~p~~~~~l~~L~~L~l~~N~l~~~-----~~~~~~~l~~L~~l~l~~N~l~~~-----~~~~~~l~~l~~l~l~~ 200 (594)
. +...+...++|+.|+|++|+|+.. +...+..+++|+.|+|++|.++.. .......++|+.|++++
T Consensus 173 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 173 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 252 (344)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred cccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhc
Confidence 2 222344556677777777766531 223455666777777777766432 11224456666777766
Q ss_pred CC
Q 007668 201 NR 202 (594)
Q Consensus 201 N~ 202 (594)
|+
T Consensus 253 n~ 254 (344)
T d2ca6a1 253 CL 254 (344)
T ss_dssp CC
T ss_pred Cc
Confidence 64
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=3.3e-08 Score=101.28 Aligned_cols=108 Identities=20% Similarity=0.185 Sum_probs=81.8
Q ss_pred ccCCeeecccCccCCCC-CCCcCCCCccceeecccccccC----CCChhhhCCCCCceEeccCCcCCCC----CCcccc-
Q 007668 96 DQLKFLNLHSNNFYGEI-PSELGNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISSNSLSDY----IPPSLG- 165 (594)
Q Consensus 96 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~~~~~~- 165 (594)
++|+.|||++|++++.. ..-+..+++|+.|+|++|.|+. .++..+..+++|++|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 47899999999998421 3346678999999999999883 3455678899999999999998631 112222
Q ss_pred ccCCCcEEEeecccccccC-----CCCcccccCCcccccCCCC
Q 007668 166 KLQRLITFNVSNNFLVGAI-----PSDGVLTKFSESSFFGNRG 203 (594)
Q Consensus 166 ~l~~L~~l~l~~N~l~~~~-----~~~~~l~~l~~l~l~~N~~ 203 (594)
...+|+.|+|++|+++... .....+++|+.|++++|+.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i 124 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL 124 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccc
Confidence 2357999999999997542 1235678999999999974
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.09 E-value=1.2e-07 Score=90.88 Aligned_cols=58 Identities=29% Similarity=0.419 Sum_probs=26.6
Q ss_pred ccCCeeecccCccCCC-CCCCcCCCCccceeecccccccCCCChhhhCCCCCceEeccC
Q 007668 96 DQLKFLNLHSNNFYGE-IPSELGNCTELQGLSLQSNYLSGSIPSELGNLSNLLNLDISS 153 (594)
Q Consensus 96 ~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 153 (594)
.+|++|||++|.++.. ++..+..+++|++|+|++|.+++..+..+..+++|++|+|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 3455555554444321 222344445555555555544444444444445555555544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=8.9e-06 Score=75.82 Aligned_cols=130 Identities=16% Similarity=0.092 Sum_probs=85.2
Q ss_pred eeeeecc-eEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCC--CCeeeeeeeEEeCCCceEEEEEccCCCch
Q 007668 314 IIGSGGF-GTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIK--HRYLVNLRGYCNSPTSKLLIYDFLPGGSL 390 (594)
Q Consensus 314 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~gsL 390 (594)
.+..|.. +.||+....++..+++|.-..... ..+..|+..++.+. .-.+.+++++..++...++||+|+++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3445554 679999988888889997654322 24677888777663 23356678888888888999999988766
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHhhh------------------------------------------------
Q 007668 391 DEALHERSEQLDWDARLNIIMGAAKGLAYLHH------------------------------------------------ 422 (594)
Q Consensus 391 ~~~l~~~~~~l~~~~~~~i~~~ia~~L~~LH~------------------------------------------------ 422 (594)
.+.. ... ...+.++++.|.-||.
T Consensus 94 ~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 4421 010 1112223333333331
Q ss_pred ---c----CCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 423 ---D----CSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 423 ---~----~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
. ....++|+|+.+.||+++++..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12348999999999999987667899998765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.91 E-value=6.6e-07 Score=78.07 Aligned_cols=108 Identities=10% Similarity=0.158 Sum_probs=63.6
Q ss_pred CcEEEEEcccC-CCCCC----CCccccCcccCCeeecccCccCCC----CCCCcCCCCccceeecccccccCC----CCh
Q 007668 72 KRVITLSLTNH-KLSGP----ISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGS----IPS 138 (594)
Q Consensus 72 ~~l~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 138 (594)
++|++|+|+++ .++.. +-..+...++|++|+|++|.+... +...+...+.|++|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 56788888763 45421 223455566788888888777521 222344556777777777777632 222
Q ss_pred hhhCCCCCceEeccCCcCCCC-------CCccccccCCCcEEEeeccc
Q 007668 139 ELGNLSNLLNLDISSNSLSDY-------IPPSLGKLQRLITFNVSNNF 179 (594)
Q Consensus 139 ~~~~l~~L~~L~l~~N~l~~~-------~~~~~~~l~~L~~l~l~~N~ 179 (594)
.+...++|++|+|++|.+..+ +...+...+.|+.|+++.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 345556777777777766542 12233445667777766554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.44 E-value=0.00027 Score=70.04 Aligned_cols=77 Identities=12% Similarity=0.043 Sum_probs=47.7
Q ss_pred cceeeeecceEEEEEEecC-CcEEEEEeeccc----c---hhhHHHHHHHHHHHhhCC-C--CeeeeeeeEEeCCCceEE
Q 007668 312 DHIIGSGGFGTVYKLAMDD-GNVFALKRIDKL----N---EGFDRFFERELEILGSIK-H--RYLVNLRGYCNSPTSKLL 380 (594)
Q Consensus 312 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~l 380 (594)
.+.||.|....||++...+ ++.++||.-... . .........|.+.+..+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998765 578899865321 1 111233556888777662 2 334455544 4456689
Q ss_pred EEEccCCCch
Q 007668 381 IYDFLPGGSL 390 (594)
Q Consensus 381 v~e~~~~gsL 390 (594)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.40 E-value=1.6e-05 Score=68.98 Aligned_cols=90 Identities=19% Similarity=0.172 Sum_probs=64.0
Q ss_pred cCcccCCeeecccC-ccCCC----CCCCcCCCCccceeecccccccC----CCChhhhCCCCCceEeccCCcCCCC----
Q 007668 93 GKLDQLKFLNLHSN-NFYGE----IPSELGNCTELQGLSLQSNYLSG----SIPSELGNLSNLLNLDISSNSLSDY---- 159 (594)
Q Consensus 93 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~---- 159 (594)
.+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.+.. .+...+...+.|++|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34588999999874 45421 22346677889999999998873 2334456678899999999998742
Q ss_pred CCccccccCCCcEEEeecccccc
Q 007668 160 IPPSLGKLQRLITFNVSNNFLVG 182 (594)
Q Consensus 160 ~~~~~~~l~~L~~l~l~~N~l~~ 182 (594)
+-..+...+.|+.|+|++|.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~ 114 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSV 114 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCC
Confidence 12345566789999999887653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.28 E-value=6.1e-06 Score=71.62 Aligned_cols=109 Identities=22% Similarity=0.291 Sum_probs=58.8
Q ss_pred CcEEEEEccc-CCCCCC----CCccccCcccCCeeecccCccCCC----CCCCcCCCCccceeecccccccCC----CCh
Q 007668 72 KRVITLSLTN-HKLSGP----ISADLGKLDQLKFLNLHSNNFYGE----IPSELGNCTELQGLSLQSNYLSGS----IPS 138 (594)
Q Consensus 72 ~~l~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 138 (594)
++|++|+|++ +.|+.. +-..+...++|++|+|++|.++.. +-..+...+.|+.|++++|.++.. +..
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5677777776 445411 223444566777777777766532 122344556677777777766522 223
Q ss_pred hhhCCCCCceEec--cCCcCCC----CCCccccccCCCcEEEeecccc
Q 007668 139 ELGNLSNLLNLDI--SSNSLSD----YIPPSLGKLQRLITFNVSNNFL 180 (594)
Q Consensus 139 ~~~~l~~L~~L~l--~~N~l~~----~~~~~~~~l~~L~~l~l~~N~l 180 (594)
.+...++|+.++| ++|.+.. .+...+...++|+.|+++.|..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 4455566665444 4455542 1223344566666666655543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.86 E-value=0.00085 Score=64.42 Aligned_cols=134 Identities=14% Similarity=0.131 Sum_probs=76.1
Q ss_pred ceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCCCee--eeeee-----EEeCCCceEEEEEccCCCchhh
Q 007668 320 FGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKHRYL--VNLRG-----YCNSPTSKLLIYDFLPGGSLDE 392 (594)
Q Consensus 320 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g-----~~~~~~~~~lv~e~~~~gsL~~ 392 (594)
.-.||++...+|+.+++|..+... ...+++..|.+.+..|....+ +..+. ........+.+++|++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 458999999999999999765432 235667888888877742211 11111 1233455678899987643321
Q ss_pred ----h----------hhh--------cCCCCCHH----------------------HHHHHHHHHHHHHHHh-hhcCCCC
Q 007668 393 ----A----------LHE--------RSEQLDWD----------------------ARLNIIMGAAKGLAYL-HHDCSPR 427 (594)
Q Consensus 393 ----~----------l~~--------~~~~l~~~----------------------~~~~i~~~ia~~L~~L-H~~~~~~ 427 (594)
. +|. .....++. .....+..+...+.-. .+....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 110 00111211 1122222232222222 1222457
Q ss_pred eeeCCCCCCCeEecCCCcEEEeecccccc
Q 007668 428 IIHRDIKSSNILLDGNLEARVSDFGLAKL 456 (594)
Q Consensus 428 ivH~Dlk~~NIll~~~~~~~l~Dfgl~~~ 456 (594)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999754 45899997753
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.72 E-value=3.9e-05 Score=66.30 Aligned_cols=111 Identities=16% Similarity=0.118 Sum_probs=76.7
Q ss_pred ccCcccCCeeeccc-CccCCC----CCCCcCCCCccceeecccccccCC----CChhhhCCCCCceEeccCCcCCCC---
Q 007668 92 LGKLDQLKFLNLHS-NNFYGE----IPSELGNCTELQGLSLQSNYLSGS----IPSELGNLSNLLNLDISSNSLSDY--- 159 (594)
Q Consensus 92 ~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~--- 159 (594)
..+.++|++|+|++ |.++.. +-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.+...
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34568999999998 556521 233456789999999999998743 223456778999999999998642
Q ss_pred -CCccccccCCCcEEEe--ecccccccC-----CCCcccccCCcccccCCC
Q 007668 160 -IPPSLGKLQRLITFNV--SNNFLVGAI-----PSDGVLTKFSESSFFGNR 202 (594)
Q Consensus 160 -~~~~~~~l~~L~~l~l--~~N~l~~~~-----~~~~~l~~l~~l~l~~N~ 202 (594)
+-..+...++|+.++| ++|.+.... ......++|+.|++..|.
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 2245677889987666 567774321 112456678888876654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.50 E-value=0.014 Score=55.05 Aligned_cols=156 Identities=17% Similarity=0.151 Sum_probs=84.0
Q ss_pred CCHHHHHHHhcCCCcccee-----eeecceEEEEEEecCCcEEEEEeecccchhhHHHHHHHHHHHhhCCC-----Ceee
Q 007668 297 YSSKDIIKKLETLDDDHII-----GSGGFGTVYKLAMDDGNVFALKRIDKLNEGFDRFFERELEILGSIKH-----RYLV 366 (594)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv 366 (594)
.+.+++.....+|..+++. ..|.--+.|+....+|+ +++|+...... .+++..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 4667888888888776554 35666888999887665 78888754321 2345556666666632 2222
Q ss_pred eeee---EEeCCCceEEEEEccCCCchhhh--------------hhhc--------CCCCC------------------H
Q 007668 367 NLRG---YCNSPTSKLLIYDFLPGGSLDEA--------------LHER--------SEQLD------------------W 403 (594)
Q Consensus 367 ~l~g---~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~--------~~~l~------------------~ 403 (594)
...+ +.........++.++.+...... ++.. ..... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 2110 11223344566666655432211 0000 00000 0
Q ss_pred HHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 007668 404 DARLNIIMGAAKGLAYLHH-DCSPRIIHRDIKSSNILLDGNLEARVSDFGLAK 455 (594)
Q Consensus 404 ~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~~l~Dfgl~~ 455 (594)
......+..+...+...+. ....++||+|+.+.||+++++...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222222232333222 234589999999999999988777899999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.34 E-value=0.0051 Score=60.48 Aligned_cols=73 Identities=15% Similarity=0.169 Sum_probs=48.0
Q ss_pred ceeeeecceEEEEEEecCC--------cEEEEEeecccchhhHHHHHHHHHHHhhCC-CCeeeeeeeEEeCCCceEEEEE
Q 007668 313 HIIGSGGFGTVYKLAMDDG--------NVFALKRIDKLNEGFDRFFERELEILGSIK-HRYLVNLRGYCNSPTSKLLIYD 383 (594)
Q Consensus 313 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 383 (594)
+.|+.|-.-.+|++...++ ..|.++..-. ... .....+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5688899999999887643 4556555442 222 234567888888774 3333467777643 68999
Q ss_pred ccCCCchh
Q 007668 384 FLPGGSLD 391 (594)
Q Consensus 384 ~~~~gsL~ 391 (594)
|+++..+.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99875543
|